Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABCC5	"EST277145, MOAT-C, MRP5, SMRP"	ENSG00000114770	"ATP binding cassette subfamily C member 5"	O15440	3	183919934-184017939	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 167.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 196.0;Inhibitory neurons: 122.8;Rod photoreceptor cells: 121.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 136.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044067, HPA052295"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA044067: AB_2678797, HPA052295: AB_2681789"	"unprognostic (9.39e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (4.46e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.91e-3)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (1.10e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.24e-2)"	15.4	23.2	42.5	16.3	44.2	22.4	13.1	48.4	50.0	30.9	167.1	24.4	10.8	21.6	10.4	44.5	16.1	17.9	47.2	45.5	43.6	41.6	7.9	15.6	13.1	44.0	39.5	23.4	13.0	24.0	41.7	17.2	44.7	27.8	22.1	126.2	18.4	13.7	117.5	24.1	23.2	16.1	34.0	37.1	82.3	16.5	46.3	15.3	13.8	40.3	11.8	34.8	35.2	43.2	21.5	11.5	25.9	30.8	25.7	28.3	40.0	16.8	13.3	14.8	16.2	17.9	15.8	22.5	38.6	16.2	22.6	83.3	32.1	18.6	19.3	24.4	31.1	48.1	32.5	18.0	10.3	14.8	36.5	45.6	18.3	15.9	10.6	30.3	17.8	65.6	45.6	30.8	25.7	56.7	40.7	17.1	26.7	38.4	21.7	28.1	8.7	13.4	54.4	136.4	46.6	27.8	17.1	93.5	29.3	33.3	56.6	4.9	20.4	17.4	16.6	22.3	23.8	11.7	24.3	21.1	12.5	29.2	17.9	11.7	4.6	8.3	6.9	2.2	4.4	3.1	3.8	3.1	3.6	4.5	4.3	6.0	16.4	5.6	4.2	1.3	5.7	4.5	42.5	44.2	48.4	50.0	45.5	43.6	44.0	39.5	44.7	34.0	46.3	43.2	8.3	9.6	5.3	39.2	6.4	8.9	14.4	18.3	35.3	39.1	10.5	11.3	37.2	2.8	37.2	44.1	196.0	3.2	7.7	23.3	7.9	5.7	6.0	10.4	18.0	9.5	59.3	21.2	101.3	4.5	5.0	12.5	91.3	20.8	5.1	31.0	6.8	3.3	49.7	33.7	122.8	6.4	20.3	32.7	6.5	3.5	8.1	29.3	12.4	32.8	8.3	13.8	9.2	82.4	62.7	7.9	20.2	7.9	7.5	9.3	5.1	4.8	44.9	121.1	0.0	27.4	15.4	6.8	18.8	41.3	12.1	4.5	8.6	14.9	7.5	61.5
ABHD10	FLJ11342	ENSG00000144827	"Abhydrolase domain containing 10, depalmitoylase"	Q9NUJ1	3	111979010-111993368	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036991, HPA036992, HPA066081"	Supported		Approved	Mitochondria	"Intracellular and membrane"	No	No		71000	"Cluster 46: Basophils - DNA binding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA036991: AB_2675420, HPA036992: AB_10672345, HPA066081: AB_2685610"	"unprognostic (1.65e-1)"	"prognostic favorable (7.57e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.91e-2)"	"prognostic favorable (4.72e-9)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.18e-3)"	"unprognostic (2.76e-2)"	11.0	21.9	23.0	10.6	25.3	10.9	15.0	24.5	29.3	11.3	22.9	14.1	11.7	11.1	50.8	8.2	14.9	10.1	25.0	23.9	24.6	49.4	34.4	10.1	17.9	23.5	23.2	19.8	13.7	16.7	27.9	10.8	23.7	20.4	14.7	27.0	25.5	13.7	14.1	10.0	10.3	10.0	24.4	14.6	14.9	16.4	26.3	21.8	31.1	19.6	16.2	9.5	8.3	25.3	40.2	34.1	36.4	12.0	20.5	27.5	19.8	41.4	21.5	33.0	31.7	35.3	22.4	36.0	22.6	17.2	22.7	21.6	16.3	23.0	44.9	12.1	20.6	29.7	15.4	30.7	16.3	60.3	30.4	16.9	16.7	17.0	42.4	22.7	35.9	42.1	13.9	14.9	36.7	13.7	56.9	27.9	23.7	43.8	53.2	50.9	23.4	16.7	34.6	17.1	24.6	17.9	33.2	23.7	39.8	14.3	26.8	21.8	20.6	19.7	25.3	14.4	21.7	23.6	9.0	61.4	20.1	32.4	21.5	29.4	16.5	25.2	9.8	21.6	16.8	26.2	12.2	11.3	28.1	21.6	15.4	13.9	2.5	11.4	17.3	17.8	13.2	16.1	23.0	25.3	24.5	29.3	23.9	24.6	23.5	23.2	23.7	24.4	26.3	25.3	9.1	0.0	7.2	11.1	19.7	7.0	10.2	12.1	14.2	21.8	12.7	10.9	26.1	7.2	12.4	11.0	8.4	19.2	16.1	7.0	35.2	5.2	1.0	11.1	10.3	8.8	12.1	24.2	16.0	7.8	14.9	12.3	12.8	6.8	9.5	9.5	10.0	26.2	14.1	42.1	16.2	13.4	6.1	19.5	7.0	3.0	10.5	11.0	10.6	15.0	10.7	20.4	12.3	14.6	15.6	5.4	4.0	7.5	25.0	5.1	7.0	42.5	19.5	16.2	0.0	7.9	8.9	29.7	37.0	13.6	8.2	5.5	14.6	19.2	12.1	4.5
ACTR8	"ARP8, INO80N"	ENSG00000113812	"Actin related protein 8"	Q9H981	3	53867066-53882152	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 44.3;Late spermatids: 85.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 56.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065236			Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Centrosome	"HPA065236: AB_2685442"	"unprognostic (9.05e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (2.21e-4)"	"unprognostic (2.97e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (5.11e-6)"	"unprognostic (2.24e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.68e-2)"	"prognostic favorable (7.88e-9)"	"unprognostic (3.68e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.15e-1)"	8.4	6.8	7.8	9.8	8.6	9.4	9.3	10.5	9.0	9.2	13.0	9.3	7.4	9.8	9.0	9.2	9.0	8.1	18.5	8.3	9.3	13.0	8.7	9.2	13.9	8.6	9.6	10.3	9.4	14.7	7.2	11.0	8.5	9.0	12.0	7.6	8.8	8.6	9.0	9.2	7.2	11.0	8.8	9.4	9.6	21.5	9.3	13.4	12.1	12.6	14.8	11.5	7.3	9.6	11.9	14.4	27.5	22.9	22.2	27.6	20.6	27.4	34.8	36.3	28.7	22.6	14.1	36.1	7.9	37.9	26.7	9.9	21.0	18.8	34.1	14.7	8.7	35.2	21.9	24.3	26.1	38.6	30.8	21.8	19.1	37.6	23.4	28.0	28.4	18.9	16.4	12.2	37.0	13.8	12.9	23.0	25.7	17.0	22.7	16.8	17.3	21.8	27.5	32.7	8.1	23.5	17.8	15.4	16.1	25.9	9.9	21.1	19.7	27.5	17.8	25.6	25.2	33.9	46.4	36.3	20.4	27.7	17.6	56.2	8.2	10.5	9.2	12.0	9.2	9.8	8.5	8.8	10.7	6.1	8.9	9.6	4.3	15.1	7.4	7.8	15.0	8.0	7.8	8.6	10.5	9.0	8.3	9.3	8.6	9.6	8.5	8.8	9.3	9.6	6.3	3.2	7.7	6.5	9.4	7.8	6.0	12.3	5.7	6.8	5.4	5.1	19.5	10.0	8.6	3.7	4.2	12.7	11.6	5.7	21.5	15.1	44.3	5.9	12.0	8.8	10.8	7.8	7.1	15.6	11.3	7.8	12.2	7.6	5.7	10.9	8.2	5.4	11.5	1.7	8.5	10.6	12.2	7.6	6.9	85.9	10.8	10.0	5.4	4.7	11.9	7.6	13.4	8.0	6.2	15.5	3.5	9.8	13.6	6.3	5.9	24.1	5.0	5.3	0.0	5.5	20.8	27.6	20.3	7.3	6.5	10.3	11.5	13.5	6.3	6.5
ACVR1B	"ActRIB, ACVRLK4, ALK4, SKR2"	ENSG00000135503	"Activin A receptor type 1B"	P36896	12	51951699-51997078	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 3.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026126, HPA063761"	Approved		Approved	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB026126: , HPA063761: AB_2685115"	"unprognostic (8.66e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.60e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.79e-2)"	16.5	10.3	20.7	10.0	20.8	13.5	13.2	13.6	23.4	13.9	9.1	24.6	28.2	8.8	18.0	20.9	15.3	12.2	10.1	21.5	13.3	34.3	29.9	14.7	6.4	12.5	13.9	9.4	40.7	52.7	14.7	11.1	13.1	14.0	24.4	17.4	32.8	15.3	13.1	45.6	26.1	8.1	9.5	8.8	24.9	15.7	16.1	7.6	11.4	8.8	7.4	12.6	18.8	18.3	11.4	24.3	18.6	10.3	20.9	16.2	10.5	12.6	14.2	13.1	9.9	49.5	17.1	5.0	17.2	13.8	14.6	19.6	17.8	15.2	13.5	7.3	21.0	12.3	5.9	15.6	23.8	19.9	43.8	32.0	19.4	14.8	18.6	13.9	18.7	17.7	13.3	14.9	11.8	23.2	19.1	17.2	18.0	24.0	8.5	10.2	14.4	6.4	37.2	17.0	23.5	19.5	13.6	19.2	9.0	13.1	21.1	12.8	12.0	9.0	13.6	10.2	6.1	9.0	6.8	6.7	9.7	9.4	11.8	2.5	1.2	3.9	0.3	1.8	0.5	0.0	0.3	0.3	0.7	0.2	0.8	0.4	1.0	0.0	2.2	0.3	0.5	0.3	20.7	20.8	13.6	23.4	21.5	13.3	12.5	13.9	13.1	9.5	16.1	18.3	8.0	3.2	13.4	8.1	2.9	18.6	10.1	9.2	23.3	45.3	11.3	8.6	5.9	17.2	12.0	25.8	29.2	0.7	2.0	49.7	3.9	17.7	2.9	12.3	8.1	10.9	24.6	0.8	34.8	14.4	0.8	12.6	19.9	9.0	11.4	9.4	17.9	24.4	4.0	37.0	30.2	28.7	2.0	16.7	5.3	8.4	9.9	10.0	7.2	9.4	10.1	8.8	1.0	21.6	11.3	13.3	22.1	9.4	2.3	15.1	31.8	17.0	15.8	24.5	6.6	17.5	12.2	3.8	16.5	17.7	25.3	0.5	4.6	5.6	24.7	15.5
AGAP5	"CTGLF2, Em:AC073389.1"	ENSG00000172650	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 5"	A6NIR3	10	73674287-73697881	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 79.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA042490	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA042490: AB_2678022"	"unprognostic (1.84e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.52e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.04e-3)"	"unprognostic (4.33e-3)"	"unprognostic (5.83e-5)"	"unprognostic (3.33e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.17e-2)"	3.2	5.1	2.7	3.8	3.1	3.2	4.3	4.2	3.7	3.9	4.4	3.5	3.5	3.3	4.2	3.2	3.3	2.6	5.5	2.7	3.2	4.4	6.9	3.6	4.4	3.0	2.8	4.8	9.9	1.9	4.7	2.6	3.2	4.7	3.1	5.3	6.3	2.5	8.7	6.5	4.0	2.2	2.1	5.0	4.3	8.4	3.4	3.1	4.0	2.1	2.8	3.3	3.5	4.6	2.4	2.9	3.8	4.2	3.0	2.3	5.7	2.9	2.1	2.0	1.7	3.9	3.3	2.9	2.4	2.3	0.8	5.9	2.8	2.4	1.3	3.4	3.3	2.3	6.7	4.5	2.5	5.9	3.7	2.4	2.6	2.3	6.2	5.2	1.6	4.2	3.0	5.8	1.8	2.3	2.3	7.7	1.1	2.6	7.9	3.1	1.6	2.2	2.0	2.3	1.7	1.5	1.7	6.2	3.5	2.7	3.5	4.7	2.9	2.5	3.4	2.5	3.8	6.9	3.7	1.7	2.6	6.7	1.1	0.6	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	2.7	3.1	4.2	3.7	2.7	3.2	3.0	2.8	3.2	2.1	3.4	4.6	2.1	0.0	9.0	4.2	1.5	1.9	0.3	0.8	0.0	2.4	2.4	1.7	0.0	1.5	3.7	3.7	6.2	1.7	2.1	1.0	0.0	1.6	79.9	2.6	2.3	2.1	0.0	2.7	6.4	2.2	0.7	1.7	4.6	1.5	3.8	2.5	3.9	3.5	1.5	3.3	6.3	2.0	0.0	1.3	2.2	18.9	1.2	1.9	1.8	1.9	2.4	1.7	2.1	4.5	8.4	2.7	0.5	3.8	1.6	1.1	3.2	0.6	6.6	2.7	0.0	0.9	0.9	4.2	2.4	0.9	1.3	0.7	1.8	1.3	2.1	0.7
AL021997.2		ENSG00000276302	"Novel protein"		6	28267121-28281580	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.0;U-266/84: 2.0"															NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"					"unprognostic (6.64e-2)"	"unprognostic (2.11e-1)"		"unprognostic (6.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.45e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.51e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.74e-4)"	"unprognostic (7.03e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.05e-1)"	0.5	0.7	0.3	0.5	0.4	0.2	0.3	0.5	0.9	0.2	0.0	0.2	0.7	0.4	0.4	0.1	0.2	0.1	0.1	0.5	0.6	0.4	0.1	0.2	0.2	0.5	0.2	0.4	0.1	0.4	0.2	0.2	0.3	0.1	0.0	1.0	0.5	0.0	0.4	0.2	0.8	0.0	0.0	0.3	0.5	0.4	0.3	0.0	0.2	0.0	0.2	0.1	0.1	0.9	0.2	0.0	0.1	0.9	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.3	0.0	0.4	0.4	0.1	0.7	2.0	0.0	0.2	0.0	0.2	0.6	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.4	0.3	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.4	0.4	1.3	0.0	0.1	0.5	0.2	0.1	0.0	0.0	0.1	0.1	0.7	0.5	1.3	2.0	0.0	0.1	1.2	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.5	0.9	0.5	0.6	0.5	0.2	0.3	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALDH8A1	ALDH12	ENSG00000118514	"Aldehyde dehydrogenase 8 family member A1"	Q9H2A2	6	134917393-134950115	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	16	"kidney: 72.2;liver: 247.2"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 142.5;Proximal tubular cells: 136.9"	"Group enriched"	"Detected in some"	7	"liver cancer: 26.3;renal cancer: 17.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.9;Hep G2: 2.9;K-562: 3.0;RPTEC TERT1: 3.3;U-266/70: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA026292, HPA055414"	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA		110000	"Cluster 46: Basophils - DNA binding"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Centrosome	Nucleoplasm	"HPA026292: AB_1844741, HPA055414: AB_2682810"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.99e-2)"	"prognostic favorable (9.87e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.86e-5)"	1.3	1.3	6.4	0.7	7.1	2.4	1.2	6.9	9.8	1.5	2.2	3.3	0.8	1.2	2.1	0.8	1.0	0.9	0.7	6.5	3.8	72.2	247.2	0.9	0.6	5.3	4.4	0.5	0.9	0.4	0.8	0.5	6.2	1.7	0.8	2.8	0.8	0.8	3.6	1.7	1.1	0.9	3.1	1.3	1.2	0.5	5.4	0.7	0.6	0.3	0.6	1.9	0.9	8.3	0.1	0.5	0.8	0.5	0.2	0.1	0.6	0.2	0.2	0.0	0.5	0.2	0.3	0.1	0.2	0.0	0.1	0.6	0.6	0.0	0.4	0.6	2.9	2.0	2.1	2.9	0.3	0.8	1.0	0.8	0.9	0.2	0.4	0.6	0.2	0.8	3.0	1.1	0.1	0.0	0.9	1.0	0.2	0.2	0.3	0.0	0.2	0.2	3.3	0.4	0.8	0.2	0.1	0.0	0.5	0.2	0.3	0.2	0.2	0.2	1.6	0.6	0.8	2.8	1.0	0.5	0.3	0.7	0.2	2.5	0.3	0.3	0.4	0.1	0.1	0.4	0.4	0.2	0.0	0.4	0.3	0.3	0.8	0.8	0.1	0.4	0.5	0.3	6.4	7.1	6.9	9.8	6.5	3.8	5.3	4.4	6.2	3.1	5.4	8.3	0.3	3.2	0.6	3.6	0.8	0.0	0.2	0.2	0.0	2.6	0.7	0.9	0.6	1.5	0.7	31.3	0.0	0.2	0.3	0.1	19.6	0.2	0.1	0.4	0.4	0.7	0.0	0.0	14.3	0.0	1.7	0.4	0.0	1.6	0.0	0.5	2.5	142.5	0.1	3.3	12.9	0.1	0.0	2.5	0.3	0.0	0.0	0.8	0.0	1.0	0.7	0.3	0.0	3.0	9.6	0.0	0.1	0.0	0.3	0.1	0.0	136.9	0.0	1.8	0.0	1.2	0.5	0.0	0.0	0.0	0.4	0.0	0.9	0.5	0.2	0.1
ALOX12B	12R-LOX	ENSG00000179477	"Arachidonate 12-lipoxygenase, 12R type"	O75342	17	8072636-8087716	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Isomerase, Lyase, Oxidoreductase"	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 90.2"	"Cell type enhanced"	"Detected in some"		"Horizontal cells: 1.7;Rod photoreceptor cells: 1.2;Spermatogonia: 1.2;Suprabasal keratinocytes: 1.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 11.2"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"basophil: 4.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.3"	"Cell line enhanced"	"Detected in some"		"A549: 1.1;HEK 293: 1.3;hTCEpi: 1.6;JURKAT: 2.7;OE19: 1.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA024002	Supported		Supported	Vesicles,Cytosol		NA	NA		7000	"Cluster 46: Basophils - DNA binding"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol	Vesicles	"HPA024002: AB_1844757"	"unprognostic (1.27e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.18e-2)"		"unprognostic (1.26e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.40e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.66e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.46e-2)"	0.0	0.0	0.4	0.1	0.5	0.1	2.1	0.4	0.6	5.7	0.0	0.1	0.3	0.0	0.0	5.6	0.2	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.5	0.4	0.2	0.0	0.2	1.2	0.1	0.0	0.5	0.4	0.1	0.6	0.8	0.0	0.4	90.2	0.2	0.0	0.1	0.2	0.2	0.2	0.4	0.6	0.0	0.0	19.1	0.0	15.0	0.1	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.4	0.2	0.3	0.0	0.0	0.0	1.3	0.0	0.4	0.1	0.0	0.2	0.0	0.0	1.6	0.1	0.5	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.8	0.0	0.9	0.0	0.4	0.4	0.0	0.4	0.5	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.2	0.0	0.4	0.6	0.1	0.2	0.0	0.1	0.5	0.7	0.0	0.1	0.0	0.1	0.0	0.1	0.4	0.5	0.4	0.6	0.4	0.2	0.4	0.2	0.5	0.1	0.4	0.1	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.5	0.0	0.2	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.3	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.5	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.8	1.2	0.0	1.8	0.0	0.0	0.0	0.1	0.1
AP1S3		ENSG00000152056	"Adaptor related protein complex 1 subunit sigma 3"	Q96PC3	2	223751686-223838027	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 52.8"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Cytotrophoblasts: 48.2;Pancreatic endocrine cells: 44.2;Urothelial cells: 69.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.9;dendritic cells: 4.0;granulocytes: 4.9"	"Cell line enhanced"	"Detected in many"		"CACO-2: 151.1;RPTEC TERT1: 56.8;RT4: 52.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA066782	Approved		Supported	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles		"HPA066782: AB_2685720"	"unprognostic (9.45e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.89e-1)"	"unprognostic (1.65e-3)"	"prognostic unfavorable (3.36e-5)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.08e-5)"	"unprognostic (1.56e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.61e-2)"	0.7	0.8	3.4	3.3	3.2	4.0	2.1	3.9	3.5	2.2	0.5	2.7	5.3	0.9	52.8	4.8	2.3	5.2	0.5	2.8	3.0	5.6	1.4	4.7	4.2	2.0	1.6	0.5	2.4	3.8	1.1	6.6	1.5	2.9	2.6	5.7	1.6	5.4	0.9	1.9	5.0	0.7	1.1	2.8	9.8	0.9	3.2	1.6	14.4	0.3	5.2	8.1	1.2	2.1	28.7	17.7	2.4	12.0	1.5	0.6	13.5	11.5	2.4	4.9	4.2	151.1	21.8	11.0	8.0	1.7	5.8	43.8	6.4	30.3	6.8	15.3	8.9	1.2	33.7	15.7	0.6	3.4	1.3	0.6	31.2	9.1	30.1	11.2	3.4	5.8	1.8	2.9	2.9	12.3	0.6	0.9	3.8	32.8	15.5	4.3	0.1	4.5	56.8	52.1	7.4	2.1	5.4	11.8	3.8	6.1	5.0	6.3	2.0	1.6	4.6	3.1	9.2	10.2	9.0	28.2	4.4	2.0	6.0	4.9	0.5	0.3	0.6	0.4	0.5	4.9	0.4	0.4	1.2	2.7	0.4	0.5	1.8	0.6	0.2	4.0	1.0	0.4	3.4	3.2	3.9	3.5	2.8	3.0	2.0	1.6	1.5	1.1	3.2	2.1	0.4	35.3	6.7	8.8	24.2	4.2	32.6	15.3	4.0	3.3	4.3	1.8	1.7	0.0	15.8	11.0	64.6	48.2	13.6	3.6	9.8	17.5	0.2	8.1	2.1	2.1	2.4	0.0	19.3	18.1	3.4	3.5	11.7	26.1	3.8	0.8	0.7	0.4	4.7	6.7	9.6	3.6	16.2	1.6	38.1	0.0	0.3	7.5	3.6	4.7	7.4	1.9	6.2	10.6	4.0	44.2	4.6	0.0	10.7	26.6	5.4	4.5	10.3	5.9	0.0	1.1	1.8	0.3	1.9	6.3	4.1	13.1	6.9	1.0	4.7	69.6
AP4B1	"BETA-4, SPG47"	ENSG00000134262	"Adaptor related protein complex 4 subunit beta 1"	Q9Y6B7	1	113894194-113905201	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 31.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028162, HPA028652"	Approved		Approved	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA028162: AB_10610976, HPA028652: AB_10601451"	"unprognostic (8.90e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.01e-2)"	"prognostic unfavorable (8.60e-7)"	"unprognostic (3.45e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (3.73e-6)"	"unprognostic (5.08e-3)"	"unprognostic (7.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.55e-2)"	9.7	8.5	12.5	11.1	13.1	20.5	9.3	14.6	14.6	11.9	10.9	11.5	10.6	9.7	14.2	12.1	11.0	7.0	11.2	13.0	13.0	9.7	8.4	9.5	14.3	11.6	11.4	13.7	14.0	4.8	13.7	5.9	11.8	9.6	12.7	20.0	7.6	6.2	11.7	11.5	12.8	9.1	11.5	20.1	10.4	11.1	13.3	16.1	11.0	9.1	13.9	9.2	10.0	13.3	11.0	9.8	10.0	11.8	15.7	14.1	6.4	10.1	9.8	13.0	14.0	6.8	7.7	21.5	15.9	12.4	6.5	9.7	11.3	13.4	16.5	16.6	9.8	17.6	13.6	8.3	9.5	19.6	17.3	16.1	6.7	25.5	15.3	7.8	22.7	20.9	12.3	18.5	17.6	65.2	15.6	21.6	9.4	7.7	19.0	15.0	19.5	13.3	13.2	5.5	10.2	8.5	10.1	19.1	7.8	9.5	5.7	15.4	21.8	15.0	13.9	17.4	20.8	15.2	15.8	21.3	24.6	26.0	25.1	15.9	10.5	8.6	14.7	10.8	15.6	9.5	11.7	12.6	12.9	11.9	12.7	11.1	1.2	12.2	8.5	9.1	10.4	9.5	12.5	13.1	14.6	14.6	13.0	13.0	11.6	11.4	11.8	11.5	13.3	13.3	7.2	3.2	6.7	7.5	12.3	3.6	3.3	5.4	4.6	6.8	3.2	4.3	8.7	5.7	11.9	3.7	31.3	3.8	12.0	7.8	1.9	7.7	3.6	4.6	4.7	7.6	3.0	18.1	11.4	26.8	3.5	7.0	11.2	5.2	2.5	4.5	7.5	4.1	5.2	8.4	11.6	5.3	6.1	7.3	4.9	2.3	2.8	6.9	7.2	7.5	6.1	4.7	3.1	11.6	10.0	10.9	6.9	4.9	7.4	2.8	6.5	3.3	5.2	21.0	13.1	6.1	6.2	16.4	11.5	5.7	3.7	1.6	14.8	6.4	9.0	3.3
AQR	"fSAP164, IBP160, KIAA0560"	ENSG00000021776	"Aquarius intron-binding spliceosomal factor"	O60306	15	34851782-34969742	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 114.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040624, HPA055647"			Enhanced	Nucleoplasm		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA040624: AB_2677050, HPA055647: AB_2682874"	"unprognostic (1.73e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (4.83e-4)"	"unprognostic (2.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.13e-2)"	3.7	3.9	4.5	3.4	5.7	4.0	5.9	7.8	5.2	5.7	3.9	4.2	3.4	4.5	4.1	3.5	4.4	3.1	2.7	4.7	5.0	5.2	4.0	3.6	4.2	4.1	4.7	5.0	4.1	5.2	2.5	4.4	4.5	4.0	4.2	8.0	3.3	3.7	2.8	4.2	3.6	3.8	4.5	4.7	3.8	5.6	4.9	7.0	5.4	3.5	4.7	4.0	3.5	5.8	5.3	13.5	8.7	9.3	11.6	10.7	4.5	6.4	8.1	8.3	7.4	6.1	3.2	4.3	4.0	10.8	5.4	8.2	14.8	9.1	9.1	6.1	6.0	13.8	11.4	5.6	6.6	11.3	6.2	8.4	5.9	6.5	6.9	7.7	7.1	3.3	9.9	4.2	8.3	3.6	6.6	7.5	8.7	12.2	5.5	8.9	15.0	4.3	8.3	9.2	9.5	7.4	10.3	9.7	2.3	7.6	6.9	8.7	9.3	6.1	3.4	4.3	5.7	5.0	6.6	8.5	7.7	9.6	6.3	3.6	2.0	1.2	2.6	2.2	2.3	1.6	2.3	2.6	1.7	2.3	2.3	2.6	1.0	2.1	1.4	2.3	2.0	1.4	4.5	5.7	7.8	5.2	4.7	5.0	4.1	4.7	4.5	4.5	4.9	5.8	27.0	12.8	26.0	45.4	27.9	9.6	13.7	17.0	15.4	28.6	19.9	15.6	14.7	17.2	28.1	14.7	114.7	16.4	31.4	18.2	3.9	13.4	38.2	20.6	26.7	24.1	13.2	21.0	39.8	14.3	14.4	18.6	20.4	22.1	24.1	28.8	31.1	18.5	14.9	25.2	44.0	19.1	12.2	18.6	5.1	8.4	20.8	21.8	16.0	29.0	27.9	14.3	22.6	42.3	42.2	18.5	12.1	18.4	22.9	18.8	17.4	12.9	27.1	41.1	6.6	42.8	16.9	19.4	22.2	22.4	9.7	13.3	27.0	46.5	21.6	13.5
ARIH1	"ARI, HARI, HHARI, UBCH7BP"	ENSG00000166233	"Ariadne RBR E3 ubiquitin protein ligase 1"	Q9Y4X5	15	72474330-72602987	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 47.8;testis: 42.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003295	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA003295: AB_1845017"	"unprognostic (3.31e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.21e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.43e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.96e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.70e-2)"	8.5	7.9	2.5	10.1	3.9	16.5	6.0	7.0	5.8	6.4	7.1	8.2	9.5	7.5	3.2	6.8	5.4	4.4	11.4	4.4	4.0	5.2	6.2	7.3	4.9	3.4	2.7	9.0	6.6	3.9	5.9	6.5	3.6	5.8	3.3	10.4	4.3	4.8	47.8	7.6	7.4	6.3	3.0	6.0	6.3	42.5	3.8	3.9	5.0	8.5	4.1	7.6	6.5	4.3	17.6	18.0	17.5	10.2	8.9	6.2	20.6	19.3	7.0	8.6	5.9	18.3	14.6	17.2	28.4	8.3	30.3	24.8	18.1	10.1	4.8	30.6	12.4	13.0	22.5	12.4	6.3	19.6	14.4	7.4	3.4	9.5	12.2	8.2	6.4	12.4	13.8	19.7	8.5	11.5	18.9	7.5	18.9	6.3	6.5	21.4	21.3	9.8	4.8	29.0	16.3	18.4	25.1	11.2	31.4	23.0	9.0	22.0	16.7	14.1	19.6	54.8	27.4	20.7	45.2	20.6	9.2	17.5	15.2	1.6	0.2	0.7	0.5	0.4	0.4	0.2	0.3	0.3	0.2	0.6	0.4	0.4	1.0	0.6	0.2	0.3	0.8	0.1	2.5	3.9	7.0	5.8	4.4	4.0	3.4	2.7	3.6	3.0	3.8	4.3	79.5	19.2	37.7	88.5	64.0	66.3	52.7	13.3	76.2	63.3	74.9	53.3	46.9	30.0	25.7	18.4	91.8	18.4	83.3	32.9	3.9	18.4	110.3	108.7	84.8	50.7	46.5	24.8	141.6	18.9	21.8	43.3	63.7	148.4	43.2	43.7	40.0	28.5	19.0	62.2	152.0	31.2	8.2	30.5	42.1	55.4	28.6	67.5	16.0	104.0	24.2	25.7	27.8	129.7	135.1	24.7	19.1	27.4	60.9	55.8	20.8	13.9	33.0	58.8	19.7	96.8	59.9	45.3	32.1	68.8	59.8	40.8	68.3	36.8	27.0	63.7
ASB3	ASB-3	ENSG00000115239	"Ankyrin repeat and SOCS box containing 3"	Q9Y575	2	53532672-53860160	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003940	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 6: Brain - Smell perception"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"			"HPA003940: AB_1845067"	"unprognostic (8.32e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.31e-3)"	"unprognostic (4.77e-1)"	"unprognostic (1.64e-4)"	"unprognostic (5.45e-5)"	"unprognostic (6.73e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.82e-1)"	"unprognostic (1.43e-5)"	"unprognostic (3.87e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.82e-1)"	8.4	11.5	28.1	8.3	29.9	15.0	10.3	32.0	32.8	10.4	14.3	7.6	6.7	11.4	14.0	8.4	9.5	7.8	9.6	29.1	23.8	9.0	10.8	10.0	11.0	18.9	25.9	12.2	7.4	10.3	14.5	11.5	18.4	13.0	8.0	23.4	8.8	10.2	7.2	9.6	8.6	8.2	17.5	12.7	7.1	11.5	24.7	17.2	11.6	7.7	12.2	7.9	9.8	27.9	15.4	12.5	26.8	10.6	17.6	14.7	23.0	16.3	11.5	12.2	15.2	10.8	10.9	14.5	26.1	11.6	22.6	9.4	19.6	12.1	18.0	29.0	17.6	16.0	16.2	21.2	13.7	20.7	12.2	12.3	8.0	11.4	22.4	21.1	15.1	18.9	17.6	17.9	18.1	9.9	23.4	27.3	20.7	14.3	10.8	21.5	20.2	11.9	13.9	12.8	19.1	15.0	18.8	17.4	15.3	23.2	6.8	11.4	13.9	19.0	11.3	15.1	18.8	26.4	13.3	8.1	16.3	15.5	16.3	16.6	6.9	12.9	9.0	6.6	12.7	12.2	10.4	10.2	7.5	10.4	11.1	11.1	5.0	11.2	7.5	6.2	11.6	6.8	28.1	29.9	32.0	32.8	29.1	23.8	18.9	25.9	18.4	17.5	24.7	27.9	5.9	25.6	23.2	16.3	14.4	0.0	6.3	0.0	12.5	16.1	5.1	6.1	0.0	5.7	14.9	1.8	4.2	11.6	6.4	1.5	0.0	4.8	5.0	6.6	7.2	6.0	1.2	9.0	3.6	2.7	10.0	9.1	7.1	3.1	16.4	5.5	4.6	4.4	4.6	3.3	3.1	3.6	0.0	5.7	0.0	2.5	9.6	5.9	0.0	3.7	4.0	10.1	9.2	26.7	3.5	4.4	1.5	9.8	18.9	3.2	3.3	3.9	12.4	10.3	6.6	6.5	5.7	16.8	14.5	8.9	0.0	7.7	11.3	6.5	3.0	3.4
ATAT1	"C6orf134, Em:AB023049.7, FLJ13158, MEC17"	ENSG00000137343	"Alpha tubulin acetyltransferase 1"	Q5SQI0	6	30626842-30646823	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 87.6;Late spermatids: 42.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 8.0;AN3-CA: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046816, HPA050999"	Approved		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Golgi apparatus, Cytosol"		"HPA046816: AB_2679822, HPA050999: AB_2681303"	"unprognostic (3.98e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.67e-2)"	"unprognostic (8.86e-2)"	"unprognostic (8.18e-3)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (1.49e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (7.78e-5)"	"unprognostic (2.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.35e-4)"	5.3	6.0	2.3	0.6	2.9	0.6	7.6	1.8	3.3	12.4	0.9	8.6	0.5	9.7	3.6	7.6	9.8	0.7	5.5	2.6	3.3	11.3	7.6	5.8	0.6	2.3	2.7	13.4	6.0	0.2	21.3	0.4	2.5	13.5	0.6	2.5	7.7	0.3	4.9	6.6	7.8	0.7	1.9	5.6	7.4	13.5	2.5	0.7	9.3	0.0	0.7	9.2	8.4	3.1	1.4	0.7	8.0	5.3	0.9	0.7	0.6	0.3	0.0	0.2	0.4	2.3	1.4	0.1	1.1	1.1	2.2	1.5	2.5	0.9	0.0	1.0	4.2	0.1	0.1	2.6	0.4	0.5	1.1	1.4	0.5	0.3	0.0	1.0	0.5	3.8	1.5	0.0	1.3	1.5	1.0	0.3	0.4	2.2	0.0	1.0	0.1	0.4	1.3	2.4	0.3	3.2	0.6	0.6	0.4	0.0	2.9	0.4	1.0	3.0	1.3	0.0	0.5	0.9	2.5	0.8	1.6	3.4	2.1	0.5	0.4	0.3	0.1	0.3	0.1	0.5	0.2	0.1	0.4	0.2	0.4	0.4	0.3	0.1	0.2	0.5	0.1	0.1	2.3	2.9	1.8	3.3	2.6	3.3	2.3	2.7	2.5	1.9	2.5	3.1	6.2	0.0	1.5	14.7	6.4	5.6	14.0	16.9	14.2	9.0	9.4	11.4	1.9	5.7	8.6	14.7	10.4	11.9	4.1	7.6	7.9	11.9	87.6	9.0	7.7	7.9	18.0	3.0	7.8	4.5	6.3	6.9	8.2	8.0	1.3	16.0	3.3	2.9	6.1	1.7	11.4	8.9	14.2	1.6	3.1	42.4	4.1	3.1	0.0	5.6	9.1	12.5	6.2	16.6	13.1	9.3	10.8	8.6	4.1	11.6	9.7	5.4	10.8	10.7	6.6	8.0	7.8	12.4	11.8	8.0	5.4	8.9	4.7	6.1	11.1	15.3
ATF7-NPFF		ENSG00000267281	"ATF7-NPFF readthrough"		12	53506688-53625979	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"brain: 1.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"A549: 1.4"									HPA003384	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA003384: AB_1078234"	"unprognostic (1.14e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.37e-4)"	"unprognostic (6.25e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.91e-2)"	"unprognostic (2.26e-7)"	"unprognostic (9.21e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.72e-1)"	"unprognostic (9.77e-3)"	0.1	0.0	0.1	0.0	0.5	0.3	0.0	1.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.5	0.2	0.1	0.1	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.8	0.2	0.0	0.5	0.2	0.2	0.0	1.0	0.2	1.4	0.0	0.1	0.5	0.7	0.0	0.0	0.4	0.5	0.1	0.1	0.2	0.5	0.1	0.0	0.0	0.4	0.1	0.3	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.5	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.7	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.2	0.0	0.8	0.5	0.1	0.6	0.7	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.1	0.7	0.0	0.0	0.4	0.1	0.1	0.1	0.5	1.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.8	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
ATP2C1	"ATP2C1A, BCPM, KIAA1347, PMR1, SPCA1"	ENSG00000017260	"ATPase secretory pathway Ca2+ transporting 1"	P98194	3	130850595-131016712	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 162.6;Excitatory neurons: 172.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010207, HPA035116, HPA069684"	Supported		Supported	"Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"CAB010207: AB_2061744, HPA035116: AB_10673106, HPA069684: AB_2686169"	"unprognostic (1.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (5.06e-6)"	"unprognostic (7.66e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (8.44e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.73e-2)"	"unprognostic (3.06e-1)"	32.2	32.7	34.0	25.3	36.6	38.6	32.9	31.8	42.8	33.4	76.9	36.5	23.9	30.9	28.0	23.6	37.2	27.2	31.9	40.7	38.6	44.7	28.5	51.4	21.9	37.0	38.9	28.8	22.6	78.0	22.7	32.7	40.3	85.8	35.9	59.4	29.2	25.2	28.1	31.9	26.9	31.0	33.6	19.5	31.5	25.2	48.8	36.2	35.0	21.1	26.2	31.6	18.1	48.6	133.1	51.1	49.9	48.5	136.7	110.0	53.9	141.2	186.8	69.4	87.0	83.5	106.3	47.6	95.6	134.4	96.4	153.6	95.1	77.9	100.8	104.4	34.2	127.2	51.5	39.0	87.2	51.2	148.4	86.8	76.6	73.2	82.2	126.3	74.6	59.3	37.3	84.1	86.7	59.0	50.6	40.9	57.0	71.7	54.8	36.3	49.9	75.6	127.5	87.7	76.7	45.9	121.4	37.8	72.8	70.8	55.7	41.7	102.6	73.3	40.8	95.5	65.8	54.6	71.1	69.9	75.8	38.0	62.6	30.6	8.9	15.9	7.4	7.6	7.0	5.6	7.3	6.6	9.5	3.6	4.9	4.9	4.3	11.5	9.6	8.2	9.3	6.5	34.0	36.6	31.8	42.8	40.7	38.6	37.0	38.9	40.3	33.6	48.8	48.6	30.2	38.5	53.0	162.6	17.4	39.4	34.5	34.8	26.7	25.9	34.4	22.4	30.2	35.8	41.1	46.0	20.9	16.3	15.5	39.0	5.9	35.3	17.5	26.9	34.1	27.8	35.6	23.3	172.5	38.0	27.6	25.9	33.1	55.8	28.5	28.2	26.7	27.4	27.7	82.4	136.5	32.4	36.7	26.2	34.8	18.9	16.1	39.5	21.4	128.4	20.5	26.4	19.6	148.3	154.3	51.1	27.5	14.7	18.5	69.0	16.3	19.8	52.7	33.4	6.6	27.7	25.9	16.2	14.1	24.7	52.8	17.6	19.5	17.3	31.2	36.9
BIRC2	"API1, c-IAP1, cIAP1, hiap-2, MIHB, RNF48"	ENSG00000110330	"Baculoviral IAP repeat containing 2"	Q13490	11	102347211-102378670	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005513, CAB020661"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoli fibrillar center, Cytosol"	Nucleoplasm	"CAB020661: , HPA005513: AB_1846746"	"unprognostic (1.36e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.20e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.64e-2)"	23.2	27.6	18.4	25.8	19.6	36.4	28.2	20.0	23.4	27.5	22.5	27.2	23.6	25.7	30.2	18.1	19.7	24.8	23.6	17.9	19.9	28.8	44.3	22.6	34.5	19.7	19.4	21.8	33.7	20.4	18.8	29.4	19.8	21.4	26.0	22.2	21.1	16.1	29.7	18.2	25.2	21.6	20.1	26.7	23.5	24.6	18.8	50.6	22.2	32.9	27.1	30.4	20.4	24.9	34.0	24.7	37.3	29.3	46.1	63.3	23.9	128.3	48.8	71.9	43.4	30.9	81.7	37.1	123.5	59.2	40.3	36.7	24.5	33.8	85.7	50.0	12.6	37.2	17.6	37.8	46.9	22.9	23.0	40.8	64.4	41.2	52.3	66.2	50.1	22.2	34.4	0.2	131.0	10.9	24.3	20.1	18.1	40.1	23.7	11.9	48.4	24.9	55.4	38.5	15.5	20.3	44.7	26.9	40.7	56.7	42.5	27.3	82.7	150.7	34.4	46.2	84.2	14.9	21.9	25.0	32.6	28.2	112.5	97.2	43.3	104.4	22.9	42.2	18.9	15.7	21.5	21.3	33.8	15.1	27.4	27.7	67.6	34.3	46.7	20.4	33.2	27.5	18.4	19.6	20.0	23.4	17.9	19.9	19.7	19.4	19.8	20.1	18.8	24.9	61.8	41.7	41.1	17.0	52.6	67.2	109.2	53.6	39.9	24.4	52.3	52.8	58.6	67.2	49.5	64.4	29.2	38.4	77.9	85.7	43.0	49.8	20.8	63.2	54.0	51.0	48.5	80.0	22.4	73.7	27.8	55.9	28.5	85.7	62.7	43.7	59.3	182.1	41.5	20.2	21.7	54.3	46.8	84.3	71.5	11.2	36.4	71.1	51.6	26.2	81.2	34.3	55.6	21.6	33.1	54.5	71.1	29.0	49.2	75.0	82.1	110.1	56.6	31.0	26.3	45.7	48.9	44.7	42.4	28.4	62.8	35.2	57.1	36.4	44.2	82.5
BLM	"BS, RECQ2, RECQL3"	ENSG00000197299	"BLM RecQ like helicase"	P54132	15	90717346-90816166	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.7;lymphoid tissue: 7.9;salivary gland: 7.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 18.3;Oligodendrocyte precursor cells: 58.3;Plasma cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005689	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA005689: AB_1845372"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.75e-2)"	"unprognostic (9.89e-2)"	"unprognostic (6.12e-5)"	"unprognostic (2.82e-2)"	"unprognostic (4.55e-3)"	"unprognostic (5.24e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.55e-15)"	"unprognostic (6.53e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-2)"	0.3	0.2	0.9	3.6	1.1	5.7	0.5	2.3	0.9	0.1	0.3	1.4	1.0	0.4	0.4	0.6	0.3	0.3	0.3	0.8	1.1	0.1	0.1	0.4	6.4	1.2	1.4	0.1	0.2	0.0	0.6	1.2	1.1	0.1	1.7	2.4	7.8	0.0	0.5	0.4	1.6	0.4	1.0	1.6	1.1	2.2	0.9	7.9	0.3	0.1	6.2	1.0	0.2	1.0	13.0	14.4	20.4	12.6	0.1	0.9	14.6	9.4	3.2	11.1	13.4	11.7	10.1	35.1	5.9	2.6	14.1	20.4	25.7	7.1	15.1	19.1	20.5	36.4	14.8	3.9	0.0	33.7	17.3	0.3	0.1	10.6	4.7	1.3	7.9	16.9	32.7	9.9	11.0	7.4	28.3	14.5	22.2	24.9	4.2	25.4	39.1	14.7	2.3	18.9	14.6	14.7	8.5	11.5	4.8	18.1	7.2	23.4	3.7	8.6	13.6	9.6	21.0	6.4	30.4	39.5	5.6	25.8	15.7	1.7	0.6	2.6	1.6	0.8	2.6	4.6	1.4	2.1	0.7	2.3	1.0	1.1	0.7	3.1	1.0	0.7	3.2	0.9	0.9	1.1	2.3	0.9	0.8	1.1	1.2	1.4	1.1	1.0	0.9	1.0	0.9	3.2	8.9	1.0	12.9	0.3	0.5	0.5	0.6	3.6	1.3	1.0	7.9	0.0	4.2	0.0	2.1	5.5	6.9	2.2	1.9	1.0	2.7	1.3	1.3	2.0	0.0	18.3	0.7	0.7	6.8	1.8	3.6	1.7	13.3	8.1	2.2	0.6	5.7	0.0	8.6	1.3	0.0	7.7	1.3	1.6	0.0	7.7	0.0	7.5	2.7	1.7	10.3	58.3	2.6	1.2	0.3	0.4	20.6	0.7	0.2	0.0	5.4	7.1	0.0	0.9	1.7	17.1	12.9	2.2	0.6	1.0	10.2	0.7	4.0	0.4
BLZF1	JEM-1	ENSG00000117475	"Basic leucine zipper nuclear factor 1"	Q9H2G9	1	169367970-169396540	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 85.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025703, HPA027331, HPA067113"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA025703: AB_1845379, HPA027331: AB_1845380, HPA067113: AB_2685781"	"unprognostic (5.25e-2)"	"unprognostic (9.03e-2)"	"unprognostic (9.31e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.34e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.81e-3)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (3.28e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.18e-1)"	14.9	13.1	8.2	12.5	10.3	25.6	19.4	11.3	10.3	14.6	9.4	13.9	12.3	15.6	14.3	32.4	11.3	16.3	16.0	8.9	9.0	17.0	14.9	13.0	11.8	9.9	9.4	14.5	9.5	15.1	8.7	18.2	9.7	15.6	15.6	22.8	12.7	16.0	11.3	18.0	12.7	17.9	9.7	12.5	13.1	35.0	9.3	13.7	18.7	11.0	16.2	16.6	14.7	14.3	52.8	16.6	16.5	13.6	24.9	37.6	26.2	46.6	32.0	48.1	52.5	19.5	33.3	7.5	26.8	31.6	30.7	38.6	16.6	30.3	37.4	16.8	16.1	13.7	20.0	13.6	26.4	27.2	18.9	27.6	36.9	35.8	31.7	27.3	25.1	14.9	25.6	20.0	46.0	10.8	12.1	12.7	19.9	38.2	25.2	6.8	26.0	16.6	48.1	17.5	9.3	30.6	30.3	41.3	36.9	28.3	44.8	20.4	30.5	28.9	22.5	26.7	39.6	20.4	26.1	19.5	22.1	11.7	44.6	85.6	12.2	51.5	12.2	16.2	16.0	11.3	15.0	14.1	10.8	10.4	13.2	14.4	25.1	19.8	15.8	8.2	23.9	10.9	8.2	10.3	11.3	10.3	8.9	9.0	9.9	9.4	9.7	9.7	9.3	14.3	14.7	22.4	16.4	34.9	11.7	18.4	46.7	22.6	16.5	14.3	18.0	12.1	29.6	11.5	24.4	11.0	14.6	18.3	15.2	18.2	23.5	24.2	131.4	28.0	18.6	11.9	12.6	16.0	30.2	13.2	17.3	18.7	22.4	28.5	26.0	12.3	12.5	4.8	14.3	33.7	32.8	11.7	14.2	10.7	6.8	72.8	14.6	11.6	14.2	17.8	10.3	21.2	17.5	30.2	57.8	36.7	11.6	17.7	13.9	17.0	15.4	22.4	31.6	27.9	0.0	23.0	21.7	84.9	25.8	16.7	15.6	20.1	18.8	17.1	11.6	65.3
BMI1	"PCGF4, RNF51"	ENSG00000168283	"BMI1 proto-oncogene, polycomb ring finger"	P35226	10	22321099-22331484	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 134.0;Late spermatids: 165.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 508.3;U-937: 583.9"									"CAB011120, HPA030471, HPA030472"	Supported		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	"Nucleoli, Cytosol"	"CAB011120: , HPA030471: AB_2673491, HPA030472: AB_10601090"	"unprognostic (5.44e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.24e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.76e-3)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (2.60e-8)"	"unprognostic (9.43e-2)"	"unprognostic (7.95e-2)"	"unprognostic (7.84e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.44e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.91e-3)"	"unprognostic (3.41e-2)"	29.0	31.1	26.6	25.1	35.1	21.9	36.0	29.9	42.4	27.6	28.2	26.2	19.7	30.7	29.7	21.9	22.6	23.9	20.5	25.0	27.8	26.0	35.6	23.4	27.7	29.5	30.1	21.7	25.7	56.9	25.0	28.7	31.6	33.7	21.5	40.4	19.9	26.1	44.4	14.4	20.8	36.2	29.9	36.2	22.5	35.3	28.1	24.9	23.9	35.5	27.0	23.8	14.8	45.4	74.9	36.1	41.2	12.7	68.9	54.6	40.5	49.7	22.2	37.3	43.5	37.6	93.4	38.1	32.8	45.6	42.2	26.1	59.1	35.0	45.4	508.3	72.8	104.7	28.7	42.9	41.1	39.8	55.7	35.5	58.8	41.2	45.3	47.0	26.2	62.1	105.4	63.3	48.6	30.2	106.9	11.4	9.3	36.3	83.4	79.6	57.1	37.3	35.3	25.2	33.8	66.0	32.7	42.5	57.3	17.8	38.5	153.8	56.4	41.4	122.6	99.6	67.6	76.1	110.8	83.1	59.5	583.9	27.4	15.1	1.3	2.5	5.2	3.0	7.0	4.4	5.3	5.0	0.9	2.2	4.4	4.3	0.6	5.2	2.1	1.6	4.1	2.0	26.6	35.1	29.9	42.4	25.0	27.8	29.5	30.1	31.6	29.9	28.1	45.4	18.9	25.6	24.0	0.0	23.1	15.9	20.5	12.4	22.8	20.9	24.4	20.3	19.0	22.8	19.8	12.9	8.4	12.7	14.2	5.6	13.7	16.3	134.0	12.1	25.3	24.0	13.2	19.1	0.0	18.2	22.2	19.8	7.7	9.8	12.0	12.6	28.5	30.7	9.9	30.3	0.0	9.9	14.2	19.7	25.6	165.1	36.1	13.8	37.4	0.0	17.5	13.9	15.5	0.0	0.0	22.9	7.3	36.5	33.9	29.1	4.6	13.0	16.9	15.2	19.7	26.5	28.6	19.8	22.2	11.2	14.6	6.7	22.4	17.0	10.3	20.4
BMP6	"VGR, VGR1"	ENSG00000153162	"Bone morphogenetic protein 6"	P22004	6	7726099-7881728	"Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.0;Hepatic stellate cells: 16.8;Inhibitory neurons: 22.8;Microglial cells: 74.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 37.0;HUVEC TERT2: 149.6;Karpas-707: 81.6;SiHa: 70.0;TIME: 74.3;U-266/84: 41.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002773, HPA062683"	Approved		Approved	Mitochondria	"Secreted to blood"	No	No	4970000	46000	"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"CAB002773: , HPA062683: AB_2684832"	"prognostic favorable (6.45e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.20e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.29e-3)"	16.5	3.1	5.1	2.2	5.9	0.4	12.7	3.9	6.2	3.2	7.8	3.7	3.0	3.5	0.6	2.0	2.4	2.1	5.1	3.9	3.7	17.8	1.9	9.1	1.5	4.9	4.5	8.2	0.6	0.6	4.6	18.1	4.7	2.8	2.7	0.1	2.3	2.6	3.1	3.5	3.0	2.3	4.8	4.6	4.7	2.2	5.7	0.9	1.5	1.3	2.4	3.3	3.0	4.1	0.9	2.4	0.3	0.0	0.4	0.3	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	37.0	1.1	1.6	0.5	1.1	0.2	0.0	0.0	5.7	15.9	21.8	1.4	0.8	1.1	16.7	0.0	0.0	0.7	2.4	9.6	149.6	0.0	0.0	81.6	0.0	0.3	0.0	0.0	0.8	0.5	12.0	0.6	0.0	15.3	0.5	0.0	12.3	0.0	70.0	0.0	0.0	9.3	0.0	0.0	74.3	0.0	4.7	0.5	2.6	11.3	41.3	0.1	2.3	0.0	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	5.1	5.9	3.9	6.2	3.9	3.7	4.9	4.5	4.7	4.8	5.7	4.1	23.0	0.0	0.5	1.6	1.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	3.5	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.8	0.2	8.9	0.0	0.0	7.8	0.0	0.1	2.0	0.0	2.0	0.0	1.5	16.8	0.6	0.3	0.0	22.8	0.0	0.0	0.8	2.1	4.2	0.0	1.5	1.8	74.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	0.0	6.8	0.3	0.0	0.0	0.3	0.0	0.0	4.7	0.4	0.1	1.3	0.1	0.1	0.3	0.4	0.4	0.0	0.0
BORA	"C13orf34, FLJ22624"	ENSG00000136122	"BORA aurora kinase A activator"	Q6PGQ7	13	72727749-72756198	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 13.5;Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA040866	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA040866: AB_10794868"	"unprognostic (9.93e-2)"	"unprognostic (7.18e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.37e-4)"	"unprognostic (2.65e-2)"	"unprognostic (2.82e-3)"	"unprognostic (6.18e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.32e-12)"	"unprognostic (7.04e-3)"	"unprognostic (2.88e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.28e-2)"	1.6	1.3	1.2	4.3	1.2	6.0	2.4	1.4	1.7	1.6	1.9	4.2	4.3	1.3	1.5	3.5	1.4	1.3	1.0	1.2	1.3	1.8	1.7	1.8	7.6	1.6	1.3	1.2	1.7	0.5	1.9	2.3	1.5	1.8	5.0	3.5	1.9	1.0	1.1	4.2	3.5	1.7	1.1	4.2	3.2	4.0	1.4	8.1	1.9	0.9	6.8	2.2	2.2	1.5	32.5	8.5	19.6	14.7	2.4	2.4	11.6	9.8	8.6	17.9	18.1	20.6	17.2	23.8	6.4	6.4	10.3	15.0	17.1	11.5	22.1	20.9	12.3	28.7	11.4	15.8	1.7	54.2	17.1	1.9	2.6	8.9	15.1	5.0	14.6	22.8	12.7	10.7	14.6	9.8	20.8	21.8	10.8	36.8	6.0	16.4	12.3	10.6	6.5	10.0	6.9	7.0	12.0	12.8	10.2	15.0	6.4	24.6	4.8	5.8	9.7	8.3	16.3	6.9	7.0	14.8	16.3	24.8	13.9	1.3	1.1	0.5	1.9	1.9	2.3	1.6	1.8	2.0	1.9	1.9	1.6	2.5	0.1	1.8	1.2	1.4	1.9	1.1	1.2	1.2	1.4	1.7	1.2	1.3	1.6	1.3	1.5	1.1	1.4	1.5	1.6	3.2	2.8	3.6	5.4	0.6	1.3	2.2	3.4	1.7	1.4	1.3	0.3	1.5	2.1	1.8	2.1	7.5	3.9	3.1	0.0	1.9	12.6	2.2	2.3	1.4	0.0	13.5	4.3	2.6	11.5	1.7	3.6	2.4	1.3	5.1	1.8	0.4	4.6	8.4	3.1	2.7	0.0	2.8	1.5	2.7	0.9	2.8	0.0	3.7	3.5	1.1	4.1	2.5	7.3	1.7	2.2	1.2	5.2	1.2	3.2	0.8	2.7	2.3	13.1	1.6	1.5	11.8	4.3	3.4	1.1	2.9	4.1	1.5	5.8	1.4
BRPF3	KIAA1286	ENSG00000096070	"Bromodomain and PHD finger containing 3"	Q9ULD4	6	36196744-36232790	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022787	Uncertain		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Mitochondria	"HPA022787: AB_1845454"	"unprognostic (1.44e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.51e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.28e-1)"	6.6	11.9	3.5	7.6	4.3	12.1	8.4	9.0	5.4	8.4	0.1	13.1	11.7	11.9	6.1	7.9	8.8	8.6	7.3	5.5	1.9	11.8	6.9	7.4	6.2	0.6	1.4	11.9	18.0	14.5	4.4	7.5	0.7	9.6	12.9	6.4	15.7	10.9	12.1	12.6	13.8	10.2	0.3	9.0	10.7	19.9	2.1	9.4	12.1	12.2	6.2	7.4	4.7	4.0	10.6	10.0	24.6	19.4	13.3	11.2	21.0	15.6	16.3	21.5	16.9	29.4	9.8	16.3	16.4	15.4	27.0	10.0	21.8	11.2	18.8	15.6	13.5	11.5	9.3	17.6	14.0	9.1	15.5	14.4	9.4	25.6	12.8	15.6	16.3	7.7	24.5	14.6	11.9	15.0	10.4	3.9	12.4	12.9	8.5	29.9	10.1	5.1	6.9	21.4	35.0	11.0	12.7	13.8	12.9	15.1	15.4	24.6	17.2	22.3	18.9	6.1	18.3	12.0	16.8	12.1	3.7	14.1	26.9	0.7	0.0	0.3	0.4	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.4	0.0	0.0	0.1	0.2	0.1	3.5	4.3	9.0	5.4	5.5	1.9	0.6	1.4	0.7	0.3	2.1	4.0	5.7	6.4	12.7	8.8	5.6	9.6	7.2	4.6	9.6	9.0	21.1	11.7	13.7	10.0	7.3	5.5	6.2	4.8	9.7	28.1	0.0	6.6	15.3	7.3	10.9	7.2	19.7	5.7	16.6	10.8	4.1	9.8	10.2	12.7	2.5	16.6	9.7	18.2	4.5	0.0	11.4	27.5	6.1	5.7	6.6	14.0	11.1	4.9	7.2	6.5	5.4	6.1	9.2	13.6	11.0	11.2	13.6	9.4	10.5	11.3	21.5	13.5	4.5	7.2	0.0	11.1	8.0	25.7	17.5	7.3	11.4	8.2	6.3	14.2	16.2	10.2
BTBD7	"FLJ10648, FUP1"	ENSG00000011114	"BTB domain containing 7"	Q9P203	14	93237550-93333092	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 175.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049926, HPA053406"	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Focal adhesion sites"		"HPA049926: AB_2680956, HPA053406: AB_2682137"	"unprognostic (3.36e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.97e-3)"	"unprognostic (4.34e-2)"	"prognostic favorable (1.69e-6)"	"unprognostic (7.27e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.72e-2)"	"unprognostic (9.52e-2)"	3.9	2.7	1.2	2.2	2.1	5.6	3.4	3.6	1.8	3.4	0.0	3.3	1.8	3.5	1.5	4.5	3.4	2.0	3.1	1.2	2.7	3.9	2.9	3.8	1.2	3.0	3.1	3.5	3.4	4.0	1.9	2.6	2.6	2.9	2.3	2.5	3.6	1.7	4.7	4.1	3.3	2.1	1.7	2.3	3.0	8.0	3.6	1.2	3.5	1.6	1.4	3.5	3.9	4.1	6.6	4.0	5.2	1.8	2.9	2.5	9.0	6.0	3.8	5.0	3.0	4.5	4.9	4.3	4.9	6.5	3.6	6.1	4.6	10.4	7.7	5.1	3.5	2.9	2.5	3.3	1.7	7.6	3.6	3.6	2.0	5.1	7.3	3.8	7.5	1.7	3.1	3.5	5.2	7.2	2.0	2.9	3.2	3.3	11.2	5.9	7.6	0.9	6.1	15.5	6.7	6.2	7.9	3.0	2.1	5.6	5.3	5.4	8.9	4.2	4.3	3.0	5.3	2.5	3.5	3.9	2.1	2.1	3.0	0.8	0.1	1.3	0.3	0.2	0.1	0.6	0.2	0.3	0.1	0.4	0.1	0.2	0.5	0.1	0.3	0.4	0.4	0.0	1.2	2.1	3.6	1.8	1.2	2.7	3.0	3.1	2.6	1.7	3.6	4.1	53.6	51.3	27.7	76.4	29.0	32.4	29.0	18.1	26.7	27.9	31.9	23.9	20.9	30.0	19.6	55.2	37.5	24.2	31.6	34.5	13.7	32.3	47.9	58.2	55.7	48.5	28.8	23.4	80.2	24.6	22.5	35.6	29.0	75.5	24.7	33.3	51.4	18.6	17.8	26.9	81.6	26.2	14.2	27.7	39.5	45.7	23.6	36.1	10.6	99.3	39.5	23.9	26.8	89.0	175.7	45.2	22.0	39.5	36.0	45.8	22.1	39.3	22.9	30.4	13.1	58.3	56.4	23.7	36.6	32.9	36.9	30.6	28.2	33.1	27.7	64.5
BTRC	"beta-TrCP1, betaTrCP, bTrCP, bTrCP1, FBXW1A, Fwd1"	ENSG00000166167	"Beta-transducin repeat containing E3 ubiquitin protein ligase"	Q9Y297	10	101354033-101557321	"Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 109.7;Excitatory neurons: 154.0;Inhibitory neurons: 144.4;Oligodendrocyte precursor cells: 183.5;Oligodendrocytes: 148.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031156, CAB032986"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB032986: AB_2243598, HPA031156: AB_2673764"	"unprognostic (1.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.41e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.80e-3)"	"unprognostic (5.05e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.23e-1)"	5.2	9.2	16.3	3.8	19.3	2.8	8.5	8.9	17.4	6.8	7.8	6.3	3.9	6.1	10.5	8.4	7.7	5.8	14.6	18.9	16.3	8.0	6.4	4.9	4.2	10.7	12.6	11.0	6.5	13.1	9.4	7.9	13.7	8.8	4.7	21.6	6.9	5.9	12.2	6.8	4.7	7.1	10.0	6.5	5.7	13.8	16.3	6.4	8.5	12.1	5.6	6.4	6.7	13.7	8.7	13.0	17.2	20.0	16.1	14.1	6.3	12.0	18.4	11.8	10.0	9.0	6.5	13.8	11.8	9.9	12.3	12.9	14.1	13.0	11.7	9.5	11.5	10.1	8.0	11.5	8.9	14.9	5.7	9.0	14.7	10.4	18.4	22.4	15.3	12.7	11.0	4.5	12.0	7.2	9.8	7.5	7.8	9.0	9.9	12.4	24.6	2.8	10.3	5.4	12.9	11.2	8.1	3.5	11.3	19.2	9.2	5.1	12.7	6.1	10.3	8.6	8.5	7.5	18.2	8.7	6.4	7.3	3.9	1.8	1.7	1.8	2.9	1.5	2.8	2.5	3.0	2.5	2.3	2.1	3.4	2.8	1.1	2.5	1.6	1.1	2.8	1.6	16.3	19.3	8.9	17.4	18.9	16.3	10.7	12.6	13.7	10.0	16.3	13.7	8.6	3.2	9.4	109.7	6.9	5.6	4.1	6.9	12.5	32.5	10.0	7.4	28.0	8.6	10.6	3.7	29.2	11.5	6.1	5.0	7.9	9.7	41.9	11.7	12.4	9.0	3.0	20.6	154.0	7.2	7.2	10.3	3.6	10.6	13.9	10.1	6.4	6.7	5.9	16.8	144.4	4.9	6.1	3.5	2.5	21.6	9.0	5.0	1.8	69.3	4.6	13.6	8.2	183.5	148.0	7.9	3.2	10.5	6.3	6.6	5.5	9.4	13.0	26.0	6.6	8.3	7.6	33.8	18.3	7.4	7.1	12.4	8.2	5.9	4.8	6.2
BUB1	"BUB1A, BUB1L, hBUB1"	ENSG00000169679	"BUB1 mitotic checkpoint serine/threonine kinase"	O43683	2	110637528-110678063	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 11.9;lymphoid tissue: 27.5;testis: 30.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 24.8;Granulosa cells: 66.1;Plasma cells: 35.2;Spermatocytes: 85.6;Spermatogonia: 20.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 221.5"	"Region enhanced"	"Detected in single"		"white matter: 1.7"	"Not detected"	"Not detected"			HPA006123			Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA006123: AB_1845498"	"unprognostic (7.74e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.72e-3)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (1.61e-1)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (1.03e-5)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.37e-5)"	"unprognostic (1.76e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.45e-2)"	"unprognostic (3.64e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	0.5	0.4	0.1	8.4	0.3	11.9	1.2	0.1	0.1	0.9	0.0	4.3	4.0	1.0	3.5	4.7	0.5	0.9	0.6	0.1	0.1	0.3	0.6	1.2	15.9	0.1	0.6	0.4	0.2	0.7	0.0	3.2	0.3	0.3	5.7	0.1	0.9	0.1	0.1	2.7	3.5	2.2	0.0	5.6	1.9	30.3	0.4	27.5	0.4	0.2	17.0	2.4	1.6	0.3	96.0	29.4	68.5	46.8	3.8	5.3	38.8	50.9	32.9	85.6	62.3	58.3	55.0	64.7	30.9	30.1	80.1	43.2	93.9	35.0	105.7	51.4	45.6	221.5	26.2	50.6	0.8	63.5	57.0	1.7	2.8	65.2	33.1	12.7	49.8	73.2	96.8	126.5	76.8	33.7	126.3	39.0	71.2	39.4	55.3	69.3	64.2	102.7	18.3	27.0	48.3	21.4	34.2	31.4	27.2	44.1	24.0	60.6	19.1	39.7	57.5	28.8	69.0	67.3	65.5	75.4	24.2	48.6	69.8	1.1	0.0	0.2	0.2	0.0	0.3	0.5	0.9	0.5	0.1	0.5	0.6	0.4	0.0	0.5	0.0	0.9	1.5	0.3	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.6	0.3	0.0	0.4	0.3	0.2	0.0	1.5	0.0	5.5	0.5	0.5	2.0	0.6	0.0	0.9	0.8	1.1	0.0	1.6	0.0	0.0	5.8	2.5	2.4	0.0	0.3	13.5	4.5	1.5	1.1	0.0	24.8	0.2	0.0	9.8	2.2	2.0	2.2	0.0	66.1	1.8	0.3	8.1	0.0	0.2	3.1	4.1	1.6	1.4	7.5	0.3	2.0	0.0	0.0	0.6	0.0	0.0	0.5	1.0	0.1	0.0	0.4	35.2	0.5	0.3	0.1	1.8	0.0	6.6	0.2	3.7	85.6	20.0	4.0	0.4	0.7	2.9	0.5	5.9	0.9
C10orf82	"Em:AC016825.4, MGC33547"	ENSG00000165863	"Chromosome 10 open reading frame 82"	Q8WW14	10	116663696-116670264	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"testis: 84.5"	"Group enriched"	"Detected in some"	113	"Early spermatids: 1053.9;Late spermatids: 1926.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 2.4"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	103	"basophil: 10.2"	"Lineage enriched"	"Detected in single"	103	"granulocytes: 10.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;Hep G2: 2.8;NTERA-2: 1.4;SuSa: 2.5;T-47d: 3.5"	"Not detected"	"Not detected"							HPA043022			Approved	Mitochondria		Yes	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 34: Spermatids - Unknown function"	Mitochondria		"HPA043022: "	"unprognostic (9.98e-2)"	"unprognostic (2.09e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.52e-2)"		"unprognostic (3.46e-3)"	"unprognostic (3.48e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.50e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.07e-1)"	0.3	1.7	0.3	0.2	0.2	0.0	0.9	0.1	0.4	0.4	0.0	0.9	0.1	0.0	0.2	0.3	0.2	0.1	0.4	0.2	0.8	1.2	0.0	0.0	0.0	0.3	0.5	3.6	1.1	0.0	1.0	0.0	0.4	0.9	0.2	0.1	0.2	0.7	0.0	0.2	0.4	0.0	0.2	0.1	0.4	84.5	0.9	0.0	1.6	0.1	0.0	0.3	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.4	0.2	0.8	0.3	0.5	0.4	0.2	0.9	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	1.1	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1053.9	0.3	0.2	0.5	1.2	0.0	0.5	0.2	0.1	0.1	0.0	0.7	0.0	5.6	0.0	0.0	0.1	0.0	1.8	1.1	0.0	0.0	0.0	1926.7	9.0	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	5.3	0.0	0.7	0.1	0.1	0.0	0.0	13.1	0.4	0.2	10.5	8.0	0.0	0.0	0.0	0.1	8.0	1.2	0.3
C11orf65	"MFI, MGC33948"	ENSG00000166323	"Chromosome 11 open reading frame 65"	Q8NCR3	11	108308519-108467531	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 50.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 689.1;Spermatocytes: 192.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 29: Early spermatids - Spermatogenesis"				"unprognostic (8.05e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.54e-5)"	"unprognostic (2.72e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.87e-2)"	"unprognostic (2.50e-2)"	0.5	1.0	0.8	0.7	1.7	0.3	0.6	1.2	1.2	0.4	0.6	0.3	0.1	0.3	2.5	0.3	1.5	0.8	0.7	0.7	1.2	2.1	2.6	0.3	0.7	1.4	1.3	0.4	0.9	0.9	0.5	0.4	1.6	0.6	0.4	2.9	0.5	0.5	0.5	0.7	0.3	0.1	1.4	0.6	0.4	50.9	1.2	0.8	1.7	0.2	0.4	0.4	0.2	2.5	0.6	0.2	0.5	0.7	0.8	1.5	1.3	0.5	0.2	0.1	0.1	0.9	2.0	0.6	1.8	0.5	0.7	1.0	1.3	1.0	0.5	0.7	0.5	0.9	0.3	0.1	0.6	0.9	0.1	1.6	0.6	0.3	2.2	0.5	0.5	2.7	1.6	0.8	1.1	1.0	0.9	0.6	0.3	1.5	0.7	0.7	0.6	0.9	0.9	0.7	1.8	0.3	0.8	0.3	0.8	0.4	3.5	0.1	0.8	0.7	0.8	0.3	0.1	1.2	0.6	2.5	0.6	0.8	0.7	0.4	0.0	0.0	0.1	0.3	0.5	0.1	0.1	0.1	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.4	0.3	0.1	0.8	1.7	1.2	1.2	0.7	1.2	1.4	1.3	1.6	1.4	1.2	2.5	1.0	0.0	1.1	23.2	2.2	0.4	1.8	1.3	1.8	16.9	1.4	1.3	1.3	0.0	1.8	3.7	31.3	1.6	0.4	0.3	3.9	2.0	689.1	10.7	1.6	1.1	1.2	0.0	3.4	2.0	0.9	1.3	1.1	1.5	2.5	1.1	0.7	2.2	0.7	6.7	4.9	0.6	2.0	0.0	0.3	97.2	5.3	0.6	3.6	11.2	0.2	5.9	1.0	17.6	25.1	1.1	0.1	4.1	0.9	0.3	0.6	5.2	6.1	43.2	6.6	2.4	0.9	192.1	33.5	1.1	0.1	1.0	1.6	2.5	0.5	1.0
C1orf105		ENSG00000180999	"Chromosome 1 open reading frame 105"	O95561	1	172420685-172468831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"heart muscle: 17.4;testis: 26.3"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 193.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"BEWO: 27.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 43: Testis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (2.50e-2)"	"unprognostic (2.48e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.07e-4)"	"unprognostic (1.27e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.47e-2)"		"unprognostic (8.22e-2)"	"unprognostic (1.92e-1)"		"unprognostic (1.18e-1)"	"unprognostic (7.65e-4)"	"unprognostic (3.85e-1)"		"unprognostic (1.94e-1)"	0.0	0.2	0.7	0.0	0.7	2.1	0.0	1.5	0.6	0.0	0.2	0.0	0.1	0.0	5.4	0.5	0.0	0.1	17.4	0.5	0.3	0.2	0.2	0.0	0.1	0.6	0.5	0.0	0.5	0.0	0.0	0.6	0.6	1.3	0.0	0.2	1.2	0.1	1.3	0.7	0.6	0.0	0.1	0.1	0.1	26.3	0.6	0.4	0.2	3.3	0.0	0.0	0.0	1.1	0.0	0.3	0.3	0.1	0.0	0.0	27.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.3	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	3.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.7	1.5	0.6	0.5	0.3	0.6	0.5	0.6	0.1	0.6	1.1	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	193.9	0.0	0.0	0.3	0.0	0.0	0.5	0.6	13.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.0	0.0	24.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.9	0.0	0.0	1.2	0.0	0.0	3.8	1.9	0.0	0.0	0.0	0.5	2.7	45.6	3.2	0.0	0.0	1.8	0.0	0.1	0.1	0.0
C1orf210	"MGC52423, TEMP"	ENSG00000253313	"Chromosome 1 open reading frame 210"	Q8IVY1	1	43281877-43285617	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 125.9;Paneth cells: 100.8;Proximal enterocytes: 128.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	14	"basophil: 2.2"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in some"		"A-431: 12.1;BEWO: 13.0;CACO-2: 12.6;CAPAN-2: 39.8;OE19: 33.1;SK-BR-3: 13.8;T-47d: 15.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA013788	Uncertain		Uncertain	"Nucleoli,Nucleoli rim"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Nucleoli rim"		"HPA013788: AB_1845637"	"unprognostic (1.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (7.57e-3)"	"unprognostic (3.94e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.61e-2)"	0.2	0.1	0.3	2.9	0.3	0.2	14.5	0.7	0.5	8.2	0.3	32.4	43.9	1.3	13.0	17.0	6.1	9.9	0.1	0.3	0.2	21.8	6.2	9.0	0.1	0.3	0.4	0.1	22.8	10.3	8.4	1.6	0.4	8.1	30.2	0.5	19.5	3.8	0.0	16.2	38.7	1.2	0.2	0.1	29.1	0.3	0.3	1.0	16.9	0.0	2.3	3.2	8.1	0.8	12.1	0.0	0.0	0.1	0.0	0.0	13.0	0.0	0.0	0.0	0.0	12.6	39.8	0.0	0.3	0.0	0.0	9.0	0.0	5.6	0.0	0.0	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.0	0.0	0.2	0.1	33.1	0.0	0.1	0.1	0.4	1.0	7.8	4.6	0.3	0.1	13.8	0.0	2.1	15.2	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.3	0.7	0.5	0.3	0.2	0.3	0.4	0.4	0.2	0.3	0.8	0.1	22.4	16.1	0.3	0.6	1.1	6.2	11.5	2.8	0.0	22.4	12.8	0.0	28.6	13.8	22.0	0.0	12.9	0.0	125.9	29.4	21.3	0.1	8.5	1.4	0.2	33.6	0.0	0.0	33.7	3.9	0.2	25.5	14.2	0.0	0.0	0.0	1.2	0.7	0.0	0.0	42.4	8.2	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.3	100.8	0.0	0.0	6.6	128.1	39.6	7.3	0.0	0.0	0.0	0.7	0.3	0.0	8.9	2.6	4.7	0.3	0.0	37.0	8.8
C1orf56	"FLJ20519, MENT"	ENSG00000143443	"Chromosome 1 open reading frame 56"	Q9BUN1	1	151047751-151051986	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 76.5"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 213.9;Early spermatids: 440.4;Langerhans cells: 245.2;Spermatocytes: 308.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 15.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037429, HPA037430"	Enhanced				"Secreted to blood"	NA	NA		87000000	"Cluster 46: Basophils - DNA binding"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA037429: AB_10671755, HPA037430: AB_2675473"	"unprognostic (7.60e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.83e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.70e-3)"	"unprognostic (3.28e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.61e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.79e-2)"	4.6	10.2	2.1	1.5	2.9	0.6	4.4	3.3	2.5	5.7	3.1	4.9	2.1	5.3	3.2	5.4	5.7	2.6	7.9	1.9	2.2	6.5	8.3	2.9	1.6	2.9	2.8	5.9	7.6	3.4	10.0	1.2	2.6	6.4	0.7	1.9	5.5	3.1	6.5	4.2	3.5	1.2	2.9	4.3	5.5	76.5	2.4	0.4	8.2	2.3	0.4	5.1	5.0	3.2	4.1	8.0	2.7	1.2	4.4	4.2	2.4	2.2	3.2	1.4	1.1	3.5	5.6	0.9	3.5	2.4	3.0	5.3	1.5	0.3	0.8	5.2	1.7	1.0	5.9	4.3	3.0	1.1	0.9	3.1	1.7	2.1	0.8	2.7	2.1	1.7	2.2	2.1	1.3	15.9	1.5	2.8	4.5	3.2	4.4	1.3	2.7	2.9	1.2	2.3	3.6	7.0	7.0	3.7	5.5	5.0	7.3	3.0	2.2	1.9	3.3	5.1	2.0	4.7	4.0	12.2	3.5	0.6	2.4	223.6	22.7	50.4	90.8	54.5	70.3	46.7	78.6	80.8	19.7	51.7	64.8	90.8	69.8	59.0	48.2	28.1	48.9	4.1	2.1	2.9	3.3	2.5	1.9	2.2	2.9	2.8	2.6	2.9	2.4	3.2	57.6	6.4	10.1	19.2	56.8	64.6	38.1	20.8	4.6	20.2	80.3	46.2	7.1	40.0	17.1	42.3	20.9	53.8	213.9	15.6	39.2	21.2	440.4	12.3	20.4	34.4	14.8	12.4	27.6	14.5	35.9	34.5	4.1	12.5	38.8	10.7	66.8	38.3	30.9	18.5	25.6	14.4	16.2	95.5	245.2	80.7	28.6	50.4	88.9	24.4	78.0	20.0	119.4	26.7	37.2	32.4	19.5	25.6	50.9	35.7	8.8	36.5	10.8	26.6	26.3	41.4	35.3	308.8	13.7	3.9	83.3	89.5	90.7	11.5	15.0	46.2
C21orf58		ENSG00000160298	"Chromosome 21 open reading frame 58"	P58505	21	46300181-46323875	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.4;pituitary gland: 20.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 141.9;Enteroendocrine cells: 69.4;Erythroid cells: 80.2;Respiratory ciliated cells: 164.1;Spermatocytes: 80.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"basophil: 4.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 4.4"	"Cell line enhanced"	"Detected in many"		"REH: 62.0"	"Not detected"	"Not detected"							"HPA035110, HPA035111"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 14: REH - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nuclear bodies"	"HPA035110: AB_10603683, HPA035111: AB_2674468"	"unprognostic (2.19e-1)"	"unprognostic (6.74e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.08e-2)"	"prognostic favorable (7.00e-4)"	"unprognostic (4.74e-3)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.20e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-10)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.07e-2)"	1.5	1.7	1.9	3.6	2.4	13.1	2.0	2.6	2.3	3.5	3.0	3.2	4.7	2.0	0.7	3.9	26.4	1.0	1.3	1.8	1.9	1.5	1.7	4.8	6.3	2.8	4.6	2.6	2.5	1.2	20.7	2.0	2.0	2.9	2.6	2.5	2.3	1.5	1.7	5.3	4.4	1.3	1.8	3.4	3.5	7.1	2.5	12.8	2.1	0.7	3.8	2.1	2.7	3.2	26.0	11.6	30.2	19.0	2.9	4.0	16.7	15.7	5.7	10.8	10.5	5.4	18.6	18.6	3.8	4.4	12.5	20.3	8.1	6.7	3.2	19.9	17.8	29.9	35.2	3.1	0.7	8.6	16.6	1.7	1.4	7.7	1.9	4.0	6.8	45.4	17.4	48.1	8.9	10.6	42.7	11.6	13.0	7.2	5.7	62.0	13.6	16.6	3.4	4.8	24.7	15.4	11.7	8.3	3.7	6.4	20.5	17.1	4.7	6.6	18.4	6.6	9.6	19.3	9.3	8.8	11.6	37.1	17.4	4.4	0.2	0.6	0.4	0.1	0.2	0.1	0.5	0.6	0.0	0.9	0.9	0.7	0.3	0.3	0.1	1.0	0.8	0.5	1.9	2.4	2.6	2.3	1.8	1.9	2.8	4.6	2.0	1.8	2.5	3.2	2.1	3.2	2.6	4.2	3.1	0.9	1.6	7.0	2.8	19.5	6.2	8.8	3.0	0.0	16.6	1.8	27.1	7.7	9.4	13.9	0.0	1.7	17.3	141.9	7.7	2.3	69.4	80.2	2.7	1.0	5.9	5.9	11.7	4.5	2.5	21.4	2.2	1.5	4.0	5.0	2.5	12.8	14.2	1.6	1.9	32.5	5.3	6.2	0.0	0.0	1.3	5.9	5.2	1.5	4.2	1.2	4.1	2.6	4.8	2.0	3.0	0.7	164.1	28.2	0.0	2.6	5.5	80.8	45.3	8.5	1.4	1.4	3.7	3.9	16.8	0.9
C2CD3	DKFZP586P0123	ENSG00000168014	"C2 domain containing 3 centriole elongation regulator"	Q4AC94	11	74012718-74171210	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 70.5;Alveolar cells type 2: 114.6;Excitatory neurons: 57.4;Respiratory ciliated cells: 57.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 17.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 60.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038552, HPA038553, HPA040433"	Approved		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Centrosome"		"HPA038552: AB_10669542, HPA038553: AB_2676080, HPA040433: AB_2676981"	"unprognostic (3.94e-1)"	"unprognostic (7.89e-2)"	"unprognostic (3.68e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.48e-5)"	"unprognostic (1.99e-1)"	"unprognostic (4.96e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.92e-1)"	3.9	4.7	15.4	5.1	14.8	9.9	3.7	21.7	22.9	4.2	16.7	4.0	3.9	4.8	4.5	3.9	7.8	3.7	2.9	18.5	14.4	4.9	5.8	4.2	5.0	16.9	13.8	4.7	2.2	6.2	3.7	5.9	15.3	4.3	5.2	8.2	4.3	3.5	3.5	6.0	4.2	4.2	11.2	5.9	4.3	11.0	15.8	7.7	7.0	3.4	5.4	3.9	2.7	19.4	9.3	14.3	11.7	14.3	5.2	4.8	5.6	13.7	8.8	16.0	13.0	24.4	7.4	9.0	9.2	5.2	15.5	13.9	14.7	3.8	19.3	12.4	7.0	12.4	21.3	10.8	8.8	12.0	16.9	4.8	4.8	13.4	9.7	5.1	9.0	11.1	14.2	15.7	13.3	7.7	14.1	8.3	9.4	17.8	7.7	14.3	60.4	9.0	4.6	13.0	15.6	9.2	22.4	8.4	21.2	11.9	16.5	7.8	12.7	10.3	17.0	10.1	11.0	11.7	8.5	26.1	4.0	6.0	11.1	17.8	2.0	3.0	2.2	2.3	2.0	2.3	1.4	1.8	1.3	4.4	2.1	2.1	12.6	2.9	4.7	2.0	1.0	0.7	15.4	14.8	21.7	22.9	18.5	14.4	16.9	13.8	15.3	11.2	15.8	19.4	6.5	70.5	114.6	28.1	10.5	5.2	3.6	4.8	9.6	8.7	6.2	5.8	5.1	4.3	36.0	9.2	4.2	3.8	5.6	7.6	0.0	4.0	33.0	18.4	9.4	9.8	7.7	12.2	57.4	2.6	2.9	9.6	15.3	8.9	36.6	8.5	5.0	3.0	5.0	11.8	52.1	5.0	4.1	7.6	6.6	24.7	4.4	12.7	7.2	26.2	4.9	4.8	10.3	37.7	38.5	3.8	2.8	6.4	9.5	3.4	3.4	1.8	57.1	14.8	6.6	7.2	5.2	11.1	6.9	6.4	4.5	2.3	14.0	5.4	5.4	4.7
C9orf131	MGC41945	ENSG00000174038	"Chromosome 9 open reading frame 131"	Q5VYM1	9	35041095-35045986	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 35.8"	"Group enriched"	"Detected in some"	18	"Early spermatids: 129.6;Late spermatids: 35.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 6.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 9.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA022029			Approved	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria		"HPA022029: AB_10960628"	"unprognostic (1.10e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.23e-3)"	"unprognostic (2.47e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.34e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.90e-4)"	"unprognostic (4.19e-3)"	0.3	0.2	0.8	0.5	0.8	2.6	0.7	6.3	2.2	1.3	0.3	0.6	0.3	2.7	1.3	0.2	0.1	2.1	0.4	1.3	1.0	0.4	0.7	0.2	0.8	0.8	0.1	0.2	0.2	0.4	0.1	0.5	0.8	0.2	0.7	1.4	0.1	0.1	1.3	1.1	0.3	0.2	0.0	0.5	0.4	35.8	1.1	0.1	0.7	0.0	0.2	0.5	0.0	1.8	2.0	0.3	0.2	0.1	0.4	0.0	0.8	0.4	0.0	0.0	0.0	0.6	1.2	0.4	0.2	0.0	0.7	1.4	0.0	0.0	0.2	0.3	0.3	0.8	2.0	0.5	0.0	0.3	0.7	0.0	0.3	0.0	0.0	0.0	0.3	0.7	1.8	1.6	0.0	0.4	0.3	0.8	0.4	0.5	0.0	0.0	0.2	0.0	0.2	9.1	0.2	0.0	0.5	0.0	0.3	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.4	0.8	0.0	0.1	0.8	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.8	0.8	6.3	2.2	1.3	1.0	0.8	0.1	0.8	0.0	1.1	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	129.6	0.5	0.5	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	35.7	1.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.0	4.4	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0
CA13	"CAXIII, FLJ37995, MGC59868"	ENSG00000185015	"Carbonic anhydrase 13"	Q8N1Q1	8	85220587-85284073	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 14.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 33.3;Proximal enterocytes: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 15.6;OE19: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024689, CAB025567"	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA		27000	"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Nucleoli	"Nucleoplasm, Vesicles"	"CAB025567: , HPA024689: AB_1846004"	"unprognostic (1.12e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.16e-5)"	"unprognostic (2.21e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.39e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.13e-1)"	"prognostic favorable (9.40e-4)"	"unprognostic (7.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.00e-1)"	1.8	2.1	1.2	1.2	1.2	0.3	2.3	1.4	1.3	2.1	0.7	2.5	12.0	0.9	0.6	5.0	1.1	5.4	3.6	1.0	1.7	5.7	3.7	2.4	0.6	0.9	1.5	1.1	1.1	9.0	2.9	0.3	0.8	1.2	3.0	2.3	4.8	0.7	0.4	5.6	14.6	0.8	0.6	0.7	5.9	0.7	1.1	0.7	5.0	0.3	2.9	2.1	2.5	1.3	0.2	0.4	0.8	0.1	0.5	0.6	0.4	1.0	1.1	0.1	2.9	7.2	5.4	0.4	0.5	1.2	6.0	2.3	2.2	2.9	0.2	1.6	0.9	15.6	2.0	6.7	1.4	0.2	0.6	2.2	0.5	0.2	1.2	1.8	1.6	0.6	4.0	2.9	2.6	0.0	0.3	0.2	0.4	30.6	0.4	0.2	2.2	0.1	8.1	0.3	0.2	0.0	0.5	0.0	1.6	1.0	0.5	0.8	1.5	2.8	3.9	0.1	1.6	1.1	0.6	1.9	5.7	2.2	2.6	0.7	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.2	1.2	1.2	1.4	1.3	1.0	1.7	0.9	1.5	0.8	0.6	1.1	1.3	1.7	3.2	12.4	7.2	2.9	1.8	2.7	2.7	3.4	1.8	7.0	4.7	6.4	4.3	10.5	12.9	33.3	0.3	2.1	12.3	9.8	4.0	11.3	4.7	2.5	2.7	4.8	3.2	12.2	1.6	0.3	2.9	9.7	7.7	0.0	0.3	8.6	5.8	1.1	0.0	13.7	4.3	2.0	2.5	3.3	13.1	0.0	3.0	5.4	1.9	1.0	1.9	8.2	16.1	4.4	4.4	4.3	0.0	6.9	1.9	52.6	21.0	9.5	5.1	0.0	8.1	1.9	1.3	2.1	9.1	3.1	0.3	2.2	1.0	5.4	2.4
CACNA1D	"CACH3, CACN4, CACNL1A2, Cav1.3, CCHL1A2"	ENSG00000157388	"Calcium voltage-gated channel subunit alpha1 D"	Q01668	3	53328963-53813733	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Cancer-related genes, Deafness, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 251.2;Inhibitory neurons: 354.1;Microglial cells: 126.5;Oligodendrocyte precursor cells: 197.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	10	"basophil: 3.7"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 22.7;RPMI-8226: 55.5;SK-BR-3: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020215	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear membrane"		"HPA020215: AB_1845860"	"unprognostic (5.85e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.09e-2)"	"unprognostic (2.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (8.34e-8)"	"unprognostic (1.14e-1)"	"unprognostic (3.05e-2)"	"unprognostic (8.09e-3)"	"unprognostic (6.70e-3)"	0.1	6.6	7.0	0.2	4.3	0.7	1.8	2.3	10.4	6.0	0.0	1.5	1.7	3.7	7.3	0.5	7.7	2.0	0.6	3.6	0.8	2.2	1.0	3.7	0.1	0.0	1.2	0.5	2.8	1.2	3.5	0.6	0.4	3.0	1.5	4.3	0.5	1.8	0.2	0.7	2.4	0.7	3.5	1.8	0.8	1.6	6.1	0.2	2.9	0.2	0.1	0.6	0.1	6.0	0.0	0.5	0.1	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	2.7	2.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	2.1	0.1	0.0	0.4	0.9	0.0	0.0	0.2	55.5	0.5	3.6	4.7	2.1	0.3	10.1	1.1	0.0	2.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	3.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.0	4.3	2.3	10.4	3.6	0.8	0.0	1.2	0.4	3.5	6.1	6.0	0.6	3.2	36.2	7.8	0.6	0.9	0.8	4.6	2.2	33.3	7.2	1.8	2.3	10.0	9.1	1.8	35.5	0.9	0.5	3.0	0.0	7.2	4.9	4.3	40.1	2.4	59.4	2.7	251.2	2.3	0.2	3.4	5.1	3.3	12.6	1.7	0.0	3.4	0.2	8.4	354.1	3.8	2.0	0.8	4.0	8.3	4.4	2.1	5.4	126.5	0.5	4.0	0.0	197.5	29.9	3.8	5.6	27.1	0.1	1.7	9.5	2.7	9.5	12.9	0.0	0.2	8.6	1.0	3.7	0.5	1.0	0.3	1.7	9.6	7.6	0.9
CAPN1	"CANP, CANPL1, muCANP, muCL"	ENSG00000014216	"Calpain 1"	P07384	11	65180566-65212006	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 276.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 516.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005992	Enhanced		Supported	Cytosol		NA	NA		9100000	"Cluster 46: Basophils - DNA binding"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA005992: AB_1845924"	"unprognostic (2.07e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.33e-1)"	"prognostic favorable (7.06e-8)"	"unprognostic (5.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.98e-1)"	44.8	43.1	27.8	51.9	26.1	66.5	48.4	29.7	30.1	80.9	28.3	78.6	80.4	56.3	27.5	276.2	92.3	55.5	53.1	27.7	33.0	53.1	44.3	56.9	57.0	41.4	31.5	44.5	71.7	36.6	40.8	56.2	43.4	62.1	57.6	9.6	118.7	67.4	84.8	125.1	88.1	45.3	33.9	50.2	65.5	6.1	37.9	49.5	71.5	55.3	86.4	83.4	117.4	27.4	285.6	147.9	42.9	97.2	77.9	104.3	127.0	84.1	144.2	103.0	74.9	94.8	250.2	71.2	136.0	179.3	111.1	409.8	60.9	366.9	32.2	76.4	44.1	170.8	80.4	93.7	76.2	40.6	228.0	107.3	196.8	85.9	43.2	92.6	178.5	50.6	103.1	55.9	87.4	181.8	83.1	130.6	120.5	145.2	133.8	80.7	43.0	43.2	138.1	516.5	76.2	55.7	87.4	331.4	80.3	45.8	142.8	77.9	147.1	73.1	50.5	159.0	38.5	33.8	26.9	86.6	127.5	48.8	82.3	87.6	57.5	77.9	39.4	51.2	31.0	30.8	30.7	35.8	48.4	31.7	17.6	24.9	33.1	34.8	30.4	38.1	35.9	74.8	27.8	26.1	29.7	30.1	27.7	33.0	41.4	31.5	43.4	33.9	37.9	27.4	27.3	25.6	27.9	21.5	39.6	59.9	127.3	120.5	56.9	10.7	44.7	36.6	22.0	74.4	81.0	77.3	20.9	238.5	61.4	184.2	39.2	180.5	0.5	41.9	26.3	31.3	44.3	58.3	15.9	115.8	111.7	39.6	57.6	58.2	46.9	48.6	37.9	36.7	88.7	21.9	15.2	76.9	59.0	51.2	34.0	2.0	43.5	67.1	48.0	14.0	112.7	38.5	61.8	6.6	1.9	179.4	124.1	50.8	17.7	78.6	155.6	34.6	71.1	16.2	39.5	25.3	36.7	0.5	2.8	102.0	68.9	196.6	40.2	35.4	125.3	156.6
CASK	"CAGH39, FGS4, LIN2, TNRC8"	ENSG00000147044	"Calcium/calmodulin dependent serine protein kinase"	O14936	X	41514934-41923554	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 135.8;Oligodendrocyte precursor cells: 447.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 47.1"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 47.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001949, HPA023857"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"CAB001949: , HPA023857: AB_1846035"	"unprognostic (6.30e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavorable (6.11e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.85e-2)"	10.2	11.1	13.6	11.9	12.9	7.3	15.7	12.3	11.1	11.6	12.4	25.3	32.1	11.1	9.4	13.7	10.5	18.5	6.8	14.2	17.1	16.4	13.4	12.2	12.5	13.2	19.4	13.5	12.8	11.8	6.3	16.3	15.7	10.6	27.3	19.8	13.2	8.3	5.0	9.3	31.9	12.0	15.4	12.4	19.8	3.6	25.2	15.4	10.6	6.1	10.4	15.3	8.8	18.0	27.4	32.5	31.4	19.1	21.6	18.6	10.9	23.2	18.7	13.2	12.3	72.3	42.6	0.4	12.0	29.3	23.8	52.3	35.2	23.2	22.8	25.4	20.9	0.6	27.7	26.2	22.1	4.4	3.6	19.8	63.2	25.1	30.1	27.5	11.6	15.3	2.2	21.3	30.2	30.9	8.4	2.2	29.7	37.6	22.6	12.7	79.8	13.2	31.2	54.8	29.7	15.6	43.7	17.7	13.9	52.7	19.0	0.8	14.2	24.4	25.8	22.1	13.3	7.6	5.2	9.5	24.4	3.1	16.9	47.1	1.5	8.7	0.8	1.1	0.8	0.7	0.9	1.3	0.4	0.9	1.2	1.1	1.7	4.3	0.7	0.5	4.5	0.6	13.6	12.9	12.3	11.1	14.2	17.1	13.2	19.4	15.7	15.4	25.2	18.0	13.0	12.8	20.4	101.9	8.8	32.6	42.7	11.1	8.0	42.2	23.7	16.5	7.8	8.6	14.6	7.3	22.9	2.0	12.1	25.8	50.9	13.7	0.9	9.6	24.1	16.0	13.8	0.8	96.6	14.5	0.7	18.8	18.8	11.9	0.0	17.4	8.9	15.0	21.3	50.5	135.8	28.7	14.2	2.8	21.5	1.0	9.9	10.7	10.6	60.0	2.5	9.3	0.0	447.8	59.7	22.1	24.1	9.4	7.0	16.4	35.2	20.9	15.7	25.7	19.7	38.2	20.6	2.9	2.1	13.9	32.5	1.6	26.5	47.7	41.8	33.2
CASP9	"APAF-3, ICE-LAP6, MCH6, PPP1R56"	ENSG00000132906	"Caspase 9"	P55211	1	15490832-15526534	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001473, CAB004348, HPA046488"	Approved		Approved	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"CAB004348: AB_673489, HPA001473: AB_1078401, HPA046488: AB_2679670"	"prognostic favorable (5.91e-4)"	"unprognostic (2.42e-1)"	"unprognostic (8.94e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.90e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.21e-2)"	"unprognostic (5.48e-2)"	"prognostic favorable (1.67e-5)"	12.0	50.8	14.1	7.0	14.5	11.5	8.9	16.1	18.8	19.3	13.3	11.8	6.4	14.4	12.5	14.1	22.5	9.4	16.4	14.2	13.0	20.7	14.8	10.8	6.9	14.8	14.2	57.6	37.8	12.0	32.4	7.1	14.1	19.2	5.3	12.3	8.9	9.8	12.7	5.5	11.0	6.6	13.6	10.6	12.4	25.9	14.6	8.7	25.9	9.4	7.9	12.9	12.8	17.1	10.4	17.8	4.6	8.9	11.0	5.4	5.3	7.5	9.9	11.1	12.7	12.5	10.1	13.4	16.2	7.5	13.1	4.2	10.5	8.2	11.7	5.9	11.6	9.8	32.8	10.8	10.8	10.6	11.5	9.7	11.5	15.3	3.8	8.3	8.7	13.3	20.4	13.4	5.8	5.2	3.3	8.6	5.9	11.3	8.2	7.4	13.4	16.4	12.3	6.7	4.4	9.0	9.6	1.8	15.6	12.1	5.7	7.9	4.8	13.8	5.8	15.6	5.1	13.3	21.5	16.3	8.9	9.9	5.0	54.2	24.7	54.8	11.0	17.4	8.2	21.3	6.6	7.6	25.1	30.0	3.1	4.8	36.3	29.3	18.9	11.4	6.9	15.0	14.1	14.5	16.1	18.8	14.2	13.0	14.8	14.2	14.1	13.6	14.6	17.1	2.8	3.2	3.7	18.3	17.1	2.9	8.2	5.0	4.6	3.2	7.0	4.7	9.3	11.5	7.3	18.4	6.2	17.0	8.0	7.0	1.9	7.5	12.6	10.9	5.2	3.3	3.0	5.7	7.9	9.1	10.8	5.6	12.8	7.6	1.3	5.7	4.2	4.7	9.5	5.0	9.9	6.3	6.1	4.8	12.9	5.5	2.1	12.9	0.0	6.5	4.8	7.5	10.3	9.5	8.8	8.4	7.3	3.8	9.9	4.0	9.8	7.2	8.9	6.3	0.0	5.3	9.7	16.4	7.1	6.0	2.4	35.7	6.4	7.9	5.6	7.4
CCDC126	FLJ23031	ENSG00000169193	"Coiled-coil domain containing 126"	Q96EE4	7	23597382-23644708	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 34.6"	"Group enriched"	"Detected in all"	18	"Early spermatids: 642.3;Late spermatids: 490.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"basophil: 479.0"	"Lineage enriched"	"Detected in all"	23	"granulocytes: 479.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010969, HPA026883"	Uncertain		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		39000000	"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Golgi apparatus"		"HPA010969: , HPA026883: AB_1846131"	"unprognostic (2.02e-1)"	"unprognostic (2.76e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.90e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.29e-2)"	"unprognostic (7.35e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.28e-1)"	6.5	7.5	3.7	4.5	4.1	7.6	8.4	6.5	4.9	6.6	2.5	5.2	8.6	7.2	4.8	5.9	6.4	5.9	5.0	3.6	4.6	7.2	11.6	6.1	8.9	5.0	5.2	6.8	8.4	11.7	4.3	4.5	4.5	5.5	6.1	8.4	5.4	5.5	7.1	4.8	7.0	6.2	4.6	6.3	6.5	34.6	4.7	5.4	9.4	10.0	8.8	6.3	4.4	4.1	6.0	4.1	8.9	11.3	14.6	8.1	20.4	7.4	7.3	6.2	9.0	4.3	1.9	12.8	11.3	6.2	11.8	3.4	3.9	3.5	8.1	2.7	5.1	2.2	1.6	5.6	5.8	5.9	10.9	8.7	10.0	2.0	1.9	5.2	8.4	5.3	5.2	3.5	7.6	2.8	4.1	7.1	4.2	7.9	5.1	2.7	14.0	3.9	6.5	2.7	5.4	10.2	7.6	7.2	5.6	13.8	6.1	5.4	10.2	3.7	6.5	8.4	5.9	9.9	10.5	9.2	4.1	8.5	20.2	479.0	18.0	86.7	14.7	17.0	17.6	20.7	15.8	17.0	15.6	19.3	19.2	15.0	35.2	16.8	17.1	3.2	19.3	15.6	3.7	4.1	6.5	4.9	3.6	4.6	5.0	5.2	4.5	4.6	4.7	4.1	17.3	6.4	8.1	12.7	12.8	19.1	7.9	8.0	13.6	14.1	15.4	10.7	9.0	12.8	8.2	12.9	8.4	10.2	9.3	7.3	7.9	10.1	642.3	11.1	9.0	10.8	15.0	4.8	14.0	9.1	6.8	11.5	13.3	9.5	7.0	3.7	10.8	15.2	6.9	8.4	17.4	8.7	16.2	7.9	9.6	490.0	11.5	9.5	14.2	12.2	11.4	7.7	14.4	18.6	20.1	10.4	7.3	14.3	12.8	8.3	8.4	8.9	14.6	14.1	13.1	12.0	12.9	31.1	26.3	12.1	23.7	20.2	11.3	29.2	5.9	6.9
CCDC130	MGC10471	ENSG00000104957	"Coiled-coil domain containing 130"	P13994	19	13731760-13763296	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056977	Approved		Approved	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA056977: AB_2683297"	"unprognostic (6.54e-2)"	"unprognostic (5.72e-3)"	"unprognostic (2.13e-3)"	"unprognostic (1.27e-3)"	"unprognostic (2.71e-1)"	"prognostic favorable (7.83e-5)"	"unprognostic (7.04e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.69e-2)"	"prognostic favorable (2.34e-4)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.82e-4)"	24.4	20.9	17.3	20.5	21.1	23.1	26.2	18.3	24.8	30.4	21.2	24.8	17.1	27.3	3.6	22.5	28.9	11.7	26.8	17.3	20.7	26.9	24.7	27.2	23.4	22.9	20.1	37.5	25.8	13.1	28.9	15.0	22.1	27.2	7.5	13.4	24.3	10.6	28.2	26.4	29.6	10.9	17.9	31.3	25.0	20.4	21.2	16.5	32.6	11.6	12.2	25.5	27.1	28.7	14.9	10.1	19.3	19.7	12.5	9.7	11.9	15.6	13.2	14.3	13.5	9.5	10.2	12.6	11.3	12.5	11.4	14.4	8.9	8.0	4.6	21.6	26.2	9.7	34.3	14.5	24.4	9.5	24.9	13.8	17.3	17.6	12.0	15.2	16.6	23.2	9.9	22.9	9.0	11.1	25.8	21.1	13.2	7.7	20.1	22.1	9.4	17.1	11.4	16.8	11.8	15.5	10.0	10.4	25.0	9.7	8.3	22.5	13.7	23.2	9.6	27.9	20.4	36.5	14.8	10.3	20.2	22.6	16.2	18.3	12.9	20.3	13.2	11.3	16.4	15.2	14.2	14.1	13.1	18.0	13.0	14.8	13.5	14.4	15.2	10.8	12.8	11.3	17.3	21.1	18.3	24.8	17.3	20.7	22.9	20.1	22.1	17.9	21.2	28.7	25.5	9.6	17.9	21.5	29.0	13.4	15.4	20.2	15.4	30.3	18.6	18.4	14.5	8.6	18.6	29.5	27.1	17.3	31.4	25.6	7.9	17.6	40.2	22.7	24.8	22.4	18.7	16.0	19.8	15.7	19.1	19.5	53.0	26.9	24.6	34.9	17.5	10.8	18.0	26.9	24.9	18.1	24.4	18.6	33.8	24.4	19.0	21.9	24.9	15.0	24.9	26.0	17.5	14.1	30.3	18.1	25.5	17.0	27.3	12.8	32.1	18.9	23.0	41.7	26.3	16.6	23.6	35.5	20.3	19.2	15.6	35.0	31.0	31.8	17.5	11.0
CCR2	"CC-CKR-2, CD192, CKR2, CMKBR2, FLJ78302, MCP-1-R"	ENSG00000121807	"C-C motif chemokine receptor 2"	P41597	3	46353744-46360940	"CD markers, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"	"Host-virus interaction, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 40.4;Kupffer cells: 43.1;Macrophages: 25.2;monocytes: 34.9;Plasma cells: 26.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 560.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 185.5;THP-1: 89.8;U-266/70: 416.5;U-266/84: 177.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"spinal cord: 2.4"	"CAB003793, HPA063255"	Approved		Supported	"Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	"Nucleoli fibrillar center"	"CAB003793: AB_344889, HPA063255: "	"unprognostic (1.09e-2)"	"unprognostic (6.28e-4)"	"unprognostic (3.49e-2)"	"unprognostic (6.35e-4)"	"unprognostic (1.89e-2)"	"unprognostic (4.16e-4)"	"unprognostic (8.06e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (6.33e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.19e-1)"	2.6	1.9	0.1	25.9	0.1	1.9	3.1	0.1	0.2	1.6	0.3	4.6	7.5	1.2	0.9	1.2	1.2	3.4	1.1	0.1	0.1	1.2	2.1	5.8	11.6	0.4	0.2	1.1	0.8	0.3	0.2	0.8	0.2	1.2	5.1	0.0	3.1	1.7	0.5	1.9	5.7	7.1	0.3	20.4	5.2	1.0	0.2	4.3	1.1	0.5	7.2	5.5	1.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.1	0.0	0.0	2.7	0.0	185.5	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	89.8	0.0	0.0	0.0	0.0	0.3	416.5	177.7	0.0	0.1	3.3	0.1	560.9	146.2	2.6	11.9	12.8	89.2	7.9	24.3	20.2	145.2	1.8	0.6	0.7	3.8	14.0	0.4	113.6	11.4	81.6	0.1	0.1	0.1	0.2	0.1	0.1	0.4	0.2	0.2	0.3	0.2	0.3	0.1	0.0	1.3	0.0	5.8	0.3	0.0	0.0	0.6	0.0	0.1	0.1	0.3	1.5	0.0	0.0	0.0	0.1	40.4	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	4.4	0.0	0.0	0.0	0.4	1.1	0.1	0.0	0.0	1.8	0.9	0.8	0.0	0.0	0.0	0.0	43.1	10.5	0.7	0.0	25.2	0.0	0.0	34.9	0.0	1.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	8.2	0.1	0.1	0.0
CD200R1	"CD200R, HCRTR2, MOX2R, OX2R"	ENSG00000163606	"CD200 receptor 1"	Q8TD46	3	112921205-112975103	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 7.9"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 14.8;granulocytes: 15.2;Hepatic stellate cells: 14.6;Hofbauer cells: 31.8;Langerhans cells: 19.9;T-cells: 12.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	4	"basophil: 234.9"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 234.9"	"Cell line enriched"	"Detected in some"	8	"HEL: 25.5"									HPA068512			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		2000000	"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"HPA068512: AB_2732784"	"unprognostic (1.49e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.06e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.77e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.12e-3)"	1.7	1.2	0.3	3.0	0.4	1.7	1.4	0.2	0.6	0.7	0.7	1.5	1.6	0.7	0.3	3.8	0.5	1.9	0.6	0.4	0.3	0.5	2.4	1.9	4.4	0.3	0.2	0.3	0.5	0.5	0.2	5.3	0.3	0.6	2.3	0.1	0.6	0.7	0.1	2.6	2.0	1.1	0.2	7.9	1.5	0.7	0.2	3.4	0.5	0.9	4.6	1.9	0.5	0.2	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.3	25.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.0	1.2	0.0	234.9	2.9	53.6	4.0	1.3	7.0	9.9	13.8	7.9	22.9	5.6	13.4	6.1	0.8	2.5	0.4	0.5	4.3	5.2	0.3	0.4	0.2	0.6	0.4	0.3	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.0	1.1	1.6	4.4	1.9	0.1	0.0	14.8	0.0	0.2	0.3	0.3	0.0	0.1	0.0	0.0	0.3	1.9	0.0	0.0	0.0	0.1	1.0	0.1	0.5	0.0	4.0	5.7	0.0	0.2	0.9	0.0	0.1	15.2	0.0	14.6	0.1	31.8	0.0	2.2	0.0	0.0	6.7	19.9	0.0	0.0	9.1	5.4	5.6	5.2	0.0	0.0	1.0	0.7	0.1	0.0	0.0	2.7	0.1	0.0	0.1	1.2	0.0	0.0	0.3	0.4	0.8	0.3	5.8	0.9	0.7	12.4	0.0	0.0	0.2
CD244	"2B4, NAIL, NKR2B4, Nmrk, SLAMF4"	ENSG00000122223	"CD244 molecule"	Q9BZW8	1	160830160-160862887	"CD markers, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.0;lymphoid tissue: 16.8"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 28.4;Kupffer cells: 17.7;NK-cells: 66.9;T-cells: 21.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	4	"basophil: 472.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 472.1"	"Cell line enhanced"	"Detected in some"		"HEL: 20.6;HMC-1: 69.4;NB-4: 14.4;U-937: 28.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA		280000	"Cluster 46: Basophils - DNA binding"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (6.11e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.95e-6)"	"unprognostic (5.79e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.93e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.40e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.79e-1)"	2.1	0.4	0.3	3.7	0.4	10.0	0.4	0.3	0.5	0.3	0.3	1.1	3.0	0.3	0.3	0.4	0.5	1.0	0.6	0.4	0.3	0.3	4.2	3.3	3.4	0.4	0.3	1.0	0.1	0.1	0.1	0.4	0.3	0.4	1.4	0.0	1.1	0.4	0.3	0.3	2.8	1.1	0.3	16.8	1.0	2.7	0.3	2.8	0.2	0.2	2.0	1.3	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.4	6.8	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	2.1	14.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	2.6	1.1	0.1	0.0	28.7	0.0	472.1	43.3	107.9	71.3	59.1	35.2	0.3	3.7	39.7	41.0	0.2	5.3	36.0	3.1	78.5	73.6	2.4	0.2	70.7	0.3	0.4	0.3	0.5	0.4	0.3	0.4	0.3	0.3	0.3	0.3	0.4	0.1	3.2	6.1	0.3	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.0	5.2	0.0	0.1	0.2	0.0	2.1	0.7	1.7	0.0	0.3	0.5	0.1	3.8	0.0	0.7	0.2	0.6	0.0	0.1	0.0	0.0	17.7	3.1	2.4	1.8	8.3	0.0	0.0	8.5	0.0	66.9	0.0	0.2	0.0	0.0	2.2	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.2	0.1	0.0	0.1	0.0	21.9	0.5	0.0	0.0
CD84	"hCD84, mCD84, SLAMF5"	ENSG00000066294	"CD84 molecule"	Q9UIB8	1	160541095-160579516	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Autophagy, Cell adhesion, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.2"	"Cell type enhanced"	"Detected in many"		"granulocytes: 187.1;Hofbauer cells: 91.1;Kupffer cells: 177.0;Macrophages: 90.6;monocytes: 76.4;T-cells: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 23.8;HEL: 45.3;HL-60: 13.1;HMC-1: 49.7;MOLT-4: 12.9;U-698: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063316, HPA068020, HPA070502"	Enhanced		Enhanced	"Vesicles,Plasma membrane"		NA	NA		35000000	"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	Vesicles	"HPA063316: , HPA068020: , HPA070502: AB_2686274"	"unprognostic (4.38e-2)"	"unprognostic (6.16e-3)"	"unprognostic (1.00e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.54e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-1)"	3.3	2.4	1.9	19.4	2.1	7.9	2.7	2.3	2.4	2.8	1.9	3.2	2.4	1.4	0.9	2.2	1.1	6.2	1.4	1.7	1.9	0.8	5.2	7.8	24.2	5.2	3.1	1.5	2.0	0.9	0.4	7.1	4.5	1.1	4.5	0.2	1.4	3.4	0.4	1.3	4.6	4.0	3.8	15.2	3.6	1.9	5.2	9.9	1.1	0.7	13.2	4.7	0.8	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	45.3	0.1	0.0	0.0	13.1	49.7	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.9	0.1	0.0	0.0	12.9	9.7	0.0	0.0	0.0	0.4	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	30.8	0.0	2.9	0.0	32.7	9.6	15.0	8.2	8.0	6.5	6.3	7.0	10.1	7.1	6.0	4.0	7.4	1.2	1.4	3.2	4.1	10.5	8.8	1.9	2.1	2.3	2.4	1.7	1.9	5.2	3.1	4.5	3.8	5.2	7.2	1.3	0.0	6.4	0.0	27.4	2.4	0.7	0.0	0.6	0.2	0.6	1.5	1.2	2.8	1.3	0.0	0.0	0.5	20.5	0.2	0.0	0.1	0.9	0.5	0.2	4.2	0.0	21.5	0.1	0.2	0.5	1.2	2.6	0.2	187.1	0.1	3.3	1.1	91.1	0.0	0.2	0.1	0.0	177.0	42.2	1.5	0.6	90.6	5.4	34.7	76.4	0.0	4.1	0.0	0.1	0.0	0.0	0.0	10.8	0.9	0.3	0.3	0.7	0.2	0.0	1.6	1.5	0.1	0.4	0.5	2.4	1.0	46.8	2.9	0.2	0.6
CDC14A	"cdc14, Cdc14A1, Cdc14A2, DFNB105, DFNB32"	ENSG00000079335	"Cell division cycle 14A"	Q9UNH5	1	100345001-100520277	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Hearing"	"Hydrolase, Protein phosphatase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 28.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 145.9;Early spermatids: 171.5;Late spermatids: 191.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023783	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023783: AB_1846352"	"unprognostic (3.72e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-4)"	"unprognostic (4.88e-3)"	"unprognostic (6.30e-2)"	"unprognostic (3.97e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.66e-2)"	3.6	1.5	3.9	4.6	3.1	15.5	11.3	2.7	4.2	5.4	5.2	6.0	7.3	5.3	2.7	2.2	13.0	3.3	2.3	3.7	4.5	6.3	1.8	5.9	7.2	4.3	4.9	4.6	2.0	6.0	3.6	5.1	3.3	7.6	6.0	5.5	3.4	3.0	2.6	3.8	10.7	4.7	3.5	6.7	5.8	28.2	3.6	6.4	5.8	2.8	4.4	4.4	3.3	3.2	3.3	2.6	8.1	9.3	2.9	2.1	5.7	4.1	2.7	3.9	3.1	8.9	2.7	1.6	3.0	2.4	3.2	2.5	5.6	2.3	4.0	3.4	13.7	5.8	2.3	2.9	1.1	7.8	9.8	1.8	0.6	4.3	1.4	2.0	7.0	3.3	44.7	4.8	5.8	1.4	6.3	8.7	5.1	2.1	3.3	6.8	10.6	1.7	2.8	7.2	1.5	2.7	4.3	4.1	5.6	3.9	1.9	10.0	3.1	2.2	4.9	3.8	2.5	2.4	0.9	2.5	2.7	7.3	1.3	12.2	3.6	9.0	6.9	3.3	12.5	4.5	10.9	8.2	3.5	2.9	10.2	5.5	5.4	4.4	2.3	6.2	6.0	4.1	3.9	3.1	2.7	4.2	3.7	4.5	4.3	4.9	3.3	3.5	3.6	3.2	14.1	3.2	5.5	145.9	10.6	3.7	4.5	1.7	4.6	0.4	15.8	11.0	6.6	0.0	4.4	1.8	4.2	2.7	23.2	18.4	0.0	3.0	171.5	48.3	11.8	13.5	4.8	3.8	4.3	1.9	1.0	7.0	6.6	51.1	15.2	4.8	7.1	1.0	2.8	0.0	1.4	4.0	2.0	5.5	7.3	191.7	5.0	11.1	5.4	51.5	9.3	11.4	6.2	53.8	3.6	3.1	11.2	0.7	13.5	5.2	22.9	2.5	22.5	3.8	0.0	6.2	6.0	2.3	3.6	4.9	2.4	2.2	44.1	3.0	3.7	4.1
CDKL1	KKIALRE	ENSG00000100490	"Cyclin dependent kinase like 1"	Q00532	14	50326265-50416461	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 23.4;Excitatory neurons: 46.2;Oligodendrocyte precursor cells: 46.8;Oligodendrocytes: 25.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 18.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059605, HPA065919"	Uncertain		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Vesicles	"HPA059605: AB_2684080, HPA065919: AB_2685578"	"unprognostic (4.12e-3)"	"unprognostic (3.22e-1)"	"unprognostic (4.54e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.23e-3)"	"unprognostic (9.36e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.36e-2)"	"unprognostic (5.53e-8)"	"unprognostic (1.21e-1)"	"unprognostic (7.96e-2)"	"unprognostic (9.39e-3)"	"unprognostic (3.31e-3)"	13.5	3.6	3.4	4.9	4.4	3.6	3.5	1.4	9.0	13.9	3.7	8.8	13.2	13.9	3.2	5.2	15.4	5.2	2.3	5.5	2.3	19.4	1.6	6.5	6.5	2.0	2.1	13.8	1.3	1.2	0.6	6.5	2.9	5.9	6.6	20.2	2.8	9.0	7.1	13.5	6.9	8.5	2.9	7.0	4.9	2.0	1.8	1.9	7.9	1.0	2.6	6.9	6.6	8.1	7.7	4.9	3.5	4.3	5.3	6.1	2.3	2.2	3.2	1.9	2.0	4.0	5.9	6.1	2.8	3.2	3.2	5.9	0.8	0.3	1.9	8.9	3.1	12.2	4.6	3.9	6.2	9.7	5.3	1.5	3.0	3.2	8.0	2.4	6.7	10.3	3.3	4.8	1.1	2.5	2.8	4.7	1.9	2.6	3.9	3.3	3.8	3.1	5.3	6.6	4.6	3.4	4.2	18.3	2.1	1.3	2.4	6.2	4.0	6.7	4.1	7.1	5.0	2.4	1.8	2.9	1.7	8.7	7.6	3.2	1.4	2.6	3.5	1.4	3.1	2.6	2.3	3.2	0.8	3.0	1.9	1.9	0.7	2.3	0.2	0.8	2.4	1.3	3.4	4.4	1.4	9.0	5.5	2.3	2.0	2.1	2.9	2.9	1.8	8.1	3.2	19.2	9.9	6.5	3.0	3.1	4.1	0.2	3.4	0.7	0.4	0.5	0.5	0.0	2.6	11.0	0.0	0.1	2.3	7.2	5.9	1.4	0.4	23.4	9.6	3.3	1.8	6.1	46.2	1.8	0.1	7.6	1.1	4.9	1.3	3.2	6.4	0.3	0.4	0.0	20.6	2.1	2.0	0.9	1.5	1.5	9.0	1.5	0.0	7.5	0.8	0.9	2.1	46.8	25.4	1.9	4.8	3.4	0.2	3.1	4.9	8.0	20.4	0.7	0.0	4.0	4.6	0.0	0.3	4.7	2.7	0.3	4.2	3.6	5.2	2.2
CDRT4	FLJ36674	ENSG00000239704	"CMT1A duplicated region transcript 4"	Q8N9R6	17	15436015-15503608	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	36	"Early spermatids: 65.8;Late spermatids: 202.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 10.1;NB-4: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021590	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"HPA021590: AB_1848906"	"unprognostic (5.46e-6)"	"unprognostic (9.47e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.51e-2)"	"unprognostic (7.74e-3)"	"unprognostic (9.29e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.10e-5)"	"unprognostic (2.00e-3)"	"unprognostic (1.74e-6)"	"unprognostic (1.00e-1)"	"unprognostic (4.17e-1)"	"unprognostic (4.18e-1)"	"unprognostic (9.27e-2)"	5.8	18.7	14.1	1.7	12.9	6.1	9.3	14.3	12.0	19.3	13.2	10.6	0.9	8.8	23.7	10.8	20.7	3.2	5.7	12.2	13.9	16.5	10.0	8.8	5.0	11.7	13.5	20.4	19.8	1.5	48.0	2.5	11.6	20.1	4.6	11.8	15.9	3.8	1.8	21.8	11.9	2.3	8.4	15.9	11.4	15.3	14.7	3.2	23.5	0.8	2.9	9.0	12.8	12.0	2.5	2.2	2.8	1.0	2.4	1.7	2.9	0.9	2.5	1.1	1.0	1.4	0.7	0.0	1.2	1.4	0.2	0.8	3.0	2.4	1.7	0.5	0.4	0.4	2.0	10.1	0.7	0.9	3.9	1.9	3.6	1.6	4.0	4.3	2.6	1.0	0.5	1.6	2.1	0.4	1.0	8.0	0.9	0.4	0.8	0.4	0.0	0.0	2.9	2.0	0.4	1.3	0.8	0.4	0.8	6.2	1.1	2.0	2.4	0.3	1.1	1.0	1.0	2.2	0.9	0.1	0.0	0.0	0.3	0.9	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	14.1	12.9	14.3	12.0	12.2	13.9	11.7	13.5	11.6	8.4	14.7	12.0	0.4	0.0	1.1	0.0	0.3	0.1	0.2	0.2	0.0	1.4	0.6	0.5	0.1	0.0	0.1	0.0	0.0	0.4	0.2	0.6	0.0	0.8	65.8	0.7	0.2	0.2	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.4	2.5	1.4	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	202.7	0.0	0.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.6	1.8	0.0	0.0	0.4	0.4	0.0	3.7	1.5	0.0	0.3	0.2	1.0	0.7	0.0	0.0	0.1	0.2	0.5	1.0	0.3
CELA2B	"ELA2B, RP11-265F14.2"	ENSG00000215704	"Chymotrypsin like elastase 2B"	P08218	1	15465909-15491395	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1672	"pancreas: 20446.9"	"Cell type enriched"	"Detected in some"	73	"Exocrine glandular cells: 1227.6"	"Cancer enriched"	"Detected in single"	574	"pancreatic cancer: 69.9"	"Group enriched"	"Detected in some"	4	"cerebellum: 2.0;cerebral cortex: 3.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"U-138 MG: 3.9"														"Secreted to digestive system"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 25: Pancreas - Digestion"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 1: Pancreatic cells - Digestion"				"unprognostic (4.36e-3)"	"unprognostic (5.45e-2)"	"unprognostic (6.66e-2)"	"unprognostic (5.31e-3)"	"unprognostic (4.47e-3)"	"unprognostic (1.37e-3)"	"unprognostic (4.66e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.22e-6)"	"unprognostic (2.47e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.80e-2)"	1.1	3.0	0.0	0.5	0.0	1.0	0.6	2.0	3.2	0.4	0.0	0.2	3.7	0.4	0.1	0.3	0.1	0.6	4.5	0.3	0.6	0.2	0.6	0.3	1.2	0.2	0.2	12.2	20446.9	0.0	0.1	1.2	0.0	0.3	0.0	1.7	3.4	0.0	0.3	1.0	2.4	0.0	0.0	0.3	1.2	0.7	0.4	0.0	0.8	0.0	0.0	0.1	0.1	0.3	0.0	0.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.5	0.8	0.4	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.2	0.3	0.6	0.2	0.2	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	0.0	1.4	1227.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.1	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0
CENPE	"KIF10, PPP1R61"	ENSG00000138778	"Centromere protein E"	Q02224	4	103105349-103198445	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein, Motor protein"	"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 10.0;lymphoid tissue: 9.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 75.1;Extravillous trophoblasts: 28.4;Granulosa cells: 32.0;Spermatocytes: 75.3;Spermatogonia: 51.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA011110, HPA042294"	Enhanced		Enhanced	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA011110: , HPA042294: AB_10797386"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.64e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.40e-8)"	"unprognostic (2.49e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.88e-5)"	"unprognostic (1.15e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.95e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-1)"	0.4	0.2	0.4	2.7	0.4	10.0	0.6	0.3	0.5	0.4	0.4	1.8	1.5	0.6	0.0	2.0	0.2	0.8	0.2	0.3	0.6	0.2	0.5	0.8	5.6	0.5	0.5	0.1	0.1	0.3	0.0	1.4	0.9	0.3	2.0	0.4	0.3	0.2	0.0	2.0	1.7	1.1	0.3	1.2	1.1	4.1	0.5	9.2	0.2	0.6	4.9	0.8	0.6	0.5	42.6	11.8	42.2	20.5	2.7	6.2	8.4	36.7	18.2	26.9	17.9	19.6	22.2	28.6	9.2	13.7	19.2	18.2	30.3	15.1	42.2	35.9	11.3	33.5	26.8	13.6	0.4	39.9	18.6	1.8	1.1	21.7	18.0	6.0	22.9	25.2	34.4	32.5	34.8	15.6	31.5	18.9	13.8	17.0	17.9	20.9	38.5	9.3	8.0	8.4	19.3	11.5	32.9	22.9	9.0	16.0	12.9	13.9	26.1	25.8	27.2	27.2	38.6	15.9	28.6	28.8	14.2	21.7	27.8	2.9	0.0	0.3	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.3	1.5	0.2	0.6	0.0	0.4	0.4	0.3	0.5	0.3	0.6	0.5	0.5	0.9	0.3	0.5	0.5	1.4	3.2	2.2	1.0	6.6	3.6	1.5	2.9	0.0	7.6	1.8	2.7	1.9	0.0	1.3	0.0	8.4	12.7	3.9	4.7	0.0	0.5	7.7	3.5	5.7	4.2	1.2	75.1	2.0	0.0	28.4	6.5	4.6	6.9	7.0	32.0	4.2	0.9	14.1	0.0	1.9	4.3	4.1	10.4	5.7	3.5	0.9	9.6	0.0	0.0	6.0	1.3	2.1	0.5	3.1	1.8	1.4	2.6	16.0	1.4	0.8	0.3	0.3	2.6	0.0	5.7	7.4	75.3	51.0	8.3	2.8	3.6	6.6	7.0	11.6	1.9
CERS2	"FLJ10243, LASS2, SP260"	ENSG00000143418	"Ceramide synthase 2"	Q96G23	1	150960583-150975003	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 732.2"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 200.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027262, HPA078737"	Approved		Supported	"Nuclear membrane,Endoplasmic reticulum"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 15: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Nuclear membrane, Endoplasmic reticulum"		"HPA027262: AB_1852717, HPA078737: "	"unprognostic (1.01e-1)"	"unprognostic (2.70e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.29e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.03e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.05e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.85e-1)"	95.0	307.2	126.3	53.1	171.3	80.1	100.1	170.2	165.7	96.8	141.7	81.5	94.5	79.9	89.6	46.2	94.1	97.1	71.8	125.5	144.8	261.4	732.2	135.0	56.4	201.5	168.5	104.4	129.3	159.4	84.7	113.8	192.1	83.2	88.6	38.1	61.5	82.7	37.5	46.9	102.8	99.2	158.7	65.1	128.0	49.8	157.2	67.5	161.4	57.3	69.9	91.0	70.7	223.7	154.3	175.8	138.1	277.9	395.1	237.1	100.8	153.1	217.9	278.1	189.1	188.4	248.5	137.7	244.3	242.4	174.6	165.5	195.5	160.7	247.6	194.0	157.7	193.4	107.5	219.3	277.6	216.4	218.5	214.0	197.9	254.3	315.6	341.4	174.3	189.8	210.4	281.0	363.4	255.6	134.2	135.7	200.9	499.4	299.6	160.0	95.4	208.4	311.5	127.2	121.7	185.8	169.6	278.7	183.8	172.1	335.6	296.5	145.4	196.4	93.6	180.1	267.9	189.5	229.0	841.7	222.4	91.0	200.7	212.1	80.2	136.0	76.9	43.7	93.6	34.6	70.3	78.8	69.5	31.9	60.6	60.1	86.5	63.4	32.8	70.1	86.7	88.5	126.3	171.3	170.2	165.7	125.5	144.8	201.5	168.5	192.1	158.7	157.2	223.7	46.3	67.3	67.9	8.8	23.1	24.1	38.2	37.0	18.2	7.5	52.8	27.6	2.8	120.1	23.2	53.3	4.2	77.8	40.2	60.7	13.7	104.6	7.5	24.9	39.9	47.9	24.6	24.8	5.5	92.8	42.4	44.2	16.3	29.7	36.8	33.0	38.9	200.5	55.9	3.3	5.9	29.3	30.5	45.2	35.2	7.9	56.2	54.5	37.4	5.6	39.4	26.5	26.8	7.5	51.3	103.7	32.4	40.3	29.2	52.4	98.8	81.7	21.2	9.9	39.5	37.2	33.8	13.8	6.8	13.9	15.6	54.2	34.3	39.0	29.1	34.2
CGRRF1	"CGR19, RNF197"	ENSG00000100532	"Cell growth regulator with ring finger domain 1"	Q99675	14	54509812-54539292	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 145.4;Spermatocytes: 112.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002930	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA002930: AB_1078507"	"unprognostic (1.81e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.61e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (2.25e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.64e-3)"	"prognostic favorable (2.57e-8)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.74e-1)"	9.9	9.2	20.5	3.9	21.1	7.9	11.9	22.2	25.8	9.6	21.2	11.7	5.3	11.0	13.8	5.9	11.2	5.9	12.3	20.2	21.2	14.5	7.8	7.5	6.0	21.2	21.4	10.0	13.1	12.8	12.7	7.0	21.2	11.3	6.9	13.6	8.5	10.9	19.3	4.2	8.5	8.6	22.1	8.5	9.7	22.3	20.9	5.6	12.7	12.5	5.3	10.1	7.5	22.3	10.4	8.6	9.7	8.6	16.7	10.6	7.3	9.5	10.2	14.6	15.2	8.7	11.7	5.9	11.9	8.2	15.8	9.1	10.8	8.4	18.5	11.9	8.7	8.3	1.7	10.6	20.1	4.6	4.4	10.9	16.7	11.0	18.1	9.6	10.6	9.3	3.3	7.6	13.6	19.0	4.9	7.2	6.0	9.5	15.3	10.8	12.3	2.9	11.8	13.3	6.4	6.3	8.3	3.9	16.1	8.7	11.3	4.2	9.3	18.2	14.3	7.2	8.7	5.0	6.4	8.5	10.0	5.6	12.0	61.9	12.4	22.6	19.1	15.4	18.7	18.2	19.9	20.2	10.4	19.4	20.0	18.6	12.5	20.3	19.0	9.0	22.3	19.7	20.5	21.1	22.2	25.8	20.2	21.2	21.2	21.4	21.2	22.1	20.9	22.3	20.3	9.6	11.5	21.5	22.6	7.6	17.4	26.7	16.5	18.6	18.3	18.7	22.1	14.3	17.3	16.5	10.4	14.7	21.8	17.5	23.5	21.6	145.4	13.7	15.1	20.3	10.7	4.2	14.2	16.9	11.5	22.3	5.6	13.1	29.2	12.7	18.9	10.6	17.0	11.8	13.8	9.1	28.5	14.8	10.3	41.5	16.8	24.8	16.0	12.2	15.5	29.4	16.5	17.1	24.3	17.7	13.1	22.6	11.5	16.8	15.6	27.3	22.6	15.9	19.7	17.0	25.0	112.2	36.0	10.0	3.4	12.0	24.0	12.3	11.0	14.0
CHD7	"CRG, FLJ20357, FLJ20361, KIAA1416"	ENSG00000171316	"Chromodomain helicase DNA binding protein 7"	Q9P2D1	8	60678740-60868028	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 241.8;Oligodendrocyte precursor cells: 298.6;Oligodendrocytes: 255.7;Rod photoreceptor cells: 198.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"B-cells: 14.9;granulocytes: 17.6;T-cells: 6.6"	"Cell line enhanced"	"Detected in many"		"AF22: 51.5;SCLC-21H: 46.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053075			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Nucleoli	"HPA053075: AB_2682035"	"unprognostic (3.77e-2)"	"unprognostic (3.28e-3)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (5.34e-5)"	"unprognostic (9.59e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.09e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.17e-1)"	3.6	1.9	10.3	3.9	17.2	22.1	3.5	71.5	11.0	2.0	2.5	4.6	4.6	2.2	2.2	4.9	2.3	1.9	3.8	9.4	11.5	3.8	3.2	4.6	5.8	19.7	17.2	1.0	4.4	5.3	6.1	4.3	18.8	2.7	4.0	23.7	3.9	1.7	10.4	5.2	6.4	1.7	11.4	5.6	3.5	2.9	15.6	2.6	4.1	4.1	5.7	3.4	3.2	17.7	8.0	4.0	51.5	9.2	0.1	0.0	16.2	0.4	0.1	1.8	1.6	10.0	7.3	15.5	0.9	0.1	2.3	4.8	26.7	7.9	1.6	5.9	14.3	36.5	7.0	13.2	2.1	11.1	6.5	1.0	5.9	0.0	8.5	3.1	7.7	12.5	2.7	13.4	1.2	8.3	17.5	12.7	35.4	8.1	1.8	36.0	12.1	5.0	4.1	9.1	46.9	23.2	1.4	5.9	14.9	18.0	10.5	10.5	9.0	0.5	8.3	0.5	4.3	14.2	8.7	23.7	3.0	1.2	13.4	14.9	0.4	17.6	3.2	0.2	4.1	10.1	3.6	1.1	0.1	14.9	6.6	2.4	9.3	0.0	0.8	0.8	0.3	0.6	10.3	17.2	71.5	11.0	9.4	11.5	19.7	17.2	18.8	11.4	15.6	17.7	35.9	32.1	17.5	68.6	64.3	30.3	35.9	10.8	9.6	36.3	16.6	14.6	35.8	27.1	20.7	16.5	241.8	8.2	17.4	31.8	1.9	17.7	15.9	34.0	4.1	40.5	87.3	3.8	6.8	11.3	8.6	6.4	28.5	37.6	41.0	39.8	21.4	12.6	14.9	70.7	17.8	39.9	32.6	10.8	10.4	8.9	0.9	13.6	21.4	118.0	13.9	121.3	15.5	298.6	255.7	16.9	27.4	0.4	29.1	42.9	17.4	5.4	20.4	198.5	0.0	49.7	9.8	8.0	12.9	25.5	32.4	6.2	21.4	3.0	34.1	35.8
CLEC16A	"Gop-1, KIAA0350"	ENSG00000038532	"C-type lectin domain containing 16A"	Q2KHT3	16	10944564-11182186	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 130.9;Early spermatids: 118.7;Excitatory neurons: 93.3;Inhibitory neurons: 135.1;Late spermatids: 84.8;Oligodendrocyte precursor cells: 69.4;Oligodendrocytes: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HDLM-2: 110.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035814, HPA035815, HPA061385"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 43: Testis - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Vesicles"		"HPA035814: AB_10600801, HPA035815: AB_10671937, HPA061385: AB_2684498"	"unprognostic (3.41e-1)"	"unprognostic (4.58e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.22e-3)"	"unprognostic (4.54e-2)"	"unprognostic (7.78e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.49e-1)"	"prognostic favorable (2.92e-6)"	"unprognostic (2.69e-1)"	"unprognostic (1.79e-1)"	"unprognostic (8.22e-2)"	"unprognostic (3.03e-1)"	10.2	12.8	12.1	7.2	13.4	13.2	9.4	16.7	17.3	11.2	23.6	9.5	8.2	9.0	6.9	13.9	9.4	4.8	14.6	11.3	11.1	16.6	16.2	12.8	9.3	13.8	14.5	8.2	8.9	11.7	17.3	7.0	13.8	11.3	5.9	11.5	9.1	5.7	17.5	14.2	10.8	6.2	9.7	12.4	10.4	46.8	21.0	10.9	13.3	8.3	8.8	9.1	10.4	11.7	11.6	12.1	9.0	11.9	14.8	10.3	8.0	11.7	11.4	9.6	12.5	13.5	21.1	22.8	26.6	14.3	10.6	10.1	11.6	21.7	12.3	110.3	12.5	10.4	16.4	14.4	10.4	11.5	21.5	12.3	10.4	15.9	13.4	8.8	13.3	12.4	17.6	13.8	11.5	19.0	18.2	9.1	7.2	10.0	9.5	24.6	7.6	13.5	20.1	8.4	11.5	15.3	16.8	17.1	9.1	10.4	12.1	17.7	14.2	12.4	16.1	18.3	10.4	9.7	9.2	18.7	15.5	16.4	13.1	2.7	1.9	1.4	2.2	1.5	1.3	1.7	1.8	1.5	1.5	2.8	2.1	1.8	2.6	1.8	3.0	2.0	1.4	1.1	12.1	13.4	16.7	17.3	11.3	11.1	13.8	14.5	13.8	9.7	21.0	11.7	7.1	16.0	10.0	130.9	12.8	7.1	3.7	5.9	11.4	11.7	5.2	5.1	5.9	8.6	8.8	3.7	37.5	3.4	5.5	12.1	0.0	6.0	118.7	7.5	6.0	6.1	7.7	8.6	93.3	6.4	2.6	6.2	9.2	8.0	8.2	5.7	9.7	12.6	4.8	11.8	135.1	7.9	6.1	5.4	6.2	84.8	5.6	6.8	3.6	40.3	8.6	3.9	4.1	69.4	72.9	6.5	4.0	8.6	8.8	3.5	10.3	3.5	8.9	18.3	0.0	7.4	4.5	27.1	8.4	13.4	8.2	3.8	8.6	3.3	6.7	4.9
CLGN		ENSG00000153132	Calmegin	O14967	4	140388453-140427661	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 59.5;testis: 113.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 313.3;Early spermatids: 162.4;Endometrial ciliated cells: 93.4;Muller glia cells: 176.4;Spermatocytes: 465.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 53.0;MOLT-4: 47.8;U-251 MG: 73.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020709, HPA048761, HPA058627"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 43: Testis - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Endoplasmic reticulum"		"CAB020709: , HPA048761: AB_2680514, HPA058627: AB_2683782"	"unprognostic (6.74e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.73e-3)"	"unprognostic (6.14e-2)"	"unprognostic (4.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.38e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.01e-1)"	0.4	6.6	0.9	1.0	0.7	2.4	2.7	3.8	1.6	0.9	2.0	2.6	0.5	1.6	0.6	1.2	13.7	0.4	59.5	0.9	2.6	0.4	3.2	0.5	0.7	2.7	1.9	0.3	2.2	0.6	11.2	0.2	2.6	22.5	1.3	17.2	1.0	0.7	0.4	0.2	1.3	1.5	1.2	0.2	2.0	113.6	2.3	2.4	2.7	1.6	1.2	0.6	0.1	0.9	0.2	10.2	10.3	6.9	4.0	21.1	2.4	0.1	9.4	10.0	18.6	0.3	0.9	0.0	27.8	0.9	8.4	0.2	7.5	0.1	16.2	0.4	9.0	3.0	9.8	7.4	41.4	38.9	0.6	2.2	39.2	1.0	0.9	53.0	0.2	9.6	2.0	0.0	0.0	0.5	47.8	0.5	12.0	0.2	28.1	31.5	0.0	0.4	0.0	0.3	16.8	29.8	6.5	4.1	1.8	3.8	1.9	5.6	0.0	27.4	4.7	9.7	73.6	14.4	31.7	19.9	43.4	1.6	2.9	0.9	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	3.8	1.6	0.9	2.6	2.7	1.9	2.6	1.2	2.3	0.9	0.8	0.0	2.2	0.3	0.1	0.0	0.9	8.5	1.2	9.2	3.3	1.8	313.3	0.0	6.4	0.0	4.2	0.5	0.0	0.5	0.0	1.2	162.4	93.4	1.3	11.9	5.3	8.6	7.2	4.2	0.1	10.2	0.0	11.3	0.0	10.1	0.7	3.7	0.1	25.2	6.7	0.4	30.5	0.0	0.0	60.2	5.0	0.7	1.8	0.0	0.1	176.4	0.0	6.6	0.6	0.9	3.9	4.5	0.1	33.8	0.2	0.1	24.6	16.3	0.0	0.6	2.0	465.5	23.9	2.8	0.1	0.3	0.7	0.2	0.8	1.3
CLINT1	"CLINT, ENTH, EPNR, KIAA0171"	ENSG00000113282	"Clathrin interactor 1"	Q14677	5	157785743-157859145	"Plasma proteins, Predicted intracellular proteins, Transporters"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"basophil: 749.5"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 749.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043280, HPA056947"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA		540000	"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	Nucleoplasm	"HPA043280: AB_10793944, HPA056947: AB_2683283"	"unprognostic (1.92e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (2.95e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.88e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (3.56e-1)"	28.6	34.4	10.3	42.8	11.9	101.1	31.4	10.6	14.8	36.4	17.7	53.9	68.3	26.4	54.2	72.0	37.8	61.4	34.2	11.8	12.7	70.4	89.5	36.3	49.4	11.8	11.9	26.9	49.3	113.2	17.8	47.1	11.4	29.5	53.4	16.0	50.8	42.4	53.1	39.7	55.7	31.9	11.0	31.0	69.2	20.3	12.4	50.7	56.0	41.0	73.8	64.5	38.8	11.4	65.6	91.7	64.3	59.8	86.3	71.0	91.6	89.7	87.5	83.4	115.9	128.7	100.0	121.3	100.3	82.6	112.0	95.8	87.1	100.4	120.7	57.9	70.4	80.6	80.4	65.2	85.5	112.9	105.6	52.5	75.6	94.7	105.6	53.6	80.0	69.6	70.6	66.1	69.9	56.7	88.7	60.5	67.8	63.6	93.9	78.8	96.9	103.0	84.8	115.4	56.6	62.1	64.5	111.7	87.4	81.2	76.4	78.0	83.7	74.6	56.3	69.5	89.4	76.1	77.9	154.4	61.0	126.2	67.5	749.5	46.5	179.7	43.6	49.2	75.2	47.5	41.4	43.7	62.7	46.2	35.9	38.8	17.6	58.6	53.4	48.5	66.2	53.1	10.3	11.9	10.6	14.8	11.8	12.7	11.8	11.9	11.4	11.0	12.4	11.4	68.6	60.9	132.9	25.1	76.0	57.1	83.7	69.4	80.2	21.6	74.4	44.2	103.9	105.8	137.8	68.0	8.4	45.1	73.8	73.5	95.9	93.4	4.1	116.5	82.4	52.8	54.5	54.9	31.9	64.0	71.9	71.8	119.3	141.9	84.7	40.2	21.0	86.8	30.5	11.8	29.0	78.9	38.7	42.9	87.8	5.6	47.2	73.0	35.6	28.1	94.1	25.5	73.2	39.2	31.4	53.7	62.6	28.6	158.3	92.5	50.3	94.5	148.5	19.0	39.5	67.2	61.9	44.2	40.2	156.3	78.3	68.3	65.5	82.0	99.0	271.5
CNOT6L	"Ccr4b, DKFZp434K098"	ENSG00000138767	"CCR4-NOT transcription complex subunit 6 like"	Q96LI5	4	77713387-77819615	"Enzymes, Predicted intracellular proteins"	"mRNA processing, RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 366.6;T-cells: 240.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042688	Uncertain		Supported	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA042688: AB_10794384"	"unprognostic (3.91e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.72e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (4.51e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-3)"	11.8	9.5	6.9	22.4	7.7	29.5	13.4	14.4	8.1	12.4	6.1	12.9	13.1	11.1	9.8	16.6	11.6	14.0	6.1	6.4	10.1	13.2	19.6	11.6	36.1	7.5	7.7	13.6	19.9	17.8	6.0	22.5	7.1	11.7	15.5	12.9	12.6	12.2	7.2	13.7	13.6	14.5	8.2	23.6	14.7	11.2	11.5	49.5	14.4	8.6	38.5	15.7	8.4	9.0	17.0	9.6	12.5	9.1	14.7	13.6	13.1	13.1	17.8	11.9	15.9	3.5	18.3	26.5	15.4	18.9	8.6	10.9	17.5	18.7	14.9	28.4	10.0	25.4	9.8	10.3	9.1	24.0	22.9	8.1	22.7	12.1	24.3	10.9	38.2	21.2	22.7	38.0	13.9	9.0	52.3	14.0	6.2	13.4	3.2	12.4	38.4	21.5	12.5	13.5	16.0	7.2	23.3	20.1	7.9	15.4	6.8	13.7	35.6	10.9	11.5	19.9	7.3	48.1	21.0	35.1	12.3	11.9	8.6	21.4	4.4	10.6	9.4	7.0	9.9	5.5	7.2	7.7	4.4	7.2	6.7	8.2	6.9	8.2	10.3	6.4	6.4	4.1	6.9	7.7	14.4	8.1	6.4	10.1	7.5	7.7	7.1	8.2	11.5	9.0	93.0	22.4	21.0	34.3	101.1	57.9	13.3	15.9	59.2	39.5	30.5	20.8	16.7	31.5	24.0	36.8	39.6	31.1	366.6	16.9	60.7	8.2	4.7	30.1	24.6	54.0	26.3	31.5	74.8	12.4	8.6	25.1	26.5	46.2	38.0	22.1	45.3	32.6	17.1	32.0	70.7	29.8	14.2	41.0	50.1	3.7	18.6	50.0	24.9	105.9	39.2	19.3	128.8	68.9	60.7	11.0	16.1	12.8	178.5	33.9	28.4	26.3	17.0	43.5	32.9	26.6	29.2	49.4	39.9	44.7	66.1	24.4	240.0	37.9	24.1	26.7
COG3	SEC34	ENSG00000136152	"Component of oligomeric golgi complex 3"	Q96JB2	13	45464898-45536701	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040353, HPA054470"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA040353: AB_10794027, HPA054470: AB_2732585"	"unprognostic (1.75e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.04e-3)"	"unprognostic (9.69e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (9.53e-4)"	"unprognostic (5.82e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.71e-1)"	11.2	15.0	7.5	9.3	7.7	11.8	15.6	10.5	9.3	15.2	10.5	16.2	12.6	13.0	16.8	12.4	12.2	9.5	11.8	7.4	7.2	12.3	29.5	10.4	10.7	7.0	7.0	15.1	20.8	12.3	14.9	13.0	7.0	18.7	18.9	10.0	18.0	12.4	11.4	13.2	13.2	12.1	6.8	12.4	14.7	9.7	7.5	12.2	17.0	9.7	10.9	12.7	13.1	9.4	8.3	7.4	13.9	12.6	17.9	20.4	13.2	13.5	19.1	15.4	12.8	10.8	14.9	11.3	5.9	16.2	11.4	17.7	11.6	13.7	23.3	8.9	9.3	12.7	9.2	19.2	22.1	18.8	11.7	15.4	20.3	10.3	36.1	18.6	15.2	11.0	8.3	6.8	18.7	12.9	10.5	17.6	11.4	41.5	8.7	12.1	8.1	10.6	14.4	13.4	6.9	12.5	8.7	17.1	18.2	13.1	11.7	19.3	14.4	7.4	5.7	13.9	8.7	9.4	5.4	11.7	14.2	9.4	13.5	3.5	1.9	3.6	3.4	2.2	3.6	2.2	2.6	2.9	1.4	2.3	2.9	2.7	1.7	2.5	1.3	3.4	3.0	1.7	7.5	7.7	10.5	9.3	7.4	7.2	7.0	7.0	7.0	6.8	7.5	9.4	15.8	9.6	31.4	23.2	18.9	15.8	15.2	13.1	14.2	9.7	22.0	17.9	19.7	24.3	19.8	12.9	14.6	14.2	35.5	32.5	15.6	11.6	24.1	15.0	20.1	16.7	22.2	11.4	39.3	37.9	18.8	14.3	26.0	30.8	17.1	22.4	18.9	72.8	10.8	10.1	34.7	54.5	6.1	20.9	9.0	9.0	14.0	13.3	10.6	22.5	13.2	7.6	15.5	34.2	36.9	22.7	32.8	13.5	31.3	26.6	29.4	17.3	11.7	11.2	6.6	12.8	11.7	12.7	8.9	17.7	16.1	32.8	21.2	21.7	24.4	37.3
COG6	"COD2, KIAA1134"	ENSG00000133103	"Component of oligomeric golgi complex 6"	Q9Y2V7	13	39655627-39791665	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 123.1;Inhibitory neurons: 99.9;Oligodendrocyte precursor cells: 82.9;Oligodendrocytes: 89.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040410, HPA040441"	Uncertain		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles, Golgi apparatus"		"HPA040410: AB_10793964, HPA040441: AB_10794030"	"unprognostic (2.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.81e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.81e-2)"	"unprognostic (9.59e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.60e-3)"	"prognostic favorable (2.81e-4)"	"unprognostic (4.87e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.24e-1)"	8.7	10.5	2.1	7.9	3.8	2.1	9.7	5.3	5.8	12.0	5.0	9.3	10.5	9.2	4.4	10.6	9.9	10.5	15.8	5.5	2.6	9.8	8.9	6.8	8.3	2.1	2.3	14.2	19.0	18.3	13.3	13.7	3.2	13.0	8.4	7.2	13.0	8.8	6.4	10.1	9.7	7.7	1.7	8.0	12.5	16.4	2.1	8.8	14.0	8.5	7.7	10.2	6.4	6.1	10.8	7.0	10.8	7.7	21.0	26.5	20.6	17.0	24.1	14.2	17.4	8.6	16.8	18.2	9.6	24.7	16.7	13.5	11.5	12.9	15.1	21.5	16.1	17.7	7.0	12.5	12.0	17.9	18.1	11.2	15.9	8.9	10.0	17.8	13.9	16.5	7.5	6.8	23.1	11.0	13.4	16.5	10.6	30.2	8.9	12.8	29.3	8.8	10.0	13.6	6.3	8.2	15.4	12.8	13.0	14.8	14.9	11.2	20.7	7.9	9.3	17.6	8.5	5.3	5.5	13.6	23.4	9.5	23.6	3.0	3.2	4.0	3.8	5.0	6.6	4.7	4.9	5.3	4.5	4.4	4.1	5.4	0.7	7.1	3.1	2.5	6.4	4.2	2.1	3.8	5.3	5.8	5.5	2.6	2.1	2.3	3.2	1.7	2.1	6.1	8.7	19.2	7.8	46.0	12.6	9.7	5.9	9.5	8.0	15.2	11.0	8.4	22.0	2.8	10.2	12.9	10.4	15.6	9.5	9.9	5.9	7.7	23.4	13.9	14.8	8.5	9.1	9.5	123.1	10.0	29.6	12.3	10.7	13.0	10.1	9.7	12.1	9.6	8.6	5.0	99.9	19.8	8.2	6.7	3.9	12.6	13.4	7.6	1.8	37.5	5.9	15.5	7.2	82.9	89.4	8.7	10.8	12.8	17.7	5.0	10.2	12.4	13.2	12.5	6.6	12.2	9.7	39.0	27.4	11.9	13.4	16.0	10.3	12.6	10.3	5.7
CRIM1	S52	ENSG00000150938	"Cysteine rich transmembrane BMP regulator 1"	Q9NZV1	2	36355778-36551135	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 163.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 262.9;Hepatic stellate cells: 207.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 466.5;fHDF/TERT166: 462.5;TIME: 651.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000556	Enhanced				"Intracellular and membrane"	NA	NA		170000	"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA000556: AB_1078567"	"unprognostic (2.15e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.11e-3)"	"unprognostic (8.19e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (9.51e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.67e-2)"	88.3	14.6	27.0	18.8	28.1	3.5	58.9	9.4	23.5	26.7	51.4	28.7	14.9	26.6	16.7	30.5	34.4	32.2	34.5	20.3	28.8	70.0	16.0	50.1	14.8	23.5	21.9	36.9	23.5	29.2	7.4	163.8	21.2	25.8	23.2	29.5	31.1	32.6	50.1	27.2	18.2	35.7	22.1	47.1	17.5	12.4	36.1	9.9	33.8	36.5	8.7	38.9	22.2	17.1	100.9	75.4	15.2	17.5	69.1	78.0	125.0	466.5	244.7	255.4	133.4	95.3	34.2	0.2	297.9	462.5	166.1	42.8	11.4	75.2	206.5	1.1	8.7	3.2	96.7	55.5	221.5	2.2	0.6	110.1	55.2	102.4	182.4	238.4	361.9	1.9	4.7	0.7	271.6	9.2	0.2	1.2	11.9	5.2	22.1	5.4	19.6	15.5	159.8	41.1	1.8	0.2	81.5	26.4	3.4	56.2	72.3	2.0	651.1	321.7	116.1	40.4	229.1	25.5	0.5	0.9	94.7	0.4	100.8	1.4	0.1	0.5	0.6	0.0	0.4	0.3	0.2	0.3	0.1	0.2	0.0	0.3	0.2	0.4	0.6	2.1	0.2	0.0	27.0	28.1	9.4	23.5	20.3	28.8	23.5	21.9	21.2	22.1	36.1	17.1	262.9	12.8	43.3	100.2	5.4	66.0	38.5	30.1	43.9	12.0	55.6	72.9	34.4	47.1	26.5	132.4	2.1	111.9	27.1	49.5	3.9	33.5	1.0	37.1	27.7	159.8	31.8	10.7	85.1	2.6	40.6	41.0	10.2	75.9	1.3	27.4	207.1	3.6	27.7	0.0	57.5	37.7	36.7	7.7	32.5	2.0	19.0	8.2	39.2	135.9	7.1	18.5	6.2	65.9	17.2	26.5	30.9	19.9	6.9	75.5	11.5	38.4	28.9	42.5	46.0	18.4	164.6	2.1	9.4	22.0	30.1	173.5	17.1	5.7	33.2	58.3
CSNK2A2	"CK2alpha', CSNK2A1"	ENSG00000070770	"Casein kinase 2 alpha 2"	P19784	16	58157907-58198106	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 112.7"	"Group enriched"	"Detected in all"	5	"Early spermatids: 227.4;Late spermatids: 281.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		92000	"Cluster 46: Basophils - DNA binding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"				"unprognostic (9.49e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.40e-5)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (6.84e-3)"	"unprognostic (2.93e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.06e-3)"	"unprognostic (7.07e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.14e-2)"	21.0	14.1	19.3	9.0	20.2	6.4	19.0	18.9	22.1	23.0	23.7	32.1	10.0	21.0	29.0	15.7	20.3	14.1	21.2	20.0	19.7	17.3	15.9	16.2	14.2	19.1	20.4	32.4	34.2	23.9	15.7	15.5	19.2	15.5	12.4	13.5	17.0	16.7	41.1	64.8	14.2	21.9	19.8	12.6	27.9	112.7	20.3	18.3	18.0	26.8	17.3	24.2	19.6	19.9	28.1	35.3	24.5	19.1	46.2	62.5	27.6	24.7	41.8	47.7	30.7	64.0	23.2	44.2	38.8	29.6	18.9	29.2	41.6	37.2	53.4	16.9	28.3	23.4	18.0	56.1	66.5	32.6	20.5	66.9	88.9	33.8	65.9	62.0	45.4	43.6	53.4	15.1	31.0	15.8	41.2	21.9	23.4	16.6	45.7	48.4	38.7	25.7	33.1	28.7	20.5	18.4	39.7	20.3	63.6	41.9	13.9	24.6	33.6	27.8	33.7	23.3	25.7	36.2	30.2	63.2	24.3	21.8	24.4	1.1	0.2	0.3	0.7	0.1	0.4	0.6	1.1	0.4	0.2	0.6	1.8	1.3	0.0	0.7	0.1	1.9	0.0	0.1	19.3	20.2	18.9	22.1	20.0	19.7	19.1	20.4	19.2	19.8	20.3	19.9	30.6	12.8	22.5	19.2	16.7	29.6	10.9	13.0	8.6	24.0	19.3	19.9	24.4	12.8	7.6	9.2	4.2	15.9	28.3	16.4	7.9	14.5	227.4	24.7	37.8	25.8	16.8	10.3	27.7	17.2	26.1	17.7	8.6	29.5	8.2	37.0	19.6	17.0	16.9	18.5	19.1	11.9	4.1	25.5	23.0	281.0	14.3	23.1	12.4	20.6	14.2	25.3	18.6	20.6	26.1	25.0	11.5	19.5	9.2	18.1	16.0	16.3	13.4	21.7	13.1	29.2	23.2	48.1	36.8	12.6	29.0	24.5	20.3	35.6	17.5	23.0
CTCF	"CFAP108, FAP108"	ENSG00000102974	"CCCTC-binding factor"	P49711	16	67562467-67639177	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Chromosome partition, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004122, CAB062550, CAB068181, CAB068182"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB062550: AB_2665624, CAB068181: AB_2665625, CAB068182: AB_2665626, HPA004122: AB_2667139"	"unprognostic (2.70e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.70e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (1.71e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (3.47e-1)"	"unprognostic (5.99e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.11e-2)"	17.3	14.5	10.6	20.6	12.2	34.6	17.5	17.4	12.7	21.3	7.4	18.9	15.9	20.8	13.8	20.2	19.9	14.6	15.9	10.7	11.9	18.4	18.7	16.4	29.0	10.3	10.2	22.3	18.4	28.3	12.9	20.4	10.3	17.2	21.6	18.4	17.1	17.7	30.5	23.3	19.4	20.3	9.0	22.7	18.3	10.5	10.2	69.6	19.3	28.4	35.4	19.7	20.0	16.2	34.6	51.2	66.9	26.7	29.9	25.5	54.2	32.4	33.6	45.9	43.5	42.3	34.5	106.6	26.0	27.7	26.2	43.8	65.3	35.7	51.5	38.5	44.0	63.9	28.5	49.3	20.4	73.7	59.7	20.8	42.5	34.6	38.2	27.5	35.5	83.1	57.7	43.3	38.6	66.7	156.8	27.4	58.3	38.7	34.5	113.5	54.9	58.7	28.2	48.7	57.0	40.0	57.3	33.2	27.9	35.2	41.0	45.3	33.8	39.3	41.3	30.5	35.7	38.6	52.6	151.2	23.1	43.1	43.1	6.8	2.3	3.4	4.3	2.4	4.1	5.5	4.8	3.5	2.1	7.4	3.8	4.4	6.8	3.5	4.8	5.6	3.9	1.4	10.6	12.2	17.4	12.7	10.7	11.9	10.3	10.2	10.3	9.0	10.2	16.2	38.0	22.4	29.8	19.9	50.4	22.3	24.3	11.4	35.3	35.5	35.6	33.9	32.6	27.1	28.1	23.9	8.4	27.4	54.0	29.2	19.6	31.3	2.1	29.8	43.9	37.3	31.2	52.6	23.0	33.6	33.7	29.9	27.0	40.2	19.6	39.1	23.9	24.0	24.0	45.4	24.2	26.4	16.2	26.7	12.6	3.6	24.8	31.1	12.4	32.8	29.2	32.3	49.4	17.1	32.8	32.5	16.5	28.6	62.6	35.6	18.8	24.5	16.7	27.6	19.7	38.6	41.4	18.4	27.3	38.8	24.7	29.6	47.9	32.6	23.8	30.0
CXXC1	"CFP1, CGBP, hCGBP, HsT2645, PCCX1, PHF18, SPP1, ZCGPC1"	ENSG00000154832	"CXXC finger protein 1"	Q9P0U4	18	50282343-50287839	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044511	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA044511: AB_10963081"	"unprognostic (4.47e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (4.18e-6)"	"unprognostic (3.82e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.08e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.41e-2)"	18.1	26.7	24.4	22.8	25.4	45.9	19.3	29.8	30.5	28.0	25.9	23.6	27.3	23.3	10.3	23.6	24.9	17.5	19.9	24.6	24.6	25.5	24.5	19.2	34.3	24.6	24.5	30.0	38.7	20.3	21.0	16.0	25.2	24.4	15.9	13.6	32.4	21.4	20.2	29.5	23.5	14.9	22.8	29.6	25.7	22.8	25.0	30.7	23.2	13.1	21.1	25.6	23.7	26.3	24.6	31.9	33.4	46.9	28.9	16.2	46.9	34.3	28.4	38.5	32.1	21.6	19.6	60.2	17.6	22.0	18.5	44.6	51.6	37.0	21.7	51.9	33.0	57.9	42.3	39.5	19.6	126.4	68.7	19.5	32.9	38.0	51.0	26.0	25.0	58.8	29.9	63.8	27.3	37.7	71.6	67.7	47.8	16.9	22.4	74.5	26.9	56.5	26.8	13.9	48.4	47.2	18.0	17.8	21.6	21.2	22.9	56.9	29.2	45.1	28.4	18.4	29.6	119.1	87.7	52.5	28.4	58.6	35.5	24.7	18.8	34.0	24.0	22.0	25.0	26.9	21.6	23.6	21.9	27.5	23.1	18.9	8.1	22.6	18.8	15.5	26.4	20.6	24.4	25.4	29.8	30.5	24.6	24.6	24.6	24.5	25.2	22.8	25.0	26.3	18.1	19.2	27.4	21.9	27.8	26.8	13.1	21.7	21.1	15.3	20.2	17.4	7.3	18.6	23.8	18.4	14.6	34.5	23.7	31.4	13.7	19.4	13.8	20.9	13.8	18.3	35.3	14.9	10.2	21.8	39.2	16.6	33.1	17.6	8.2	20.5	16.8	15.3	22.0	8.4	8.7	25.0	26.4	20.2	17.2	9.8	19.9	21.0	8.8	7.5	21.3	19.3	43.3	9.5	9.4	21.8	26.1	19.5	41.5	13.3	26.5	14.9	21.4	13.5	6.6	19.5	16.9	49.4	22.1	24.5	30.1	37.1	27.7	18.3	26.5	12.0
CYP11A1	"CYP11A, P450SCC"	ENSG00000140459	"Cytochrome P450 family 11 subfamily A member 1"	P05108	15	74337759-74367646	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Steroidogenesis, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"adrenal gland: 1009.9"	"Cell type enhanced"	"Detected in some"		"Extravillous trophoblasts: 345.1;Peritubular cells: 173.8;Syncytiotrophoblasts: 1452.0;Theca cells: 637.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	48	"basophil: 10.2"	"Lineage enriched"	"Detected in single"	48	"granulocytes: 10.2"	"Group enriched"	"Detected in some"	5	"BEWO: 55.2;HEL: 46.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 1.8;hippocampal formation: 1.1;hypothalamus: 1.3;midbrain: 4.5;pons: 1.1"	HPA016436	Enhanced					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA016436: AB_1847423"	"unprognostic (8.89e-2)"	"unprognostic (6.96e-2)"	"unprognostic (4.95e-3)"	"unprognostic (9.31e-2)"	"unprognostic (9.42e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.55e-3)"	"unprognostic (8.06e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.45e-2)"	"unprognostic (9.66e-4)"	"unprognostic (2.40e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.04e-2)"	"unprognostic (7.95e-2)"	2.0	1009.9	2.0	0.6	2.1	0.1	1.9	2.3	2.0	2.0	3.5	0.8	0.3	1.6	0.8	6.3	2.4	0.4	1.4	2.0	2.1	0.6	3.6	0.6	0.1	2.8	2.5	38.9	0.3	0.0	2.8	25.2	2.8	1.2	0.2	0.7	1.2	0.5	2.5	0.6	0.8	0.9	2.6	4.9	0.9	23.0	1.9	0.3	0.3	1.0	2.1	0.5	1.0	1.9	0.0	0.0	0.0	0.2	0.0	0.4	55.2	0.1	0.0	0.4	0.1	0.0	0.0	0.0	1.3	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.2	46.8	1.2	0.5	0.2	0.0	0.2	1.9	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	11.1	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	2.1	2.3	2.0	2.0	2.1	2.8	2.5	2.8	2.6	1.9	1.9	0.1	0.0	0.0	6.2	0.0	0.3	0.0	0.0	34.1	0.1	0.6	0.9	1.2	2.8	0.0	0.0	0.0	144.6	0.0	0.0	1.9	0.0	1.6	0.2	4.9	0.8	0.0	0.0	0.2	0.0	345.1	10.0	0.0	0.2	0.0	41.3	0.0	3.6	22.0	0.0	0.2	0.0	0.0	0.0	0.0	6.7	48.7	0.4	0.0	1.0	0.6	6.2	0.0	0.0	0.2	0.5	0.0	173.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	1.2	4.6	2.8	8.7	0.0	1452.0	0.0	637.4	0.0	0.0
CYP3A5	"CP35, P450PCN3, PCN3"	ENSG00000106258	"Cytochrome P450 family 3 subfamily A member 5"	P20815	7	99648194-99679998	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 177.7;liver: 276.1"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 377.4;Distal enterocytes: 382.7;Gastric mucus-secreting cells: 506.6;Hepatocytes: 454.5;Paneth cells: 451.6;Proximal enterocytes: 1074.6;Urothelial cells: 380.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 38.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 9.7;Hep G2: 7.9;OE19: 28.3"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Cytosol	Vesicles	"HPA072245: , HPA075539: "	"unprognostic (2.13e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.73e-1)"	"prognostic favorable (3.72e-5)"	"unprognostic (1.37e-3)"	"unprognostic (1.21e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.85e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-4)"	"unprognostic (6.58e-3)"	3.3	14.4	0.1	3.8	0.4	0.6	6.5	0.8	0.9	5.1	0.4	28.4	127.3	3.1	3.0	22.1	3.1	32.7	1.0	0.3	0.0	10.6	276.1	9.2	1.4	0.6	0.0	0.8	47.0	0.0	0.9	0.4	0.4	21.6	21.0	0.7	2.9	5.7	0.9	20.5	177.7	1.1	0.0	0.8	86.5	0.4	0.0	2.1	1.0	0.0	3.2	10.4	13.1	0.5	1.6	3.3	1.6	1.9	0.4	0.6	0.5	1.5	0.0	0.0	0.0	9.7	7.4	1.0	1.5	0.0	1.2	1.2	0.0	0.0	0.0	1.8	1.2	1.2	0.7	7.9	0.1	2.0	0.6	0.0	2.1	0.0	0.0	1.4	0.0	0.9	3.3	2.0	0.0	0.3	2.6	3.8	0.4	28.3	0.8	0.6	1.6	2.2	0.4	1.5	1.2	1.7	0.9	0.8	3.2	1.6	0.5	0.7	1.2	1.8	1.6	1.6	1.2	1.0	2.6	1.7	1.6	2.6	1.5	0.4	0.3	0.4	0.4	0.3	0.9	0.2	0.6	0.6	0.2	0.1	0.4	0.5	0.5	0.4	0.2	0.3	0.5	0.2	0.1	0.4	0.8	0.9	0.3	0.0	0.6	0.0	0.4	0.0	0.0	0.5	0.9	12.8	14.8	1.3	4.8	46.1	112.7	31.0	59.7	13.7	1.1	0.4	1.3	377.4	27.3	3.7	12.5	1.7	1.7	382.7	0.0	63.4	2.0	3.1	2.2	6.3	54.6	21.7	8.6	50.7	1.2	8.5	506.6	10.3	10.1	1.8	8.2	454.5	0.6	8.4	11.0	140.5	6.1	9.5	4.5	0.5	2.5	4.1	3.6	2.8	4.9	4.0	10.3	7.1	6.5	80.1	451.6	2.6	6.4	156.3	1074.6	10.8	12.1	21.6	0.0	2.5	3.4	15.1	6.4	107.3	59.0	1.5	7.5	3.1	139.8	380.4
CYTH1	"B2-1, cytohesin-1, D17S811E, PSCD1"	ENSG00000108669	"Cytohesin 1"	Q15438	17	78674048-78782297	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 98.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047498			Uncertain	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Nucleoli	"HPA047498: "	"unprognostic (3.82e-3)"	"unprognostic (5.49e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.48e-4)"	"unprognostic (6.60e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.69e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.10e-1)"	30.5	26.2	41.1	52.4	53.2	69.0	23.4	45.5	45.2	16.1	38.0	30.1	22.6	12.5	8.6	50.8	16.4	25.7	31.0	40.3	45.5	22.8	33.8	44.5	78.9	52.3	50.8	10.2	29.3	10.7	14.8	27.1	51.7	24.6	32.9	82.9	32.0	8.1	35.9	31.3	41.3	16.6	44.3	57.5	43.0	15.8	50.2	58.9	26.2	22.9	89.0	25.0	25.6	68.5	24.6	16.9	16.6	14.3	11.2	14.1	15.9	11.4	10.0	13.6	15.9	10.7	26.8	18.2	11.1	15.0	23.3	21.2	8.1	29.6	10.9	38.4	22.5	7.4	22.9	19.8	8.0	15.3	70.5	6.9	23.9	15.5	15.9	9.3	44.4	59.9	12.4	68.1	16.3	12.5	98.7	13.6	4.2	39.7	14.9	25.9	18.4	64.3	14.8	16.9	9.5	34.6	20.0	38.2	16.6	16.7	18.8	17.7	21.2	10.7	15.6	17.1	11.8	78.5	39.0	66.0	7.9	15.1	11.4	150.2	41.6	85.6	96.5	51.5	69.1	63.6	79.6	78.5	35.9	55.4	86.4	74.7	85.9	59.0	48.8	49.3	66.2	93.6	41.1	53.2	45.5	45.2	40.3	45.5	52.3	50.8	51.7	44.3	50.2	68.5	65.9	60.9	52.1	48.3	83.4	41.2	31.0	28.1	45.5	65.5	18.4	14.9	18.8	18.6	34.5	5.5	110.5	3.0	123.6	50.4	7.9	12.1	29.6	62.6	17.4	58.9	27.6	11.2	29.9	18.5	8.3	16.5	58.6	110.3	36.0	13.7	27.8	28.7	48.9	43.7	58.9	49.3	34.6	80.2	135.1	46.1	4.4	76.8	37.4	61.8	121.7	21.1	122.6	52.3	170.9	42.7	32.8	5.3	88.6	39.0	16.3	6.9	50.5	78.3	6.6	8.6	10.4	16.0	15.6	54.8	34.4	7.3	113.1	10.6	20.6	58.4
DCLRE1C	"A-SCID, ARTEMIS, FLJ11360, SCIDA, SNM1C"	ENSG00000152457	"DNA cross-link repair 1C"	Q96SD1	10	14897359-14954432	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Adaptive immunity, DNA damage, DNA recombination, DNA repair, Immunity"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069295			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Golgi apparatus"	"HPA069295: AB_2686112"	"unprognostic (8.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (1.30e-4)"	"unprognostic (8.02e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (7.98e-4)"	"unprognostic (1.91e-1)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (9.03e-8)"	"unprognostic (2.43e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.45e-3)"	4.2	3.3	2.2	8.0	3.2	14.0	6.1	5.7	3.4	4.5	3.7	4.3	5.2	4.4	3.8	7.1	3.7	4.0	2.3	2.2	2.2	3.5	2.6	4.9	14.1	2.8	2.7	4.5	3.1	3.8	2.2	4.4	3.1	4.0	5.2	4.9	4.5	3.7	3.0	6.9	5.4	3.9	2.5	10.4	5.9	1.9	2.9	12.3	5.5	2.7	12.8	5.4	5.1	3.7	16.2	7.8	6.9	13.8	6.4	8.2	6.6	9.7	5.3	13.0	13.5	8.9	13.4	21.7	3.8	7.6	9.2	13.7	7.6	5.1	10.9	13.4	8.0	16.7	8.9	6.0	5.1	10.0	18.4	6.6	4.8	12.7	5.3	8.2	7.4	13.9	10.5	17.4	8.6	7.4	14.9	9.9	4.7	14.4	3.5	17.2	9.2	12.1	6.5	6.0	3.6	6.9	10.7	10.2	27.5	5.3	12.8	18.5	6.0	8.3	11.6	17.1	10.8	9.9	19.1	21.5	8.1	10.5	11.8	27.4	13.9	20.0	12.1	18.9	14.5	25.1	14.1	15.0	20.9	28.1	12.2	13.2	13.2	11.0	17.5	22.4	11.9	8.9	2.2	3.2	5.7	3.4	2.2	2.2	2.8	2.7	3.1	2.5	2.9	3.7	6.6	3.2	6.9	17.9	27.6	17.3	20.8	10.9	5.7	24.8	7.8	4.3	4.4	11.5	26.1	14.7	62.6	15.1	21.8	10.9	3.9	9.9	26.8	8.5	8.6	8.2	6.7	22.7	12.4	11.1	21.9	10.2	7.1	13.1	6.3	14.1	10.4	1.9	10.2	32.0	10.6	7.3	10.2	19.8	20.6	2.3	12.5	13.3	19.6	16.9	21.8	10.4	35.0	12.5	11.9	14.9	15.5	11.3	13.4	21.5	12.3	2.7	22.3	47.9	19.7	18.1	11.9	13.9	18.5	7.3	21.2	5.1	14.8	12.4	8.6	41.4
DCN	"DSPG2, SLRR1B"	ENSG00000011465	Decorin	P07585	12	91140484-91183217	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Corneal dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 1218.7;Fibroblasts: 7960.2;Leydig cells: 6281.9;Peritubular cells: 1856.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"basophil: 24.5"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 24.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 3291.1;ASC TERT1: 2371.6;BJ hTERT+: 2546.6;HSkMC: 2289.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"spinal cord: 544.7"	"HPA003315, CAB017118, HPA064736, CAB068930"	Enhanced				"Secreted to extracellular matrix"	NA	NA		1900000	"Cluster 46: Basophils - DNA binding"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB017118: , CAB068930: AB_425394, HPA003315: AB_1078639, HPA064736: AB_2685340"	"unprognostic (1.73e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (3.06e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.59e-3)"	"unprognostic (7.56e-3)"	1522.3	1171.7	60.6	272.0	80.0	4.4	2342.2	63.5	119.2	1493.0	111.6	549.9	163.5	1308.5	1302.0	932.8	1213.4	1802.7	2108.9	66.8	60.3	394.8	459.6	955.8	130.4	68.9	60.9	2681.4	257.9	80.2	112.0	1534.8	75.7	451.6	493.0	3.1	362.5	462.3	469.0	713.4	336.6	1027.8	70.2	20.0	434.5	279.6	72.8	183.0	479.3	1328.3	293.6	1895.5	783.7	57.9	0.2	0.4	4.4	0.6	3291.1	2371.6	6.2	608.7	2546.6	28.8	28.5	0.3	0.9	1.1	0.5	523.5	0.6	2.1	0.8	1.9	4.9	0.7	0.5	0.6	20.4	0.1	717.4	1.3	1.4	2289.4	8.9	78.3	38.5	12.1	1.0	0.2	0.8	0.7	63.0	0.6	1.5	10.8	1.2	0.4	1.6	0.7	2.3	2.8	3.4	0.5	2.7	11.9	10.3	1.1	0.9	1.8	0.6	0.4	0.9	132.3	1.2	497.5	0.6	3.3	3.1	2.0	8.0	2.0	0.8	24.5	0.3	0.6	0.3	0.1	0.3	0.3	0.3	0.2	0.1	0.6	0.4	0.4	2.7	0.4	0.2	0.7	0.2	0.0	60.6	80.0	63.5	119.2	66.8	60.3	68.9	60.9	75.7	70.2	72.8	57.9	351.1	41.7	44.1	2.3	4.1	609.1	5.4	0.0	264.6	1.9	25.5	31.5	154.7	10.0	11.8	20.2	0.0	31.2	12.8	0.0	1.9	1.0	25.0	39.4	1218.7	158.7	0.0	2.7	0.8	0.0	30.0	7960.2	54.0	22.0	21.5	0.2	214.9	1.4	58.8	0.0	17.1	0.1	0.0	2.8	962.7	103.0	6281.9	52.5	606.5	122.7	0.0	3.3	0.0	0.0	1.4	2.7	0.5	1856.9	23.2	5.8	0.0	0.4	5.8	0.7	210.4	236.8	408.2	13.4	9.2	36.8	482.5	63.9	72.3	70.2	0.0	10.7
DDX59	"DKFZP564B1023, ZNHIT5"	ENSG00000118197	"DEAD-box helicase 59"	Q5T1V6	1	200623896-200669907	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047166	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 50: Non-specific - Ribosome"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Actin filaments"		"HPA047166: AB_2679966"	"unprognostic (1.99e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.43e-3)"	"unprognostic (4.16e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (9.02e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.66e-2)"	"unprognostic (5.98e-2)"	15.4	16.1	13.5	14.2	15.4	33.1	26.5	17.1	18.8	16.2	15.6	14.2	10.2	17.6	20.0	13.5	15.5	12.2	13.3	14.0	14.7	16.4	17.8	14.5	17.0	16.0	15.0	17.6	18.8	15.0	11.3	18.7	17.3	15.2	15.0	17.4	14.4	13.2	32.8	26.2	14.3	14.1	16.3	22.4	12.1	11.0	15.1	22.0	16.2	20.1	16.9	15.0	14.7	17.8	17.5	20.1	22.6	19.0	10.1	17.4	49.9	19.1	17.4	20.5	16.5	6.3	20.2	17.9	9.5	15.7	16.4	16.2	13.0	19.4	14.5	56.8	13.3	13.6	26.4	18.6	20.2	19.5	24.0	18.8	29.1	15.4	41.7	16.7	15.9	24.8	17.4	25.9	20.1	20.0	12.0	29.0	23.8	10.5	16.3	10.1	15.5	34.7	21.9	19.8	13.8	35.7	30.8	31.7	35.6	28.8	27.3	27.3	14.4	17.1	9.5	16.8	20.0	19.5	27.2	23.5	16.3	12.2	30.0	33.3	12.4	24.7	15.1	11.1	12.4	14.9	12.5	13.8	10.6	14.8	12.7	11.8	22.9	16.4	22.0	11.8	19.8	10.2	13.5	15.4	17.1	18.8	14.0	14.7	16.0	15.0	17.3	16.3	15.1	17.8	22.5	19.2	20.1	8.8	19.9	16.2	13.1	16.1	24.5	4.3	10.0	13.2	18.4	7.2	10.6	7.3	2.1	22.2	14.6	9.8	15.6	8.8	2.4	14.6	13.3	16.7	1.2	10.5	4.5	8.2	28.0	14.9	6.6	12.8	20.8	7.1	14.3	7.3	13.0	6.7	6.1	11.0	14.2	12.0	13.0	1.1	8.1	16.1	5.4	8.4	18.5	8.3	25.7	19.1	10.3	8.8	7.9	13.5	13.1	12.0	8.0	11.6	10.8	6.7	0.0	22.8	15.7	14.2	20.0	12.9	15.6	43.8	18.9	9.3	8.5	11.1
DENND2C	"dJ1156J9.1, DKFZp686G0351, DKFZp779P1149, FLJ37099, RP5-1156J9.1"	ENSG00000175984	"DENN domain containing 2C"	Q68D51	1	114582848-114670422	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 17.7;skeletal muscle: 41.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 109.1;Basal prostatic cells: 138.2;Glandular and luminal cells: 192.7;Squamous epithelial cells: 114.9;Suprabasal keratinocytes: 171.8;Urothelial cells: 340.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"basophil: 3.0"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"U-2197: 11.8;U-266/70: 25.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029935, HPA054955"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 59: Non-specific - Translation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA029935: AB_10601208, HPA054955: AB_2682648"	"unprognostic (2.25e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.89e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.57e-2)"	0.9	0.5	0.8	0.3	0.8	1.0	1.9	0.9	0.9	4.2	2.2	0.6	0.7	1.5	0.8	17.7	0.9	1.2	1.1	1.1	0.4	0.6	2.0	1.5	0.4	0.6	0.6	1.1	1.2	1.7	0.6	0.1	0.7	1.4	0.6	1.5	2.7	1.4	41.6	12.4	0.6	1.1	0.3	0.4	0.9	5.5	0.6	0.4	1.4	1.7	3.4	2.6	7.0	0.5	2.1	0.0	0.1	1.4	1.7	1.8	0.4	0.6	1.1	0.7	1.1	0.3	0.0	0.1	0.9	4.1	1.4	7.4	1.4	4.6	0.7	0.1	1.8	1.2	0.4	0.1	0.5	0.0	1.8	1.8	4.4	2.7	2.3	0.1	0.2	0.5	0.2	0.3	2.4	6.0	0.2	0.1	0.9	0.0	1.1	0.0	6.2	0.1	0.1	5.7	0.0	0.0	4.5	0.1	0.5	1.1	0.9	0.3	0.3	1.0	1.5	11.8	0.2	25.4	4.8	0.0	1.0	0.0	0.8	3.0	0.0	0.9	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.8	0.8	0.9	0.9	1.1	0.4	0.6	0.6	0.7	0.3	0.6	0.5	6.6	28.9	2.2	3.3	3.3	109.1	138.2	32.5	60.3	20.4	5.2	5.3	8.7	11.5	21.3	7.3	20.9	0.1	1.9	1.1	0.0	7.2	29.5	100.3	15.7	8.6	0.0	0.0	2.8	7.5	0.1	6.9	5.6	192.7	2.5	8.1	15.4	11.7	0.3	0.0	0.8	0.9	4.1	2.2	9.3	12.9	5.0	14.0	7.2	9.4	1.1	2.3	1.0	5.0	3.5	33.0	0.2	2.2	17.6	79.5	0.1	0.8	46.8	10.3	0.0	21.7	6.6	47.9	59.7	114.9	171.8	0.0	3.7	1.3	1.5	340.4
DNAJB13	"RSPH16A, TSARG6"	ENSG00000187726	"DnaJ heat shock protein family (Hsp40) member B13"	P59910	11	73951026-73970366	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Chaperone	"Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 53.2;testis: 18.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 90.6;Endometrial ciliated cells: 114.8;Late spermatids: 62.9;Respiratory ciliated cells: 104.2"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.7;Karpas-707: 2.6;RPTEC TERT1: 4.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA052465, HPA061330"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"		"HPA052465: AB_2681842, HPA061330: AB_2732659"	"unprognostic (1.07e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.20e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.72e-4)"	"unprognostic (5.00e-2)"	"unprognostic (4.73e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (2.10e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.40e-2)"	0.1	0.1	1.5	1.2	1.5	4.4	0.2	1.0	1.4	5.5	12.2	0.1	0.6	2.0	5.2	0.1	53.2	2.2	0.1	2.0	1.9	1.0	0.1	3.1	2.1	4.8	5.7	0.3	0.8	0.1	1.1	0.5	3.6	0.9	0.0	0.4	0.6	2.9	0.3	0.1	2.9	0.1	4.0	1.3	0.2	18.9	2.4	0.0	0.2	0.0	0.0	0.2	0.1	1.8	0.0	0.4	0.3	0.7	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.7	0.2	0.9	2.1	0.2	0.3	0.5	0.1	0.0	0.0	2.7	0.3	1.0	0.9	0.3	0.0	0.2	0.6	0.0	0.4	0.1	0.0	0.0	0.0	1.4	0.2	2.6	0.4	0.3	0.6	0.9	0.2	0.2	1.5	0.4	1.2	1.1	4.5	0.5	0.3	1.0	0.5	2.2	0.2	0.4	0.3	0.7	0.0	0.0	0.6	0.6	0.0	2.2	2.0	1.9	0.0	0.3	0.1	0.7	0.1	0.2	0.2	0.0	0.0	0.3	0.2	0.1	0.1	0.2	0.1	0.3	0.0	0.1	0.0	0.7	0.2	0.1	1.5	1.5	1.0	1.4	2.0	1.9	4.8	5.7	3.6	4.0	2.4	1.8	0.2	3.2	0.0	2.0	0.0	0.0	1.9	11.1	0.0	0.2	0.1	0.3	0.2	0.0	7.6	1.8	0.0	0.1	0.0	0.1	0.0	1.7	90.6	114.8	2.4	0.2	0.0	0.0	0.4	0.0	0.1	0.5	0.0	13.4	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.3	10.2	0.0	0.0	62.9	1.2	0.3	1.8	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	1.2	0.0	1.3	1.4	1.0	104.2	0.9	0.0	1.1	3.3	19.5	1.5	0.0	0.0	0.0	0.3	0.0	0.0	1.2
DNAJB7	HSC3	ENSG00000172404	"DnaJ heat shock protein family (Hsp40) member B7"	Q7Z6W7	22	40859549-40862113	"Predicted intracellular proteins"		Chaperone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	12	"testis: 10.4"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 553.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA000534	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA000534: AB_1078693"	"unprognostic (3.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.16e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.62e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.46e-4)"	"unprognostic (3.32e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.45e-2)"	0.1	0.1	0.1	0.1	0.2	0.5	0.1	0.8	0.7	0.2	0.4	0.1	0.4	0.2	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.0	0.2	0.0	0.2	0.2	0.1	0.8	0.2	0.0	0.4	0.1	0.5	0.0	0.0	0.1	0.1	10.4	0.2	0.0	0.3	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.1	0.4	0.4	0.2	0.1	0.0	0.2	0.2	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.2	0.3	0.3	0.1	0.3	0.2	0.2	0.0	0.1	0.3	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.8	0.7	0.2	0.1	0.1	0.1	0.2	0.0	0.2	0.7	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.1	0.4	0.8	0.0	0.0	553.5	1.5	0.8	0.4	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.4	4.5	0.2	0.0	0.0	0.1	1.7	0.5	0.4	0.0	0.0	0.0	98.5	2.8	0.2	0.0	0.0	0.0	0.9	0.0	1.0	0.7	0.0	0.0	2.6	0.1	0.1	6.0	0.0	0.0	11.2	0.0	0.3	0.1	2.9	1.5	0.0	0.0	0.3	0.2	0.2	0.9	0.1
DPH7	"C9orf112, FLJ90634, RRT2, WDR85"	ENSG00000148399	"Diphthamide biosynthesis 7"	Q9BTV6	9	137554444-137578925	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 189.9;Spermatogonia: 100.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022911	Uncertain		Approved	"Nuclear bodies"		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 50: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies"		"HPA022911: AB_1858823"	"unprognostic (1.43e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.60e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.48e-2)"	"prognostic favorable (6.52e-4)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (2.30e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (3.23e-4)"	8.2	12.3	3.4	2.6	3.6	4.2	9.5	4.5	4.1	15.7	3.9	13.8	2.2	12.6	7.0	9.0	14.6	2.6	9.4	3.6	3.3	10.2	10.9	9.4	4.7	3.7	3.3	12.8	20.3	6.3	13.5	3.4	4.0	15.0	4.1	2.8	9.9	5.4	8.3	11.0	12.2	4.8	3.3	15.2	12.3	9.3	3.8	5.6	12.8	2.4	5.3	11.2	11.1	5.7	4.5	5.2	8.2	7.6	6.2	5.1	10.2	5.1	5.2	9.1	7.7	11.0	5.4	10.6	9.3	5.9	4.8	9.8	10.6	10.1	8.3	9.2	13.2	4.9	6.6	3.7	7.0	10.6	9.5	5.4	7.6	5.1	9.2	6.5	14.4	7.1	9.2	5.7	7.2	15.3	8.2	9.9	10.4	19.9	13.3	13.7	3.7	7.6	6.9	4.5	10.8	7.3	8.7	7.0	5.4	5.7	7.9	9.1	6.5	6.2	5.4	7.7	9.5	3.7	9.1	12.5	3.9	6.1	6.3	9.5	5.1	6.2	4.5	4.8	6.3	5.6	7.2	6.4	5.9	4.7	5.1	4.9	1.6	4.5	4.0	8.0	5.4	4.6	3.4	3.6	4.5	4.1	3.6	3.3	3.7	3.3	4.0	3.3	3.8	5.7	21.0	6.4	11.9	21.2	17.7	16.7	9.8	18.9	8.0	18.7	14.7	20.6	15.5	2.8	11.5	1.8	50.1	22.1	22.5	7.7	3.9	10.6	3.0	11.1	17.1	13.8	6.7	5.5	17.2	9.2	14.9	14.5	13.3	10.2	10.8	26.5	8.2	6.5	11.9	16.8	21.5	11.7	6.1	6.6	7.2	7.5	16.4	8.8	8.8	15.0	9.9	15.4	23.7	16.1	28.2	11.5	10.3	15.8	24.7	18.6	7.2	5.2	14.2	58.8	19.7	13.1	16.0	189.9	100.0	11.4	18.9	12.2	18.0	19.9	15.0	11.1
DPY19L1	KIAA0877	ENSG00000173852	"Dpy-19 like C-mannosyltransferase 1"	Q2PZI1	7	34928876-35038271	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 206.2;Excitatory neurons: 132.8;Late spermatids: 72.0;Oligodendrocytes: 95.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059139	Uncertain		Approved	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA059139: AB_2683921"	"unprognostic (4.66e-2)"	"unprognostic (1.11e-3)"	"unprognostic (8.53e-3)"	"unprognostic (2.47e-3)"	"unprognostic (2.50e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.02e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (3.21e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.12e-2)"	10.8	13.2	16.5	12.1	18.6	11.2	6.4	22.2	22.3	15.9	11.0	10.6	5.3	18.9	4.1	7.6	10.7	15.2	14.9	18.0	23.2	7.0	19.5	14.7	10.7	23.6	22.9	9.0	5.6	4.1	6.2	21.6	22.0	9.0	12.1	27.9	7.1	8.4	3.5	4.6	6.2	19.3	25.2	15.7	10.1	38.1	21.5	4.8	11.4	6.1	9.8	16.5	5.5	33.4	16.7	64.6	36.2	46.3	69.7	55.3	7.5	36.6	30.7	22.4	29.3	15.5	42.4	24.2	52.1	38.2	92.4	29.1	27.2	20.1	50.1	12.4	22.2	35.3	40.2	25.7	24.5	33.6	31.6	27.3	16.5	29.7	20.1	63.1	93.5	11.9	26.9	95.8	79.3	8.1	0.3	33.3	23.3	39.2	28.9	24.7	47.8	34.8	85.0	57.4	16.7	43.4	32.8	4.2	19.4	56.5	32.6	38.6	109.1	44.3	53.1	30.9	50.2	42.3	99.9	27.6	54.9	30.5	126.2	0.9	0.5	0.0	1.2	0.7	1.3	0.4	0.5	1.0	0.5	0.7	0.1	0.5	0.1	0.6	0.2	0.5	0.3	0.3	16.5	18.6	22.2	22.3	18.0	23.2	23.6	22.9	22.0	25.2	21.5	33.4	12.1	28.9	16.4	42.7	3.9	7.1	5.6	4.4	2.2	8.4	7.4	5.8	13.3	5.7	10.0	7.3	18.8	14.5	10.2	11.2	0.0	7.7	206.2	17.0	23.4	13.9	14.9	8.2	132.8	16.4	4.1	11.3	10.7	16.9	27.3	6.5	20.3	15.4	8.7	11.8	35.1	5.1	4.1	11.1	7.5	72.0	9.3	8.0	5.4	30.0	4.4	8.6	3.1	30.2	95.5	24.0	4.5	10.1	8.0	9.5	1.0	1.9	12.4	12.8	0.0	7.5	8.5	9.1	4.6	3.2	4.8	21.2	6.9	4.4	8.5	13.7
EFCAB10		ENSG00000185055	"EF-hand calcium binding domain 10"	A6NFE3	7	105565120-105600875	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 29.7;testis: 23.5"	"Group enriched"	"Detected in some"	11	"Early spermatids: 205.9;Endometrial ciliated cells: 138.5;Late spermatids: 78.7;Respiratory ciliated cells: 243.9;Spermatocytes: 96.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA019751	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA019751: AB_1848011"	"unprognostic (1.20e-1)"	"unprognostic (2.24e-3)"	"unprognostic (8.96e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.11e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.58e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-3)"	"unprognostic (6.87e-2)"	"unprognostic (3.07e-9)"	"unprognostic (2.13e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.67e-2)"	0.5	0.5	1.0	0.6	2.0	2.4	0.5	1.7	1.3	1.6	11.1	0.6	0.5	1.0	0.2	0.8	29.7	0.2	0.5	1.7	2.3	0.9	1.0	3.2	0.8	5.4	6.9	0.9	1.4	0.0	2.1	0.2	3.8	0.9	0.3	1.3	0.8	0.0	1.2	1.1	0.7	0.0	3.8	1.1	0.6	23.5	3.0	0.1	0.7	0.0	0.1	0.5	0.6	2.4	1.4	3.8	2.0	1.3	0.3	0.1	0.8	1.8	0.0	0.0	0.1	0.7	0.9	1.9	1.6	0.0	0.3	0.5	0.0	0.0	0.0	0.7	3.4	0.9	3.0	2.1	0.2	1.2	1.2	0.1	0.0	0.0	0.0	1.2	0.0	0.9	2.8	1.5	0.0	2.9	1.3	2.5	3.4	0.9	1.4	0.9	2.1	4.1	0.2	0.8	1.8	2.5	1.1	3.9	0.6	2.5	0.7	1.4	1.0	1.9	1.3	4.0	1.2	2.1	2.7	1.7	1.1	1.9	0.9	1.0	0.3	0.2	0.4	0.2	0.4	0.3	0.4	0.3	0.1	0.6	0.6	0.5	0.3	0.3	0.2	0.4	0.3	0.1	1.0	2.0	1.7	1.3	1.7	2.3	5.4	6.9	3.8	3.8	3.0	2.4	0.1	0.0	4.4	0.3	0.2	0.0	0.1	11.8	0.0	0.7	0.2	0.3	0.3	0.0	13.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	205.9	138.5	1.2	0.3	0.0	0.0	3.4	0.0	0.1	0.3	0.0	2.2	0.0	0.1	0.0	0.0	0.1	0.0	2.1	0.0	6.1	0.0	0.0	78.7	2.5	0.4	0.0	0.0	0.0	0.1	0.0	1.5	0.7	0.0	0.0	1.5	0.8	0.2	0.0	0.5	243.9	0.2	0.0	0.6	3.5	96.3	2.5	0.0	0.0	0.1	0.5	0.1	0.0	0.1
EFR3B	"FLJ37871, KIAA0953"	ENSG00000084710	"EFR3 homolog B"	Q9Y2G0	2	25042076-25159135	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.1;skeletal muscle: 20.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 127.0;Excitatory neurons: 58.5;Inhibitory neurons: 110.7;Late spermatids: 46.0;Microglial cells: 54.4;Oligodendrocytes: 51.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.3;BEWO: 12.0;SH-SY5Y: 10.7;SK-BR-3: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038089, HPA071831"	Uncertain		Supported	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Actin filaments, Cytosol"	"HPA038089: AB_10672618, HPA071831: "	"unprognostic (9.31e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.24e-3)"	"unprognostic (3.82e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.49e-6)"	"unprognostic (4.83e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-1)"	0.8	1.6	23.0	0.6	53.1	0.3	0.5	22.4	29.5	0.5	0.0	1.1	0.4	0.7	5.1	0.3	0.6	0.5	4.5	51.7	19.0	1.3	0.2	2.5	0.3	45.3	24.0	0.8	0.4	3.9	9.3	1.7	47.5	0.5	0.6	11.0	0.3	0.8	20.0	0.6	0.5	1.2	9.8	3.4	0.9	2.5	27.7	0.3	3.4	3.8	0.2	0.5	0.4	12.1	0.2	8.3	9.5	10.3	0.5	0.1	12.0	1.0	0.2	0.5	0.1	6.7	0.4	0.1	0.6	1.4	3.3	0.6	7.5	0.0	0.1	1.6	1.8	1.6	0.3	0.6	0.0	0.1	0.8	0.1	0.0	2.3	0.1	0.7	0.3	0.2	0.1	0.4	0.2	0.9	0.2	0.5	1.9	0.1	6.6	0.8	9.1	0.3	0.1	0.3	4.0	10.7	1.2	18.0	5.9	5.3	0.9	0.1	0.5	0.5	2.7	4.1	2.0	0.7	0.9	0.1	7.3	0.1	1.9	1.3	0.1	0.3	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0.0	0.0	23.0	53.1	22.4	29.5	51.7	19.0	45.3	24.0	47.5	9.8	27.7	12.1	3.1	28.9	1.1	127.0	0.0	0.0	0.8	0.0	0.0	9.9	0.3	1.0	9.7	0.0	0.0	9.2	22.9	0.1	0.1	0.7	0.0	0.3	20.6	1.3	0.3	6.7	3.6	0.0	58.5	0.8	0.2	1.0	0.0	0.3	0.0	1.1	2.9	0.0	0.9	5.0	110.7	0.1	0.0	0.0	0.3	46.0	1.2	0.1	0.0	54.4	0.0	22.0	0.0	19.6	51.2	0.7	0.0	2.6	0.1	0.6	0.5	0.1	0.0	10.7	0.0	1.6	1.4	2.4	2.2	0.0	0.1	0.1	0.1	0.2	0.3	0.4
ELF1		ENSG00000120690	"E74 like ETS transcription factor 1"	P32519	13	40931924-41061440	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 200.9"	"Cell type enhanced"	"Detected in all"		"T-cells: 365.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 271.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001755, CAB005172"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB005172: AB_631428, HPA001755: AB_1078732"	"unprognostic (1.21e-1)"	"unprognostic (8.73e-3)"	"unprognostic (4.20e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.02e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.11e-2)"	"unprognostic (8.98e-2)"	"unprognostic (3.72e-2)"	64.2	22.5	8.8	64.3	14.5	200.9	45.3	13.8	9.9	45.8	11.1	45.6	53.4	35.3	28.9	52.6	41.1	59.6	29.1	8.9	12.4	31.9	50.4	47.3	95.3	19.7	14.1	34.6	56.1	39.8	9.7	48.6	19.5	35.2	48.3	4.2	35.3	33.9	21.3	38.5	57.8	43.9	13.7	68.3	49.7	15.1	14.9	134.5	54.9	25.9	96.9	61.3	36.5	21.0	35.5	20.5	15.3	15.3	68.6	72.6	57.2	35.9	84.9	48.7	55.1	51.2	90.9	199.7	22.1	60.4	36.5	78.7	2.9	45.4	30.8	44.9	23.7	179.6	16.3	36.5	50.9	103.3	271.2	75.1	78.5	32.9	62.0	32.8	69.2	93.1	45.0	51.7	32.4	32.5	136.6	63.1	12.1	117.7	15.8	179.2	25.1	58.7	49.9	54.8	6.1	21.3	31.0	31.0	62.9	21.2	22.0	132.8	63.8	21.5	12.4	17.7	13.0	23.7	14.8	131.2	29.0	65.0	45.9	265.9	60.4	134.2	70.0	66.1	73.8	63.0	79.3	77.9	58.6	65.1	84.8	75.9	97.4	73.0	98.4	38.9	86.8	80.1	8.8	14.5	13.8	9.9	8.9	12.4	19.7	14.1	19.5	13.7	14.9	21.0	156.8	76.9	68.0	51.6	326.8	108.8	188.2	86.0	90.0	2.8	71.5	37.7	41.3	52.9	86.1	57.0	10.4	35.7	292.0	62.9	19.6	70.2	47.7	121.6	69.5	122.0	58.1	78.8	8.2	69.4	55.8	79.0	64.2	126.0	323.1	8.1	91.4	25.2	97.5	3.3	8.6	57.0	95.6	115.4	206.3	21.9	42.9	244.1	120.9	125.5	123.5	8.1	133.9	52.8	138.7	65.9	54.4	43.2	211.5	150.4	58.7	28.3	84.6	3.7	39.5	52.7	52.8	7.7	11.2	95.6	114.8	53.5	365.3	26.9	56.0	221.9
EME1	"FLJ31364, MMS4L, SLX2A"	ENSG00000154920	"Essential meiotic structure-specific endonuclease 1"	Q96AY2	17	50373220-50381483	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.4;epididymis: 6.3;testis: 5.7"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 4.6;Extravillous trophoblasts: 4.8;Granulosa cells: 4.5;Spermatocytes: 13.2;Spermatogonia: 9.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	33	"basophil: 18.6"	"Lineage enriched"	"Detected in single"	33	"granulocytes: 18.6"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016127, HPA052188"	Supported		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies, Cytosol"		"CAB016127: AB_2278026, HPA052188: "	"unprognostic (3.81e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.94e-5)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.83e-3)"	"unprognostic (0.00e+0)"	"unprognostic (9.82e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.41e-1)"	0.5	0.3	0.2	1.7	0.3	4.4	0.6	0.1	0.4	0.5	0.0	0.9	0.8	0.4	6.3	1.1	0.3	0.3	0.2	0.1	0.1	0.2	0.4	0.4	2.3	0.3	0.2	0.5	0.2	0.1	0.1	1.4	0.3	0.2	1.3	0.4	0.5	0.1	0.2	1.1	0.7	0.6	0.1	0.9	0.5	5.7	0.3	3.3	0.2	0.0	2.6	0.4	0.5	0.4	13.9	20.0	26.2	13.7	1.2	2.6	18.8	14.2	5.4	19.3	17.7	31.7	11.0	11.0	18.3	5.7	12.0	10.7	24.5	11.3	27.3	21.7	19.3	26.3	23.3	14.8	0.1	10.9	8.4	0.5	0.8	22.3	9.2	2.6	4.5	31.2	16.3	25.6	11.6	15.2	25.0	13.9	15.1	14.2	13.6	25.5	50.7	15.4	4.3	5.6	10.1	20.2	8.7	4.8	8.1	20.9	16.8	12.3	3.1	24.8	14.9	16.6	19.7	16.0	17.4	10.5	7.8	12.2	15.6	18.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.2	0.3	0.1	0.4	0.1	0.1	0.3	0.2	0.3	0.1	0.3	0.4	0.1	0.0	1.1	0.3	0.8	0.1	0.3	0.5	0.6	1.5	0.5	0.3	0.4	0.0	0.7	0.0	0.0	4.6	0.5	0.6	0.0	0.3	0.5	0.8	0.7	0.4	0.0	3.8	0.1	0.0	4.8	0.8	2.0	0.5	0.0	4.5	0.0	0.3	2.2	0.0	0.1	0.9	0.0	0.0	1.4	0.6	0.6	0.8	0.0	0.0	1.0	0.5	1.0	0.0	0.3	0.1	0.0	0.0	2.5	0.1	0.1	0.0	0.9	0.3	0.0	0.6	1.0	13.2	9.1	1.5	0.1	1.1	0.5	0.6	1.3	0.2
ENPP2	"ATX, PD-IALPHA, PDNP2"	ENSG00000136960	"Ectonucleotide pyrophosphatase/phosphodiesterase 2"	Q13822	8	119557086-119673453	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chemotaxis, Lipid degradation, Lipid metabolism"	Hydrolase	"Cancer-related genes, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 383.3;choroid plexus: 753.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1041.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 46.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 53.8"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 53.8"	"Cell line enhanced"	"Detected in many"		"AF22: 111.4;ASC diff: 147.7;ASC TERT1: 312.5;BJ: 103.2;BJ hTERT+: 188.9;fHDF/TERT166: 124.2;HSkMC: 144.7;U-2197: 108.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023700, HPA053652"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Secreted to blood"	NA	NA		1200000000	"Cluster 46: Basophils - DNA binding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Golgi apparatus"	"Actin filaments"	"HPA023700: AB_1848170, HPA053652: AB_2682218"	"unprognostic (1.17e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.70e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"prognostic favorable (2.07e-5)"	"unprognostic (5.54e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	104.7	46.7	98.9	62.0	208.4	2.7	89.7	188.1	150.1	73.6	753.4	32.6	67.5	139.2	20.2	9.0	55.7	39.9	9.9	111.0	133.0	76.6	28.5	42.7	109.8	246.2	164.4	15.2	15.9	20.2	11.8	252.3	244.4	26.4	32.3	6.9	9.9	27.3	8.9	17.5	45.8	85.1	147.8	51.4	26.9	31.3	153.7	20.8	10.8	23.9	85.8	45.1	18.1	383.3	0.0	0.0	111.4	0.0	147.7	312.5	0.4	103.2	188.9	43.9	42.1	0.0	0.0	0.1	1.3	124.2	0.1	0.3	2.3	0.0	31.3	8.7	3.4	0.0	0.2	3.1	67.0	0.0	0.5	144.7	1.3	89.3	4.3	0.6	0.5	0.1	0.1	18.1	2.5	0.0	0.1	0.7	4.4	0.0	0.5	0.1	0.1	0.6	0.3	0.0	1.1	2.2	0.1	0.4	0.2	4.2	0.1	0.0	0.0	89.6	1.9	108.6	0.9	0.9	0.0	0.0	75.0	0.8	2.4	53.8	0.2	9.5	0.0	0.1	0.1	0.4	0.5	0.0	1.0	0.1	3.0	1.1	0.5	0.4	0.2	6.8	0.0	0.6	98.9	208.4	188.1	150.1	111.0	133.0	246.2	164.4	244.4	147.8	153.7	383.3	231.4	12.8	3.6	2.0	1.8	10.6	0.5	0.0	19.9	1.9	2.1	2.8	1.8	35.8	0.6	1.8	0.0	5.2	4.9	0.3	1.9	0.1	83.9	12.7	8.8	79.9	54.0	0.8	2.5	0.0	2.2	76.9	3.6	1.4	6.3	0.4	31.1	0.8	65.8	0.0	4.2	3.3	0.0	18.6	14.9	9.5	3.1	16.2	46.2	6.5	0.1	6.4	0.0	16.6	1041.6	0.7	2.6	3.4	1.9	0.1	4.2	47.6	3.7	1.2	0.0	3.1	9.6	1.7	0.4	7.8	5.3	6.4	1.7	1.1	2.8	1.4
ENTPD5	"CD39L4, NTPDase-5, PCPH"	ENSG00000187097	"Ectonucleoside triphosphate diphosphohydrolase 5 (inactive)"	O75356	14	73958010-74019399	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 107.2;kidney: 95.2;liver: 263.7"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 209.3;Hepatocytes: 134.8;Intestinal goblet cells: 77.1;Proximal enterocytes: 87.0"	"Group enriched"	"Detected in all"	5	"liver cancer: 18.2;prostate cancer: 39.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 18.3;eosinophil: 9.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 18.3"	"Cell line enhanced"	"Detected in all"		"RT4: 57.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002927	Enhanced				"Secreted to blood"	NA	NA		5900000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA002927: AB_1078744"	"unprognostic (4.19e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	"unprognostic (6.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.55e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (1.25e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.92e-3)"	8.2	7.7	5.0	11.4	7.3	8.0	12.4	7.1	6.7	7.3	7.1	94.6	72.1	6.3	7.7	11.3	5.7	12.1	7.7	5.1	6.3	95.2	263.7	6.5	5.5	7.6	7.3	6.7	4.9	7.7	5.0	5.6	7.8	37.7	107.2	9.4	10.7	4.4	15.0	8.1	68.4	9.7	6.5	6.0	42.3	8.6	7.3	4.6	6.1	9.1	5.6	16.9	7.2	9.0	9.5	7.8	8.2	15.1	16.5	15.5	9.4	9.6	7.9	6.4	7.1	5.6	10.9	10.6	4.7	12.8	6.0	10.8	8.5	14.1	7.2	8.8	4.0	7.9	5.7	30.9	15.5	4.7	8.8	12.9	14.0	8.7	18.2	8.8	13.1	17.1	8.8	15.4	9.7	13.6	5.4	5.6	2.5	8.5	15.7	6.0	8.0	5.2	11.4	57.1	5.8	6.0	16.6	12.9	9.2	6.4	18.7	4.1	10.8	12.6	12.7	7.5	7.2	10.1	16.9	8.3	8.0	8.8	11.5	18.3	1.2	9.4	2.5	2.3	1.3	1.4	1.3	1.8	1.7	1.5	2.1	2.1	0.1	0.5	1.4	0.9	1.6	1.3	5.0	7.3	7.1	6.7	5.1	6.3	7.6	7.3	7.8	6.5	7.3	9.0	8.0	16.0	6.7	8.1	4.9	3.7	6.2	8.9	5.2	6.6	15.0	7.9	5.2	10.0	11.3	7.3	4.2	8.2	4.3	209.3	25.4	6.9	19.5	10.0	13.6	7.0	16.2	36.6	5.9	12.9	6.7	7.9	23.0	25.8	1.3	9.6	9.7	134.8	6.2	10.1	8.2	77.1	14.2	9.7	1.9	12.7	2.8	5.2	5.4	11.2	5.4	4.9	8.2	2.0	11.3	9.1	58.4	5.7	3.6	28.5	87.0	63.1	6.4	12.2	13.1	6.0	5.9	27.2	19.1	8.5	3.4	3.3	4.9	10.3	60.9	39.0
EPAS1	"bHLHe73, HIF2A, HLF, MOP2, PASD2"	ENSG00000116016	"Endothelial PAS domain protein 1"	Q99814	2	46293667-46386697	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Congenital erythrocytosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 412.0;placenta: 445.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 831.5;Endothelial cells: 425.8;Hepatic stellate cells: 538.7;Syncytiotrophoblasts: 349.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"basophil: 20.6;eosinophil: 8.4"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 20.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 267.3;BJ hTERT+: 266.7;HHSteC: 326.3;RT4: 339.8;TIME: 337.8;U-138 MG: 284.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031200, HPA069697"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA031200: AB_2673785, HPA069697: AB_2732139"	"unprognostic (1.74e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.67e-2)"	"unprognostic (6.00e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.29e-2)"	"prognostic favorable (2.63e-4)"	"unprognostic (6.66e-3)"	"unprognostic (7.75e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.36e-1)"	296.0	52.1	53.4	66.1	48.6	2.3	166.7	44.6	47.7	72.9	139.1	57.1	46.3	87.9	26.0	72.7	80.1	83.2	122.1	39.2	44.7	89.5	110.1	412.0	47.9	60.5	54.2	34.5	59.6	79.4	25.9	445.6	60.2	51.8	42.6	53.6	40.0	66.3	80.5	42.9	50.9	71.7	45.6	84.6	42.8	20.0	75.4	17.9	138.1	153.6	40.3	94.9	47.8	44.6	32.2	33.5	2.1	2.5	153.8	98.6	267.3	98.7	266.7	55.6	60.1	5.8	5.5	0.1	23.8	188.5	55.2	15.2	0.6	79.0	41.3	0.9	1.6	0.0	10.3	71.8	326.3	0.1	19.8	145.0	106.9	108.7	75.8	41.0	193.1	0.7	3.1	0.2	34.2	27.8	0.9	0.8	1.3	22.4	18.5	1.0	3.7	10.5	34.5	339.8	1.4	68.5	77.4	175.5	21.0	68.3	11.7	14.1	337.8	284.0	8.1	38.3	8.4	0.2	0.2	0.1	207.4	5.4	7.4	20.6	0.1	8.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.1	53.4	48.6	44.6	47.7	39.2	44.7	60.5	54.2	60.2	45.6	75.4	44.6	831.5	76.9	151.7	28.4	4.1	48.2	69.8	108.6	43.9	4.5	27.4	29.5	79.2	32.9	124.9	3.7	10.4	126.2	6.6	112.6	1.9	23.0	12.9	36.1	32.7	425.8	4.2	18.7	1.2	52.4	299.9	76.8	32.1	67.6	41.2	2.3	538.7	78.0	55.5	0.0	1.6	13.9	22.4	60.9	30.3	52.7	12.5	21.4	28.4	155.5	0.6	95.5	0.0	31.2	1.3	26.1	53.7	6.4	3.9	57.8	45.9	30.2	31.7	59.3	282.7	23.3	250.5	1.5	4.6	65.0	33.2	349.7	15.9	4.7	23.6	85.7
ETS1	"ETS-1, EWSR2, FLJ10768"	ENSG00000134954	"ETS proto-oncogene 1, transcription factor"	P14921	11	128458761-128587558	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Immunity, Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 328.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 263.1;dendritic cells: 378.9;Endothelial cells: 190.4;Hepatic stellate cells: 213.8;NK-cells: 399.6;T-cells: 323.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 352.9;JURKAT: 362.3;U-698: 462.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002575, HPA063230"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB002575: AB_563721, HPA063230: AB_2684965"	"unprognostic (1.76e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.18e-3)"	"unprognostic (6.22e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (2.02e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.48e-3)"	101.2	19.2	11.7	145.7	10.4	35.3	65.4	9.8	14.1	35.9	8.9	31.2	26.9	36.5	9.3	21.8	20.2	62.5	43.0	8.9	11.3	30.4	47.6	76.2	277.1	13.1	14.7	27.0	20.1	28.4	7.8	56.3	13.4	17.1	31.4	1.8	16.5	20.7	25.6	18.1	49.3	38.1	11.6	185.8	46.1	8.0	15.2	328.8	39.8	42.3	250.2	67.9	19.2	11.3	87.7	15.7	72.8	0.3	30.7	49.3	0.2	65.7	140.2	80.9	77.3	5.1	91.7	312.1	65.7	109.5	184.7	29.8	7.0	190.0	169.0	66.6	1.1	352.9	6.4	0.3	82.2	36.7	4.0	97.2	15.0	69.6	252.2	46.1	67.9	362.3	0.6	63.3	98.1	0.0	185.7	27.4	27.0	7.9	55.0	50.4	118.7	24.5	64.2	95.6	0.9	5.0	34.5	0.7	73.6	48.5	0.3	17.7	126.1	180.5	57.1	35.5	109.1	46.7	8.9	462.5	32.2	68.0	162.1	51.2	0.1	6.6	20.4	0.3	28.9	12.3	27.0	25.0	0.2	9.2	32.5	26.1	1.1	27.8	1.0	6.2	33.3	9.5	11.7	10.4	9.8	14.1	8.9	11.3	13.1	14.7	13.4	11.6	15.2	11.3	263.1	25.6	26.5	2.9	125.6	114.8	41.0	12.4	1.8	0.0	8.2	7.2	9.0	4.3	24.3	11.0	0.0	0.2	378.9	13.1	0.0	31.9	6.2	26.3	51.0	190.4	15.5	13.7	2.0	22.6	0.5	45.5	17.3	66.2	19.6	1.3	213.8	5.4	7.3	0.0	25.6	15.0	10.2	18.3	48.2	1.5	14.0	12.5	69.4	65.6	16.8	0.2	399.6	55.3	9.5	99.3	6.6	15.4	129.6	26.8	2.2	4.6	5.9	0.2	105.2	55.5	76.6	0.7	1.8	1.5	63.2	0.4	323.2	40.4	5.8	32.6
EXO1	"HEX1, hExoI"	ENSG00000174371	"Exonuclease 1"	Q9UQ84	1	241847967-241895148	"Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, Immunity, Meiosis"	"DNA-binding, Endonuclease, Excision nuclease, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 17.3;lymphoid tissue: 11.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.3;Erythroid cells: 7.4;Extravillous trophoblasts: 16.7;Plasma cells: 11.8;Spermatocytes: 9.3;Spermatogonia: 9.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053079, HPA069738"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA053079: AB_2682037, HPA069738: AB_2732140"	"unprognostic (6.33e-3)"	"unprognostic (8.54e-3)"	"unprognostic (9.47e-3)"	"prognostic unfavorable (8.21e-4)"	"unprognostic (2.43e-1)"	"unprognostic (6.34e-2)"	"prognostic unfavorable (6.94e-7)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.40e-2)"	"unprognostic (4.81e-3)"	"unprognostic (9.40e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.57e-1)"	0.5	0.3	0.2	3.3	0.2	17.3	1.2	0.1	0.7	0.5	0.1	3.2	2.9	0.8	0.0	2.5	0.3	0.4	0.2	0.3	0.1	0.3	0.5	0.6	5.8	0.1	0.2	0.2	0.3	0.7	0.1	3.3	0.2	0.2	3.7	0.0	0.5	0.2	0.1	1.8	2.5	1.2	0.2	1.5	1.6	5.7	0.3	11.1	0.4	0.0	6.4	1.2	0.8	0.4	41.3	26.8	43.4	28.6	2.7	6.7	36.5	53.4	17.7	46.7	50.5	33.9	22.5	44.3	25.3	12.6	25.1	40.0	55.5	22.5	54.8	69.5	48.4	41.5	28.8	17.3	1.0	59.8	29.4	1.7	1.1	46.8	12.5	5.7	14.7	43.4	84.6	57.0	37.8	19.0	65.9	33.6	60.4	49.7	26.0	46.2	40.5	47.5	9.6	25.6	48.1	60.9	34.8	27.9	19.5	20.2	25.8	36.6	5.5	44.9	39.5	42.7	72.9	41.5	59.0	71.3	15.6	48.1	54.9	0.8	0.2	0.0	0.2	0.0	0.0	0.3	0.2	0.2	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.9	0.3	0.2	0.2	0.1	0.7	0.3	0.1	0.1	0.2	0.2	0.2	0.3	0.4	0.2	0.0	0.0	0.3	0.7	0.8	0.1	0.7	0.0	0.0	0.3	0.5	2.3	0.0	0.1	0.0	0.0	5.3	0.2	1.2	0.0	0.1	9.3	0.3	0.4	0.7	0.0	7.4	1.0	0.0	16.7	0.9	1.1	0.5	0.0	4.6	0.4	0.0	3.3	0.0	2.9	0.5	0.0	0.3	0.8	2.1	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0	11.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	9.3	9.8	2.7	0.1	4.0	0.8	0.8	1.9	0.3
FABP7	"B-FABP, BLBP"	ENSG00000164434	"Fatty acid binding protein 7"	O15540	6	122779716-122784074	"Metabolic proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 366.1;choroid plexus: 164.8;retina: 175.3;tongue: 199.3"	"Cell type enriched"	"Detected in some"	6	"Muller glia cells: 1407.3"	"Group enriched"	"Detected in many"	6	"glioma: 139.3;renal cancer: 51.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"AF22: 105.5;U-251 MG: 28.8;WM-115: 63.7"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 1195.2"	"Low region specificity"	"Detected in all"			"CAB025488, HPA028825, CAB058697"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB025488: , CAB058697: AB_2665600, HPA028825: AB_10602130"	"prognostic favorable (2.49e-4)"	"unprognostic (1.56e-2)"		"unprognostic (2.53e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.29e-1)"		"unprognostic (1.14e-1)"	"unprognostic (7.11e-2)"		"unprognostic (2.09e-2)"	"unprognostic (3.42e-2)"	"prognostic unfavorable (1.65e-6)"	"unprognostic (9.83e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.66e-2)"	1.9	0.4	184.8	0.1	210.5	0.3	38.0	228.1	366.1	1.2	164.8	0.7	0.1	0.1	0.2	0.8	0.1	0.1	0.3	198.7	176.2	0.8	0.3	0.0	0.1	188.0	175.5	0.1	0.1	0.0	8.0	0.4	171.2	0.3	0.1	175.3	8.8	3.9	8.8	41.8	0.1	0.0	170.8	0.0	0.4	0.2	174.0	1.8	0.0	199.3	0.1	0.2	0.4	182.9	0.0	0.1	105.5	0.0	0.0	0.0	3.8	0.0	0.9	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	8.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.0	0.1	0.2	0.1	0.2	0.0	0.1	28.8	0.0	0.0	0.0	1.2	0.1	63.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	184.8	210.5	228.1	366.1	198.7	176.2	188.0	175.5	171.2	170.8	174.0	182.9	0.1	0.0	0.0	14.0	0.0	12.2	0.3	0.0	0.0	11.6	44.5	38.9	1.3	0.0	0.0	0.0	12.5	4.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	2.9	0.0	228.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	5.0	1.1	0.0	0.0	0.0	1.4	0.0	0.0	0.1	30.2	0.0	0.0	1407.3	0.0	41.7	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	48.0	0.0	0.5	0.3	0.0	0.3	0.0	18.9	7.1	0.3	0.0	0.0	0.0
FAM117A		ENSG00000121104	"Family with sequence similarity 117 member A"	Q9C073	17	49710332-49789180	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 76.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 56.4;Erythroid cells: 104.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 50.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 82.0;U-266/84: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022531	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA022531: AB_2101087"	"prognostic favorable (5.30e-5)"	"unprognostic (8.06e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.69e-1)"	"prognostic favorable (8.25e-7)"	"unprognostic (4.05e-1)"	"unprognostic (3.58e-1)"	"prognostic favorable (1.81e-4)"	"unprognostic (1.99e-2)"	"unprognostic (3.73e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.66e-2)"	13.5	7.3	7.6	14.8	6.8	76.5	12.5	10.0	5.9	12.6	37.4	22.8	10.6	20.4	9.6	9.4	16.7	10.4	18.9	9.6	4.8	9.0	11.7	12.1	22.9	6.3	4.6	21.6	16.0	18.6	14.6	5.4	6.1	10.0	8.5	8.0	13.5	11.3	4.0	19.1	18.7	16.7	3.3	34.2	13.3	19.0	6.7	23.5	14.5	6.3	17.4	20.2	10.5	5.0	7.2	1.7	11.4	0.2	5.0	1.0	20.2	2.4	4.0	4.3	7.1	51.2	11.8	34.4	12.4	1.4	19.1	4.1	9.0	8.5	3.3	2.4	14.5	37.9	0.1	16.6	5.6	5.8	29.1	4.9	7.1	7.1	3.9	4.4	7.8	28.9	46.9	28.1	4.1	18.6	37.5	31.1	17.0	10.0	5.7	11.6	9.6	18.4	6.7	6.4	11.1	7.5	2.4	1.1	8.5	11.1	16.7	21.5	0.7	4.2	3.4	4.6	2.0	82.0	60.2	23.0	3.6	8.4	3.5	50.4	1.7	9.1	8.5	1.1	9.2	23.6	5.5	7.2	1.3	15.3	4.5	6.2	3.6	12.8	0.3	3.6	5.9	3.4	7.6	6.8	10.0	5.9	9.6	4.8	6.3	4.6	6.1	3.3	6.7	5.0	15.5	6.4	9.3	5.2	19.5	9.1	1.3	2.1	7.4	15.1	14.6	21.7	22.2	1.5	4.1	7.3	14.6	1.1	56.4	2.2	5.9	2.0	4.1	4.2	5.9	9.9	10.7	104.4	4.5	3.5	1.9	9.3	9.2	7.9	2.5	2.9	7.1	8.6	1.2	5.0	4.0	4.9	6.1	2.9	4.5	5.6	14.3	7.6	7.2	1.9	13.0	3.5	37.0	2.0	2.3	3.8	1.0	15.4	34.9	2.6	0.5	3.6	1.5	4.0	0.0	14.2	10.2	15.5	14.5	8.8	14.1	0.8	27.9	5.5	2.7	1.1
FAM124B	FLJ22746	ENSG00000124019	"Family with sequence similarity 124 member B"	Q9H5Z6	2	224378698-224402107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 8.5"	"Group enriched"	"Detected in some"	4	"Adipocytes: 13.8;Endothelial cells: 10.8;Erythroid cells: 9.4;granulocytes: 4.5"	"Cancer enriched"	"Detected in many"	10	"testis cancer: 7.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 29.5;eosinophil: 17.2"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"HUVEC TERT2: 103.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA070240	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Mitochondria	"HPA070240: AB_2686238"	"unprognostic (2.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.87e-3)"	"unprognostic (2.49e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.28e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.36e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.36e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.80e-3)"	5.2	0.5	1.4	1.1	1.2	4.7	4.3	1.4	1.7	1.5	0.9	0.9	1.0	1.6	0.3	1.4	1.2	1.2	1.8	1.3	1.6	0.6	1.9	2.3	0.7	1.8	1.7	0.4	0.4	2.4	0.2	8.5	1.5	0.5	1.0	0.2	0.8	0.5	1.2	1.8	1.0	2.3	1.6	0.5	0.6	0.3	1.7	1.1	1.0	4.6	0.7	1.5	1.4	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.5	0.1	0.0	0.0	0.0	15.0	0.0	0.1	0.0	0.0	0.0	103.4	0.0	4.8	0.2	0.0	0.1	0.0	0.1	6.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.7	7.5	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	29.5	3.0	17.2	0.2	2.3	0.0	0.0	0.7	0.0	7.9	0.0	0.0	0.0	0.1	5.4	0.8	0.0	2.5	1.1	1.4	1.2	1.4	1.7	1.3	1.6	1.8	1.7	1.5	1.6	1.7	1.1	13.8	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.3	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	1.2	0.3	0.2	10.8	0.0	9.4	0.2	0.0	0.1	0.4	0.0	0.8	4.5	0.0	2.2	0.4	0.4	0.0	0.2	0.0	0.0	0.9	0.6	0.0	0.0	0.7	0.0	1.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.3	0.0	0.1	0.1	0.0	0.1	1.1	0.1	0.0	0.0
FAM161B	"C14orf44, FLJ31697"	ENSG00000156050	"FAM161 centrosomal protein B"	Q96MY7	14	73931501-73950414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 62.9;Late spermatids: 142.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019125	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA019125: AB_1845570"	"unprognostic (1.50e-1)"	"unprognostic (9.03e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.76e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (6.78e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.60e-1)"	2.7	8.7	6.6	1.7	6.6	1.2	4.8	5.8	8.2	5.3	3.4	3.9	3.3	5.2	4.3	4.1	5.5	2.7	5.4	6.4	5.9	7.2	5.1	2.8	1.8	6.8	5.7	12.8	2.2	4.3	7.6	2.4	7.1	6.0	2.7	10.1	2.8	5.2	7.9	2.1	3.3	3.4	5.5	3.1	3.3	18.8	6.1	1.9	4.2	4.8	1.8	5.5	3.8	6.6	2.1	1.6	2.2	3.4	4.7	3.5	2.0	3.6	2.8	6.0	5.8	1.5	2.6	3.3	2.3	4.2	2.5	3.9	0.9	1.7	4.1	9.2	1.8	1.6	1.6	1.7	4.0	1.1	2.3	2.6	3.4	6.1	2.2	4.4	2.7	3.4	1.0	1.6	4.3	3.3	3.1	4.2	0.5	1.4	3.5	2.1	2.9	1.3	3.1	3.1	2.7	2.5	5.1	2.3	3.1	1.6	8.1	1.5	2.9	12.4	5.6	3.1	2.2	3.3	2.2	2.1	6.3	1.9	2.2	3.2	1.3	1.9	1.1	0.3	1.3	0.7	1.2	1.7	0.2	0.9	0.6	0.4	0.4	1.3	0.4	0.3	0.7	0.9	6.6	6.6	5.8	8.2	6.4	5.9	6.8	5.7	7.1	5.5	6.1	6.6	3.5	3.2	4.8	4.9	3.0	0.6	2.1	1.0	3.4	8.9	3.7	3.8	3.4	0.0	3.2	1.8	4.2	1.5	1.9	3.5	0.0	1.0	62.9	5.9	3.9	2.2	0.0	1.7	7.3	1.6	1.1	4.6	7.1	4.5	0.0	5.0	2.5	0.7	2.9	3.3	8.6	4.1	2.0	1.2	0.7	142.7	3.4	1.4	1.8	2.8	2.2	8.0	6.2	5.5	2.9	1.2	0.8	9.4	1.4	0.8	4.3	4.2	9.4	16.7	6.6	5.2	4.2	11.0	6.1	0.6	0.9	2.2	3.3	9.6	1.4	0.9
FAM227B	"C15orf33, FLJ32800"	ENSG00000166262	"Family with sequence similarity 227 member B"	Q96M60	15	49326962-49620929	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.5;Early spermatids: 41.0;Oligodendrocytes: 55.1;Spermatocytes: 48.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA049774, HPA061695"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA049774: AB_2680873, HPA061695: AB_2684588"	"unprognostic (1.19e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.28e-4)"	"unprognostic (3.32e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.57e-3)"	"unprognostic (6.32e-3)"	"unprognostic (6.41e-2)"	"unprognostic (7.48e-5)"	"unprognostic (2.70e-1)"	"unprognostic (9.01e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.76e-1)"	1.1	5.1	4.2	1.9	5.1	1.5	6.6	4.2	5.2	4.7	4.6	4.3	2.8	6.3	7.3	3.5	7.7	3.4	7.3	3.9	4.8	7.7	7.5	2.7	4.8	4.8	5.0	9.9	6.4	5.6	6.4	1.3	5.2	5.7	2.8	7.9	5.3	5.1	7.9	3.9	2.3	3.9	4.9	2.8	3.6	10.4	4.5	6.8	7.4	8.9	4.4	3.5	2.2	6.3	0.8	0.7	5.1	2.8	1.5	3.0	0.6	2.1	2.8	3.2	5.1	0.7	2.4	1.5	4.9	3.5	3.7	0.8	1.8	3.1	3.7	3.7	1.5	3.2	1.3	1.7	4.2	1.5	1.3	3.1	4.0	1.8	2.0	6.2	3.0	7.7	5.4	2.4	7.1	3.5	3.2	1.3	2.0	1.2	1.3	2.7	4.5	8.1	4.8	1.0	3.8	5.3	1.9	2.5	6.2	3.7	3.1	1.1	2.2	2.2	1.7	3.0	1.3	12.2	9.8	4.8	2.4	3.9	2.4	5.8	0.2	1.7	3.4	0.5	4.5	2.8	3.5	4.6	0.3	3.5	5.8	5.6	0.3	2.7	0.6	3.4	3.4	2.0	4.2	5.1	4.2	5.2	3.9	4.8	4.8	5.0	5.2	4.9	4.5	6.3	1.1	9.6	4.8	39.5	5.8	2.8	5.4	5.4	3.4	4.3	6.2	7.6	10.8	1.5	9.4	3.7	0.0	1.7	3.3	1.3	25.4	3.9	41.0	19.1	3.1	2.8	8.4	2.1	12.8	3.2	1.5	3.7	3.6	3.2	3.8	1.8	1.8	4.1	0.6	5.0	12.1	1.8	6.1	0.6	2.0	21.1	4.1	2.0	3.6	5.6	0.6	11.7	4.1	16.1	55.1	2.5	1.6	3.0	6.1	2.6	1.9	12.5	21.3	8.0	0.0	4.7	2.0	48.7	13.2	2.5	4.3	0.4	5.7	6.3	2.2	2.6
FANCD2	"FA-D2, FACD, FAD, FANCD"	ENSG00000144554	"FA complementation group D2"	Q9BXW9	3	10026414-10101932	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 25.2;Spermatocytes: 62.5;Spermatogonia: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 120.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB016117, HPA063742"	Approved		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB016117: AB_2278211, HPA063742: AB_2685110"	"unprognostic (3.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.08e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.59e-3)"	"prognostic unfavorable (5.00e-5)"	"unprognostic (1.23e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.41e-10)"	"unprognostic (9.11e-3)"	"unprognostic (3.99e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.89e-2)"	1.1	0.7	2.7	7.7	2.1	17.8	3.4	1.6	5.3	1.5	1.1	4.0	3.2	2.0	0.7	2.5	2.6	2.0	0.5	3.4	1.6	0.9	1.1	1.9	12.2	3.9	1.4	3.6	0.8	0.8	0.5	4.7	3.0	1.9	6.4	3.1	4.9	1.0	4.8	4.5	4.0	2.0	2.4	6.4	3.5	11.8	2.3	9.8	1.9	0.4	13.0	2.3	1.3	5.1	24.1	25.4	46.5	13.2	2.4	3.5	120.7	22.0	9.8	31.3	25.4	18.8	23.0	46.7	9.8	7.0	25.1	20.2	48.8	16.7	31.0	22.6	33.0	63.6	39.6	17.9	0.4	48.1	37.9	1.2	2.6	34.1	18.4	4.2	18.4	39.3	39.6	51.6	23.1	27.2	40.6	17.9	56.1	18.1	17.6	43.4	37.7	32.5	10.3	26.7	13.0	25.3	26.4	20.1	8.3	33.5	31.0	29.4	10.6	24.6	28.4	15.1	31.5	21.7	46.4	77.2	14.1	47.7	43.2	2.7	0.6	1.9	0.6	0.5	0.6	2.4	0.9	0.5	0.4	3.2	1.1	0.9	1.5	1.0	1.4	1.8	1.5	0.5	2.7	2.1	1.6	5.3	3.4	1.6	3.9	1.4	3.0	2.4	2.3	5.1	0.7	0.0	0.5	0.7	12.5	4.6	3.5	2.9	2.8	3.1	4.5	2.7	2.0	1.5	1.9	1.8	10.4	12.7	5.6	3.1	0.0	1.9	5.9	2.6	1.5	2.1	1.2	25.2	3.0	3.5	15.2	2.6	2.0	3.4	1.3	11.8	3.3	1.5	5.7	0.0	2.6	3.2	6.1	3.8	7.0	8.0	2.1	3.7	3.6	1.9	4.9	0.6	1.0	1.5	2.4	1.8	3.6	1.5	8.1	2.2	0.5	0.7	2.0	5.6	19.7	2.6	2.1	62.5	30.2	4.1	2.7	7.0	5.2	1.6	7.6	3.1
FBLN5	"ARMD3, DANCE, EVEC, UP50"	ENSG00000140092	"Fibulin 5"	Q9UBX5	14	91869411-91947987	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Age-related macular degeneration, Charcot-Marie-Tooth disease, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Fibroblasts: 209.4;Leydig cells: 626.6;Peritubular cells: 794.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 6.6"	"Group enriched"	"Detected in many"	19	"granulocytes: 6.6;T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 457.1;ASC TERT1: 234.6;BJ: 202.0;BJ hTERT+: 202.5;fHDF/TERT166: 394.6;HSkMC: 216.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000848, HPA000868, CAB025843"	Supported		Uncertain	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		12000000	"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB025843: , HPA000848: AB_1078620, HPA000868: AB_1078619"	"unprognostic (5.53e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.78e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.73e-2)"	"prognostic favorable (6.75e-4)"	"unprognostic (5.21e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.90e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.18e-2)"	"unprognostic (3.17e-3)"	182.2	73.4	10.7	17.7	12.8	7.5	110.4	7.4	12.5	124.9	15.7	80.3	19.1	178.4	40.0	26.8	143.0	130.2	211.1	9.4	8.6	108.4	29.3	164.8	25.5	15.5	10.9	107.3	46.4	16.8	14.5	67.0	14.2	49.0	20.6	0.6	55.8	70.9	30.4	66.9	52.7	88.7	13.1	130.9	68.9	35.6	12.7	21.8	79.5	36.0	15.7	117.5	93.3	7.5	0.0	1.6	0.2	0.0	457.1	234.6	22.5	202.0	202.5	5.8	4.5	4.7	0.0	0.0	4.2	394.6	0.6	0.1	9.8	1.0	1.0	0.0	2.3	0.4	4.7	0.0	74.2	0.0	0.1	216.6	0.4	3.9	14.1	2.8	10.4	0.1	0.0	0.1	25.3	0.4	0.5	0.5	0.5	0.0	0.5	0.4	30.2	0.2	1.2	0.1	0.2	0.1	12.3	0.7	2.6	7.0	2.9	0.3	1.9	3.2	6.6	3.8	0.1	0.1	0.0	0.2	0.4	0.0	0.0	6.6	0.1	2.2	0.8	0.2	0.5	0.0	0.3	0.1	0.0	0.1	1.1	1.8	2.5	0.0	0.2	0.0	0.1	0.4	10.7	12.8	7.4	12.5	9.4	8.6	15.5	10.9	14.2	13.1	12.7	7.5	31.4	83.3	13.1	0.0	2.1	9.2	2.4	7.1	1.8	0.0	11.2	9.3	5.2	0.0	11.5	5.5	0.0	2.5	2.5	0.1	5.9	4.7	5.9	13.3	67.4	15.2	0.0	0.4	2.6	4.7	2.5	209.4	2.0	12.0	2.5	1.8	34.2	0.4	7.8	0.0	3.6	0.1	18.3	2.5	18.4	27.5	626.6	5.8	21.4	15.9	1.6	0.0	8.2	5.0	2.3	2.2	0.0	794.8	0.7	1.3	0.0	32.5	21.4	0.0	6.6	28.0	14.5	3.0	2.8	1.3	8.7	3.7	15.5	3.5	0.4	1.2
FBXL3	"FBL3, FBL3A, FBXL3A"	ENSG00000005812	"F-box and leucine rich repeat protein 3"	Q9UKT7	13	76992598-77027195	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"		"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053283, HPA065626"			Enhanced	"Nuclear bodies"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nuclear bodies"		"HPA053283: AB_2682100, HPA065626: AB_2685523"	"unprognostic (3.98e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.24e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.12e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.10e-3)"	"unprognostic (8.52e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.78e-1)"	45.7	25.0	17.9	24.0	20.4	69.1	42.6	23.5	26.1	31.7	12.4	27.4	24.0	31.4	23.1	27.9	27.4	24.2	25.1	17.1	17.5	37.8	31.4	29.8	32.7	17.6	17.4	44.6	20.8	29.7	9.7	32.5	18.3	29.9	25.1	21.1	22.9	26.2	30.0	30.5	25.0	27.8	18.5	31.3	22.2	30.0	17.0	36.2	48.0	37.9	31.4	25.4	23.1	28.1	43.4	11.1	21.4	14.8	50.7	50.1	17.0	48.6	39.6	28.3	36.0	16.0	30.1	27.9	31.6	43.1	17.1	31.9	21.4	26.1	40.4	55.7	56.8	36.2	32.9	14.3	33.6	46.7	26.9	42.5	34.2	22.6	31.0	33.1	37.7	15.3	14.0	20.8	34.0	15.8	33.7	25.0	8.2	37.0	20.1	27.3	24.3	17.0	30.2	22.7	25.2	20.5	31.0	30.0	28.4	14.5	16.6	51.1	46.7	27.1	17.8	18.6	23.9	26.5	32.9	25.6	46.9	33.1	30.0	8.0	1.9	4.6	2.1	2.9	2.9	2.6	3.8	2.2	1.9	2.8	4.5	3.1	5.2	2.1	3.1	2.0	5.1	1.4	17.9	20.4	23.5	26.1	17.1	17.5	17.6	17.4	18.3	18.5	17.0	28.1	35.9	44.8	22.2	31.6	48.9	67.3	38.0	17.0	50.1	25.1	36.5	21.6	21.6	12.8	15.4	22.0	10.4	33.0	42.4	54.8	41.1	17.9	41.2	26.8	29.0	38.3	23.9	50.7	30.4	18.8	41.7	42.8	17.3	34.7	28.5	20.4	32.2	28.5	23.3	37.0	29.8	23.9	22.4	36.1	41.5	24.6	74.6	33.3	42.7	37.5	36.5	45.4	20.6	33.7	58.1	19.1	25.7	74.9	33.6	40.2	38.3	29.2	19.9	24.3	59.2	46.1	52.7	52.5	58.9	40.9	56.1	28.5	44.9	22.7	23.1	38.5
FBXL4	"FBL4, FBL5"	ENSG00000112234	"F-box and leucine rich repeat protein 4"	Q9UKA2	6	98868535-98948006	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 97.0;Oligodendrocytes: 94.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029140, CAB033362"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nuclear speckles"		"CAB033362: AB_2103974, HPA029140: AB_10611967"	"unprognostic (1.24e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.62e-1)"	5.8	8.0	5.9	5.3	8.4	5.1	7.7	7.6	5.5	7.0	5.5	6.2	5.9	6.9	11.2	5.3	7.7	6.6	5.9	4.6	7.1	13.1	15.7	5.9	6.1	8.0	8.3	8.2	9.4	12.7	4.8	6.8	8.4	8.0	6.9	5.1	9.9	6.6	9.4	5.7	5.8	6.2	7.2	5.3	7.4	4.1	7.4	9.0	12.2	7.2	6.4	5.7	5.3	11.0	5.7	9.0	7.6	10.2	12.5	22.8	8.2	12.7	10.7	7.3	10.3	4.1	10.7	13.1	11.5	10.6	12.8	8.1	8.8	9.2	11.1	21.4	7.2	9.3	6.2	9.4	9.7	11.5	8.9	13.0	16.4	6.6	18.4	20.4	9.5	10.2	12.6	10.1	13.4	5.6	4.3	5.5	4.0	7.5	5.5	14.6	5.2	10.7	13.9	8.2	9.5	7.7	6.7	8.9	12.2	9.2	6.6	8.2	13.3	8.4	3.7	11.9	9.3	3.4	3.4	5.5	10.5	10.4	10.2	18.4	4.7	13.0	4.6	4.5	6.1	7.1	4.6	4.6	3.8	5.7	5.9	5.6	5.9	4.3	6.0	2.5	6.1	3.9	5.9	8.4	7.6	5.5	4.6	7.1	8.0	8.3	8.4	7.2	7.4	11.0	12.2	19.2	11.9	42.7	14.2	9.7	8.2	9.0	12.0	14.9	9.1	8.3	16.2	5.7	8.8	36.8	22.9	10.1	9.5	9.8	19.6	9.7	5.4	10.6	14.5	10.8	7.2	20.2	46.9	11.0	10.7	13.7	14.3	7.9	8.9	20.8	11.4	19.4	8.9	10.1	58.3	13.7	8.2	12.3	6.4	2.1	19.0	11.8	5.4	41.2	14.9	10.6	12.3	97.0	94.4	7.5	9.8	12.8	8.8	13.9	12.5	11.8	11.3	13.3	13.1	12.7	10.0	4.1	6.4	12.4	8.5	9.9	9.3	16.9	10.4	8.2
FBXO11	"FBX11, UBR6"	ENSG00000138081	"F-box protein 11"	Q86XK2	2	47789316-47906498	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002690			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"		"HPA002690: AB_1848448"	"unprognostic (1.18e-1)"	"unprognostic (8.65e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.20e-2)"	27.9	19.6	24.5	19.1	25.9	32.2	20.9	32.7	28.7	21.1	21.0	19.7	16.8	33.1	24.8	18.7	22.2	20.9	22.8	26.5	25.6	21.7	26.8	22.5	25.7	22.8	23.1	34.4	19.6	30.2	17.5	23.0	24.0	22.7	20.1	33.3	16.5	20.4	28.3	19.1	17.3	29.7	22.9	24.2	19.1	41.0	25.9	22.5	26.1	28.7	27.7	22.1	16.9	25.2	52.8	26.9	62.9	53.9	42.6	40.2	37.2	36.0	48.6	32.6	31.9	22.9	25.9	32.8	45.4	50.2	40.5	25.6	42.5	37.1	47.9	22.3	21.5	31.6	21.3	36.6	41.0	33.5	32.1	39.3	41.7	28.8	48.2	51.9	42.1	16.6	31.3	33.9	40.4	25.5	31.7	32.8	38.2	34.7	26.2	40.9	58.3	25.5	47.1	42.5	44.1	52.3	34.2	31.5	54.6	46.4	14.7	27.9	46.4	40.2	37.2	27.5	40.0	28.9	16.5	60.9	27.4	30.8	42.1	4.3	1.1	2.1	1.5	1.2	1.6	2.1	1.4	1.7	1.4	1.5	2.6	1.7	2.6	2.2	1.1	2.0	1.6	1.1	24.5	25.9	32.7	28.7	26.5	25.6	22.8	23.1	24.0	22.9	25.9	25.2	40.6	16.0	39.0	100.9	34.1	67.0	44.4	22.0	24.5	45.1	22.3	15.1	11.0	15.7	24.9	18.4	33.3	19.6	37.8	24.7	11.7	17.2	34.4	38.6	40.3	39.4	23.9	17.1	151.4	15.2	16.0	37.0	23.4	48.6	29.1	37.3	33.2	20.0	25.5	55.5	134.8	17.1	24.4	40.1	81.4	40.4	30.1	51.8	35.6	137.7	30.9	30.2	25.7	138.7	143.8	25.8	17.1	39.9	36.3	44.3	17.3	14.6	37.4	42.5	19.7	42.3	34.6	86.6	50.7	24.2	59.0	36.0	35.6	33.4	19.5	65.1
FBXO45	Fbx45	ENSG00000174013	"F-box protein 45"	P0C2W1	3	196568611-196589059	"Predicted intracellular proteins"	"Neurogenesis, Ubl conjugation pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040730	Uncertain		Approved	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA040730: AB_10959311"	"unprognostic (7.17e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (7.61e-5)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.13e-2)"	"unprognostic (9.48e-3)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.16e-5)"	"prognostic unfavorable (4.93e-5)"	"unprognostic (5.18e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.65e-1)"	5.1	4.2	10.7	6.1	11.5	13.9	7.3	11.8	14.8	4.5	6.8	6.9	5.3	4.7	3.0	8.9	3.6	4.4	3.6	11.0	10.9	3.7	6.9	4.5	6.7	10.7	10.9	5.0	4.6	7.2	3.1	5.4	10.4	5.1	7.0	8.2	4.0	4.3	13.8	12.7	5.1	5.0	11.6	5.1	5.5	12.2	11.5	8.8	3.7	11.5	10.0	6.8	5.0	11.7	45.5	8.5	17.6	22.4	11.6	11.4	20.9	19.7	9.0	15.3	15.6	23.9	15.1	19.1	33.1	12.8	22.8	19.0	33.9	22.5	28.1	27.7	15.3	34.8	15.5	15.1	11.1	46.9	17.1	5.8	24.9	17.3	31.8	8.0	16.9	30.5	42.4	39.2	17.2	45.3	27.5	21.9	27.4	40.3	32.5	23.1	23.0	46.2	12.9	18.3	35.6	24.4	21.4	36.8	23.5	15.4	63.3	31.1	16.8	17.7	19.1	25.7	53.8	38.3	68.5	52.6	15.4	59.6	17.3	1.3	0.9	1.1	0.8	0.9	1.4	0.5	0.8	0.5	1.2	0.8	0.8	0.9	0.4	0.6	1.1	1.4	1.6	0.4	10.7	11.5	11.8	14.8	11.0	10.9	10.7	10.9	10.4	11.6	11.5	11.7	10.2	12.8	4.1	6.5	6.6	9.8	10.2	5.6	4.6	20.1	10.5	7.7	10.8	4.3	4.2	3.7	14.6	2.6	11.5	7.9	0.0	4.4	15.5	8.0	12.9	8.0	17.4	6.1	13.8	7.7	4.6	7.8	10.7	8.8	1.3	6.9	7.9	9.9	5.8	13.5	15.0	8.2	4.1	9.1	11.0	18.9	5.6	7.6	5.4	8.4	8.3	9.3	4.1	6.6	12.4	8.3	4.8	6.4	8.0	14.8	4.0	3.4	6.8	10.7	0.0	10.5	7.5	32.4	24.4	9.4	13.5	1.9	8.2	7.1	9.8	14.5
FMN1	"DKFZP686C2281, FLJ45135, FMN, LD, MGC125288, MGC125289"	ENSG00000248905	"Formin 1"	Q68DA7	15	32765544-33194714	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.9;retina: 30.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 117.0;Cone photoreceptor cells: 221.0;Excitatory neurons: 439.4;Inhibitory neurons: 340.0"	"Cancer enriched"	"Detected in many"	9	"melanoma: 14.5"	"Region enriched"	"Detected in some"	7	"cerebral cortex: 16.9"	"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 21.4;RH-30: 26.9;SK-MEL-30: 28.7;T-47d: 24.8;U-138 MG: 17.2;U-2197: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005465, HPA046786"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA005465: AB_1859515, HPA046786: AB_10963545"	"unprognostic (1.57e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-3)"	"unprognostic (3.67e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.53e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.73e-1)"	"unprognostic (4.32e-1)"	"unprognostic (7.61e-2)"	1.8	0.8	0.0	2.4	0.0	1.2	3.0	0.0	16.9	5.3	0.0	5.7	1.3	1.0	0.7	2.0	3.1	2.4	0.9	0.0	0.0	2.8	0.5	3.4	0.9	2.3	0.0	0.2	1.2	1.4	3.7	3.7	0.0	1.8	4.4	30.0	4.2	1.2	0.7	4.2	1.8	2.2	0.0	1.0	7.9	10.2	1.7	3.8	2.5	0.5	0.6	1.3	3.6	0.0	3.8	4.0	0.8	0.4	0.1	0.4	4.9	5.4	4.1	1.5	4.0	0.6	5.0	0.6	1.8	6.1	3.4	3.7	0.1	3.7	3.9	0.0	0.2	3.1	0.8	0.4	0.2	0.0	0.2	1.5	0.2	7.9	0.1	3.1	0.0	0.1	0.0	21.4	8.8	3.9	0.1	0.0	1.1	7.0	0.3	0.6	26.9	4.9	1.8	1.5	0.3	0.9	0.0	3.3	28.7	0.9	24.8	0.0	4.9	17.2	2.7	17.9	1.6	0.0	0.0	0.9	7.3	0.2	10.1	1.3	0.2	0.0	0.1	0.0	0.2	0.0	0.2	0.2	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	2.3	0.0	0.0	0.0	1.7	0.0	0.4	41.7	46.9	10.1	1.6	3.7	3.2	2.0	3.4	117.0	7.7	5.1	3.1	14.3	17.3	0.0	221.0	12.0	5.4	13.3	11.7	5.7	16.5	17.4	2.4	2.7	9.0	0.4	439.4	1.8	5.9	2.6	97.9	7.0	24.0	1.8	0.0	0.4	10.9	47.1	340.0	16.8	16.2	28.0	3.9	12.8	0.9	29.6	33.8	64.6	5.8	6.9	0.0	8.0	61.9	11.4	11.4	0.7	2.2	4.5	4.0	1.6	29.4	102.4	0.0	13.0	1.0	18.4	16.0	7.3	3.4	18.3	5.0	0.1	9.9	5.7
FNBP1L	"C1orf39, FLJ20275, TOCA1"	ENSG00000137942	"Formin binding protein 1 like"	Q5T0N5	1	93448118-93554661	"Predicted intracellular proteins"	"Autophagy, Endocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 7.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065273	Approved		Supported	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA065273: AB_2685452"	"unprognostic (1.83e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.57e-3)"	"unprognostic (8.46e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (5.89e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"prognostic favorable (4.72e-7)"	"unprognostic (3.59e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.78e-1)"	28.3	7.8	13.6	5.4	25.8	2.1	33.0	13.6	13.8	18.0	13.8	17.3	20.6	16.8	18.6	8.9	13.4	14.5	20.0	12.0	15.4	36.1	13.3	16.8	3.1	14.6	19.1	13.9	17.3	20.8	10.5	17.2	14.2	15.6	17.5	12.4	43.1	11.5	17.4	12.7	20.2	12.3	15.9	2.8	23.7	15.0	14.4	6.5	31.8	21.4	4.0	14.9	13.2	12.7	29.7	16.2	83.4	46.8	17.6	12.4	92.8	14.6	9.9	10.8	15.0	19.9	9.2	0.1	29.4	14.3	29.0	14.9	20.3	16.7	15.4	18.5	15.2	15.8	23.5	29.9	8.8	2.8	0.3	23.0	27.2	10.2	14.8	28.2	52.1	18.1	6.2	0.1	25.8	13.8	11.6	1.2	63.7	50.5	16.4	24.4	63.7	7.8	47.5	44.6	32.6	47.0	45.4	88.0	25.8	97.3	33.5	4.0	52.1	25.2	31.7	0.6	10.2	9.1	7.5	0.2	2.5	0.4	17.5	7.3	0.1	0.7	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.4	0.0	0.2	0.0	0.0	0.0	1.5	0.2	0.1	13.6	25.8	13.6	13.8	12.0	15.4	14.6	19.1	14.2	15.9	14.4	12.7	130.0	109.0	42.1	48.0	4.3	26.5	61.5	27.5	18.2	13.3	62.9	59.1	42.6	40.0	60.9	62.5	4.2	37.6	2.2	35.4	56.7	77.9	12.1	61.1	30.0	49.8	67.0	36.6	41.0	48.4	35.7	20.5	50.0	91.7	16.4	19.6	25.0	21.0	11.8	69.0	110.8	33.0	14.2	4.7	22.7	19.7	8.1	10.6	39.2	80.6	7.1	18.8	0.0	55.3	4.2	55.8	34.5	3.8	1.0	56.0	43.6	50.8	53.8	10.0	26.3	5.9	49.9	23.4	37.2	22.0	25.7	17.1	4.1	10.2	38.4	75.6
GAB3		ENSG00000160219	"GRB2 associated binding protein 3"	Q8WWW8	X	154675249-154751583	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 20.4;dendritic cells: 32.0;Erythroid cells: 20.4;granulocytes: 20.8;Kupffer cells: 24.7;Microglial cells: 30.9;NK-cells: 39.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 21.3;HMC-1: 23.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA010090	Approved		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"	"Nucleoplasm, Cytosol"	"HPA010090: AB_1849362"	"unprognostic (2.67e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.19e-1)"	3.7	2.1	1.8	7.0	3.5	12.5	2.3	2.6	3.4	1.8	2.2	2.6	3.4	2.0	3.8	1.7	1.9	3.7	7.4	2.0	2.6	1.0	1.9	6.0	7.6	4.7	2.2	1.3	1.0	2.7	0.4	3.7	5.0	1.3	3.4	1.2	2.1	1.9	1.3	3.6	4.2	3.5	2.1	13.9	2.6	4.9	3.6	5.2	3.6	1.6	6.6	3.1	1.1	8.6	0.8	0.0	0.7	1.0	0.9	2.3	0.5	0.3	0.6	0.2	0.3	0.0	0.5	2.5	0.7	0.0	1.5	0.4	0.6	0.4	0.0	2.9	1.0	21.3	2.9	2.4	1.6	6.5	23.3	0.9	0.2	2.0	0.8	0.8	5.2	2.0	4.8	7.3	1.0	0.3	2.4	6.6	0.2	0.0	0.1	3.5	0.0	0.3	1.3	0.0	3.0	0.4	0.3	0.3	0.4	0.5	0.9	3.7	4.8	1.2	1.9	0.8	0.6	8.0	7.0	2.5	2.0	8.4	0.6	26.4	5.9	8.7	13.3	5.7	10.2	1.0	3.5	9.7	5.8	1.3	1.2	6.8	9.0	2.5	3.6	3.3	0.8	5.0	1.8	3.5	2.6	3.4	2.0	2.6	4.7	2.2	5.0	2.1	3.6	8.6	9.9	0.0	6.7	0.7	6.0	0.6	0.0	0.3	0.0	0.1	0.2	0.6	20.4	0.0	1.3	0.0	0.0	0.1	32.0	0.0	0.0	0.8	0.3	0.5	1.2	8.3	0.0	20.4	0.3	0.5	0.6	2.3	0.0	0.1	20.8	2.2	6.1	0.3	13.8	0.0	0.3	0.0	0.0	24.7	5.8	1.7	1.8	18.8	0.0	30.9	16.1	2.6	39.1	8.5	0.3	0.4	0.0	4.5	7.5	0.1	0.0	0.2	1.7	0.4	6.6	0.7	6.6	0.1	1.0	0.2	1.0	0.1	18.6	0.5	0.0	0.1
GAL3ST1	CST	ENSG00000128242	"Galactose-3-O-sulfotransferase 1"	Q99999	22	30554635-30574665	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.6;intestine: 24.4;kidney: 18.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 30.0;Muller glia cells: 35.3;Oligodendrocyte precursor cells: 26.7;Oligodendrocytes: 53.6;Proximal enterocytes: 48.1;Proximal tubular cells: 24.6"	"Cancer enriched"	"Detected in many"	6	"renal cancer: 38.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 27.6;CACO-2: 7.7;EFO-21: 14.6;K-562: 6.6;OE19: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001220, HPA077138"	Approved		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 45: Intestine - Brush border"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles	Nucleoplasm	"HPA001220: AB_1078933, HPA077138: "	"unprognostic (2.69e-2)"	"unprognostic (3.12e-4)"	"unprognostic (5.93e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (2.33e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.56e-2)"	1.3	0.2	14.8	0.4	33.3	0.8	1.1	27.7	25.8	2.7	0.3	5.2	23.0	2.4	1.7	0.5	3.1	5.2	1.1	14.6	18.3	18.4	4.0	1.9	0.7	32.9	29.0	2.3	6.9	0.7	1.5	0.9	31.0	3.1	2.4	2.3	0.5	1.4	3.1	1.6	24.4	0.3	23.2	0.3	8.2	5.0	29.1	0.1	0.2	0.3	0.0	1.6	1.8	51.6	0.0	27.6	0.5	0.2	0.0	0.0	2.0	0.0	0.2	0.0	0.0	7.7	3.8	0.4	14.6	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.7	0.4	0.4	5.7	0.6	0.2	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.4	6.6	0.6	0.0	0.2	0.3	1.1	3.9	10.6	0.4	0.2	0.0	0.7	1.1	0.1	0.3	1.8	0.0	0.4	0.2	0.7	0.2	0.2	0.8	0.2	0.2	0.3	0.0	2.4	1.2	0.3	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.3	0.1	0.1	0.5	0.0	0.0	0.6	0.0	0.0	14.8	33.3	27.7	25.8	14.6	18.3	32.9	29.0	31.0	23.2	29.1	51.6	0.5	0.0	0.0	2.3	0.3	0.4	0.1	0.0	0.0	0.8	0.6	3.3	0.6	30.0	0.0	3.7	0.0	0.1	0.0	14.0	15.6	7.0	1.1	1.1	0.3	0.3	10.9	2.7	2.0	11.1	0.1	0.3	5.1	2.4	0.0	0.9	0.0	1.6	0.1	0.0	1.9	5.7	0.0	0.3	0.3	0.8	1.5	0.2	0.0	0.0	0.0	35.3	0.0	26.7	53.6	5.0	8.8	2.2	0.1	0.4	48.1	24.6	0.1	1.3	0.0	2.1	0.3	12.4	14.3	0.0	0.3	0.3	0.2	0.0	7.6	0.1
GALNT3	"GalNAc-T3, HFTC, HHS"	ENSG00000115339	"Polypeptide N-acetylgalactosaminyltransferase 3"	Q14435	2	165747588-165794659	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 77.3"	"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 152.8;Pancreatic endocrine cells: 188.1;Prostatic glandular cells: 155.7;Urothelial cells: 274.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 50.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 85.4;HaCaT: 108.3;HBEC3-KT: 69.2;hTCEpi: 88.2;OE19: 201.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA007613	Enhanced		Supported	"Golgi apparatus"		NA	NA		440000	"Cluster 46: Basophils - DNA binding"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"		"HPA007613: AB_1078941"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (1.16e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (4.10e-4)"	"unprognostic (4.13e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.57e-1)"	1.5	1.7	1.7	8.4	2.1	54.0	26.0	2.7	1.8	29.3	4.3	48.9	43.5	5.2	9.3	27.4	38.8	32.2	0.6	1.8	3.4	10.9	2.4	14.0	3.7	4.5	5.2	6.8	26.2	6.9	9.8	6.4	3.3	25.2	53.2	3.7	55.3	8.2	0.3	15.3	39.5	2.5	7.0	20.1	77.3	25.8	1.9	3.3	25.4	0.4	12.3	17.3	12.6	5.4	61.5	0.0	0.6	0.2	0.1	2.6	43.0	18.3	7.7	6.6	16.0	32.0	85.4	0.4	0.1	0.0	0.1	108.3	0.0	69.2	13.5	1.3	13.0	0.0	14.9	0.3	0.3	14.5	0.4	0.5	88.2	0.0	30.3	2.1	0.1	2.9	0.0	55.0	5.0	42.7	0.5	5.6	0.1	201.1	7.8	0.2	0.0	1.7	17.8	42.0	6.5	0.1	0.3	49.6	16.8	1.9	21.7	0.9	0.5	0.1	1.0	0.1	0.3	34.4	16.3	1.3	0.2	14.0	0.6	50.5	6.8	32.2	10.2	9.0	7.5	6.6	3.1	5.8	11.4	6.0	1.0	3.4	25.2	10.6	13.8	17.3	5.6	6.2	1.7	2.1	2.7	1.8	1.8	3.4	4.5	5.2	3.3	7.0	1.9	5.4	1.0	12.8	34.4	7.8	13.6	38.0	107.9	36.5	29.6	0.6	45.0	26.8	0.4	35.8	45.9	66.2	0.0	8.5	37.7	68.6	3.9	70.2	127.5	91.8	5.2	2.9	23.4	1.3	10.5	113.2	22.5	2.3	102.4	70.5	45.7	0.7	1.1	0.6	8.2	0.0	5.1	152.8	28.5	1.9	12.4	14.1	2.5	8.3	16.0	1.0	7.5	16.1	15.5	27.6	1.4	188.1	46.5	0.4	29.7	155.7	32.6	3.1	89.3	1.0	6.6	0.6	4.3	71.5	1.1	42.4	41.3	11.2	14.4	1.2	61.8	274.4
GAS8	"DRC4, GAS11"	ENSG00000141013	"Growth arrest specific 8"	O95995	16	90019629-90044975	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 198.3;Late spermatids: 277.8;Respiratory ciliated cells: 82.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041311, HPA048238"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"	Cytosol	"Plasma membrane"	"HPA041311: AB_2677402, HPA048238: AB_2680324"	"unprognostic (2.23e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (3.01e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.47e-1)"	"prognostic favorable (7.67e-4)"	"unprognostic (3.06e-2)"	"prognostic favorable (1.09e-7)"	"unprognostic (1.98e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.19e-2)"	5.2	10.3	9.5	2.8	9.7	1.4	6.3	10.0	14.3	7.8	12.3	7.7	2.6	6.5	10.1	8.4	18.9	6.1	15.4	9.5	9.9	13.8	5.5	7.1	2.8	10.3	10.0	8.9	10.5	16.3	14.1	2.1	10.1	7.3	3.0	5.0	11.4	8.6	15.1	4.5	3.9	4.4	10.3	3.4	8.2	16.8	10.9	2.5	12.5	10.0	2.0	6.3	5.8	10.2	17.9	14.5	1.8	8.5	7.8	6.2	14.3	3.6	8.8	13.9	4.1	14.1	13.0	1.0	9.1	7.1	8.4	17.8	5.9	9.9	3.3	0.0	10.7	3.7	9.0	16.2	8.7	2.2	2.8	7.9	6.0	10.4	4.7	6.3	8.3	5.8	14.3	2.1	6.1	41.9	2.5	9.9	11.6	11.3	7.4	0.7	15.7	1.0	17.4	8.5	14.6	10.7	18.4	9.7	21.0	1.6	19.6	8.4	6.2	8.6	10.3	4.7	8.3	3.4	5.4	0.0	21.3	2.7	15.1	1.7	1.2	1.4	0.7	2.0	0.7	0.4	1.0	1.4	1.7	0.8	0.8	0.7	1.5	0.0	1.3	1.9	1.6	0.8	9.5	9.7	10.0	14.3	9.5	9.9	10.3	10.0	10.1	10.3	10.9	10.2	5.9	22.4	11.3	20.5	3.1	1.1	4.7	7.0	5.7	11.9	14.1	10.8	7.9	25.8	13.4	22.0	20.9	3.0	0.7	5.9	13.7	17.1	198.3	45.5	7.1	5.8	6.0	3.0	27.5	10.9	3.6	5.5	12.2	10.0	2.5	16.1	7.1	4.8	4.1	26.9	24.6	6.3	8.2	0.8	1.4	277.8	14.0	2.3	5.4	1.9	1.3	12.4	0.0	13.0	6.0	10.0	4.6	7.5	1.1	5.8	5.3	30.9	82.3	28.0	6.6	6.7	9.5	28.7	11.9	7.2	2.6	1.6	1.6	25.2	5.3	5.8
GATC	"15E1.2, FLJ37000"	ENSG00000257218	"Glutamyl-tRNA amidotransferase subunit C"	O43716	12	120446444-120463749	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	Ligase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"				"unprognostic (2.10e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.46e-2)"	"prognostic unfavorable (4.21e-5)"	"unprognostic (1.68e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.92e-2)"	10.0	10.3	11.6	8.4	13.2	7.5	12.0	15.2	15.1	11.1	10.2	10.2	11.7	8.3	10.9	8.7	7.7	7.3	6.6	12.1	12.6	15.3	16.4	8.6	10.2	13.2	12.9	9.9	37.8	13.0	7.9	9.2	13.6	8.6	10.7	12.8	10.5	7.9	8.5	9.5	10.2	7.7	12.8	9.2	9.6	4.6	13.1	11.9	11.6	8.0	11.8	10.0	8.3	15.8	12.7	40.7	19.4	22.6	23.4	23.1	13.8	16.1	15.0	17.5	12.9	37.9	9.3	25.2	17.6	14.7	15.5	20.4	30.7	17.6	17.1	19.4	28.7	24.1	25.3	25.4	25.8	23.4	13.6	21.7	18.8	13.7	24.4	24.0	24.8	23.4	33.3	12.9	17.9	20.0	26.3	25.8	12.3	19.0	25.7	17.6	22.5	33.9	20.7	21.5	35.7	17.3	28.8	15.1	21.0	15.3	26.8	12.9	21.9	14.6	13.5	19.8	12.6	18.4	32.6	32.5	19.8	14.5	23.5	7.0	5.3	4.0	6.1	3.6	5.9	6.2	4.7	3.6	3.9	5.9	4.3	5.0	3.7	4.7	5.5	6.2	5.4	5.4	11.6	13.2	15.2	15.1	12.1	12.6	13.2	12.9	13.6	12.8	13.1	15.8	14.8	3.2	19.1	11.4	13.0	9.4	20.6	4.4	16.5	17.6	13.4	12.4	6.2	18.6	13.8	18.4	16.7	13.3	16.4	18.3	11.7	17.8	3.2	14.6	19.5	17.2	27.0	10.1	14.0	24.4	12.3	12.5	11.2	18.2	24.1	17.6	18.5	22.8	11.3	18.5	12.8	15.5	6.1	14.9	4.2	1.9	14.6	14.6	3.6	4.7	18.5	12.0	11.3	13.6	13.6	29.4	14.1	20.3	13.9	25.8	19.8	22.4	7.5	14.1	6.6	20.0	12.0	11.7	8.0	15.3	9.9	14.9	12.6	11.7	19.3	22.0
GFPT1	"GFA, GFAT, GFAT1, GFPT"	ENSG00000198380	"Glutamine--fructose-6-phosphate transaminase 1"	Q06210	2	69319780-69387250	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms"	"Aminotransferase, Transferase"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 184.2;Intestinal goblet cells: 244.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047240			Approved	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		NA	NA		93000	"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Nucleoli"	"Nucleoli fibrillar center"	"HPA047240: "	"unprognostic (4.38e-3)"	"unprognostic (8.20e-2)"	"prognostic favorable (7.13e-5)"	"unprognostic (2.97e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.84e-2)"	"unprognostic (5.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.58e-1)"	31.2	17.9	6.6	21.5	6.5	15.0	22.4	5.5	7.1	37.8	31.5	74.3	38.4	15.6	41.6	16.4	24.3	32.5	24.8	7.0	11.0	21.6	23.1	17.0	10.6	4.9	10.5	12.0	33.7	26.2	18.9	36.0	10.8	36.7	76.6	10.4	42.4	25.9	10.2	6.0	41.2	23.2	5.3	9.5	64.3	46.6	8.0	10.2	91.8	13.9	15.9	21.8	9.2	6.8	46.6	42.7	34.7	20.9	107.7	75.8	73.5	97.1	94.5	44.7	59.3	109.5	50.5	31.7	31.9	92.9	61.4	22.6	47.1	28.6	73.6	38.4	18.4	38.2	25.0	94.5	123.0	27.9	17.9	47.8	132.5	88.7	158.8	55.5	43.4	29.8	34.8	58.3	85.2	30.9	31.3	22.9	37.0	116.7	27.4	28.2	79.1	18.3	70.6	42.0	25.2	11.9	35.2	52.4	93.7	73.5	22.7	17.2	61.8	37.2	62.3	64.6	47.5	39.5	32.2	25.4	65.7	18.3	46.9	9.2	3.5	4.9	7.5	4.3	7.0	6.4	6.5	8.3	4.7	3.6	6.3	6.2	1.2	5.2	5.2	4.4	5.0	4.2	6.6	6.5	5.5	7.1	7.0	11.0	4.9	10.5	10.8	5.3	8.0	6.8	14.6	51.3	49.5	15.7	29.8	28.4	21.6	31.7	26.7	13.7	50.6	16.5	43.1	42.9	54.5	44.1	12.5	28.6	30.3	184.2	17.6	34.1	123.9	54.4	54.1	17.2	75.1	3.8	49.2	89.5	70.3	37.6	110.1	60.0	24.1	19.2	17.9	53.6	17.0	6.7	56.3	244.0	16.2	10.0	31.4	23.7	23.3	16.0	53.4	27.2	28.1	10.6	13.4	42.7	43.8	66.0	83.3	28.2	82.1	72.3	62.5	30.0	89.7	14.0	19.7	21.6	41.8	134.1	45.3	20.3	21.0	34.3	33.4	15.7	135.3	56.3
GNG2		ENSG00000186469	"G protein subunit gamma 2"	P59768	14	51826195-51979342	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 113.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 251.8;Early spermatids: 714.4;Late spermatids: 1146.4;NK-cells: 246.1"	"Cancer enhanced"	"Detected in all"		"glioma: 15.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 77.2;fHDF/TERT166: 140.2;MOLT-4: 112.5;SH-SY5Y: 89.2;WM-115: 249.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003534, CAB018380"	Uncertain	Supported	Approved	"Vesicles,Plasma membrane"		NA	NA		170000	"Cluster 46: Basophils - DNA binding"	"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"	Vesicles	"CAB018380: AB_631547, HPA003534: AB_1079004"	"unprognostic (6.11e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.64e-4)"	"unprognostic (8.47e-2)"	"prognostic unfavorable (3.90e-6)"	"unprognostic (9.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.59e-2)"	51.3	22.0	38.5	41.1	44.8	64.0	21.0	0.8	55.4	11.9	10.9	24.1	15.2	12.2	5.1	14.1	5.8	17.3	13.5	54.1	75.2	7.5	12.7	19.0	47.7	10.6	20.5	14.4	7.3	3.5	14.9	19.5	27.2	10.6	19.6	15.0	8.1	9.0	5.6	7.8	21.2	19.8	13.6	61.7	15.9	113.4	46.4	62.0	5.7	13.1	45.4	22.2	5.3	22.2	0.0	3.1	77.2	48.6	11.6	15.0	1.2	12.9	15.9	6.1	4.9	6.4	0.2	0.2	1.8	140.2	8.9	0.3	10.4	0.0	4.2	36.4	1.2	0.0	0.7	0.0	6.0	7.4	0.3	25.1	0.0	6.2	0.5	32.2	0.0	67.9	0.0	6.5	39.7	0.0	112.5	12.0	41.1	0.0	9.5	39.4	6.1	2.0	6.4	0.0	11.5	89.2	0.3	0.1	34.5	2.7	0.0	0.3	0.0	18.7	3.1	0.3	9.9	0.2	0.0	5.5	15.5	39.2	249.0	379.4	64.0	177.1	162.8	111.9	110.5	38.1	88.9	134.2	65.8	36.2	55.5	98.5	185.2	25.2	177.3	28.0	143.2	158.6	38.5	44.8	0.8	55.4	54.1	75.2	10.6	20.5	27.2	13.6	46.4	22.2	11.6	6.4	7.2	3.3	101.3	11.5	0.4	0.0	2.2	18.7	1.5	1.9	1.0	1.5	0.0	3.7	2.1	0.6	251.8	0.8	1.9	0.2	714.4	0.5	2.7	11.7	175.8	20.4	66.2	0.0	0.6	23.9	11.7	0.8	32.3	0.2	11.0	0.9	51.1	0.0	59.6	2.4	0.0	94.1	60.0	1146.4	9.9	84.0	55.2	24.4	33.3	0.7	246.1	96.0	3.2	0.5	0.1	6.0	62.7	0.2	0.1	0.9	0.0	2.2	39.5	10.2	12.2	11.2	4.6	1.3	6.7	0.7	191.5	2.2	0.5	0.2
GOLGA1	"golgin-97, MGC33154"	ENSG00000136935	"Golgin A1"	Q92805	9	124878275-124948492	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013065, HPA044329, HPA050555"	Supported		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"		"CAB013065: AB_221447, HPA044329: AB_2678897, HPA050555: AB_2681174"	"unprognostic (5.44e-2)"	"unprognostic (9.35e-2)"	"unprognostic (6.92e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (9.34e-2)"	"unprognostic (4.43e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.03e-3)"	"unprognostic (3.06e-1)"	"unprognostic (6.28e-3)"	"unprognostic (4.05e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.52e-2)"	8.7	9.4	5.4	8.7	7.0	5.9	7.8	5.8	6.3	8.0	7.1	10.8	10.1	8.8	5.9	9.9	7.7	7.6	10.2	5.1	5.9	6.8	9.5	7.5	7.6	6.1	6.4	8.0	10.8	9.1	8.0	5.6	6.9	8.3	9.3	37.7	8.4	8.3	13.2	10.8	9.6	8.6	6.1	8.5	8.7	15.2	6.8	5.3	8.2	9.6	7.4	10.4	8.1	9.0	8.4	14.7	8.6	9.1	14.7	13.0	11.0	13.5	14.3	14.0	10.2	9.7	9.6	5.6	6.5	15.0	10.8	21.2	7.1	11.4	10.2	8.0	7.0	5.9	20.5	12.9	16.9	7.1	13.7	8.8	8.1	13.5	16.3	9.9	12.7	7.0	9.8	9.4	10.0	17.5	5.1	8.0	3.2	19.7	13.5	3.2	12.7	12.3	7.0	11.3	5.0	9.5	16.2	13.0	8.5	7.6	25.1	5.0	14.8	13.0	7.2	16.8	12.6	11.4	19.6	6.5	16.3	7.4	13.8	8.1	3.4	4.3	4.2	3.5	3.4	3.0	2.6	4.5	3.3	3.5	2.7	2.5	7.6	3.2	2.8	4.6	2.7	1.3	5.4	7.0	5.8	6.3	5.1	5.9	6.1	6.4	6.9	6.1	6.8	9.0	11.8	6.4	14.4	32.3	8.1	2.0	4.2	5.8	6.2	16.3	10.2	10.2	21.0	7.2	10.8	5.5	64.6	6.8	11.5	11.7	3.9	9.5	16.2	10.4	13.6	10.0	5.4	5.0	31.7	8.9	4.9	7.8	10.7	8.8	15.8	14.6	10.8	14.8	6.6	18.5	31.4	9.7	12.2	7.3	4.2	9.8	5.9	9.3	8.8	20.6	10.1	15.2	9.2	27.2	34.3	9.0	2.7	9.1	11.1	4.5	7.8	6.1	17.8	38.0	6.6	15.4	12.3	50.1	21.4	11.0	4.3	8.6	9.1	10.9	8.8	4.0
GRB10		ENSG00000106070	"Growth factor receptor bound protein 10"	Q13322	7	50590063-50793462	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 87.6;Early spermatids: 143.0;Late spermatids: 212.6;Oligodendrocytes: 124.7;Rod photoreceptor cells: 81.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"basophil: 10.0;eosinophil: 3.0"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 10.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB019423, HPA027502, HPA031818"	Enhanced		Supported	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles		"CAB019423: AB_2112883, HPA027502: AB_10602325, HPA031818: AB_2674057"	"unprognostic (2.82e-2)"	"unprognostic (1.69e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.83e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.31e-3)"	"unprognostic (4.44e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.73e-3)"	"unprognostic (8.16e-3)"	"unprognostic (2.63e-2)"	"unprognostic (8.50e-2)"	27.6	26.0	29.5	6.5	33.6	10.0	25.0	25.2	32.5	18.2	28.5	27.2	17.2	19.8	10.3	9.5	18.8	21.6	34.8	26.5	40.2	29.3	32.1	20.6	6.0	31.5	41.8	14.2	94.3	10.5	24.3	14.7	40.2	20.1	6.4	83.5	16.5	15.0	57.4	9.1	13.3	16.1	21.6	36.8	17.6	18.1	48.2	2.8	27.8	76.0	4.0	31.0	15.9	33.5	0.3	32.5	51.6	21.1	23.5	17.8	27.6	13.1	11.3	24.9	29.7	19.8	0.4	0.7	22.6	16.7	71.0	3.1	53.5	13.9	12.2	0.4	21.6	56.7	32.6	14.4	49.8	36.0	84.1	46.4	21.0	38.6	37.4	23.9	62.7	3.9	109.5	0.6	18.7	4.0	6.4	48.0	56.9	27.2	55.4	16.8	0.0	0.3	16.0	13.1	22.7	0.2	1.6	8.1	68.7	33.0	27.7	71.6	78.7	21.8	29.6	45.4	50.4	2.1	0.7	0.4	68.9	32.2	75.2	10.0	0.1	3.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	29.5	33.6	25.2	32.5	26.5	40.2	31.5	41.8	40.2	21.6	48.2	33.5	46.3	6.4	8.3	3.9	1.2	7.5	5.3	9.4	7.4	12.1	14.8	9.0	13.5	47.1	5.2	5.5	87.6	4.5	0.3	6.9	1.9	18.3	143.0	5.3	12.4	45.2	0.0	19.0	64.8	24.4	16.5	15.4	5.6	9.7	0.0	0.8	53.2	26.8	1.6	5.0	55.0	2.8	6.1	9.7	5.5	212.6	1.8	4.0	7.2	40.3	0.8	21.8	0.0	41.7	124.7	36.4	3.0	0.4	0.6	22.2	11.2	22.2	2.3	81.9	0.0	9.2	10.9	1.9	16.2	1.2	4.3	2.6	1.5	0.9	3.8	7.0
GSR		ENSG00000104687	"Glutathione-disulfide reductase"	P00390	8	30678066-30727846	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 32.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001538, CAB008632, HPA064806"	Approved		Supported	Cytosol		NA	NA		81000000	"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"CAB008632: AB_1616690, HPA001538: AB_1078986, HPA064806: "	"unprognostic (1.23e-1)"	"prognostic favorable (3.37e-4)"	"prognostic favorable (4.08e-5)"	"unprognostic (2.89e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (3.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.92e-3)"	"prognostic favorable (1.80e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	13.6	23.3	12.3	18.7	11.1	25.9	11.0	10.6	11.7	28.5	25.8	42.5	54.3	16.0	21.6	37.3	21.6	30.5	25.4	12.9	12.5	45.3	35.8	17.4	23.6	9.5	14.2	23.1	26.5	82.3	14.8	23.5	12.0	35.3	46.6	12.8	25.8	29.4	28.9	12.8	50.8	17.9	10.7	22.1	41.8	11.6	17.6	26.7	16.9	21.3	24.0	22.5	27.7	11.2	49.4	197.8	35.9	40.1	35.8	38.3	29.1	23.4	46.8	31.8	36.7	66.0	31.3	95.8	94.8	32.0	96.1	59.2	62.3	51.1	33.1	22.6	40.7	104.6	67.0	197.8	88.4	38.6	159.7	72.6	28.5	48.9	20.9	33.5	43.3	57.3	73.2	55.1	67.9	44.1	147.1	32.0	65.4	191.9	31.5	43.8	41.9	59.3	56.0	124.3	28.2	31.8	31.2	87.8	58.8	40.7	37.5	32.6	63.8	21.0	34.7	37.3	35.2	20.2	29.4	70.0	51.9	51.8	62.4	32.3	5.9	15.0	5.0	5.4	8.8	3.6	4.5	5.4	6.0	2.3	2.8	3.7	8.2	3.6	7.9	3.9	4.5	3.1	12.3	11.1	10.6	11.7	12.9	12.5	9.5	14.2	12.0	10.7	17.6	11.2	8.2	3.2	20.8	12.7	13.7	4.2	15.2	9.4	52.3	6.7	6.7	5.0	26.8	30.0	15.0	12.9	16.7	17.0	20.3	61.8	9.8	11.4	8.4	61.4	13.4	9.9	34.1	28.6	18.1	19.8	6.3	10.0	33.1	41.3	6.3	64.3	12.1	43.4	18.2	3.3	27.4	51.7	8.2	40.5	5.8	18.9	7.2	22.1	8.8	11.2	20.6	12.6	17.5	12.5	10.0	15.2	32.0	10.9	15.6	27.5	75.7	19.0	11.7	8.0	6.6	7.0	8.6	1.2	3.4	39.6	5.4	6.4	17.3	17.2	47.5	33.5
H2BW2	"H2BFM, H2BM"	ENSG00000101812	"H2B.W histone 2"	P0C1H6	X	104039949-104042454	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 3.3;Karpas-707: 3.6"															NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"													"unprognostic (1.87e-1)"					"unprognostic (1.87e-1)"		"unprognostic (1.54e-1)"	0.4	0.4	2.9	0.3	2.8	0.6	0.6	3.9	4.4	0.4	2.4	0.2	0.3	1.3	0.8	0.2	0.8	0.6	0.1	2.9	2.9	0.2	0.0	0.2	0.9	2.8	2.8	1.9	0.0	0.3	0.0	0.1	2.9	0.5	0.3	0.7	0.4	0.6	0.2	0.7	0.2	1.1	2.7	0.5	0.3	2.3	2.8	2.0	0.2	0.6	0.7	0.4	0.0	2.8	0.0	0.3	2.8	1.9	0.5	1.0	0.2	0.3	0.2	0.6	0.8	0.6	0.1	0.6	0.2	0.2	0.4	0.0	0.2	0.0	1.2	0.7	1.4	0.4	0.0	0.0	0.6	0.2	0.4	0.1	0.2	0.8	0.2	3.3	0.5	1.4	0.0	3.6	1.2	0.5	1.8	0.0	1.3	0.0	0.2	0.9	1.1	0.3	0.9	0.7	0.5	2.3	0.0	0.0	0.0	0.9	0.0	0.4	0.9	2.0	0.3	0.4	0.7	0.2	0.0	1.2	0.3	0.2	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	2.9	2.8	3.9	4.4	2.9	2.9	2.8	2.8	2.9	2.7	2.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HARBI1	"C11orf77, FLJ32675"	ENSG00000180423	"Harbinger transposase derived 1"	Q96MB7	11	46602861-46617909	"Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 70.9;Late spermatids: 73.0;Spermatocytes: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038671, HPA045457"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"		"HPA038671: AB_10675947, HPA045457: AB_2679332"	"unprognostic (1.29e-1)"	"unprognostic (6.82e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.23e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.34e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.13e-1)"	2.0	2.6	2.6	2.4	4.5	5.6	2.4	3.3	4.2	2.3	2.3	3.0	2.6	1.7	3.4	2.3	2.1	2.0	2.5	2.7	3.1	2.9	3.3	2.2	3.4	3.5	3.5	1.4	2.4	2.2	2.5	2.8	3.6	2.2	3.4	2.7	2.8	1.9	2.6	3.2	2.8	3.0	2.8	2.4	4.0	12.1	4.0	4.2	2.7	2.0	3.4	2.6	1.5	7.3	3.3	5.3	4.3	4.1	8.4	5.1	5.1	4.7	4.5	6.3	8.0	3.7	3.7	5.8	2.9	3.9	7.1	6.3	4.6	4.1	5.9	6.7	5.5	5.9	3.9	4.2	9.8	5.5	7.6	6.5	10.7	4.2	8.2	2.4	4.0	6.2	9.4	7.0	5.3	7.1	6.8	2.3	11.8	10.8	6.4	4.5	6.1	10.3	4.8	3.9	4.1	3.4	5.6	5.9	6.8	5.7	9.9	4.7	3.8	6.3	4.9	8.4	4.3	6.6	7.7	6.3	4.8	3.2	6.6	21.9	7.6	10.9	9.6	10.3	6.7	4.7	7.6	7.0	6.4	6.6	7.2	8.0	11.2	6.9	9.8	8.3	10.2	4.4	2.6	4.5	3.3	4.2	2.7	3.1	3.5	3.5	3.6	2.8	4.0	7.3	1.0	0.0	1.3	1.3	2.2	1.0	2.7	4.0	1.8	3.5	2.5	1.8	2.3	1.5	4.4	0.0	2.1	4.9	1.5	2.1	5.9	4.1	70.9	4.7	2.2	1.4	1.2	13.5	1.5	2.2	3.4	1.7	2.0	4.7	0.0	1.6	1.8	2.8	3.3	3.3	1.5	2.2	8.2	3.3	0.8	73.0	3.1	1.7	1.8	0.0	4.2	2.9	1.0	0.5	4.6	3.0	0.8	1.9	3.4	1.6	3.4	3.5	6.1	3.7	0.0	2.1	2.0	25.2	13.5	1.7	2.7	9.3	2.2	2.2	1.7	2.3
HCRT	"OX, PPOX"	ENSG00000161610	"Hypocretin neuropeptide precursor"	O43612	17	42184060-42185452	"Disease related genes, Human disease related genes, Predicted secreted proteins"		Neuropeptide	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1067	"brain: 384.8"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 1.8;Enteroendocrine cells: 3.0;Kupffer cells: 1.6;Oligodendrocyte precursor cells: 2.0;Proximal enterocytes: 1.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Region enriched"	"Detected in many"	7	"hypothalamus: 384.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"hypothalamus: 93.5"	"Region enriched"	"Detected in some"	21	"hypothalamus: 25.3"	"HPA064801, CAB079778"	Enhanced	Supported			"Secreted to blood"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 58: T-cells - T-cell receptor"			"CAB079778: , HPA064801: "			"unprognostic (3.34e-2)"		"unprognostic (7.76e-5)"					"unprognostic (3.21e-2)"	"unprognostic (3.01e-2)"		"unprognostic (2.20e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-1)"			0.1	0.0	1.8	0.1	1.9	0.1	0.0	0.6	1.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	384.8	0.0	0.0	0.0	0.0	0.6	3.1	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	52.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.1	0.5	0.3	0.2	0.3	0.1	0.6	0.3	0.3	0.0	0.1	0.0	0.0	0.1	0.0	1.8	1.9	0.6	1.2	0.5	384.8	0.6	3.1	1.7	0.3	52.6	0.6	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.0	0.0	1.8	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.5	0.1	0.1	3.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.7	0.2	0.6	0.0	0.4	0.8	0.0	1.6	1.0	0.2	0.0	0.3	0.0	1.0	0.8	0.1	0.0	2.0	0.3	0.4	0.1	0.0	0.4	0.0	1.6	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.9	0.1	0.9	0.1
HEATR5A	"C14orf125, DKFZP434I1735"	ENSG00000129493	"HEAT repeat containing 5A"	Q86XA9	14	31291788-31420550	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 67.8;Oligodendrocytes: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 120.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 120.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049539	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA049539: AB_2680809"	"unprognostic (2.63e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.75e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.47e-3)"	"unprognostic (3.97e-2)"	"unprognostic (9.37e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (1.11e-6)"	"unprognostic (1.00e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.00e-2)"	8.6	11.1	8.9	8.9	12.5	7.0	8.0	11.0	8.8	9.6	9.7	14.1	10.3	7.3	5.8	10.0	8.9	7.4	16.3	8.2	12.9	10.2	8.7	8.9	5.7	13.8	11.6	6.2	4.8	9.1	7.5	12.1	15.5	5.8	11.4	7.4	8.0	5.7	12.1	4.2	12.0	10.3	10.1	8.0	7.5	8.2	10.5	3.5	7.6	20.3	6.7	10.9	6.6	18.5	28.3	43.3	12.2	15.7	29.0	27.3	25.3	33.6	28.3	18.0	18.3	17.4	21.1	15.1	31.4	50.7	10.8	18.6	23.2	10.3	25.5	11.5	21.4	11.4	56.5	73.8	16.9	21.9	15.8	12.8	5.5	15.4	14.6	14.1	22.8	6.9	23.4	15.2	21.0	25.2	8.2	9.4	9.3	17.8	25.2	4.7	24.1	8.6	11.9	17.5	5.1	15.3	77.2	35.3	78.4	17.0	20.0	6.2	35.4	13.1	19.6	22.5	13.6	14.9	42.3	23.8	3.9	12.0	19.5	120.4	11.8	47.3	2.7	11.7	1.6	4.7	1.9	2.4	8.2	3.6	1.6	2.9	38.4	3.7	18.1	3.7	2.0	4.6	8.9	12.5	11.0	8.8	8.2	12.9	13.8	11.6	15.5	10.1	10.5	18.5	7.8	28.9	20.2	58.4	7.5	5.9	2.4	6.3	5.2	12.1	9.9	5.5	17.0	5.7	15.5	18.4	14.6	13.1	2.7	33.5	1.9	11.7	3.5	16.3	9.0	8.7	6.7	2.5	27.1	11.7	10.8	13.1	9.7	7.4	11.4	6.9	10.4	14.8	10.6	1.7	38.8	13.5	10.2	14.8	10.8	1.3	12.2	13.6	10.6	42.2	15.1	19.2	1.0	67.8	96.6	17.6	22.4	11.7	10.1	6.3	17.3	8.9	21.8	9.3	0.0	18.1	9.6	21.7	13.2	10.0	7.2	18.1	5.9	11.4	13.1	4.9
HEATR5B	"DKFZp686P15184, KIAA1414"	ENSG00000008869	"HEAT repeat containing 5B"	Q9P2D3	2	36968383-37084372	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 62.3;Inhibitory neurons: 58.9;Oligodendrocyte precursor cells: 57.3;Oligodendrocytes: 69.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042025, HPA055639"	Approved		Approved	"Nuclear speckles,Vesicles,Cytosol"		NA	NA		6800	"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles, Vesicles, Cytosol"		"HPA042025: AB_10959880, HPA055639: AB_2682870"	"unprognostic (3.11e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.07e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.70e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.33e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.80e-3)"	"unprognostic (8.69e-2)"	"unprognostic (4.18e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.95e-1)"	9.7	8.8	7.1	15.0	7.1	24.3	14.5	11.7	9.8	9.9	4.9	9.9	10.8	9.5	16.9	11.7	8.1	10.7	9.7	7.4	6.4	9.3	9.3	10.8	31.9	5.8	5.2	9.8	18.2	13.4	6.3	10.2	6.4	11.4	13.5	24.3	14.3	7.7	4.9	18.2	11.5	8.3	3.9	19.0	12.3	9.6	7.0	24.7	11.8	9.4	31.2	10.1	8.5	8.1	16.2	8.1	11.7	17.8	11.9	11.7	14.9	10.1	7.4	9.0	9.1	9.6	10.9	34.6	7.1	8.6	11.9	13.4	11.6	8.2	11.7	17.0	12.6	22.6	11.3	13.1	7.4	24.5	28.5	10.8	11.2	13.0	12.3	9.9	15.5	18.3	21.6	29.8	10.9	9.6	21.5	17.4	7.7	16.7	5.6	20.5	11.9	26.3	10.5	13.8	14.3	12.6	10.6	16.7	7.8	11.7	12.0	7.9	17.2	13.5	7.7	9.9	7.9	18.5	16.2	39.0	11.0	14.3	9.0	18.3	5.0	12.3	7.7	2.8	7.1	9.7	8.5	8.7	9.0	14.0	8.7	7.6	5.2	7.5	4.4	11.2	9.7	5.9	7.1	7.1	11.7	9.8	7.4	6.4	5.8	5.2	6.4	3.9	7.0	8.1	12.9	22.4	10.3	35.9	20.8	9.8	4.2	4.7	6.8	13.0	11.9	8.3	20.8	8.6	7.1	5.5	10.4	7.0	24.4	11.3	1.9	4.6	6.3	14.8	10.0	9.5	5.4	18.7	62.3	6.2	6.2	9.4	25.5	11.1	7.0	9.8	11.7	7.8	6.3	16.8	58.9	8.9	6.1	17.0	15.7	2.6	9.0	13.2	7.2	56.2	9.2	6.5	16.5	57.3	69.7	8.8	6.3	6.4	17.6	5.5	12.7	5.4	12.8	16.2	19.7	6.5	10.6	3.6	11.2	11.7	11.6	5.6	14.5	7.7	8.7	4.9
HECTD1	KIAA1131	ENSG00000092148	"HECT domain E3 ubiquitin protein ligase 1"	Q9ULT8	14	31100112-31207804	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 218.4"	"Cell type enhanced"	"Detected in all"		"Urothelial cells: 302.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002929, HPA054461"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nucleoli"		"HPA002929: AB_1850574, HPA054461: AB_2682496"	"unprognostic (6.71e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (6.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.91e-3)"	43.0	48.6	27.8	23.1	33.6	54.0	37.6	58.6	33.7	43.5	34.0	38.3	25.1	37.0	30.7	74.6	33.8	26.7	47.2	27.2	30.9	37.0	74.3	32.9	28.7	30.2	30.1	38.5	34.7	56.5	34.4	35.5	32.5	30.7	31.2	66.9	42.6	31.0	218.4	50.8	33.6	30.8	28.0	30.4	43.7	42.7	31.3	26.3	51.3	133.6	37.3	39.8	51.5	36.6	95.1	54.6	49.2	30.4	144.0	77.2	44.7	54.8	54.1	47.4	39.7	41.0	47.8	72.1	57.8	97.3	34.0	62.6	63.2	47.7	69.6	44.5	24.9	75.6	44.3	163.9	66.9	81.8	52.7	66.3	64.4	52.2	80.9	63.6	87.5	42.2	54.4	32.1	72.8	72.4	31.8	31.7	36.0	76.6	47.5	53.6	58.0	30.4	71.3	93.2	36.2	40.8	79.8	54.5	49.0	56.3	58.7	49.5	93.4	56.6	42.9	41.9	49.0	34.3	52.9	79.0	28.0	37.3	49.7	9.1	5.7	8.3	4.5	4.8	5.2	4.8	5.2	4.1	6.4	6.3	4.2	4.3	3.0	6.3	3.8	5.3	5.6	2.4	27.8	33.6	58.6	33.7	27.2	30.9	30.2	30.1	32.5	28.0	31.3	36.6	63.4	48.1	80.8	84.5	60.7	86.7	93.5	61.2	48.3	98.9	40.8	28.6	108.1	25.8	94.8	71.7	98.0	70.2	72.1	40.9	11.7	44.2	3.6	101.6	83.0	60.0	48.7	41.2	89.9	36.1	42.9	59.9	96.8	118.1	32.9	81.6	46.4	84.7	29.0	65.6	101.1	33.0	63.1	43.9	34.5	8.7	69.0	54.0	33.8	90.9	65.1	40.9	78.2	100.0	127.9	52.6	33.9	74.4	71.1	106.3	37.1	22.4	148.4	194.5	46.0	77.4	78.9	50.6	100.0	83.7	114.9	140.0	61.4	97.0	44.5	302.9
HECTD4	"C12orf51, FLJ34154, KIAA0614"	ENSG00000173064	"HECT domain E3 ubiquitin protein ligase 4"		12	112160188-112382439	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 141.8;Excitatory neurons: 190.4;Inhibitory neurons: 180.0;Oligodendrocyte precursor cells: 109.1;Oligodendrocytes: 138.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041062, HPA045473"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Nucleoplasm	"HPA041062: AB_2677281, HPA045473: AB_2679338"	"unprognostic (9.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (2.97e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.58e-2)"	"unprognostic (4.51e-3)"	6.7	6.5	6.3	3.1	6.1	14.2	6.8	15.6	6.9	10.0	3.4	11.3	2.0	9.5	4.0	11.0	8.4	3.1	6.8	5.9	2.0	7.5	7.6	7.8	3.8	1.0	0.8	8.5	8.8	6.1	11.7	4.1	1.3	10.5	3.6	10.8	7.9	4.0	8.0	10.7	7.6	4.2	0.4	7.6	10.0	6.8	1.2	6.5	13.5	5.6	4.1	8.8	9.7	6.7	5.1	9.2	7.7	6.1	8.7	7.4	3.2	3.2	3.6	4.8	4.0	8.6	1.3	5.2	3.2	6.7	5.4	4.6	10.8	4.3	3.9	7.0	9.4	8.6	10.7	3.8	2.6	6.1	6.3	4.7	4.8	7.3	5.1	8.7	7.7	9.6	10.2	3.9	4.5	4.4	6.7	7.7	3.3	5.7	7.1	8.3	4.2	3.3	2.4	8.8	12.8	8.0	9.2	7.5	2.8	7.2	5.3	6.7	11.0	5.2	4.0	5.7	4.6	11.8	5.7	6.5	4.1	3.3	2.9	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.2	0.2	0.2	0.3	0.0	0.0	6.3	6.1	15.6	6.9	5.9	2.0	1.0	0.8	1.3	0.4	1.2	6.7	14.7	19.2	20.8	96.9	15.7	11.5	8.4	8.3	18.8	54.3	15.1	11.7	20.1	12.8	9.4	12.9	141.8	10.9	15.2	14.6	0.0	8.0	7.0	23.9	25.9	14.2	27.6	47.4	190.4	8.7	5.2	11.2	23.9	32.2	8.2	17.9	15.7	15.2	6.6	80.8	180.0	14.2	8.2	11.1	6.7	6.3	11.5	12.6	7.2	66.5	11.1	17.7	14.4	109.1	138.8	10.3	9.0	15.8	15.8	12.8	9.2	5.6	16.0	53.8	0.0	19.3	14.6	25.0	7.8	22.1	14.9	8.9	12.9	12.4	14.0	9.0
HELQ	Hel308	ENSG00000163312	"Helicase, POLQ like"	Q8TDG4	4	83407343-83455855	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036852, HPA036853"	Approved		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"	Nucleoplasm	"HPA036852: AB_2675349, HPA036853: AB_10672102"	"unprognostic (4.58e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.13e-3)"	"unprognostic (7.14e-2)"	"unprognostic (8.62e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-1)"	4.8	9.1	2.2	5.0	2.6	4.6	5.5	4.0	2.8	5.4	4.6	4.0	3.1	4.9	4.5	3.4	4.6	3.8	5.1	2.1	2.4	5.4	5.5	4.0	9.3	2.2	2.3	8.1	3.7	5.6	4.4	3.2	2.5	3.9	3.9	5.5	4.6	4.0	7.2	3.9	4.5	4.3	2.4	6.2	3.7	6.0	2.4	8.0	5.8	8.1	7.5	4.4	4.0	3.0	4.0	2.9	6.0	4.0	7.5	7.2	3.1	5.5	7.9	7.2	6.9	2.9	4.1	11.2	4.3	5.1	4.9	4.0	6.9	3.9	7.7	6.5	3.3	6.3	4.8	3.9	4.5	8.4	15.9	6.1	5.5	5.9	5.8	6.1	5.3	7.2	8.8	9.4	7.0	4.3	7.5	5.9	2.7	6.0	2.2	5.9	7.1	3.9	6.2	2.3	4.7	4.2	5.6	6.2	6.6	5.9	3.8	8.3	4.6	5.4	4.8	6.7	4.4	8.7	3.8	9.2	4.7	6.1	6.1	3.4	1.7	3.6	3.1	2.2	3.2	3.4	3.3	3.2	2.6	5.1	5.6	4.7	1.3	3.6	3.1	2.5	4.5	1.6	2.2	2.6	4.0	2.8	2.1	2.4	2.2	2.3	2.5	2.4	2.4	3.0	14.1	3.2	14.0	14.4	23.1	4.2	8.6	6.6	12.0	10.2	6.7	9.0	12.3	5.7	7.7	5.5	8.4	10.9	11.4	4.5	11.7	6.7	28.3	7.3	10.2	10.2	0.0	7.8	17.0	5.4	10.3	11.1	4.1	7.7	7.6	9.8	10.0	4.1	10.2	6.7	21.3	5.5	4.1	7.2	5.4	8.9	13.1	9.9	7.2	20.6	10.7	7.8	17.5	10.6	15.7	4.4	8.3	7.9	15.8	5.4	7.6	11.8	15.9	13.8	0.0	11.2	11.9	24.3	12.7	7.0	3.8	11.5	18.2	17.4	5.5	6.1
HMGB2	HMG2	ENSG00000164104	"High mobility group box 2"	P26583	4	173331376-173334432	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, DNA recombination, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	12	"bone marrow: 2347.2;lymphoid tissue: 939.2"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 1915.4;Extravillous trophoblasts: 872.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 798.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 2454.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003506, CAB037206, HPA053314, HPA073663"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Secreted to blood"	NA	Yes		1200000	"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"CAB037206: AB_1079071, HPA003506: AB_1079070, HPA053314: AB_2682109, HPA073663: "	"unprognostic (2.82e-1)"	"unprognostic (8.52e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (3.76e-5)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (7.60e-12)"	"unprognostic (1.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.21e-2)"	90.3	31.0	36.3	146.1	38.4	2347.2	89.1	35.4	49.9	79.0	33.0	117.1	93.2	92.3	47.3	115.6	78.8	43.5	85.8	33.2	38.3	74.3	37.8	83.8	390.4	37.5	36.8	118.9	27.2	18.3	35.4	111.0	38.0	46.9	122.2	134.1	59.8	35.2	72.4	75.1	108.7	65.5	36.3	159.5	66.0	136.0	36.1	939.2	56.4	57.0	388.9	68.2	86.1	40.1	498.2	114.6	976.8	444.4	118.2	118.2	375.1	366.3	271.3	386.7	345.7	329.0	673.6	1645.5	79.2	203.0	207.4	190.3	645.0	196.1	601.0	1004.0	303.4	1823.2	308.8	487.8	115.7	1642.8	683.4	114.7	59.2	194.2	439.1	211.5	402.8	866.1	703.9	2282.4	358.9	409.9	2454.9	1513.7	355.4	289.4	199.3	1226.7	499.7	620.4	227.0	208.8	838.6	759.0	365.5	209.6	166.6	340.8	291.1	1173.2	236.0	175.5	513.6	219.0	554.9	734.8	437.1	1869.4	149.1	1178.4	464.4	798.0	135.9	407.0	94.1	57.6	86.2	72.5	137.8	131.1	112.8	57.6	88.4	85.3	316.7	83.0	49.1	43.2	266.4	107.6	36.3	38.4	35.4	49.9	33.2	38.3	37.5	36.8	38.0	36.3	36.1	40.1	167.0	28.9	64.1	5.9	153.2	158.8	141.5	131.8	75.1	48.9	75.3	107.8	229.0	38.6	78.3	55.2	35.5	472.6	222.9	116.5	142.8	25.9	30.4	71.2	71.7	128.0	74.7	1915.4	2.7	16.1	872.5	121.5	63.2	76.5	110.6	210.5	171.7	26.5	210.1	45.4	4.7	191.2	109.9	295.0	142.9	33.1	105.3	233.9	67.6	6.5	241.9	81.8	132.8	1.0	4.8	11.3	75.2	57.6	268.6	114.2	65.4	51.0	149.8	143.5	78.9	71.7	134.4	493.6	400.9	233.6	134.0	128.7	289.5	42.3	284.7	89.0
HOXA5	"HOX1, HOX1C"	ENSG00000106004	"Homeobox A5"	P20719	7	27141052-27143681	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 80.9;epididymis: 49.0;fallopian tube: 49.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 99.6;Breast myoepithelial cells: 27.2;Proximal tubular cells: 27.1;Squamous epithelial cells: 46.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	51	"medulla oblongata: 38.3;pons: 10.5;spinal cord: 24.6;white matter: 16.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 94.2;HEK 293: 160.4;RPTEC TERT1: 36.2"	"Region enriched"	"Detected in single"	220	"pons and medulla: 22.0"	"Group enriched"	"Detected in some"	33	"medulla oblongata: 4.4;spinal cord: 16.3"							NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"				"unprognostic (2.43e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.87e-1)"	"unprognostic (7.80e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.02e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.00e-2)"	"unprognostic (4.37e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.00e-1)"	16.8	80.9	0.2	3.0	0.1	3.1	11.6	0.2	0.4	7.1	0.0	18.7	2.7	12.3	49.0	5.2	49.4	0.9	0.2	0.1	0.1	25.5	0.8	19.9	1.8	38.3	0.4	2.9	1.4	3.3	0.0	0.2	10.5	8.6	6.9	0.0	0.0	9.8	6.7	7.8	13.7	6.2	24.6	3.3	11.7	0.6	0.0	0.5	1.1	0.3	0.1	11.8	4.6	16.6	5.7	2.8	0.0	94.2	0.1	0.0	0.4	1.6	1.2	1.7	1.5	1.7	9.7	3.1	13.5	3.0	2.0	7.6	5.3	0.4	1.7	1.4	160.4	2.2	1.2	5.7	0.9	3.6	2.5	10.3	0.5	3.1	5.4	0.0	20.8	5.5	0.4	0.0	3.2	1.7	0.0	1.1	0.0	2.1	2.9	13.4	0.4	0.0	36.2	7.6	10.9	0.1	7.2	0.0	3.6	0.3	1.1	1.3	8.3	0.3	1.2	5.6	3.9	0.0	0.1	3.3	0.7	10.8	10.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.6	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.4	0.1	0.1	38.3	0.4	10.5	24.6	0.0	16.6	9.3	0.0	1.1	0.0	0.9	3.4	6.4	0.1	99.6	0.0	17.3	27.2	8.0	0.0	0.0	0.0	0.0	0.0	2.8	17.0	7.9	0.1	0.0	0.9	19.7	8.4	9.0	2.5	0.0	0.0	0.0	11.5	2.6	0.4	0.0	0.0	21.0	0.0	0.6	0.0	0.0	10.8	0.0	2.5	1.5	0.3	0.3	9.2	1.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	15.5	0.0	1.0	2.2	9.6	27.1	0.1	0.0	0.0	4.5	14.3	0.9	0.7	46.7	2.8	0.1	1.7	0.2	18.8	6.3
HPGD	SDR36C1	ENSG00000164120	"15-hydroxyprostaglandin dehydrogenase"	P15428	4	174490175-174523154	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism"	Oxidoreductase	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 235.0;urinary bladder: 376.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 457.8;Extravillous trophoblasts: 701.7;granulocytes: 864.5;Proximal enterocytes: 500.6;Urothelial cells: 922.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 52.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 123.7;T-reg: 45.0"	"Group enriched"	"Detected in many"	73	"granulocytes: 123.7;T-cells: 45.0"	"Cell line enhanced"	"Detected in many"		"A549: 157.8;ASC diff: 110.6;HEL: 355.0;OE19: 102.1;RT4: 565.7;SuSa: 121.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004919, HPA005679"	Enhanced		Supported	Nucleoplasm,Cytosol		No	NA		20000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Nucleoplasm	"HPA004919: AB_1079081, HPA005679: AB_1079080"	"unprognostic (1.23e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.34e-2)"	"prognostic favorable (3.20e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.37e-4)"	"unprognostic (2.33e-2)"	9.2	16.5	1.0	11.4	0.7	2.7	159.9	0.5	1.2	32.2	8.7	60.9	152.2	45.5	36.5	81.6	13.4	24.9	1.6	1.2	2.8	60.2	210.8	91.0	5.5	1.4	2.0	1.1	2.6	85.3	2.1	99.1	1.0	10.2	57.4	1.0	7.7	4.0	2.5	39.8	117.3	63.7	0.8	10.3	235.0	1.6	2.2	12.2	1.7	3.0	26.6	376.0	83.0	0.7	0.0	157.8	0.0	0.0	110.6	5.4	0.4	0.0	0.0	0.0	0.4	45.1	0.2	0.1	0.0	0.0	0.2	14.2	16.0	0.0	0.0	0.3	2.9	355.0	10.8	0.3	0.0	2.1	0.9	5.6	2.6	0.0	0.1	0.1	0.0	22.6	0.2	0.0	0.0	0.3	1.2	0.3	1.4	102.1	7.4	16.3	0.3	1.3	36.2	565.7	0.9	0.4	0.0	1.3	3.5	121.3	0.1	0.0	0.3	0.0	0.2	0.1	0.0	28.4	0.0	0.1	0.3	0.2	0.0	123.7	0.3	16.6	9.9	0.0	15.6	0.4	5.2	4.5	0.7	0.2	1.6	4.0	1.3	1.1	0.0	0.0	45.0	3.0	1.0	0.7	0.5	1.2	1.2	2.8	1.4	2.0	1.0	0.8	2.2	0.7	3.4	16.0	33.0	0.0	4.3	17.3	80.8	6.9	45.5	3.3	14.5	6.7	0.8	35.8	23.6	22.0	0.0	48.5	38.5	457.8	21.5	7.4	1.4	5.7	5.4	18.2	8.4	17.2	0.8	94.5	701.7	25.3	196.7	36.4	864.5	1.5	13.9	245.7	21.4	0.0	9.7	60.7	0.0	14.8	19.5	0.5	19.9	29.2	76.5	5.6	2.9	0.0	10.3	0.0	4.1	42.4	254.7	0.0	50.2	76.8	500.6	131.1	4.4	0.8	0.0	2.4	3.7	0.5	1.0	53.4	22.4	56.6	42.7	65.0	58.9	922.8
HPGDS	"GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS"	ENSG00000163106	"Hematopoietic prostaglandin D synthase"	O60760	4	94298535-94342876	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 18.7"	"Group enriched"	"Detected in many"	18	"granulocytes: 1056.2;Hofbauer cells: 631.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	28	"basophil: 18.1"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 18.1"	"Group enriched"	"Detected in some"	8	"HEL: 46.2;HMC-1: 13.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA024035	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		250000	"Cluster 46: Basophils - DNA binding"	"Cluster 19: Lung - Lung function"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"	"Vesicles, Cytosol"	Nucleoplasm	"HPA024035: AB_1855743"	"unprognostic (5.71e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.01e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.75e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	3.4	1.9	2.2	1.1	2.1	1.1	4.0	2.3	3.1	3.5	2.1	5.1	5.8	2.4	2.3	2.9	1.4	6.9	1.8	2.3	2.3	1.5	0.8	9.4	0.6	2.7	2.6	0.5	0.5	0.8	0.4	18.7	2.9	2.6	5.3	0.1	1.5	1.3	0.5	3.3	5.6	3.3	2.6	0.3	2.8	0.7	3.1	2.0	0.3	1.7	0.9	4.8	1.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.2	0.0	0.0	0.0	3.5	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.1	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	2.2	2.1	2.3	3.1	2.3	2.3	2.7	2.6	2.9	2.6	3.1	3.5	0.3	12.8	44.7	1.0	0.2	4.1	0.8	0.0	0.6	0.0	0.2	0.8	0.3	0.0	3.7	0.0	0.0	3.6	0.7	0.5	0.0	0.5	0.1	0.2	0.0	2.0	7.1	12.2	0.8	0.0	3.0	3.0	3.6	0.0	1056.2	0.0	0.0	0.0	631.9	0.0	0.6	0.0	0.0	11.4	13.1	0.0	0.3	16.3	3.6	32.8	0.1	0.0	0.0	0.0	0.5	0.1	1.2	0.4	2.1	3.9	0.0	0.0	1.5	0.1	0.0	0.6	0.4	0.0	0.1	0.0	5.4	5.5	20.5	0.3	0.9	0.2
HPS4	"BLOC3S2, KIAA1667, LE"	ENSG00000100099	"HPS4 biogenesis of lysosomal organelles complex 3 subunit 2"	Q9NQG7	22	26443423-26483837	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Albinism, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 114.7;Rod photoreceptor cells: 119.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 86.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033106, HPA050189"	Approved		Approved	Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 52: Non-specific - Transcription"	Centrosome		"CAB033106: AB_2264349, HPA050189: AB_2681046"	"unprognostic (1.55e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.82e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.46e-2)"	6.6	8.9	10.4	6.5	11.4	10.3	6.7	11.1	10.5	9.0	12.2	6.7	5.4	6.9	7.7	9.9	9.2	6.1	4.5	10.3	11.5	8.6	8.5	6.5	8.5	10.9	10.8	12.1	12.7	12.1	11.0	5.6	11.2	8.3	5.5	7.6	6.6	7.7	4.6	14.0	7.3	7.1	10.7	9.0	8.1	13.1	11.4	13.0	9.8	5.0	9.6	6.9	8.4	10.5	16.3	7.5	15.5	15.9	11.5	13.6	8.2	9.7	18.8	21.4	19.1	7.9	7.8	15.4	7.5	11.8	12.1	13.2	14.9	21.0	19.3	11.4	15.4	15.6	6.3	13.3	20.5	18.4	17.0	13.3	17.1	19.5	34.5	18.1	14.2	25.5	17.4	19.0	15.7	6.9	31.2	6.2	9.3	15.0	8.0	86.3	18.3	20.4	9.9	10.1	17.6	13.0	9.4	10.6	46.7	11.6	11.5	13.9	8.8	24.8	46.2	12.4	12.2	28.1	23.4	50.5	16.2	11.8	16.3	10.8	3.2	3.1	4.8	2.3	4.5	5.5	3.9	4.1	4.3	4.7	4.5	5.0	1.1	7.2	2.1	5.7	2.8	4.7	10.4	11.4	11.1	10.5	10.3	11.5	10.9	10.8	11.2	10.7	11.4	10.5	16.6	12.8	32.4	28.7	38.7	12.5	28.3	28.9	17.1	52.6	14.4	12.4	6.3	17.2	25.5	42.3	114.7	21.7	31.7	11.6	17.6	20.4	24.3	16.3	17.2	18.6	26.5	48.1	18.4	27.1	19.4	14.1	28.1	14.1	42.4	40.6	22.5	14.2	24.8	43.7	31.1	20.1	44.7	18.3	12.2	24.3	32.6	19.1	48.0	19.7	14.9	23.7	21.6	32.6	36.4	45.0	13.6	19.9	25.1	29.4	18.0	15.7	28.1	119.3	0.0	16.0	12.2	32.3	46.6	11.1	14.9	20.0	20.6	23.6	21.4	26.9
HSBP1L1	"FLJ10967, MGC189743"	ENSG00000226742	"Heat shock factor binding protein 1 like 1"	C9JCN9	18	79964582-79970822	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"granulocytes: 31.9;T-cells: 26.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 162.8;SK-MEL-30: 100.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048273	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA048273: AB_2680337"	"unprognostic (2.08e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.70e-2)"	"unprognostic (8.15e-3)"	"unprognostic (8.86e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.53e-3)"	"unprognostic (7.41e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.76e-2)"	9.6	17.4	18.4	2.9	17.8	2.9	9.6	19.9	26.4	10.0	23.4	16.0	6.7	7.6	11.1	17.4	8.7	5.7	6.7	17.2	18.1	18.6	29.7	10.7	4.2	19.1	18.5	6.6	20.4	19.7	6.7	9.9	19.6	10.2	13.1	14.8	12.8	7.6	12.5	16.0	6.5	5.7	18.1	5.2	10.1	0.8	20.3	4.3	8.9	10.6	4.9	6.2	10.6	17.2	32.2	8.6	0.3	0.5	4.6	15.4	12.7	14.3	32.2	14.8	13.0	16.5	21.7	0.0	3.6	18.8	0.2	18.3	28.5	18.9	7.0	30.6	6.7	0.0	8.8	9.6	162.8	0.0	0.0	18.0	49.6	1.7	10.8	31.5	0.3	4.8	0.0	0.0	0.7	26.8	0.1	0.0	0.0	17.6	30.1	0.3	0.0	0.0	53.7	7.6	0.5	1.8	15.2	20.9	100.2	1.4	11.9	7.6	0.0	0.1	0.0	0.4	0.1	0.0	16.7	0.0	0.2	8.9	0.6	31.9	6.8	8.6	5.8	4.4	6.9	2.2	10.1	6.2	2.8	2.5	26.0	14.0	0.4	5.2	1.6	3.3	4.9	6.2	18.4	17.8	19.9	26.4	17.2	18.1	19.1	18.5	19.6	18.1	20.3	17.2	36.4	54.5	34.5	12.1	5.0	39.8	66.0	135.5	67.2	12.0	89.8	93.6	12.4	48.6	109.2	49.7	22.9	126.6	9.6	119.8	68.4	63.8	1.3	47.2	13.2	23.0	11.5	11.4	5.7	62.1	67.1	16.0	31.6	59.4	19.0	37.2	30.0	122.5	44.7	20.2	11.0	81.3	71.2	20.5	18.0	1.3	19.9	16.0	39.2	6.5	4.0	33.2	6.2	1.0	3.1	137.3	99.6	24.5	2.3	80.2	70.6	80.6	80.3	33.0	0.0	6.3	15.9	1.3	1.3	46.8	57.8	117.4	12.2	34.5	99.6	104.4
HSDL2	"C9orf99, SDR13C1"	ENSG00000119471	"Hydroxysteroid dehydrogenase like 2"	Q6YN16	9	112380080-112472405	"Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 181.3"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 214.8;Early spermatids: 153.9;Granulosa cells: 187.2;Late spermatids: 163.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	5	"granulocytes: 54.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042890, HPA050453"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA042890: AB_2678216, HPA050453: AB_2681131"	"unprognostic (3.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.90e-3)"	"prognostic favorable (9.23e-6)"	"unprognostic (3.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (9.29e-7)"	"unprognostic (1.44e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.35e-2)"	76.3	63.6	28.1	13.3	30.1	11.6	22.8	25.1	29.5	23.3	27.6	31.7	38.9	22.8	11.5	29.8	21.2	19.0	89.9	24.8	33.1	69.0	149.0	28.7	13.9	25.4	33.2	50.8	20.0	21.8	8.8	16.8	27.1	20.3	26.9	12.6	18.8	15.9	151.7	31.1	32.2	20.5	26.6	18.6	24.6	14.0	32.0	19.6	30.4	181.3	15.8	29.2	15.0	28.5	45.0	39.4	29.0	14.8	49.0	48.4	33.4	30.1	18.6	21.1	17.7	77.0	49.4	28.5	16.2	44.4	26.9	50.6	31.9	42.2	25.8	120.9	21.0	30.0	58.5	76.1	30.7	17.1	18.5	52.0	29.9	31.3	22.8	30.5	24.8	34.7	42.3	18.9	58.2	29.6	42.5	15.3	17.2	106.9	50.3	27.1	87.4	42.7	44.5	40.4	20.7	14.5	75.8	49.5	26.0	23.7	70.0	20.0	28.3	30.2	27.9	85.2	29.6	21.5	57.3	13.5	37.0	24.8	18.2	54.3	8.4	32.8	4.6	8.1	6.8	6.9	4.8	5.0	9.5	8.4	5.6	5.9	48.0	5.9	11.5	9.4	8.7	4.9	28.1	30.1	25.1	29.5	24.8	33.1	25.4	33.2	27.1	26.6	32.0	28.5	32.0	99.3	84.3	48.6	14.1	13.3	17.5	21.6	29.6	9.3	12.0	13.3	214.8	14.3	32.2	14.7	6.2	26.5	18.3	23.7	64.6	15.5	153.9	38.6	38.3	19.1	14.9	32.8	10.8	18.7	30.9	31.1	29.0	27.8	30.4	187.2	17.2	124.2	35.7	6.7	12.2	32.2	8.2	23.6	12.5	163.0	27.4	27.5	8.8	15.9	47.3	24.1	6.2	16.1	19.3	13.2	23.5	47.0	20.9	16.0	52.4	111.1	37.7	14.5	46.0	18.1	46.9	12.9	16.4	34.2	16.2	31.7	16.2	108.9	36.2	29.5
HSH2D	"ALX, FLJ14886, HSH2"	ENSG00000196684	"Hematopoietic SH2 domain containing"	Q96JZ2	19	16134028-16158575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.0;lymphoid tissue: 37.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 78.5;dendritic cells: 101.3;Gastric mucus-secreting cells: 40.2;NK-cells: 82.4;Plasma cells: 134.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 232.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 41.0;HL-60: 43.5;HMC-1: 56.4;NB-4: 140.1;RPMI-8226: 63.2;U-266/84: 41.9;U-937: 137.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036616			Approved	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA036616: AB_10671962"	"unprognostic (1.69e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (9.46e-6)"	"unprognostic (1.06e-1)"	"unprognostic (5.50e-3)"	"unprognostic (5.21e-3)"	"unprognostic (9.35e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.21e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (6.49e-6)"	"unprognostic (9.17e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (3.47e-5)"	1.6	0.7	0.5	16.8	1.1	47.0	3.3	1.1	1.1	3.0	1.2	9.8	12.7	1.3	1.8	1.7	3.2	5.4	0.4	0.5	0.4	1.5	2.2	5.6	27.2	1.5	0.7	0.5	4.3	2.3	4.0	1.5	1.1	5.1	9.3	0.3	9.5	2.9	0.4	0.4	20.5	1.0	0.7	37.7	12.7	0.4	1.0	8.7	2.6	1.2	35.7	7.5	0.7	2.8	15.0	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	2.2	21.3	41.0	0.6	0.0	0.8	0.7	0.0	0.6	0.0	2.3	0.1	0.6	0.5	2.6	0.0	43.5	56.4	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.1	37.4	0.0	9.0	0.1	140.1	0.0	5.5	0.0	3.0	0.0	63.2	0.4	5.6	0.1	0.1	0.0	1.3	0.3	0.0	0.3	15.9	0.2	0.1	0.1	0.2	0.2	5.7	41.9	23.6	0.2	137.3	0.0	232.1	15.5	100.9	17.1	22.0	15.8	56.4	7.6	11.2	25.5	35.8	6.9	9.2	182.6	85.2	38.8	7.6	13.0	16.7	0.5	1.1	1.1	1.1	0.5	0.4	1.5	0.7	1.1	0.7	1.0	2.8	1.0	3.2	8.9	0.0	78.5	0.3	1.2	3.0	0.6	0.0	3.6	1.9	0.6	5.7	11.3	5.5	0.0	2.6	101.3	18.9	0.0	6.7	0.0	4.5	1.5	0.8	8.4	32.2	0.5	5.1	4.1	0.7	40.2	7.9	6.3	0.1	1.4	0.6	1.1	0.0	0.4	19.1	2.0	3.4	2.4	0.1	0.0	7.3	10.6	1.0	10.7	0.0	82.4	1.0	0.3	9.7	18.0	0.0	134.0	2.6	17.9	0.3	7.9	0.0	0.0	1.1	0.7	0.1	0.5	0.1	0.1	3.4	31.0	0.2	9.3	4.1
HSPA13	STCH	ENSG00000155304	"Heat shock protein family A (Hsp70) member 13"	P48723	21	14371115-14383484	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 231.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014797	Approved				"Intracellular and membrane"	NA	NA		3300000	"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA014797: AB_1857567"	"unprognostic (2.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.77e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.41e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.46e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-2)"	13.5	24.0	12.3	17.7	14.3	23.5	15.7	11.1	16.0	19.1	8.4	12.4	10.0	21.9	26.4	9.1	8.5	12.3	13.8	13.9	21.1	16.3	13.3	12.9	15.8	12.6	14.0	16.4	9.3	24.0	17.3	22.8	17.0	15.4	12.6	23.3	9.4	16.9	3.4	3.8	10.0	19.2	13.8	15.1	12.7	22.7	16.7	16.9	27.7	8.0	17.4	18.4	5.0	13.4	21.2	17.0	65.7	38.2	46.6	37.4	41.8	58.6	68.9	47.8	54.5	16.1	22.8	36.7	40.3	42.4	71.1	9.1	30.8	20.1	79.6	38.5	24.0	35.8	16.4	30.4	119.5	58.8	44.0	33.4	64.4	68.4	117.0	60.5	40.6	32.6	30.5	231.9	52.7	21.2	39.6	17.9	49.0	9.9	23.2	36.6	57.8	81.2	25.1	8.1	15.0	36.7	43.6	22.6	84.6	33.4	31.1	38.7	40.7	62.1	51.7	49.3	43.4	87.5	70.5	29.2	69.9	37.2	79.5	23.1	4.8	4.9	6.6	5.4	11.4	7.1	7.0	7.1	5.5	3.7	7.7	7.4	1.9	12.1	4.9	8.3	6.0	6.1	12.3	14.3	11.1	16.0	13.9	21.1	12.6	14.0	17.0	13.8	16.7	13.4	14.0	9.6	14.1	11.4	29.7	12.7	14.7	16.9	20.5	41.0	15.6	8.6	14.6	4.3	10.8	3.7	14.6	22.1	25.1	5.1	0.0	8.6	6.8	6.6	31.4	14.6	14.9	26.7	21.0	10.4	31.1	26.4	5.6	15.1	19.0	21.2	12.5	11.8	14.5	60.6	28.2	8.1	4.1	15.8	28.9	2.8	9.9	16.7	23.2	12.2	8.6	34.8	8.2	31.7	15.5	9.3	3.7	19.2	131.4	15.2	2.9	7.5	7.8	21.9	13.1	23.6	25.0	40.2	12.7	12.9	10.2	64.2	24.6	11.9	4.1	13.6
HTR1F	"5-HT1F, HTR1EL"	ENSG00000179097	"5-hydroxytryptamine receptor 1F"	P30939	3	87792706-87993839	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 1.8;retina: 3.6"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 232.6;Inhibitory neurons: 79.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 1.3;LHCN-M2: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA005555	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA005555: AB_1856708"	"unprognostic (1.66e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.78e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.80e-2)"	"unprognostic (2.67e-6)"	"unprognostic (1.25e-4)"	"unprognostic (1.55e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.31e-2)"	0.7	0.2	0.0	0.0	0.1	0.6	0.4	0.0	1.5	0.4	0.0	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.2	0.0	0.3	0.1	0.0	0.4	0.1	0.3	0.1	0.3	1.8	0.0	0.1	0.0	3.6	0.0	0.3	0.1	0.1	0.0	0.4	0.0	0.6	0.0	0.1	0.0	0.3	0.5	0.1	0.2	0.2	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.5	2.2	0.0	0.0	4.6	0.0	0.4	0.0	0.0	0.0	0.1	0.8	0.3	0.2	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	2.2	0.0	3.0	232.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.0	0.1	0.0	0.6	0.5	0.2	0.0	0.4	1.8	13.1	0.2	20.4	0.0	2.5	3.9	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.5	19.7	0.1	12.7	0.3	1.9	0.0	0.0	0.0	0.2	0.2	0.1	0.1
IFT80	"FAP167, KIAA1374, WDR56"	ENSG00000068885	"Intraflagellar transport 80"	Q9P2H3	3	160256986-160399880	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 254.5;Respiratory ciliated cells: 71.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035868	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA035868: AB_10959463"	"unprognostic (2.71e-2)"	"unprognostic (4.47e-3)"	"unprognostic (2.13e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.03e-1)"	"unprognostic (7.25e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.29e-2)"	"unprognostic (5.95e-2)"	"unprognostic (6.70e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.52e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.60e-3)"	7.5	10.0	17.2	8.3	25.6	6.2	11.5	17.0	26.2	13.3	20.6	7.7	6.1	14.6	16.9	8.9	17.3	11.6	10.0	17.6	20.0	17.9	7.6	14.5	12.1	18.7	21.0	16.5	10.2	27.5	25.7	7.6	18.7	9.8	9.9	25.1	7.3	10.8	4.7	12.3	8.3	10.8	15.4	9.4	11.2	24.1	19.7	18.2	18.2	6.8	11.6	8.9	8.9	40.1	23.9	16.3	36.9	16.9	34.0	59.8	9.1	20.0	29.3	15.1	19.8	13.3	33.9	15.5	25.7	18.9	22.9	20.3	13.1	19.3	33.7	23.1	14.5	20.7	23.4	9.5	33.8	9.9	17.4	33.2	13.0	17.2	18.4	68.1	17.1	19.7	8.9	28.8	23.8	11.5	18.4	11.7	11.6	15.0	9.5	16.3	19.3	26.3	31.5	6.9	22.0	23.2	21.9	20.6	26.1	23.9	34.5	11.3	15.3	15.5	10.5	21.2	19.9	41.7	28.9	28.5	26.7	17.8	15.6	0.9	0.5	0.5	0.6	0.2	0.6	0.8	0.7	0.7	0.7	0.7	1.0	0.7	0.4	0.9	0.5	1.4	1.0	0.6	17.2	25.6	17.0	26.2	17.6	20.0	18.7	21.0	18.7	15.4	19.7	40.1	6.5	41.7	33.0	42.7	7.0	3.3	5.9	7.5	15.4	16.7	6.4	3.8	7.2	18.6	14.4	23.9	16.7	3.1	7.3	3.8	7.9	5.6	30.5	39.0	19.0	7.0	11.4	11.6	61.7	1.8	2.9	13.8	5.6	9.6	2.5	13.3	6.8	4.0	2.9	1.7	44.9	5.2	2.0	4.1	2.7	9.5	16.4	4.4	1.8	27.2	2.5	8.0	7.2	46.3	254.5	2.6	2.6	21.8	10.9	2.4	1.9	6.7	71.7	18.1	6.6	8.3	8.3	43.2	10.4	8.5	3.8	0.7	8.8	11.6	5.1	3.6
IL11RA		ENSG00000137070	"Interleukin 11 receptor subunit alpha"	Q14626	9	34650702-34661902	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Craniosynostosis, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 57.8;Late spermatids: 97.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 36.8;HSkMC: 38.2"					"Low region specificity"	"Detected in all"			"HPA013162, CAB032830, HPA036652"	Supported				"Secreted to blood"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"CAB032830: AB_2123745, HPA013162: AB_2668790, HPA036652: AB_2675229"	"unprognostic (7.76e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.89e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.93e-2)"	"unprognostic (8.71e-2)"	26.6	14.8	20.0	15.5	22.9	13.7	30.2	23.9	23.8	44.6	17.2	58.0	21.7	32.9	12.2	16.3	36.8	19.5	66.4	20.6	20.4	21.9	50.7	22.6	32.0	21.4	21.5	38.0	12.9	29.2	21.8	10.3	20.4	30.3	11.4	18.7	26.1	15.7	30.0	61.3	37.9	19.6	20.8	33.3	26.0	18.3	21.6	16.9	48.0	28.5	21.1	32.2	34.1	22.9	2.5	5.5	11.7	11.7	16.5	28.9	5.5	13.8	19.1	8.8	11.9	2.0	4.6	2.6	3.7	36.8	3.3	5.0	3.4	5.0	3.5	23.8	9.2	7.9	23.4	1.0	8.4	2.7	4.3	38.2	6.1	4.9	1.7	11.9	5.6	16.4	3.3	5.4	11.3	1.6	3.6	18.6	2.5	2.0	3.7	5.6	2.3	2.7	2.9	2.5	3.4	12.3	1.7	3.7	5.3	6.1	10.1	10.2	5.2	4.1	10.0	3.2	0.0	3.7	2.6	1.0	10.9	3.1	20.1	2.1	1.0	0.0	1.4	1.4	2.1	0.8	2.7	2.2	1.3	1.0	2.5	1.8	0.3	1.0	0.3	0.5	1.7	1.7	20.0	22.9	23.9	23.8	20.6	20.4	21.4	21.5	20.4	20.8	21.6	22.9	15.8	3.2	14.3	26.8	2.6	17.5	5.8	3.6	6.2	19.6	6.4	25.1	37.9	1.5	3.6	3.7	14.6	11.3	5.1	3.7	0.0	1.9	18.3	0.7	4.4	15.2	9.1	0.8	4.3	0.7	4.1	42.7	3.1	1.3	0.0	57.8	17.5	32.1	4.6	23.5	9.0	5.0	0.0	3.5	19.6	97.2	11.1	3.6	32.0	4.7	2.6	15.2	6.2	5.0	7.3	0.3	4.3	5.7	2.4	2.9	7.0	2.4	1.4	9.0	0.0	32.9	8.9	4.6	21.6	1.4	14.1	12.4	6.0	12.2	5.2	1.7
IL17B	"IL-17B, IL-20, MGC138900, MGC138901, NIRF, ZCYTO7"	ENSG00000127743	"Interleukin 17B"	Q9UHF5	5	149371324-149404202	"Cancer-related genes, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 44.8;Peritubular cells: 13.2;Sertoli cells: 26.3;Smooth muscle cells: 7.6;Theca cells: 9.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"basophil: 1.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"HEL: 1.3;Karpas-707: 1.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042441	Uncertain				"Secreted to blood"	NA	NA	75000		"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 36: HEL - Hemostasis"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA042441: AB_10797014"	"unprognostic (2.83e-4)"	"unprognostic (2.71e-2)"	"unprognostic (4.90e-3)"	"unprognostic (9.22e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.03e-2)"	"unprognostic (9.62e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.54e-2)"	"unprognostic (9.30e-3)"	"unprognostic (3.22e-1)"	"unprognostic (6.98e-8)"	"unprognostic (2.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.10e-1)"	1.4	2.2	0.0	1.0	0.0	0.2	2.9	0.5	0.1	3.2	0.0	3.1	0.3	4.3	0.0	1.5	1.1	0.4	1.1	0.0	0.0	0.7	0.0	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.1	2.4	0.1	0.4	2.8	2.1	0.3	0.9	1.3	2.2	0.0	0.6	0.8	3.7	0.0	0.0	0.1	0.2	0.0	1.4	0.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.8	44.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.3	0.0	0.0	0.1	0.2	0.6	1.3	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.0	1.0	1.1	3.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	26.3	0.6	7.6	0.1	0.1	0.0	0.3	0.0	0.0	9.9	0.0	0.1
INPP5B		ENSG00000204084	"Inositol polyphosphate-5-phosphatase B"	P32019	1	37860697-37947057	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 47.5;Inhibitory neurons: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028803	Approved		Supported	Cytosol		NA	NA		8400	"Cluster 46: Basophils - DNA binding"	"Cluster 50: Non-specific - Ribosome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA028803: AB_10612121"	"unprognostic (2.28e-2)"	"unprognostic (8.91e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (1.11e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (5.33e-4)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (6.11e-5)"	"unprognostic (1.03e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.28e-1)"	13.3	9.3	9.5	10.3	10.7	20.7	11.9	14.7	11.8	16.1	11.5	18.7	6.9	13.9	9.9	7.2	15.7	8.4	12.8	9.2	9.3	10.8	16.2	14.7	18.5	11.5	10.2	23.9	10.5	8.9	11.9	10.4	11.4	10.9	10.0	12.5	8.4	11.1	9.1	10.8	13.4	11.9	9.0	17.3	13.7	7.0	10.5	13.4	12.2	6.0	18.7	16.8	11.7	15.3	6.8	4.6	10.7	15.7	12.3	15.8	18.5	7.5	12.5	9.6	13.2	7.2	9.4	23.2	3.6	12.9	5.0	9.1	14.3	6.0	12.8	16.2	6.3	35.8	15.4	4.9	17.7	19.0	47.4	17.8	3.7	10.2	6.6	9.4	11.0	16.4	11.7	25.6	12.4	5.3	16.7	21.4	15.5	9.5	3.9	18.7	21.3	10.9	5.5	6.2	4.3	6.8	8.8	4.2	18.9	15.7	5.2	15.8	10.6	8.8	7.9	8.5	7.1	20.8	11.8	18.3	10.1	15.8	8.1	27.3	2.9	16.5	7.0	2.3	9.9	7.1	4.8	6.7	6.1	7.6	6.1	5.8	3.7	6.2	6.0	5.4	6.8	4.9	9.5	10.7	14.7	11.8	9.2	9.3	11.5	10.2	11.4	9.0	10.5	15.3	5.7	28.9	26.3	35.3	11.8	2.2	5.8	2.1	4.0	14.7	2.2	2.3	3.2	1.5	6.4	1.8	25.0	4.1	7.9	3.9	0.0	2.4	10.7	2.3	8.4	5.9	3.5	6.5	47.5	4.4	15.4	6.3	16.8	3.3	8.2	6.9	5.3	7.8	5.2	23.5	48.5	5.0	6.1	8.1	5.4	15.9	8.4	8.3	7.2	35.6	11.3	4.6	28.8	20.1	39.4	3.0	4.7	9.1	8.5	4.5	3.5	2.6	5.8	18.9	6.6	7.7	7.1	4.6	8.1	3.4	3.3	4.7	11.2	7.7	4.7	4.1
INSL6	RIF1	ENSG00000120210	"Insulin like 6"	Q9Y581	9	5123880-5185647	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"retina: 6.8;testis: 14.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 134.0;Excitatory neurons: 22.0;Inhibitory neurons: 26.2;Late spermatids: 17.9;Microglial cells: 21.5;Spermatocytes: 35.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.1;Karpas-707: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021364	Enhanced				"Secreted to blood"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA021364: AB_1851807"	"unprognostic (3.85e-4)"	"unprognostic (7.41e-4)"						"unprognostic (1.28e-1)"		"unprognostic (1.94e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.30e-1)"		"unprognostic (2.52e-3)"	0.1	0.3	0.5	0.6	0.7	1.5	0.0	1.1	1.2	0.0	0.1	0.2	0.3	0.4	0.0	0.4	0.1	0.5	0.5	0.4	0.9	0.1	0.1	0.2	1.0	0.6	0.2	0.4	0.0	0.0	0.0	0.8	0.6	0.2	0.0	6.8	0.2	0.0	0.3	1.0	0.2	0.0	0.1	1.1	0.6	14.9	0.5	0.1	0.2	0.0	0.1	0.1	0.0	1.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	1.1	0.3	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.3	1.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.2	0.2	0.1	0.2	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.7	1.1	1.2	0.4	0.9	0.6	0.2	0.6	0.1	0.5	1.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	134.0	0.1	0.0	0.1	0.0	0.0	22.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	26.2	0.0	0.0	0.0	0.0	17.9	1.2	0.0	0.0	21.5	0.0	0.0	0.0	9.5	8.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	35.7	10.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0
ISG20L2	FLJ12671	ENSG00000143319	"Interferon stimulated exonuclease gene 20 like 2"	Q9H9L3	1	156721891-156728766	"Predicted intracellular proteins"	"Ribosome biogenesis"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 95.7"	"Group enriched"	"Detected in all"	30	"Early spermatids: 816.3;Late spermatids: 2897.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028005, HPA054285"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA028005: AB_2126319, HPA054285: "	"unprognostic (1.67e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (3.52e-1)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (6.15e-5)"	"unprognostic (1.02e-1)"	"unprognostic (9.55e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.40e-1)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (5.11e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.82e-3)"	"unprognostic (2.32e-1)"	12.0	10.5	6.2	11.4	6.1	16.7	10.7	8.3	8.1	10.7	4.9	12.5	9.2	12.9	7.5	18.5	11.5	9.0	10.2	6.9	6.2	11.8	13.5	10.0	14.9	6.1	6.0	13.8	11.7	9.3	9.1	11.9	5.8	11.3	12.3	6.6	11.3	8.0	9.8	14.6	12.0	12.4	5.6	13.3	12.2	95.7	6.0	12.2	9.7	6.6	17.0	15.3	12.4	6.3	29.8	22.6	19.1	20.5	19.4	14.2	29.5	20.4	17.9	26.3	18.2	30.2	21.3	56.7	24.3	15.3	11.9	39.2	47.0	32.2	19.9	28.4	30.6	30.9	16.4	17.8	18.9	73.7	32.3	14.3	32.4	24.6	24.7	17.1	24.2	23.9	49.5	25.4	17.0	40.4	31.8	21.3	62.9	60.3	38.0	37.5	22.3	35.9	19.6	23.8	40.4	48.5	24.8	69.8	21.3	27.8	44.5	45.8	16.2	15.2	22.4	18.8	41.9	33.9	56.3	70.3	13.8	37.1	20.2	28.2	8.7	17.2	8.5	11.0	9.8	7.2	6.5	8.7	8.2	8.6	6.6	7.7	15.1	12.1	12.4	5.5	6.7	6.1	6.2	6.1	8.3	8.1	6.9	6.2	6.1	6.0	5.8	5.6	6.0	6.3	16.4	28.9	43.4	4.9	43.6	52.9	40.4	18.9	46.7	22.4	30.5	23.6	10.1	18.6	29.1	7.3	25.0	34.9	57.7	32.0	17.6	21.2	816.3	21.7	22.8	24.9	31.8	29.8	13.5	17.3	37.5	24.2	26.0	38.5	27.8	22.7	21.4	18.6	21.3	23.5	9.8	32.3	10.2	28.4	38.0	2897.0	29.2	33.2	23.2	2.8	21.6	19.8	36.0	6.0	6.3	23.6	16.7	25.9	38.4	38.0	33.8	13.9	19.5	20.5	26.3	30.2	24.5	48.0	27.3	41.7	60.7	37.5	51.5	23.4	31.5	45.8
ITGAM	"CD11B, CR3A, MAC-1"	ENSG00000169896	"Integrin subunit alpha M"	P11215	16	31259967-31332892	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity, Innate immunity"	"Integrin, Receptor"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"bone marrow: 182.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 45.4;granulocytes: 35.5;Hofbauer cells: 47.2;Kupffer cells: 117.7;Langerhans cells: 45.5;Macrophages: 83.2;Microglial cells: 41.2;monocytes: 87.4;NK-cells: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"HMC-1: 50.0;NB-4: 19.9;U-937: 22.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002274, CAB025091, CAB072870"	Enhanced					NA	NA		1000000	"Cluster 46: Basophils - DNA binding"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"CAB025091: , CAB072870: AB_2665722, HPA002274: AB_1078435"	"unprognostic (1.82e-2)"	"unprognostic (1.70e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.40e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (6.93e-5)"	"unprognostic (9.89e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (3.99e-2)"	"unprognostic (5.03e-2)"	13.4	4.7	3.4	24.7	3.5	182.8	3.0	4.5	4.2	3.3	4.8	3.0	2.2	2.0	0.7	2.6	2.3	5.9	2.9	3.6	5.1	1.0	3.5	16.4	7.4	6.7	5.7	1.6	2.3	1.3	0.1	7.7	7.3	1.5	3.4	0.3	2.4	2.2	1.4	1.7	3.5	11.2	6.5	13.1	3.1	1.4	8.6	5.2	1.0	3.1	10.4	8.0	0.2	10.8	0.8	1.8	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.5	0.8	1.3	0.9	0.0	0.4	0.1	0.0	0.4	0.0	7.6	0.0	1.0	0.0	0.0	0.0	1.8	50.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	19.9	0.0	0.0	0.0	0.3	0.1	1.0	0.0	2.2	0.0	0.0	0.0	0.5	0.4	0.0	0.2	4.3	0.1	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	22.6	0.1	93.3	55.7	70.2	31.1	20.9	1.9	4.8	3.3	9.5	9.5	1.0	0.9	7.7	58.4	54.4	3.2	0.6	1.2	27.0	3.4	3.5	4.5	4.2	3.6	5.1	6.7	5.7	7.3	6.5	8.6	10.8	1.4	3.2	9.8	0.7	9.3	1.1	0.3	1.5	0.0	0.0	1.8	3.8	2.3	4.3	1.8	0.0	0.0	0.3	45.4	0.0	0.0	1.2	0.5	0.3	0.4	1.6	3.6	9.4	1.0	0.0	0.7	1.1	1.1	0.5	35.5	0.5	2.2	1.2	47.2	0.0	1.0	0.1	0.0	117.7	45.5	1.8	0.3	83.2	0.0	41.2	87.4	0.0	75.2	3.0	0.3	0.9	0.0	0.0	4.5	0.5	0.0	0.2	0.9	0.0	13.1	1.2	0.5	0.7	0.9	0.5	1.0	0.8	14.9	0.0	0.3	0.2
JAGN1	"FLJ14602, GL009"	ENSG00000171135	"Jagunal homolog 1"	Q8N5M9	3	9890574-9894349	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA067610			Approved	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles		"HPA067610: "	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.37e-2)"	"unprognostic (6.36e-3)"	"unprognostic (9.93e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.49e-1)"	29.6	43.5	21.3	15.7	22.3	12.1	26.6	23.8	28.9	21.9	24.6	26.3	27.0	23.4	39.7	19.4	25.7	16.4	22.9	21.6	23.1	30.1	62.6	17.4	19.2	22.5	22.3	25.5	40.2	31.5	17.8	20.6	22.5	20.9	30.2	19.9	24.0	20.8	36.1	27.6	26.4	20.5	22.9	17.6	30.8	14.1	22.7	24.0	17.8	30.1	23.6	23.0	21.0	23.6	32.7	54.0	39.8	23.9	116.9	121.5	128.3	43.8	65.2	49.4	49.6	40.6	43.1	51.4	19.6	44.2	54.0	28.1	63.1	59.5	48.9	38.4	65.7	62.4	55.7	73.7	99.4	45.6	37.3	115.3	89.4	63.6	73.2	51.0	47.0	45.8	65.0	34.5	59.2	99.0	37.8	80.5	50.1	65.3	74.3	31.0	32.5	64.4	73.3	45.9	25.0	46.4	29.6	31.8	58.1	35.8	50.4	56.8	39.9	26.2	28.1	29.3	35.4	60.2	94.5	60.7	33.1	55.7	44.9	100.9	61.8	31.1	48.1	48.6	50.5	52.5	46.8	45.9	57.4	53.3	50.9	48.0	24.9	51.9	37.9	58.1	54.7	67.9	21.3	22.3	23.8	28.9	21.6	23.1	22.5	22.3	22.5	22.9	22.7	23.6	28.7	32.1	17.5	5.2	38.6	27.5	47.8	84.1	30.7	27.3	53.0	58.8	14.1	55.8	43.5	38.6	10.4	74.7	30.8	49.5	21.5	80.6	3.2	33.0	33.5	36.3	25.8	30.9	4.8	98.1	80.1	37.9	30.1	22.9	8.2	36.5	42.8	52.4	55.8	23.5	5.7	55.2	59.0	40.7	22.5	6.8	39.4	29.8	37.4	4.7	75.3	52.3	50.4	8.0	8.0	73.5	55.7	38.7	35.3	66.2	114.2	55.9	40.6	23.3	46.0	31.6	31.7	66.0	51.2	35.8	36.8	52.9	31.3	48.8	58.3	39.2
JAK2	JTK10	ENSG00000096968	"Janus kinase 2"	O60674	9	4984390-5129948	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Chromatin regulator, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 93.4;Inhibitory neurons: 122.3;Microglial cells: 106.8;Oligodendrocyte precursor cells: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 132.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 132.5"	"Group enriched"	"Detected in many"	5	"ASC diff: 42.2;HDLM-2: 75.0;HEL: 154.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013089, HPA040820, HPA043870"	Approved		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"CAB013089: AB_2533647, HPA040820: AB_2677151, HPA043870: AB_2678708"	"unprognostic (2.24e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.85e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.37e-3)"	15.6	7.6	3.2	19.2	3.7	21.7	8.9	6.3	9.1	8.5	1.1	6.7	6.5	11.3	8.6	8.8	8.0	10.5	24.5	2.7	3.1	6.8	4.5	10.9	18.2	3.3	1.8	11.5	3.8	6.5	2.9	11.0	2.0	6.8	6.5	12.8	4.0	6.2	9.8	11.2	7.7	9.5	3.5	17.6	13.4	9.8	1.7	7.5	4.8	8.9	12.7	11.7	9.1	3.9	6.8	3.7	3.7	6.3	42.2	12.4	1.1	9.1	8.6	7.2	4.6	1.2	2.0	0.3	2.1	5.4	5.4	2.3	4.4	5.1	4.9	75.0	1.4	154.7	7.6	1.7	10.0	10.5	7.1	9.5	2.1	2.8	4.5	7.6	6.6	5.1	10.9	17.4	11.6	2.2	2.9	12.8	3.3	3.3	4.3	5.1	8.2	2.2	4.7	3.5	4.2	2.4	2.6	3.5	2.8	3.6	2.0	15.4	13.1	10.2	3.6	10.7	6.4	3.1	6.4	1.5	13.6	4.7	5.3	132.5	20.5	38.2	5.6	20.1	4.5	5.6	4.1	3.1	26.5	4.9	2.2	2.8	19.2	9.6	16.4	9.7	4.5	7.7	3.2	3.7	6.3	9.1	2.7	3.1	3.3	1.8	2.0	3.5	1.7	3.9	14.3	16.0	7.9	31.6	12.9	9.7	3.3	4.9	10.8	8.0	5.2	3.4	30.0	0.0	6.7	7.3	8.4	1.9	13.9	11.7	1.9	3.3	8.6	5.1	11.2	9.4	3.0	19.8	93.4	3.9	0.9	8.9	38.7	5.6	14.0	11.4	4.6	1.9	14.2	8.4	122.3	4.5	0.0	33.6	28.8	7.1	23.6	38.9	5.4	106.8	49.5	12.6	8.2	69.9	42.3	7.0	20.9	33.4	10.7	3.0	3.9	3.3	7.1	11.2	0.0	9.7	12.5	15.0	5.5	11.6	8.4	3.4	10.4	5.1	4.1	4.5
JRK	"jerky, JH8"	ENSG00000234616	"Jrk helix-turn-helix protein"	O75564	8	142657460-142681968	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052675			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	"Nuclear bodies"	"HPA052675: AB_2681910"	"unprognostic (3.65e-2)"	"unprognostic (5.30e-2)"	"unprognostic (9.67e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.84e-2)"	"unprognostic (6.58e-6)"	"unprognostic (1.05e-1)"	"unprognostic (3.87e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.69e-2)"	3.7	4.5	5.9	4.1	6.1	2.1	4.0	7.9	7.4	7.4	4.0	5.9	3.0	6.7	3.4	4.9	5.5	2.5	5.9	5.8	4.7	7.9	4.0	3.9	5.4	6.2	5.2	8.5	5.4	4.6	6.4	3.0	5.5	6.2	2.8	3.8	4.7	4.0	7.5	6.0	5.3	3.7	4.3	7.2	5.7	6.6	6.2	5.1	6.9	4.7	5.9	5.7	4.7	6.8	6.5	6.9	8.0	6.4	7.6	10.8	4.8	10.4	4.2	11.9	6.8	6.3	13.1	11.0	4.1	8.2	8.2	8.7	7.0	6.2	6.0	8.5	12.0	11.2	25.3	7.2	3.1	8.6	7.5	7.2	5.4	7.6	4.3	6.0	6.8	13.1	12.0	4.8	10.1	11.1	10.1	4.8	6.8	4.6	9.6	13.1	5.0	6.2	4.1	11.1	14.5	9.6	18.1	7.3	4.3	5.0	7.3	5.2	8.1	9.1	19.5	9.1	5.5	6.3	7.6	6.3	6.9	10.7	9.0	1.0	0.7	0.9	0.9	0.5	0.5	0.4	1.0	0.9	0.7	1.2	1.3	1.0	0.8	0.6	0.2	0.6	0.6	0.4	5.9	6.1	7.9	7.4	5.8	4.7	6.2	5.2	5.5	4.3	6.2	6.8	3.5	6.4	1.1	8.5	4.8	0.0	2.5	0.0	2.2	14.7	4.5	3.3	11.5	4.3	0.6	7.3	20.9	4.4	8.6	3.2	3.9	2.8	1.9	1.4	4.9	6.5	9.1	12.0	11.3	2.5	2.7	3.7	6.6	2.1	1.3	15.5	8.2	2.6	3.0	10.1	11.0	3.1	0.0	6.6	0.0	2.2	11.5	3.4	0.0	8.4	4.5	4.4	12.3	9.5	9.5	5.6	1.4	11.7	4.3	3.7	2.7	2.7	0.7	10.0	0.0	5.8	4.8	9.1	19.4	3.2	0.0	2.2	2.5	6.8	4.2	4.5
KCNE1B		ENSG00000276289	"Potassium voltage-gated channel subfamily E regulatory subunit 1B"	A0A087WTH5	21	7816675-7829926	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 7.1;fallopian tube: 5.7;heart muscle: 6.2"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 1.2;Kupffer cells: 1.2;Respiratory ciliated cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.0;eosinophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.8;SuSa: 1.1"															NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (5.41e-4)"	"unprognostic (8.78e-2)"		"unprognostic (7.14e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.34e-2)"		"unprognostic (1.78e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.47e-2)"	"unprognostic (3.24e-1)"		"unprognostic (1.73e-3)"	"unprognostic (6.59e-2)"	"unprognostic (1.49e-1)"			0.2	0.0	0.3	0.0	0.4	0.1	0.9	0.4	0.9	0.2	7.1	0.1	0.0	0.1	0.1	0.1	5.7	0.0	6.2	1.0	0.2	2.6	0.9	1.0	0.0	1.4	1.7	0.0	0.0	0.7	0.3	0.2	0.8	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.8	1.1	0.6	0.1	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.4	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.4	0.9	1.0	0.2	1.4	1.7	0.8	1.1	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNJ13	"Kir1.4, Kir7.1, LCA16"	ENSG00000115474	"Potassium inwardly rectifying channel subfamily J member 13"	O60928	2	232765802-232776565	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Cataract, Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"choroid plexus: 159.5;intestine: 91.3"	"Group enriched"	"Detected in some"	4	"Muller glia cells: 54.8;Proximal enterocytes: 217.4;Undifferentiated cells: 68.1"	"Cancer enriched"	"Detected in some"	5	"melanoma: 5.9"	"Group enriched"	"Detected in many"	4	"cerebellum: 7.3;hippocampal formation: 8.0;thalamus: 5.3;white matter: 3.4"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"U-2197: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051609			Approved	"Nuclear membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Nuclear membrane"		"HPA051609: "	"unprognostic (4.29e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.03e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.12e-2)"		"unprognostic (2.26e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.11e-2)"	0.1	0.1	0.4	0.0	1.3	0.4	0.1	7.3	1.1	0.1	159.5	0.1	7.9	0.1	0.3	0.1	0.0	2.2	0.1	8.0	0.4	3.3	0.2	0.1	0.2	1.3	0.8	0.2	0.8	15.8	0.2	0.0	1.3	0.1	0.0	13.7	0.2	1.1	0.1	3.2	91.3	0.1	0.4	0.1	2.3	0.5	5.3	0.1	7.0	0.0	0.0	0.1	0.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.3	0.0	0.2	0.2	0.1	0.0	1.9	0.3	0.3	0.3	0.0	0.4	0.2	0.6	0.2	0.1	0.3	0.7	0.3	0.3	0.4	0.4	0.3	1.0	0.0	0.4	1.3	7.3	1.1	8.0	0.4	1.3	0.8	1.3	0.4	5.3	3.4	0.1	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.5	0.5	0.0	0.0	1.8	0.0	0.0	0.2	0.1	1.9	0.0	3.0	0.7	0.3	0.2	0.0	0.0	1.1	1.3	0.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	25.7	0.0	0.0	0.0	0.6	0.0	0.1	21.4	0.0	0.0	54.8	0.0	1.5	2.0	0.0	8.8	0.0	0.0	0.1	217.4	0.2	0.0	1.7	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.0	68.1	0.0
KDM5A	"JARID1A, RBBP2"	ENSG00000073614	"Lysine demethylase 5A"	P29375	12	280057-389320	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 45.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006201			Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear bodies"	Cytosol	"HPA006201: AB_1079160"	"unprognostic (2.75e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.81e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.77e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.60e-2)"	"unprognostic (7.69e-2)"	8.1	8.7	5.8	11.4	8.3	45.5	11.1	11.6	8.5	8.6	10.0	8.2	7.2	9.7	7.1	8.9	7.6	8.0	5.2	6.2	6.5	7.8	9.9	8.8	15.3	6.8	5.7	11.0	9.4	10.1	4.2	11.8	6.5	8.6	9.9	9.6	6.7	7.3	5.5	12.5	7.3	9.4	6.0	13.5	8.8	21.1	6.7	21.6	9.1	7.6	14.4	8.7	7.2	15.0	14.4	25.3	18.3	14.2	16.1	15.2	20.3	12.5	16.5	18.4	19.8	15.2	17.0	24.0	3.9	21.0	16.0	13.3	19.2	14.2	21.9	37.9	15.9	29.3	26.5	9.0	13.0	38.6	22.1	16.6	13.1	22.6	29.9	18.8	18.8	21.0	17.9	32.7	15.7	9.7	27.9	11.0	28.4	12.3	7.9	25.7	47.5	11.4	8.8	32.6	7.0	20.5	24.5	11.0	13.0	25.0	11.9	24.0	26.0	12.0	17.0	13.6	21.1	11.5	13.6	53.7	15.5	16.5	18.0	64.5	21.8	44.4	31.4	25.0	32.3	27.1	24.6	25.9	22.8	32.0	26.3	22.8	63.0	35.8	28.9	32.0	20.9	22.5	5.8	8.3	11.6	8.5	6.2	6.5	6.8	5.7	6.5	6.0	6.7	15.0	53.1	64.1	61.6	61.7	80.6	33.0	22.2	30.1	48.9	69.0	35.3	27.9	38.2	31.5	39.0	35.0	116.7	48.8	103.3	51.3	3.9	37.4	96.8	60.2	72.8	51.6	69.7	51.3	71.7	31.6	34.7	47.2	39.8	99.8	54.4	106.9	42.8	30.9	30.2	87.5	59.1	40.0	40.7	52.5	37.5	32.5	48.4	63.9	26.6	57.1	82.9	48.3	105.0	68.3	85.9	38.7	37.0	55.7	73.1	32.4	33.6	11.8	40.2	71.9	59.2	64.0	59.9	137.1	104.8	50.1	47.6	71.1	80.1	67.5	40.1	42.0
KLHL20	"KHLHX, KLEIP"	ENSG00000076321	"Kelch like family member 20"	Q9Y2M5	1	173714941-173786692	"Predicted intracellular proteins"	"Protein transport, Transport, Ubl conjugation pathway"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 132.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025034, HPA053704"	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus, Cytosol"		"HPA025034: AB_1852578, HPA053704: AB_2682234"	"unprognostic (2.97e-3)"	"unprognostic (3.11e-2)"	"unprognostic (8.27e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.51e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.62e-2)"	13.8	10.2	5.8	7.6	7.1	5.9	8.7	7.3	6.7	11.8	4.7	9.7	6.7	13.6	6.9	9.8	8.1	9.3	10.8	6.5	6.3	10.8	16.2	10.0	9.7	7.4	6.7	12.0	6.0	7.9	5.3	11.4	7.1	13.1	8.9	9.0	6.1	9.3	12.5	9.5	7.8	13.4	6.9	10.3	7.5	15.9	6.5	12.3	8.4	13.9	9.1	10.0	8.2	6.9	12.8	8.0	12.5	13.1	28.7	26.4	10.2	19.7	19.2	14.9	15.6	5.8	8.7	9.0	16.4	21.3	7.9	12.5	11.2	14.2	17.4	11.0	6.0	8.2	10.8	6.9	18.4	15.5	9.3	22.6	16.1	13.8	18.4	17.3	22.2	9.0	18.5	10.0	27.6	4.7	9.1	8.0	13.3	11.3	36.1	9.7	15.4	9.8	11.4	8.1	5.3	14.7	18.0	12.1	12.3	16.9	10.8	18.0	22.2	14.3	8.6	17.6	15.7	13.3	7.4	13.5	9.4	11.0	16.2	7.0	2.9	4.3	4.5	3.2	4.0	3.6	4.4	5.5	2.8	3.5	5.6	5.7	1.6	3.2	2.4	4.6	5.6	2.3	5.8	7.1	7.3	6.7	6.5	6.3	7.4	6.7	7.1	6.9	6.5	6.9	21.8	16.0	25.9	36.2	17.3	11.1	8.1	13.5	8.0	13.3	8.0	8.0	12.8	17.2	12.8	12.9	37.5	13.1	18.1	13.5	1.9	9.9	132.4	4.4	14.0	23.4	9.6	11.1	28.1	12.1	10.1	18.2	16.3	5.6	7.6	14.9	42.1	21.0	11.2	11.8	37.3	9.1	10.2	18.5	9.1	30.2	22.4	10.0	3.6	18.7	9.4	16.4	20.6	33.7	35.2	11.4	8.9	28.6	12.3	8.8	16.3	14.1	8.2	20.7	0.0	20.9	16.4	55.8	35.6	11.3	10.5	9.9	16.9	24.1	9.7	7.8
KLHL35	FLJ33790	ENSG00000149243	"Kelch like family member 35"	Q6PF15	11	75422394-75433203	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 5.2;testis: 9.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 39.6;Early spermatids: 25.9;Late spermatids: 28.4;Spermatogonia: 56.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 15.8;HMC-1: 10.3;PC-3: 8.9;SiHa: 18.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039864, HPA070736"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Centrosome"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"	"Nucleoli fibrillar center"	"HPA039864: AB_10794204, HPA070736: "	"unprognostic (3.53e-2)"	"prognostic favorable (4.63e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.88e-2)"	"unprognostic (4.15e-3)"	"unprognostic (4.98e-2)"	"unprognostic (3.92e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.39e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.28e-1)"	0.6	0.8	3.9	0.0	4.9	0.0	0.9	1.9	3.9	0.7	1.3	0.2	0.0	0.3	0.0	0.4	0.4	0.1	0.8	3.5	5.1	0.3	0.0	0.7	0.0	4.4	3.4	0.2	1.8	0.0	0.9	0.0	5.2	0.2	0.0	0.6	0.8	0.1	0.4	0.9	0.1	0.1	2.7	1.1	1.1	9.3	4.4	0.1	0.6	0.2	0.0	0.3	0.3	3.8	0.0	0.3	0.1	0.0	0.2	1.3	0.0	0.9	0.0	0.9	0.1	15.8	1.3	0.0	4.3	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.8	4.1	10.3	0.2	0.2	0.0	0.0	0.1	0.4	2.7	0.0	0.0	1.1	0.7	0.3	0.1	0.2	3.2	8.9	0.0	0.0	0.9	0.7	0.2	1.2	1.0	18.4	3.4	0.0	0.0	3.4	2.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.8	0.0	0.2	0.0	0.4	0.2	0.3	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.4	3.9	4.9	1.9	3.9	3.5	5.1	4.4	3.4	5.2	2.7	4.4	3.8	0.7	9.6	3.4	0.3	1.1	1.3	1.8	0.5	4.0	39.6	6.4	4.8	1.0	1.5	2.8	3.7	8.4	1.5	0.7	0.6	3.9	1.7	25.9	2.1	3.0	1.1	4.2	0.4	3.9	3.1	1.7	3.0	2.6	4.0	4.5	1.5	2.9	0.1	1.2	1.7	3.5	1.4	0.0	1.2	2.1	28.4	2.8	2.9	1.8	0.0	1.6	2.5	3.1	0.0	4.4	3.7	0.4	1.2	0.1	1.3	0.3	0.4	1.6	11.1	6.6	1.3	1.6	10.2	56.7	0.9	2.3	2.5	1.1	2.2	0.7	1.4
KRBA2		ENSG00000184619	"KRAB-A domain containing 2"	Q6ZNG9	17	8356902-8376704	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 34.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 16.7;Rod photoreceptor cells: 30.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA022849	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA022849: AB_1852996"	"unprognostic (9.17e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.98e-2)"	"unprognostic (8.35e-3)"	"unprognostic (7.44e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.61e-4)"	"unprognostic (6.14e-2)"	"unprognostic (5.02e-7)"	"unprognostic (1.82e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.08e-1)"	1.7	1.9	3.4	1.7	4.8	1.1	2.5	5.3	4.5	2.4	2.5	1.5	1.6	2.4	2.5	1.4	1.7	1.2	6.9	3.4	3.6	3.6	0.8	1.6	1.6	3.8	3.6	2.6	1.7	3.9	1.8	1.8	3.9	2.6	1.6	34.5	2.4	1.7	6.2	3.0	1.7	1.8	2.5	1.7	1.6	2.0	4.1	2.5	2.8	6.8	1.3	1.7	1.5	6.8	0.4	3.6	4.6	4.4	2.0	2.8	2.3	0.6	1.3	1.6	2.3	0.0	1.5	0.3	2.6	0.5	1.1	0.9	1.6	0.5	2.2	1.9	1.0	0.6	2.5	1.3	0.7	0.2	1.0	2.5	0.2	1.8	0.6	1.0	2.9	2.3	0.1	0.6	1.4	0.7	1.9	0.5	0.7	0.2	1.2	3.4	2.5	0.4	1.2	2.4	1.6	3.0	3.4	1.2	1.0	3.1	1.5	0.2	1.5	1.3	2.2	0.5	0.7	1.6	0.9	0.3	1.6	0.1	3.1	10.1	1.3	2.3	2.0	1.2	1.9	1.7	2.0	1.6	0.8	2.9	3.5	1.9	1.6	1.5	2.7	1.6	2.2	0.4	3.4	4.8	5.3	4.5	3.4	3.6	3.8	3.6	3.9	2.5	4.1	6.8	9.9	0.0	1.1	6.2	2.2	0.3	1.3	1.3	4.6	3.6	2.9	3.0	0.7	1.5	0.4	1.8	16.7	2.5	1.7	1.5	3.9	3.4	0.4	0.9	3.0	4.5	4.2	7.4	2.6	1.1	0.6	2.8	2.6	0.9	5.1	3.5	2.2	0.4	0.9	3.3	4.1	1.5	2.0	1.0	1.0	0.6	1.5	1.2	1.8	1.9	1.2	2.9	4.1	5.5	4.1	2.1	0.1	3.0	3.8	0.6	1.3	1.4	2.3	30.2	0.0	2.4	2.9	2.3	2.4	3.1	0.9	1.2	2.4	2.5	1.6	0.3
L2HGDH	"C14orf160, FLJ12618"	ENSG00000087299	"L-2-hydroxyglutarate dehydrogenase"	Q9H9P8	14	50237563-50312229	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 56.3;Excitatory neurons: 60.5;Inhibitory neurons: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065409, HPA069708"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 9: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA065409: AB_2685485, HPA069708: AB_2686179"	"unprognostic (1.74e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.33e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.97e-1)"	"prognostic favorable (9.75e-10)"	"unprognostic (1.24e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-2)"	4.6	2.5	2.9	2.2	2.9	2.7	3.7	6.1	5.5	2.3	1.3	4.3	4.7	2.4	3.0	5.1	3.1	2.0	5.2	2.7	2.5	19.6	12.6	1.8	2.6	1.2	2.4	2.5	3.9	6.1	2.3	1.7	1.1	3.3	5.0	11.4	2.8	3.2	15.5	5.1	3.6	2.5	1.2	1.3	4.3	3.9	2.4	3.0	4.8	14.7	3.4	2.4	2.3	4.1	24.3	16.6	6.8	6.6	3.3	2.2	19.1	7.9	4.4	12.2	14.3	26.8	10.8	19.0	9.0	3.2	9.7	17.4	20.6	8.2	13.5	15.2	11.9	41.1	10.9	3.7	3.1	14.7	13.7	2.0	5.2	8.1	7.0	3.1	5.3	19.3	14.7	11.6	3.2	29.0	16.7	6.7	9.9	20.6	17.6	15.6	22.0	14.8	11.4	28.0	13.8	9.9	23.3	17.5	10.4	9.0	22.9	4.0	5.0	7.7	21.5	9.0	10.6	10.5	25.6	26.3	4.3	7.3	8.8	8.6	0.4	0.9	0.9	0.1	2.2	0.8	1.1	1.0	0.6	0.6	1.3	1.7	0.5	1.7	0.1	1.0	1.6	0.5	2.9	2.9	6.1	5.5	2.7	2.5	1.2	2.4	1.1	1.2	2.4	4.1	1.9	41.7	19.2	16.6	5.1	3.7	2.7	2.1	8.6	15.5	3.9	2.2	14.7	2.8	20.4	12.9	56.3	6.4	6.1	4.8	15.6	3.8	35.1	5.2	2.8	4.6	7.8	7.4	60.5	4.2	6.6	5.3	7.7	5.6	18.9	6.0	2.9	14.2	2.1	11.8	61.4	4.3	0.0	2.7	0.6	8.8	2.5	3.3	1.8	13.1	2.4	6.1	7.2	20.6	18.9	2.5	3.6	4.5	3.3	2.7	6.0	21.7	18.4	40.3	0.0	5.8	3.9	14.3	12.6	10.5	6.3	4.9	5.0	4.6	7.6	2.1
L34079.1		ENSG00000268361	"Novel protein"		19	43554692-43593036	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA			"Cluster 46: Basophils - DNA binding"																								0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.3	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.3	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LEMD2	"dJ482C21.1, LEM2, NET25"	ENSG00000161904	"LEM domain nuclear envelope protein 2"	Q8NC56	6	33771202-33789130	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017340	Supported		Supported	"Nuclear membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear membrane"		"HPA017340: AB_2296925"	"unprognostic (9.01e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.98e-1)"	"unprognostic (8.29e-3)"	"unprognostic (6.53e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (2.43e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.12e-2)"	40.5	45.8	46.0	35.0	47.9	63.3	39.6	53.1	50.8	52.6	44.6	45.3	31.9	44.1	29.7	50.2	45.9	30.0	46.7	43.9	44.0	51.5	49.9	51.2	45.4	52.0	47.0	53.7	54.5	39.3	56.5	38.5	47.9	51.9	30.0	29.7	43.3	31.3	37.4	51.8	50.1	30.4	46.3	70.1	44.9	45.5	47.2	46.1	53.0	28.1	41.6	43.8	44.9	54.4	36.6	40.5	67.3	66.1	37.6	40.3	50.9	39.1	59.7	48.5	50.9	30.6	37.8	33.8	53.5	55.6	136.7	62.0	39.4	52.1	34.0	35.9	36.6	12.7	45.8	40.3	78.4	26.1	42.6	44.3	96.5	51.6	88.1	80.0	52.8	43.9	36.3	38.3	42.8	30.8	48.6	64.1	39.2	53.5	23.2	31.8	27.8	28.3	52.0	50.5	47.8	37.8	23.4	74.0	52.6	68.0	49.5	70.7	24.6	67.8	26.3	36.6	46.5	49.8	43.0	24.0	26.7	40.3	83.0	1.6	1.7	3.2	2.3	1.5	2.9	2.2	2.5	2.3	1.7	2.3	2.0	2.3	1.4	1.5	2.1	2.9	2.8	1.2	46.0	47.9	53.1	50.8	43.9	44.0	52.0	47.0	47.9	46.3	47.2	54.4	19.8	3.2	9.0	16.0	17.4	10.8	13.4	7.9	14.2	18.6	10.0	7.1	10.0	8.6	5.2	9.2	18.8	24.9	18.6	24.3	1.9	9.4	24.9	7.5	10.1	18.5	5.4	8.6	14.5	6.8	36.6	12.2	15.3	10.6	12.7	16.6	12.5	7.7	17.5	43.7	17.4	17.7	6.1	14.5	12.4	44.2	10.5	13.5	12.4	14.0	9.4	14.0	13.4	14.6	18.2	13.2	20.1	16.1	11.9	14.6	14.8	6.6	7.2	13.1	19.7	12.7	15.2	24.6	7.4	8.9	10.2	29.8	15.2	12.5	15.9	13.2
LMOD3		ENSG00000163380	"Leiomodin 3"	Q0VAK6	3	69106065-69123032	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 111.2;skeletal muscle: 459.8;tongue: 228.2"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 278.1"	"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 1.6"	"Region enriched"	"Detected in single"	4	"midbrain: 2.3"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	4	"HSkMC: 2.9"	"Not detected"	"Not detected"							HPA036034	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA036034: AB_10673494"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.63e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.98e-4)"	"unprognostic (3.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.96e-1)"	0.2	0.1	0.3	0.2	0.4	0.2	0.1	0.3	0.5	0.1	0.2	0.1	0.2	0.0	0.2	6.4	0.0	0.3	111.2	0.3	0.3	0.1	0.1	0.5	0.2	0.3	2.3	0.0	0.4	0.0	0.9	0.5	0.3	3.8	0.1	1.3	9.0	0.4	459.8	0.2	0.2	0.1	0.1	0.7	0.4	0.1	0.2	0.1	0.1	228.2	0.0	0.8	0.1	0.5	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.3	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.1	0.2	1.6	0.2	0.4	0.2	0.2	0.2	0.3	0.4	0.3	0.1	0.3	0.3	0.4	0.4	0.2	0.4	0.2	0.4	0.1	0.3	0.4	0.3	0.5	0.3	0.3	0.3	2.3	0.3	0.1	0.2	0.5	0.5	0.0	0.0	0.3	6.2	2.3	1.5	2.1	0.0	5.0	2.4	1.8	278.1	5.7	1.3	0.0	39.6	0.8	10.0	2.4	0.0	1.0	1.6	3.4	1.2	2.4	0.0	0.0	0.1	0.0	2.1	8.2	0.0	10.0	17.8	0.5	0.7	1.2	0.7	6.7	2.0	1.9	6.1	2.2	28.1	0.5	0.3	2.2	12.4	0.0	3.9	1.0	13.4	0.0	0.3	1.1	0.2	1.2	0.9	2.6	6.1	0.4	0.3	18.1	0.0	33.1	3.4	0.6	0.1	0.8	1.4	0.4	8.2	0.9	1.1	2.5
LRR1	"LRR-1, MGC20689, PPIL5"	ENSG00000165501	"Leucine rich repeat protein 1"	Q96L50	14	49598761-49614672	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 29.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 129.5;Spermatocytes: 151.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA065703, HPA069364"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"	Vesicles	"HPA065703: AB_2685537, HPA069364: AB_2686129"	"unprognostic (2.73e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.85e-2)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (7.34e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (4.90e-7)"	"unprognostic (6.86e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.04e-2)"	5.7	5.5	1.6	9.1	1.7	22.6	5.6	1.7	2.1	3.0	1.6	12.2	9.6	3.7	2.4	6.7	3.3	3.6	3.2	1.5	1.6	3.1	6.1	4.2	14.0	1.8	1.7	2.4	4.3	2.9	1.2	4.0	1.8	3.2	10.0	3.2	4.1	3.4	4.0	4.7	10.1	6.1	1.7	7.5	4.6	29.1	1.8	23.2	3.4	4.8	13.3	5.4	3.5	1.9	66.5	39.3	34.2	38.4	15.1	10.6	38.2	35.0	30.8	72.5	68.7	38.4	49.1	60.9	25.1	22.9	23.2	41.7	42.2	29.8	64.1	56.5	31.3	27.4	29.4	24.6	8.5	64.5	34.2	6.9	11.3	33.9	19.4	9.2	35.8	49.2	29.3	45.4	49.2	55.2	87.2	60.1	22.5	31.7	53.0	54.8	56.2	41.4	25.4	27.1	36.9	21.7	33.1	35.3	25.4	12.1	49.9	49.6	13.1	50.6	83.1	24.8	44.4	23.6	35.9	69.0	23.6	47.7	42.9	22.4	14.2	25.4	10.1	22.7	13.5	16.1	13.3	14.8	15.0	12.6	10.8	12.3	8.2	11.1	16.9	17.7	15.7	10.5	1.6	1.7	1.7	2.1	1.5	1.6	1.8	1.7	1.8	1.7	1.8	1.9	6.4	3.2	6.5	2.0	12.1	15.6	5.7	12.0	4.6	3.8	6.5	5.6	3.6	5.7	9.3	3.7	2.1	12.6	9.2	11.8	1.9	16.8	129.5	3.4	5.3	8.9	4.8	48.4	0.9	22.7	34.2	7.8	6.6	2.9	14.5	9.5	6.8	6.6	21.6	1.7	1.1	11.0	12.2	10.4	19.2	41.6	7.5	11.5	10.6	2.8	16.7	8.1	13.4	1.0	2.0	14.1	3.7	3.4	31.3	11.2	8.7	7.5	4.3	5.2	6.6	5.5	8.0	151.7	14.0	8.8	14.9	7.7	10.5	7.5	14.5	7.0
LYPD6B	"CT116, LYPD7"	ENSG00000150556	"LY6/PLAUR domain containing 6B"	Q8NI32	2	149038107-149215262	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 95.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 245.7;Gastric mucus-secreting cells: 87.7;Inhibitory neurons: 77.8;Late spermatids: 118.5;Suprabasal keratinocytes: 69.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 17.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"basophil: 13.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 13.8"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 64.8;LHCN-M2: 102.3;NB-4: 34.7;RT4: 54.7;SK-BR-3: 32.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049239	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"			"HPA049239: AB_2680688"	"unprognostic (2.42e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.42e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.59e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.32e-3)"	0.3	0.2	3.5	0.4	2.5	0.2	16.4	1.6	5.3	2.8	1.6	1.7	2.6	0.9	1.2	4.1	23.4	37.3	0.0	4.3	4.1	20.5	0.9	1.7	0.4	2.3	7.3	0.4	12.3	16.1	0.4	0.8	3.0	11.1	3.3	1.0	5.8	15.2	0.2	95.5	1.2	0.3	1.9	2.8	41.3	34.1	8.0	0.3	0.2	0.0	1.9	14.2	6.3	2.1	1.4	0.0	0.0	1.5	0.0	0.1	0.1	8.0	1.5	6.6	2.5	1.0	0.0	0.0	0.0	64.8	0.0	14.0	1.5	1.3	20.6	0.0	7.4	0.0	1.9	0.0	0.2	0.0	0.1	0.6	21.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	102.3	24.3	0.0	34.7	2.0	14.6	0.3	0.0	0.4	4.3	3.2	54.7	3.9	0.1	0.4	32.1	0.0	6.3	4.8	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.8	13.8	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.5	2.5	1.6	5.3	4.3	4.1	2.3	7.3	3.0	1.9	8.0	2.1	0.5	0.0	2.0	2.3	5.5	29.8	21.0	30.6	6.2	0.0	23.4	17.1	1.4	42.9	23.9	46.0	0.0	0.1	0.1	4.0	7.9	12.4	245.7	5.2	0.3	1.0	2.4	2.7	4.6	19.1	0.7	0.8	87.7	5.7	0.0	0.4	0.0	0.1	0.1	0.0	77.8	3.9	8.2	0.0	2.8	118.5	2.1	0.4	5.4	0.0	0.6	0.0	0.0	0.0	0.4	30.9	6.0	0.0	4.5	40.6	5.7	0.2	21.4	0.0	0.0	0.0	1.3	4.2	1.7	3.5	69.0	0.3	1.1	0.0	3.5	53.7
MAFK	"NFE2U, P18"	ENSG00000198517	"MAF bZIP transcription factor K"	O60675	7	1530702-1543043	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 94.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-2 OS: 82.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026820, HPA060841"	Enhanced		Enhanced	Nucleoplasm		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB026820: , HPA060841: AB_2684377"	"unprognostic (6.82e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.19e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.14e-1)"	40.9	31.0	37.0	13.0	34.8	19.5	34.4	26.8	34.8	30.9	38.2	61.1	18.2	34.7	1.8	30.1	33.6	11.6	80.5	26.8	28.0	50.3	32.8	60.0	9.4	35.5	33.3	21.7	39.7	4.2	25.6	25.4	32.2	49.2	4.7	2.4	25.6	10.7	78.6	38.6	31.1	6.7	30.2	21.0	37.2	9.7	35.6	22.9	27.3	13.1	4.9	39.4	35.7	43.2	50.0	35.0	1.2	5.2	3.9	4.8	26.2	32.3	18.3	7.7	5.4	25.2	13.4	11.6	11.7	8.2	51.8	38.1	2.9	9.2	3.3	17.9	25.2	6.8	50.8	18.7	8.7	16.2	20.7	4.8	11.8	12.9	9.6	9.5	7.1	35.7	17.8	6.2	3.6	32.7	18.2	57.6	11.2	12.2	35.2	27.1	1.2	19.5	7.3	20.2	14.8	5.4	19.5	56.4	14.6	7.5	22.0	21.3	16.8	11.8	82.3	59.5	17.9	11.8	3.9	19.8	15.5	22.0	17.1	0.5	0.4	1.2	0.6	0.2	0.6	0.3	0.3	0.7	0.2	0.5	0.7	0.5	0.6	0.5	0.5	1.5	0.7	0.4	37.0	34.8	26.8	34.8	26.8	28.0	35.5	33.3	32.2	30.2	35.6	43.2	33.0	41.7	17.6	2.0	8.8	63.9	52.2	21.3	37.0	2.2	33.7	20.2	2.8	11.5	25.7	31.3	2.1	11.0	13.2	45.8	1.9	15.2	2.9	57.3	13.3	24.6	23.2	8.2	8.8	14.9	9.0	16.6	20.4	94.3	9.5	6.6	9.7	14.8	10.9	11.8	3.7	24.4	16.2	13.2	27.9	6.0	4.7	18.0	19.6	9.4	8.7	7.1	8.2	0.5	3.1	46.2	38.9	3.0	6.0	60.8	27.4	2.5	29.6	1.6	13.1	33.2	27.1	0.9	4.0	25.8	57.7	78.0	11.0	2.0	19.8	73.5
MAPKBP1	"KIAA0596, NPHP20"	ENSG00000137802	"Mitogen-activated protein kinase binding protein 1"	O60336	15	41774434-41827855	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 204.3;Excitatory neurons: 62.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030832, HPA030833"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA030832: AB_10601869, HPA030833: AB_2673628"	"unprognostic (2.53e-1)"	"unprognostic (9.18e-2)"	"unprognostic (6.56e-2)"	"prognostic favorable (1.47e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (1.08e-3)"	"unprognostic (6.03e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-2)"	6.2	10.5	10.9	4.6	12.4	4.4	7.7	31.1	13.7	11.1	10.1	10.2	9.6	9.9	4.5	18.6	10.4	4.6	6.4	9.9	8.5	7.1	4.1	6.0	3.9	9.0	8.0	15.1	5.5	4.2	12.7	5.4	9.0	8.9	3.6	9.0	7.5	5.9	5.1	24.2	9.9	9.0	5.3	8.0	9.3	34.4	9.1	6.3	13.4	3.7	6.8	12.2	12.0	10.2	7.4	3.8	10.0	9.5	10.9	10.8	6.9	10.1	25.5	9.1	6.6	7.6	2.7	1.8	8.1	8.3	12.5	17.2	9.8	28.5	6.5	6.7	2.7	7.3	12.8	2.6	4.7	4.7	14.5	5.6	22.3	14.3	25.9	14.8	13.4	11.9	4.6	3.4	12.9	1.5	4.0	4.2	1.1	4.3	7.6	4.3	7.2	0.7	5.3	8.1	11.3	6.3	5.7	5.9	4.5	10.2	7.1	3.7	10.6	13.0	6.2	12.4	10.0	7.3	12.7	4.3	8.7	6.3	11.0	1.1	0.4	0.3	0.8	0.1	0.6	0.4	0.4	0.3	0.5	0.4	0.6	0.5	0.1	0.6	0.5	0.1	0.2	0.5	10.9	12.4	31.1	13.7	9.9	8.5	9.0	8.0	9.0	5.3	9.1	10.2	7.1	6.4	10.3	33.0	3.5	54.7	10.0	8.6	36.5	14.5	5.4	8.9	3.4	2.8	7.3	3.7	204.3	6.8	5.6	4.0	0.0	3.0	15.7	10.9	7.1	9.5	4.8	0.8	62.2	3.7	4.4	5.8	9.2	8.9	1.3	12.2	5.3	2.6	3.9	15.2	55.1	1.7	4.1	2.5	6.1	27.1	7.2	5.0	8.8	33.7	4.2	4.4	3.1	34.7	51.9	4.6	1.8	7.9	5.1	12.5	8.1	0.5	13.0	8.9	13.1	7.8	5.7	12.7	4.2	27.7	53.6	5.3	5.8	8.0	2.5	15.2
MCFD2	"F5F8D, LMAN1IP, SDNSF"	ENSG00000180398	"Multiple coagulation factor deficiency 2, ER cargo receptor complex subunit"	Q8NI22	2	46901870-46941855	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 253.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022410, HPA034593"	Supported				"Intracellular and membrane"	NA	NA		1200000	"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"			"CAB022410: , HPA034593: AB_2674239"	"unprognostic (1.16e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.98e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.93e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (4.64e-4)"	52.0	155.5	41.3	35.6	43.1	34.7	55.1	38.1	40.3	50.4	69.5	32.2	32.5	54.5	42.1	45.9	41.9	44.9	42.3	41.3	46.8	59.4	111.8	45.0	32.1	33.5	41.3	79.2	104.1	52.5	38.7	70.1	41.6	54.0	26.9	83.3	149.7	82.9	83.3	26.0	33.4	52.5	28.0	44.6	33.9	30.9	48.6	30.8	121.0	84.6	34.2	41.2	29.2	34.7	147.7	86.9	74.7	59.7	151.5	215.1	115.4	248.4	254.1	129.4	116.8	116.9	109.4	96.4	297.7	294.7	154.3	81.8	67.0	127.0	207.7	64.5	67.2	101.9	87.1	182.5	236.5	94.8	158.6	163.2	77.8	206.7	178.7	247.9	210.8	28.0	199.3	56.0	266.8	48.7	56.9	67.6	63.9	102.3	84.1	68.3	133.2	106.7	80.3	59.3	23.9	62.2	93.1	46.9	116.0	86.3	33.1	80.6	341.1	298.3	130.5	97.0	164.2	42.0	43.8	76.4	320.2	88.0	100.8	27.2	21.4	29.7	9.6	23.3	12.2	12.5	10.9	10.2	18.4	12.8	14.3	9.8	12.0	9.9	18.3	16.9	9.7	14.0	41.3	43.1	38.1	40.3	41.3	46.8	33.5	41.3	41.6	28.0	48.6	34.7	50.8	105.8	89.1	16.6	29.6	48.2	56.5	65.3	36.5	69.3	64.4	48.5	70.3	38.6	68.8	47.8	39.6	75.5	25.4	26.6	21.5	88.6	144.3	76.4	60.2	64.7	26.8	28.2	19.6	178.5	64.5	70.1	20.4	69.9	50.5	44.1	53.9	155.1	54.5	38.7	23.8	28.5	18.3	40.5	31.3	113.7	62.7	39.2	12.4	7.5	33.8	253.2	12.3	16.1	16.2	152.7	23.1	59.5	43.8	82.4	42.2	41.3	69.6	51.3	65.7	63.9	55.4	48.9	32.6	39.6	44.9	102.1	23.4	74.3	22.8	75.8
MED26	"CRSP7, CRSP70"	ENSG00000105085	"Mediator complex subunit 26"	O95402	19	16574907-16629062	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 35.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 65.4;Late spermatids: 67.4;Spermatocytes: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA057997, HPA071835"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA057997: AB_2732618, HPA071835: AB_2686455"	"unprognostic (2.02e-2)"	"prognostic favorable (2.46e-4)"	"unprognostic (2.47e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.60e-3)"	"unprognostic (5.03e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (5.50e-5)"	"unprognostic (9.43e-3)"	"unprognostic (1.64e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.98e-3)"	4.5	3.8	4.4	3.8	4.0	11.0	4.1	5.1	4.7	4.0	4.0	4.1	2.4	4.3	1.8	5.2	3.2	2.3	3.2	5.0	5.1	2.8	3.7	4.0	4.9	5.2	4.7	4.7	3.9	3.5	3.6	3.2	4.7	4.2	1.9	2.0	4.5	2.4	6.9	6.4	3.6	2.5	3.6	4.7	3.6	35.9	4.5	4.4	3.1	3.2	4.6	3.9	4.6	4.2	11.1	4.2	3.8	8.3	4.8	3.8	11.1	6.3	4.4	6.7	6.0	6.3	6.5	17.6	6.5	4.0	2.1	8.2	5.9	6.3	4.6	13.0	12.2	6.9	4.2	5.1	4.7	7.9	6.3	4.6	6.1	5.7	5.9	4.0	3.6	9.1	11.5	20.7	4.2	11.1	8.4	7.4	9.0	5.2	13.4	8.7	5.8	19.3	4.0	4.3	10.0	5.4	5.5	5.3	6.4	2.7	3.9	10.3	4.5	8.5	6.8	10.4	8.5	14.3	12.6	14.4	6.0	10.4	5.0	0.7	0.1	0.1	0.5	0.3	0.1	0.4	0.0	0.2	0.2	0.7	0.3	0.0	0.3	0.4	0.1	1.4	0.7	0.1	4.4	4.0	5.1	4.7	5.0	5.1	5.2	4.7	4.7	3.6	4.5	4.2	13.7	3.2	12.7	11.4	11.8	14.1	5.0	3.8	11.4	4.2	14.3	12.2	1.1	2.8	3.0	5.5	10.4	6.2	15.8	5.9	3.9	4.4	65.4	12.9	7.7	6.1	2.4	5.0	8.6	4.0	11.1	7.0	5.6	16.6	1.3	5.8	4.2	5.6	5.0	5.0	7.6	4.7	2.0	8.5	10.7	67.4	6.5	9.9	1.8	1.9	4.9	6.0	4.1	7.1	8.5	6.0	3.0	3.8	15.9	6.7	3.6	2.0	3.5	6.4	0.0	17.7	8.0	54.1	19.4	11.5	10.7	16.8	11.0	6.1	5.1	8.7
METTL7A	DKFZP586A0522	ENSG00000185432	"Methyltransferase like 7A"	Q9H8H3	12	50923472-50932510	"Metabolic proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 440.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 986.4;Kupffer cells: 308.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 95.7;classical monocyte: 35.7;eosinophil: 70.7;intermediate monocyte: 38.0;memory B-cell: 32.4;myeloid DC: 31.0;naive B-cell: 34.4;non-classical monocyte: 59.5;plasmacytoid DC: 25.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 420.7;Karpas-707: 401.7;RPMI-8226: 238.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA017434			Supported	"Lipid droplets"		NA	NA		18000	"Cluster 46: Basophils - DNA binding"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 15: Hepatocytes - Hemostasis"	"Lipid droplets"		"HPA017434: AB_1853835"	"unprognostic (2.31e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.85e-3)"	"unprognostic (9.43e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.68e-3)"	"unprognostic (5.48e-2)"	"unprognostic (9.94e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.49e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (8.64e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.22e-2)"	143.6	86.7	59.6	35.2	71.9	15.2	54.6	66.1	53.6	43.9	67.7	67.7	62.8	42.9	29.7	39.1	89.1	79.6	28.1	48.4	66.9	144.9	440.5	60.1	49.4	79.6	79.1	90.7	115.6	48.1	17.3	25.4	69.0	28.5	63.3	15.5	60.7	41.6	64.6	26.1	60.5	62.0	61.9	53.6	87.4	19.3	68.8	29.7	243.2	53.2	50.2	50.7	35.4	68.0	1.5	0.2	8.4	61.3	420.7	115.0	130.0	1.1	8.9	1.0	1.5	4.7	5.2	69.7	5.2	4.6	1.0	8.2	6.1	6.9	0.3	7.1	15.4	17.0	11.1	43.2	88.0	4.5	33.7	118.0	0.9	0.9	0.5	2.1	26.9	2.5	10.1	401.7	3.9	0.0	3.3	19.8	44.6	1.6	0.0	3.7	0.5	238.2	20.3	79.1	21.9	37.3	1.5	41.0	1.0	11.5	114.4	4.1	17.1	1.0	1.2	4.8	0.5	18.7	3.7	30.3	7.8	8.4	0.5	95.7	35.7	70.7	2.4	38.0	1.5	32.4	1.0	2.2	31.0	34.4	0.3	1.6	2.1	10.3	59.5	25.3	9.4	17.7	59.6	71.9	66.1	53.6	48.4	66.9	79.6	79.1	69.0	61.9	68.8	68.0	73.5	201.9	125.6	96.0	47.2	8.7	53.4	41.8	30.1	2.9	37.4	26.7	14.1	240.2	72.5	71.7	0.0	76.7	19.9	159.0	43.0	11.9	2.2	64.2	48.1	43.5	67.9	131.8	4.1	37.3	29.6	83.0	75.4	28.4	32.9	16.5	140.7	986.4	37.3	8.4	5.1	64.4	30.5	308.8	23.1	10.6	216.6	73.2	12.4	45.0	59.8	114.2	29.9	43.2	10.6	3.5	59.3	149.0	65.7	30.2	134.6	145.6	263.1	5.3	52.6	57.3	42.2	1.6	1.4	28.3	9.2	38.3	12.9	52.7	74.8	46.2
MEX3C	"FLJ38871, RKHD2, RNF194"	ENSG00000176624	"Mex-3 RNA binding family member C"	Q5U5Q3	18	51174550-51218333	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 118.4"	"Group enriched"	"Detected in many"	6	"Early spermatids: 555.3;Late spermatids: 514.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040603	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA040603: AB_10805714"	"unprognostic (1.09e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.88e-2)"	"unprognostic (8.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (8.49e-5)"	"unprognostic (4.34e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.17e-1)"	17.6	13.5	9.1	17.0	9.9	49.4	17.4	12.5	12.3	16.4	9.0	13.5	12.6	17.6	10.4	15.5	14.0	18.6	10.8	10.5	9.8	11.9	14.0	13.7	23.6	10.5	10.0	23.5	14.7	17.9	1.7	16.1	10.6	11.5	14.1	14.8	9.6	12.2	9.7	9.2	13.4	20.1	10.7	22.3	13.3	118.4	9.3	40.9	16.1	17.1	26.6	20.2	2.4	11.6	23.8	19.6	71.2	26.8	27.7	36.8	49.6	32.8	37.4	18.9	22.2	33.6	17.3	53.0	13.2	44.2	30.4	44.6	27.9	42.7	31.0	43.0	12.5	10.7	19.1	29.0	44.5	75.2	22.3	28.2	46.5	26.9	76.4	47.0	41.8	36.0	11.3	95.7	40.0	18.0	63.8	24.3	32.1	13.3	15.0	61.7	36.5	46.7	31.1	9.5	34.8	39.1	30.4	12.4	117.7	54.3	13.5	34.3	43.2	46.3	30.9	15.1	28.1	64.5	12.4	87.2	32.9	31.3	110.7	9.7	1.2	1.5	2.3	1.0	2.0	1.9	2.4	2.4	1.4	1.1	0.9	2.3	0.4	3.4	0.7	1.1	2.0	1.4	9.1	9.9	12.5	12.3	10.5	9.8	10.5	10.0	10.6	10.7	9.3	11.6	25.2	19.2	5.0	6.8	18.6	38.2	10.3	12.4	11.4	12.6	25.9	23.2	14.5	14.3	11.2	3.7	20.9	5.2	56.6	9.0	5.9	12.1	555.3	18.9	22.7	30.0	6.7	7.4	8.0	8.5	7.0	18.2	6.1	34.9	12.7	79.3	10.4	7.6	7.7	11.8	7.9	9.4	12.2	10.9	20.5	514.0	16.1	13.8	19.6	5.6	8.2	10.0	34.0	14.1	13.3	16.5	3.9	15.1	20.6	15.4	9.1	9.3	6.4	14.8	0.0	30.2	17.7	14.4	14.2	18.1	45.9	4.2	24.2	14.9	11.5	19.6
MFAP3L	"KIAA0626, NYD-sp9"	ENSG00000198948	"Microfibril associated protein 3 like"	O75121	4	169986597-170033031	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.5;choroid plexus: 88.8"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1840.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 5.7;eosinophil: 1.8;neutrophil: 3.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 22.5;RT4: 38.0;SK-BR-3: 34.3;SuSa: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017986, HPA062306, HPA077490"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Cell Junctions"	"HPA017986: AB_1853842, HPA062306: , HPA077490: AB_2686842"	"unprognostic (8.04e-3)"	"unprognostic (8.67e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.96e-1)"	"unprognostic (7.58e-2)"	"prognostic favorable (1.42e-8)"	"unprognostic (6.59e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-4)"	"unprognostic (2.40e-3)"	2.0	3.4	32.9	0.9	61.0	3.2	12.0	49.1	34.4	13.0	88.8	2.7	0.6	5.1	38.9	0.8	4.2	2.6	1.7	35.2	40.1	30.0	37.4	2.7	0.9	46.3	58.3	0.6	1.5	6.5	4.1	3.0	48.5	2.8	2.0	25.0	2.1	12.8	5.1	24.5	1.0	4.1	38.8	1.5	1.3	46.3	54.9	0.6	2.8	2.3	0.5	10.1	1.8	65.5	0.4	5.7	3.0	3.1	2.6	1.3	1.1	6.2	0.9	2.8	2.5	1.9	0.4	0.0	0.2	9.6	5.4	2.9	10.9	1.4	1.2	0.0	4.7	0.0	6.7	2.4	1.4	0.0	22.5	1.8	3.4	0.3	1.0	1.5	0.3	3.5	0.9	1.1	5.8	3.4	1.0	0.8	3.1	0.7	4.7	0.0	1.8	0.0	8.1	38.0	2.5	5.5	5.1	34.3	11.6	19.1	1.9	0.0	0.2	2.9	11.2	5.5	11.9	0.6	0.0	0.0	7.5	1.2	11.4	5.7	0.1	1.8	0.6	0.7	0.3	0.0	0.5	0.1	0.2	0.0	0.2	0.1	3.5	0.0	0.0	0.5	0.1	4.6	32.9	61.0	49.1	34.4	35.2	40.1	46.3	58.3	48.5	38.8	54.9	65.5	1.0	0.0	5.6	112.6	0.6	2.5	0.4	0.1	2.8	12.2	8.5	9.7	3.4	0.0	0.2	36.8	20.9	3.1	0.2	0.6	5.9	0.5	417.5	8.5	1.1	2.0	2.4	11.2	36.3	1.1	1.0	0.6	0.0	12.4	4.5	11.0	3.3	49.1	1.2	3.3	25.0	0.3	0.0	1.0	0.7	1840.0	5.3	13.5	7.2	3.7	1.5	2.9	2.1	53.8	127.6	1.4	0.3	9.1	0.5	0.9	0.3	24.0	0.3	15.8	19.7	1.7	4.2	17.6	13.2	0.3	8.4	9.4	0.6	1.4	0.8	2.2
MFSD6	FLJ20160	ENSG00000151690	"Major facilitator superfamily domain containing 6"	Q6ZSS7	2	190408355-190509205	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 110.6;Respiratory ciliated cells: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 79.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022274	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA022274: AB_2142776"	"unprognostic (9.47e-2)"	"unprognostic (7.01e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.13e-3)"	"unprognostic (1.78e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.92e-1)"	"unprognostic (3.77e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (3.46e-2)"	"unprognostic (3.27e-1)"	"unprognostic (9.14e-2)"	"unprognostic (9.18e-2)"	20.8	40.3	29.1	12.7	31.7	7.6	21.3	37.0	40.3	21.8	0.0	31.8	19.8	10.5	32.8	40.6	19.5	15.8	17.9	35.5	27.6	10.8	2.3	26.4	14.8	45.8	48.3	4.1	16.8	64.5	35.4	8.6	52.4	23.0	28.9	14.9	30.8	32.3	6.4	29.8	24.6	14.4	28.6	20.9	32.1	7.9	38.3	19.9	38.9	14.2	20.6	22.9	21.5	51.2	25.1	15.2	0.5	5.2	10.6	13.6	20.4	12.7	25.3	8.4	10.5	5.6	31.1	39.1	5.8	26.4	15.6	41.5	7.4	22.1	9.5	79.7	11.6	20.9	14.2	2.9	4.2	8.3	6.4	2.1	39.3	12.5	8.1	27.1	3.0	30.5	5.4	42.2	2.2	9.7	38.8	1.8	3.4	27.1	16.1	8.6	1.2	34.1	15.9	45.1	47.5	12.2	17.9	41.7	24.9	1.7	13.6	9.5	12.6	1.4	2.9	16.6	19.7	19.3	8.6	13.8	13.5	16.9	6.9	4.6	1.1	0.4	1.4	0.3	1.5	1.6	1.8	2.0	1.5	0.7	0.9	1.9	0.1	2.1	0.5	0.7	3.5	0.8	29.1	31.7	37.0	40.3	35.5	27.6	45.8	48.3	52.4	28.6	38.3	51.2	48.6	32.1	20.0	7.2	7.6	6.4	11.5	11.7	10.8	9.7	16.8	9.8	21.4	5.7	30.3	23.9	8.4	0.2	14.9	25.1	0.0	13.2	46.8	27.9	5.9	26.7	35.4	7.8	55.7	20.5	0.2	8.9	31.1	22.5	24.0	8.7	16.1	0.8	4.0	28.6	47.9	42.7	12.2	4.0	8.0	13.7	5.6	12.3	8.8	11.2	9.7	6.8	3.1	41.7	110.6	24.9	20.8	5.3	14.9	13.5	13.6	1.0	88.5	7.9	0.0	16.7	7.2	1.0	1.4	28.8	18.3	0.0	17.0	18.6	21.1	22.7
MRPS31	IMOGN38	ENSG00000102738	"Mitochondrial ribosomal protein S31"	Q92665	13	40729128-40771190	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 412.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039083, HPA046344"	Uncertain		Supported	Nucleoli,Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	Nucleoli	"HPA039083: AB_2676340, HPA046344: AB_2679629"	"unprognostic (9.62e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.96e-3)"	"unprognostic (1.84e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.92e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.54e-2)"	11.7	14.8	9.1	14.0	9.6	14.4	16.9	10.5	12.5	10.7	9.1	15.8	14.8	16.6	13.8	14.7	15.1	10.2	24.0	8.7	9.5	19.6	28.8	11.5	23.5	9.6	9.7	19.2	10.4	14.3	7.5	12.6	10.1	11.3	15.6	13.7	13.7	11.0	27.5	13.5	15.3	15.2	9.3	13.2	15.0	17.9	9.2	17.8	19.6	26.2	24.9	13.2	10.0	11.8	19.0	17.9	29.5	19.5	19.8	23.2	29.6	23.7	16.5	30.7	20.5	46.0	27.4	110.5	22.6	13.7	41.3	48.8	37.4	29.6	36.2	29.4	28.1	45.9	12.7	29.7	16.5	47.4	21.3	18.8	21.4	25.3	21.2	20.3	23.8	31.2	31.3	11.3	19.8	21.5	37.2	46.2	28.7	64.2	20.9	35.0	24.3	20.8	40.3	21.6	12.9	18.7	16.5	27.0	39.3	35.1	23.7	41.5	14.6	9.5	16.0	22.3	24.9	8.7	17.4	55.7	19.5	33.3	18.6	30.9	15.3	24.9	29.4	16.4	28.8	36.8	32.5	29.9	19.5	33.5	38.5	34.3	11.3	28.7	18.4	19.1	36.5	17.8	9.1	9.6	10.5	12.5	8.7	9.5	9.6	9.7	10.1	9.3	9.2	11.8	27.5	48.1	19.2	24.5	35.0	9.7	33.0	106.0	33.0	35.1	22.4	31.6	73.7	28.6	77.2	22.0	18.8	62.7	31.2	18.7	109.5	43.0	74.9	55.5	38.6	32.5	23.4	29.8	28.8	33.6	41.5	27.9	18.8	38.1	23.4	32.8	37.9	76.9	26.0	42.1	37.8	37.4	91.6	17.0	12.5	14.2	35.4	18.1	19.6	26.2	39.8	32.3	32.0	36.7	45.1	30.0	19.5	30.5	52.1	15.8	32.4	93.4	412.5	51.2	46.0	39.5	38.1	72.6	49.8	30.2	13.4	68.0	37.7	45.2	35.5	25.5
MTERF1	MTERF	ENSG00000127989	"Mitochondrial transcription termination factor 1"	Q99551	7	91692008-91880702	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA044894, HPA069560"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA044894: AB_10966284, HPA069560: AB_2686154"	"unprognostic (5.57e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.46e-3)"	"unprognostic (7.62e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.22e-3)"	4.7	6.1	4.0	7.9	5.1	10.1	9.2	4.7	5.1	5.5	4.1	7.6	7.0	7.0	7.6	7.3	5.9	5.4	5.9	4.2	5.2	8.4	11.3	5.2	14.0	4.5	4.1	8.3	5.9	6.5	5.0	7.1	5.0	6.1	7.8	6.5	7.5	5.9	5.0	6.3	6.8	6.1	4.1	9.7	8.1	6.6	4.8	11.4	7.5	8.9	13.3	5.7	5.8	6.8	17.3	15.0	13.3	9.0	12.2	13.9	12.6	14.2	14.3	15.8	19.6	16.9	17.7	36.8	11.9	11.0	21.3	15.2	21.3	13.4	23.9	1.9	14.5	16.1	17.2	13.4	11.6	29.3	15.7	17.2	16.3	15.8	18.5	11.4	12.9	8.1	31.2	15.0	18.1	22.2	31.5	27.0	22.2	20.1	16.5	9.3	19.2	23.4	15.8	17.5	12.8	23.4	13.9	30.1	29.0	24.3	10.9	19.4	9.5	18.4	22.2	25.4	14.9	19.4	21.9	48.7	13.0	9.4	26.9	46.0	12.9	18.5	14.6	11.2	18.5	22.0	19.2	21.9	14.1	23.9	26.1	20.7	6.2	16.1	13.5	11.2	20.1	15.1	4.0	5.1	4.7	5.1	4.2	5.2	4.5	4.1	5.0	4.1	4.8	6.8	5.5	9.6	10.6	6.2	10.5	0.0	3.9	0.0	14.8	0.0	5.3	6.7	5.3	5.7	2.5	3.7	0.0	9.3	8.0	3.4	5.9	5.9	1.5	4.5	7.0	4.9	1.2	8.2	7.9	5.2	6.3	6.2	7.7	4.0	5.1	8.3	6.4	9.6	5.1	0.0	7.2	2.6	0.0	6.0	0.0	2.1	6.8	5.9	0.0	5.6	7.1	0.0	10.3	8.0	15.2	4.1	3.1	7.2	12.6	3.9	7.2	8.2	1.5	0.0	13.1	5.0	5.3	14.0	10.5	6.3	0.0	4.5	8.0	8.5	4.1	2.7
MTHFSD	FLJ12998	ENSG00000103248	"Methenyltetrahydrofolate synthetase domain containing"	Q2M296	16	86530178-86555235	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041333	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Vesicles"		"HPA041333: AB_10795006"	"unprognostic (4.09e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (9.88e-5)"	"unprognostic (2.66e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.29e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.77e-1)"	"unprognostic (5.85e-3)"	7.2	8.2	5.3	8.7	6.5	6.3	10.4	6.3	6.2	9.2	7.6	8.7	7.4	9.6	10.6	10.1	13.0	8.4	7.9	5.2	5.1	7.6	7.9	8.3	11.7	6.4	6.2	11.5	9.9	11.8	9.3	8.1	6.4	10.2	10.5	6.6	11.0	8.1	11.3	12.7	8.6	8.3	6.1	10.6	9.7	17.7	6.4	10.6	11.0	8.3	11.7	8.9	8.8	9.6	15.7	14.6	14.2	12.3	11.8	18.0	17.0	15.3	11.1	19.0	9.4	13.0	25.8	14.2	16.3	13.4	10.2	21.4	15.8	15.0	17.7	9.4	12.8	12.9	20.0	12.0	16.0	10.1	6.9	11.4	23.4	24.4	20.9	16.4	11.5	20.5	26.9	0.0	13.9	19.8	12.6	15.0	9.3	12.9	18.3	38.6	8.0	11.2	11.1	9.4	13.8	9.5	34.7	6.8	12.6	14.1	34.5	10.3	11.9	18.3	15.7	12.2	15.1	11.1	14.7	41.6	16.7	15.8	18.2	5.9	4.8	2.4	4.7	3.5	5.0	4.6	5.2	4.9	6.0	3.4	4.2	5.0	1.9	6.3	4.3	2.7	4.5	4.8	5.3	6.5	6.3	6.2	5.2	5.1	6.4	6.2	6.4	6.1	6.4	9.6	6.4	6.4	5.9	10.4	6.4	1.1	2.7	4.2	1.2	0.0	6.8	7.1	4.4	2.8	4.7	5.5	0.0	7.9	5.6	7.2	11.7	5.2	35.6	7.4	5.9	4.6	4.2	7.4	6.6	4.2	4.5	4.5	2.6	4.9	4.5	9.4	5.7	3.4	6.1	0.0	7.1	5.3	2.0	5.5	2.0	18.8	6.5	4.3	3.6	3.7	4.7	0.0	6.2	5.5	13.5	3.6	3.6	8.2	4.1	2.6	5.3	4.4	8.2	0.0	6.6	2.2	5.5	11.4	4.0	4.5	1.4	7.7	3.8	5.7	5.5	2.0
MTURN	"C7orf41, Ells1, FLJ25903"	ENSG00000180354	"Maturin, neural progenitor differentiation regulator homolog"	Q8N3F0	7	30134986-30162762	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	14	"brain: 1933.2;choroid plexus: 740.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 156.5"	"Cancer enhanced"	"Detected in all"		"glioma: 29.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 8.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 8.2;NK-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 52.9;HEL: 96.2;SCLC-21H: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029507	Enhanced		Approved	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"HPA029507: AB_10601149"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.70e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-3)"	"unprognostic (9.80e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.11e-3)"	"unprognostic (8.11e-3)"	"prognostic favorable (7.64e-13)"	"unprognostic (9.50e-2)"	"unprognostic (7.64e-2)"	"unprognostic (4.64e-1)"	"unprognostic (3.26e-1)"	88.4	10.8	1190.3	9.7	1373.7	23.3	41.6	1103.3	1933.2	25.7	740.3	35.8	5.4	19.4	95.3	19.5	21.1	10.4	25.0	946.3	1044.1	50.3	4.1	20.9	5.4	1359.2	1275.8	33.4	12.9	15.7	17.4	7.5	1312.7	19.2	10.0	41.0	35.2	23.8	36.6	23.2	13.8	17.0	1311.0	8.3	26.4	10.9	1260.6	7.5	14.7	59.8	5.4	32.1	20.0	1483.6	12.5	2.1	7.1	7.6	52.9	35.9	6.4	6.0	7.0	2.0	2.8	1.0	5.0	0.7	4.8	13.3	11.0	2.4	16.4	23.6	6.4	5.4	13.2	96.2	16.1	6.7	4.1	4.8	30.8	17.9	10.8	6.2	10.9	8.6	3.2	13.1	6.4	5.0	13.8	4.8	5.6	2.3	4.9	11.6	7.5	0.5	16.3	21.4	24.1	5.1	68.7	18.2	3.8	19.1	19.4	6.6	13.5	7.1	15.5	7.8	8.5	16.6	8.5	8.3	12.7	1.1	10.4	10.3	4.0	8.2	0.3	3.6	0.3	0.2	0.1	0.5	0.2	0.1	0.4	0.3	0.1	0.3	2.2	2.1	0.0	1.0	0.7	1.4	1190.3	1373.7	1103.3	1933.2	946.3	1044.1	1359.2	1275.8	1312.7	1311.0	1260.6	1483.6	38.9	16.0	20.0	18.6	5.6	37.5	17.8	6.6	13.1	0.0	48.3	40.8	27.6	17.2	10.2	44.1	0.0	2.6	32.1	3.2	156.5	8.3	14.1	46.6	16.9	18.9	54.1	35.1	55.9	8.6	7.3	24.6	7.7	52.6	6.3	16.6	26.0	5.0	5.3	0.0	34.7	9.1	0.0	23.4	16.8	32.5	17.1	29.3	55.2	37.5	12.1	0.0	6.2	16.6	77.1	10.4	5.9	12.4	4.9	26.6	0.4	11.2	26.6	0.0	6.6	17.8	30.2	2.0	7.3	11.4	36.8	2.2	7.4	5.9	6.0	23.0
MYB	c-myb	ENSG00000118513	"MYB proto-oncogene, transcription factor"	P10242	6	135181308-135219173	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 35.2;breast: 20.1;intestine: 26.5;lymphoid tissue: 66.1"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 47.8;Erythroid cells: 83.2;granulocytes: 26.0;Intestinal goblet cells: 32.7;Ionocytes: 26.4;Respiratory ciliated cells: 37.2;Undifferentiated cells: 52.0"	"Group enriched"	"Detected in many"	5	"breast cancer: 17.7;colorectal cancer: 16.4;stomach cancer: 5.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basophil: 4.6;eosinophil: 5.4;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 219.8;MOLT-4: 403.1;NB-4: 208.5;REH: 244.9;THP-1: 343.8;U-937: 186.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB017704, HPA071605"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB017704: , HPA071605: "	"unprognostic (1.69e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-2)"	"prognostic favorable (9.65e-4)"	"unprognostic (2.41e-11)"	"prognostic favorable (9.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.40e-2)"	0.3	0.5	1.6	5.3	1.7	35.2	20.1	0.0	0.7	1.6	0.4	25.3	10.9	1.0	0.1	3.0	8.4	0.9	0.1	0.3	0.2	0.1	0.4	2.0	6.3	0.9	1.0	0.0	0.3	3.6	0.0	0.4	0.6	1.4	26.5	0.3	0.6	0.9	0.1	3.0	9.4	1.4	0.2	1.2	2.0	0.7	0.3	66.1	0.1	0.0	7.0	1.1	1.3	0.1	1.8	0.3	1.9	3.0	0.0	0.1	0.3	1.0	0.6	1.1	1.1	0.3	1.4	10.9	0.4	0.3	0.4	0.9	5.6	0.0	0.7	18.0	2.5	138.8	1.0	0.5	0.1	219.8	105.1	0.0	0.1	0.6	0.0	0.5	0.3	133.4	114.6	20.1	1.1	11.6	403.1	208.5	1.5	19.2	1.7	244.9	5.9	33.2	0.3	1.5	10.5	6.9	0.5	10.4	0.6	0.5	7.9	343.8	0.4	0.3	1.6	7.9	2.4	27.7	7.7	66.0	0.1	186.1	2.3	4.6	0.7	5.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.5	0.4	0.2	1.6	1.7	0.0	0.7	0.3	0.2	0.9	1.0	0.6	0.2	0.3	0.1	0.2	0.0	1.3	0.0	2.3	2.7	1.3	1.3	0.6	0.9	47.8	12.6	0.4	2.8	7.1	0.0	0.0	1.4	9.1	18.1	0.0	0.0	0.1	24.3	0.3	0.3	17.6	83.2	0.6	0.8	0.4	0.5	4.6	2.2	26.0	0.4	0.0	0.0	1.1	0.0	2.7	32.7	26.4	1.2	1.7	0.2	0.0	2.1	8.8	0.0	2.8	0.9	0.0	0.0	0.2	0.1	10.2	0.0	4.6	2.1	2.3	0.0	37.2	0.0	0.0	0.6	0.9	0.0	1.8	10.2	7.0	0.3	3.6	0.1	52.0	2.2
NAALADL1		ENSG00000168060	"N-acetylated alpha-linked acidic dipeptidase like 1"	Q9UQQ1	11	65044818-65058553	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"intestine: 99.3"	"Cell type enriched"	"Detected in many"	11	"Proximal enterocytes: 588.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 182.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.8;fHDF/TERT166: 7.8;HHSteC: 20.2;HSkMC: 13.5;SCLC-21H: 10.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA047123	Enhanced		Uncertain	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 9: Intestine - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"HPA047123: AB_2679942"	"unprognostic (2.98e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.75e-4)"	"unprognostic (2.10e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.80e-2)"	13.9	3.2	4.4	6.6	4.1	21.1	12.1	4.7	6.0	23.5	7.0	18.4	19.8	18.8	4.6	7.3	15.2	9.4	10.5	3.9	4.1	7.4	2.6	10.9	10.9	4.7	4.3	16.6	2.3	2.0	6.0	2.3	4.6	13.8	7.1	1.9	4.9	11.5	2.7	5.4	99.3	10.5	4.6	15.3	8.2	8.7	4.4	3.4	5.7	4.1	6.9	12.7	14.5	4.0	0.0	0.0	0.1	0.2	0.5	5.8	1.0	2.3	0.0	2.8	1.3	0.0	0.0	0.1	0.0	7.8	0.0	0.0	0.0	0.2	0.1	0.9	0.4	0.0	0.2	3.5	20.2	0.0	0.0	13.5	0.0	2.7	0.0	0.1	3.6	0.1	0.0	0.3	0.0	0.2	0.2	0.7	0.0	0.1	0.1	0.1	0.0	1.0	0.2	0.0	10.5	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.8	0.0	0.1	0.1	182.0	21.2	35.9	29.6	14.6	15.8	25.7	23.8	14.8	16.3	29.8	27.0	15.0	3.7	80.2	8.8	0.7	45.2	24.6	4.4	4.1	4.7	6.0	3.9	4.1	4.7	4.3	4.6	4.6	4.4	4.0	19.1	0.0	0.0	0.0	8.0	3.6	3.4	5.6	6.2	2.0	0.8	9.1	1.8	1.5	0.4	0.0	0.0	0.2	9.8	31.3	3.9	0.1	0.8	0.4	5.8	11.1	1.2	2.5	0.3	0.8	0.3	11.4	1.1	0.2	19.7	4.3	16.8	0.4	2.8	10.1	0.4	21.0	2.0	5.6	5.7	2.6	11.8	5.2	16.0	1.0	17.3	12.2	41.2	1.0	0.1	0.2	50.0	18.0	1.1	0.5	588.6	0.5	0.5	0.9	0.0	8.3	11.1	1.6	3.5	1.3	3.3	0.4	11.1	3.9	11.8	0.4
NAP1L4	NAP2	ENSG00000205531	"Nucleosome assembly protein 1 like 4"	Q99733	11	2944431-2992377	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011567	Approved		Supported	Nucleoplasm		NA	NA		3100000	"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB011567: AB_776638"	"unprognostic (1.61e-1)"	"prognostic favorable (9.77e-4)"	"unprognostic (8.99e-2)"	"unprognostic (9.64e-3)"	"unprognostic (2.96e-3)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (1.68e-7)"	"unprognostic (1.80e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.54e-1)"	39.6	43.5	44.3	36.1	59.2	50.3	41.3	53.0	178.1	46.7	70.3	60.3	20.1	45.4	17.3	79.6	41.2	32.5	111.4	41.3	52.1	63.7	56.2	40.5	65.7	57.2	53.8	42.9	38.0	63.5	61.4	36.8	60.2	51.9	34.2	38.6	66.4	32.1	146.1	49.0	53.8	39.1	52.2	59.0	56.6	87.4	56.4	78.8	44.6	110.7	75.8	61.9	52.1	72.2	82.8	59.9	81.7	65.7	83.9	92.4	37.7	159.8	104.1	145.4	132.5	129.7	208.4	149.5	95.3	98.0	15.1	140.0	21.9	136.3	166.8	159.2	57.5	106.7	151.4	168.2	57.7	93.0	110.5	77.8	65.1	78.6	59.1	12.0	88.9	77.6	139.3	150.7	128.0	74.5	206.4	4.2	199.8	98.9	75.2	101.4	98.1	117.0	12.2	131.7	121.4	104.3	80.5	118.1	78.3	82.5	7.3	7.4	67.8	112.5	104.4	152.4	13.8	79.3	136.5	201.5	8.4	66.0	75.3	67.5	22.9	32.6	42.3	24.0	39.9	24.7	51.9	53.0	27.2	28.4	45.7	52.1	14.5	57.6	30.4	25.0	70.5	48.0	44.3	59.2	53.0	178.1	41.3	52.1	57.2	53.8	60.2	52.2	56.4	72.2	53.6	44.8	49.8	56.2	64.3	70.1	67.4	76.9	83.1	80.4	54.6	48.3	200.4	42.9	69.0	75.4	45.9	103.8	99.4	37.2	97.8	78.7	97.0	107.7	65.9	55.4	45.4	168.7	36.9	50.4	109.2	56.6	54.0	91.1	74.6	100.6	43.5	50.0	47.3	65.6	56.6	41.4	67.1	30.8	44.7	142.6	48.1	49.7	35.6	38.4	65.3	67.5	95.8	60.8	125.3	74.1	26.8	50.0	100.7	76.1	39.8	76.9	92.6	68.1	46.0	58.8	64.7	166.1	129.0	102.3	66.9	91.3	123.8	79.7	55.1	83.7
NAPB	"SNAP-BETA, SNAPB"	ENSG00000125814	"NSF attachment protein beta"	Q9H115	20	23374519-23421519	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"brain: 126.9;retina: 154.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 203.4;Cone photoreceptor cells: 66.7;Excitatory neurons: 68.8;Horizontal cells: 67.3;Late spermatids: 75.6;Rod photoreceptor cells: 84.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 31.8;U-937: 32.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037225, CAB037227, HPA046149, HPA050196"	Supported		Uncertain	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Cytosol		"CAB037225: AB_477555, CAB037227: AB_477554, HPA046149: AB_2679557, HPA050196: AB_2681048"	"unprognostic (3.89e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.54e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.71e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.46e-3)"	"unprognostic (7.52e-3)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.60e-2)"	6.7	24.3	89.3	5.2	98.3	10.6	6.5	53.4	126.9	10.7	8.1	10.0	5.0	7.4	8.8	7.3	9.4	4.8	7.1	102.4	92.6	8.3	7.3	8.3	5.8	90.7	42.4	13.3	6.6	7.8	18.5	8.7	90.5	8.0	6.7	154.1	6.9	5.9	6.4	7.7	8.0	6.0	38.0	8.7	7.1	8.9	48.3	6.1	9.0	3.1	4.4	8.2	9.5	84.1	5.8	3.7	6.0	6.2	6.6	6.1	8.5	7.4	4.0	5.9	5.1	4.4	5.1	8.6	8.6	4.4	4.3	7.3	7.8	5.0	7.1	2.8	5.8	9.4	5.4	10.5	7.8	7.0	5.4	6.1	6.5	4.2	5.2	5.4	4.4	8.6	8.0	11.0	9.4	4.0	7.2	6.4	2.6	4.7	6.7	4.8	4.9	6.5	7.7	6.2	31.8	10.1	4.3	4.1	7.1	8.7	4.2	4.4	5.2	5.6	4.1	6.2	5.4	8.0	6.7	3.8	2.9	32.9	5.7	2.5	0.5	0.0	1.9	0.5	0.6	0.6	0.8	0.9	0.8	1.2	0.7	1.2	0.6	0.6	0.9	0.6	1.0	0.9	89.3	98.3	53.4	126.9	102.4	92.6	90.7	42.4	90.5	38.0	48.3	84.1	4.1	12.8	6.5	30.0	6.6	8.7	5.6	4.1	6.2	203.4	4.2	2.9	6.0	7.2	6.8	14.7	66.7	7.0	5.9	3.6	0.0	3.3	39.9	4.4	5.8	7.5	10.2	2.5	68.8	1.4	5.4	7.4	3.1	3.8	11.4	14.3	9.7	5.5	5.2	67.3	63.8	2.7	14.2	7.2	10.2	75.6	9.0	4.0	10.6	24.4	7.9	20.5	15.5	38.2	37.2	2.9	1.8	9.1	4.7	6.4	9.2	3.6	6.1	84.8	6.6	5.4	5.5	13.4	11.2	3.9	8.4	6.2	6.5	9.3	4.2	4.6
NAV1	"DKFZp781D0314, FLJ12560, FLJ14203, KIAA1151, MGC14961, POMFIL3, steerin-1"	ENSG00000134369	"Neuron navigator 1"	Q8NEY1	1	201622885-201826969	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 169.1;Inhibitory neurons: 161.7;Oligodendrocyte precursor cells: 713.8;Oligodendrocytes: 224.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.4;myeloid DC: 2.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.1;granulocytes: 3.4"	"Cell line enhanced"	"Detected in many"		"TIME: 187.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012302, HPA018127, HPA027887"	Enhanced		Approved	Microtubules		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	Microtubules		"CAB012302: AB_776716, HPA018127: AB_1854317, HPA027887: AB_10601040"	"unprognostic (2.14e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.45e-1)"	"unprognostic (9.10e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.68e-1)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (3.10e-6)"	"unprognostic (3.45e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	19.6	2.7	17.4	8.2	18.3	1.6	15.2	8.0	17.7	11.7	0.0	12.3	3.7	10.1	4.3	8.6	7.2	7.5	26.6	17.5	20.3	4.6	1.9	11.1	4.1	24.6	17.9	3.7	4.4	5.2	5.2	11.8	15.1	7.5	5.4	5.4	7.8	6.7	4.8	7.7	6.2	10.3	9.9	3.6	5.3	4.4	21.8	2.8	9.4	6.7	3.7	14.9	12.6	32.5	1.6	2.9	29.0	3.8	84.3	69.5	51.7	44.6	43.0	35.5	30.9	0.0	15.7	0.6	0.7	61.4	19.4	21.5	22.0	14.9	28.4	2.5	3.2	1.4	5.6	0.0	22.5	0.2	19.1	30.6	5.4	62.4	36.0	94.9	80.7	1.8	0.8	2.6	29.8	0.4	0.0	0.1	42.4	0.7	1.7	3.9	65.0	9.3	4.8	4.3	21.9	4.5	11.1	47.6	14.5	19.2	0.4	1.2	187.8	54.5	11.1	54.7	39.4	8.1	2.3	0.2	59.2	5.9	47.5	3.4	0.5	0.1	0.2	0.3	0.1	0.3	0.2	0.0	2.1	0.3	0.2	0.1	0.0	0.1	0.3	0.5	0.0	0.3	17.4	18.3	8.0	17.7	17.5	20.3	24.6	17.9	15.1	9.9	21.8	32.5	77.4	3.2	1.5	169.1	3.1	11.0	2.2	5.9	8.0	34.6	4.8	4.3	29.2	1.5	4.8	12.9	0.0	14.9	0.9	4.7	0.0	13.0	3.6	1.6	6.4	39.3	52.8	1.7	98.2	8.3	54.1	45.8	8.2	4.4	17.7	54.5	21.0	0.7	14.5	25.2	161.7	3.4	6.1	18.3	15.8	3.8	10.8	15.1	23.2	69.3	60.6	11.8	1.0	713.8	224.6	21.7	4.2	0.7	4.9	2.3	0.9	0.6	3.5	4.0	6.6	119.3	18.8	0.6	2.6	16.9	7.0	15.7	2.0	6.6	5.0	3.2
NAV2	"FLJ10633, FLJ11030, FLJ23707, HELAD1, KIAA1419, POMFIL2, RAINB1"	ENSG00000166833	"Neuron navigator 2"	Q8IVL1	11	19350724-20121601	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 55.7;heart muscle: 61.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 466.8;Excitatory neurons: 333.8;Inhibitory neurons: 525.7;Oligodendrocyte precursor cells: 863.6;Oligodendrocytes: 354.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 89.9;SH-SY5Y: 81.9;TIME: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011755, HPA011891"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA011755: AB_1854319, HPA011891: AB_1854318"	"unprognostic (7.71e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.76e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.28e-2)"	7.4	1.6	11.6	3.3	18.8	1.8	12.0	16.1	10.8	6.3	3.5	16.2	4.4	7.6	11.1	6.5	4.4	1.8	61.2	9.6	13.8	9.5	14.9	9.5	1.8	55.7	43.7	3.1	8.8	6.0	5.1	14.8	36.5	6.2	4.9	8.7	15.0	9.3	2.6	6.7	4.1	8.5	39.3	1.4	7.2	0.9	27.7	2.5	16.9	9.4	3.9	5.7	7.4	35.6	16.2	4.7	10.2	1.4	33.7	21.6	11.0	13.3	22.6	17.2	13.0	18.2	2.1	0.1	0.6	20.1	28.0	1.9	0.6	10.4	20.1	3.8	1.2	0.4	25.1	20.9	6.1	0.0	0.5	14.1	26.5	8.3	89.9	12.7	23.2	0.1	1.9	8.0	50.2	17.2	0.0	0.1	26.4	5.3	13.1	0.1	47.1	2.6	14.8	4.6	18.2	81.9	10.3	7.9	14.8	54.2	0.3	0.0	65.2	39.6	6.3	47.7	12.7	2.7	2.0	0.1	13.5	0.8	12.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.6	18.8	16.1	10.8	9.6	13.8	55.7	43.7	36.5	39.3	27.7	35.6	5.5	64.1	22.6	466.8	1.4	4.2	23.6	13.8	14.2	4.6	33.6	31.0	14.3	8.6	18.3	20.2	0.0	31.8	0.8	2.8	13.7	20.3	2.6	34.4	4.6	14.5	10.8	0.0	333.8	21.3	23.3	16.5	11.2	62.1	1.3	152.4	11.7	47.0	10.7	26.9	525.7	10.1	18.3	1.4	5.0	7.9	0.9	3.2	16.0	194.9	1.0	28.9	0.0	863.6	354.4	37.5	0.8	4.1	0.4	33.7	1.8	0.4	24.0	2.4	0.0	30.7	17.8	1.5	0.6	23.1	3.7	14.6	1.7	54.7	9.2	17.8
NCAPH2	"384D8-2, CAP-H2, hCAP-H2"	ENSG00000025770	"Non-SMC condensin II complex subunit H2"	Q6IBW4	22	50508224-50524780	"Predicted intracellular proteins"	"DNA condensation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067932, HPA069056"	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge"	"HPA067932: AB_2685926, HPA069056: AB_2686076"	"unprognostic (2.01e-1)"	"prognostic favorable (2.24e-8)"	"unprognostic (3.65e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (2.92e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.26e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.00e-1)"	25.7	21.9	32.9	24.5	33.6	78.8	26.9	32.7	39.2	31.8	25.4	29.3	17.7	29.8	12.4	30.3	30.0	13.0	36.7	32.0	30.9	26.6	27.6	28.2	27.6	32.6	29.0	37.6	40.7	16.7	38.6	17.1	28.7	28.4	11.7	15.5	25.7	16.6	30.7	32.6	28.4	14.7	27.5	33.2	30.2	52.3	28.5	29.6	28.9	19.3	20.2	25.9	26.9	33.5	60.7	32.1	53.8	57.1	15.8	18.4	71.6	45.8	31.6	81.8	89.5	67.2	41.4	68.8	25.5	32.9	45.5	47.1	49.0	44.2	23.5	40.3	82.8	39.8	86.7	63.6	19.1	90.3	69.5	16.1	27.6	64.4	22.2	12.2	26.2	59.4	51.5	132.5	33.4	83.9	61.7	109.9	39.3	34.9	37.9	103.3	71.0	77.2	23.8	40.6	35.6	47.5	36.7	55.4	44.3	16.5	37.5	86.7	17.6	64.2	80.5	54.4	72.3	67.7	45.8	110.1	48.8	45.7	62.3	11.9	9.8	18.2	18.7	11.6	22.9	16.0	19.4	19.1	8.0	14.2	19.9	17.3	11.4	13.9	14.4	11.8	19.3	15.5	32.9	33.6	32.7	39.2	32.0	30.9	32.6	29.0	28.7	27.5	28.5	33.5	10.1	22.4	24.5	12.1	15.9	18.9	23.8	17.5	6.2	18.3	11.5	12.6	19.6	15.7	10.4	9.2	4.2	36.3	15.5	24.6	15.6	16.6	36.8	8.5	7.5	12.9	13.1	31.5	8.6	23.5	55.1	13.8	14.8	14.5	17.1	16.3	8.9	10.6	19.3	8.4	8.8	18.8	6.1	7.9	16.3	111.5	17.4	9.2	12.4	3.7	16.2	14.7	18.6	3.0	8.2	17.3	13.5	17.3	26.6	15.2	18.4	9.5	5.9	16.1	19.7	17.8	16.9	36.2	39.7	10.9	18.5	31.5	15.9	7.6	22.6	18.2
NFRKB	"DKFZp547B2013, INO80G"	ENSG00000170322	"Nuclear factor related to kappaB binding protein"	Q6P4R8	11	129863636-129895590	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007082, HPA007128"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA007082: AB_1079481, HPA007128: AB_1079482"	"unprognostic (1.22e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.41e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (6.36e-3)"	"unprognostic (1.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.31e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.15e-2)"	"unprognostic (6.57e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.93e-2)"	9.8	9.0	7.2	10.8	9.9	22.7	11.0	9.7	7.3	15.0	9.1	11.8	13.1	15.6	17.5	13.2	17.9	9.9	7.5	8.3	6.5	10.6	11.8	10.8	14.5	4.9	5.5	20.6	13.9	10.5	11.7	13.1	5.5	12.4	10.1	9.8	14.3	13.3	15.4	21.9	12.4	13.5	4.5	11.2	11.2	20.3	7.2	15.0	20.0	9.7	13.4	12.6	13.8	6.7	17.9	16.8	37.4	20.3	15.6	15.4	23.5	12.2	11.0	14.2	13.9	52.6	30.1	42.6	32.5	9.4	20.8	44.8	36.5	23.8	13.2	16.9	31.9	84.2	32.8	22.2	11.4	21.7	27.3	9.9	25.9	23.3	24.3	16.3	24.9	28.1	49.9	31.5	14.4	16.2	18.6	37.1	19.1	26.2	39.1	27.2	16.3	19.6	17.7	55.6	19.0	20.0	27.4	26.7	7.3	27.5	62.3	19.9	19.7	21.1	20.6	15.6	15.4	10.0	13.3	39.0	8.8	41.9	18.5	6.6	5.1	6.3	6.0	5.8	6.3	3.3	6.1	5.1	5.1	3.9	5.0	4.2	6.0	2.4	5.2	4.5	4.4	4.5	7.2	9.9	9.7	7.3	8.3	6.5	4.9	5.5	5.5	4.5	7.2	6.7	6.2	9.6	15.0	17.0	10.0	29.3	16.8	17.5	18.8	10.2	12.1	10.0	7.6	20.0	17.0	7.3	10.4	19.2	7.8	9.5	7.9	11.9	14.8	12.9	14.4	9.5	8.5	9.4	13.1	10.0	15.6	9.7	6.1	17.8	10.8	14.1	8.9	10.9	10.4	8.4	10.7	9.7	8.2	7.7	6.2	7.1	14.6	8.4	14.2	9.4	12.4	9.7	12.3	12.1	7.7	10.9	8.0	10.5	10.5	15.4	15.6	8.1	12.9	11.1	32.9	10.8	14.2	43.0	49.0	10.7	35.2	23.3	13.1	9.4	12.2	17.9
NKRF	"ITBA4, NRF"	ENSG00000186416	"NFKB repressing factor"	O15226	X	119588337-119606443	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001476			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 41: Macrophages - Immune response"	Nucleoli	Nucleoplasm	"HPA001476: AB_1079488"	"unprognostic (6.12e-3)"	"unprognostic (7.58e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.74e-3)"	"prognostic unfavorable (4.92e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.56e-3)"	"unprognostic (2.62e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.08e-3)"	4.4	6.5	11.3	5.7	11.8	6.9	5.4	9.6	16.9	4.2	7.3	3.7	4.1	3.9	4.0	5.6	4.4	3.5	4.1	11.5	13.1	6.1	6.0	4.1	8.7	11.2	10.1	6.1	3.8	5.2	5.5	6.5	11.5	4.1	3.5	5.3	4.0	3.5	5.5	6.2	4.3	4.0	9.4	5.9	4.1	1.9	11.4	9.5	4.6	4.6	8.4	6.3	4.3	10.6	17.9	18.3	10.4	11.3	8.7	8.5	15.5	10.7	8.5	14.1	15.0	19.8	15.3	31.8	18.4	9.2	12.1	20.4	43.8	16.4	17.2	16.4	28.9	16.8	20.3	12.9	8.3	33.5	11.8	9.5	13.2	16.3	19.2	9.6	14.1	15.3	18.5	12.6	12.5	27.6	20.8	25.2	23.1	26.2	19.9	16.5	15.2	32.7	18.8	12.7	16.7	14.2	15.2	23.1	16.5	10.6	9.7	20.0	12.2	8.7	9.5	19.3	27.1	10.5	14.1	32.9	9.3	36.3	10.1	1.1	0.5	0.7	1.0	0.8	1.1	1.3	1.2	1.3	0.6	1.2	1.9	1.6	0.1	0.5	0.3	0.9	1.8	0.8	11.3	11.8	9.6	16.9	11.5	13.1	11.2	10.1	11.5	9.4	11.4	10.6	5.4	6.4	8.9	5.9	11.1	19.4	10.4	4.1	6.8	13.3	6.1	6.9	4.5	8.6	3.1	5.5	27.1	14.4	8.5	3.0	1.9	4.2	0.1	6.1	7.4	7.0	10.7	2.5	20.6	3.6	14.3	6.1	3.1	8.1	14.7	6.6	3.3	3.9	6.4	8.4	20.6	4.4	10.2	7.5	33.1	0.6	7.8	11.6	5.4	7.5	5.6	4.4	1.0	9.0	9.2	4.1	1.9	6.8	5.2	10.7	3.6	4.4	3.9	7.9	0.0	10.1	7.2	1.7	1.9	6.9	25.7	14.9	15.7	6.9	7.4	9.5
NLK		ENSG00000087095	"Nemo like kinase"	Q9UBE8	17	28041737-28196381	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 78.6"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 154.3;Early spermatids: 261.1;Excitatory neurons: 315.5;Late spermatids: 355.3;Oligodendrocytes: 366.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	45	"basophil: 29.9"	"Lineage enriched"	"Detected in single"	45	"granulocytes: 29.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018192, HPA056511"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA018192: AB_1854525, HPA056511: AB_2683160"	"unprognostic (7.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.54e-2)"	"unprognostic (5.64e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.59e-3)"	"unprognostic (2.72e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.92e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.57e-2)"	8.2	36.6	16.7	8.6	27.6	9.9	9.4	5.7	41.9	7.9	1.0	9.0	10.3	7.0	11.2	5.5	6.4	8.7	11.5	28.5	9.2	16.6	11.1	9.1	16.4	11.9	10.4	5.0	14.3	28.2	11.1	12.2	8.4	8.2	9.2	78.6	7.4	10.8	6.6	5.9	10.2	5.9	6.5	12.2	8.9	22.0	12.2	13.2	16.8	6.7	15.4	10.1	4.5	30.1	9.5	11.6	28.4	9.7	6.1	7.6	12.1	9.6	10.9	16.9	13.1	59.4	9.1	13.6	13.8	8.4	20.2	8.6	19.6	18.7	19.3	29.7	12.2	52.2	11.2	9.9	10.3	11.6	51.0	9.6	11.9	10.4	12.5	16.0	20.4	36.3	20.1	15.9	16.4	11.6	28.8	13.4	10.4	20.1	5.5	23.8	17.2	10.0	32.0	12.2	19.6	7.2	14.4	14.4	62.4	32.2	22.0	18.2	19.2	11.7	14.1	9.0	19.5	17.6	17.9	13.1	11.6	12.6	13.0	29.9	0.3	0.3	0.5	0.4	0.2	0.6	0.5	0.6	0.3	0.3	0.3	0.6	0.2	0.2	0.5	0.5	0.5	0.3	16.7	27.6	5.7	41.9	28.5	9.2	11.9	10.4	8.4	6.5	12.2	30.1	17.8	22.4	6.0	57.8	7.8	5.4	3.8	3.0	5.7	94.4	8.7	5.0	27.4	5.7	5.3	33.1	154.3	3.7	4.3	11.4	1.9	3.9	261.1	8.9	5.8	15.0	28.2	11.8	315.5	6.4	3.5	4.8	5.1	11.9	24.1	17.6	9.3	9.4	8.8	37.0	98.2	10.0	2.0	16.9	6.0	355.3	5.6	11.3	16.0	103.0	7.9	11.2	6.2	104.5	366.6	5.7	8.1	2.6	6.4	5.4	5.1	8.4	9.5	89.9	13.1	5.0	6.9	37.1	11.8	4.1	4.8	6.4	5.5	6.7	10.3	6.6
NPAT	"E14, p220"	ENSG00000149308	"Nuclear protein, coactivator of histone transcription"	Q14207	11	108157215-108222638	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 51.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045908, HPA066370"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"		"HPA045908: AB_2679493, HPA066370: AB_2685665"	"unprognostic (6.93e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.60e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.38e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.04e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.93e-1)"	4.6	4.2	1.6	8.1	2.1	4.5	6.9	7.4	2.8	6.4	3.9	5.4	4.1	6.7	5.9	4.6	4.6	4.7	4.3	1.4	2.4	5.6	5.6	5.4	14.9	2.6	3.0	7.6	3.1	6.8	3.2	6.6	2.4	5.6	6.2	6.6	4.4	4.4	3.1	5.2	4.9	5.1	2.2	9.9	5.9	7.0	2.3	12.0	8.3	5.3	13.3	7.0	3.8	3.0	7.9	6.3	9.7	12.1	11.7	8.5	7.9	11.6	14.6	10.0	14.9	13.0	16.8	13.5	15.2	7.3	11.2	14.6	13.4	11.7	17.8	12.2	5.3	22.5	6.8	6.7	5.0	17.0	14.3	8.1	6.7	17.6	11.2	7.8	14.3	15.5	21.2	6.5	14.1	3.9	21.0	9.1	8.0	12.6	8.7	14.3	13.6	18.5	6.4	11.3	10.3	9.5	14.9	8.8	11.3	10.1	10.0	8.3	11.8	17.3	9.3	10.3	10.5	4.5	6.1	51.9	4.3	12.4	13.7	6.8	1.6	2.9	4.9	2.6	5.5	4.1	5.7	6.3	1.8	4.3	8.9	7.5	1.9	5.3	2.9	1.5	4.6	3.2	1.6	2.1	7.4	2.8	1.4	2.4	2.6	3.0	2.4	2.2	2.3	3.0	23.1	19.2	13.2	24.2	40.8	16.3	16.4	10.5	27.3	16.5	12.0	7.6	15.2	4.3	13.2	12.9	29.2	10.3	32.8	5.6	1.9	8.4	4.9	11.1	15.0	21.1	10.3	29.5	25.5	6.8	8.2	15.9	12.2	14.2	19.6	16.7	22.9	9.1	7.4	10.1	32.2	7.9	8.2	13.0	12.8	3.2	15.8	13.8	8.8	19.7	14.5	11.8	27.8	19.6	24.3	6.8	6.5	17.0	37.8	14.1	7.1	5.6	10.9	16.9	6.6	19.8	13.1	26.2	32.5	14.0	13.2	14.1	35.3	14.9	8.7	15.9
NPIPB3	"KIAA0220, NPIPL3"	ENSG00000169246	"Nuclear pore complex interacting protein family member B3"	Q92617	16	21402237-21448567	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 2.8;Gastric mucus-secreting cells: 2.0;Skeletal myocytes: 3.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 161.9"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (2.68e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.66e-5)"	"unprognostic (1.50e-7)"	"unprognostic (1.30e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.94e-2)"	"unprognostic (9.00e-4)"	53.3	47.1	141.3	37.2	137.3	149.4	47.7	127.7	184.3	71.8	111.9	72.4	28.5	38.3	51.8	44.4	58.6	28.5	60.8	118.8	134.1	71.1	65.1	66.3	77.0	133.3	147.3	49.6	47.2	13.1	70.5	21.9	127.9	74.9	34.9	51.7	43.5	22.6	87.9	140.9	76.7	28.1	90.1	99.7	51.3	46.6	134.8	53.6	75.6	24.1	34.8	48.0	52.5	122.8	37.9	37.2	24.5	40.1	30.0	18.1	73.5	25.7	9.6	13.3	14.1	57.5	44.0	56.4	24.1	38.9	17.7	47.0	13.6	41.4	12.5	30.8	20.6	26.6	58.7	161.9	25.6	48.8	46.0	8.8	16.8	35.3	44.3	20.4	19.4	52.5	49.7	77.3	20.4	69.7	51.8	114.0	41.0	22.5	42.5	75.7	25.4	35.0	28.8	23.2	27.8	21.1	15.7	32.5	25.9	47.2	35.7	20.7	29.5	62.9	36.4	6.4	40.4	37.8	30.8	49.2	25.0	38.3	34.9	3.5	2.3	1.5	2.6	1.4	1.2	2.2	1.5	1.6	1.2	2.4	2.0	1.3	2.1	2.0	1.1	4.8	0.9	0.1	141.3	137.3	127.7	184.3	118.8	134.1	133.3	147.3	127.9	90.1	134.8	122.8	0.1	0.0	0.0	1.6	0.5	2.8	0.4	0.2	0.6	0.0	0.1	0.0	1.1	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.7	0.0	0.0	1.7	0.0	0.0	1.0	2.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.3	0.6	0.0	0.0	0.2	1.8	1.9	0.0	0.0	1.0	1.5	1.3	0.0	0.0	0.0	0.7	0.8	0.0	0.0	1.7	0.0	0.0	3.1	0.8	0.0	0.0	1.3	1.7	0.0	0.8	0.2	0.0	0.2
NPW	PPL8	ENSG00000183971	"Neuropeptide W"	Q8N729	16	2009926-2020755	"Predicted intracellular proteins, Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 10.6"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 188.1;Enteroendocrine cells: 158.5"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 17.9"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	6	"NB-4: 43.5;PC-3: 35.6;RPMI-8226: 74.7;SCLC-21H: 118.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.2"	HPA064874	Approved				"Secreted to blood"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 15: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA064874: AB_2685378"	"unprognostic (7.54e-2)"	"unprognostic (4.45e-3)"	"unprognostic (3.20e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.85e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.20e-2)"	"unprognostic (6.26e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.81e-5)"	"unprognostic (6.53e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.41e-1)"	"unprognostic (3.43e-2)"	0.4	0.1	1.0	0.4	0.7	1.2	0.1	0.6	3.6	1.1	1.1	0.5	0.6	1.1	1.3	0.4	0.6	0.0	0.1	0.7	1.9	0.4	10.6	0.1	0.2	0.7	0.9	0.4	0.4	0.0	2.7	0.1	0.7	0.3	0.1	0.0	0.1	0.2	0.0	1.7	0.2	0.2	0.5	0.7	2.4	1.2	2.5	0.0	0.2	0.0	0.4	0.2	0.6	1.0	0.4	1.7	0.2	2.5	0.4	0.0	0.7	0.9	0.2	0.5	1.0	3.8	1.5	0.4	0.1	0.8	0.6	0.8	1.1	0.3	0.5	1.8	2.9	0.1	3.0	1.7	2.3	0.4	0.1	1.0	1.3	0.9	1.9	0.1	0.0	2.5	10.8	1.7	0.1	0.9	0.4	43.5	1.9	1.5	35.6	10.5	0.0	74.7	0.4	0.0	118.8	9.9	1.3	2.2	0.3	0.6	5.6	4.4	1.7	0.3	0.6	0.5	0.1	3.6	1.1	1.1	0.6	0.9	0.4	1.2	0.7	0.7	0.2	0.4	0.6	0.4	0.1	0.0	0.7	0.4	0.2	0.1	1.5	0.6	0.2	0.4	0.4	0.2	1.0	0.7	0.6	3.6	0.7	1.9	0.7	0.9	0.7	0.5	2.5	1.0	2.5	0.0	0.0	0.0	2.9	2.0	3.2	1.9	4.0	1.5	2.7	7.1	0.3	0.0	2.0	0.0	0.0	1.2	0.1	6.0	0.0	0.5	0.9	9.9	188.1	4.4	158.5	12.2	0.4	0.2	0.9	14.0	15.8	8.5	8.9	0.5	0.7	35.9	2.3	0.0	0.7	35.8	0.0	0.3	0.3	2.1	2.1	1.6	3.6	0.0	0.1	0.0	0.0	0.0	0.1	2.1	12.4	2.2	1.5	11.9	3.2	0.8	0.3	0.3	0.0	0.5	2.7	8.8	35.4	4.1	2.3	1.6	2.3	1.6	3.9	4.6
NR4A2	"HZF-3, NOT, NURR1, RNR1, TINUR"	ENSG00000153234	"Nuclear receptor subfamily 4 group A member 2"	P43354	2	156324437-156342348	"Cancer-related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 129.3;bone marrow: 130.8;ovary: 129.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 511.7;dendritic cells: 410.4;Langerhans cells: 782.3;Macrophages: 577.5;T-cells: 465.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 16.0;HMC-1: 10.9;SK-MEL-30: 8.1;U-266/70: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000543, CAB010481"	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"		"CAB010481: AB_2298676, HPA000543: AB_1854631"	"unprognostic (4.26e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.42e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.04e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.14e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.43e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.11e-1)"	40.0	129.3	4.3	24.5	44.1	130.8	15.6	36.2	8.8	18.3	5.9	9.5	2.9	15.0	1.7	11.4	28.2	32.7	36.6	15.1	3.6	19.2	20.2	18.8	6.3	3.2	9.2	129.2	9.2	8.8	54.0	5.2	2.8	25.6	18.7	5.3	19.2	15.5	11.6	12.8	7.8	14.5	0.9	4.6	19.9	5.6	2.5	9.7	15.2	7.8	1.4	50.9	14.0	6.4	0.9	1.3	0.5	1.8	3.2	0.7	0.9	1.1	5.5	0.4	1.3	0.0	3.3	0.0	1.2	0.4	0.4	1.6	2.6	0.7	0.4	1.3	1.4	1.0	16.0	0.0	0.6	0.7	10.9	0.6	1.2	0.4	0.4	2.1	0.3	0.0	1.6	1.0	1.1	1.9	0.0	0.8	2.1	1.5	0.8	0.2	0.7	3.3	0.6	0.8	2.7	0.1	2.6	4.1	8.1	0.3	0.2	1.0	0.7	2.9	0.8	0.7	0.4	14.2	1.8	0.0	5.3	1.0	7.0	1.9	1.7	2.4	1.0	0.3	0.5	0.4	0.3	0.5	1.9	0.3	0.5	0.2	6.5	0.0	0.7	0.0	0.4	0.5	4.3	44.1	36.2	8.8	15.1	3.6	3.2	9.2	2.8	0.9	2.5	6.4	70.7	25.6	124.7	7.8	511.7	218.6	25.8	87.5	298.7	11.8	120.8	160.1	11.9	17.2	58.3	71.7	50.1	4.7	410.4	35.0	0.0	13.1	36.7	209.6	33.9	111.9	206.4	12.0	5.8	9.1	6.5	164.9	103.9	349.7	349.3	4.3	45.0	6.8	125.1	0.0	0.8	95.4	42.7	161.1	782.3	37.2	4.1	577.5	241.9	5.6	7.9	1.6	3.1	4.0	2.3	11.7	41.9	0.7	203.5	49.1	25.9	0.4	54.6	33.4	13.1	63.0	169.8	1.8	3.3	230.2	213.7	9.9	465.1	34.4	57.5	29.5
NRROS	"ELLP3030, GARPL1, LRRC33, MGC50789, UNQ3030"	ENSG00000174004	"Negative regulator of reactive oxygen species"	Q86YC3	3	196639694-196662004	"Disease related genes, Predicted membrane proteins"		"Growth factor binding"	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 40.2;Erythroid cells: 27.5;Hofbauer cells: 76.9;Kupffer cells: 35.5;Langerhans cells: 59.9;Macrophages: 33.3;Microglial cells: 31.9;NK-cells: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 4.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.3;granulocytes: 4.2;monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"HEL: 53.1;HMC-1: 106.4;Karpas-707: 66.7;MOLT-4: 59.8;NB-4: 138.5;RPMI-8226: 68.9;THP-1: 60.5;U-937: 76.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031586	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 57: B-cells - Immune response"			"HPA031586: AB_10601543"	"unprognostic (5.28e-2)"	"unprognostic (8.92e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.67e-2)"	"unprognostic (3.20e-2)"	"prognostic unfavorable (9.63e-4)"	"unprognostic (2.32e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	7.8	2.6	1.9	8.6	1.5	32.7	5.1	1.5	1.6	2.5	1.6	2.7	2.4	2.9	0.5	2.0	2.8	4.2	2.9	1.8	3.0	2.8	2.5	7.7	10.5	2.7	1.9	1.2	1.1	0.9	1.2	9.9	2.7	2.0	1.6	0.3	2.4	1.6	1.3	2.0	5.1	4.1	2.7	15.7	2.3	1.3	3.4	7.7	2.2	2.5	3.6	4.5	2.1	4.4	0.1	0.0	0.3	0.0	0.4	1.0	0.1	0.4	2.1	0.4	0.3	0.1	0.2	0.0	6.7	0.4	0.3	0.1	1.1	0.0	0.1	4.0	0.1	53.1	0.0	0.0	0.5	43.7	106.4	0.4	0.0	1.7	0.7	2.1	4.3	48.6	5.5	66.7	1.2	0.1	59.8	138.5	4.4	0.0	0.1	15.7	0.1	68.9	0.1	0.4	0.3	0.0	0.1	0.1	28.0	0.9	0.1	60.5	0.5	0.5	0.2	1.9	0.1	26.5	43.1	12.1	3.4	76.1	0.7	4.2	1.0	1.8	0.3	1.0	0.1	0.3	0.2	0.2	1.3	0.2	0.1	0.2	0.0	0.3	1.1	0.2	0.3	0.7	1.9	1.5	1.5	1.6	1.8	3.0	2.7	1.9	2.7	2.7	3.4	4.4	5.6	0.0	0.5	0.0	40.2	1.5	0.1	0.0	2.2	0.4	0.4	0.3	0.3	0.0	0.6	0.0	4.2	0.3	15.5	0.0	0.0	0.0	1.4	0.0	0.4	10.1	0.0	27.5	1.8	0.0	0.7	0.7	0.5	0.1	14.5	0.1	15.4	0.2	76.9	0.0	2.7	0.0	0.0	35.5	59.9	0.4	0.6	33.3	8.8	31.9	24.1	0.1	33.0	1.0	0.3	0.0	0.0	0.7	25.7	0.0	0.0	0.1	0.0	0.4	6.6	0.3	0.3	2.7	0.4	0.2	0.9	0.5	10.8	0.5	0.0	0.0
NUP160	"FLJ22583, KIAA0197"	ENSG00000030066	"Nucleoporin 160"	Q12769	11	47778087-47848555	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		15000	"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"				"unprognostic (8.72e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.59e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-1)"	13.3	9.5	5.1	17.3	6.6	20.0	16.5	9.4	6.5	13.5	8.6	12.1	11.8	17.6	11.4	11.0	15.5	10.9	8.7	5.1	6.2	14.2	14.5	14.0	20.6	6.4	6.2	19.6	14.7	16.3	9.9	20.7	6.1	12.7	14.9	15.2	11.7	11.5	11.1	12.6	11.5	16.5	5.8	15.1	10.8	14.5	5.9	30.9	16.9	9.3	21.6	14.6	11.7	9.2	24.4	31.7	52.2	36.6	30.3	34.8	67.3	30.7	22.7	40.8	46.8	40.3	36.2	33.2	20.3	28.0	41.0	52.1	96.5	30.4	45.3	29.1	66.7	36.6	131.3	44.1	20.2	108.1	24.0	27.4	18.7	29.0	56.5	16.6	32.5	52.9	103.7	45.5	22.0	41.9	72.9	47.6	78.4	53.7	33.1	86.2	78.3	29.8	20.9	42.2	43.0	49.0	72.8	35.6	27.6	45.7	44.6	41.1	22.1	44.6	38.4	75.2	41.7	19.7	19.9	83.8	22.0	45.2	45.2	8.6	7.5	13.3	9.9	9.5	13.6	15.3	11.7	10.8	12.3	14.8	15.4	11.5	4.3	9.7	6.8	16.3	9.8	7.1	5.1	6.6	9.4	6.5	5.1	6.2	6.4	6.2	6.1	5.8	5.9	9.2	15.0	22.4	18.8	39.5	31.0	22.9	35.7	18.6	20.5	24.8	14.8	11.2	7.8	12.8	19.4	20.2	43.8	33.1	31.4	10.3	15.6	17.7	27.6	17.9	16.3	17.9	19.2	19.6	35.2	16.7	30.4	19.2	15.3	20.3	19.7	23.3	19.2	12.0	15.2	6.7	50.1	14.6	20.3	10.1	19.8	11.5	24.2	14.4	10.6	44.0	15.7	19.7	24.7	61.9	53.8	16.4	8.6	21.8	21.8	32.9	10.9	10.5	15.0	48.4	19.7	19.6	17.2	18.2	22.0	16.4	27.7	30.8	25.3	20.5	15.7	34.8
OOSP2	"FLJ36198, OOSP2A, PLAC1L, TMEM122"	ENSG00000149507	"Oocyte secreted protein 2"	Q86WS3	11	60040409-60048044	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	180	"testis: 18.0"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 7.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050914	Enhanced				"Secreted in male reproductive system"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 74: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA050914: AB_2681271"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR14L1P	"OR5AV1, OR5AV1P"	ENSG00000198452	"Olfactory receptor family 14 subfamily L member 1 pseudogene"		1	247617143-247622372	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"brain: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.0"	"Immune cell enriched"	"Detected in single"	53	"basophil: 5.2"	"Lineage enriched"	"Detected in single"	53	"granulocytes: 5.2"	"Group enriched"	"Detected in some"	9	"HEL: 2.0;HMC-1: 5.8"															NA	NA			"Cluster 46: Basophils - DNA binding"		"Cluster 3: HMC-1 - Innate immune response"																"unprognostic (3.03e-2)"						0.0	0.0	0.1	0.1	0.2	0.6	0.1	1.0	0.2	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.0		0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.1		0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.2	2.0	0.2	0.1	0.0	0.1	5.8	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.2	0.2	0.1	0.2	0.3	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.0	0.2	0.4	0.1	0.1	0.2	0.2	0.2	0.2	0.1	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
P2RY10	P2Y10	ENSG00000078589	"P2Y receptor family member 10"	O00398	X	78945332-78963727	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 79.3;granulocytes: 29.2;Langerhans cells: 38.5;monocytes: 32.5;Plasma cells: 32.6;T-cells: 55.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"basophil: 256.1"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 121.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036757, HPA065766"	Enhanced					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA036757: AB_10696786, HPA065766: AB_2685556"	"unprognostic (3.02e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.50e-6)"	"unprognostic (6.62e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-4)"	"unprognostic (3.33e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-2)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.99e-2)"	0.8	0.5	0.4	14.6	0.5	8.2	0.9	1.4	1.1	1.0	0.0	2.7	3.1	0.8	0.3	1.1	0.4	3.2	0.4	0.4	0.1	0.4	1.6	2.4	27.4	0.2	0.0	0.4	1.5	0.0	0.1	0.3	0.2	1.3	3.6	0.6	1.2	0.2	0.2	0.6	6.4	0.7	0.0	16.6	3.9	0.3	0.2	10.3	0.6	0.1	25.8	5.4	0.4	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	14.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.2	0.3	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	121.8	0.0	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	9.9	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.2	0.2	0.1	0.0	26.5	0.1	1.4	0.2	0.3	0.1	256.1	0.2	158.1	12.6	0.9	11.4	73.1	28.0	25.5	4.0	74.1	25.7	19.5	27.9	18.1	10.9	2.8	41.7	13.2	0.4	0.5	1.4	1.1	0.4	0.1	0.2	0.0	0.2	0.0	0.2	0.5	0.7	0.0	1.7	0.0	79.3	1.8	0.0	0.0	0.0	0.0	0.3	0.3	1.2	0.0	0.6	0.0	0.0	0.0	15.0	0.0	0.0	0.2	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.4	0.0	0.8	0.5	0.1	29.2	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.6	38.5	0.0	0.0	3.6	8.8	0.0	32.5	0.0	9.2	0.0	0.0	0.0	0.0	0.0	32.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	2.0	0.0	55.1	0.0	0.0	0.3
PACS1	"FLJ10209, KIAA1175"	ENSG00000175115	"Phosphofurin acidic cluster sorting protein 1"	Q6VY07	11	66070272-66244744	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 113.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038914	Approved		Approved	Microtubules,Cytosol		NA	NA		17000	"Cluster 46: Basophils - DNA binding"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Microtubules, Cytosol"		"HPA038914: AB_10672831"	"unprognostic (7.03e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.37e-3)"	"unprognostic (5.31e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.46e-1)"	30.6	24.0	26.4	33.7	28.4	26.0	26.4	28.4	29.0	30.4	11.0	29.7	13.3	26.7	17.7	32.1	22.2	23.6	45.4	27.2	18.5	28.0	11.4	30.2	49.8	18.2	20.4	32.4	26.8	18.7	21.6	18.9	17.1	34.6	10.2	35.1	92.8	22.2	22.4	27.6	25.6	30.3	13.0	34.9	24.9	42.2	20.7	35.1	34.0	17.2	46.2	33.9	29.6	18.8	44.1	45.6	21.1	13.3	38.5	46.1	23.7	59.3	41.9	40.6	25.2	28.4	34.3	27.6	38.2	102.5	37.7	27.9	15.6	42.7	54.4	43.7	18.3	45.0	41.7	41.2	45.8	6.5	34.6	46.8	19.8	37.0	47.2	78.1	39.8	18.2	16.7	52.2	44.7	83.3	48.1	16.8	9.8	12.0	21.2	31.6	21.5	47.9	28.9	43.4	29.8	33.6	61.5	34.5	29.1	33.9	39.7	8.3	54.4	52.2	23.1	71.9	25.6	26.2	19.1	7.4	45.0	10.4	26.0	3.7	1.3	2.8	3.4	1.0	2.2	2.9	3.1	2.9	1.3	4.8	3.5	3.1	7.4	2.0	2.9	0.8	4.0	3.0	26.4	28.4	28.4	29.0	27.2	18.5	18.2	20.4	17.1	13.0	20.7	18.8	19.9	3.2	3.0	93.7	41.3	10.1	17.6	8.8	16.5	31.4	16.5	16.3	16.9	8.6	12.1	12.9	50.1	8.1	31.9	2.8	5.9	20.5	17.0	11.1	17.3	18.2	6.1	14.1	113.5	62.7	10.9	15.8	13.7	16.3	23.5	80.3	26.0	4.6	13.1	92.5	90.0	2.2	6.1	14.5	14.7	27.6	18.6	22.7	10.6	96.5	33.4	13.9	38.1	87.4	49.2	54.7	1.2	18.0	13.5	23.3	1.0	13.1	11.8	41.2	13.1	12.3	16.5	20.6	21.8	16.5	9.9	5.7	36.3	16.5	3.6	17.0
PAN3		ENSG00000152520	"Poly(A) specific ribonuclease subunit PAN3"	Q58A45	13	28138506-28295335	"Enzymes, Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 154.6;Microglial cells: 209.9;Oligodendrocyte precursor cells: 171.4;Oligodendrocytes: 222.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028817	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 44: Endometrium - Transcription"			"HPA028817: AB_10602016"	"unprognostic (3.25e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.39e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.26e-3)"	"unprognostic (5.78e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.42e-2)"	17.1	9.8	7.8	14.2	8.9	31.3	18.1	16.4	10.8	16.1	12.2	13.9	9.6	15.3	20.6	12.5	16.1	11.0	8.5	7.9	8.1	13.4	11.0	14.6	21.5	8.5	8.4	16.3	17.0	10.1	12.5	11.8	8.9	14.1	12.6	15.8	14.8	12.1	6.8	20.1	18.7	10.8	8.6	25.8	13.0	14.2	7.9	21.5	17.4	5.7	19.4	13.1	15.3	11.8	9.9	6.2	16.8	17.9	8.2	11.6	13.9	10.1	16.1	10.5	10.0	10.3	21.2	34.9	7.1	14.9	11.8	14.4	15.1	11.9	17.8	19.8	7.9	28.3	8.7	8.9	10.9	21.6	17.0	11.5	11.9	8.9	18.1	13.5	14.2	16.2	14.1	10.4	11.6	13.6	23.6	52.2	18.0	13.6	5.9	54.5	17.9	12.8	16.7	13.2	15.8	12.5	11.9	17.3	13.9	10.3	9.2	40.6	13.8	10.5	8.9	10.3	9.8	7.9	6.1	35.6	6.2	16.2	13.1	22.8	10.1	13.4	9.0	9.6	9.6	12.3	10.2	9.2	9.8	11.4	11.5	11.1	22.5	11.9	14.4	15.6	8.7	11.2	7.8	8.9	16.4	10.8	7.9	8.1	8.5	8.4	8.9	8.6	7.9	11.8	32.3	16.0	19.5	97.9	42.9	66.3	16.2	10.2	18.8	27.3	36.1	16.9	7.8	17.2	14.8	16.5	29.2	18.1	51.1	13.6	1.9	13.6	21.3	33.2	25.7	26.8	27.1	61.0	131.4	12.5	15.9	23.7	19.4	38.5	16.5	26.3	28.9	10.7	13.7	26.9	154.6	18.0	16.2	41.4	88.0	12.4	26.4	34.7	56.9	209.9	35.4	13.7	35.0	171.4	222.3	13.6	21.5	21.8	28.9	35.0	13.2	14.3	16.6	37.8	13.1	31.6	26.2	26.5	23.0	22.5	80.7	24.1	36.1	17.1	17.0	31.2
PBX1		ENSG00000185630	"PBX homeobox 1"	P40424	1	164555584-164899296	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Steroidogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 382.3;Excitatory neurons: 475.9;Inhibitory neurons: 405.0;Oligodendrocyte precursor cells: 327.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 93.0;NTERA-2: 111.5;SK-BR-3: 186.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003505, HPA003881, CAB018768"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB018768: AB_675783, HPA003505: AB_1855019, HPA003881: AB_1855020"	"unprognostic (2.26e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.21e-3)"	"unprognostic (6.94e-3)"	"unprognostic (5.95e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.25e-1)"	24.3	32.1	16.5	11.8	22.3	3.1	36.1	10.7	18.0	88.3	1.9	52.3	22.4	136.8	21.6	30.1	74.6	37.6	24.0	15.3	14.1	29.4	7.7	20.7	4.5	8.8	32.7	52.1	48.1	29.5	14.3	19.5	6.7	38.0	19.8	17.1	43.8	53.8	36.3	10.2	19.9	125.2	13.7	10.2	21.9	6.8	12.6	10.9	35.1	26.5	8.1	40.2	41.5	12.1	2.9	74.4	82.4	19.1	50.8	23.3	3.4	25.2	20.9	8.4	6.1	14.2	11.8	0.0	5.5	47.8	4.3	22.8	31.7	8.1	3.6	3.1	31.3	93.0	56.5	0.3	34.7	0.0	22.2	24.4	0.0	5.4	2.1	19.2	0.3	0.0	0.2	0.0	2.2	47.1	0.2	0.6	111.5	3.8	4.5	0.0	21.6	27.0	6.3	44.1	2.5	39.6	27.8	186.1	0.1	71.4	73.2	0.0	0.5	3.7	8.6	24.2	8.1	8.5	61.2	0.1	0.4	0.2	0.4	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	16.5	22.3	10.7	18.0	15.3	14.1	8.8	32.7	6.7	13.7	12.6	12.1	28.6	22.4	18.6	382.3	2.8	22.8	115.0	39.8	70.6	39.9	129.9	87.8	50.0	98.7	25.3	33.1	110.5	101.3	1.5	29.2	33.2	47.9	91.3	47.7	144.3	47.0	90.9	30.3	475.9	68.7	7.3	126.7	32.1	38.5	71.7	57.6	68.9	18.7	9.7	5.0	405.0	38.2	50.8	1.9	17.5	124.4	63.6	12.1	16.0	125.5	1.6	33.5	1.0	327.2	227.4	31.7	72.5	103.8	2.8	41.5	40.4	57.9	37.3	30.6	39.5	142.0	70.9	2.3	17.5	83.6	28.1	104.7	7.6	168.0	43.7	75.9
PCBP3	"FLJ44028, PCBP3-OT1, PCBP3OT"	ENSG00000183570	"Poly(rC) binding protein 3"	P57721	21	45643694-45942454	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.6;retina: 81.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 159.4;Cone photoreceptor cells: 50.1;Horizontal cells: 116.1;Late spermatids: 79.8;Muller glia cells: 49.3;Rod photoreceptor cells: 83.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 29.0;HDLM-2: 56.9;HSkMC: 40.8;SH-SY5Y: 46.9;U-87 MG: 25.0;U-937: 31.3"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 229.1"					"HPA030247, HPA073145"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Mitochondria"	Vesicles	"HPA030247: AB_10601244, HPA073145: "	"unprognostic (3.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.01e-4)"	"unprognostic (9.89e-4)"	"unprognostic (2.74e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.96e-6)"	"unprognostic (8.67e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.97e-2)"	7.3	7.1	8.9	7.5	6.8	8.9	4.5	34.6	11.9	8.2	2.8	13.7	1.7	8.7	7.5	1.4	5.3	2.6	3.4	13.5	8.1	4.8	1.3	2.8	3.3	32.3	12.0	3.9	2.7	0.1	22.6	1.2	31.3	2.3	1.6	81.5	1.8	0.8	0.4	2.1	8.7	7.8	8.9	10.0	4.7	14.8	17.9	18.9	1.0	1.7	2.9	4.1	2.8	9.5	0.0	0.0	0.5	0.0	13.7	29.0	0.2	1.8	0.4	3.1	1.4	0.0	0.0	0.0	0.7	8.2	3.9	0.1	1.7	0.0	0.5	56.9	0.2	0.0	0.0	0.0	13.7	0.0	0.0	40.8	0.2	0.5	0.8	0.0	0.0	2.0	0.0	0.2	1.8	0.7	16.5	3.3	0.8	0.1	2.8	0.0	0.1	2.4	0.0	0.0	4.9	46.9	1.2	0.0	0.0	1.3	0.0	8.7	0.0	0.0	0.1	12.3	0.0	0.7	3.1	0.0	25.0	31.3	1.1	2.1	0.2	3.0	0.7	0.1	0.1	1.3	0.4	0.0	0.0	1.4	0.7	0.1	0.7	0.3	0.1	0.0	0.4	0.2	8.9	6.8	34.6	11.9	13.5	8.1	32.3	12.0	31.3	8.9	17.9	9.5	0.6	0.0	0.0	2.3	6.2	0.3	0.1	0.3	0.0	159.4	0.1	0.5	3.6	0.0	0.7	1.8	50.1	0.1	0.3	0.0	0.0	0.1	36.5	0.2	8.9	2.2	3.0	0.0	3.8	0.2	0.1	2.3	0.5	0.3	0.0	0.2	2.2	0.0	0.4	116.1	4.6	0.1	0.0	0.0	0.7	79.8	8.4	0.9	3.6	1.0	0.0	49.3	0.0	0.5	5.5	0.9	0.1	12.8	4.1	1.3	0.0	0.4	0.0	83.1	0.0	1.1	3.9	34.1	21.2	0.0	0.0	0.0	2.5	0.2	0.2	0.5
PDCD1LG2	"B7-DC, bA574F11.2, Btdc, CD273, PD-L2, PDL2"	ENSG00000197646	"Programmed cell death 1 ligand 2"	Q9BQ51	9	5510531-5571282	"Cancer-related genes, CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 17.9;Langerhans cells: 13.1;Microglial cells: 12.2;monocytes: 26.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 71.4;BJ hTERT+: 111.6;HDLM-2: 88.1;TIME: 49.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA013411	Approved		Uncertain	Cytosol	"Secreted - unknown location"	NA	NA		31000000	"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA013411: AB_1855102"	"unprognostic (3.93e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.51e-3)"	"unprognostic (6.68e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.77e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.37e-3)"	"unprognostic (5.79e-2)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (5.00e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.51e-3)"	4.4	0.8	0.4	6.9	0.6	0.3	4.3	0.5	0.5	2.5	0.3	1.7	0.7	2.2	1.2	2.0	2.4	3.4	2.7	0.4	0.8	1.2	4.2	7.1	10.4	1.1	0.6	1.6	0.6	0.4	0.2	4.8	1.1	1.0	2.1	0.0	1.3	1.4	1.5	1.4	1.5	3.1	0.9	15.1	1.4	0.6	0.7	5.0	1.0	2.2	6.2	4.2	2.2	1.3	6.0	0.0	0.0	0.0	4.7	5.4	0.1	71.4	111.6	33.7	40.4	0.0	0.3	0.0	0.2	29.2	4.8	0.5	0.1	9.7	33.3	88.1	0.0	0.0	0.0	0.0	26.5	0.0	0.0	5.0	0.1	15.8	18.5	9.7	22.4	0.0	0.0	8.5	41.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.0	0.7	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.2	0.0	0.1	49.7	24.0	1.4	11.8	20.1	1.2	0.1	0.1	13.6	0.0	3.0	1.5	0.3	0.0	0.5	1.4	0.6	0.2	0.7	0.3	0.3	0.1	0.0	0.3	0.7	0.0	0.1	0.0	1.1	0.3	0.4	0.6	0.5	0.5	0.4	0.8	1.1	0.6	1.1	0.9	0.7	1.3	6.1	6.4	0.5	1.6	0.4	1.0	0.1	0.7	1.8	0.0	0.2	1.5	0.1	0.0	0.7	0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.0	0.0	0.4	2.2	0.0	0.0	1.6	0.2	17.9	6.7	0.5	0.0	3.8	0.2	6.8	0.0	2.9	0.0	1.4	0.0	0.0	5.3	13.1	0.0	5.9	2.5	1.8	12.2	26.4	0.0	0.0	1.0	2.4	3.7	0.0	2.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	2.2	3.1	0.0	0.0	0.3	1.0	0.8	1.1	0.1	0.0	0.1
PDCD4	H731	ENSG00000150593	"Programmed cell death 4"	Q53EL6	10	110871795-110900006	"Predicted intracellular proteins"	Apoptosis	RNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 505.4"	"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 786.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 295.6;U-266/70: 320.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001032, HPA027214, CAB037024"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB037024: AB_1841089, HPA001032: AB_1079586, HPA027214: AB_1855107"	"unprognostic (4.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.37e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.25e-1)"	45.7	30.7	15.0	53.2	15.7	74.0	146.6	18.1	16.9	49.3	24.7	157.6	90.7	67.0	36.2	151.3	57.7	43.4	22.4	13.7	17.2	26.2	36.2	32.8	60.7	15.7	18.5	133.6	505.4	283.9	40.3	97.0	15.4	55.3	130.4	50.4	255.0	60.4	11.8	104.2	100.2	51.3	15.5	67.6	102.3	29.9	16.6	73.9	154.5	18.7	95.4	42.2	61.8	17.3	26.5	25.4	40.6	43.7	61.6	110.7	23.8	29.9	89.7	14.7	25.7	16.0	65.0	252.3	81.7	43.5	11.4	118.8	26.1	79.4	32.4	219.7	50.6	127.5	146.9	27.9	26.9	65.2	135.8	88.0	247.4	15.7	84.0	67.6	28.2	40.1	35.3	119.6	37.6	69.7	24.2	76.4	10.6	19.0	46.3	10.4	71.6	138.7	24.8	36.8	17.8	73.6	58.7	31.6	109.1	44.6	295.6	121.3	71.8	22.6	16.8	17.1	11.0	320.1	163.8	143.6	22.2	87.4	24.5	186.1	19.5	52.4	54.0	27.0	96.0	54.1	49.7	59.8	23.0	39.5	43.0	53.2	38.3	84.7	29.6	38.5	29.0	40.4	15.0	15.7	18.1	16.9	13.7	17.2	15.7	18.5	15.4	15.5	16.6	17.3	85.3	19.2	50.0	16.3	132.0	133.1	88.1	104.6	113.3	61.8	148.1	113.9	16.8	42.9	90.3	25.8	31.3	229.5	246.1	348.0	35.2	70.8	20.2	66.7	132.5	79.1	33.6	94.2	26.2	101.4	78.4	72.1	82.0	59.4	132.9	111.7	97.1	23.6	56.5	21.9	44.4	150.6	81.4	84.1	49.7	11.0	145.1	66.1	291.7	46.9	57.4	40.9	75.2	36.7	70.6	45.0	244.3	222.7	134.7	51.3	292.1	28.1	47.8	206.1	39.5	69.4	48.6	63.3	72.2	200.8	165.2	786.0	229.2	176.8	190.3	73.3
PDPR	PDP3	ENSG00000090857	"Pyruvate dehydrogenase phosphatase regulatory subunit"	Q8NCN5	16	70114332-70162537	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 54.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048092, HPA070386"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Mitochondria		"HPA048092: AB_2680261, HPA070386: AB_2686263"	"unprognostic (8.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.04e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (8.36e-4)"	"unprognostic (8.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.24e-2)"	11.5	12.6	10.7	8.1	13.3	15.9	11.3	14.7	11.4	13.1	9.8	14.5	9.1	14.1	11.9	8.1	12.8	6.7	14.7	10.7	11.4	16.3	8.6	9.6	11.1	11.8	12.4	13.5	12.3	10.2	10.4	9.0	11.8	10.9	11.8	12.1	10.3	9.6	23.2	12.2	13.7	15.1	10.6	15.4	12.0	19.1	12.5	15.8	13.0	13.6	12.5	13.8	9.8	13.9	6.9	19.4	17.9	33.0	32.6	20.9	12.1	11.1	19.4	17.4	13.1	25.1	13.4	14.4	19.1	35.8	16.1	26.7	26.4	24.1	20.3	3.5	9.1	35.8	12.7	17.6	9.3	39.9	27.9	28.0	22.6	25.1	23.0	25.2	18.7	26.6	24.6	6.6	15.3	20.8	25.3	23.3	27.8	4.9	10.0	49.0	18.5	14.9	13.8	16.3	8.3	12.3	30.2	6.2	8.2	24.2	24.4	12.4	10.9	20.4	27.3	17.6	17.9	15.4	17.9	50.9	9.1	13.8	13.5	1.6	1.5	1.4	1.4	1.5	2.0	0.9	1.1	1.3	1.6	1.5	1.3	1.5	1.1	0.9	1.5	1.5	1.3	1.0	10.7	13.3	14.7	11.4	10.7	11.4	11.8	12.4	11.8	10.6	12.5	13.9	12.6	22.4	18.2	18.6	13.0	2.8	4.9	3.5	18.2	21.6	14.2	12.1	19.2	17.2	9.1	1.8	31.3	7.7	16.0	12.1	5.9	5.3	54.4	13.7	16.0	17.4	4.9	17.4	18.0	6.7	7.8	16.1	11.7	17.1	18.3	23.9	17.2	11.2	16.4	32.0	20.3	10.0	4.1	17.8	3.5	20.8	10.8	15.7	7.2	10.3	12.2	11.2	15.5	9.5	13.9	6.8	6.1	16.6	11.7	10.3	11.6	4.4	12.7	20.8	19.7	22.7	11.5	10.8	15.4	11.1	1.8	4.9	11.9	12.7	14.5	4.6
PEX12		ENSG00000108733	"Peroxisomal biogenesis factor 12"	O00623	17	35574795-35578863	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 17.2;Spermatocytes: 21.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069386	Enhanced					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA069386: AB_2686135"	"unprognostic (1.45e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.64e-2)"	"prognostic favorable (3.58e-5)"	"unprognostic (2.60e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	3.9	6.8	6.7	3.6	7.2	1.5	5.5	7.9	9.1	5.3	6.7	3.4	3.6	4.3	10.7	3.4	5.6	3.2	9.1	6.8	7.1	8.2	9.0	3.4	4.8	6.8	6.9	8.2	4.0	7.8	4.7	4.7	6.8	5.7	2.9	4.6	5.5	6.9	10.3	4.2	3.5	3.5	7.3	3.9	3.9	6.8	7.0	3.2	7.7	10.8	4.5	3.7	2.7	8.4	2.8	3.7	5.4	4.4	11.0	9.9	3.9	7.3	8.3	6.0	6.3	3.2	3.0	6.4	11.6	4.1	4.9	7.3	6.6	4.8	5.2	2.3	8.7	4.7	3.8	5.9	12.8	6.7	1.2	9.2	9.2	3.7	10.9	7.7	4.6	5.2	7.5	6.6	7.2	2.9	7.9	3.8	2.2	6.3	5.8	3.8	9.3	6.4	7.1	4.2	4.0	4.0	4.6	3.0	9.6	6.5	7.4	3.7	3.7	5.6	3.5	6.3	4.9	13.3	9.9	7.5	6.0	5.1	5.2	2.2	1.5	3.0	1.8	1.1	3.2	2.3	3.0	1.8	1.7	2.6	4.1	3.5	1.0	2.0	1.2	1.7	2.4	1.4	6.7	7.2	7.9	9.1	6.8	7.1	6.8	6.9	6.8	7.3	7.0	8.4	2.7	3.2	0.5	6.5	3.3	0.6	1.9	1.3	1.8	2.1	2.4	2.2	6.3	0.0	2.7	3.7	0.0	6.7	1.4	1.3	3.9	3.5	17.2	1.9	2.3	3.9	1.2	0.8	1.3	1.1	4.1	2.6	2.6	1.5	2.5	2.0	3.3	5.4	2.9	1.7	1.9	1.7	2.0	2.6	0.6	3.0	3.1	1.5	1.8	1.0	0.9	8.3	1.0	4.5	2.8	2.2	1.0	1.5	0.5	2.4	2.7	3.3	1.8	2.2	0.0	2.6	3.7	21.0	10.2	1.4	1.3	5.2	2.8	3.0	2.2	1.3
PEX2	"PAF-1, PMP35, PXMP3, RNF72, ZWS3"	ENSG00000164751	"Peroxisomal biogenesis factor 2"	P28328	8	76980258-77001044	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 133.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010983, HPA011410, HPA027729"	Approved		Supported	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles		"HPA010983: , HPA011410: AB_1854922, HPA027729: AB_10610416"	"unprognostic (6.42e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.35e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.19e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.48e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.09e-3)"	39.8	45.9	33.1	33.5	36.6	35.8	53.9	34.2	45.6	40.7	38.6	43.1	39.8	33.3	42.4	32.9	41.8	31.9	39.7	32.1	35.1	53.6	43.7	36.5	39.4	37.3	34.5	33.3	39.0	57.7	27.2	24.7	37.6	44.2	39.6	66.5	50.9	83.4	61.8	24.5	41.0	35.3	37.3	36.5	48.3	22.1	34.5	48.8	53.2	44.6	35.7	35.7	31.3	43.3	88.2	29.3	46.9	47.9	50.7	63.2	24.5	64.4	75.3	49.9	55.2	18.4	76.9	50.2	93.6	59.9	39.7	33.3	33.1	50.1	61.2	93.3	28.5	61.1	26.0	28.3	33.9	51.5	46.5	70.9	43.5	37.8	45.6	77.0	55.3	79.3	34.4	46.7	53.9	26.4	90.4	30.1	27.2	126.4	26.3	16.5	37.4	42.1	59.9	61.6	16.7	43.0	41.9	192.0	36.9	39.8	58.7	36.1	54.7	44.4	58.1	57.7	32.4	86.0	53.8	87.9	56.5	26.7	50.2	179.9	55.6	102.6	57.2	58.0	51.2	46.1	39.6	46.5	46.3	50.5	51.6	49.3	38.6	83.1	67.8	46.8	48.6	71.7	33.1	36.6	34.2	45.6	32.1	35.1	37.3	34.5	37.6	37.3	34.5	43.3	28.0	48.1	25.2	32.3	29.7	18.1	31.0	57.8	28.5	28.9	38.9	33.1	27.2	28.6	38.4	27.6	12.5	42.8	38.3	30.2	133.1	52.3	5.6	36.5	19.9	20.7	28.9	25.6	11.9	49.1	24.8	29.8	20.4	22.2	18.3	20.2	25.7	36.7	26.6	13.5	15.2	37.5	48.8	39.1	22.4	7.3	29.5	26.8	28.4	16.9	36.3	68.4	53.5	31.7	45.9	42.0	28.2	35.7	41.7	36.3	43.3	61.4	36.6	34.4	6.6	34.9	24.6	13.7	20.8	28.6	21.0	34.8	37.6	27.7	30.0	43.0
PGAM5	"BXLBv68, MGC5352"	ENSG00000247077	"PGAM family member 5, mitochondrial serine/threonine protein phosphatase"	Q96HS1	12	132710819-132722734	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Necrosis	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036978, HPA036979, CAB068215"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB068215: AB_2665674, HPA036978: AB_10964347, HPA036979: AB_10960559"	"unprognostic (9.57e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.13e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.53e-2)"	10.5	17.7	13.0	17.0	12.7	16.3	9.7	12.7	17.0	9.8	10.1	16.1	15.2	10.9	6.6	23.9	12.4	8.7	20.0	19.0	12.5	14.3	28.9	9.3	21.2	9.3	9.7	7.2	25.8	10.7	9.9	10.7	10.1	9.4	11.3	6.0	15.5	11.5	33.2	17.1	13.2	11.3	7.9	12.8	13.3	16.5	10.8	14.8	11.6	19.0	16.1	15.6	11.8	11.3	72.2	134.3	28.2	79.5	19.4	15.6	66.1	37.4	22.0	59.1	33.0	168.6	40.2	92.3	67.2	31.2	30.4	61.2	132.9	67.5	24.1	47.3	106.7	110.7	61.6	89.2	44.0	105.8	61.8	19.4	48.8	69.0	73.6	19.3	43.6	73.4	143.3	36.9	23.5	128.5	144.5	105.7	108.0	61.8	94.4	109.4	31.2	73.3	38.4	97.4	102.8	58.0	62.2	86.1	38.9	22.2	108.9	57.5	38.2	29.9	65.5	60.6	89.9	77.2	124.8	133.5	38.8	85.3	51.1	4.9	1.1	0.3	1.1	1.2	1.8	1.7	1.3	1.3	1.0	1.7	1.3	1.7	0.9	1.6	1.7	3.3	1.1	0.8	13.0	12.7	12.7	17.0	19.0	12.5	9.3	9.7	10.1	7.9	10.8	11.3	6.6	3.2	6.1	3.9	8.9	11.5	16.7	2.6	2.2	9.5	7.8	5.5	15.1	15.7	1.5	5.5	14.6	7.6	11.9	11.7	5.9	5.8	14.5	6.3	6.3	7.0	13.1	5.0	5.1	7.9	14.4	4.9	4.1	9.3	0.0	7.1	5.7	22.4	7.3	6.7	3.9	8.9	2.0	6.9	5.8	20.6	5.9	4.7	3.6	1.9	5.3	4.4	3.1	2.0	2.3	7.5	6.9	6.8	9.7	19.5	5.2	11.5	4.5	12.9	6.6	8.0	6.4	15.1	10.1	10.8	17.3	6.2	7.4	9.2	15.7	16.1
PGPEP1L		ENSG00000183571	"Pyroglutamyl-peptidase I like"	A6NFU8	15	98968229-99007792	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 30.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.1;Distal tubular cells: 1.9;Early spermatids: 3.8;Excitatory neurons: 3.8;Inhibitory neurons: 3.3;Late spermatids: 1.7;Skeletal myocytes: 2.1;Spermatocytes: 2.7;Spermatogonia: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA041781	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 33: Striated muscle - Muscle contraction"		"Cluster 37: Myocytes - Muscle contraction"			"HPA041781: AB_10795642"	"unprognostic (2.48e-1)"	"unprognostic (2.82e-2)"		"unprognostic (8.26e-2)"	"unprognostic (2.43e-3)"	"unprognostic (7.18e-2)"		"unprognostic (3.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.44e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.65e-1)"	0.2	0.1	0.7	0.2	0.9	0.1	0.4	0.0	1.1	0.2	0.0	0.5	0.2	0.2	0.0	0.8	0.1	0.5	3.8	0.5	0.4	0.4	0.0	0.2	0.3	0.2	0.3	0.1	0.5	0.0	0.1	0.2	0.1	0.5	0.0	0.1	0.6	0.5	30.9	0.1	0.1	0.1	0.0	0.0	0.2	2.0	0.4	0.1	0.1	7.5	0.0	0.3	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	1.1	0.5	0.4	0.2	0.3	0.1	0.0	0.4	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	3.8	0.1	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.9	2.7	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1
PGRMC2	"DG6, PMBP"	ENSG00000164040	"Progesterone receptor membrane component 2"	O15173	4	128269237-128288829	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 274.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041172, HPA058652"	Approved		Approved	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		76000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Nuclear bodies, Plasma membrane, Cytosol"		"HPA041172: AB_2677345, HPA058652: AB_2683786"	"unprognostic (6.16e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-2)"	"prognostic favorable (3.62e-4)"	"unprognostic (6.03e-2)"	"unprognostic (6.57e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.24e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.80e-2)"	"prognostic favorable (9.60e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.03e-2)"	107.3	51.9	23.8	38.1	25.6	41.7	76.6	25.8	29.8	58.4	34.1	68.1	127.3	52.3	51.3	57.5	44.2	53.4	50.7	25.0	30.2	96.0	173.8	42.7	30.6	25.6	29.6	57.9	74.2	80.5	49.0	85.3	27.7	53.0	65.2	55.1	55.3	73.2	54.4	98.2	121.9	67.4	26.6	32.5	95.8	39.5	28.5	28.0	65.6	44.0	40.8	56.3	51.0	29.8	123.3	44.4	80.3	64.9	339.8	177.6	80.5	164.6	182.7	119.4	158.3	46.4	123.6	86.3	187.8	213.4	138.8	70.1	74.3	81.6	149.3	49.7	42.7	58.0	111.3	88.3	429.1	84.7	41.7	140.9	161.3	100.3	123.3	277.0	109.1	55.0	98.2	105.6	173.7	38.2	78.9	39.2	63.1	148.5	39.7	62.5	64.2	59.8	176.8	42.9	63.3	59.7	92.4	103.1	97.3	131.2	79.7	38.0	203.5	100.0	81.4	103.8	77.3	121.0	106.0	91.3	109.9	74.4	70.1	2.2	1.0	2.0	1.5	0.9	0.7	1.2	1.8	1.5	0.6	0.9	1.6	1.5	0.9	1.1	0.7	2.4	2.0	0.6	23.8	25.6	25.8	29.8	25.0	30.2	25.6	29.6	27.7	26.6	28.5	29.8	95.9	54.5	41.0	16.6	27.0	100.1	49.7	27.8	54.1	22.4	49.2	32.8	60.7	58.6	35.9	44.1	10.4	85.4	41.2	68.2	29.4	57.3	80.9	42.2	59.1	50.0	35.5	104.2	20.4	74.2	146.6	69.9	53.0	64.2	12.0	31.0	47.2	125.1	35.3	11.8	19.1	67.8	40.7	15.7	39.5	49.5	46.3	22.1	67.6	13.1	19.0	98.6	21.6	13.6	25.0	69.7	50.6	37.6	48.9	58.0	177.3	111.0	27.4	41.1	13.1	63.3	53.1	33.3	27.3	51.9	111.8	274.9	32.4	39.4	58.8	34.4
PHF8	"JHDM1F, KDM7B, KIAA1111, ZNF422"	ENSG00000172943	"PHD finger protein 8"	Q9UPP1	X	53936676-54048958	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, Oxidoreductase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 70.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 57.9;Spermatogonia: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038779, HPA062015"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA038779: AB_10675950, HPA062015: AB_2684658"	"unprognostic (6.35e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (3.74e-5)"	11.6	8.1	8.3	13.3	11.1	16.2	13.8	9.5	10.3	13.9	20.0	11.6	10.3	14.1	70.6	13.4	14.1	9.2	9.8	7.8	11.2	9.7	28.7	13.5	16.3	10.1	9.4	19.3	17.8	10.8	13.9	13.2	11.2	16.0	9.6	14.6	12.8	18.3	11.0	13.1	14.2	9.4	8.1	13.9	12.7	40.1	10.2	18.6	13.2	7.8	15.8	14.1	13.5	13.3	16.1	14.0	20.4	19.9	12.2	9.6	33.3	12.0	10.4	12.9	11.4	15.7	12.8	23.4	6.9	10.8	13.9	16.5	51.1	10.3	13.7	36.4	23.8	14.2	18.1	15.8	9.6	22.4	25.6	10.9	14.0	15.0	20.2	9.7	12.0	24.3	18.7	33.2	7.6	16.1	30.6	16.9	37.2	11.0	19.6	29.7	22.5	22.9	8.9	19.2	29.2	14.5	31.6	20.5	10.5	31.2	20.5	15.5	14.3	10.3	14.5	19.2	10.0	25.1	25.4	28.3	12.2	27.9	11.3	6.1	2.7	4.4	3.2	4.8	5.1	2.3	3.3	3.9	2.9	3.1	2.5	2.8	4.4	3.5	3.2	2.3	5.3	3.4	8.3	11.1	9.5	10.3	7.8	11.2	10.1	9.4	11.2	8.1	10.2	13.3	9.5	9.6	10.3	17.3	11.2	8.9	9.4	4.5	15.4	13.7	13.9	8.1	7.8	5.7	5.4	9.2	12.5	13.9	14.1	8.3	0.0	5.1	54.9	34.5	11.3	11.3	5.4	5.2	19.7	4.6	4.7	6.9	10.7	40.2	14.0	15.0	7.9	39.4	6.8	8.4	22.0	8.8	10.2	11.8	6.4	31.4	9.3	11.6	3.6	20.6	9.2	6.1	9.2	27.2	30.0	4.4	9.4	6.4	14.4	10.9	9.2	3.7	16.5	15.3	6.6	11.6	9.2	57.9	58.7	15.2	9.8	12.2	13.5	6.3	8.3	14.7
PI4K2B	"FLJ11105, PI4KIIB, PIK42B"	ENSG00000038210	"Phosphatidylinositol 4-kinase type 2 beta"	Q8TCG2	4	25160663-25279204	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 57.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004099	Enhanced		Supported	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA004099: AB_1855353"	"unprognostic (1.02e-1)"	"unprognostic (6.34e-3)"	"prognostic favorable (9.64e-5)"	"unprognostic (2.75e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.68e-2)"	"unprognostic (7.54e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.06e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.07e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.47e-2)"	7.9	8.9	3.4	14.0	3.9	14.1	16.5	3.6	4.5	11.4	5.8	18.7	39.0	8.0	5.8	16.7	8.7	8.3	4.5	3.2	4.1	12.9	57.9	16.5	18.1	4.3	3.6	5.2	9.5	7.7	3.4	12.0	4.5	11.4	20.4	4.9	23.5	7.9	2.4	13.1	31.6	9.1	4.5	13.5	22.7	12.1	3.7	19.7	24.1	4.8	18.9	14.3	8.1	5.3	33.8	9.9	16.7	14.6	18.2	33.9	31.3	50.8	48.6	48.4	58.1	14.0	37.7	86.3	11.5	45.3	37.5	14.7	37.3	24.6	41.7	28.9	12.2	30.4	23.3	26.1	14.2	61.9	21.0	21.6	17.9	18.6	19.2	12.9	28.0	27.0	20.7	76.2	37.0	18.8	58.3	39.7	23.6	40.5	13.6	34.4	58.1	47.5	32.2	32.2	28.9	6.2	24.5	17.1	12.0	17.0	25.7	27.3	33.8	31.8	8.4	18.3	32.5	76.3	49.5	77.4	34.5	45.4	30.6	5.3	1.1	3.4	1.5	1.2	1.0	1.4	1.5	1.5	0.8	1.2	1.2	1.4	1.7	0.9	0.9	1.5	3.5	0.6	3.4	3.9	3.6	4.5	3.2	4.1	4.3	3.6	4.5	4.5	3.7	5.3	5.6	6.4	18.5	21.5	14.9	15.0	15.8	9.9	8.0	2.1	8.4	5.3	0.0	5.7	12.2	9.2	0.0	21.6	6.7	20.2	5.9	5.5	1.0	10.0	3.4	7.1	8.4	25.7	8.7	7.1	12.6	6.1	16.3	8.5	0.0	3.5	6.8	40.4	10.3	1.7	13.7	13.7	8.2	15.4	13.9	1.0	4.4	8.6	5.4	11.2	10.3	0.7	4.1	30.2	20.1	5.8	8.2	4.5	27.4	14.1	16.8	20.3	10.4	3.4	0.0	5.3	7.2	9.6	10.3	18.3	15.6	13.5	10.3	4.4	13.9	18.2
PIK3R4	"p150, VPS15"	ENSG00000196455	"Phosphoinositide-3-kinase regulatory subunit 4"	Q99570	3	130678934-130746829	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036032, HPA036033"	Approved		Approved	Vesicles,Microtubules		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Vesicles	Microtubules	"HPA036032: AB_10610281, HPA036033: AB_2674911"	"unprognostic (7.50e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.26e-2)"	"prognostic favorable (4.40e-6)"	"unprognostic (8.25e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.05e-1)"	8.8	8.5	3.7	7.8	4.2	8.9	10.0	5.2	4.9	9.4	5.6	8.2	7.5	10.1	7.9	8.0	9.1	7.2	7.6	4.1	4.5	10.5	21.2	9.6	9.4	3.2	3.6	12.4	6.9	17.6	6.1	9.7	3.8	9.8	8.1	16.5	7.6	9.6	7.3	7.8	8.0	10.4	3.8	10.0	7.5	11.4	3.2	11.4	13.1	8.6	10.4	9.0	6.5	7.1	20.7	12.9	18.5	13.4	26.6	21.1	12.8	15.0	17.9	20.2	23.3	16.7	17.1	24.2	18.4	15.2	16.1	28.7	30.7	23.3	31.6	14.7	11.3	19.7	13.8	11.7	12.2	30.3	9.5	14.7	16.4	21.7	13.6	12.6	19.0	13.8	23.3	11.9	18.1	18.1	24.9	9.2	23.3	18.6	12.4	17.2	21.4	21.9	13.2	16.7	17.0	12.4	21.6	13.4	15.3	21.5	18.6	13.1	15.2	15.5	13.3	17.6	12.2	13.8	13.5	31.2	17.0	11.3	14.7	9.7	5.3	7.0	6.3	6.0	9.3	5.6	5.7	4.7	6.9	3.5	6.6	6.0	4.4	8.5	6.6	2.4	6.8	5.3	3.7	4.2	5.2	4.9	4.1	4.5	3.2	3.6	3.8	3.8	3.2	7.1	8.3	6.4	8.7	18.6	8.8	3.8	3.9	5.7	10.8	8.1	5.7	4.7	7.7	8.6	9.6	11.0	14.6	5.6	7.2	5.5	1.9	5.0	4.4	8.9	7.5	8.9	3.0	9.2	28.5	5.8	3.4	6.9	13.3	9.9	9.5	9.5	7.5	18.2	5.9	5.0	30.3	6.8	8.2	6.4	2.6	3.1	9.6	7.3	5.4	20.6	7.1	9.0	6.2	22.1	32.9	6.6	4.3	11.7	6.9	4.8	6.2	4.2	12.6	12.6	6.6	8.9	6.2	17.0	13.9	9.5	4.4	4.2	7.5	9.6	6.1	3.4
PIM1	PIM	ENSG00000137193	"Pim-1 proto-oncogene, serine/threonine kinase"	P11309	6	37170152-37175428	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 219.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 368.2;Suprabasal keratinocytes: 228.6;Urothelial cells: 455.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 321.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 321.3"	"Cell line enhanced"	"Detected in all"		"HEL: 219.9;HMC-1: 391.5;K-562: 192.7;U-698: 735.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003941, CAB017040"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Nucleoplasm, Nucleoli"	"CAB017040: , HPA003941: AB_1079618"	"unprognostic (1.25e-2)"	"unprognostic (4.77e-1)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.14e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.26e-3)"	"unprognostic (2.90e-1)"	152.8	14.4	8.5	42.3	8.6	219.0	46.2	10.5	10.7	82.9	10.0	45.8	39.2	46.3	2.6	201.5	66.4	52.6	65.4	7.9	11.6	27.0	58.0	49.8	38.5	15.1	12.2	60.4	20.4	3.4	14.8	28.9	12.8	22.5	17.8	8.2	41.1	7.5	36.3	109.8	44.4	38.1	12.3	61.7	40.3	10.7	11.6	26.6	22.7	5.8	26.8	101.6	113.3	12.1	19.1	7.9	12.1	6.7	27.2	14.5	141.9	6.7	20.3	13.5	21.5	28.3	26.2	38.3	10.4	8.0	30.2	21.7	12.7	20.1	12.3	174.4	8.4	219.9	8.7	37.0	27.9	3.8	391.5	49.0	24.5	12.4	8.3	14.9	4.0	9.2	192.7	59.7	2.2	5.0	12.3	19.9	22.7	35.4	12.1	29.7	22.0	45.7	3.9	114.4	58.8	11.9	14.7	1.7	3.8	27.9	3.2	6.5	7.4	7.8	23.3	35.6	8.5	28.0	15.9	735.7	3.4	55.3	8.1	321.3	8.0	113.5	60.3	7.3	77.7	7.1	53.4	53.8	6.3	5.2	47.1	36.9	61.7	39.8	4.2	1.9	41.3	42.1	8.5	8.6	10.5	10.7	7.9	11.6	15.1	12.2	12.8	12.3	11.6	12.1	41.1	22.4	16.0	2.9	35.1	127.8	166.5	63.3	26.7	4.9	9.6	5.3	36.0	18.6	37.6	9.2	0.0	36.5	55.0	50.4	5.9	40.6	4.8	40.3	125.8	33.3	37.1	368.2	2.4	17.2	121.8	67.4	26.0	92.0	49.3	27.5	11.0	33.8	53.6	15.2	2.2	12.4	44.7	44.3	47.4	12.4	8.1	53.9	44.4	4.7	72.3	7.6	112.3	1.0	0.9	60.7	34.2	3.0	190.1	109.6	51.1	17.2	12.9	1.7	0.0	34.2	41.3	14.5	33.9	92.8	228.6	80.7	118.0	1.1	7.8	455.2
PLGLB1	"PLGL, PRP-B"	ENSG00000183281	"Plasminogen like B1"	Q02325	2	87002559-87021852	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Tissue enriched"	"Detected in all"	6	"liver: 234.9"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 95.9"	"Cancer enriched"	"Detected in single"	7	"liver cancer: 0.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"																"Secreted to blood"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 15: Liver - Metabolism"	"Cluster 24: NB-4 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (7.25e-2)"	"unprognostic (7.25e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.39e-5)"	"unprognostic (7.04e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.53e-4)"	"unprognostic (1.60e-1)"	"unprognostic (4.56e-4)"	"unprognostic (9.90e-3)"	"unprognostic (2.96e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.98e-5)"	3.6	5.5	19.9	4.5	19.9	8.5	3.6	33.4	26.5	6.9	21.3	4.9	3.9	5.9	8.2	4.0	4.3	4.7	5.9	20.0	20.3	8.5	234.9	3.3	7.9	16.7	17.4	6.7	4.1	2.2	9.5	2.3	16.0	6.6	2.7	42.5	4.8	3.2	8.8	14.2	5.3	2.4	15.0	9.5	4.0	4.3	20.0	7.2	5.6	4.4	4.3	4.9	4.9	19.6	2.7	3.7	4.6	2.6	3.6	5.2	4.5	3.2	2.3	1.7	2.6	2.9	6.9	7.3	3.3	1.3	1.3	2.4	1.2	0.5	1.8	8.2	3.1	5.8	6.6	3.1	2.5	3.5	1.5	4.0	4.2	4.7	4.8	7.9	0.8	8.0	3.0	5.9	2.2	3.9	13.3	11.5	5.9	2.4	2.4	3.1	1.7	3.9	4.5	2.9	3.6	4.0	2.9	2.5	2.7	4.6	1.3	7.6	5.0	3.3	2.3	2.3	2.0	6.7	5.1	2.9	1.9	4.7	1.9	1.9	0.3	0.4	0.7	0.1	0.6	1.2	0.7	0.5	0.1	0.8	0.9	0.5	1.0	0.4	0.3	0.6	1.1	0.1	19.9	19.9	33.4	26.5	20.0	20.3	16.7	17.4	16.0	15.0	20.0	19.6	1.3	0.0	3.4	0.7	1.0	1.1	0.3	0.4	1.2	10.3	1.1	1.0	2.6	1.5	1.5	0.0	6.2	0.2	1.5	0.7	0.0	1.1	0.8	1.0	1.0	1.6	1.2	4.0	0.9	0.2	0.2	1.6	0.5	0.9	0.0	1.0	1.8	95.9	0.2	5.0	1.1	2.5	0.0	1.3	0.4	0.3	1.2	1.1	3.6	0.0	1.6	2.7	1.0	0.0	0.8	0.3	0.3	1.9	0.9	0.5	0.7	1.8	2.3	18.2	0.0	2.5	1.0	0.7	0.5	1.5	1.3	0.0	1.4	0.9	0.9	0.3
PMM2	"CDG1, CDG1a, CDGS, PMI, PMI1"	ENSG00000140650	"Phosphomannomutase 2"	O15305	16	8788823-8849325	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	8	"basophil: 210.5"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 210.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040852, HPA063649"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		21000	"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA040852: AB_10794069, HPA063649: AB_2685074"	"unprognostic (8.62e-3)"	"unprognostic (8.00e-3)"	"prognostic favorable (1.04e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.14e-3)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (8.97e-6)"	"unprognostic (1.22e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.02e-2)"	18.5	18.3	3.3	15.1	4.6	6.4	16.7	3.3	4.2	13.7	8.4	26.0	25.0	10.6	11.9	29.0	10.7	10.6	13.2	3.8	3.5	16.7	51.8	13.8	13.7	3.6	3.7	7.5	36.5	10.2	12.1	15.5	3.5	14.2	26.0	1.5	22.6	7.4	9.7	16.2	21.3	12.5	3.5	14.0	19.6	4.5	3.9	9.6	11.3	5.9	14.2	21.7	15.7	3.6	26.1	56.5	12.3	32.7	21.8	33.7	27.4	39.8	47.3	38.8	41.6	42.5	31.5	41.0	16.3	69.4	20.2	35.1	25.3	48.5	39.2	30.7	29.0	13.6	33.0	73.8	40.4	36.9	31.6	50.4	33.7	41.1	37.9	18.1	40.1	24.5	18.9	39.6	26.0	68.3	37.9	33.9	52.8	60.0	35.8	47.2	27.4	82.8	43.5	45.0	23.5	43.7	32.7	71.4	23.9	19.5	46.4	31.7	47.7	27.8	31.5	76.6	39.5	48.2	43.3	51.5	23.4	45.5	38.0	210.5	16.5	3.2	7.9	13.0	11.7	9.5	7.0	10.2	12.1	7.8	7.7	7.5	26.5	6.2	8.4	10.9	5.7	10.9	3.3	4.6	3.3	4.2	3.8	3.5	3.6	3.7	3.5	3.5	3.9	3.6	16.5	16.0	24.1	12.7	18.4	3.8	11.6	7.7	14.8	4.7	10.6	9.5	3.1	4.3	28.8	0.0	14.6	8.9	11.9	11.2	9.8	16.3	0.9	15.9	32.0	11.7	7.7	9.0	29.3	28.5	11.9	16.6	23.9	38.5	22.8	12.9	2.5	12.8	5.5	1.7	26.1	21.2	2.0	4.7	1.7	0.9	6.2	10.4	1.8	21.5	9.6	2.5	9.2	22.6	21.6	23.3	9.7	2.2	49.5	12.6	12.3	17.4	16.8	9.0	0.0	13.5	9.8	2.0	4.2	27.0	4.1	10.7	16.0	13.1	12.6	14.9
PMS2	"H_DJ0042M02.9, HNPCC4, MLH4, PMSL2"	ENSG00000122512	"PMS1 homolog 2, mismatch repair system component"	P54278	7	5970925-6009106	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010235, HPA066490, HPA070310"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"CAB010235: AB_2167281, HPA066490: AB_2685677, HPA070310: AB_2686250"	"unprognostic (5.13e-2)"	"unprognostic (6.55e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.38e-2)"	"prognostic favorable (1.23e-5)"	"unprognostic (5.31e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.81e-2)"	5.3	5.1	6.7	5.3	7.2	5.8	6.5	6.3	7.6	4.8	2.8	4.8	5.7	4.9	5.0	5.3	5.7	4.0	4.1	7.4	5.8	10.4	4.7	4.4	8.4	5.3	5.6	5.7	3.9	11.0	4.6	4.8	5.5	5.2	4.7	8.4	5.7	5.5	4.5	11.9	5.3	5.3	4.4	5.9	5.0	4.0	5.2	8.8	9.2	3.5	8.9	5.1	4.9	7.0	15.1	16.7	12.9	32.2	9.0	13.6	10.9	7.8	5.8	6.6	5.6	14.0	9.9	28.2	8.7	10.9	17.2	19.6	19.2	6.6	8.0	11.3	7.2	12.0	12.5	10.1	15.9	15.8	9.4	15.1	14.8	5.4	22.3	11.4	13.7	15.2	22.9	12.6	11.9	15.5	5.2	17.1	13.3	7.6	9.6	16.3	15.3	14.0	16.4	11.0	11.9	25.7	13.3	23.0	16.2	18.0	27.1	11.8	12.4	9.3	21.2	14.2	14.6	19.8	32.8	27.5	7.2	15.3	22.9	5.0	2.9	1.9	4.5	4.1	4.9	3.4	3.5	3.8	3.0	3.4	4.4	3.4	1.4	2.3	1.8	3.1	3.4	3.4	6.7	7.2	6.3	7.6	7.4	5.8	5.3	5.6	5.5	4.4	5.2	7.0	12.2	12.8	8.2	11.4	13.6	5.0	9.3	10.9	15.9	13.2	10.7	11.3	3.2	12.8	9.7	11.0	22.9	9.4	15.2	1.8	35.2	5.5	9.9	11.0	14.6	10.1	5.4	8.4	14.0	3.3	6.3	6.6	8.2	11.8	5.1	11.4	7.9	7.6	5.2	30.3	12.2	2.2	10.2	7.1	5.9	6.6	12.8	6.3	7.2	5.6	8.7	7.8	20.6	3.5	8.3	4.7	2.6	10.1	9.6	12.6	2.2	39.5	9.3	14.3	26.3	10.0	8.0	34.5	11.7	10.5	8.1	12.7	11.4	11.9	2.6	11.1
PNRC2		ENSG00000189266	"Proline rich nuclear receptor coactivator 2"	Q9NPJ4	1	23956839-23963462	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027820, HPA045837"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA027820: AB_10602147, HPA045837: AB_2679467"	"prognostic favorable (6.02e-4)"	"unprognostic (5.99e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.10e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.45e-3)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.44e-2)"	"prognostic favorable (4.05e-4)"	82.7	82.5	49.5	80.6	52.1	141.0	78.5	53.4	62.0	69.6	56.1	98.1	99.5	87.4	68.6	62.8	58.3	80.5	75.2	49.6	51.9	99.6	66.8	76.0	137.0	52.6	50.7	79.3	52.2	94.3	34.8	103.3	54.4	70.5	92.2	56.2	55.0	56.9	49.8	46.1	84.2	71.8	50.9	87.5	81.9	33.7	51.9	133.5	122.2	63.6	109.5	100.1	51.4	57.8	107.8	42.0	179.5	124.9	121.5	110.7	68.6	116.7	103.7	132.7	106.1	122.7	132.5	291.7	111.5	74.8	49.9	93.5	121.6	101.8	146.7	208.6	78.7	277.5	131.8	130.2	103.3	272.1	122.3	83.9	125.8	109.2	101.0	86.8	130.3	148.4	239.6	159.5	79.0	87.5	169.4	103.3	243.8	101.7	76.5	189.7	116.7	125.0	134.8	113.8	107.4	93.5	101.0	85.7	123.7	130.9	93.6	168.6	105.3	85.6	82.2	84.6	75.4	133.7	164.8	197.6	58.0	259.0	89.8	230.8	112.7	126.8	103.5	115.0	108.8	129.1	112.5	112.2	109.1	131.1	124.9	106.8	74.2	108.6	112.2	77.4	129.4	178.3	49.5	52.1	53.4	62.0	49.6	51.9	52.6	50.7	54.4	50.9	51.9	57.8	119.0	185.9	109.2	11.4	122.5	13.3	231.7	2.0	99.0	33.6	110.5	109.6	84.8	58.6	62.2	62.5	18.8	129.8	104.7	160.5	238.7	90.5	6.9	86.0	96.1	97.3	100.4	157.0	7.9	127.8	101.4	128.7	66.3	130.9	76.5	84.1	86.7	30.0	68.6	20.2	6.4	109.3	0.0	82.3	10.9	14.2	78.9	109.0	1.8	13.1	81.8	66.9	127.7	6.0	11.8	119.2	157.7	81.3	48.8	187.6	90.3	112.0	56.1	28.7	46.0	104.3	104.5	21.2	24.4	97.8	12.6	141.7	104.0	203.9	110.2	314.0
POC1B	"FLJ14923, TUWD12, WDR51B"	ENSG00000139323	"POC1 centriolar protein B"	Q8TC44	12	89419718-89526047	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 73.2;Late spermatids: 96.3;Oligodendrocytes: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 45: Intestine - Brush border"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"				"unprognostic (1.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.28e-2)"	"prognostic favorable (9.59e-5)"	"unprognostic (4.86e-3)"	"unprognostic (6.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.18e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.05e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (3.10e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.69e-2)"	6.0	5.6	8.1	6.3	10.8	6.5	8.0	9.7	11.2	11.4	6.0	12.6	11.9	8.7	4.9	5.9	12.3	8.4	5.8	7.5	9.1	11.9	8.0	6.6	7.9	10.3	9.4	7.3	4.8	9.3	5.2	7.0	10.1	5.3	12.8	5.4	8.0	6.3	4.9	4.3	12.7	6.3	9.9	8.9	10.9	7.2	8.9	7.6	8.1	7.2	8.0	8.4	5.9	14.1	13.4	12.0	12.2	21.6	12.3	9.6	8.5	13.3	12.7	10.5	9.4	7.1	6.1	5.3	3.5	9.2	11.2	10.2	10.6	15.4	16.1	17.9	9.2	11.3	4.0	9.2	7.2	17.5	13.1	6.4	10.7	13.3	21.9	25.6	21.7	19.6	11.9	10.9	13.5	8.9	13.2	17.0	5.9	25.1	30.8	15.3	12.9	15.1	17.0	16.1	11.2	12.1	10.3	15.7	18.9	14.7	24.6	8.0	12.9	9.0	3.1	12.7	10.8	13.7	12.1	12.5	7.5	14.6	10.1	12.1	9.8	14.8	15.0	10.0	19.2	9.4	10.6	13.2	8.9	10.4	8.5	11.6	10.3	18.9	9.4	2.3	10.6	11.1	8.1	10.8	9.7	11.2	7.5	9.1	10.3	9.4	10.1	9.9	8.9	14.1	8.6	9.6	9.4	30.7	15.5	9.1	9.1	9.5	4.6	6.8	8.6	4.6	8.2	17.2	18.6	3.7	31.3	5.8	19.1	12.0	15.6	9.2	60.5	53.1	11.4	10.0	10.2	22.3	39.4	12.5	3.6	8.3	18.8	73.2	17.7	9.7	8.2	6.8	7.2	5.0	25.0	13.9	10.2	14.1	17.7	96.3	7.2	14.2	10.6	15.9	11.2	6.9	18.6	30.7	99.1	9.2	14.8	8.2	15.1	13.0	15.3	19.4	30.3	41.1	0.0	6.3	8.0	14.6	2.6	10.7	11.9	5.6	20.1	6.2	14.2	22.2
POLR3B	"C128, FLJ10388, RPC2"	ENSG00000013503	"RNA polymerase III subunit B"	Q9NW08	12	106357748-106510198	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	"Nucleotidyltransferase, Transferase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036466	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA036466: AB_10671842"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.09e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.24e-2)"	4.5	8.7	3.1	4.8	4.4	5.2	5.0	4.3	4.6	4.7	3.7	5.3	4.2	4.6	5.2	8.6	5.1	3.6	5.8	3.4	2.9	6.8	9.0	4.7	4.1	2.2	2.3	7.5	4.9	11.1	2.4	6.7	2.3	5.6	5.7	6.2	4.7	4.0	6.5	11.0	3.4	5.4	2.7	3.3	5.4	6.1	3.2	4.7	6.0	8.3	5.6	4.9	4.3	3.6	16.2	7.6	16.4	7.8	13.9	13.1	22.9	21.9	13.0	15.2	11.6	14.0	4.4	20.6	7.7	14.2	5.6	14.8	19.5	19.2	18.5	16.6	13.1	15.7	10.1	12.0	9.2	26.1	17.0	11.7	13.4	15.1	17.3	10.3	11.5	9.8	24.5	6.5	11.2	12.0	19.1	8.7	17.8	11.9	28.5	11.6	9.8	13.5	8.6	21.8	17.3	9.6	13.6	18.2	13.4	10.8	17.0	7.9	11.0	8.3	10.0	13.6	13.1	8.1	22.4	30.3	3.8	15.9	9.2	5.6	2.0	1.5	2.0	2.2	2.7	2.1	2.2	2.2	2.6	1.3	3.0	1.9	1.3	2.1	2.2	0.9	2.7	1.7	3.1	4.4	4.3	4.6	3.4	2.9	2.2	2.3	2.3	2.7	3.2	3.6	2.4	0.0	9.2	14.4	4.7	1.8	1.7	4.5	4.6	6.0	3.4	3.7	10.3	2.8	7.0	5.5	6.2	11.0	3.8	3.8	1.9	5.1	7.1	3.9	7.0	3.3	4.2	3.8	22.3	4.6	9.3	4.4	9.2	3.9	5.1	4.8	3.6	11.0	3.1	3.3	24.1	5.6	2.0	1.6	0.3	5.2	3.7	2.4	3.6	9.4	1.0	2.4	2.1	17.1	22.4	3.8	1.1	4.9	4.9	1.5	1.7	3.4	7.2	7.2	6.6	6.9	4.1	16.5	10.9	8.9	3.0	7.4	4.1	7.2	5.1	1.2
POP1		ENSG00000104356	"POP1 homolog, ribonuclease P/MRP subunit"	Q99575	8	98117293-98159835	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066194			Supported	Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA066194: AB_2732742"	"prognostic unfavorable (2.54e-4)"	"unprognostic (9.42e-2)"	"unprognostic (5.96e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.46e-2)"	"prognostic unfavorable (1.26e-6)"	"prognostic unfavorable (9.88e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.96e-1)"	2.1	1.6	1.7	3.5	1.5	1.5	2.1	3.4	2.3	1.4	1.2	1.9	1.5	1.7	1.4	3.0	1.8	1.3	1.6	1.3	1.2	2.0	1.9	1.6	3.6	1.1	1.4	2.9	1.7	1.7	1.5	1.2	1.1	1.5	4.8	2.4	1.4	1.3	1.7	3.0	1.6	1.8	0.8	2.1	1.9	3.1	1.6	2.6	1.5	1.2	4.4	2.5	1.5	1.8	21.9	12.9	13.8	12.8	4.8	3.3	9.1	18.3	15.2	18.7	13.8	13.4	13.8	15.3	25.6	12.9	9.0	14.3	40.3	18.2	18.9	11.1	17.0	30.0	10.2	9.2	2.1	16.4	18.4	2.8	3.3	20.8	8.2	5.7	14.8	7.2	17.0	13.5	17.7	17.4	23.8	8.3	10.4	25.1	17.6	19.4	7.5	11.0	13.5	11.5	32.8	7.7	8.4	14.2	6.4	7.9	19.2	6.0	18.4	16.3	11.6	20.8	36.5	13.3	13.6	32.7	12.8	17.3	14.6	9.4	5.1	3.9	7.4	5.7	6.0	4.9	5.4	5.0	5.0	8.1	6.8	6.5	0.8	3.8	2.9	6.2	4.9	2.1	1.7	1.5	3.4	2.3	1.3	1.2	1.1	1.4	1.1	0.8	1.6	1.8	2.3	3.2	3.9	10.7	4.7	3.7	8.2	3.8	4.0	7.0	2.5	2.3	3.9	0.0	3.8	5.5	0.0	4.1	4.1	2.7	5.9	8.8	13.8	2.4	6.4	4.2	0.0	5.0	17.7	5.9	3.4	5.8	6.6	2.9	1.3	5.9	1.8	5.4	3.4	1.7	19.0	1.7	2.0	2.4	0.8	3.0	5.3	3.3	0.0	3.7	7.9	2.7	10.3	8.5	11.0	7.8	1.0	4.5	5.2	4.8	1.1	8.5	2.6	9.5	6.6	4.0	6.1	7.7	19.1	9.8	2.4	3.0	4.4	6.1	3.9	5.1
POU5F1B	"OTF3C, OTF3P1, POU5F1P1"	ENSG00000212993	"POU class 5 homeobox 1B"	Q06416	8	127322183-127420066	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"choroid plexus: 3.1"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 4.2;Distal enterocytes: 3.2;Endometrial ciliated cells: 5.5;Glandular and luminal cells: 10.6"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.1;EFO-21: 1.5;hTERT-HME1: 3.7;NTERA-2: 1.9"									HPA058267			Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA058267: AB_2683659"	"unprognostic (1.74e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.58e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.65e-1)"	"unprognostic (5.85e-2)"	"unprognostic (9.31e-4)"	"unprognostic (2.21e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.25e-1)"	"unprognostic (6.56e-2)"	"unprognostic (5.11e-2)"	"unprognostic (5.60e-10)"	"unprognostic (1.21e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.33e-3)"	0.2	0.1	0.2	0.1	0.2	0.2	0.7	0.7	0.3	0.3	3.1	0.4	0.1	0.5	0.6	0.2	0.5	0.2	0.0	0.5	0.2	0.5	0.2	0.2	0.3	0.3	0.5	0.2	0.2	0.4	0.1	0.2	0.3	0.6	0.5	0.2	1.7	0.3	0.1	0.6	0.1	0.1	0.0	0.2	0.3	0.2	0.2	0.2	0.5	0.0	0.2	0.1	0.2	0.2	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.0	1.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	3.7	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.2	0.1	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.2	0.7	0.3	0.5	0.2	0.3	0.5	0.3	0.0	0.2	0.2	1.0	0.0	0.5	0.0	0.2	0.3	0.3	0.3	0.0	0.0	1.0	0.9	0.7	0.0	0.4	0.0	4.2	0.0	0.1	3.2	1.9	1.5	0.3	5.5	0.9	1.4	0.0	0.0	0.0	1.8	0.0	0.4	0.0	10.6	0.0	0.0	0.4	0.1	0.0	1.7	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	2.3	0.0	0.1	0.2	2.7	0.4	0.9	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.6	0.0	0.4	0.0	1.3	0.4
PPM1E	"CaMKP-N, KIAA1072, POPX1, PP2CH"	ENSG00000175175	"Protein phosphatase, Mg2+/Mn2+ dependent 1E"	Q8WY54	17	58755854-58985179	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 39.2;retina: 22.3"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 220.9;Horizontal cells: 77.4;Inhibitory neurons: 288.4;Oligodendrocyte precursor cells: 109.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.7;prostate cancer: 3.0"	"Group enriched"	"Detected in many"	4	"cerebral cortex: 31.6;hippocampal formation: 39.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 12.2;HAP1: 19.9;MOLT-4: 9.9;SCLC-21H: 9.1;SH-SY5Y: 18.7;THP-1: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018462, HPA019263"	Approved		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli	Nucleoplasm	"HPA018462: AB_1855623, HPA019263: AB_1855624"	"unprognostic (2.50e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.99e-2)"	"unprognostic (5.30e-1)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.22e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.80e-5)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-7)"	"unprognostic (1.05e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.12e-2)"	0.1	5.5	5.3	0.1	4.8	0.0	0.1	1.0	31.6	0.2	0.0	0.1	0.1	0.3	0.9	0.0	1.5	0.1	1.0	39.2	7.3	0.7	1.0	0.2	0.2	1.9	4.2	0.2	0.6	0.3	1.3	0.0	3.2	1.4	0.0	22.3	0.2	0.0	0.0	0.0	0.2	0.3	0.3	0.2	0.5	6.7	8.0	0.2	0.1	0.1	0.2	0.1	0.1	2.3	0.0	0.1	12.2	0.6	0.0	0.0	0.9	0.0	0.0	0.9	1.4	0.0	0.0	8.0	0.1	0.1	2.7	0.0	19.9	0.0	0.5	0.2	5.9	0.0	0.2	0.0	1.3	0.6	2.6	0.3	1.6	0.1	0.0	0.6	0.0	4.9	2.1	0.0	0.0	3.6	9.9	0.0	3.5	0.0	1.0	0.0	1.5	0.0	0.0	0.0	9.1	18.7	0.3	0.0	1.3	0.1	0.0	8.7	0.0	0.0	2.2	0.0	2.9	0.1	0.1	5.4	0.3	0.0	2.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	4.8	1.0	31.6	39.2	7.3	1.9	4.2	3.2	0.3	8.0	2.3	0.1	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	22.0	0.1	0.4	3.3	0.0	1.8	0.0	31.3	0.0	0.0	0.1	0.0	0.0	30.8	3.9	0.1	0.3	3.0	0.0	220.9	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	1.4	0.1	77.4	288.4	0.0	0.0	0.3	0.0	17.6	0.0	0.1	0.0	5.6	0.0	4.2	0.0	109.1	38.4	0.0	0.2	0.4	0.0	1.3	0.0	0.1	0.0	13.8	0.0	0.0	0.5	12.1	2.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0
PPP2R5A	"B56A, B56alpha, PR61A"	ENSG00000066027	"Protein phosphatase 2 regulatory subunit B'alpha"	Q15172	1	212285410-212361853	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 252.7;Late spermatids: 547.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059288, HPA078841"	Approved		Supported	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA059288: AB_2683966, HPA078841: "	"unprognostic (3.56e-1)"	"unprognostic (2.71e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.40e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.39e-1)"	60.2	12.0	35.5	20.0	40.6	86.5	38.3	34.4	34.9	24.7	27.4	34.2	25.7	20.1	18.4	51.3	19.2	27.7	50.4	31.0	35.6	35.6	51.6	57.7	31.0	36.3	40.8	15.3	36.9	23.5	13.2	35.9	36.1	22.6	37.0	23.9	36.3	22.2	36.7	30.8	33.4	22.2	35.0	49.5	44.5	17.4	42.6	36.3	41.8	56.6	31.3	34.7	30.2	39.6	45.4	19.1	9.5	19.1	102.5	62.2	76.1	19.6	38.3	21.9	20.6	57.1	45.7	31.9	14.5	31.5	22.9	32.0	18.3	27.9	22.8	27.5	23.1	20.7	19.9	20.8	33.1	43.3	30.7	25.7	36.4	20.1	29.0	27.7	53.3	28.0	29.6	33.4	12.1	19.7	17.1	28.5	16.0	40.6	39.5	22.0	15.2	40.6	38.5	20.9	13.6	9.1	27.3	84.7	65.0	40.0	52.7	38.0	11.4	15.3	15.6	24.2	21.2	50.9	42.7	42.1	18.4	32.6	11.5	18.0	2.0	10.1	4.4	2.3	3.0	1.4	3.4	4.0	1.4	2.2	2.0	4.0	9.8	3.3	3.3	1.5	5.2	1.4	35.5	40.6	34.4	34.9	31.0	35.6	36.3	40.8	36.1	35.0	42.6	39.6	66.7	99.3	104.4	71.5	34.2	68.6	22.1	9.0	40.9	24.6	30.1	18.5	65.8	47.1	17.4	14.7	2.1	10.9	56.2	51.2	97.8	25.9	252.7	25.5	17.7	53.3	16.2	22.9	21.3	34.8	26.9	18.7	43.8	53.5	40.0	6.6	38.6	52.2	22.1	52.2	13.8	33.9	8.2	34.8	20.6	547.2	19.3	34.1	17.8	45.0	35.1	37.4	53.5	32.6	115.2	27.8	32.5	14.3	29.6	31.0	30.8	20.9	21.3	11.1	32.9	14.8	36.5	18.4	10.9	66.2	81.3	8.2	54.1	58.3	30.8	45.7
PPP3R1	"CALNB1, CNB, CNB1"	ENSG00000221823	"Protein phosphatase 3 regulatory subunit B, alpha"	P63098	2	68178857-68256237	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 189.9"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005610, HPA047157"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		42000	"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	Cytosol	"CAB005610: AB_325975, HPA047157: AB_2679960"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (9.08e-6)"	"unprognostic (5.90e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (3.59e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.70e-5)"	"unprognostic (5.24e-3)"	"unprognostic (5.35e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-1)"	53.7	37.7	56.1	32.4	92.9	73.6	27.1	38.0	127.3	27.3	0.0	27.6	25.7	31.0	26.1	30.0	23.3	28.0	20.6	99.0	24.2	21.4	58.2	27.7	40.2	23.5	18.4	24.9	20.7	17.0	18.3	36.6	24.9	26.3	27.8	189.9	24.9	30.1	88.8	33.6	23.9	35.3	14.4	34.2	24.8	20.6	30.0	42.6	23.8	31.0	40.5	32.9	28.6	64.5	61.5	51.7	69.7	48.4	47.4	54.3	70.5	86.3	75.9	98.8	86.8	75.9	55.4	85.7	28.7	61.4	69.5	41.8	74.4	64.8	120.0	59.4	52.9	284.0	38.3	71.1	93.1	111.9	92.2	55.1	57.6	76.9	78.0	55.9	67.2	72.2	67.8	96.8	73.2	53.8	96.1	99.4	81.9	52.0	44.4	69.1	90.6	139.9	61.7	66.1	91.4	64.2	50.4	72.3	65.9	45.0	33.9	51.8	69.5	84.6	76.5	64.2	75.1	53.8	62.6	124.7	61.3	115.2	54.0	1.5	0.5	1.3	0.2	0.3	0.5	0.2	0.3	0.1	0.5	0.3	0.3	0.5	2.7	0.3	0.6	0.7	0.3	0.4	56.1	92.9	38.0	127.3	99.0	24.2	23.5	18.4	24.9	14.4	30.0	64.5	37.0	9.6	12.7	81.6	40.4	74.8	11.6	7.0	72.8	22.2	21.0	13.1	17.9	10.0	7.7	16.5	52.1	11.7	34.0	20.5	11.7	7.1	20.0	19.9	23.0	34.0	15.1	52.8	151.2	8.7	17.2	24.2	18.8	29.1	19.7	11.2	15.4	19.2	24.7	11.8	93.1	15.6	4.1	40.0	105.1	7.7	9.9	54.7	35.6	105.9	21.2	27.8	18.6	72.9	77.5	12.9	10.6	8.6	39.2	17.3	12.6	20.1	5.8	92.7	13.1	14.4	29.8	2.9	6.1	64.0	70.5	12.0	39.9	14.2	13.2	21.3
PRKG2	"cGKII, PKG2, PRKGR2"	ENSG00000138669	"Protein kinase cGMP-dependent 2"	Q13237	4	81087370-81215117	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 13.1;prostate: 9.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 35.3;Excitatory neurons: 32.6;Inhibitory neurons: 66.1;Oligodendrocyte precursor cells: 106.6;Proximal enterocytes: 19.7;Smooth muscle cells: 29.8"	"Group enriched"	"Detected in some"	4	"melanoma: 4.1;prostate cancer: 2.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.0;ASC TERT1: 3.8;HEL: 21.2;hTCEpi: 4.0;SCLC-21H: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007386, CAB018739"	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 10: Non-specific - Unknown function"			"CAB018739: AB_2284387, HPA007386: AB_1079678"	"unprognostic (6.14e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.01e-4)"	"unprognostic (4.33e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.06e-1)"	1.0	0.2	2.1	0.2	1.5	0.5	1.5	0.5	1.7	1.0	0.0	2.4	9.6	0.4	0.3	2.8	0.3	0.2	4.3	1.5	1.6	0.5	0.0	3.3	0.2	3.5	2.7	0.0	1.4	0.0	2.2	0.0	3.8	9.6	2.8	0.3	0.3	3.4	0.0	1.2	13.1	0.5	2.2	0.0	0.9	0.9	6.0	1.0	0.9	0.0	0.4	0.5	0.6	1.0	0.1	0.3	0.1	0.0	5.0	3.8	0.0	0.3	0.0	0.0	0.0	0.4	2.4	0.0	0.2	0.9	0.0	0.1	0.3	1.5	0.0	0.4	0.0	21.2	0.6	0.1	0.0	0.0	0.0	0.5	4.0	0.0	0.0	1.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.1	0.9	0.6	0.4	0.0	0.0	0.1	0.0	0.9	6.3	0.0	0.0	0.2	0.0	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.1	1.5	0.5	1.7	1.5	1.6	3.5	2.7	3.8	2.2	6.0	1.0	0.3	35.3	2.6	1.0	0.3	0.0	0.9	0.1	1.2	0.0	0.3	0.1	4.9	0.0	2.0	0.0	0.0	0.0	0.1	5.5	0.0	0.2	10.3	0.3	0.6	0.1	0.0	8.0	32.6	0.0	0.1	2.5	0.0	0.1	1.3	0.1	0.0	0.0	0.1	0.0	66.1	1.7	0.0	0.0	0.0	2.2	0.0	0.1	0.0	12.2	0.1	0.0	0.0	106.6	1.1	0.9	9.2	0.0	0.5	0.8	19.7	0.2	0.8	0.0	0.0	0.1	29.8	0.0	1.3	0.8	0.1	0.0	0.4	0.0	0.7	0.3
PRPF38A	"FLJ14936, Prp38"	ENSG00000134748	"Pre-mRNA processing factor 38A"	Q8NAV1	1	52404602-52420836	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053099, HPA058407"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA053099: AB_2682044, HPA058407: AB_2683709"	"unprognostic (1.29e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (7.16e-4)"	"unprognostic (1.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.15e-3)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (3.83e-2)"	"unprognostic (7.84e-3)"	"unprognostic (7.06e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.69e-2)"	"prognostic unfavorable (7.41e-5)"	"unprognostic (6.54e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.82e-1)"	9.0	8.1	11.8	10.7	12.2	19.3	13.3	16.2	14.2	12.1	10.5	11.2	8.4	14.1	9.8	9.5	11.4	7.1	7.4	11.3	12.3	10.4	7.9	9.7	15.7	12.2	12.5	17.3	7.9	8.9	9.6	9.9	12.1	10.1	12.1	17.6	8.4	9.0	6.7	11.4	10.7	9.0	11.6	11.2	8.2	8.9	11.8	21.1	12.2	8.1	15.0	8.7	10.3	13.5	17.6	8.5	29.8	14.3	11.5	11.3	17.6	11.8	8.0	19.1	18.3	15.5	8.5	36.2	12.0	8.1	14.8	12.8	42.6	12.8	24.7	19.8	32.4	48.7	31.1	16.3	14.2	54.8	17.2	8.7	11.2	20.9	20.0	14.5	16.3	25.9	45.4	9.2	11.5	9.9	42.5	32.8	36.6	18.6	19.7	41.3	44.8	30.3	16.9	10.4	19.7	24.0	23.8	19.3	23.8	20.0	13.6	43.8	12.9	10.8	16.2	16.3	23.5	17.4	26.6	35.7	15.9	47.0	14.0	12.3	6.2	8.9	7.4	7.1	10.2	7.2	8.3	9.1	7.9	6.5	11.3	8.8	4.8	11.1	7.5	4.3	8.9	5.7	11.8	12.2	16.2	14.2	11.3	12.3	12.2	12.5	12.1	11.6	11.8	13.5	37.5	41.7	32.1	8.5	49.1	53.0	92.7	48.8	33.6	35.9	34.4	32.1	29.9	22.8	41.1	16.5	93.8	60.5	52.6	69.9	35.2	36.9	84.6	36.8	34.3	47.6	35.8	44.6	6.7	29.4	77.9	33.8	20.4	31.6	60.1	43.1	34.6	19.3	40.0	25.2	7.2	42.7	32.6	35.8	40.0	18.6	25.7	34.4	30.2	1.9	40.4	49.4	70.0	7.1	7.4	27.0	49.1	33.4	47.3	47.0	61.2	34.9	28.3	47.8	52.6	53.8	33.2	109.8	55.1	38.1	56.0	103.4	57.6	44.7	62.2	67.9
PRR29	"C17orf72, DKFZp761M2312, FLJ11724"	ENSG00000224383	"Proline rich 29"	P0C7W0	17	63998351-64004305	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 58.2"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 57.4;Respiratory ciliated cells: 89.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 4.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.5;REH: 3.7;TIME: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051264			Uncertain	Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoli		"HPA051264: "	"unprognostic (2.05e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.92e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.22e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.63e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.30e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.98e-3)"	2.0	0.3	3.2	0.5	2.5	0.3	2.2	1.8	1.2	6.1	12.7	0.4	0.2	0.6	0.3	0.2	58.2	0.7	1.5	4.1	4.2	1.9	0.2	10.4	0.4	12.7	16.0	0.6	0.3	0.9	10.7	0.3	7.3	0.7	0.0	0.0	0.5	0.6	0.6	0.4	0.7	0.2	9.0	5.7	0.3	13.9	4.0	0.2	4.7	0.0	0.3	0.8	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.2	0.0	3.5	0.0	0.3	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	1.0	0.5	0.0	0.0	0.0	1.3	0.0	0.1	0.7	0.1	3.7	0.0	1.5	0.3	0.0	0.2	1.0	0.0	0.1	0.2	0.5	0.5	0.0	2.8	0.1	1.1	0.4	0.1	0.4	0.1	0.2	0.4	0.1	0.0	0.9	0.2	0.0	0.4	0.5	0.1	0.1	0.4	0.2	0.1	0.2	0.7	0.4	0.2	0.2	0.4	0.0	0.2	0.3	3.2	2.5	1.8	1.2	4.1	4.2	12.7	16.0	7.3	9.0	4.0	3.9	3.3	0.0	2.8	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.5	0.6	0.2	1.5	9.9	3.7	0.0	0.0	0.7	0.0	0.0	0.1	12.4	57.4	0.5	2.1	0.0	0.0	0.5	0.0	0.1	0.6	0.0	1.1	0.0	1.6	1.8	0.5	0.3	0.0	0.4	0.0	0.0	0.0	0.0	10.5	0.0	0.9	0.0	1.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.7	2.0	0.0	0.0	0.1	89.6	0.0	0.0	0.3	0.3	18.1	1.4	0.0	0.0	0.3	0.7	3.5	0.0	0.1
PRSS57	"PRSSL1, UNQ782"	ENSG00000185198	"Serine protease 57"	Q6UWY2	19	685546-695498	"Enzymes, Predicted secreted proteins"		"Heparin-binding, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	102	"bone marrow: 165.3"	"Cell type enriched"	"Detected in some"	9	"Erythroid cells: 77.8"	"Cancer enriched"	"Detected in single"	10	"pancreatic cancer: 2.2"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"NB-4: 377.2;THP-1: 184.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"				"unprognostic (2.89e-1)"	"unprognostic (1.43e-1)"		"unprognostic (2.10e-1)"		"unprognostic (3.99e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.70e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.56e-2)"		0.1	0.0	0.0	0.0	0.0	165.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.1	7.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	377.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	184.4	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	3.2	0.0	5.9	1.1	0.0	0.4	0.2	0.0	0.0	0.0	3.1	1.5	0.0	0.0	0.5	0.7	2.5	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	77.8	0.1	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.5	0.0	0.0	0.2	0.0	0.0	2.5	1.0	8.2	0.0	0.1	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0
PRXL2C	"AAED1, C9orf21"	ENSG00000158122	"Peroxiredoxin like 2C"	Q7RTV5	9	96639577-96655317	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.8;Cardiomyocytes: 18.3;Cytotrophoblasts: 15.7;dendritic cells: 22.5;Extravillous trophoblasts: 69.9;Hofbauer cells: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 45.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 45.7"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 38.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021294	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"			"HPA021294: AB_1845818"	"unprognostic (4.17e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.35e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.83e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (3.13e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.70e-2)"	13.3	5.6	3.5	6.1	3.8	11.5	10.1	3.6	4.3	6.5	3.9	7.6	3.7	8.0	2.9	5.5	8.0	8.4	13.8	3.7	3.7	5.5	6.9	9.7	4.9	5.2	4.0	5.0	6.0	3.2	3.1	6.4	5.0	5.3	4.2	1.2	3.9	3.7	11.3	4.9	5.6	10.9	4.4	7.1	5.5	5.2	4.4	3.4	8.2	7.9	5.3	8.5	5.2	5.0	11.0	5.6	2.7	9.6	22.5	38.4	10.7	12.1	18.1	10.0	9.6	12.7	12.2	0.3	9.8	19.8	19.4	10.4	9.5	5.8	6.0	11.3	5.9	6.3	4.9	10.5	17.2	5.1	17.3	18.3	10.0	7.0	8.8	9.9	8.8	4.4	12.6	4.6	10.4	7.8	0.2	9.0	3.7	4.5	10.5	0.2	8.0	0.2	14.2	2.5	4.3	5.4	8.8	7.4	6.5	8.0	2.9	9.0	16.1	16.8	7.0	16.4	8.0	12.2	5.8	4.2	7.2	4.7	15.7	45.7	9.6	23.2	10.1	11.4	10.6	10.1	9.4	10.1	8.7	7.6	4.9	8.2	2.0	5.8	11.1	5.6	10.6	3.5	3.5	3.8	3.6	4.3	3.7	3.7	5.2	4.0	5.0	4.4	4.4	5.0	23.8	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	15.7	22.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	69.9	10.7	0.0	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	6.3	8.9	0.0	0.0	0.0
PSME4	"KIAA0077, PA200"	ENSG00000068878	"Proteasome activator subunit 4"	Q14997	2	53864069-53970993	"Predicted intracellular proteins"	"Differentiation, DNA damage, DNA repair, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.8"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 238.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060922	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA060922: AB_2684386"	"unprognostic (2.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavorable (8.99e-4)"	"unprognostic (7.26e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (4.76e-2)"	"unprognostic (6.67e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.89e-1)"	7.4	8.6	5.3	8.1	8.8	16.1	12.1	5.7	7.4	15.4	11.1	9.8	5.9	16.1	6.2	8.8	8.0	11.9	16.9	6.4	7.1	7.0	16.6	8.0	11.1	7.1	7.0	6.7	7.9	8.3	6.8	8.5	6.4	10.0	8.4	8.9	14.5	7.4	59.8	7.2	7.1	15.0	5.0	9.5	10.6	33.6	8.1	10.7	14.4	45.2	12.2	13.2	8.1	12.6	28.0	18.3	27.6	8.5	9.1	19.4	18.1	29.1	25.6	29.3	23.6	28.3	10.6	38.7	26.1	29.4	14.1	18.1	32.1	23.5	52.7	29.4	18.8	59.8	18.3	38.5	11.7	32.1	17.1	14.8	14.2	33.1	26.6	12.1	30.4	10.1	48.1	24.0	26.3	10.9	19.5	15.4	26.7	13.7	15.4	22.8	41.9	25.3	15.7	27.1	20.6	23.1	18.2	23.9	14.8	17.4	18.1	12.7	39.6	25.5	21.4	19.7	27.0	17.1	16.6	24.9	20.1	26.4	16.1	0.5	0.1	0.5	0.7	0.3	0.4	0.6	0.4	0.4	0.3	0.9	0.5	0.7	0.4	0.6	0.2	0.4	0.3	0.1	5.3	8.8	5.7	7.4	6.4	7.1	7.1	7.0	6.4	5.0	8.1	12.6	20.0	16.0	35.0	58.1	33.1	75.8	72.4	37.4	60.9	20.6	40.0	19.6	63.5	20.0	45.4	22.0	45.9	16.1	51.0	20.1	3.9	20.8	99.7	60.0	49.6	27.3	40.6	28.8	100.3	37.1	12.8	27.2	41.3	97.0	28.5	34.9	18.5	34.3	19.5	25.2	83.5	19.5	30.5	28.7	47.7	92.5	21.1	35.1	28.4	71.2	28.0	15.7	36.0	64.3	238.5	43.6	9.3	10.5	61.3	92.5	8.7	10.3	39.0	27.8	13.1	48.9	26.5	36.0	18.0	79.3	66.1	29.7	42.6	14.0	18.8	107.3
RAB11FIP2	"KIAA0941, nRip11, Rab11-FIP2"	ENSG00000107560	"RAB11 family interacting protein 2"	Q7L804	10	118004916-118046941	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 82.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037726	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Nucleoplasm	"HPA037726: AB_10672390"	"unprognostic (1.97e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (9.69e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.17e-1)"	8.6	6.6	5.2	6.6	7.0	13.8	6.9	4.8	8.5	10.2	2.4	8.2	3.6	18.8	28.5	6.3	11.8	8.3	6.1	7.1	3.4	12.2	5.4	7.6	6.9	2.8	4.6	9.9	5.6	6.3	4.3	8.2	2.2	10.8	4.9	10.3	4.8	24.7	5.0	5.9	5.5	19.5	3.7	6.6	17.2	7.8	5.3	6.2	11.4	7.5	5.5	7.6	6.2	6.1	7.1	8.8	7.3	9.3	11.9	15.0	7.8	13.8	15.8	8.3	8.6	7.4	7.4	14.5	10.8	14.0	6.1	4.8	10.1	6.1	12.8	3.8	10.9	5.1	9.1	5.1	17.2	9.7	5.5	14.8	11.3	11.6	25.4	11.0	5.1	9.3	3.9	12.1	10.9	2.5	7.5	7.3	6.2	3.1	6.2	6.4	26.0	4.9	12.4	5.6	1.7	13.5	9.8	3.9	17.3	8.7	3.0	8.9	7.7	11.2	8.9	13.3	13.8	8.9	7.8	9.4	11.5	16.4	7.0	0.2	0.2	0.2	0.2	0.1	0.2	0.3	0.2	0.2	0.1	0.4	0.4	0.2	0.3	0.1	0.1	0.5	0.1	0.0	5.2	7.0	4.8	8.5	7.1	3.4	2.8	4.6	2.2	3.7	5.3	6.1	16.7	57.7	31.5	79.7	17.7	10.3	8.8	4.4	12.5	28.1	10.1	10.7	25.8	24.3	6.0	42.3	29.2	11.6	15.1	5.5	7.9	12.6	16.5	13.1	31.0	14.1	14.5	17.4	63.8	18.7	7.9	29.1	14.8	15.7	3.8	28.0	11.4	8.6	11.4	38.7	57.9	6.6	4.1	23.0	12.2	6.6	33.5	16.2	23.2	34.7	19.4	26.0	15.5	53.8	82.9	16.6	4.7	28.6	17.0	11.1	5.4	18.1	7.3	31.4	26.3	34.0	25.8	14.9	21.2	9.2	9.5	5.2	12.9	19.2	6.5	6.4
RAB27A	"GS2, HsT18676, RAB27, RAM"	ENSG00000069974	"RAB27A, member RAS oncogene family"	P51159	15	55202966-55319113	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	Exocytosis	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 119.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 147.1;Intestinal goblet cells: 252.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 261.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 208.7;K-562: 238.0;Karpas-707: 179.4;SK-MEL-30: 188.3;U-937: 185.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001333, CAB034046"	Enhanced					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 37: Intestine - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 27: Mucus-secreting cells - Mucin production"			"CAB034046: AB_2176724, HPA001333: AB_1079730"	"prognostic favorable (2.56e-4)"	"unprognostic (9.75e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.77e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (1.67e-4)"	"unprognostic (4.23e-2)"	"unprognostic (4.34e-1)"	"unprognostic (7.95e-3)"	"unprognostic (4.32e-1)"	17.5	27.8	3.5	40.2	3.9	100.2	13.9	4.4	4.4	12.9	5.6	53.0	30.0	12.8	5.0	20.6	12.3	17.6	7.7	3.4	6.7	19.2	43.6	42.4	46.0	5.8	5.0	8.0	29.2	11.4	31.4	17.6	5.9	61.2	66.1	4.2	18.3	11.8	3.2	12.8	40.9	25.8	5.0	30.8	119.9	10.0	5.9	19.3	30.5	7.0	46.2	37.5	13.9	5.7	23.0	10.0	9.7	11.3	8.3	38.8	9.5	29.4	32.5	19.2	26.4	7.0	15.6	0.9	22.3	16.0	38.9	16.0	15.7	27.0	18.3	84.9	9.7	5.4	37.6	18.1	56.0	208.7	26.5	34.3	44.2	29.0	71.6	80.7	46.9	26.4	238.0	179.4	20.7	27.7	1.5	57.6	3.6	38.9	14.7	32.4	27.3	50.3	28.7	17.7	14.9	7.1	31.4	15.2	188.3	24.3	13.3	162.2	25.3	52.5	20.3	33.1	33.6	72.0	88.2	6.0	70.2	185.1	19.0	261.3	72.4	99.8	59.2	30.1	58.2	8.0	28.6	61.9	39.0	13.4	13.9	37.4	114.9	34.1	24.0	2.1	36.2	48.9	3.5	3.9	4.4	4.4	3.4	6.7	5.8	5.0	5.9	5.0	5.9	5.7	27.5	76.9	147.1	12.7	18.6	14.1	25.7	19.2	6.2	3.0	16.3	18.3	7.4	15.7	50.1	11.0	2.1	6.3	81.0	18.5	13.7	24.6	2.8	10.1	15.6	32.1	74.3	12.8	12.5	87.6	18.7	16.9	93.3	16.7	31.7	8.8	41.7	41.7	15.6	0.0	12.2	252.0	12.2	33.3	15.2	2.2	7.5	31.1	71.2	10.3	71.9	2.4	104.0	10.1	7.1	62.9	15.9	13.9	38.6	32.3	14.6	6.7	31.3	4.4	19.7	9.4	15.8	9.3	4.6	7.1	15.5	7.5	81.4	4.6	18.4	23.4
RAB3GAP2	"DKFZP434D245, KIAA0839, RAB3-GAP150, SPG69"	ENSG00000118873	"RAB3 GTPase activating non-catalytic protein subunit 2"	Q9H2M9	1	220148293-220272453	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Cataract, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026273, HPA027299"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Plasma membrane"	"HPA026273: AB_1856007, HPA027299: AB_1856008"	"prognostic unfavorable (3.05e-4)"	"unprognostic (2.80e-3)"	"unprognostic (1.76e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.40e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.56e-1)"	10.1	9.0	6.3	9.6	6.7	10.2	11.2	11.4	7.8	8.7	23.5	8.8	7.8	9.4	8.4	9.0	7.0	7.9	9.3	7.3	9.3	11.7	10.0	8.6	12.6	6.7	6.9	9.6	8.6	18.6	6.2	11.5	9.0	8.5	8.3	18.1	9.2	7.9	8.7	7.9	7.8	9.3	5.7	9.2	9.4	6.6	7.5	13.1	12.8	12.2	14.4	9.1	6.0	9.1	21.3	15.8	18.9	14.3	21.2	25.1	21.4	21.4	20.3	18.9	22.2	14.7	17.3	26.4	14.8	20.9	14.3	19.9	19.8	16.4	21.8	22.1	12.9	20.6	21.5	13.8	27.9	29.8	20.3	20.0	18.4	18.5	28.5	21.2	17.6	11.4	36.2	16.6	21.6	6.0	23.0	10.5	40.8	11.4	9.3	12.5	26.0	23.7	16.1	17.3	18.8	22.7	22.2	21.4	35.3	20.3	22.4	28.0	25.7	20.6	9.6	14.4	23.2	14.6	19.2	22.8	17.7	24.6	24.8	10.0	2.8	5.6	4.8	3.6	5.9	4.8	4.7	6.2	3.8	3.8	4.1	4.9	1.8	2.8	3.9	2.4	6.0	3.3	6.3	6.7	11.4	7.8	7.3	9.3	6.7	6.9	9.0	5.7	7.5	9.1	28.5	41.7	21.9	60.7	30.4	11.6	13.6	15.8	17.6	57.9	18.9	16.3	34.8	32.9	23.4	25.8	68.8	18.5	30.6	23.8	5.9	17.4	4.3	21.4	27.7	22.3	35.4	18.7	106.8	16.7	13.5	23.4	20.4	28.5	19.6	40.8	28.9	24.2	25.4	42.1	105.1	22.1	16.2	29.0	9.4	2.8	18.0	22.2	14.2	68.4	25.2	39.8	26.8	82.0	81.5	21.7	14.2	25.9	24.7	21.0	19.4	14.9	17.2	50.5	6.6	24.1	20.4	17.7	13.6	17.5	9.8	23.1	27.1	23.6	19.3	13.2
RAB6A	RAB6	ENSG00000175582	"RAB6A, member RAS oncogene family"	P20340	11	73675638-73761137	"Predicted intracellular proteins"	"ER-Golgi transport, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009936, HPA059131"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"CAB009936: AB_2175466, HPA059131: AB_2683916"	"unprognostic (2.84e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (8.18e-5)"	"unprognostic (1.79e-1)"	"unprognostic (9.44e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (8.67e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (9.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.36e-1)"	71.2	69.8	87.7	53.0	96.5	38.4	50.6	85.4	112.8	64.4	79.3	66.2	71.6	66.9	53.0	100.2	54.0	55.6	99.5	101.8	100.9	75.1	85.3	68.5	45.7	106.0	90.1	64.5	49.0	67.5	36.4	91.4	112.9	64.0	70.6	56.1	47.8	64.9	107.5	55.0	83.4	79.8	80.0	56.9	54.9	36.1	97.4	54.2	98.7	101.7	60.8	78.9	62.4	93.4	86.2	66.3	105.8	68.5	135.9	154.3	141.7	130.4	124.6	111.1	100.8	131.5	146.4	73.2	136.6	174.0	94.9	94.6	68.4	135.3	142.5	84.6	25.6	118.2	68.6	110.9	114.2	78.1	113.1	114.7	246.8	113.5	165.0	124.4	135.9	75.7	71.3	111.5	133.3	99.6	85.7	54.7	42.2	192.0	62.3	64.8	193.9	132.5	135.2	146.6	83.0	70.5	136.1	136.7	290.9	104.7	107.2	71.0	165.0	113.3	56.9	193.5	56.6	71.9	89.5	149.5	46.3	63.2	104.6	227.9	81.8	133.2	84.2	87.6	76.2	56.1	70.3	75.5	62.9	50.7	52.0	61.8	61.9	78.6	88.6	33.7	86.3	111.1	87.7	96.5	85.4	112.8	101.8	100.9	106.0	90.1	112.9	80.0	97.4	93.4	66.3	32.1	51.0	79.7	59.2	83.5	49.4	57.2	88.2	53.9	45.8	30.4	64.2	35.8	42.7	68.0	87.6	109.9	55.3	85.2	43.0	66.0	8.8	51.5	41.3	78.7	52.0	47.5	133.6	49.5	162.3	60.5	52.5	51.2	48.8	83.7	72.5	63.7	65.7	40.4	119.0	61.8	75.3	58.4	85.7	9.5	52.8	58.3	72.9	49.6	74.2	47.7	52.5	130.7	109.4	79.0	61.7	61.7	86.3	57.8	102.7	54.1	47.2	54.2	26.3	47.4	65.5	74.2	53.4	106.5	112.7	173.6	63.8	45.0	50.8	69.8
RASSF1	"123F2, NORE2A, RDA32, REH3P21"	ENSG00000068028	"Ras association domain family member 1"	Q9NS23	3	50329782-50340980	"Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 116.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 252.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040735	Approved					NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA040735: AB_10671692"	"unprognostic (5.02e-2)"	"prognostic favorable (2.64e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.00e-3)"	"prognostic favorable (2.60e-4)"	"prognostic unfavorable (9.77e-4)"	"unprognostic (3.80e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (8.58e-5)"	"unprognostic (4.27e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.71e-2)"	50.1	18.9	19.2	23.2	19.5	84.3	46.0	19.6	20.1	44.1	18.1	28.4	15.6	29.7	11.1	26.2	35.4	21.5	47.7	18.4	19.2	39.0	24.7	61.2	39.5	20.8	20.0	31.2	35.3	7.5	22.2	25.8	20.4	31.6	11.6	6.1	30.2	11.8	28.5	38.9	39.6	18.1	20.7	72.3	31.7	38.5	20.4	16.3	29.7	14.3	25.5	32.3	37.4	22.1	37.4	15.1	11.1	18.5	25.0	33.8	16.2	62.5	40.9	52.6	41.8	34.7	27.3	18.0	9.4	67.3	23.6	19.6	23.3	26.1	28.3	44.6	15.2	61.8	51.9	18.4	28.6	61.2	65.2	26.1	18.1	52.0	18.4	15.4	23.7	21.8	26.2	40.7	24.1	13.1	23.3	81.9	14.7	31.2	44.9	19.0	11.4	41.4	15.7	10.8	13.0	23.9	55.6	37.2	41.5	11.2	22.3	59.2	22.9	36.1	27.2	52.0	31.3	16.5	11.7	39.4	20.3	75.6	66.1	252.6	23.3	79.5	77.0	41.5	48.3	44.3	24.6	55.3	24.9	33.6	15.7	37.7	18.4	64.6	59.1	18.5	27.5	42.0	19.2	19.5	19.6	20.1	18.4	19.2	20.8	20.0	20.4	20.7	20.4	22.1	76.6	16.0	8.1	4.6	50.7	73.8	36.3	22.6	34.1	11.6	32.7	22.9	14.3	12.8	14.4	1.8	14.6	27.5	116.1	12.2	5.9	23.1	2.4	16.5	16.3	47.4	16.7	33.2	3.8	26.5	28.1	29.1	27.0	17.6	57.1	9.0	26.0	4.3	38.6	3.3	3.8	19.4	22.4	27.7	43.8	10.4	19.0	28.7	90.7	9.4	23.2	6.1	93.7	2.0	6.0	40.9	17.4	14.7	63.8	24.7	12.1	10.2	7.7	10.1	26.3	19.3	50.4	33.1	11.0	19.2	50.2	16.6	67.2	9.0	15.2	21.3
RBM14-RBM4		ENSG00000248643	"RBM14-RBM4 readthrough"		11	66616626-66646469	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 5.5;Club cells: 5.0;Excitatory neurons: 8.7;Inhibitory neurons: 8.7;Microglial cells: 5.6;Oligodendrocytes: 10.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 10.0"									HPA047849	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA047849: AB_2680180"	"unprognostic (2.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.77e-4)"	"unprognostic (3.92e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.77e-4)"	"unprognostic (5.74e-7)"	"unprognostic (1.43e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.10e-2)"	0.6	0.8	3.5	0.4	2.5	3.0	0.5	3.4	3.4	0.6	2.9	1.3	0.1	0.8	0.8	1.0	0.7	0.6	2.7	2.6	3.6	1.0	3.0	0.7	0.6	2.9	1.9	0.6	1.1	0.3	1.0	0.4	1.8	1.1	0.4	0.7	0.9	0.5	1.0	0.6	1.0	0.5	1.3	1.1	1.0	0.5	2.6	0.8	1.0	0.4	0.4	1.1	0.7	3.4	1.6	0.9	0.7	1.3	1.0	0.1	0.8	0.9	0.5	1.6	0.3	2.6	0.5	0.9	1.3	0.7	1.2	2.5	1.8	0.6	0.6	0.8	0.7	2.7	1.8	2.0	0.5	1.7	1.5	0.4	0.5	0.8	0.2	0.6	0.0	1.4	3.8	1.4	1.0	3.2	2.5	10.0	1.7	1.9	4.4	2.8	3.4	1.5	0.7	1.8	2.2	1.0	0.7	2.3	5.9	0.5	1.4	1.2	0.7	2.1	1.5	1.7	1.1	1.1	1.0	1.7	1.8	1.2	1.8	4.8	4.3	5.9	4.6	4.8	2.7	5.9	2.9	3.1	4.3	5.9	1.9	2.5	2.8	3.5	5.0	8.4	2.1	3.6	3.5	2.5	3.4	3.4	2.6	3.6	2.9	1.9	1.8	1.3	2.6	3.4	0.5	0.0	1.1	5.5	1.1	0.0	0.5	0.1	1.2	1.1	0.4	0.4	0.0	1.5	5.0	0.0	4.2	0.5	2.0	0.3	0.0	0.5	1.7	1.4	0.9	0.6	0.0	0.4	8.7	0.2	0.4	0.8	1.1	1.1	0.0	0.7	0.0	0.5	0.2	0.0	8.7	0.5	0.0	0.3	0.3	0.9	0.0	1.2	0.0	5.6	0.0	0.1	0.0	4.0	10.3	0.4	0.1	0.0	1.0	0.5	0.0	0.4	3.6	0.8	0.0	0.8	0.4	1.0	0.9	1.0	0.1	1.1	1.0	0.5	0.2	0.8
RBM26	"ARRS2, C13orf10, FLJ20957, PPP1R132, PRO1777, SE70-2, ZC3H17"	ENSG00000139746	"RNA binding motif protein 26"	Q5T8P6	13	79311824-79406477	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 251.4;Oligodendrocytes: 253.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040252	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"		"HPA040252: AB_10672895"	"unprognostic (5.55e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.09e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.18e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (3.46e-4)"	"prognostic unfavorable (5.87e-6)"	"unprognostic (8.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-2)"	"prognostic favorable (8.20e-4)"	21.7	26.0	17.1	28.5	21.8	37.2	25.6	32.0	30.1	24.9	13.7	21.0	18.6	28.2	28.1	20.9	24.2	17.5	18.8	19.5	18.3	20.3	21.1	21.5	40.4	14.2	14.4	32.8	27.9	19.2	30.2	24.2	15.0	21.2	21.9	40.9	23.7	18.6	26.0	32.4	28.5	20.3	13.8	33.7	25.0	30.0	16.7	29.9	25.4	19.4	34.2	20.8	21.5	22.2	55.3	29.1	70.1	35.9	30.7	32.2	38.1	37.0	30.9	37.5	38.7	39.1	45.9	82.1	29.5	27.3	24.7	51.4	53.0	36.3	54.2	49.6	56.3	63.4	68.0	35.8	23.9	119.9	48.6	21.9	29.6	38.6	53.3	34.4	39.8	50.5	49.0	26.8	41.9	18.7	73.3	63.3	43.6	49.3	16.9	72.9	57.5	43.8	34.9	31.4	53.2	35.6	31.8	38.2	23.4	42.4	34.4	99.0	38.0	31.8	31.7	25.9	38.0	38.5	36.0	100.0	51.6	66.0	38.6	3.8	1.4	2.8	2.9	2.0	3.0	3.7	2.8	2.7	0.8	5.5	4.2	3.7	2.0	2.3	1.5	2.6	3.3	1.0	17.1	21.8	32.0	30.1	19.5	18.3	14.2	14.4	15.0	13.8	16.7	22.2	50.2	57.7	83.5	148.9	80.9	34.7	35.1	25.0	47.8	63.7	36.5	31.0	42.1	35.8	35.6	25.8	73.0	34.3	72.4	34.8	9.8	25.4	49.2	29.0	59.9	43.3	49.1	41.9	251.4	26.0	31.5	41.6	32.1	36.6	55.8	75.9	60.0	40.3	32.9	57.2	170.8	39.2	32.6	53.7	23.0	27.3	65.0	41.6	16.0	137.7	58.0	37.9	56.7	217.6	253.0	27.0	31.5	47.4	65.8	51.1	28.4	19.6	37.7	72.0	52.6	71.3	43.1	102.3	78.1	47.3	35.5	23.0	54.8	57.7	37.5	33.7
RBM48	"C7orf64, DKFZp564O0523, HSPC304"	ENSG00000127993	"RNA binding motif protein 48"	Q5RL73	7	92528773-92540481	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021777, HPA025306"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA021777: AB_1845763, HPA025306: AB_1845764"	"unprognostic (2.79e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.59e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.51e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.43e-2)"	"unprognostic (8.04e-2)"	8.3	8.6	8.2	5.6	9.4	14.1	8.2	10.1	12.1	9.0	6.5	8.0	5.3	8.2	4.8	7.6	8.4	3.8	10.0	8.5	7.5	7.4	9.0	6.4	8.4	9.0	7.7	9.8	8.5	4.6	7.5	4.6	9.1	8.2	4.6	6.5	8.3	3.3	13.5	8.0	9.0	3.7	7.3	11.3	8.0	8.9	8.5	6.5	8.4	7.0	6.4	7.3	8.3	12.1	5.5	4.0	6.8	11.1	6.5	7.3	5.4	6.5	5.2	6.4	6.1	4.9	6.9	8.0	11.8	4.4	9.9	6.2	6.6	4.6	7.9	7.8	9.4	5.3	12.0	5.8	5.2	10.2	7.1	5.2	8.5	7.2	6.5	8.9	6.9	10.1	11.5	13.1	6.9	5.6	12.1	10.1	6.1	6.9	5.8	6.5	6.1	9.8	5.9	5.9	7.6	9.9	5.7	11.6	8.6	8.3	3.7	8.5	4.4	11.7	6.3	9.1	8.9	8.6	11.1	13.3	5.3	8.6	11.0	67.8	12.4	30.3	23.2	16.3	25.7	28.5	25.1	23.7	12.3	28.7	32.1	27.3	19.2	26.2	13.3	14.3	25.7	16.0	8.2	9.4	10.1	12.1	8.5	7.5	9.0	7.7	9.1	7.3	8.5	12.1	13.5	12.8	7.5	8.1	23.5	8.5	13.2	11.9	12.5	12.7	8.7	7.7	16.7	5.7	10.9	3.7	0.0	10.9	18.8	6.9	7.9	9.2	9.4	9.5	12.3	13.8	0.0	8.6	20.5	6.0	5.8	11.7	6.6	12.9	30.4	11.9	7.9	3.7	6.2	11.8	15.8	4.0	14.2	6.8	6.4	5.9	5.9	8.1	5.4	5.6	9.8	11.5	26.8	11.1	34.3	5.5	6.2	6.4	16.6	10.5	7.0	9.6	7.8	13.2	13.1	15.0	13.7	24.0	15.5	9.9	11.4	15.3	18.9	8.4	5.7	11.8
RBM6	"3G2, DEF-3, DEF3, g16, NY-LU-12"	ENSG00000004534	"RNA binding motif protein 6"	P78332	3	49940007-50100045	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026272, HPA027164"	Enhanced		Approved	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 72: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	"Cytoplasmic bodies"	"HPA026272: AB_1847592, HPA027164: AB_1847593"	"unprognostic (3.81e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.97e-3)"	"unprognostic (8.84e-3)"	"unprognostic (5.09e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (4.31e-2)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (7.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (5.13e-5)"	65.2	75.5	51.4	43.7	50.5	45.8	58.3	56.9	96.4	108.2	53.0	81.5	43.4	70.0	34.5	51.7	81.7	27.6	74.3	51.0	54.8	74.3	78.1	64.7	59.8	53.6	51.0	96.2	89.7	36.7	72.8	30.3	50.0	98.2	39.5	64.3	50.3	36.0	44.0	54.3	78.0	42.2	48.1	103.5	69.3	66.1	53.1	48.6	74.9	25.7	50.1	67.2	68.5	51.7	28.6	18.0	73.0	48.1	70.8	38.4	25.9	47.8	41.0	40.8	42.7	31.0	31.4	147.2	27.0	47.0	41.1	23.6	61.2	40.9	51.3	57.3	23.2	68.6	46.1	41.3	40.0	71.3	69.4	36.0	50.5	45.7	50.9	76.4	52.2	37.0	57.0	36.0	39.3	26.9	66.8	106.0	57.9	34.7	32.0	26.1	31.0	38.0	40.4	57.0	28.8	51.6	43.7	31.0	30.9	62.9	25.3	55.7	48.8	41.2	48.0	33.3	48.6	49.7	123.7	84.9	23.7	58.6	40.6	16.4	8.5	5.2	13.3	4.6	11.2	12.3	9.3	8.2	8.8	11.5	9.3	10.2	5.6	7.2	8.8	9.6	7.0	6.1	51.4	50.5	56.9	96.4	51.0	54.8	53.6	51.0	50.0	48.1	53.1	51.7	76.0	57.7	75.2	172.4	87.4	54.0	43.0	34.2	67.7	120.1	43.5	33.8	35.7	40.0	45.9	62.5	102.2	38.2	91.9	46.4	11.7	33.4	31.9	51.2	69.5	57.2	47.3	51.9	195.6	28.0	33.0	53.9	64.7	46.3	43.0	93.0	45.7	36.0	27.8	92.5	216.8	44.5	36.7	56.1	82.2	25.2	65.6	50.1	60.5	161.1	66.1	43.4	62.8	154.3	177.9	34.3	32.4	60.5	106.9	51.2	60.9	17.7	49.1	145.7	46.0	55.6	63.7	135.3	56.7	46.7	45.3	36.3	66.4	66.3	39.5	35.2
RBSN	ZFYVE20	ENSG00000131381	"Rabenosyn, RAB effector"	Q9H1K0	3	15070073-15099163	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044878	Approved		Supported	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA044878: AB_10967610"	"unprognostic (6.76e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.00e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.72e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.78e-1)"	9.0	7.0	12.5	6.7	12.5	18.2	7.7	10.2	13.0	9.1	1.1	10.7	4.7	9.3	7.1	8.9	8.7	5.4	9.8	13.4	11.4	5.4	8.4	8.4	6.6	12.1	12.5	12.7	5.9	9.7	6.1	7.9	11.1	7.4	5.3	13.6	5.9	9.0	13.1	10.2	7.1	9.0	12.8	7.7	7.8	6.6	13.0	5.5	11.2	9.9	6.1	9.1	7.5	11.8	11.2	16.0	12.8	16.6	13.8	10.2	33.9	12.0	11.5	14.1	12.7	9.7	6.5	7.8	6.8	15.9	8.2	7.0	16.5	14.5	12.4	9.9	14.6	8.9	19.7	8.0	9.5	9.0	9.4	11.1	16.1	18.1	12.0	8.3	11.6	8.7	13.5	8.9	10.8	14.7	4.9	4.5	11.0	7.1	12.7	6.4	14.6	8.6	7.3	12.6	3.4	12.0	14.7	8.9	10.7	9.4	22.8	6.5	14.2	12.7	13.3	12.5	17.1	7.9	12.6	9.2	12.2	10.0	12.2	8.1	4.6	11.1	4.4	6.4	3.9	4.4	6.1	5.5	3.8	7.4	7.7	5.2	11.7	3.1	5.6	3.6	4.3	2.7	12.5	12.5	10.2	13.0	13.4	11.4	12.1	12.5	11.1	12.8	13.0	11.8	10.4	16.0	19.0	19.6	9.2	0.0	6.7	0.0	6.8	21.6	7.6	7.0	20.4	8.6	9.9	3.7	22.9	10.4	8.4	6.0	5.9	8.4	17.4	6.4	11.1	12.4	1.2	9.5	21.8	9.6	9.6	14.6	10.2	8.8	10.1	16.4	14.6	14.0	10.7	21.9	23.9	6.9	0.0	15.8	0.0	18.0	19.0	12.1	0.0	8.4	10.5	15.5	7.2	16.1	25.2	9.6	5.1	14.7	12.1	12.6	8.1	6.9	8.0	23.1	6.6	17.5	10.4	12.4	14.0	11.0	0.0	12.9	9.9	10.6	5.4	10.0
RC3H2	"FLJ20301, FLJ20713, MNAB, RNF164"	ENSG00000056586	"Ring finger and CCCH-type domains 2"	Q9HBD1	9	122844556-122905359	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Ubl conjugation pathway"	"Repressor, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042863, HPA062144"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA042863: AB_2678204, HPA062144: AB_2732677"	"unprognostic (6.05e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (5.50e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.26e-1)"	11.9	8.9	8.8	12.1	10.8	32.5	10.4	14.0	10.0	13.5	4.4	10.4	9.9	11.9	8.1	13.0	9.7	11.0	13.8	10.9	7.9	12.7	13.4	11.5	18.5	7.1	7.4	11.2	6.8	15.8	9.6	14.6	7.6	9.7	11.2	16.0	9.0	9.1	11.8	10.0	9.4	13.9	7.1	14.1	11.8	11.6	8.0	18.8	12.9	15.3	17.2	14.4	9.0	10.5	17.3	26.2	33.5	18.2	17.4	19.8	17.8	22.0	24.4	25.2	21.8	31.2	18.8	28.8	16.7	29.8	30.1	40.9	35.4	25.1	27.7	13.4	13.5	16.4	44.4	21.3	23.1	19.9	26.5	19.9	25.5	24.3	34.6	22.0	35.6	25.4	24.1	21.6	32.9	23.9	20.2	14.7	17.7	24.9	21.8	19.7	54.8	19.4	25.8	13.9	38.3	25.8	39.2	24.9	21.2	22.8	29.2	17.2	33.9	20.5	17.3	27.7	39.8	14.0	25.4	32.1	22.3	18.2	23.1	10.0	4.6	6.0	6.1	7.3	5.1	4.3	4.8	6.0	4.1	5.8	4.5	4.5	8.0	4.0	6.7	6.5	5.1	2.8	8.8	10.8	14.0	10.0	10.9	7.9	7.1	7.4	7.6	7.1	8.0	10.5	33.8	41.7	32.8	20.9	27.7	11.0	13.6	20.0	20.5	19.2	15.6	10.5	34.8	12.8	17.3	9.2	37.5	15.7	26.6	18.9	3.9	12.0	5.9	27.6	30.9	28.3	23.3	22.7	38.4	11.4	15.2	18.4	23.9	40.1	17.1	21.9	29.6	19.5	9.6	28.6	35.1	19.8	12.2	27.4	19.4	9.5	13.4	21.4	14.2	30.9	26.1	16.9	24.7	35.2	39.3	23.5	9.0	18.0	22.5	24.3	14.8	12.0	17.7	20.2	19.7	16.3	24.1	30.7	17.9	23.3	14.8	23.0	28.8	15.4	14.7	27.3
RCBTB1	"CLLD7, CLLL7, FLJ10716"	ENSG00000136144	"RCC1 and BTB domain containing protein 1"	Q8NDN9	13	49531946-49585558	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 44.8;Cone photoreceptor cells: 64.6;Oligodendrocyte precursor cells: 75.4;Oligodendrocytes: 76.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056783			Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA056783: AB_2683234"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.52e-2)"	"prognostic favorable (5.51e-5)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (1.17e-3)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.49e-2)"	10.9	22.7	24.3	9.9	30.5	14.4	13.2	26.8	30.1	9.2	21.3	7.5	6.5	16.7	20.1	5.6	13.1	9.8	16.2	22.5	30.6	19.0	8.9	13.2	14.8	28.1	28.3	7.7	11.3	48.6	14.5	13.1	27.4	11.2	8.6	49.6	7.9	19.1	7.7	8.3	8.0	14.7	27.1	14.9	10.7	9.2	28.5	19.5	44.2	16.0	11.3	9.5	6.8	31.2	5.7	12.9	27.8	25.3	36.2	31.4	16.2	21.2	21.0	15.7	16.1	10.9	14.0	19.3	4.6	17.5	13.6	7.9	20.8	32.6	26.9	28.5	16.2	23.1	10.7	28.1	43.5	18.6	17.6	28.1	19.6	13.1	20.8	20.7	27.7	37.3	10.4	8.2	31.9	5.3	27.1	10.8	29.0	19.1	7.8	34.8	20.9	12.3	19.6	15.3	14.6	19.4	10.8	8.2	21.7	23.4	11.0	13.3	19.7	11.8	9.5	24.8	10.5	8.4	10.9	31.1	10.5	18.3	16.9	17.1	6.0	6.4	2.7	7.4	3.3	4.5	4.5	2.2	7.6	2.8	2.8	2.7	3.0	2.8	8.9	1.0	9.1	3.5	24.3	30.5	26.8	30.1	22.5	30.6	28.1	28.3	27.4	27.1	28.5	31.2	6.9	44.8	10.8	11.8	6.7	3.7	2.5	2.8	20.5	10.2	7.4	4.4	18.9	8.6	9.3	1.8	64.6	3.0	5.3	1.5	7.9	7.4	0.4	6.3	16.3	10.4	16.2	8.0	13.0	5.0	3.5	4.7	3.6	5.8	2.5	12.1	6.4	7.8	8.8	10.1	13.9	2.9	2.0	14.1	5.5	0.7	3.4	9.0	8.8	23.4	8.3	6.0	3.1	75.4	76.8	5.0	0.7	5.7	6.3	3.5	0.7	12.8	10.3	37.7	39.5	3.1	10.2	1.9	6.0	2.3	2.4	1.1	6.4	35.4	2.1	2.3
RDH11	"ARSDR1, MDT1, SDR7C1"	ENSG00000072042	"Retinol dehydrogenase 11"	Q8TC12	14	67676800-67695793	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Cataract, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 582.0"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 241.8;Muller glia cells: 299.7;Prostatic glandular cells: 285.7"	"Cancer enriched"	"Detected in all"	13	"prostate cancer: 286.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB046011	Enhanced				"Intracellular and membrane"	NA	NA		340000	"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 5: Muller glia cells - Visual perception"			"CAB046011: AB_11129613"	"unprognostic (1.38e-1)"	"unprognostic (6.86e-3)"	"unprognostic (1.77e-1)"	"prognostic favorable (2.62e-4)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (9.29e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (1.30e-7)"	"unprognostic (1.65e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.74e-2)"	23.6	59.5	39.3	24.5	43.2	13.9	28.7	50.2	54.4	32.6	35.9	29.2	34.1	33.2	86.0	34.6	23.5	42.7	17.6	40.4	47.2	106.0	153.1	34.9	20.4	49.2	47.7	28.9	42.6	79.8	23.4	21.9	49.3	582.0	31.4	73.9	44.2	34.4	8.3	31.4	23.9	43.6	49.8	22.2	31.9	28.4	46.1	30.7	61.7	13.5	26.2	34.3	30.3	58.4	183.7	81.9	71.3	82.0	111.5	100.4	59.3	68.0	134.2	83.7	150.9	68.6	216.7	31.7	51.2	64.6	104.8	142.5	104.0	150.8	113.7	63.0	42.6	65.1	40.7	69.0	106.9	24.3	46.0	94.4	98.0	109.3	92.0	63.9	97.4	87.0	52.1	101.1	77.2	97.5	72.2	38.8	40.4	49.7	92.8	53.6	87.4	45.8	194.1	93.0	73.8	62.0	71.2	89.7	99.1	58.2	100.7	38.3	74.2	89.5	101.1	38.9	49.5	47.5	40.0	40.7	115.8	66.0	74.3	282.4	71.1	104.0	62.3	57.7	68.2	39.0	67.7	61.5	51.3	45.5	67.3	64.8	11.0	56.3	65.4	59.1	65.1	115.8	39.3	43.2	50.2	54.4	40.4	47.2	49.2	47.7	49.3	49.8	46.1	58.4	27.0	25.6	66.0	38.2	29.2	11.5	40.0	77.9	16.5	53.5	45.4	24.5	20.4	68.6	59.9	47.8	50.1	24.9	32.4	26.8	7.9	92.5	2.5	21.9	50.9	39.3	43.3	29.2	33.3	84.0	38.1	37.5	19.9	38.2	29.2	46.3	47.8	241.8	35.8	79.1	37.6	28.9	89.5	42.4	15.4	6.1	43.2	35.9	35.6	17.8	39.8	299.7	37.0	70.4	43.4	61.2	36.7	56.1	27.3	285.7	17.5	56.0	23.9	97.0	46.0	29.7	38.7	25.8	24.0	20.2	19.2	63.5	29.8	66.7	25.3	46.1
RELCH	"FLJ33841, HsT3308, HsT885, KIAA1468"	ENSG00000134444	"RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing"	Q9P260	18	62187255-62310249	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.0;Cardiomyocytes: 9.4;Cytotrophoblasts: 6.5;dendritic cells: 8.2;Extravillous trophoblasts: 4.4;Hofbauer cells: 7.2;Plasma cells: 5.2;Syncytiotrophoblasts: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039708, HPA040038"	Approved		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Centriolar satellite, Cytosol"		"HPA039708: AB_10794753, HPA040038: AB_10793860"	"unprognostic (1.33e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.44e-2)"	"unprognostic (6.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.47e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.71e-2)"	8.3	8.8	8.7	9.6	10.8	14.2	11.9	11.1	10.0	11.8	7.2	11.5	9.5	8.5	11.8	25.4	7.7	7.9	7.5	9.7	9.3	9.6	7.9	8.0	11.8	7.9	7.6	8.2	8.3	10.3	11.0	8.1	8.2	12.1	14.4	16.3	12.5	8.8	6.8	20.6	10.8	6.2	7.6	11.2	12.7	5.3	8.8	10.8	9.5	5.9	13.2	10.0	16.2	9.4	9.7	8.7	10.4	10.0	10.8	12.7	11.1	17.0	14.1	15.0	16.5	4.5	8.8	6.6	8.6	15.1	9.8	19.7	14.9	10.2	18.3	6.0	9.3	5.6	9.7	10.4	9.6	10.8	7.4	9.4	12.3	12.8	7.8	12.3	10.3	6.2	4.2	6.5	15.9	5.7	6.7	9.3	6.0	6.5	7.3	8.2	13.0	7.9	17.1	19.1	14.7	7.8	10.2	14.9	8.9	13.4	7.7	11.6	12.9	15.9	5.0	6.9	8.6	19.0	3.7	6.4	11.2	11.4	13.0	1.4	1.0	1.2	1.1	0.8	0.8	0.8	1.0	1.0	1.0	0.9	1.1	1.3	1.7	1.1	0.7	0.7	1.3	0.6	8.7	10.8	11.1	10.0	9.7	9.3	7.9	7.6	8.2	7.6	8.8	9.4	7.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	6.5	8.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	4.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	6.6	1.1	0.0	0.0	0.0
RFLNB	"Cfm1, FAM101B, MGC45871, RefilinB"	ENSG00000183688	"Refilin B"	Q8N5W9	17	439978-445939	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 101.3;Endothelial cells: 51.1;Hofbauer cells: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 201.5"	"Lineage enriched"	"Detected in many"	21	"granulocytes: 201.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 95.5;HMC-1: 222.1;NB-4: 74.8;U-937: 64.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030879, HPA060388"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Actin filaments"	"Plasma membrane, Cytosol"	"HPA030879: AB_2673643, HPA060388: AB_2732649"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (3.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.03e-3)"	19.8	5.9	2.4	7.4	2.5	77.9	15.6	2.3	2.8	8.7	10.1	13.7	3.2	10.1	3.5	3.1	7.1	4.6	12.8	3.3	2.2	8.6	3.5	13.3	5.4	2.5	2.4	5.7	3.5	3.9	4.3	10.4	2.2	9.5	1.9	1.5	4.1	2.8	7.9	6.3	9.6	6.1	2.7	10.5	8.6	3.7	2.4	16.7	8.2	3.9	4.8	11.8	5.4	2.1	30.5	8.0	4.0	18.9	13.0	9.4	20.8	48.8	21.4	15.8	7.7	0.5	1.1	0.0	1.2	95.5	7.0	3.0	11.2	1.1	14.5	0.2	6.5	1.3	1.5	2.2	19.0	11.4	222.1	5.2	0.3	5.0	1.9	6.1	16.0	4.8	4.7	0.3	18.1	0.4	0.6	74.8	8.6	0.8	0.3	3.2	8.6	0.0	2.9	0.1	0.3	43.6	19.8	0.0	17.6	14.9	0.4	34.7	3.2	12.4	11.0	7.5	0.1	7.1	7.7	0.0	0.2	64.1	19.5	201.5	6.9	80.7	6.1	5.4	6.2	0.1	6.1	5.2	2.1	0.1	9.7	8.7	35.5	2.2	7.3	9.1	4.3	3.8	2.4	2.5	2.3	2.8	3.3	2.2	2.5	2.4	2.2	2.7	2.4	2.1	101.3	0.0	4.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	3.1	7.4	0.0	0.0	1.8	1.8	0.0	0.8	16.5	0.0	0.0	1.1	0.0	2.3	1.9	51.1	0.0	0.0	0.0	0.9	1.2	9.2	0.0	6.0	1.3	12.5	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	1.9	0.0	0.0	5.9	0.0	0.0	0.5	1.5	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.5	10.7	4.2	0.0	0.0
RHBDD2	"NPD007, RHBDL7"	ENSG00000005486	"Rhomboid domain containing 2"	Q6NTF9	7	75842602-75888926	"Enzymes, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 380.1"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 300.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 398.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 165.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045074, HPA051960"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA045074: AB_10965705, HPA051960: AB_2681673"	"unprognostic (2.75e-1)"	"unprognostic (3.89e-2)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (9.79e-2)"	"prognostic unfavorable (1.81e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.75e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.87e-2)"	"prognostic favorable (8.68e-6)"	"unprognostic (3.73e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.03e-1)"	43.9	232.5	247.5	20.0	248.6	26.9	47.7	169.0	313.0	46.7	224.2	39.4	35.7	36.4	59.3	48.5	47.0	23.2	54.7	255.0	380.1	97.7	99.8	72.0	16.2	216.3	252.8	61.2	56.8	182.8	299.6	16.5	274.5	79.0	16.0	39.1	53.3	94.8	35.0	49.4	44.9	11.8	187.5	50.2	57.6	87.2	321.2	19.9	91.1	11.6	12.5	45.3	43.6	208.3	24.0	80.2	34.5	57.9	16.3	11.5	12.8	12.8	50.6	26.6	27.2	43.6	59.7	7.5	13.0	26.3	59.4	33.7	22.4	17.6	10.3	25.9	46.3	9.0	48.0	41.4	45.0	13.8	61.5	25.0	35.7	31.1	12.3	43.9	20.4	51.2	19.0	51.6	26.9	165.3	26.1	74.9	31.7	41.0	45.1	19.4	22.7	66.8	47.2	42.9	43.3	88.7	59.3	107.8	47.9	23.2	66.3	23.2	20.4	43.5	39.6	29.2	27.9	48.4	18.5	12.9	50.4	20.4	59.9	398.8	62.8	79.0	80.0	66.1	68.9	51.7	89.1	71.7	63.0	50.8	72.5	65.3	104.7	63.6	35.1	49.7	126.8	61.2	247.5	248.6	169.0	313.0	255.0	380.1	216.3	252.8	274.5	187.5	321.2	208.3	20.5	41.7	31.9	16.6	23.7	23.2	46.5	127.6	18.2	34.9	42.3	22.4	8.8	55.8	76.8	86.5	33.3	54.8	20.7	48.3	19.6	94.1	171.2	30.2	12.8	26.9	89.8	10.3	27.0	102.1	41.3	34.7	39.8	16.2	192.7	72.4	57.8	43.1	45.5	18.5	31.9	35.1	128.1	35.9	32.7	300.8	42.6	47.8	60.5	5.6	21.4	68.8	29.9	13.0	11.0	78.1	37.6	52.6	27.9	47.8	52.8	52.5	89.3	35.7	6.6	19.0	26.4	57.3	29.7	27.9	23.7	52.0	61.2	198.1	30.2	50.1
RHCE	"CD240CE, RH"	ENSG00000188672	"Rh blood group CcEe antigens"	P18577	1	25362249-25430192	"Blood group antigen proteins, CD markers, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"bone marrow: 48.5"	"Cell type enriched"	"Detected in some"	67	"Erythroid cells: 511.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HEL: 81.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Plasma membrane"		"HPA060951: , HPA077385: "	"unprognostic (1.37e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.91e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.61e-2)"	"unprognostic (5.77e-5)"	"unprognostic (1.38e-1)"	"unprognostic (3.94e-2)"	"unprognostic (7.15e-3)"	"unprognostic (1.63e-1)"	0.3	0.6	1.5	0.1	1.9	48.5	0.3	1.6	3.3	0.3	1.2	0.2	0.2	0.2	4.2	0.6	1.0	0.3	1.2	1.5	1.4	0.4	1.7	0.4	0.5	1.9	1.6	0.5	1.2	0.1	3.4	1.1	1.9	1.0	0.3	2.2	5.5	0.2	1.5	0.6	0.1	0.0	1.5	1.1	0.4	2.2	1.6	0.8	0.6	0.9	0.3	0.1	0.5	2.2	0.2	0.1	0.2	0.5	0.9	0.6	0.1	0.3	0.3	0.4	0.1	0.1	1.5	0.7	1.1	1.0	0.1	0.3	0.0	0.2	0.2	0.4	0.1	81.3	0.0	0.0	1.1	0.0	0.6	1.9	1.5	0.6	0.5	0.0	0.0	0.6	17.5	0.4	0.5	0.8	0.0	0.6	1.7	0.7	0.5	0.2	0.2	2.6	0.0	0.0	0.7	0.8	0.3	0.3	1.0	0.8	0.5	0.0	0.1	0.2	0.0	0.9	0.0	5.1	1.4	1.0	2.9	0.9	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.5	1.9	1.6	3.3	1.5	1.4	1.9	1.6	1.9	1.5	1.6	2.2	0.8	0.0	0.0	5.5	0.8	0.5	0.5	0.3	0.6	4.2	1.1	2.5	0.7	1.5	0.2	0.0	0.0	0.8	1.2	0.5	0.0	0.3	1.1	1.2	0.7	0.4	0.0	511.8	2.9	0.2	0.7	0.4	3.6	0.8	4.5	0.6	0.0	0.7	0.2	6.7	2.3	0.0	0.0	0.6	0.4	0.5	0.6	1.7	0.0	0.0	0.0	4.7	1.0	2.0	2.7	0.5	0.0	0.7	3.0	0.3	0.1	0.0	0.9	2.4	6.6	0.5	0.5	3.0	7.6	0.6	1.4	0.8	0.8	0.7	0.3	0.7
RIC8B	"FLJ10620, hSyn, RIC8"	ENSG00000111785	"RIC8 guanine nucleotide exchange factor B"	Q9NVN3	12	106774621-106889316	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 96.4;Inhibitory neurons: 93.9;Microglial cells: 58.1;Oligodendrocyte precursor cells: 76.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039970, HPA042746"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Plasma membrane"	"HPA039970: , HPA042746: AB_2678143"	"unprognostic (1.18e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.87e-3)"	"unprognostic (5.43e-2)"	"unprognostic (3.28e-2)"	"unprognostic (8.09e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.10e-3)"	"unprognostic (5.13e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.01e-2)"	5.5	5.3	7.7	3.2	26.1	1.3	4.9	7.9	9.7	5.5	6.6	6.4	3.1	7.0	4.3	3.1	6.3	5.6	8.7	6.8	8.7	7.2	5.8	3.7	2.5	6.6	11.5	5.8	6.2	11.5	7.8	3.7	6.5	4.5	3.9	12.6	3.5	8.2	7.3	2.7	4.1	6.4	5.4	4.7	4.1	4.4	9.3	6.5	9.3	8.2	2.4	5.9	4.3	8.4	3.6	11.0	20.7	8.3	9.7	11.7	2.5	11.7	9.3	10.3	9.6	3.7	3.1	2.2	8.0	6.7	4.1	6.2	7.5	4.1	12.3	25.0	10.0	7.5	5.2	4.7	7.5	7.2	4.9	6.8	5.2	6.7	3.4	12.2	9.6	7.7	4.7	0.1	9.4	2.9	8.2	7.8	10.4	5.6	11.0	7.1	12.0	7.2	8.7	3.2	15.1	9.7	8.5	5.3	5.9	7.8	4.7	4.9	9.3	8.3	4.6	5.6	8.5	6.1	13.7	0.1	4.0	4.9	12.4	0.9	1.4	1.2	1.9	0.8	2.2	0.4	1.0	0.9	1.3	0.2	0.8	0.8	0.6	0.9	0.7	0.8	1.1	1.0	7.7	26.1	7.9	9.7	6.8	8.7	6.6	11.5	6.5	5.4	9.3	8.4	10.0	6.4	7.8	47.7	5.9	3.3	3.9	5.5	5.2	14.4	8.5	7.4	33.9	25.8	5.8	3.7	10.4	7.1	5.0	10.9	7.9	21.7	5.7	12.7	17.5	11.2	18.6	5.5	96.4	4.0	3.7	10.5	7.7	7.3	8.2	10.4	15.0	9.2	3.6	6.7	93.9	7.8	8.2	6.6	3.9	5.0	12.8	4.6	7.2	58.1	3.8	5.5	14.4	76.9	52.9	6.6	4.8	19.2	2.6	1.7	7.2	6.7	10.8	45.0	13.1	18.6	9.3	18.4	8.8	2.6	2.8	1.4	7.6	10.6	6.7	1.5
RIMKLB	"FAM80B, KIAA1238, NAAGS, NAAGS-I"	ENSG00000166532	"Ribosomal modification protein rimK like family member B"	Q9ULI2	12	8681600-8783095	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 184.2;Endometrial ciliated cells: 191.3;Glandular and luminal cells: 1012.9;Late spermatids: 300.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 17.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-698: 145.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059552			Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Centriolar satellite"		"HPA059552: "	"unprognostic (5.29e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.89e-5)"	"unprognostic (2.40e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.56e-2)"	"unprognostic (8.52e-2)"	"unprognostic (8.67e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.74e-1)"	"unprognostic (3.99e-1)"	27.6	10.9	20.1	8.0	23.0	21.0	24.1	23.9	18.6	29.5	19.9	30.5	5.4	40.1	15.9	11.1	29.4	14.9	14.4	20.9	23.7	11.8	3.1	19.4	9.1	27.5	24.8	30.1	8.1	22.2	12.8	24.5	22.3	14.1	7.0	19.1	11.8	14.1	13.7	13.0	12.8	27.6	26.7	13.5	11.0	32.4	24.9	13.7	20.0	9.4	7.0	15.4	21.7	21.0	3.7	18.1	43.5	44.9	5.7	5.4	63.0	19.6	8.8	16.1	10.5	1.5	20.6	27.9	16.2	11.7	17.9	6.3	21.5	23.9	17.1	0.5	13.9	13.3	52.4	0.2	6.6	4.1	13.3	11.7	10.4	14.4	24.2	10.1	21.0	22.9	18.0	0.0	9.4	11.8	27.0	2.0	53.2	0.0	1.0	42.0	60.5	0.1	22.8	10.2	1.4	28.2	17.5	24.9	19.4	70.9	6.0	13.4	41.2	15.7	51.0	8.6	6.4	0.2	0.0	145.9	13.3	2.9	10.9	2.1	1.2	0.3	0.8	0.3	1.0	0.7	0.8	1.3	0.5	1.3	1.4	0.5	0.1	1.2	0.5	0.4	0.0	1.0	20.1	23.0	23.9	18.6	20.9	23.7	27.5	24.8	22.3	26.7	24.9	21.0	69.8	28.9	42.9	99.6	13.3	15.2	23.3	16.6	27.9	25.5	10.9	11.4	15.6	7.2	25.7	12.9	0.0	61.0	4.2	1.0	15.6	12.8	184.2	191.3	99.5	38.5	9.0	30.9	33.0	3.0	18.6	27.3	4.1	1012.9	12.0	72.3	22.9	0.0	19.9	13.5	52.7	2.1	16.2	8.8	8.0	300.3	23.3	12.4	33.8	41.2	2.0	34.2	5.2	78.9	9.5	5.8	3.7	30.9	3.8	23.4	6.7	9.1	33.9	3.6	13.1	15.6	29.6	77.1	38.3	17.8	13.4	136.5	11.0	27.7	1.5	21.5
RLBP1	CRALBP	ENSG00000140522	"Retinaldehyde binding protein 1"	P12271	15	89209869-89221614	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Sensory transduction, Transport, Vision"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"retina: 265.6"	"Cell type enriched"	"Detected in some"	34	"Muller glia cells: 3148.2"	"Group enriched"	"Detected in some"	30	"glioma: 3.7;melanoma: 7.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	53	"SK-MEL-30: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042051, HPA044083"	Enhanced	Approved	Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	"Nucleoplasm, Centrosome"	"HPA042051: AB_2732495, HPA044083: AB_2678802"	"unprognostic (3.19e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.76e-1)"		"unprognostic (8.24e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.76e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.13e-1)"		"unprognostic (8.42e-2)"	0.0	0.2	14.9	0.1	16.9	0.1	0.0	15.0	20.8	0.0	16.7	1.6	0.2	0.0	0.2	0.0	0.0	0.0	0.0	15.7	14.5	0.0	0.0	0.0	0.0	14.5	14.2	0.0	0.0	0.0	2.6	0.0	14.3	0.0	0.1	265.6	0.0	0.0	0.1	0.0	0.4	0.1	14.0	0.0	0.2	0.9	14.9	0.0	0.0	0.1	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	14.9	16.9	15.0	20.8	15.7	14.5	14.5	14.2	14.3	14.0	14.9	14.9	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.3	0.0	0.0	0.0	39.6	4.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.5	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.9	2.0	3148.2	0.0	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.9	0.0	0.0	0.0	0.2	0.2	0.0	0.0	20.0	0.0	0.0	0.0	0.0
RNF103	"hkf-1, KF1, ZFP103"	ENSG00000239305	"Ring finger protein 103"	O00237	2	86603398-86623866	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 7.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057922	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 15: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"			"HPA057922: AB_2683555"	"unprognostic (4.41e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.37e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.67e-2)"	"prognostic favorable (6.77e-5)"	14.6	15.3	25.7	9.0	28.8	13.6	20.9	35.8	31.6	15.9	22.6	21.9	18.7	23.7	45.4	14.0	16.9	19.4	37.7	24.8	25.1	15.3	54.5	11.3	8.1	26.8	27.2	16.0	24.7	25.2	15.6	15.6	25.7	23.3	16.5	10.3	18.7	17.7	21.4	14.3	23.0	21.0	27.2	10.5	22.6	15.4	26.7	8.1	10.2	19.1	10.0	14.4	13.9	30.6	9.6	12.9	6.4	9.9	28.6	18.3	10.3	13.6	20.6	6.8	9.2	7.5	16.1	15.9	15.9	20.4	24.8	11.5	8.7	10.7	10.2	13.4	11.7	9.1	5.4	16.7	27.1	3.0	13.0	26.9	21.8	10.1	12.6	24.3	20.7	7.4	3.3	9.3	19.0	11.9	7.0	8.0	2.9	19.0	9.0	4.3	27.5	9.4	25.1	14.9	10.2	10.4	16.0	35.2	14.0	8.0	13.5	7.4	23.6	13.2	6.3	13.4	8.2	32.3	11.5	10.7	10.5	5.1	6.5	4.5	0.5	7.2	0.7	0.7	1.0	0.9	1.1	1.6	1.1	1.0	1.2	0.9	1.0	2.3	0.4	0.8	2.5	0.6	25.7	28.8	35.8	31.6	24.8	25.1	26.8	27.2	25.7	27.2	26.7	30.6	22.6	9.6	14.5	0.0	16.6	48.3	35.5	13.9	33.6	15.8	45.9	31.1	40.0	31.5	22.1	20.2	4.2	13.6	15.7	72.4	1.9	17.6	16.8	20.4	17.9	22.4	31.8	16.4	0.0	28.4	7.8	27.6	44.4	30.0	18.4	19.9	22.9	68.9	9.6	18.5	0.0	45.9	12.2	14.1	29.5	9.3	25.4	19.8	10.6	0.0	8.0	17.2	2.1	0.0	0.0	33.9	41.5	23.0	41.1	45.0	56.1	12.9	33.6	9.5	6.6	40.3	25.7	27.5	12.6	32.6	44.2	40.9	19.5	9.0	24.3	48.6
RNF121	FLJ11099	ENSG00000137522	"Ring finger protein 121"	Q9H920	11	71929018-71997597	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046041	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA046041: AB_10965850"	"unprognostic (1.36e-2)"	"unprognostic (8.84e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (2.72e-6)"	"unprognostic (1.54e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.70e-1)"	7.2	9.5	8.8	6.6	8.7	5.8	11.3	8.5	9.2	9.8	9.7	8.1	15.9	8.4	20.0	7.4	11.6	7.8	10.0	8.8	9.0	16.4	11.5	7.6	8.1	8.8	9.1	11.2	10.9	24.3	9.5	11.1	8.8	10.6	10.3	15.7	15.1	13.6	17.2	8.3	13.9	11.8	9.0	6.7	9.2	8.7	9.1	7.7	12.9	14.9	10.4	9.1	7.1	8.7	10.9	22.7	20.5	14.6	19.1	15.2	13.8	16.7	17.7	25.4	26.9	46.0	20.9	9.2	14.9	18.5	26.7	22.1	22.7	21.2	26.7	13.8	13.1	14.0	21.5	21.9	14.3	12.8	11.5	14.8	17.9	28.7	18.2	27.9	46.7	13.5	23.2	8.6	22.7	23.5	9.0	14.1	13.7	43.4	21.9	11.0	44.5	7.9	28.3	18.4	13.7	14.6	22.9	20.4	30.4	20.6	22.5	9.5	32.8	19.0	17.2	11.8	14.6	9.6	10.2	9.4	16.5	8.3	17.1	4.4	2.2	2.2	3.0	2.9	3.5	3.2	2.3	2.4	2.3	1.3	2.7	2.9	1.2	3.2	2.1	3.7	2.1	2.9	8.8	8.7	8.5	9.2	8.8	9.0	8.8	9.1	8.8	9.0	9.1	8.7	9.6	6.4	9.6	12.7	9.4	8.8	11.2	22.8	10.2	16.1	12.1	10.9	9.7	12.8	13.3	20.2	20.9	32.0	17.9	15.2	7.9	26.0	6.3	8.9	10.3	6.5	9.6	13.0	19.3	32.3	26.5	11.8	9.2	10.9	7.0	11.6	8.9	14.4	14.2	10.1	16.9	13.2	26.4	6.6	12.9	3.0	13.1	7.6	10.6	15.0	15.0	19.0	10.3	18.1	19.0	29.0	11.0	12.4	17.1	10.3	31.0	20.9	10.3	21.1	19.7	10.0	14.2	25.1	19.6	6.4	5.8	31.1	10.0	13.4	9.4	9.9
RPS6KA3	"CLS, HU-3, MRX19, RSK2"	ENSG00000177189	"Ribosomal protein S6 kinase A3"	P51812	X	20149911-20267519	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 236.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003221, CAB003853, CAB013520"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553"	"unprognostic (1.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-1)"	21.1	18.8	6.9	33.7	10.2	16.2	14.8	12.7	12.8	16.1	8.5	32.8	24.1	17.5	8.5	18.7	15.1	26.9	21.1	8.7	9.4	19.5	45.0	32.3	31.3	8.4	10.0	10.6	17.2	59.4	5.9	19.5	8.5	19.9	31.8	15.7	13.2	18.0	51.8	15.0	27.6	27.8	8.7	29.2	21.1	5.5	10.6	32.9	21.2	40.3	32.6	34.2	8.5	8.0	44.9	77.0	28.4	14.8	27.1	47.3	8.6	38.0	57.4	27.8	37.7	87.7	56.2	29.3	12.8	40.0	40.5	30.9	32.8	32.2	51.1	24.8	26.1	34.6	46.2	236.8	27.7	67.8	34.2	30.3	25.1	43.5	54.4	24.3	101.9	30.4	23.1	81.0	29.4	21.2	44.2	20.7	20.6	57.8	45.9	23.3	60.0	33.8	23.9	36.9	13.1	12.8	51.1	15.3	54.4	35.3	0.1	20.0	57.3	30.1	20.8	96.3	21.7	64.3	42.1	32.1	56.9	33.1	72.6	11.9	3.8	7.9	4.7	5.3	8.3	2.4	5.4	5.2	5.6	3.2	3.7	4.5	5.8	6.6	6.0	6.7	2.9	2.2	6.9	10.2	12.7	12.8	8.7	9.4	8.4	10.0	8.5	8.7	10.6	8.0	60.6	44.8	67.5	31.6	34.8	54.4	37.0	21.2	10.2	37.8	20.4	10.8	22.9	34.3	41.1	16.5	22.9	4.0	70.0	63.5	3.9	26.3	0.4	10.8	24.0	61.1	25.0	19.1	142.2	30.5	6.7	31.6	24.5	26.1	44.3	8.3	34.6	65.4	22.6	13.5	108.4	59.1	28.5	40.8	104.3	1.5	13.1	62.6	37.4	126.5	53.7	27.5	46.4	116.6	27.0	37.4	57.9	21.1	25.5	56.6	33.5	25.1	23.3	9.7	19.7	41.5	21.3	6.4	8.7	13.8	55.5	3.6	66.0	14.2	61.1	63.8
SAMD4B	"FLJ10211, hSmaug2, MGC99832, SMGB"	ENSG00000179134	"Sterile alpha motif domain containing 4B"	Q5PRF9	19	39342396-39385710	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 166.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016800, HPA059385"	Approved		Enhanced	Cytosol		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"HPA016800: AB_1856552, HPA059385: AB_2684000"	"unprognostic (2.56e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (2.17e-6)"	"unprognostic (3.41e-2)"	"unprognostic (8.66e-2)"	"unprognostic (6.24e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.91e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.89e-2)"	46.1	39.7	37.3	24.5	48.1	20.3	42.1	31.1	37.5	56.6	18.1	47.1	18.9	49.7	16.8	65.0	47.3	26.7	39.6	34.2	34.5	33.2	31.2	45.7	15.1	51.9	45.9	60.8	34.2	36.3	48.1	26.2	39.9	41.9	15.8	23.4	42.8	33.3	36.0	54.9	34.9	27.9	35.9	32.9	40.2	41.4	40.7	19.2	44.1	19.2	15.1	46.1	52.9	53.6	97.8	131.0	65.6	49.7	62.7	75.1	54.1	55.1	60.0	43.2	35.7	114.6	53.2	32.3	70.2	88.4	56.0	46.2	65.3	50.4	29.5	65.3	106.1	32.4	55.5	48.6	64.7	35.5	32.7	74.1	58.5	70.8	52.3	52.6	41.3	42.9	97.6	34.0	53.3	65.8	38.1	17.3	52.2	63.5	51.6	45.9	42.2	28.3	36.3	77.8	66.6	65.0	72.1	48.8	39.2	49.4	39.5	37.8	54.6	70.0	50.6	153.5	97.8	64.0	62.2	35.8	93.4	26.7	70.2	1.2	1.0	1.5	1.0	0.4	0.7	1.2	0.8	0.9	0.8	0.6	1.3	0.9	2.7	0.9	0.3	0.9	0.3	0.5	37.3	48.1	31.1	37.5	34.2	34.5	51.9	45.9	39.9	35.9	40.7	53.6	28.8	12.8	30.4	55.8	21.6	33.3	62.7	22.4	12.0	56.9	37.1	32.9	8.4	24.3	18.9	36.8	166.8	25.7	21.7	26.4	5.9	26.2	6.9	44.9	42.5	31.9	51.0	19.8	26.6	27.3	23.1	39.1	19.9	55.3	18.9	39.0	36.8	26.6	20.7	52.2	31.0	28.1	10.2	25.5	38.2	5.4	43.8	28.5	19.6	25.3	18.4	31.4	16.5	34.2	106.0	41.0	19.6	33.1	19.3	65.7	20.2	12.3	30.7	67.9	65.7	43.9	30.9	70.3	42.7	15.6	43.5	54.6	20.4	33.8	24.5	65.9
SCGB3A2	"LU103, PNSP1, UGRP1"	ENSG00000164265	"Secretoglobin family 3A member 2"	Q96PL1	5	147870682-147882191	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	124	"lung: 1271.2"	"Group enriched"	"Detected in some"	8	"Alveolar cells type 2: 4396.4;Club cells: 6565.6"	"Cancer enriched"	"Detected in some"	10	"lung cancer: 211.2"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	50	"basophil: 71.6"	"Lineage enriched"	"Detected in many"	50	"granulocytes: 71.6"	"Cell line enhanced"	"Detected in many"		"A-431: 89.1;EFO-21: 52.3;NTERA-2: 61.0;PC-3: 302.9;SuSa: 120.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		800000	"Cluster 46: Basophils - DNA binding"	"Cluster 19: Lung - Lung function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"				"unprognostic (3.85e-1)"	"unprognostic (1.77e-1)"			"unprognostic (2.99e-2)"	"unprognostic (3.51e-2)"		"unprognostic (1.84e-2)"		"unprognostic (3.17e-2)"	"unprognostic (1.05e-2)"		"unprognostic (1.90e-8)"	"unprognostic (9.31e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.11e-2)"	0.6	0.6	3.3	1.5	2.4	2.4	4.0	5.3	6.0	0.7	0.6	0.6	1.0	1.7	5.0	2.1	1.4	1.2	1.7	3.3	6.2	1.2	1.3	1271.2	2.8	3.4	1.2	2.1	0.6	0.7	1.1	2.0	3.1	1.1	1.8	10.2	6.2	1.4	2.1	5.0	1.4	0.9	0.3	4.2	4.1	1.9	2.0	1.3	7.2	0.8	2.2	0.7	0.1	2.6	89.1	1.3	1.1	2.0	1.1	0.6	2.3	1.4	0.3	0.2	0.2	0.5	1.1	0.4	52.3	0.3	0.8	0.8	2.5	1.3	0.5	0.3	1.6	3.4	10.5	0.3	0.0	0.7	3.3	1.4	0.8	0.7	0.0	2.0	0.2	0.3	2.4	1.1	0.2	1.7	0.9	0.8	61.0	0.0	302.9	0.2	0.9	0.3	1.2	0.7	4.3	1.1	12.3	1.1	0.2	120.6	1.3	0.6	1.7	1.2	35.5	1.6	1.3	1.7	1.4	0.4	0.4	1.5	4.1	71.6	1.0	0.2	0.4	0.7	0.1	0.2	0.2	0.2	0.6	0.4	0.0	0.2	0.4	1.4	0.9	0.3	0.2	0.1	3.3	2.4	5.3	6.0	3.3	6.2	3.4	1.2	3.1	0.3	2.0	2.6	0.0	618.6	4396.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	6565.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	14.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.2	106.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	16.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	623.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.2
SEC23A		ENSG00000100934	"Sec23 homolog A, COPII coat complex component"	Q15436	14	39031919-39109646	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 347.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043806, HPA069974"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA		83000	"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA043806: , HPA069974: AB_2686223"	"unprognostic (2.40e-1)"	"prognostic unfavorable (5.75e-4)"	"prognostic favorable (3.56e-4)"	"unprognostic (3.30e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (1.69e-4)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.41e-3)"	45.9	32.0	11.4	31.8	14.2	13.1	20.9	18.3	16.8	36.2	31.4	40.0	57.7	42.7	19.9	34.1	21.5	32.1	46.9	13.3	18.9	23.1	80.8	20.2	21.0	13.8	14.0	33.9	12.0	8.1	10.5	27.1	15.3	34.0	34.2	38.5	10.5	52.6	54.2	12.8	52.6	90.5	7.6	20.5	16.8	23.5	12.7	18.9	17.9	58.5	22.0	40.7	17.9	15.4	52.1	90.8	76.9	74.7	161.3	173.0	25.9	195.1	176.4	135.2	166.8	93.2	44.2	12.6	46.9	279.6	54.9	41.2	99.6	86.3	208.6	39.6	36.9	21.8	67.7	347.3	122.4	35.9	31.3	134.0	48.8	91.6	73.7	114.6	130.8	26.9	15.6	30.1	125.8	47.5	32.9	16.9	18.4	81.7	91.3	44.0	111.8	19.1	84.7	75.6	8.5	20.5	132.8	43.0	51.8	68.6	51.5	12.4	138.4	75.0	57.8	110.8	52.0	27.0	36.6	56.0	50.3	31.4	70.2	70.5	34.3	38.6	26.6	29.3	38.4	23.6	33.1	34.9	31.1	21.1	34.9	28.0	29.5	42.1	27.3	26.7	38.1	31.4	11.4	14.2	18.3	16.8	13.3	18.9	13.8	14.0	15.3	7.6	12.7	15.4	35.4	16.0	26.9	34.9	30.5	25.9	33.5	15.5	15.4	39.7	11.8	10.3	54.6	15.7	18.8	31.3	68.8	16.0	36.0	87.0	7.9	9.8	13.4	11.3	42.8	41.1	24.5	6.1	48.3	5.6	43.7	55.0	26.5	18.8	27.9	56.9	118.9	133.6	25.6	30.3	51.1	31.6	12.2	36.4	32.3	18.6	74.9	24.3	24.9	48.7	25.6	19.4	32.0	34.2	44.3	17.8	34.1	71.5	38.5	37.5	88.6	32.8	10.1	58.7	39.5	27.6	51.4	18.0	15.5	15.7	24.0	24.8	32.3	31.0	30.2	56.5
SEC24A		ENSG00000113615	"SEC24 homolog A, COPII coat complex component"	O95486	5	134648785-134727909	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 89.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038901, HPA056825"	Approved		Approved	"Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoli fibrillar center, Vesicles"		"HPA038901: AB_10674843, HPA056825: AB_2683249"	"unprognostic (9.10e-3)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (2.76e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.18e-3)"	"unprognostic (4.77e-2)"	"unprognostic (3.00e-2)"	"unprognostic (9.37e-3)"	"unprognostic (8.97e-2)"	9.7	13.3	2.2	13.3	2.2	17.6	10.0	3.6	3.9	11.7	13.6	11.7	21.3	8.7	8.1	10.5	5.4	10.5	6.3	2.6	3.4	9.0	34.6	7.6	10.7	2.4	3.7	6.5	15.6	11.8	7.9	15.5	2.2	10.0	13.0	6.9	16.9	8.1	11.9	5.8	22.0	10.7	1.8	9.6	14.6	6.0	2.7	9.0	11.5	7.3	14.2	13.4	7.2	2.7	21.6	12.1	22.3	17.1	32.4	32.6	24.1	32.6	40.2	25.7	44.1	45.0	12.9	16.1	21.6	38.1	27.3	12.0	28.2	25.3	44.4	19.8	13.3	13.7	18.6	33.5	23.0	16.3	26.4	20.5	14.1	24.8	18.1	22.4	23.7	11.2	18.9	24.3	25.9	11.7	15.6	11.9	14.6	19.7	7.6	15.7	19.8	18.9	16.8	16.9	9.4	9.7	21.2	10.1	26.8	38.6	17.8	13.4	26.0	21.2	8.0	27.0	19.8	42.7	40.6	26.5	24.9	17.0	41.2	3.3	2.1	1.5	1.6	2.3	2.7	2.1	1.7	1.6	2.5	1.3	1.6	1.9	1.2	2.0	2.5	1.6	1.7	1.2	2.2	2.2	3.6	3.9	2.6	3.4	2.4	3.7	2.2	1.8	2.7	2.7	14.4	6.4	8.4	15.3	15.2	31.9	14.0	10.7	8.0	7.8	20.6	9.1	6.3	11.5	18.6	3.7	12.5	10.3	14.6	22.1	5.9	6.3	12.0	25.6	33.4	12.2	9.5	6.7	29.6	13.6	17.2	18.1	32.6	70.1	12.7	8.3	15.7	54.8	11.5	13.5	25.7	19.9	8.2	16.2	32.0	5.7	8.4	20.7	14.2	15.0	9.8	6.6	6.2	35.2	23.2	15.0	11.5	13.5	89.1	22.0	42.6	12.3	13.8	7.7	6.6	19.6	12.8	15.2	8.2	17.0	32.4	22.7	13.1	8.0	15.2	36.0
SELENON	"MDRS1, RSMD1, RSS, SELN, SEPN1"	ENSG00000162430	"Selenoprotein N"	Q9NZV5	1	25800176-25818221	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Desmin-related myopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 99.2;Exocrine glandular cells: 42.3;Granulosa cells: 31.2;Hofbauer cells: 29.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058076	Approved		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA058076: AB_2683598"	"unprognostic (2.65e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.11e-1)"	"prognostic favorable (2.23e-4)"	"unprognostic (1.93e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (3.40e-5)"	"unprognostic (1.94e-1)"	"unprognostic (4.72e-1)"	"unprognostic (3.32e-3)"	"unprognostic (6.01e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.56e-3)"	"unprognostic (5.89e-2)"	65.7	48.0	51.6	34.0	51.2	17.0	60.8	45.5	53.3	43.8	74.2	42.5	17.4	48.8	19.5	36.5	40.2	30.1	60.7	49.6	48.5	52.5	20.3	51.8	20.5	72.8	55.2	51.7	60.1	37.0	40.2	38.9	52.1	58.2	20.8	11.7	45.7	39.6	56.3	30.2	31.0	56.2	54.1	43.4	43.4	12.0	62.6	13.6	53.8	39.7	16.3	46.9	35.6	50.2	52.6	49.5	160.9	138.4	102.5	178.8	54.4	62.2	93.4	67.7	53.9	12.9	54.2	0.1	40.4	94.6	74.8	49.9	42.4	66.2	51.1	55.8	32.6	51.4	18.2	16.0	73.8	11.0	116.6	191.7	43.8	71.0	35.5	79.9	214.4	17.4	18.5	7.2	64.7	26.8	2.3	15.7	61.0	40.9	33.7	45.4	70.3	6.4	27.7	14.8	33.5	56.9	39.4	35.3	52.7	43.0	35.6	36.1	180.5	68.4	46.2	126.6	37.1	5.8	0.2	1.4	94.8	15.9	84.4	2.7	1.2	1.6	0.7	1.0	0.4	0.7	0.6	0.5	0.8	0.4	0.9	0.6	0.2	0.3	1.1	0.1	0.7	0.4	51.6	51.2	45.5	53.3	49.6	48.5	72.8	55.2	52.1	54.1	62.6	50.2	99.2	9.6	10.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	23.0	19.3	0.0	0.0	3.7	20.2	0.0	16.4	3.8	0.0	0.0	18.6	0.0	6.5	22.4	21.5	0.0	0.0	0.0	42.3	11.4	12.5	0.0	13.5	2.5	31.2	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	3.1	0.0	0.0	0.0	0.0	24.8	0.0	0.0	0.9	0.0	0.0	14.9	3.6	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	13.0	2.2	8.6	0.0	0.0
SEMA3C	"SEMAE, SemE"	ENSG00000075223	"Semaphorin 3C"	Q99985	7	80742538-80922359	"Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 92.2;Breast myoepithelial cells: 93.5;Fibroblasts: 109.6;Ionocytes: 91.6;Oligodendrocytes: 223.7;Respiratory ciliated cells: 103.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	9	"basophil: 49.6"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 49.6"	"Cell line enhanced"	"Detected in many"		"GAMG: 252.7;RT4: 238.3;T-47d: 267.0;U-2197: 349.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042418			Approved	"Golgi apparatus,Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		13000	"Cluster 46: Basophils - DNA binding"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"	"Plasma membrane"	"HPA042418: AB_10797389"	"unprognostic (1.93e-2)"	"unprognostic (2.54e-3)"	"unprognostic (4.94e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.74e-2)"	"prognostic unfavorable (5.72e-5)"	"unprognostic (9.28e-3)"	"unprognostic (1.91e-3)"	"unprognostic (1.39e-2)"	"unprognostic (9.01e-2)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (2.07e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.92e-2)"	53.8	9.5	4.9	12.7	8.1	0.8	57.3	9.1	5.5	53.0	2.6	38.4	10.6	42.7	23.1	20.5	15.4	30.0	22.1	11.0	12.7	10.0	1.3	18.4	1.0	15.0	8.0	48.5	2.6	0.8	3.7	6.0	17.5	66.6	31.3	1.0	27.3	42.3	19.3	17.9	14.1	44.4	10.0	22.2	20.6	12.9	8.4	1.4	1.8	34.3	1.1	69.8	14.4	12.8	6.6	77.0	156.4	0.6	35.2	82.5	0.3	51.8	59.7	25.9	32.5	12.4	144.7	0.0	2.1	17.7	252.7	31.2	0.7	47.0	42.4	0.1	15.8	9.9	63.6	0.7	41.3	0.7	0.2	36.1	32.3	63.6	62.0	220.2	0.5	0.0	0.5	0.1	46.4	113.7	0.2	0.3	1.4	22.2	12.2	0.1	75.5	1.2	142.9	238.3	0.8	82.4	145.7	38.9	9.5	66.3	267.0	0.2	125.2	140.1	64.2	349.2	93.9	1.2	0.0	0.1	52.8	0.0	142.3	49.6	5.7	0.9	0.0	2.4	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	2.6	0.0	1.9	3.3	0.0	1.7	4.9	8.1	9.1	5.5	11.0	12.7	15.0	8.0	17.5	10.0	8.4	12.8	7.4	9.6	8.9	3.3	0.3	26.4	41.8	92.2	10.8	0.3	15.8	93.5	38.2	1.5	39.8	7.3	6.2	0.5	1.7	56.1	1.9	3.8	0.5	20.3	11.9	7.7	6.0	4.6	41.7	6.6	1.3	109.6	17.9	34.4	5.1	13.2	1.1	0.0	8.8	0.0	16.7	15.7	91.6	3.1	14.9	2.3	7.8	9.0	55.2	20.6	8.3	1.5	1.0	3.0	223.7	68.2	12.4	52.3	0.0	53.7	12.5	0.4	103.0	0.6	0.0	38.8	17.3	0.7	2.7	3.0	18.9	0.3	1.5	9.9	30.4	70.0
SENP7		ENSG00000138468	"SUMO specific peptidase 7"	Q9BQF6	3	101324205-101513241	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 109.6;Oligodendrocyte precursor cells: 157.3;Oligodendrocytes: 134.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 44.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 44.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027259, HPA071998"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Centrosome,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Nuclear bodies, Centrosome, Cytosol"	"HPA027259: AB_1856679, HPA071998: "	"unprognostic (1.50e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.44e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (1.38e-3)"	"unprognostic (9.25e-3)"	"unprognostic (8.80e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.77e-3)"	"unprognostic (1.94e-1)"	"unprognostic (9.85e-2)"	"unprognostic (8.08e-3)"	"unprognostic (3.27e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.23e-2)"	15.1	9.7	9.7	13.7	12.7	24.7	16.9	21.8	11.8	15.8	9.7	12.5	7.3	26.8	14.7	7.8	16.1	14.2	9.5	9.3	12.3	11.4	8.7	12.8	23.1	13.9	11.7	26.3	12.8	16.9	10.2	19.4	14.0	12.7	10.8	26.0	8.9	11.5	11.2	20.8	12.4	14.7	10.1	16.9	14.1	9.1	11.5	20.5	17.5	11.2	17.7	11.8	11.4	20.3	9.2	6.1	29.4	16.4	5.6	8.2	5.3	5.2	3.8	8.5	10.4	4.0	8.3	7.0	7.9	5.1	7.8	9.1	9.4	4.8	17.0	13.0	2.7	12.7	5.1	5.5	4.5	7.4	12.2	6.4	8.5	4.3	9.6	7.6	12.2	13.4	10.5	17.6	8.1	6.1	13.7	8.6	6.0	4.8	6.3	15.2	8.0	6.4	10.1	5.2	11.3	8.8	4.8	4.8	6.5	15.0	8.0	9.8	10.2	11.8	7.1	3.9	5.2	12.2	7.8	16.4	4.1	9.7	9.8	44.1	5.9	5.9	5.8	5.4	7.3	6.4	7.8	5.8	4.8	9.0	10.3	7.1	17.3	9.3	6.3	4.1	6.9	6.1	9.7	12.7	21.8	11.8	9.3	12.3	13.9	11.7	14.0	10.1	11.5	20.3	44.5	16.0	24.9	78.4	33.0	9.1	8.4	7.4	21.1	48.3	14.4	12.2	21.6	2.8	18.4	16.5	20.9	5.8	30.8	5.4	5.9	8.1	4.1	33.1	48.5	28.4	13.1	18.7	62.4	5.2	2.7	23.4	21.4	34.1	37.2	28.6	32.9	10.3	8.2	52.2	109.6	6.5	12.2	20.5	9.5	4.0	18.3	19.1	10.6	80.6	13.6	16.7	35.0	157.3	134.4	6.9	4.1	19.5	23.5	4.8	7.0	8.5	27.5	33.8	46.0	29.7	23.3	22.8	19.9	13.4	9.9	2.5	41.0	21.1	5.9	6.1
SERINC1	"KIAA1253, TDE1L, TDE2, TMS-2"	ENSG00000111897	"Serine incorporator 1"	Q9NRX5	6	122443351-122471807	"Plasma proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035738, HPA035739"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA035738: AB_10672990, HPA035739: AB_10669536"	"unprognostic (2.83e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.45e-2)"	"unprognostic (9.84e-2)"	"unprognostic (8.27e-2)"	"unprognostic (9.07e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.50e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.22e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.00e-2)"	213.6	242.8	220.4	93.2	248.8	148.2	157.8	237.5	334.0	151.4	178.5	104.6	99.4	146.6	108.1	94.9	104.4	128.0	163.7	248.3	257.3	194.1	241.3	160.5	96.8	258.9	243.3	164.4	100.4	243.3	71.7	195.1	282.9	139.6	100.1	225.5	97.1	143.3	152.6	79.0	114.3	141.7	268.4	123.6	96.5	65.6	241.3	89.7	203.1	194.8	79.5	121.7	84.8	306.8	40.5	49.1	121.7	111.8	450.2	245.1	64.5	208.4	259.8	111.6	171.6	57.8	106.9	27.1	159.7	236.5	127.9	78.7	72.6	90.2	166.1	87.1	86.0	76.9	79.0	105.9	201.3	77.5	146.3	256.7	173.0	139.0	190.8	256.4	98.1	69.9	77.4	149.3	233.8	46.8	35.1	51.4	39.7	63.5	61.9	42.5	60.0	66.5	240.3	70.1	63.6	114.5	92.3	101.2	146.8	107.4	70.0	107.1	201.3	133.7	57.9	110.8	109.9	112.4	134.4	35.9	176.8	62.1	159.5	158.3	43.0	92.6	44.7	53.2	48.1	27.7	45.9	43.3	35.9	23.7	53.2	46.9	108.7	51.7	62.0	28.0	54.2	56.0	220.4	248.8	237.5	334.0	248.3	257.3	258.9	243.3	282.9	268.4	241.3	306.8	167.8	150.6	99.2	44.4	73.9	66.2	81.1	55.7	61.5	114.4	71.7	57.1	156.2	87.2	58.9	77.3	70.9	53.8	80.9	88.8	9.8	63.0	3.2	54.9	103.3	130.0	84.5	81.5	92.5	48.7	57.7	131.4	39.8	106.8	124.0	58.1	127.8	132.1	73.1	138.0	145.7	41.8	36.7	158.2	86.4	10.0	126.8	107.4	94.3	65.6	58.1	97.2	58.7	48.2	134.0	78.4	43.6	131.3	80.0	86.1	80.1	44.0	56.1	70.6	59.2	105.1	110.6	25.7	17.0	39.0	74.9	119.7	100.7	99.8	32.7	97.1
SFXN1	"FLJ12876, SLC56A1"	ENSG00000164466	"Sideroflexin 1"	Q9H9B4	5	175477062-175529742	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, One-carbon metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 99.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 99.8"	"Group enriched"	"Detected in all"	5	"granulocytes: 99.8;T-cells: 36.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019543, HPA063745"	Approved		Enhanced	Mitochondria		NA	NA		23000	"Cluster 46: Basophils - DNA binding"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 58: T-cells - T-cell receptor"	Mitochondria		"HPA019543: AB_1856789, HPA063745: AB_2685111"	"unprognostic (4.77e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.59e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.98e-1)"	"unprognostic (1.08e-3)"	"unprognostic (4.23e-2)"	7.6	15.4	14.0	18.2	14.8	21.9	8.1	15.0	17.4	9.3	15.0	28.1	19.3	8.5	8.0	14.7	8.7	9.8	12.3	13.3	15.3	41.6	99.7	5.9	27.0	12.1	12.6	18.7	13.1	15.8	12.9	15.3	13.2	9.6	17.7	20.7	9.6	10.4	10.9	8.8	20.1	11.3	13.0	10.5	14.6	6.6	13.8	24.0	10.5	15.7	27.0	13.8	11.2	14.8	39.9	123.1	61.7	67.0	21.0	44.4	99.2	99.1	41.5	81.3	78.3	156.5	77.6	82.3	74.9	51.9	100.4	49.7	119.0	171.9	87.8	202.1	102.4	60.6	103.4	69.0	30.3	119.6	73.3	36.5	33.1	90.3	39.2	48.3	63.3	74.9	89.1	63.4	60.2	138.3	140.3	9.7	48.7	66.5	41.1	116.3	63.1	87.8	31.3	154.2	104.6	66.7	95.6	88.9	47.8	50.5	43.1	38.3	62.3	63.9	100.3	47.5	130.2	80.2	101.8	184.6	105.1	104.9	68.1	99.8	5.1	26.3	26.2	6.7	21.4	10.7	36.4	29.2	7.3	9.3	28.4	29.3	1.6	12.7	4.3	3.5	32.3	14.2	14.0	14.8	15.0	17.4	13.3	15.3	12.1	12.6	13.2	13.0	13.8	14.8	6.0	3.2	13.5	55.2	29.1	19.5	33.5	30.6	48.9	59.3	13.7	9.9	18.1	17.2	18.8	18.4	47.9	41.4	19.0	68.9	25.4	27.7	1.2	10.9	23.3	14.2	31.2	45.4	77.3	18.7	74.2	24.8	26.0	11.3	9.5	38.1	12.8	98.7	17.2	77.4	62.9	23.9	26.4	8.1	11.4	4.0	47.2	9.5	10.6	30.9	9.0	19.8	37.0	55.3	60.1	31.8	20.1	35.0	63.4	31.6	89.8	51.1	15.5	49.9	26.3	21.7	23.1	2.8	7.4	43.6	21.6	30.9	61.9	67.2	21.7	27.0
SFXN3	"SFX3, SLC56A3"	ENSG00000107819	"Sideroflexin 3"	Q9BWM7	10	101031234-101041244	"Metabolic proteins, Predicted membrane proteins"	"Amino-acid transport, One-carbon metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 177.5;Proximal enterocytes: 119.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008028, HPA048105"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 45: Intestine - Brush border"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"HPA008028: AB_1079938, HPA048105: AB_2680265"	"unprognostic (2.55e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.94e-3)"	"prognostic unfavorable (3.79e-4)"	"unprognostic (3.84e-3)"	"unprognostic (8.46e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (3.56e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.71e-1)"	20.1	10.7	16.2	11.8	19.0	6.2	14.9	19.4	21.2	17.9	15.7	13.9	31.7	18.0	21.5	8.1	18.3	16.4	15.1	19.7	12.9	12.0	4.3	21.3	7.9	18.5	15.8	12.7	9.1	18.3	9.0	21.0	19.2	12.0	10.4	23.4	11.1	16.5	3.6	22.2	37.5	25.4	12.7	10.7	11.0	7.2	18.2	6.4	9.9	7.9	7.1	14.9	14.7	19.3	44.4	16.9	1.7	5.2	43.5	46.0	4.4	26.4	92.7	33.0	26.4	28.1	47.4	1.9	24.8	62.1	27.7	31.8	7.9	57.7	14.4	12.3	10.2	5.3	27.1	20.4	29.8	4.2	41.2	31.8	8.3	29.1	27.3	91.8	73.5	12.5	0.4	1.4	54.4	7.3	1.9	6.4	2.1	16.2	40.3	4.3	32.5	12.0	48.5	6.8	9.0	44.1	14.4	1.7	39.3	11.8	13.8	31.2	60.9	29.0	22.7	26.0	13.1	6.6	2.7	0.2	70.7	23.7	23.7	10.6	18.1	9.1	11.0	13.4	8.5	2.4	7.4	7.6	19.1	1.1	4.5	5.6	3.2	5.5	7.8	2.9	8.7	11.7	16.2	19.0	19.4	21.2	19.7	12.9	18.5	15.8	19.2	12.7	18.2	19.3	17.1	12.8	5.3	7.5	3.9	13.9	5.0	6.3	2.8	60.2	6.9	7.0	3.2	18.6	4.6	5.5	47.9	1.2	21.2	7.3	1.9	31.7	51.9	25.2	13.4	17.5	5.4	4.8	14.2	15.3	40.9	17.4	7.7	5.6	14.5	55.5	20.0	0.9	37.4	10.1	12.2	7.8	4.1	21.3	29.9	177.5	17.4	24.3	33.8	1.0	12.0	7.7	9.2	5.0	16.0	38.5	10.8	14.7	10.4	2.9	119.1	14.3	38.8	24.0	13.1	6.7	12.0	1.4	0.7	1.3	10.9	10.9	19.7	2.7	5.6	3.4
SIAH2		ENSG00000181788	"Siah E3 ubiquitin protein ligase 2"	O43255	3	150741125-150763477	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 226.7;Syncytiotrophoblasts: 389.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061293, CAB069930"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 85: Liver - Metabolism"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Vesicles	"CAB069930: AB_1217916, HPA061293: AB_2684470"	"prognostic favorable (1.17e-4)"	"unprognostic (1.04e-3)"	"unprognostic (3.83e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (8.21e-5)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.69e-2)"	15.8	78.6	16.4	20.8	19.0	44.7	17.1	17.4	24.9	48.0	17.3	17.7	13.5	33.4	18.6	46.1	27.2	14.3	16.2	16.9	16.7	12.1	61.2	13.2	35.8	15.8	15.5	24.4	20.9	15.9	11.0	43.1	17.9	19.4	15.4	7.8	16.4	34.7	12.3	30.4	12.9	29.4	15.5	24.4	17.9	8.0	16.5	25.1	8.0	12.8	45.3	23.5	39.6	26.0	54.0	13.4	10.5	20.1	35.4	26.4	41.7	22.9	26.5	27.3	32.4	28.4	24.7	31.3	31.0	24.1	22.8	31.4	28.6	20.7	25.6	24.4	19.5	61.5	16.0	94.7	50.4	34.3	16.0	24.1	47.0	16.3	36.9	21.7	21.5	60.2	15.5	110.8	17.4	66.4	58.7	17.4	33.1	52.3	26.0	44.0	22.7	110.4	17.4	17.9	38.4	19.1	17.4	15.4	39.8	23.8	99.5	50.0	15.0	17.7	15.8	40.1	31.0	130.6	55.9	42.0	17.6	48.6	9.2	8.9	2.2	8.6	1.6	1.2	2.5	2.2	2.8	2.5	2.0	2.2	1.4	1.4	4.7	1.4	1.3	2.6	1.6	0.9	16.4	19.0	17.4	24.9	16.9	16.7	15.8	15.5	17.9	15.5	16.5	26.0	15.9	6.4	4.8	6.8	99.0	146.7	82.3	11.8	153.1	47.0	32.3	22.2	17.8	25.8	11.7	22.0	37.5	192.0	62.6	30.2	13.7	8.5	3.4	56.0	29.2	22.5	38.3	226.7	14.1	6.6	23.4	28.8	44.4	96.5	10.2	18.7	20.7	54.4	32.6	35.3	11.0	39.9	14.2	115.5	102.7	2.1	44.1	70.4	44.4	14.0	22.7	32.7	32.0	5.0	11.5	10.5	17.9	30.9	128.7	56.7	20.7	17.9	16.5	2.8	13.1	11.8	29.9	0.7	10.8	154.1	142.4	389.4	86.1	28.6	34.5	81.8
SIRT1	SIR2L1	ENSG00000096717	"Sirtuin 1"	Q96EB6	10	67884656-67918390	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 292.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003855, HPA006295, HPA052351"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nucleoli fibrillar center, Mitochondria, Cytosol"	"CAB003855: AB_365497, HPA006295: AB_1079975, HPA052351: AB_2681796"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	16.4	30.2	8.9	11.0	10.4	19.8	17.5	15.6	11.9	17.1	7.8	12.5	9.2	18.5	11.9	10.9	11.9	14.0	10.6	8.5	9.9	13.4	17.3	12.6	17.7	9.3	9.2	25.1	12.1	14.0	6.9	12.7	10.0	14.0	12.0	13.5	9.9	11.2	14.6	9.6	9.7	13.7	8.8	14.3	10.3	26.8	9.4	19.2	14.7	18.5	15.1	15.5	9.5	12.9	15.1	16.8	26.2	29.4	24.4	18.7	16.3	20.4	21.0	27.4	24.3	18.7	12.6	31.4	10.8	13.7	17.1	11.7	32.8	6.9	29.3	16.9	19.0	16.7	12.1	14.7	22.3	18.1	12.3	17.3	16.2	16.6	28.3	29.4	11.2	17.6	21.6	16.7	20.3	12.1	17.0	25.0	32.5	9.6	26.6	30.3	20.6	12.4	13.1	9.1	16.8	23.0	37.4	24.4	26.8	22.5	17.7	16.6	9.4	21.2	19.8	19.0	20.1	13.9	17.7	61.8	10.9	27.2	8.9	1.3	0.8	1.1	1.1	1.0	1.6	1.8	1.2	1.5	1.3	1.0	2.2	1.3	1.0	1.2	1.3	1.2	1.0	0.6	8.9	10.4	15.6	11.9	8.5	9.9	9.3	9.2	10.0	8.8	9.4	12.9	35.7	19.2	7.4	17.0	27.6	39.1	20.9	7.2	22.8	12.5	48.3	33.4	34.8	11.5	8.7	5.5	27.1	7.1	42.5	31.2	5.9	4.3	292.2	38.4	26.2	20.6	42.9	10.3	16.0	5.6	5.4	28.0	23.4	57.1	12.0	14.8	15.4	15.8	9.1	11.8	18.4	21.0	10.2	23.4	28.7	45.6	17.7	34.1	16.0	30.9	14.8	7.1	9.2	18.6	30.7	6.2	20.6	19.5	15.8	26.0	11.2	8.4	4.1	14.0	0.0	43.4	28.8	24.2	16.3	21.1	47.5	12.4	29.1	8.9	18.7	17.2
SKP2	"FBL1, FBXL1, p45"	ENSG00000145604	"S-phase kinase associated protein 2"	Q13309	5	36151989-36196849	"Cancer-related genes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 37.9"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 134.4;Extravillous trophoblasts: 227.3;Syncytiotrophoblasts: 83.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 274.7;RH-30: 286.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013491, CAB013533, HPA051196, HPA054633"	Approved		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"CAB013491: AB_2533074, CAB013533: , HPA051196: AB_2681383, HPA054633: AB_2682550"	"unprognostic (2.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (3.72e-7)"	"prognostic favorable (8.57e-4)"	"unprognostic (5.06e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (4.77e-15)"	"unprognostic (2.50e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.19e-1)"	4.9	4.0	3.6	5.8	3.9	11.4	4.9	4.7	4.5	5.9	3.9	6.1	6.3	4.7	4.3	8.3	5.1	2.9	2.5	3.9	3.1	2.3	9.8	4.2	7.9	3.7	3.5	5.2	3.8	2.5	4.0	37.9	3.9	4.0	6.1	4.6	4.0	3.7	2.2	5.7	6.5	4.1	3.9	5.9	4.0	2.6	3.7	12.3	3.1	1.6	8.3	4.7	5.6	5.4	25.4	14.8	35.6	54.3	15.5	20.1	274.7	31.2	25.7	89.5	48.7	83.3	22.8	43.3	10.6	20.0	13.3	28.3	53.3	46.7	71.0	19.2	46.7	23.9	51.4	47.1	6.1	44.8	11.4	18.1	12.2	16.9	8.5	7.7	24.2	40.2	37.9	9.1	31.9	16.4	58.9	26.8	51.5	23.8	24.2	53.7	286.7	28.3	7.2	28.1	45.5	46.8	94.3	27.4	14.1	32.2	22.7	33.3	8.0	31.4	36.1	13.5	24.5	12.4	13.1	50.8	15.2	61.3	21.9	9.2	6.6	13.4	4.2	6.1	6.9	5.2	4.7	4.5	14.0	6.0	6.4	4.6	1.1	6.2	3.2	3.5	4.8	4.7	3.6	3.9	4.7	4.5	3.9	3.1	3.7	3.5	3.9	3.9	3.7	5.4	4.4	22.4	8.9	11.8	8.7	3.7	2.4	7.1	12.0	8.2	3.6	4.2	1.3	1.5	1.7	1.8	10.4	134.4	7.4	2.4	1.9	2.4	0.7	5.2	6.5	6.5	3.0	14.1	22.4	2.9	227.3	11.6	7.1	2.4	2.5	20.9	1.8	11.9	35.0	0.0	13.1	6.0	4.1	9.3	3.1	0.3	4.1	5.3	1.8	12.2	7.6	2.5	9.2	11.6	29.5	2.6	3.4	6.4	10.9	1.0	3.2	1.4	6.2	6.8	0.0	11.5	4.1	1.4	6.4	19.8	4.0	83.9	5.6	11.8	9.6	1.2
SLC12A8	CCC9	ENSG00000221955	"Solute carrier family 12 member 8"	A0AV02	3	125082636-125212864	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 22.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 23.9;Excitatory neurons: 38.4;granulocytes: 17.8;Inhibitory neurons: 27.8;Intestinal goblet cells: 36.6;Oligodendrocyte precursor cells: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.6;HHSteC: 33.6;OE19: 27.6;U-2197: 67.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA031123	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm		"HPA031123: AB_2301872"	"unprognostic (4.74e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.35e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.13e-2)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (7.18e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.78e-2)"	1.5	1.1	2.9	1.2	3.2	0.0	2.3	1.0	3.1	1.4	11.7	3.5	5.6	0.6	3.6	4.1	2.0	8.3	0.6	3.4	2.4	3.2	6.8	2.2	0.6	1.6	2.0	0.3	10.0	4.3	2.2	2.7	1.9	2.8	4.2	0.1	11.9	0.6	0.1	1.3	3.6	0.7	1.0	0.3	4.1	2.3	2.0	0.5	22.9	0.0	0.9	2.1	2.2	2.0	14.7	0.0	2.7	0.0	3.3	4.6	6.7	0.8	2.0	0.9	1.7	19.6	6.8	0.0	1.9	5.6	2.8	8.5	0.0	0.0	0.5	0.0	0.0	0.0	7.2	0.0	33.6	0.0	1.0	8.7	8.3	1.9	0.9	16.3	0.0	0.0	0.0	0.6	1.3	3.9	0.0	0.0	9.3	27.6	0.7	0.0	0.2	0.0	6.8	1.3	4.2	0.0	7.0	8.4	0.1	0.9	15.6	0.4	0.2	0.2	1.3	67.9	0.0	0.1	1.9	5.0	3.3	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.2	1.0	3.1	3.4	2.4	1.6	2.0	1.9	1.0	2.0	2.0	0.2	0.0	0.5	7.2	0.1	1.0	1.3	3.3	3.4	0.0	5.6	4.3	1.1	2.8	2.5	23.9	0.0	0.5	0.1	1.6	0.0	3.9	0.3	0.8	1.4	0.3	5.4	0.0	38.4	3.5	6.5	2.1	7.7	2.7	17.8	1.8	0.0	9.4	0.9	0.0	27.8	36.6	0.0	0.0	0.7	0.5	0.0	0.5	0.0	7.5	2.1	0.0	1.0	31.7	2.0	2.9	3.4	0.0	0.2	6.2	2.6	1.5	0.4	0.0	0.0	0.2	0.7	0.6	0.4	4.3	0.3	3.0	0.8	0.1	5.6	1.0
SLC25A38	FLJ20551	ENSG00000144659	"Solute carrier family 25 member 38"	Q96DW6	3	39383370-39397351	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041027	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA041027: AB_10794403"	"unprognostic (3.82e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.54e-2)"	"prognostic favorable (1.58e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.06e-1)"	"prognostic favorable (7.29e-4)"	19.1	35.4	22.2	18.8	23.3	70.0	21.0	25.9	26.8	23.8	33.6	28.1	25.3	27.3	27.6	14.5	27.3	19.4	20.7	22.9	26.3	28.7	58.0	21.0	36.2	24.2	24.1	44.1	45.6	38.7	30.7	15.4	25.3	29.2	36.9	23.0	22.5	23.9	48.2	16.7	25.2	20.3	22.6	27.2	33.8	18.7	26.0	33.6	52.0	35.7	35.4	27.8	19.1	23.3	24.3	38.3	24.3	41.2	56.4	46.4	30.8	33.6	46.1	48.3	43.7	26.3	5.6	67.8	19.6	31.6	40.7	18.4	55.2	40.1	36.0	43.6	45.0	52.0	33.5	40.2	75.6	37.7	33.9	58.8	46.1	46.2	93.2	44.6	31.5	52.8	47.7	40.6	36.4	35.2	44.7	67.0	66.2	35.9	44.3	16.2	26.4	47.7	37.5	45.4	24.3	31.1	11.9	65.9	34.0	44.5	33.5	35.0	26.9	38.3	26.4	56.2	48.9	54.7	93.1	41.9	29.3	48.3	24.7	30.7	9.6	18.1	38.8	5.7	44.7	50.8	39.1	43.3	14.9	37.8	41.7	40.5	1.0	57.0	8.4	18.5	55.3	29.2	22.2	23.3	25.9	26.8	22.9	26.3	24.2	24.1	25.3	22.6	26.0	23.3	10.4	22.4	27.4	8.5	35.6	11.5	13.0	12.5	28.5	13.2	26.1	22.6	16.8	22.8	9.6	27.6	6.2	35.2	33.1	21.9	21.5	15.7	6.5	26.6	16.3	11.1	12.6	73.7	8.9	16.9	32.6	13.7	16.8	38.5	22.2	24.0	9.7	27.0	15.2	5.0	10.1	25.6	12.2	7.0	13.7	12.9	15.5	9.8	12.4	1.9	11.2	18.9	29.9	7.1	6.2	13.4	22.2	13.5	23.3	17.7	23.1	31.3	12.3	12.6	6.6	15.2	14.9	11.0	7.8	19.4	10.2	19.4	36.6	32.8	26.7	8.4
SLC26A5	"DFNB61, PRES"	ENSG00000170615	"Solute carrier family 26 member 5"	P58743	7	103352730-103446207	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell shape, Hearing"	"Motor protein"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Astrocytes: 5.5;Excitatory neurons: 4.1;Gastric mucus-secreting cells: 7.1;Hepatic stellate cells: 5.3;Inhibitory neurons: 3.5;Microglial cells: 6.5;Oligodendrocytes: 4.2"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"basal ganglia: 10.4"							NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (3.86e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.38e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.56e-4)"	"unprognostic (4.21e-3)"	"unprognostic (8.92e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.67e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.69e-3)"	0.1	0.1	0.3	0.0	0.3	0.0	0.7	2.2	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.4	0.1	0.4	0.5	0.0	0.2	0.3	0.0	0.0	0.3	0.4	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.6	0.2	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	2.2	0.2	0.1	0.4	0.4	0.5	0.3	0.4	0.3	0.5	0.3	6.4	2.6	5.5	0.2	0.3	0.0	0.0	0.0	0.2	0.3	0.1	0.7	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.4	0.2	0.5	0.0	0.0	4.1	0.0	0.0	2.2	7.1	0.2	0.0	0.0	5.3	0.0	0.0	0.0	3.5	0.0	0.0	0.3	0.3	0.0	0.3	0.0	0.0	6.5	0.0	0.3	0.0	2.0	4.2	0.3	0.0	0.0	0.0	0.8	0.0	0.0	2.2	1.2	0.0	0.2	0.1	0.3	0.5	0.0	0.3	0.0	0.6	0.0	0.0	0.6
SLC36A1	"LYAAT-1, PAT1, TRAMD3"	ENSG00000123643	"Solute carrier family 36 member 1"	Q7Z2H8	5	151437046-151492379	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 76.3;parathyroid gland: 103.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 52.9;Early spermatids: 76.7;Excitatory neurons: 92.8;Inhibitory neurons: 62.1;Oligodendrocyte precursor cells: 48.7;Proximal enterocytes: 48.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	9	"cerebellum: 76.3"	"Group enriched"	"Detected in many"	4	"basophil: 21.7;classical monocyte: 8.7;neutrophil: 19.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 21.7;monocytes: 8.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035937	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA035937: AB_10672995"	"unprognostic (5.49e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.27e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (6.30e-5)"	"unprognostic (1.86e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (2.66e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.42e-1)"	6.3	4.9	2.0	7.9	2.8	29.5	4.0	76.3	8.4	3.6	0.0	14.8	44.2	4.0	4.4	5.4	3.3	10.4	3.1	3.1	0.0	4.7	2.8	5.6	6.1	4.6	3.2	3.2	6.2	103.2	3.7	5.5	5.3	12.5	22.5	1.9	4.8	6.2	7.8	4.9	39.3	6.6	0.0	8.5	4.4	13.4	0.6	18.4	3.1	5.9	5.3	6.0	4.2	4.1	5.4	9.2	4.7	3.2	11.6	8.5	25.4	15.4	8.6	10.4	11.7	21.2	7.8	12.4	8.9	18.5	11.1	13.0	15.1	9.5	10.2	3.4	13.1	3.8	14.7	7.1	14.9	9.3	20.3	6.2	10.8	8.8	5.8	2.9	9.4	6.7	9.0	10.5	8.9	5.9	2.7	4.6	4.7	6.8	8.6	0.0	11.4	4.9	2.7	8.0	4.2	8.0	9.6	11.4	5.6	9.5	8.7	13.4	9.5	13.8	7.7	22.8	8.7	5.0	7.6	7.9	8.8	16.0	9.4	21.7	8.7	3.6	1.5	3.8	1.1	2.0	1.4	2.5	3.0	2.1	1.1	1.0	19.6	0.4	4.1	0.6	1.6	1.3	2.0	2.8	76.3	8.4	3.1	0.0	4.6	3.2	5.3	0.0	0.6	4.1	2.1	0.0	1.7	10.4	2.3	1.5	1.4	1.1	1.2	1.0	4.1	1.3	3.0	4.3	1.3	1.8	2.1	0.6	1.9	52.9	0.0	1.8	76.7	1.1	3.6	1.4	0.0	32.4	92.8	2.0	8.1	3.6	10.2	1.3	1.3	18.0	3.6	2.0	13.9	1.7	62.1	5.4	0.0	22.7	3.0	29.5	5.0	10.6	1.8	11.2	6.2	0.8	1.0	48.7	30.4	1.8	22.2	11.7	2.3	1.9	48.4	4.6	0.6	1.1	0.0	1.7	2.4	0.5	2.0	4.5	1.3	0.3	2.4	0.8	9.8	1.8
SMARCC1	"BAF155, CRACC1, Rsc8, SRG3"	ENSG00000173473	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1"	Q92922	3	47585269-47782106	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011576, CAB016336, HPA024352, HPA026853"	Supported		Enhanced	Nucleoplasm		NA	NA		31000	"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB011576: AB_2191988, CAB016336: AB_671095, HPA024352: AB_1857274, HPA026853: AB_10603030"	"unprognostic (3.47e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.34e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (1.33e-2)"	"unprognostic (4.28e-3)"	"unprognostic (6.92e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.66e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.45e-1)"	12.2	8.1	19.6	18.6	21.1	21.2	23.5	16.2	19.6	19.3	17.0	23.0	14.7	18.3	15.6	20.1	13.1	11.8	9.4	15.9	17.7	20.0	13.8	13.1	22.2	18.3	19.8	17.8	19.5	14.3	8.3	22.2	18.8	22.4	21.9	9.6	17.0	17.1	19.0	24.1	16.9	16.3	19.7	16.3	16.9	16.7	18.9	34.8	17.7	10.3	30.3	21.0	15.9	20.9	45.1	23.4	95.7	74.9	21.0	35.7	64.3	35.1	32.7	44.5	45.1	42.3	46.6	104.3	27.7	44.4	25.8	37.7	91.2	54.3	64.6	50.3	54.1	102.4	38.4	57.7	31.4	94.8	45.3	30.1	47.0	50.1	55.2	33.1	52.8	68.7	87.5	34.4	48.4	33.4	124.4	48.9	126.8	43.2	35.4	55.1	55.5	92.0	47.2	58.0	42.6	85.5	54.5	52.7	38.9	66.5	45.8	87.1	42.7	29.6	41.7	33.9	58.0	41.9	57.1	122.0	21.6	88.1	42.5	1.9	1.6	1.7	2.7	2.6	2.4	3.9	3.0	3.7	2.1	2.6	2.8	3.3	1.9	2.0	1.9	2.2	3.1	1.9	19.6	21.1	16.2	19.6	15.9	17.7	18.3	19.8	18.8	19.7	18.9	20.9	30.4	41.7	45.9	56.5	61.7	53.0	60.5	37.4	71.7	29.3	60.3	45.5	31.5	34.3	58.9	57.0	37.5	79.7	43.7	30.1	13.7	67.9	88.9	60.2	72.3	38.3	91.6	76.9	47.3	46.7	113.0	32.7	49.5	115.7	24.6	103.8	22.1	37.8	30.2	20.2	52.2	64.5	34.6	32.3	36.9	113.1	25.4	41.6	23.2	42.2	57.7	18.9	52.5	98.0	104.9	58.8	29.0	28.6	65.3	83.7	24.1	38.0	34.0	33.0	39.5	44.7	60.1	59.4	108.3	86.0	66.8	72.5	52.4	77.6	61.8	62.4
SMIM18		ENSG00000253457	"Small integral membrane protein 18"	P0DKX4	8	30638580-30646064	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 4.4;pituitary gland: 5.4;retina: 3.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 12.3;Excitatory neurons: 2.9;Horizontal cells: 5.0;Inhibitory neurons: 5.2;Microglial cells: 4.7;Oligodendrocyte precursor cells: 5.5;Proximal tubular cells: 4.1"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066648	Supported		Uncertain	Nucleoplasm,Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Centrosome	"HPA066648: AB_2685697"	"unprognostic (2.19e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.60e-1)"		"unprognostic (7.29e-2)"	"unprognostic (4.70e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.14e-1)"	0.0	0.9	2.2	0.0	1.9	0.9	0.0	4.0	3.7	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	3.8	0.9	0.0	0.0	0.0	2.3	4.4	0.0	0.4	0.0	5.4	0.0	3.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	2.7	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	1.2	0.6	0.6	1.1	0.4	1.1	0.9	0.7	0.6	0.3	0.9	0.9	1.3	0.7	0.0	0.8	1.4	1.0	0.1	2.2	1.9	4.0	3.7	2.0	3.8	2.3	4.4	3.0	1.7	2.7	1.6	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.2	0.1	1.8	0.0	2.9	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	5.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.9	0.0	5.5	1.1	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0
SMIM22	CASIMO1	ENSG00000267795	"Small integral membrane protein 22"	K7EJ46	16	4788397-4796491	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 193.6;pancreas: 154.3;salivary gland: 147.2;stomach 1: 201.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 2005.0;Intestinal goblet cells: 1223.5;Paneth cells: 1462.9;Proximal enterocytes: 1685.8;Respiratory ciliated cells: 686.7;Undifferentiated cells: 775.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"CAPAN-2: 261.7;OE19: 247.3;RT4: 89.8;SCLC-21H: 70.7;SK-BR-3: 201.2"	"Low region specificity"	"Detected in many"							HPA077331			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA077331: AB_2686834"	"unprognostic (6.55e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.69e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.84e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.73e-3)"	1.2	0.3	0.1	14.6	1.2	3.5	48.2	4.6	2.0	45.4	0.0	193.6	129.6	8.9	50.4	10.3	77.3	33.3	0.5	0.5	0.4	42.0	1.4	24.1	0.6	2.6	0.9	0.5	154.3	0.1	48.9	2.0	2.1	42.6	122.7	1.5	147.2	36.3	0.2	10.4	128.4	6.3	0.8	0.2	201.7	33.8	2.6	0.2	1.1	0.0	2.7	46.1	6.5	3.1	0.2	0.0	0.1	0.6	0.0	0.0	1.9	0.3	0.1	0.1	0.1	0.6	261.7	0.3	7.3	0.0	0.3	1.3	0.1	0.0	0.1	0.4	1.9	0.1	5.8	0.9	0.1	0.7	0.3	0.2	1.4	0.0	0.0	0.2	0.1	0.4	0.0	0.6	0.0	1.9	0.1	0.6	0.8	247.3	0.0	0.8	0.3	23.6	1.5	89.8	70.7	0.8	0.5	201.2	0.0	0.5	15.2	0.0	0.0	0.6	0.8	1.1	0.1	0.2	0.6	0.9	0.0	0.7	0.6	1.2	0.3	0.4	0.3	0.1	0.1	0.1	0.3	0.1	0.0	0.4	0.3	0.1	0.9	0.3	0.1	0.4	0.1	0.1	0.1	1.2	4.6	2.0	0.5	0.4	2.6	0.9	2.1	0.8	2.6	3.1	1.4	48.1	117.7	0.0	5.8	2.2	22.7	92.7	0.0	4.2	363.3	267.5	0.5	183.0	154.9	250.1	0.0	3.9	3.0	2005.0	25.4	259.8	40.1	430.4	26.5	4.4	470.3	0.0	0.5	381.9	0.4	4.7	438.8	258.3	18.4	0.1	0.4	0.2	0.4	1.7	0.3	1223.5	152.5	0.0	0.8	107.3	0.6	4.2	23.2	0.0	5.3	0.6	0.0	0.0	1.3	539.9	1462.9	1.2	1.0	29.5	1685.8	99.4	686.7	4.2	0.0	0.0	15.9	38.6	0.6	2.3	2.3	3.7	6.6	0.2	775.6	148.6
SMPDL3A	"ASM3A, ASML3a, FLJ20177, yR36GH4.1"	ENSG00000172594	"Sphingomyelin phosphodiesterase acid like 3A"	Q92484	6	122789049-122809720	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 156.3;Distal enterocytes: 291.5;Paneth cells: 157.5;Proximal enterocytes: 383.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"basophil: 80.9"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 80.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 44.2;hTCEpi: 36.9;OE19: 58.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030148	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted to blood"	No	No		26000000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA030148: AB_10601591"	"unprognostic (2.60e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.30e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	15.0	23.3	4.6	18.7	5.1	22.9	23.7	8.2	9.4	72.8	8.9	60.7	45.5	13.3	6.5	13.6	7.9	17.2	5.6	5.3	5.7	47.4	80.0	14.1	21.4	5.9	5.4	9.1	20.8	32.4	7.5	44.0	5.9	21.8	65.7	6.0	13.7	16.6	39.8	64.5	77.3	8.5	5.7	27.0	30.5	2.9	5.4	5.1	9.1	55.8	16.2	35.5	30.9	7.7	0.3	2.6	6.1	2.8	44.2	19.9	19.5	10.4	27.8	3.1	6.6	3.3	2.7	0.0	1.4	6.6	8.2	4.9	1.7	5.3	2.6	0.0	5.4	2.5	9.8	9.0	28.3	0.0	0.1	24.4	36.9	3.0	5.3	12.0	5.5	0.0	3.8	0.0	12.7	9.3	0.0	0.2	1.1	58.8	8.0	0.0	10.8	0.4	15.1	4.2	4.4	0.1	1.5	18.5	27.9	3.9	3.1	1.4	11.0	5.9	3.5	0.6	6.8	0.0	0.0	0.0	8.7	4.9	13.7	80.9	4.0	1.1	0.0	4.3	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	1.3	0.0	7.5	0.0	0.0	1.4	4.6	5.1	8.2	9.4	5.3	5.7	5.9	5.4	5.9	5.7	5.4	7.7	11.8	3.2	17.8	5.2	2.4	53.7	24.5	13.7	15.9	3.0	12.2	6.6	4.0	25.8	9.7	5.5	4.2	156.3	0.4	291.5	56.7	24.6	0.2	4.2	12.6	7.1	48.7	5.7	7.4	25.7	40.4	46.3	34.7	5.2	10.1	0.8	18.9	77.8	62.7	3.3	10.5	61.7	59.0	126.3	10.0	1.2	15.5	33.4	35.6	11.2	9.9	11.5	2.1	11.1	11.0	19.5	157.5	14.3	0.9	16.7	383.1	129.3	7.5	6.2	13.1	12.8	9.9	1.1	3.7	15.5	76.0	115.1	2.0	11.4	38.9	16.6
SNX16		ENSG00000104497	"Sorting nexin 16"	P57768	8	81799581-81842866	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 82.8;Late spermatids: 137.3;Spermatocytes: 74.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024730, HPA024731, HPA024817"	Approved		Supported	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"HPA024730: AB_10600220, HPA024731: AB_1857346, HPA024817: AB_10602313"	"unprognostic (5.50e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.41e-3)"	"unprognostic (3.21e-3)"	"unprognostic (7.54e-3)"	"unprognostic (1.24e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.73e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.65e-1)"	10.1	5.2	4.7	6.0	5.7	10.7	8.2	6.6	7.6	8.6	2.5	6.3	6.4	9.7	8.3	17.3	6.2	10.8	8.1	5.3	6.6	6.6	5.5	6.7	5.1	6.1	7.4	9.6	3.1	8.9	3.7	5.5	8.6	7.3	6.6	4.9	5.7	7.7	4.6	11.2	5.7	11.9	5.8	12.0	9.0	14.9	5.7	9.4	8.7	9.4	6.7	7.0	7.7	6.7	13.8	3.8	6.6	6.3	22.9	13.7	7.3	16.6	20.2	14.1	20.6	3.4	11.1	2.2	10.0	11.4	16.5	11.0	5.1	6.8	19.5	19.9	3.1	7.1	5.2	6.2	17.4	2.9	11.5	10.5	10.6	5.4	12.5	15.8	10.0	7.8	4.5	26.0	32.9	7.2	15.6	5.1	2.8	12.6	6.2	6.6	9.5	2.4	12.7	6.7	10.9	8.3	3.1	3.9	8.3	9.8	10.3	5.5	7.7	19.5	15.6	13.5	7.2	15.1	12.5	5.7	8.4	9.1	15.7	9.2	4.5	6.1	2.1	2.8	2.0	1.6	2.5	1.7	4.0	4.4	2.9	2.8	6.2	2.6	2.4	3.0	5.0	1.9	4.7	5.7	6.6	7.6	5.3	6.6	6.1	7.4	8.6	5.8	5.7	6.7	10.6	6.4	9.4	9.8	6.4	25.2	12.1	5.0	9.6	5.5	12.1	7.6	8.8	7.2	9.3	5.5	4.2	2.3	3.7	7.5	5.9	5.9	82.8	9.4	7.8	11.5	3.0	8.2	24.7	6.0	4.0	8.5	10.7	16.2	8.2	5.0	13.9	3.5	5.7	55.5	18.4	6.2	8.2	7.0	10.0	137.3	23.3	7.2	3.6	8.4	2.3	4.3	1.0	23.1	22.2	6.7	5.5	16.1	8.6	12.6	3.7	7.3	10.9	5.2	19.7	12.1	9.3	74.2	26.5	13.0	32.0	9.9	5.4	4.2	4.7	20.7
SNX20	"SLIC-1, SLIC1"	ENSG00000167208	"Sorting nexin 20"	Q7Z614	16	50666300-50681353	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.0;lymphoid tissue: 33.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 15.3;Cardiomyocytes: 16.4;dendritic cells: 23.7;Hofbauer cells: 17.6;Kupffer cells: 17.2;Langerhans cells: 25.2;Macrophages: 19.3;monocytes: 26.1;NK-cells: 24.7;T-cells: 21.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 29.7;HMC-1: 78.5;NB-4: 48.0;RPMI-8226: 20.6;THP-1: 21.3;U-266/70: 25.7;U-937: 28.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA043649	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA043649: AB_10965697"	"unprognostic (1.53e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (5.58e-2)"	"unprognostic (5.06e-3)"	"unprognostic (9.03e-2)"	"prognostic favorable (6.56e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (6.00e-6)"	"unprognostic (3.24e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.54e-1)"	2.3	1.0	1.5	20.0	1.5	18.0	1.1	1.8	1.7	1.1	1.5	2.7	2.9	1.0	0.6	1.6	1.0	4.0	0.8	1.3	1.8	0.8	2.2	7.7	27.8	3.4	2.1	0.6	0.5	0.4	0.5	2.7	2.5	1.1	3.6	0.3	1.9	0.7	0.8	2.4	6.1	2.7	2.1	19.2	3.7	0.5	2.6	33.2	0.9	1.1	27.0	6.1	0.7	2.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	29.7	0.0	5.2	0.0	0.0	0.0	7.4	78.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.2	0.0	0.0	0.0	48.0	0.0	0.0	0.0	2.4	0.2	20.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.2	0.0	0.0	0.1	0.0	25.7	14.3	6.5	0.0	28.4	0.0	306.6	66.9	208.0	41.6	118.3	52.2	22.6	73.8	50.9	123.4	22.6	56.1	38.9	62.3	51.3	147.5	34.3	137.5	81.8	1.5	1.5	1.8	1.7	1.3	1.8	3.4	2.1	2.5	2.1	2.6	2.9	0.2	0.0	0.0	0.3	15.3	0.8	0.0	0.0	0.0	0.2	0.3	0.6	16.4	2.8	1.3	0.0	0.0	0.1	23.7	0.0	0.0	0.0	0.1	0.3	0.1	1.5	0.0	6.5	0.0	0.0	0.2	0.5	0.5	0.1	5.1	0.0	1.1	0.4	17.6	1.7	0.0	0.0	0.0	17.2	25.2	0.0	0.0	19.3	0.0	0.0	26.1	0.1	24.7	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.1	0.0	0.1	13.1	0.5	0.5	0.2	0.1	0.0	0.6	0.4	21.3	0.1	0.2	0.0
SOX30		ENSG00000039600	"SRY-box transcription factor 30"	O94993	5	157625679-157671480	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	85	"testis: 80.6"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 351.1"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.9;CACO-2: 1.3;HDLM-2: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006159, CAB009382"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 36: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"	Cytosol	"CAB009382: AB_2195963, HPA006159: AB_1080062"	"unprognostic (3.51e-2)"	"unprognostic (4.72e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.70e-4)"	"unprognostic (2.53e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.64e-4)"	"unprognostic (5.88e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.72e-2)"	"unprognostic (3.45e-1)"	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.3	0.7	0.1	0.0	0.1	0.9	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.1	80.6	0.4	0.7	0.0	0.0	0.1	0.1	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.3	0.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	4.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.3	0.1	0.3	0.1	0.0	0.0	0.2	0.3	0.2	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.5	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.6	0.0	0.0	0.1	0.0	0.6	0.0	0.0	351.1	0.5	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	71.4	1.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	42.8	11.7	0.0	0.0	0.0	0.1	0.3	0.0	0.0
SPART	"KIAA0610, SPG20, TAHCCP1"	ENSG00000133104	Spartin	Q8N0X7	13	36301638-36370180	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 75.0;Proximal tubular cells: 90.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 172.7"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 172.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039053, HPA039054"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Plasma membrane"	"HPA039053: AB_10672769, HPA039054: AB_2676323"	"unprognostic (3.73e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.10e-2)"	"unprognostic (9.18e-3)"	"unprognostic (9.58e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.62e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.79e-2)"	42.3	48.4	36.9	18.0	42.8	23.6	32.5	43.4	50.6	49.2	42.3	37.8	12.7	42.4	67.1	24.5	44.5	37.4	25.7	35.3	39.4	48.4	19.9	27.0	15.7	42.4	40.5	63.6	14.6	29.5	29.6	39.8	42.1	34.7	13.3	43.3	17.3	36.4	33.5	18.4	15.4	52.8	41.2	30.7	21.1	27.6	38.3	16.7	35.6	33.7	11.2	35.5	29.9	51.0	0.1	22.4	59.5	0.0	127.9	106.6	42.4	54.1	81.3	53.7	52.8	0.1	0.0	0.0	32.9	65.9	98.2	31.2	81.4	38.0	57.5	4.4	46.9	69.4	28.3	14.6	128.0	72.8	134.3	106.2	59.5	44.4	61.9	131.7	79.6	18.7	30.6	11.9	97.5	5.2	21.7	120.8	30.0	0.0	7.8	0.0	99.4	2.5	62.5	28.2	6.2	14.5	46.3	18.3	58.9	85.3	10.5	84.7	66.8	40.0	20.1	55.9	32.2	14.2	0.2	0.1	44.6	61.8	71.0	172.7	22.1	30.1	13.5	21.7	13.1	10.1	18.6	5.4	15.7	9.7	24.5	13.1	35.0	14.2	23.8	19.3	4.8	18.1	36.9	42.8	43.4	50.6	35.3	39.4	42.4	40.5	42.1	41.2	38.3	51.0	43.5	35.3	51.5	0.0	6.1	0.0	0.0	0.0	0.0	0.0	30.8	30.1	0.0	0.0	40.2	27.6	0.0	52.7	18.6	0.0	66.5	26.2	0.0	59.4	62.6	15.9	0.0	0.0	0.0	15.0	59.7	39.8	0.0	38.1	58.0	75.0	0.0	0.0	42.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	16.8	0.0	0.0	3.5	0.0	0.0	90.4	65.6	0.0	0.0	0.0	27.8	0.0	0.0	0.0	0.0	64.3	10.8	59.2	0.0	0.0
SPDYE1	"Ringo1, SPDYE, WBSCR19"	ENSG00000136206	"Speedy/RINGO cell cycle regulator family member E1"	Q8NFV5	7	43997897-44010122	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"testis: 7.2"	"Group enriched"	"Detected in some"	9	"Early spermatids: 54.5;Late spermatids: 56.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											HPA051750	Supported					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA051750: AB_2681590"	"unprognostic (2.16e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.98e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.95e-6)"	"unprognostic (2.68e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.19e-2)"	0.2	0.2	0.6	0.8	1.3	2.0	0.1	1.4	1.1	0.3	0.3	0.2	0.7	0.2	0.0	0.2	0.1	0.3	0.2	0.7	0.1	0.2	0.2	0.2	0.8	0.7	0.3	0.3	0.3	0.0	0.2	0.2	0.2	0.2	0.0	1.0	0.6	0.0	2.5	1.7	0.6	0.0	0.0	0.8	0.5	7.2	1.1	0.0	0.5	0.0	0.0	0.2	0.2	1.7	1.1	0.9	1.1	1.1	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.8	0.6	1.1	0.6	0.0	0.4	1.7	0.0	0.0	0.0	0.8	0.9	0.5	2.8	0.5	0.0	1.9	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	1.6	2.7	0.0	1.3	0.7	1.1	1.0	0.6	0.4	1.6	0.4	0.7	0.0	1.2	0.8	0.7	1.7	0.4	0.2	1.4	0.7	0.2	1.0	1.5	1.2	0.6	1.4	1.5	1.0	1.0	0.7	1.3	1.7	1.5	0.5	0.7	0.5	0.6	0.7	0.5	0.5	0.2	0.3	0.8	0.4	0.5	1.0	0.3	0.4	0.7	0.2	0.3	0.6	1.3	1.4	1.1	0.7	0.1	0.7	0.3	0.2	0.0	1.1	1.7	0.5	0.0	1.1	4.2	0.2	0.4	0.0	0.2	0.0	1.1	0.1	0.0	1.2	0.0	1.3	0.0	0.0	0.1	0.4	0.0	0.0	0.0	54.5	1.0	1.1	0.5	0.0	0.0	6.0	0.0	0.1	0.4	0.5	0.9	1.3	0.1	0.0	0.1	0.1	1.7	4.8	0.1	0.0	0.3	0.3	56.5	0.3	0.3	0.0	1.0	0.1	0.4	0.0	4.0	4.3	0.0	0.0	0.4	0.6	0.0	0.0	0.1	0.0	2.1	0.0	0.5	0.6	0.7	0.2	0.0	0.3	0.1	0.4	0.1	0.1	0.0
SPDYE5		ENSG00000170092	"Speedy/RINGO cell cycle regulator family member E5"	A6NIY4	7	75493625-75504304	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 3.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 7.0;Excitatory neurons: 12.1;Horizontal cells: 5.0;Inhibitory neurons: 10.2;Late spermatids: 5.5;Oligodendrocyte precursor cells: 5.5;Oligodendrocytes: 9.3"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HeLa: 3.1;RT4: 1.9"									HPA051750	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA051750: AB_2681590"	"unprognostic (2.22e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.28e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.77e-2)"	"unprognostic (7.25e-3)"	"unprognostic (2.27e-2)"	"unprognostic (6.34e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.43e-2)"	"unprognostic (9.10e-4)"	"unprognostic (1.51e-10)"	"unprognostic (4.21e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.08e-4)"	0.4	0.5	0.2	0.5	0.4	0.9	0.5	0.5	0.4	0.6	0.2	0.5	0.3	0.4	0.0	0.5	0.4	0.4	0.4	0.1	0.0	0.7	0.7	0.5	0.6	0.0	0.1	0.7	0.7	0.0	0.7	0.2	0.1	0.7	0.0	1.2	0.6	0.0	0.5	1.7	0.7	0.0	0.0	0.8	0.5	3.1	0.2	0.0	0.8	0.0	0.0	0.4	0.5	0.4	0.5	0.5	0.6	0.8	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.3	0.3	0.7	0.2	0.0	0.2	0.6	0.0	0.0	0.0	0.3	0.3	0.2	3.1	0.3	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.8	0.7	0.0	0.8	0.4	1.1	0.4	0.1	0.4	0.4	0.2	0.0	0.0	1.9	0.5	0.4	0.5	0.4	0.1	0.5	0.8	0.1	0.6	1.0	0.3	0.6	0.6	0.6	0.2	1.1	0.1	0.6	0.6	1.3	0.5	0.3	0.9	0.3	0.4	0.5	0.4	0.4	0.2	0.8	0.4	0.4	0.9	0.2	0.5	0.6	0.1	0.2	0.2	0.4	0.5	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.4	0.3	0.0	0.0	3.6	0.4	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	7.0	1.2	1.2	0.7	0.0	0.4	12.1	0.0	0.0	0.4	0.0	1.2	0.0	0.2	0.4	0.4	0.1	5.0	10.2	0.0	0.0	0.6	0.0	5.5	0.0	0.4	0.0	3.7	0.6	0.4	1.0	5.5	9.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.6	0.5	1.4	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0
SPECC1	"CYTSB, FLJ36955, HCMOGT-1, NSP"	ENSG00000128487	"Sperm antigen with calponin homology and coiled-coil domains 1"	Q5M775	17	20008865-20319026	"Disease related genes, Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 217.1;Inhibitory neurons: 220.8;Microglial cells: 187.4;Oligodendrocytes: 317.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 42.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SiHa: 75.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021421, HPA021430, HPA061073"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA		9800	"Cluster 46: Basophils - DNA binding"	"Cluster 65: Brain - Ion transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Vesicles"	"Nucleoli fibrillar center, Cytosol"	"HPA021421: AB_1857431, HPA021430: AB_1857432, HPA061073: "	"unprognostic (1.13e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.10e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (9.29e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.23e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	12.5	9.6	30.8	7.3	35.1	23.6	9.2	24.1	43.7	6.1	22.3	15.1	9.8	12.8	4.7	9.2	8.3	14.8	5.0	41.4	21.4	4.7	1.2	5.7	5.3	32.8	25.8	16.6	4.8	3.3	6.4	3.6	24.5	6.1	10.0	6.1	6.2	5.0	5.1	3.6	10.5	9.5	21.0	13.5	10.3	22.8	41.1	3.0	5.2	2.8	5.2	4.6	4.3	47.3	26.2	37.3	15.7	7.2	14.7	6.9	29.1	10.0	12.4	12.4	21.4	67.6	17.1	1.5	45.3	11.4	24.3	21.1	10.7	33.4	3.7	12.8	18.5	14.5	34.4	10.5	4.9	1.3	5.6	10.6	36.9	10.2	24.9	46.8	0.0	4.4	1.0	15.1	10.4	24.0	0.3	5.3	14.5	17.0	6.3	11.8	49.5	23.6	32.2	11.4	7.1	6.9	75.7	35.6	13.9	62.2	26.3	9.1	0.3	0.5	21.1	0.9	30.8	5.4	11.7	0.9	19.1	12.6	6.5	42.1	15.8	33.0	2.2	8.4	3.2	1.8	1.5	3.4	26.6	1.4	1.0	1.4	11.1	13.0	7.9	4.6	0.6	5.5	30.8	35.1	24.1	43.7	41.4	21.4	32.8	25.8	24.5	21.0	41.1	47.3	28.7	22.4	14.7	170.4	5.7	5.5	12.5	22.0	10.8	7.4	5.8	4.7	10.3	7.2	21.1	18.4	68.8	5.5	10.2	56.8	9.8	30.9	100.0	40.1	44.1	13.1	7.7	82.5	217.1	36.3	11.5	18.6	34.1	64.1	116.4	29.5	3.9	0.2	22.0	0.0	220.8	54.8	12.2	12.4	15.9	54.5	5.0	29.0	21.4	187.4	84.7	13.6	11.3	125.2	317.8	67.7	24.7	44.8	7.0	19.7	25.2	3.6	18.1	31.4	59.2	7.3	81.3	73.8	68.9	5.9	2.6	2.2	10.0	87.8	27.4	21.5
SPECC1L	"CYTSA, KIAA0376"	ENSG00000100014	"Sperm antigen with calponin homology and coiled-coil domains 1 like"	Q69YQ0	22	24270817-24417739	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA070614	Uncertain		Supported	"Actin filaments"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Actin filaments"		"HPA070614: AB_2686287"	"unprognostic (3.54e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.82e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.72e-3)"	"prognostic favorable (7.92e-4)"	"unprognostic (3.15e-3)"	"unprognostic (6.20e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.71e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.41e-1)"	13.0	13.1	12.3	12.4	12.8	13.3	13.8	34.0	13.5	16.6	17.7	15.8	7.8	15.9	9.7	17.5	15.5	12.5	18.6	10.8	15.7	14.6	14.4	17.2	12.5	18.1	16.2	22.0	13.3	17.3	14.6	10.1	18.9	20.1	16.9	10.7	16.2	15.1	12.7	9.2	11.6	19.0	15.8	11.1	11.5	31.9	16.6	14.5	24.0	13.1	13.8	14.9	13.0	13.7	31.1	22.8	42.9	23.7	40.1	39.2	14.5	43.1	34.1	36.8	36.4	25.5	8.4	44.9	10.3	39.5	29.0	27.0	39.2	24.2	43.4	26.1	21.1	28.5	12.9	23.4	26.7	51.2	27.0	33.1	19.2	32.8	34.2	28.8	44.0	18.9	24.5	19.0	39.3	17.3	26.6	18.5	20.7	22.5	17.1	24.0	43.3	16.1	18.4	23.3	37.2	38.3	36.5	27.5	23.8	37.1	18.3	14.4	46.3	77.2	43.7	19.3	29.3	22.7	23.4	20.0	22.6	19.0	29.2	3.9	2.4	4.8	3.3	3.5	2.5	2.8	2.2	1.6	2.3	3.1	2.7	2.9	3.2	1.3	1.6	3.7	1.6	1.9	12.3	12.8	34.0	13.5	10.8	15.7	18.1	16.2	18.9	15.8	16.6	13.7	11.6	16.0	21.3	0.0	10.4	3.6	2.7	5.0	10.2	8.4	13.8	9.4	13.7	14.3	9.1	12.9	10.4	7.3	7.9	32.8	1.9	6.7	26.9	8.3	14.9	12.0	14.4	7.6	0.0	7.4	3.2	11.4	8.2	9.8	16.5	13.4	15.7	11.4	7.3	10.1	0.0	12.2	14.2	7.3	2.2	93.7	16.1	6.9	14.2	0.0	14.8	6.4	9.2	0.0	0.0	9.0	15.0	13.5	10.7	5.7	8.9	6.1	11.9	8.5	13.1	11.3	12.5	24.1	28.5	9.8	3.1	5.9	9.3	7.6	8.0	3.8
SPESP1	SP-ESP	ENSG00000258484	"Sperm equatorial segment protein 1"	Q6UW49	15	68818221-68946811	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 73.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 400.4;Spermatocytes: 455.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 17.8;BJ hTERT+ SV40 Large T+ RasG12V: 18.6;HBF TERT88: 21.7;HMC-1: 13.4;OE19: 15.9;RPTEC TERT1: 26.8;SCLC-21H: 19.9;WM-115: 31.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA045936, HPA051040"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted in male reproductive system"	NA	NA		52000	"Cluster 46: Basophils - DNA binding"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Vesicles"	Cytosol	"HPA045936: AB_2679504, HPA051040: AB_2681322"	"unprognostic (1.14e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.73e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.67e-2)"	2.3	3.4	1.1	0.8	1.1	0.4	2.2	1.2	1.6	1.2	1.0	1.6	1.2	1.5	6.3	2.6	1.8	3.5	3.1	1.1	1.2	2.0	1.2	1.1	0.8	1.3	1.2	3.4	1.9	4.7	1.2	12.9	1.3	3.5	1.1	2.8	1.8	2.9	1.6	1.0	0.9	1.2	1.3	1.3	1.5	73.2	1.1	0.9	1.9	1.9	0.7	2.4	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	17.8	18.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	21.7	5.0	0.0	0.0	0.0	0.0	6.3	0.0	13.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	2.9	0.0	0.0	3.3	15.9	0.0	0.0	1.4	0.0	26.8	0.2	19.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	31.6	1.1	1.3	0.4	0.2	1.1	0.5	0.5	0.4	0.3	0.8	0.3	0.3	0.5	0.5	0.2	0.8	0.4	0.4	0.5	1.1	1.1	1.2	1.6	1.1	1.2	1.3	1.2	1.3	1.3	1.1	1.6	5.1	0.0	0.0	0.0	0.2	1.9	3.0	23.7	1.8	1.0	2.7	4.1	4.1	1.5	4.0	7.3	4.2	92.3	0.3	0.2	1.9	2.1	400.4	3.9	3.4	3.6	1.8	0.8	0.0	2.7	7.2	5.5	0.0	2.0	0.0	1.7	2.2	1.8	7.8	0.0	0.0	0.9	6.1	2.1	3.3	90.3	21.1	1.2	5.4	0.0	1.0	5.3	0.0	0.0	0.0	0.9	0.0	8.6	0.0	3.3	0.0	3.9	6.3	5.6	46.0	3.4	4.2	455.0	88.7	1.1	2.3	62.1	0.5	11.1	0.2	1.5
SPICE1	"CCDC52, SPICE"	ENSG00000163611	"Spindle and centriole associated protein 1"	Q8N0Z3	3	113442718-113515187	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA064843	Approved		Supported	Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Centrosome		"HPA064843: AB_2685367"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.99e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.89e-2)"	"unprognostic (4.75e-3)"	"unprognostic (6.53e-2)"	"unprognostic (4.47e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.95e-2)"	4.4	3.8	2.1	4.6	2.3	4.1	7.4	3.2	2.9	8.5	3.4	6.7	4.1	8.6	4.9	6.9	8.0	7.7	4.3	2.4	2.4	4.6	4.1	4.7	4.1	2.2	2.1	7.8	6.3	6.4	8.9	5.5	2.1	6.4	6.6	7.7	8.6	4.9	2.6	6.0	5.3	6.7	1.4	4.2	6.8	7.1	1.9	8.3	6.8	2.3	5.5	6.1	7.2	3.1	17.0	10.4	12.1	10.6	7.5	9.2	7.6	8.2	6.3	10.9	13.6	9.2	9.4	9.9	11.6	7.2	10.7	16.0	6.3	8.0	14.7	5.9	2.8	9.0	9.3	6.1	4.5	18.0	6.8	7.5	7.9	11.3	4.6	9.6	8.0	18.0	5.8	8.2	3.8	17.7	15.6	7.0	13.0	13.4	11.5	10.8	10.3	8.8	4.0	10.7	6.2	10.8	8.7	10.3	4.8	13.4	10.2	7.2	8.0	5.5	8.8	5.1	7.5	7.9	5.8	16.7	11.0	10.5	8.2	3.6	4.1	1.5	3.2	3.0	5.2	5.6	5.0	4.0	3.1	6.1	7.0	5.2	2.1	2.7	2.9	9.7	2.6	2.0	2.1	2.3	3.2	2.9	2.4	2.4	2.2	2.1	2.1	1.4	1.9	3.1	6.7	0.0	4.2	14.4	12.0	6.8	7.9	5.4	9.1	6.4	9.4	5.8	2.5	5.7	5.6	5.5	8.4	4.7	3.5	8.0	0.0	5.4	6.5	22.8	11.9	4.7	3.6	9.9	20.2	4.5	5.9	7.4	16.3	12.7	1.3	10.1	3.3	5.2	4.4	3.3	6.8	10.6	6.1	2.5	3.9	3.5	9.9	4.1	0.0	15.9	2.3	7.9	1.0	16.1	14.4	5.6	3.6	3.4	13.9	4.1	3.9	4.2	15.3	25.0	6.6	6.2	5.4	20.9	16.9	7.7	7.7	3.4	7.5	6.2	7.4	8.5
SPIN3	TDRD27	ENSG00000204271	"Spindlin family member 3"	Q5JUX0	X	56818298-56995827	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 23.8;Inhibitory neurons: 23.3;Oligodendrocyte precursor cells: 25.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 20.5"					"Low region specificity"	"Detected in all"			HPA000727	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA000727: AB_2196121"	"unprognostic (3.12e-3)"	"unprognostic (2.32e-1)"	"unprognostic (7.45e-3)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (1.20e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.85e-4)"	"prognostic favorable (6.79e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.53e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.98e-2)"	"prognostic favorable (6.30e-4)"	4.5	6.1	7.4	3.1	7.2	0.3	5.4	7.7	7.8	7.0	4.3	4.3	2.9	6.0	4.7	3.8	6.0	3.2	3.2	7.2	7.6	5.4	6.4	3.1	4.4	6.0	6.1	6.4	8.7	2.9	8.6	2.5	6.2	5.8	4.0	8.4	5.6	4.1	3.0	3.2	5.6	4.2	5.5	4.9	5.5	3.1	8.0	1.8	4.7	1.6	4.2	5.1	5.2	6.6	4.5	6.6	3.6	0.0	6.9	5.9	2.8	3.4	2.0	2.1	2.9	3.5	5.6	0.0	2.4	3.3	7.3	4.9	5.7	2.2	3.2	0.0	1.4	0.6	20.5	2.7	3.7	0.0	4.6	5.3	4.7	2.7	4.2	4.0	1.6	0.0	2.9	8.6	4.4	3.0	0.0	3.6	7.3	2.6	5.8	0.0	3.0	1.8	3.3	5.3	7.3	5.1	4.2	3.7	4.1	5.7	9.8	1.1	1.2	4.4	6.3	7.4	2.1	3.6	2.5	0.0	4.2	0.0	3.4	1.5	0.4	0.8	0.1	0.6	0.8	1.1	1.7	0.6	0.7	0.3	1.9	0.5	0.0	2.2	0.1	0.1	0.5	1.0	7.4	7.2	7.7	7.8	7.2	7.6	6.0	6.1	6.2	5.5	8.0	6.6	2.9	0.0	3.7	11.8	3.7	0.3	4.0	1.8	2.8	2.0	5.1	4.6	1.1	2.8	2.8	7.3	0.0	2.6	0.5	0.7	1.9	4.1	0.0	3.0	4.7	2.3	0.0	0.4	23.8	3.0	2.1	3.2	2.6	2.3	1.3	4.7	2.2	1.6	0.9	1.7	23.3	0.8	2.0	1.0	1.2	0.0	4.1	0.9	1.8	7.5	1.5	0.9	1.0	25.1	10.0	3.6	0.3	2.6	2.5	1.8	1.1	2.9	1.1	3.0	6.6	1.4	2.2	0.0	0.3	1.4	0.4	0.4	1.1	5.8	1.5	2.2
SPINK4	"MGC133107, PEC-60"	ENSG00000122711	"Serine peptidase inhibitor Kazal type 4"	O60575	9	33218365-33248567	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 980.5"	"Cell type enriched"	"Detected in some"	14	"Intestinal goblet cells: 8017.1"	"Group enriched"	"Detected in many"	20	"colorectal cancer: 237.5;pancreatic cancer: 269.7;stomach cancer: 111.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"basophil: 1.8"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.8"	"Group enriched"	"Detected in some"	12	"HMC-1: 175.7;OE19: 480.7"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.1"	"Low region specificity"	"Detected in single"			HPA007286	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"	"Secreted to digestive system"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA007286: AB_1080083"	"unprognostic (3.49e-2)"	"unprognostic (2.32e-1)"	"prognostic favorable (8.85e-5)"	"unprognostic (3.09e-4)"		"unprognostic (1.49e-1)"		"unprognostic (1.00e-1)"		"unprognostic (9.66e-2)"	"unprognostic (2.43e-1)"			"unprognostic (1.24e-1)"	"unprognostic (3.25e-1)"		"unprognostic (2.42e-3)"	1.4	0.6	0.0	84.2	0.0	0.6	0.1	0.7	0.3	0.0	0.1	639.5	263.4	1.8	0.0	0.1	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.7	0.1	0.1	0.0	0.9	2.1	0.9	0.0	0.1	0.0	980.5	92.1	0.1	0.5	0.2	0.1	638.1	42.2	0.0	0.2	1.4	0.3	0.0	0.1	0.0	0.0	0.0	17.4	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.4	0.0	0.0	0.0	3.5	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	11.7	27.8	1.1	0.0	0.0	175.7	0.0	0.0	0.0	0.4	0.5	0.0	0.1	4.1	0.3	0.0	3.9	0.4	2.3	0.0	480.7	0.4	0.0	0.0	0.2	0.0	0.5	0.4	1.4	15.2	3.1	0.0	0.1	14.2	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.3	0.1	1.4	0.3	0.0	1.8	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.0	0.3	0.0	0.0	0.0	21.7	0.1	0.0	0.0	0.0	0.0	5.5	12.5	0.1	0.0	56.5	0.0	0.2	1.0	0.1	0.0	0.6	88.2	0.0	0.0	0.0	0.0	0.0	43.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8017.1	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	23.9	0.0	0.5	0.1	0.1	106.8	0.0	0.1	0.2	541.4	0.0	0.0	129.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.1	191.5	0.2
SPSB1	SSB-1	ENSG00000171621	"SplA/ryanodine receptor domain and SOCS box containing 1"	Q96BD6	1	9292894-9369532	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 79.5;Proximal enterocytes: 83.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 81.5;SK-MEL-30: 71.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (5.23e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.54e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.08e-6)"	"unprognostic (3.95e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.24e-2)"	53.3	9.7	7.8	14.4	14.2	1.4	25.1	12.9	10.2	30.7	5.1	23.3	19.6	47.0	3.8	26.7	23.4	29.1	20.1	9.4	10.9	16.9	48.1	28.7	9.3	22.8	15.0	24.1	30.6	20.4	10.2	10.7	15.4	18.1	8.7	2.0	15.7	10.0	44.2	25.3	30.0	26.1	12.1	3.6	17.9	8.3	15.5	10.3	20.3	32.3	12.1	33.0	21.7	19.7	16.2	14.6	1.1	3.2	42.4	20.2	26.6	10.7	35.4	21.0	16.6	15.8	23.2	0.4	21.5	16.4	25.0	23.9	4.8	19.4	13.8	58.2	3.8	0.0	19.6	17.5	27.1	0.1	1.4	21.1	38.3	81.5	10.4	20.8	30.9	3.2	1.9	42.1	17.3	6.0	9.0	0.6	2.3	11.1	15.5	3.1	6.4	5.1	17.9	10.9	3.9	1.1	17.1	45.8	71.4	28.4	1.2	5.3	25.8	15.2	18.9	24.0	9.9	17.7	27.3	5.6	27.5	2.0	16.7	1.2	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.1	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.0	0.8	0.2	7.8	14.2	12.9	10.2	9.4	10.9	22.8	15.0	15.4	12.1	15.5	19.7	19.4	19.2	5.3	2.6	6.5	69.0	47.0	11.8	25.6	0.6	26.9	17.8	4.1	24.3	11.5	3.7	2.1	1.1	3.2	19.9	3.9	25.0	0.8	42.2	30.3	20.6	6.6	0.4	2.1	32.0	12.0	67.0	4.1	79.5	14.0	30.7	13.2	21.6	3.1	11.8	1.7	7.7	2.0	0.9	27.7	1.8	11.8	8.2	49.8	3.7	3.3	2.2	0.0	18.1	22.8	33.7	15.6	8.2	8.4	28.4	83.1	5.5	20.7	0.6	6.6	40.7	22.9	0.4	3.2	57.0	70.8	2.2	8.1	0.5	11.4	63.1
SPTY2D1	"DKFZp686I068, FLJ39441, Spt2"	ENSG00000179119	"SPT2 chromatin protein domain containing 1"	Q68D10	11	18606403-18634791	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 34.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039372, HPA040177, HPA047957"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli"		"HPA039372: AB_2676472, HPA040177: , HPA047957: AB_2680224"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.07e-4)"	"unprognostic (1.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.33e-1)"	7.5	8.7	2.3	8.6	2.4	34.3	10.0	3.6	5.9	10.6	4.3	7.8	7.0	7.6	5.6	8.1	6.6	10.1	4.9	3.0	2.7	8.9	10.3	7.3	8.2	2.3	2.9	9.7	7.8	8.1	4.0	8.7	2.4	8.7	8.2	4.5	9.4	5.6	7.9	7.4	6.5	7.8	2.4	7.3	7.5	4.2	2.7	8.5	10.0	7.5	9.6	9.4	5.3	3.1	11.8	11.2	9.0	12.7	14.3	15.1	13.5	17.3	18.9	14.2	16.8	10.4	5.2	27.0	9.3	16.3	11.0	12.1	15.3	13.4	20.5	14.1	14.0	10.6	6.4	9.5	14.1	22.6	20.4	12.7	13.6	9.3	17.8	10.1	15.3	15.8	15.3	41.7	15.9	12.2	15.5	9.3	8.5	22.8	12.6	14.2	25.1	11.4	14.9	16.9	8.8	12.3	15.1	17.8	12.3	11.7	11.0	9.6	13.7	13.7	11.7	27.1	10.8	14.3	19.0	21.0	16.4	12.6	11.8	4.7	1.9	2.9	2.7	2.9	4.1	1.2	2.6	2.8	1.7	1.1	2.4	2.6	2.2	3.7	2.8	1.4	3.1	1.8	2.3	2.4	3.6	5.9	3.0	2.7	2.3	2.9	2.4	2.4	2.7	3.1	42.3	25.6	47.7	5.2	38.0	55.8	19.6	17.1	32.5	13.7	55.0	39.5	21.6	18.6	29.9	27.6	10.4	14.3	75.3	31.7	17.6	25.3	2.4	47.4	53.8	29.1	44.3	15.4	9.9	24.9	26.5	35.3	40.2	74.1	57.7	20.5	22.9	28.5	16.3	11.8	9.6	39.4	24.4	33.4	49.6	3.2	19.0	44.3	16.0	15.0	24.4	12.4	49.4	9.0	8.9	27.7	29.8	13.9	83.6	28.0	21.0	17.4	47.5	11.4	32.9	42.9	28.2	14.2	17.3	41.6	66.3	27.5	69.7	27.1	24.4	29.2
SSH3	"FLJ10928, FLJ20515"	ENSG00000172830	"Slingshot protein phosphatase 3"	Q8TE77	11	67303478-67312607	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 11.6;eosinophil: 11.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 64.9;MCF7: 64.1;RT4: 111.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019949, HPA019957"	Approved		Approved	"Nuclear speckles,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Nuclear speckles, Cytosol"	"Plasma membrane, Actin filaments"	"HPA019949: AB_1857498, HPA019957: AB_1857499"	"unprognostic (4.38e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.50e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.61e-3)"	"unprognostic (9.30e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (2.89e-4)"	"unprognostic (1.50e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (6.78e-3)"	14.4	7.8	8.9	4.0	12.0	9.3	16.2	14.1	11.6	25.9	9.5	19.3	13.3	16.0	7.5	41.9	18.3	11.5	12.5	9.1	10.1	13.1	10.9	12.7	3.1	14.6	10.8	23.5	15.3	9.8	9.7	6.5	13.2	29.9	9.3	1.2	26.2	28.8	6.8	25.2	15.0	6.1	12.3	9.4	20.1	2.3	11.5	1.9	16.3	3.8	4.8	37.4	32.5	14.9	17.3	18.7	0.4	0.6	11.4	11.8	18.8	10.3	13.7	5.6	5.1	21.2	46.8	1.0	32.5	10.5	11.9	64.9	6.0	46.4	2.8	3.6	6.3	4.3	32.2	9.9	8.2	0.9	16.0	12.2	40.5	8.3	8.3	12.9	6.3	0.4	0.1	1.5	6.2	64.1	0.8	7.3	4.2	48.9	13.8	20.6	0.6	3.1	18.2	111.2	3.7	5.8	24.8	41.0	12.8	6.3	57.1	15.3	10.4	4.5	9.8	12.7	2.7	1.5	0.9	0.5	12.7	6.9	4.9	11.6	1.5	11.1	2.0	2.3	1.7	0.2	1.9	1.7	1.7	0.1	0.8	0.8	4.4	1.5	1.1	1.1	1.8	1.1	8.9	12.0	14.1	11.6	9.1	10.1	14.6	10.8	13.2	12.3	11.5	14.9	7.6	3.2	8.7	8.5	0.9	7.0	20.8	25.2	11.4	0.8	21.3	17.3	3.8	20.0	23.4	16.5	0.0	15.1	3.3	28.3	3.9	19.4	0.1	8.3	5.6	4.7	3.6	5.2	4.2	21.6	24.9	8.0	20.9	17.8	3.8	8.1	3.9	5.0	7.7	1.7	5.3	14.4	24.4	6.2	3.1	0.6	13.1	4.8	8.8	2.8	9.2	4.8	7.2	0.0	15.9	20.0	21.0	12.0	0.7	15.4	20.2	7.4	11.6	0.5	0.0	4.9	9.2	0.5	0.4	27.0	10.4	15.7	4.4	5.3	21.4	26.8
STARD4		ENSG00000164211	"StAR related lipid transfer domain containing 4"	Q96DR4	5	111496033-111512590	"Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046177, HPA048081"	Approved		Approved	"Plasma membrane"		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 9: Intestine - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 15: Hepatocytes - Hemostasis"	"Plasma membrane"		"HPA046177: AB_2679570, HPA048081: AB_2680253"	"unprognostic (1.13e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (1.31e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (5.89e-5)"	"unprognostic (2.00e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (2.84e-4)"	6.2	15.8	8.3	15.9	15.8	19.4	3.9	25.2	12.6	10.2	11.5	14.7	40.8	7.7	16.2	8.5	5.0	9.7	15.0	9.5	10.6	8.5	34.1	20.9	12.6	16.0	16.7	6.5	6.1	14.4	8.2	27.3	13.8	20.7	16.9	12.0	6.6	9.9	1.5	2.5	35.7	6.9	10.1	12.1	17.9	6.8	14.8	7.2	9.0	1.7	10.1	7.7	9.2	11.3	20.6	10.0	48.2	29.4	42.4	84.0	16.3	21.0	46.6	29.8	89.1	37.7	59.9	24.5	8.4	13.4	89.0	9.1	24.8	71.8	28.8	23.7	10.4	19.1	33.3	22.8	46.4	9.5	11.7	44.6	48.3	64.1	47.6	35.6	56.6	23.5	10.7	46.5	20.8	3.9	23.7	17.3	16.6	0.6	5.5	5.4	53.3	22.5	44.6	6.7	27.2	105.6	0.0	12.3	19.0	32.1	16.0	30.4	84.4	25.6	22.9	17.2	8.9	15.9	15.8	21.6	24.3	34.8	13.2	7.1	1.4	0.9	2.5	2.1	1.3	1.7	1.2	1.9	1.8	1.7	1.2	1.9	0.0	2.1	1.5	1.3	0.8	1.4	8.3	15.8	25.2	12.6	9.5	10.6	16.0	16.7	13.8	10.1	14.8	11.3	8.2	25.6	34.8	16.0	13.1	1.0	1.4	35.0	1.2	10.8	1.6	0.4	17.8	8.6	18.1	9.2	8.4	15.6	24.8	37.3	1.9	7.8	9.4	6.7	3.5	20.2	21.4	3.6	38.8	9.2	6.0	6.0	15.8	11.5	32.3	6.5	5.0	39.9	20.3	6.7	20.8	32.5	22.4	19.6	26.7	8.3	7.2	27.8	3.6	20.6	5.7	7.1	9.2	20.1	23.6	10.0	30.0	7.9	17.6	3.3	30.1	5.7	9.5	7.6	19.7	2.4	15.2	8.7	9.4	6.8	2.6	14.1	14.5	38.2	23.0	5.2
STK26	"MASK, MST4"	ENSG00000134602	"Serine/threonine kinase 26"	Q9P289	X	132023302-132075943	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 70.0;epididymis: 56.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 55.2;dendritic cells: 42.7;NK-cells: 53.5;Syncytiotrophoblasts: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 140.1;U-937: 144.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059921	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		Yes	No		360000	"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA059921: AB_2684163"	"unprognostic (6.53e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.42e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (4.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	6.0	2.5	1.0	15.2	2.7	70.0	6.0	1.7	1.3	6.8	2.5	11.5	9.6	46.6	56.3	13.1	7.4	5.6	1.4	0.7	1.5	3.5	5.2	7.2	26.2	0.8	0.8	2.1	3.7	23.5	5.0	25.2	0.7	20.0	11.6	0.2	7.3	35.8	0.9	7.8	6.9	38.1	0.6	13.2	12.2	2.2	3.8	41.3	3.7	1.2	23.5	11.8	7.4	0.7	32.9	11.3	1.3	0.0	5.2	4.9	72.0	1.0	4.0	0.5	0.6	30.1	29.0	44.6	19.4	7.3	22.1	36.5	80.8	51.1	0.0	39.1	66.6	64.6	25.9	28.4	4.7	135.3	5.1	6.9	30.0	0.1	33.7	15.1	14.2	60.0	29.2	40.4	12.2	29.0	140.1	124.9	64.4	22.0	4.3	99.9	39.7	57.9	32.6	51.8	26.6	29.6	19.2	17.0	0.9	54.9	22.0	35.4	0.3	12.8	13.7	39.0	47.9	31.0	52.0	49.8	11.7	144.8	6.5	59.1	9.5	31.6	22.8	12.4	22.4	14.5	15.2	19.6	11.3	12.6	19.7	20.6	18.2	41.0	22.7	4.2	7.2	20.4	1.0	2.7	1.7	1.3	0.7	1.5	0.8	0.8	0.7	0.6	3.8	0.7	0.9	22.4	15.6	0.0	24.7	0.0	36.4	0.0	6.8	0.0	5.9	10.9	1.3	5.7	8.1	11.0	0.0	55.2	42.7	6.5	3.9	4.5	0.6	7.4	1.8	1.7	1.2	12.8	2.0	7.1	34.7	9.6	15.3	17.9	11.4	0.5	1.4	4.4	11.8	0.0	1.4	4.8	0.0	8.8	0.0	0.4	3.4	17.3	0.0	2.8	13.5	0.0	53.5	0.0	0.2	10.9	4.0	2.2	14.5	33.6	1.9	1.5	6.6	0.0	6.6	6.7	3.6	1.8	2.5	16.1	0.0	59.1	27.4	0.6	6.5	18.2
STXBP3	UNC-18C	ENSG00000116266	"Syntaxin binding protein 3"	O00186	1	108746674-108809523	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 206.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027225	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA027225: AB_1857627"	"unprognostic (3.14e-3)"	"unprognostic (4.33e-2)"	"unprognostic (7.18e-3)"	"unprognostic (4.88e-2)"	"unprognostic (6.54e-2)"	"unprognostic (9.78e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"unprognostic (6.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.55e-2)"	23.2	24.3	28.7	27.0	38.6	23.9	27.6	37.9	41.6	24.7	23.8	28.5	26.1	27.1	25.6	25.1	19.6	28.0	20.5	26.9	32.8	40.3	25.0	23.1	27.9	39.5	35.2	20.9	28.1	42.0	14.2	28.1	39.7	23.8	29.1	34.4	21.6	19.4	19.3	27.2	33.4	24.1	35.6	26.1	25.2	16.3	32.2	31.6	37.1	24.0	25.3	31.1	21.5	50.2	47.1	18.1	30.6	16.1	36.3	35.1	42.9	42.9	38.9	27.9	28.2	16.8	18.3	41.7	28.4	34.7	25.8	27.4	20.9	25.3	38.8	46.7	28.9	34.5	23.8	21.9	28.7	54.2	56.0	27.4	34.5	31.5	34.0	34.8	35.2	26.2	26.0	39.3	39.0	31.7	34.8	42.9	32.6	30.9	28.4	28.4	45.1	22.8	45.7	38.4	18.4	16.9	52.3	49.6	64.6	27.6	20.1	49.9	40.2	36.3	21.4	50.8	37.1	26.3	24.8	34.1	65.2	41.0	56.4	62.7	17.1	42.7	14.2	20.8	18.4	11.3	16.6	14.5	16.6	10.8	14.0	13.7	48.1	17.9	24.9	7.7	20.4	11.9	28.7	38.6	37.9	41.6	26.9	32.8	39.5	35.2	39.7	35.6	32.2	50.2	35.9	12.8	25.2	59.1	25.6	44.0	37.4	32.5	14.2	38.2	21.8	20.2	36.4	32.9	34.5	20.2	20.9	43.7	38.7	46.5	45.0	38.1	7.3	33.6	29.3	32.9	21.0	22.7	30.0	27.4	35.4	36.2	16.8	33.9	69.7	18.7	15.4	16.1	31.5	26.9	31.4	28.3	24.4	45.5	44.2	5.4	33.5	41.7	39.2	48.7	57.3	40.5	41.2	68.9	206.2	34.5	27.3	31.6	20.0	32.9	30.4	47.5	28.7	19.3	19.7	34.2	33.6	26.4	24.7	16.1	40.3	95.5	36.7	29.6	26.8	44.8
SYCP2	SCP2	ENSG00000196074	"Synaptonemal complex protein 2"	Q9BX26	20	59863564-59933655	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 43.2"	"Cell type enriched"	"Detected in many"	5	"Spermatocytes: 468.5"	"Group enriched"	"Detected in many"	6	"breast cancer: 6.7;cervical cancer: 11.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 25.9;JURKAT: 47.2;MOLT-4: 54.4;SiHa: 92.2;T-47d: 82.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA062401, HPA065613"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA062401: AB_2684752, HPA065613: AB_2685519"	"unprognostic (8.10e-3)"	"unprognostic (8.28e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.50e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.74e-1)"	"unprognostic (7.02e-3)"	"unprognostic (4.84e-3)"	"unprognostic (8.48e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.21e-1)"	3.2	0.8	2.2	1.4	2.8	2.4	13.9	9.7	4.9	2.4	0.0	1.3	1.6	1.6	1.2	0.9	1.3	2.4	2.5	2.2	1.1	4.3	1.1	2.2	2.6	1.8	1.8	0.7	6.6	0.7	1.9	3.9	2.2	3.8	1.1	1.5	4.4	1.0	1.3	2.7	2.4	0.7	1.4	3.1	6.1	43.2	2.5	1.3	2.4	1.0	1.7	1.8	1.5	4.1	0.3	1.3	0.2	1.4	0.6	0.8	1.4	4.1	1.1	1.8	0.2	25.9	2.6	0.1	4.0	1.8	0.8	0.6	0.5	0.1	1.0	8.5	0.6	0.2	6.1	0.4	0.2	0.4	19.0	0.4	0.4	0.4	0.0	0.9	0.0	47.2	0.2	0.0	0.9	12.5	54.4	2.9	0.4	1.5	0.3	0.0	0.1	0.2	2.1	6.1	0.2	4.5	92.2	13.3	3.3	1.6	82.6	4.7	0.5	0.1	2.8	11.2	0.0	0.0	0.0	0.0	0.0	1.7	5.2	0.7	0.1	0.7	0.8	0.0	0.8	0.2	0.4	0.5	0.0	0.2	0.2	0.4	0.7	0.0	0.0	0.0	0.3	0.2	2.2	2.8	9.7	4.9	2.2	1.1	1.8	1.8	2.2	1.4	2.5	4.1	11.5	0.0	1.1	24.5	1.4	1.0	1.1	1.0	0.0	1.9	12.7	9.4	3.6	2.8	6.3	1.8	2.1	0.8	3.0	0.1	1.9	0.9	82.3	0.4	5.0	6.5	0.0	0.0	27.5	3.6	0.4	2.1	2.6	0.5	2.5	1.2	2.9	0.0	0.5	0.0	14.6	0.1	0.0	1.2	0.8	21.8	4.7	1.6	5.4	13.1	1.4	2.3	5.2	28.6	11.1	1.2	1.2	1.9	0.4	1.8	0.3	5.4	8.6	1.1	52.6	1.7	3.8	468.5	92.4	0.6	0.0	0.4	4.1	0.2	0.3	1.2
SYCP3		ENSG00000139351	"Synaptonemal complex protein 3"	Q8IZU3	12	101728648-101739472	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	146	"testis: 82.9"	"Group enriched"	"Detected in many"	8	"Spermatocytes: 825.7;Spermatogonia: 346.9"	"Cancer enriched"	"Detected in single"	16	"testis cancer: 5.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB032978, HPA039635, HPA043938"	Enhanced					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"CAB032978: AB_656732, HPA039635: AB_2676607, HPA043938: AB_2678740"	"unprognostic (2.86e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.61e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.86e-2)"	"unprognostic (7.15e-3)"	"unprognostic (7.81e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.07e-2)"	"unprognostic (5.86e-4)"	0.0	0.1	0.3	0.3	0.4	0.2	0.0	0.5	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	82.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	1.3	0.2	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.2	0.6	0.4	0.2	0.0	0.1	0.0	0.0	0.5	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.5	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	2.0	9.1	4.5	0.0	0.7	0.4	1.2	2.2	0.9	0.6	1.3	1.5	0.3	1.8	0.0	0.4	3.1	0.6	0.0	0.1	24.1	0.3	1.3	0.9	1.2	0.4	10.1	0.4	0.2	0.7	0.0	0.7	3.8	0.3	0.7	0.2	0.6	0.0	10.7	0.7	0.0	1.0	0.3	31.2	9.0	1.7	0.0	0.0	0.4	0.3	1.0	9.5	1.8	0.3	1.9	1.9	2.0	0.9	1.0	0.3	0.8	1.7	65.7	2.0	0.4	825.7	346.9	0.7	0.3	0.1	2.0	0.2	1.3	0.5
SYVN1	"DER3, HRD1"	ENSG00000162298	"Synoviolin 1"	Q86TM6	11	65121780-65134532	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Stress response, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 72.9;Plasma cells: 90.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 205.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005480, HPA024300, CAB037030"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Endoplasmic reticulum, Plasma membrane"	"CAB037030: AB_1840939, HPA005480: AB_1079084, HPA024300: AB_1851073"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (6.88e-4)"	"unprognostic (7.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.89e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.16e-1)"	29.2	40.3	19.3	37.1	25.6	31.0	27.6	23.2	21.4	30.7	26.7	29.2	26.1	29.1	38.8	28.4	30.6	19.7	25.3	18.6	21.2	24.5	117.5	27.0	60.9	27.9	25.6	30.9	90.9	35.0	38.2	26.2	24.6	28.5	29.0	18.7	55.9	30.3	34.2	29.3	39.4	25.9	22.8	51.2	39.4	24.3	23.4	18.3	43.4	19.0	81.1	25.8	24.8	25.9	32.4	40.6	24.0	32.5	59.8	33.8	23.8	32.8	33.5	40.9	28.8	22.2	55.0	181.0	43.8	42.4	53.8	48.8	26.4	33.3	33.6	28.4	20.0	28.6	46.8	50.2	72.3	43.3	49.6	43.3	59.0	36.1	81.0	36.4	27.0	19.0	36.4	90.1	24.3	47.9	19.1	31.2	26.1	33.6	28.0	31.9	20.3	74.0	25.7	31.5	15.6	32.0	30.4	74.1	53.3	21.0	55.4	28.2	25.9	28.3	18.6	51.2	22.4	178.1	134.2	205.9	38.1	21.8	32.3	16.8	7.4	14.0	7.4	4.7	6.5	21.9	5.2	6.9	4.4	22.6	3.7	3.9	7.0	3.5	4.7	18.4	5.3	6.6	19.3	25.6	23.2	21.4	18.6	21.2	27.9	25.6	24.6	22.8	23.4	25.9	11.5	16.0	21.4	11.1	43.5	17.6	6.9	13.8	12.0	10.7	21.0	15.5	4.0	22.8	20.8	11.0	33.3	14.5	16.4	23.1	1.9	13.6	6.6	14.2	16.2	11.3	8.4	13.2	9.6	18.9	16.5	14.2	17.9	22.1	1.3	10.1	15.0	72.9	15.1	13.5	9.5	33.6	16.2	15.3	13.2	4.1	20.5	10.8	12.4	9.4	10.5	11.0	13.4	13.0	15.8	18.2	11.7	13.2	90.5	14.9	14.0	7.7	15.1	18.7	13.1	11.9	10.7	19.3	13.2	9.7	16.1	42.8	11.7	13.6	18.6	13.8
TBCE	"HRD, KCS, KCS1, pac2"	ENSG00000285053	"Tubulin folding cofactor E"	Q15813	1	235328570-235448952	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant, Dwarfism, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA026552, HPA026557"	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"		"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA026552: AB_1857797, HPA026557: AB_1857798"																		0.9	0.7	1.1	1.3	0.8	1.3	0.8	2.4	1.7	0.8	0.1	1.0	0.8	1.5	0.5	0.6	0.7	0.6	1.1	1.0	1.3	1.2	0.7	0.8	1.5	1.9	1.1	1.9	1.6	0.8		1.3	2.2	1.2	0.9	1.9	0.7	0.8	3.5	0.8	1.4	0.7	0.5	1.0	1.2	1.6	1.4	2.4	1.0	2.4	1.2	0.9		1.7	8.4	2.5	8.9	5.7	1.5	2.4	5.9	3.7	1.9	6.3	3.3	2.2	6.6	4.4	9.0	1.5	3.8	3.9	3.4	3.2	4.5	6.3	6.7	2.2	3.5	2.8	0.6	5.6	5.2	0.8	1.0	3.4	3.9	1.3	2.3	5.2	6.2	2.3	3.9	4.2	8.1	2.0	10.0	4.8	1.9	5.2	3.8	2.0	2.2	2.7	9.3	8.5	3.6	6.4	4.0	1.3	9.5	10.8	3.5	4.6	7.8	4.5	5.2	5.6	6.5	5.8	6.2	2.5	6.0	3.0	2.5	2.4	2.3	2.9	2.4	1.8	2.0	2.4	2.6	1.3	2.4	2.1	0.5	1.8	2.5	1.8	2.7	2.1	1.1	0.8	2.4	1.7	1.0	1.3	1.9	1.1	2.2	0.5	1.4	1.7	10.1	0.0	5.9	17.9	8.9	3.1	5.2	8.2	5.2	9.2	6.9	9.4	0.0	4.3	7.0	7.3	4.2	0.0	8.6	4.3	0.0	3.5	10.9	3.4	12.3	5.9	3.5	6.9	22.4	1.6	0.0	5.5	9.7	4.3	3.8	7.7	2.2	5.9	0.0	6.7	26.1	5.3	4.1	4.7	2.7	6.2	10.8	6.6	8.8	10.3	8.9	8.9	11.3	11.6	22.0	3.1	4.1	7.5	6.6	2.9	5.2	1.4	5.7	13.1	0.0	5.9	7.6	14.0	8.8	7.5	2.8	0.0	8.8	8.5	8.3	3.9
TCEANC	MGC17403	ENSG00000176896	"Transcription elongation factor A N-terminal and central domain containing"	Q8N8B7	X	13653189-13681964	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000337, HPA001013"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nuclear speckles"		"HPA000337: , HPA001013: AB_1079371"	"unprognostic (1.44e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.74e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.29e-3)"	"unprognostic (4.03e-2)"	"unprognostic (4.29e-6)"	"unprognostic (3.82e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.63e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.11e-4)"	1.5	1.2	1.3	1.0	1.4	4.5	2.5	2.0	1.8	1.5	1.2	1.2	1.1	1.5	3.0	0.8	1.8	1.0	1.5	1.4	1.4	1.5	1.7	1.7	2.7	1.5	1.4	2.5	1.5	1.2	1.3	1.2	1.5	1.5	1.5	2.8	1.8	1.2	1.7	1.5	1.4	1.5	1.3	2.5	1.2	1.0	1.6	2.9	2.0	1.5	2.0	1.1	1.1	1.9	0.4	1.1	1.2	2.1	2.5	3.0	0.4	0.3	1.0	1.0	0.4	0.4	0.8	1.3	1.1	0.8	0.6	0.6	1.1	0.6	0.2	1.4	1.5	0.7	0.6	0.6	1.4	1.1	1.3	2.6	1.0	0.6	4.2	1.5	0.3	1.3	1.4	2.2	1.4	0.9	1.8	1.1	1.6	0.6	0.3	1.4	1.1	2.8	0.5	0.7	1.2	1.1	1.1	1.2	1.6	1.5	1.2	1.0	0.5	0.9	0.4	0.8	0.1	1.8	1.1	1.0	1.2	0.6	0.4	7.2	1.6	4.2	2.6	1.4	3.0	3.5	2.8	3.5	1.3	3.6	3.4	3.1	2.1	1.6	1.5	2.3	3.7	1.9	1.3	1.4	2.0	1.8	1.4	1.4	1.5	1.4	1.5	1.3	1.6	1.9	2.9	0.0	1.1	1.6	3.8	0.3	1.0	1.2	1.8	3.5	2.3	2.0	2.6	1.5	2.3	3.7	2.1	2.2	7.3	1.3	3.9	1.5	0.0	2.2	2.6	1.5	2.4	19.0	1.7	0.9	0.8	1.8	1.1	2.0	5.1	2.1	1.8	3.9	2.0	1.7	2.2	2.5	2.0	2.8	2.0	0.2	3.4	1.8	0.0	2.8	3.1	4.9	6.2	0.5	2.5	0.5	1.8	2.2	7.3	1.2	2.7	3.2	2.0	2.3	0.0	1.7	2.6	1.1	1.2	0.9	0.3	3.3	4.8	2.1	1.3	0.9
TENT5C	"FAM46C, FLJ20202"	ENSG00000183508	"Terminal nucleotidyltransferase 5C"	Q5VWP2	1	117606048-117628389	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Host-virus interaction"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 89.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 41.8;Breast glandular cells: 34.0;Breast myoepithelial cells: 43.2;dendritic cells: 104.5;Plasma cells: 47.7;T-cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 29.3"	"Group enriched"	"Detected in many"	17	"B-cells: 13.3;granulocytes: 29.3;T-cells: 13.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 296.2;RPMI-8226: 185.5;U-266/70: 81.7;U-266/84: 72.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA054049	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA054049: AB_2682356"	"unprognostic (3.76e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.24e-3)"	"prognostic favorable (3.75e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.55e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.36e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.91e-2)"	"prognostic favorable (2.77e-5)"	"unprognostic (6.26e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.10e-2)"	2.8	2.4	0.9	17.0	1.0	89.1	11.6	1.1	1.6	10.9	27.4	23.8	16.0	3.2	19.1	3.6	4.8	7.8	6.9	1.4	0.9	7.5	10.3	10.5	18.8	1.6	1.6	9.0	46.8	11.2	2.6	3.8	1.1	6.6	24.8	0.1	25.8	4.1	29.4	1.2	13.0	2.9	1.9	21.7	30.2	43.5	1.0	6.2	14.3	10.9	37.3	14.1	1.9	1.3	0.2	0.1	0.1	1.3	0.1	0.0	1.3	0.6	26.9	0.5	0.2	1.7	0.2	4.9	0.3	0.8	0.3	0.3	0.1	0.5	0.2	17.6	1.6	37.9	0.2	0.0	0.1	22.4	46.8	0.0	0.1	0.4	0.0	0.1	0.1	10.0	5.2	296.2	0.0	3.8	0.1	22.8	3.8	4.5	2.4	0.1	0.1	185.5	0.3	3.7	2.2	0.2	1.7	2.4	1.8	0.6	1.9	0.2	0.5	0.3	2.1	0.1	0.4	81.7	72.8	1.9	1.7	8.1	2.4	29.3	0.0	15.9	3.4	0.0	3.1	13.3	3.3	4.4	0.1	10.4	0.4	1.9	1.6	1.1	0.0	0.3	13.7	2.9	0.9	1.0	1.1	1.6	1.4	0.9	1.6	1.6	1.1	1.9	1.0	1.3	17.0	0.0	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	34.0	43.2	0.0	0.0	0.0	1.8	0.0	1.9	104.5	0.0	11.7	0.8	0.0	8.3	5.4	2.9	0.0	0.0	0.0	5.2	2.2	3.2	0.0	13.7	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	47.7	0.0	0.0	9.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	2.2	48.4	1.0	0.0	0.0
TEX35	"C1orf49, DKFZP564J047, TSC24"	ENSG00000240021	"Testis expressed 35"	Q5T0J7	1	178513109-178548602	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 117.9"	"Group enriched"	"Detected in some"	137	"Early spermatids: 1312.2;Late spermatids: 2214.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039190	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"			"HPA039190: AB_10794425"	"unprognostic (2.20e-1)"	"unprognostic (1.77e-2)"				"unprognostic (1.26e-1)"	"unprognostic (1.89e-2)"	"unprognostic (8.92e-3)"	"unprognostic (1.08e-2)"	"unprognostic (7.04e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.51e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.23e-1)"	"unprognostic (5.41e-2)"	0.3	0.2	2.3	0.3	2.5	2.2	0.6	8.7	2.7	0.2	0.0	0.3	1.6	0.5	1.4	0.4	0.2	0.3	0.6	1.3	1.6	0.2	0.2	0.4	0.6	0.7	0.5	0.6	0.4	0.4	0.0	0.5	1.0	0.5	0.6	2.0	0.3	0.2	0.3	2.2	0.4	0.3	0.0	0.7	1.6	117.9	1.4	0.3	0.5	0.3	0.4	0.3	0.1	3.4	0.2	0.1	0.1	0.5	0.3	0.9	2.8	0.1	0.2	0.2	0.1	0.0	0.3	0.4	0.2	0.3	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.1	1.1	0.4	0.0	0.1	0.2	0.1	0.0	0.2	0.7	0.3	0.1	0.3	0.2	0.4	0.1	0.2	0.3	0.5	0.9	0.0	0.1	0.3	0.0	0.2	0.4	0.4	0.2	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.7	0.4	0.3	0.5	0.1	0.7	0.6	0.2	0.3	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	2.3	2.5	8.7	2.7	1.3	1.6	0.7	0.5	1.0	0.0	1.4	3.4	0.2	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1312.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.3	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2214.6	8.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.0	11.5	7.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
TFIP11	"DKFZP434B194, Spp382, TIP39"	ENSG00000100109	"Tuftelin interacting protein 11"	Q9UBB9	22	26491225-26512505	"Plasma proteins, Predicted intracellular proteins"	"Biomineralization, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027085			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA027085: AB_1857964"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.87e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.86e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.46e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.62e-1)"	13.5	13.0	12.4	16.3	13.5	62.8	12.5	15.4	13.9	11.5	12.1	12.7	12.9	12.4	10.4	14.8	13.1	12.6	16.0	12.9	12.0	13.9	19.3	14.0	24.9	12.0	11.8	12.4	16.7	13.0	10.5	14.5	11.3	12.4	12.6	13.4	11.0	10.6	41.8	20.3	13.5	13.1	11.6	17.7	11.9	26.6	13.0	20.1	16.2	21.5	24.7	14.8	10.9	14.3	22.9	26.4	22.3	24.6	34.7	20.6	21.5	26.4	34.5	41.8	39.1	19.8	16.1	44.4	16.6	33.9	27.6	32.8	32.1	26.3	30.3	32.3	30.4	27.4	16.4	20.2	31.4	63.6	33.2	25.9	34.9	40.0	30.9	22.3	32.6	22.4	37.4	38.9	28.2	28.2	29.2	33.8	21.4	32.2	21.9	43.6	34.6	38.8	24.2	22.4	16.7	24.0	31.9	22.7	32.8	21.4	18.7	27.7	31.6	35.2	56.8	22.4	25.6	29.8	41.8	86.6	27.8	24.6	26.8	68.7	28.4	50.1	37.2	31.3	35.1	37.9	33.0	35.2	26.1	42.9	30.9	28.4	44.9	36.3	44.1	16.4	44.5	33.0	12.4	13.5	15.4	13.9	12.9	12.0	12.0	11.8	11.3	11.6	13.0	14.3	11.3	9.6	9.7	11.4	17.8	16.8	11.2	13.2	22.2	9.7	7.5	6.3	3.5	17.2	12.3	12.9	8.4	17.9	20.7	14.8	13.7	15.1	67.9	12.2	9.2	13.3	16.2	20.2	7.1	20.7	14.4	7.8	9.2	12.6	8.2	11.9	13.2	10.8	13.3	15.2	7.2	11.2	6.1	6.2	7.8	12.3	11.1	10.4	7.2	4.7	12.3	7.7	19.6	6.0	6.5	25.3	8.4	9.8	18.6	7.6	11.4	9.3	14.1	6.9	0.0	10.1	10.6	43.6	19.4	14.2	16.8	19.4	17.4	11.6	10.7	10.9
TFR2	"HFE3, TFRC2"	ENSG00000106327	"Transferrin receptor 2"	Q9UP52	7	100620416-100642779	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"		Receptor	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"liver: 346.1"	"Group enriched"	"Detected in some"	13	"Erythroid cells: 152.8;Hepatocytes: 455.7"	"Cancer enriched"	"Detected in many"	70	"liver cancer: 136.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"basophil: 2.5;eosinophil: 1.9"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 2.5"	"Group enriched"	"Detected in some"	11	"HEL: 69.7;HMC-1: 92.7;K-562: 65.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016255, HPA017171, HPA073125"	Enhanced		Approved	"Golgi apparatus"		NA	NA		410000	"Cluster 46: Basophils - DNA binding"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus"		"CAB016255: AB_628395, HPA017171: , HPA073125: "	"unprognostic (4.18e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.13e-2)"	"prognostic favorable (2.48e-4)"	"unprognostic (2.29e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.18e-9)"	"unprognostic (6.51e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.18e-2)"	0.0	0.1	0.0	0.0	0.0	22.5	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	346.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	6.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.7	0.0	7.2	0.0	1.6	92.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	65.8	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	2.1	0.3	0.9	0.4	0.0	8.5	0.3	0.6	1.2	10.0	0.8	0.0	8.4	0.1	1.7	0.1	0.0	0.4	5.8	0.1	0.6	1.2	0.0	152.8	5.4	0.2	1.1	0.5	1.5	0.2	0.0	0.2	7.1	455.7	0.3	21.9	5.4	0.3	0.0	8.6	1.7	8.4	0.0	0.4	0.0	1.0	0.2	0.4	6.2	1.5	0.7	0.1	0.1	0.0	0.4	0.6	0.1	0.1	0.3	1.9	0.0	0.4	0.7	0.7	2.9	0.2	0.6	0.1	2.6	0.1	0.6	0.5
TIMM22	"TEX4, TIM22"	ENSG00000177370	"Translocase of inner mitochondrial membrane 22"	Q9Y584	17	997129-1003671	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Protein transport, Translocation, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	40	"basophil: 4.0"	"Lineage enriched"	"Detected in single"	40	"granulocytes: 4.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045138	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 33: Fibroblasts - ECM organization"			"HPA045138: AB_10962055"	"unprognostic (2.69e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.69e-3)"	"unprognostic (3.00e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.36e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.42e-4)"	"unprognostic (1.27e-1)"	"prognostic favorable (1.41e-4)"	"unprognostic (2.45e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-3)"	7.7	9.9	6.6	3.9	7.0	6.8	7.5	9.7	8.6	6.8	8.4	8.5	2.8	7.5	8.8	8.8	6.4	1.6	15.2	6.4	6.8	9.3	6.3	6.2	3.8	7.4	6.8	7.3	7.0	10.3	9.0	6.9	8.1	7.0	4.4	4.5	7.2	1.8	12.3	8.5	6.2	5.2	7.4	7.3	8.4	6.9	7.4	6.2	6.6	12.2	6.0	7.9	6.7	8.3	3.9	0.2	13.0	12.6	19.0	8.8	4.0	12.8	8.5	10.6	13.1	8.4	4.8	4.7	2.5	21.2	9.1	3.6	26.0	14.2	21.0	0.0	0.0	9.5	1.8	0.1	18.6	5.6	1.5	11.3	9.0	13.4	20.6	10.6	17.2	0.3	1.8	13.1	12.9	0.0	17.2	6.6	9.0	11.5	17.0	8.9	6.5	6.5	17.1	0.2	4.6	10.7	4.9	5.3	10.3	12.3	8.1	10.0	18.7	12.5	9.5	10.2	15.7	2.9	0.0	4.2	10.2	8.6	12.4	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	7.0	9.7	8.6	6.4	6.8	7.4	6.8	8.1	7.4	7.4	8.3	20.2	3.2	15.9	2.0	21.7	43.6	10.7	31.5	17.1	26.4	21.4	18.5	25.3	18.6	17.8	7.3	33.3	62.8	16.3	11.8	37.2	36.2	5.9	14.9	21.2	28.2	20.4	16.8	6.9	28.2	60.8	26.9	17.3	15.8	3.8	27.1	13.9	12.1	40.4	26.9	7.1	11.9	30.5	9.7	18.9	9.7	20.2	14.6	16.0	7.5	26.9	19.1	24.7	4.0	2.8	29.0	8.6	21.4	13.2	17.0	14.2	26.7	10.2	43.7	13.1	17.4	21.4	42.7	47.2	19.5	54.1	61.6	19.0	42.7	16.8	12.9
TJAP1	"PILT, TJP4"	ENSG00000137221	"Tight junction associated protein 1"	Q5JTD0	6	43477523-43506556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Oligodendrocytes: 117.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030164, HPA030165, HPA030166"	Supported		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"		"HPA030164: AB_10599849, HPA030165: AB_2673350, HPA030166: AB_10601858"	"unprognostic (5.05e-3)"	"unprognostic (2.82e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.03e-3)"	"unprognostic (3.09e-2)"	"unprognostic (4.50e-3)"	"prognostic unfavorable (9.02e-6)"	"unprognostic (4.27e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.61e-3)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (5.15e-3)"	"unprognostic (7.51e-3)"	24.4	32.1	25.5	17.3	36.6	18.5	24.4	28.2	32.8	31.8	23.5	30.1	20.3	31.1	10.1	16.7	28.8	13.4	24.8	26.3	29.3	21.8	25.9	21.7	20.6	34.0	33.3	37.2	33.2	13.2	24.5	14.9	31.2	31.3	9.2	11.3	24.0	14.5	44.1	19.7	25.9	15.1	25.7	32.2	26.0	20.3	35.1	17.1	30.4	16.7	14.9	28.7	23.5	49.4	40.6	15.7	27.1	40.7	21.5	20.1	30.0	25.1	26.8	26.2	28.4	23.8	17.2	22.4	18.6	23.3	25.0	35.0	22.9	30.0	16.8	38.7	35.2	28.5	30.8	26.3	25.8	29.2	39.6	23.0	39.7	32.6	28.6	20.7	17.4	28.6	24.9	41.2	23.5	22.5	28.7	48.3	23.7	69.0	23.9	34.2	17.8	24.0	16.3	22.1	17.8	24.7	21.4	13.0	33.5	16.7	23.2	56.7	15.3	34.9	26.9	29.3	37.9	30.0	26.9	40.0	15.3	33.1	30.2	13.6	7.1	5.7	7.1	8.2	9.2	6.3	5.8	6.2	5.4	6.7	6.5	7.2	4.0	5.5	7.5	5.7	3.5	7.1	25.5	36.6	28.2	32.8	26.3	29.3	34.0	33.3	31.2	25.7	35.1	49.4	10.9	12.8	10.3	12.1	10.3	7.5	14.7	9.3	13.6	11.1	9.9	13.0	7.7	10.0	6.3	12.9	29.2	21.3	7.3	7.2	3.9	10.0	1.4	7.3	10.6	10.5	11.4	7.8	11.6	8.4	18.6	10.6	8.6	9.8	14.7	21.9	8.2	8.3	9.8	8.4	9.4	8.5	14.2	7.7	8.7	2.2	10.5	9.1	5.4	14.0	8.3	10.0	6.2	19.6	117.1	9.5	7.2	12.8	10.2	14.9	7.9	6.2	5.9	15.2	6.6	9.5	10.0	14.1	14.8	4.9	3.7	18.7	9.8	10.6	7.0	9.0
TLE4	"E(spl), ESG, GRG4"	ENSG00000106829	"TLE family member 4, transcriptional corepressor"	Q04727	9	79571773-79726882	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 108.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 818.9;Late spermatids: 1315.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 24.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 99.9;BJ hTERT+: 98.7;BJ hTERT+ SV40 Large T+: 89.4;fHDF/TERT166: 154.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065357			Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA065357: AB_2685479"	"unprognostic (6.68e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.83e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.94e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (6.94e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.82e-1)"	9.3	15.7	18.4	16.4	45.2	67.9	8.7	22.3	27.4	9.6	20.2	9.9	8.4	14.3	5.9	17.6	12.9	16.6	8.0	27.5	21.6	6.9	5.6	12.5	15.9	31.7	21.4	32.3	6.4	10.6	24.2	19.7	32.2	5.6	10.5	24.7	10.9	8.4	23.1	18.9	11.3	14.5	26.1	18.5	14.1	108.0	25.4	27.8	10.4	10.3	19.9	18.7	12.8	64.0	0.0	19.0	70.7	0.5	11.4	9.6	21.2	99.9	98.7	89.4	34.4	2.8	10.3	7.4	0.2	154.3	13.7	20.8	5.0	18.3	39.2	38.2	30.8	0.0	9.1	0.4	13.8	21.4	13.0	11.3	12.6	26.1	5.2	25.2	23.9	14.0	1.5	21.3	28.6	0.7	29.4	9.4	22.5	11.9	4.8	25.7	35.9	7.4	5.5	2.7	28.5	41.5	14.7	1.9	0.1	32.8	0.0	25.1	36.4	34.8	0.1	0.8	5.0	14.4	25.0	10.9	12.3	18.0	16.6	24.2	4.4	17.1	4.8	6.3	5.9	1.3	2.5	3.6	2.9	1.7	1.5	2.5	11.7	3.2	4.9	1.0	0.8	2.6	18.4	45.2	22.3	27.4	27.5	21.6	31.7	21.4	32.2	26.1	25.4	64.0	108.9	6.4	19.4	77.4	91.9	121.0	57.2	50.6	167.4	76.8	76.0	92.8	15.9	84.4	45.6	14.7	127.2	77.2	228.1	163.5	3.9	13.4	818.9	262.0	230.0	59.7	25.2	22.3	150.8	22.0	67.1	71.4	137.1	158.7	21.0	34.8	53.2	14.1	51.1	218.7	33.3	117.3	61.1	167.9	70.4	1315.5	105.6	101.7	42.7	77.8	75.3	31.0	88.6	301.6	381.0	31.7	207.6	46.6	152.7	37.8	122.0	18.1	50.4	290.2	72.3	280.7	83.9	38.3	146.0	140.0	90.8	65.0	141.0	86.8	96.0	99.9
TM9SF3	SMBP	ENSG00000077147	"Transmembrane 9 superfamily member 3"	Q9HD45	10	96518110-96587452	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039609	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA		240000	"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	Vesicles	"Golgi apparatus"	"HPA039609: AB_10673535"	"unprognostic (3.33e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.11e-2)"	"unprognostic (4.95e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.26e-2)"	"unprognostic (4.14e-3)"	"unprognostic (4.81e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.28e-3)"	"unprognostic (6.18e-2)"	57.0	53.4	28.5	54.6	33.0	36.7	58.4	33.2	34.8	65.3	34.9	111.8	116.9	62.5	69.2	57.5	46.0	89.9	39.7	27.7	34.4	68.0	75.0	43.2	42.0	33.8	31.2	62.9	73.3	70.1	22.5	67.8	35.2	91.7	94.5	43.4	83.2	56.4	26.6	38.5	112.4	50.8	35.7	41.8	183.5	34.6	30.7	44.7	87.4	41.1	44.9	72.8	34.8	43.6	146.8	97.2	106.5	149.3	151.4	112.4	127.7	197.8	146.7	84.0	67.5	116.4	281.6	107.3	107.0	175.8	105.5	135.3	97.6	108.1	156.8	121.3	83.6	95.3	81.8	92.0	114.5	197.7	107.2	105.0	108.6	118.6	203.7	253.2	94.7	96.4	97.0	119.9	132.2	66.4	77.1	76.2	68.9	237.9	59.6	94.6	134.4	84.8	120.1	106.8	49.6	110.3	104.1	98.6	103.0	126.2	171.0	73.7	165.3	103.5	87.1	104.6	183.1	123.7	152.3	98.4	140.9	134.9	73.5	5.7	2.2	3.8	3.5	2.3	4.0	2.1	3.6	3.9	2.7	1.5	2.7	3.6	2.4	3.9	2.4	7.1	4.0	1.3	28.5	33.0	33.2	34.8	27.7	34.4	33.8	31.2	35.2	35.7	30.7	43.6	115.7	51.3	43.0	43.1	53.2	116.8	118.8	63.2	51.8	57.8	103.1	73.0	65.0	121.5	88.2	141.6	56.3	77.5	89.5	238.7	21.5	80.7	27.6	93.0	162.0	99.8	123.9	68.8	59.9	146.1	97.6	98.7	212.0	192.2	40.6	75.0	78.9	126.9	60.0	58.9	64.0	368.3	69.2	85.6	125.3	12.8	93.2	73.5	103.2	49.6	56.8	58.1	54.6	69.9	79.2	132.1	140.6	82.4	88.9	196.1	141.5	59.3	65.9	54.7	65.7	89.2	121.0	45.8	38.4	73.2	120.6	140.9	63.0	74.5	246.7	156.2
TMEM164	"FLJ22679, RP13-360B22.2"	ENSG00000157600	"Transmembrane protein 164"	Q5U3C3	X	110002631-110182734	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 84.5;Distal enterocytes: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 59.7"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 59.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038784	Approved		Approved	"Vesicles,Cell Junctions"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles	"Cell Junctions"	"HPA038784: AB_10670790"	"unprognostic (2.14e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.65e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (8.17e-6)"	"unprognostic (9.85e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.95e-1)"	"unprognostic (7.66e-2)"	"prognostic favorable (3.14e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.81e-2)"	"unprognostic (4.19e-3)"	16.9	10.3	11.4	9.6	11.8	19.0	12.3	6.8	9.7	5.5	14.3	18.8	21.5	5.3	6.0	13.8	8.1	5.1	22.7	9.0	12.1	11.1	2.0	17.9	6.7	13.5	13.0	13.8	25.4	8.3	9.6	5.2	11.2	8.9	21.2	3.6	9.8	14.4	27.5	20.3	19.2	6.9	8.2	8.4	14.0	1.9	12.3	12.6	13.8	19.3	8.0	5.8	6.8	8.6	10.8	24.3	19.5	12.8	23.7	17.3	11.9	5.3	12.4	11.0	7.1	19.1	16.6	8.6	35.2	8.3	27.1	15.6	17.1	27.9	10.8	23.9	11.7	58.5	13.0	8.1	13.9	26.1	80.1	24.0	48.4	19.9	27.2	30.2	21.8	15.2	18.4	10.2	19.7	21.6	27.4	33.1	17.5	36.9	17.3	12.4	15.1	7.2	17.5	11.3	18.2	20.3	34.0	33.1	15.9	18.1	9.6	25.7	49.0	9.3	6.8	11.0	7.7	5.9	7.9	6.9	24.3	32.0	25.3	59.7	3.3	14.2	0.6	2.9	1.6	0.2	0.7	0.6	2.7	0.6	0.4	0.5	16.3	2.3	1.8	0.5	1.0	1.8	11.4	11.8	6.8	9.7	9.0	12.1	13.5	13.0	11.2	8.2	12.3	8.6	2.9	3.2	36.1	84.5	3.7	4.8	3.7	4.7	4.6	1.2	11.7	9.1	21.3	11.5	6.9	16.5	2.1	2.7	3.5	53.0	3.9	4.6	0.5	6.7	3.8	6.0	27.6	14.5	22.9	11.4	6.3	3.1	7.7	10.7	3.8	4.3	6.4	1.7	13.6	0.0	31.4	12.7	10.2	25.1	9.4	1.3	1.8	12.5	1.8	24.4	28.1	1.0	4.1	34.2	7.6	13.5	15.0	1.5	1.6	9.0	31.9	3.3	5.4	1.3	0.0	6.4	4.1	0.2	0.3	10.4	8.0	2.7	5.2	3.8	21.2	12.3
TMEM38A	"MGC3169, TRIC-A"	ENSG00000072954	"Transmembrane protein 38A"	Q9H6F2	19	16661139-16690023	"Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"skeletal muscle: 581.3;tongue: 260.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.7;Cone photoreceptor cells: 85.5;Excitatory neurons: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 36.9;eosinophil: 12.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 36.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 16.1;OE19: 15.2;U-266/70: 15.6;U-698: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048100, HPA050463"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA048100: , HPA050463: AB_2681137"	"unprognostic (1.56e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.87e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.49e-1)"	"prognostic favorable (2.78e-5)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.68e-1)"	"prognostic favorable (2.99e-10)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.96e-2)"	2.1	4.1	10.5	1.3	15.4	5.8	2.3	13.3	15.9	1.9	52.4	2.9	1.9	1.3	18.0	9.2	3.4	0.9	26.1	10.8	16.1	5.7	7.6	4.5	1.5	10.7	14.3	2.4	2.1	4.4	7.4	0.6	11.2	7.0	2.7	10.0	9.3	5.0	581.3	1.8	2.0	1.4	10.2	1.6	14.7	3.9	16.0	2.9	2.5	260.0	2.3	1.7	1.3	11.3	4.1	0.8	1.0	6.1	3.3	0.3	0.5	1.4	0.8	0.9	1.9	1.3	5.8	16.1	2.4	0.3	5.3	3.3	8.1	1.7	0.9	1.1	2.4	0.0	2.5	1.3	0.9	0.1	0.2	1.4	6.2	1.1	0.7	4.6	0.4	2.9	0.1	1.5	0.6	6.3	0.2	1.7	1.5	15.2	9.4	8.5	1.4	4.4	5.8	3.0	9.9	6.9	4.4	0.5	2.1	0.5	3.0	1.3	0.0	1.2	2.8	3.7	0.7	15.6	12.2	27.1	1.4	9.6	1.2	36.9	4.2	12.3	0.0	1.6	0.0	4.6	0.5	0.1	0.4	6.0	0.1	0.1	2.4	3.5	1.0	0.8	0.8	1.0	10.5	15.4	13.3	15.9	10.8	16.1	10.7	14.3	11.2	10.2	16.0	11.3	2.8	3.2	1.5	18.3	2.3	1.1	3.5	6.7	3.4	30.7	3.9	2.2	25.9	1.5	3.0	0.0	85.5	0.1	0.6	1.7	1.9	3.6	0.1	1.4	0.6	4.5	4.2	0.0	31.0	2.5	0.1	3.0	17.3	1.4	0.0	2.2	9.7	9.2	0.4	13.5	24.0	7.6	14.2	4.3	1.2	0.9	10.5	0.9	3.6	3.7	0.9	13.9	0.0	7.5	3.1	10.8	1.1	22.6	2.9	3.4	0.4	1.2	1.8	9.5	0.0	25.4	3.9	0.9	1.3	3.3	0.3	0.1	0.6	2.1	2.7	1.3
TMEM81	"HC3107, KVLA2788, MGC75217, UNQ2788"	ENSG00000174529	"Transmembrane protein 81"	Q6P7N7	1	205083129-205084460	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA052515			Approved	"Intermediate filaments"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Intermediate filaments"		"HPA052515: AB_2681858"	"unprognostic (9.19e-3)"	"unprognostic (3.53e-1)"	"unprognostic (1.91e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (3.25e-6)"	"unprognostic (3.66e-2)"	"unprognostic (2.68e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.48e-2)"	"prognostic unfavorable (6.65e-9)"	"unprognostic (8.91e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (2.67e-4)"	2.3	3.7	8.8	1.1	9.1	1.5	1.8	11.5	12.4	4.0	8.1	2.7	0.9	2.4	2.0	2.8	2.7	0.8	4.1	9.1	8.8	4.4	6.0	2.9	1.7	8.7	8.7	4.0	2.5	1.5	3.9	1.3	8.7	3.7	1.1	4.3	2.1	1.3	6.6	3.7	2.6	1.1	8.5	5.4	2.6	5.8	9.4	3.2	2.8	2.4	1.7	2.7	3.3	9.6	1.8	2.8	4.6	6.0	6.6	2.6	2.3	3.4	2.0	1.7	1.0	5.0	1.2	3.4	2.4	1.9	2.5	1.6	7.5	2.8	3.0	3.0	2.9	2.9	3.8	2.5	4.5	1.5	1.5	2.6	5.1	2.7	1.3	4.5	3.4	4.0	6.5	1.4	2.2	3.6	3.4	6.3	3.5	2.3	4.0	2.3	5.3	3.6	4.0	1.8	2.9	4.5	2.1	2.5	5.6	7.1	1.9	6.2	1.6	3.2	1.6	4.1	3.7	3.2	4.2	2.7	4.5	2.2	5.5	1.7	0.4	0.0	1.8	0.6	0.0	0.6	0.8	0.4	0.6	0.5	0.8	1.4	1.0	0.0	0.6	0.6	1.1	0.4	8.8	9.1	11.5	12.4	9.1	8.8	8.7	8.7	8.7	8.5	9.4	9.6	0.5	0.0	0.0	2.0	0.7	2.3	0.5	0.6	0.0	0.8	1.6	1.4	2.0	1.5	0.4	3.7	0.0	0.2	1.6	0.8	0.0	0.7	15.6	1.1	0.6	0.9	0.0	0.0	2.0	0.6	0.5	0.6	0.0	1.3	0.0	2.3	0.4	1.0	0.6	1.7	1.5	0.5	2.0	0.3	2.1	3.1	0.0	0.9	1.8	1.0	0.4	1.4	3.1	1.0	1.3	0.8	0.1	0.4	1.3	1.2	0.4	1.3	0.5	1.1	0.0	1.0	0.6	0.9	1.1	0.5	2.6	0.1	0.9	0.4	0.6	1.0
TOB1	"APRO5, TOB, TROB, TROB1"	ENSG00000141232	"Transducer of ERBB2, 1"	P50616	17	50862223-50867978	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 253.3"	"Low region specificity"	"Detected in all"							HPA047839	Approved		Approved	Nucleoplasm,Vesicles		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Vesicles	"HPA047839: AB_2680175"	"unprognostic (3.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.19e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (5.04e-5)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (3.92e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.13e-2)"	"unprognostic (6.97e-2)"	42.6	210.2	32.6	22.3	34.9	70.2	65.3	31.6	40.8	55.3	59.3	47.4	56.1	23.9	26.5	77.7	54.6	47.6	44.7	29.8	39.4	67.9	168.6	36.8	18.9	37.3	48.2	63.4	207.9	81.4	50.1	13.8	38.6	72.3	57.5	101.8	99.8	92.2	178.6	133.5	48.1	29.4	31.8	17.8	87.5	26.0	33.4	17.7	95.4	109.9	21.0	81.9	70.9	40.2	44.1	88.7	28.1	11.5	51.4	25.4	22.0	31.9	79.2	20.5	25.0	36.0	54.6	40.0	60.6	43.9	20.7	61.0	19.5	54.1	21.1	20.4	29.3	4.8	100.7	60.5	72.0	21.5	18.9	54.5	65.5	23.9	120.0	27.3	9.9	12.2	17.0	33.7	43.4	119.0	16.1	19.4	10.2	109.4	33.9	14.0	35.6	47.6	80.9	89.4	16.6	40.4	55.1	158.9	19.9	42.5	253.3	27.1	13.2	23.3	16.7	26.7	15.8	51.9	57.7	18.5	19.2	10.2	9.1	417.7	53.5	285.6	245.8	107.3	269.9	40.7	222.7	192.5	119.1	31.9	192.1	233.6	130.7	28.8	152.5	38.5	206.0	169.0	32.6	34.9	31.6	40.8	29.8	39.4	37.3	48.2	38.6	31.8	33.4	40.2	101.6	115.4	118.3	71.8	53.1	283.2	232.9	119.8	284.0	125.3	180.6	179.6	115.5	210.1	81.8	68.0	56.3	20.8	124.8	183.3	103.7	42.6	97.9	143.7	51.7	40.7	203.4	18.1	11.5	54.1	2.0	83.5	123.3	176.2	63.9	19.7	33.2	205.6	35.4	18.5	14.1	223.2	48.8	27.6	249.2	40.4	26.4	89.9	71.2	5.6	29.1	118.3	20.6	16.6	34.1	41.8	186.7	59.8	41.3	187.2	126.2	60.4	87.8	62.7	164.3	137.3	123.8	36.9	12.1	153.8	230.7	10.9	154.7	77.4	167.6	287.2
TOPBP1	"Dpb11, KIAA0259, TOP2BP1"	ENSG00000163781	"DNA topoisomerase II binding protein 1"	Q92547	3	133598175-133662380	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 104.1;Spermatocytes: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022451, HPA036738, HPA036739"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"CAB022451: , HPA036738: AB_2675280, HPA036739: AB_2675281"	"unprognostic (7.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (2.05e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (8.03e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (2.74e-3)"	"unprognostic (8.65e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.60e-1)"	7.7	4.9	3.6	13.0	4.3	33.1	10.7	5.0	4.6	6.5	3.1	9.3	8.3	8.1	5.0	8.9	5.9	6.9	6.1	4.6	3.3	5.5	7.4	7.3	19.7	3.7	3.2	7.3	7.6	6.0	3.6	12.0	3.7	6.6	11.5	8.2	7.1	5.5	6.9	11.8	9.2	8.7	3.5	10.4	8.7	22.4	3.7	29.1	7.4	7.6	18.6	8.3	7.0	4.5	44.4	27.2	43.1	35.1	8.0	10.5	32.3	33.9	26.9	41.0	52.4	37.9	27.5	80.5	29.1	24.7	49.3	50.2	62.8	22.6	62.7	48.9	28.2	75.4	38.3	23.4	7.7	81.5	57.1	12.5	13.7	40.2	23.9	15.4	28.5	46.3	47.6	55.7	32.6	30.3	79.9	43.1	35.7	50.4	23.0	53.3	53.8	58.4	14.6	30.1	40.9	45.2	41.9	22.6	35.4	41.7	37.7	74.6	19.9	43.0	38.9	43.9	37.7	33.4	53.4	150.6	25.4	42.7	38.4	1.8	0.7	2.2	0.7	0.9	1.0	0.9	0.7	0.7	0.7	0.5	0.7	0.7	0.9	1.0	0.5	1.0	1.5	0.4	3.6	4.3	5.0	4.6	4.6	3.3	3.7	3.2	3.7	3.5	3.7	4.5	17.1	22.4	21.9	10.7	22.8	12.4	8.8	7.8	20.5	15.2	14.2	14.2	10.1	12.8	19.7	11.0	2.1	20.0	33.9	11.9	9.8	12.3	69.4	8.8	16.8	16.0	7.2	42.7	24.3	13.3	19.6	14.9	16.3	13.1	7.6	34.3	7.5	9.5	11.2	3.3	19.6	13.9	6.1	16.7	8.0	104.1	10.2	18.2	8.8	11.2	27.4	10.4	28.8	16.6	13.0	14.7	11.6	9.8	37.5	10.2	6.1	6.1	8.7	9.3	13.1	20.9	12.2	81.3	43.6	22.0	11.5	14.0	23.3	17.7	14.8	10.5
TP53BP1	"53BP1, p202, TDRD30"	ENSG00000067369	"Tumor protein p53 binding protein 1"	Q12888	15	43403061-43510728	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004083, HPA008788, HPA022133, CAB079980"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Mitotic chromosome,Vesicles"		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Nuclear bodies"	"Nucleoplasm, Mitotic chromosome, Vesicles"	"CAB004083: AB_10694558, CAB079980: , HPA008788: AB_1078070, HPA022133: AB_1844382"	"unprognostic (2.12e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.34e-2)"	"unprognostic (4.07e-1)"	"unprognostic (8.06e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.99e-2)"	"unprognostic (3.38e-2)"	6.9	11.5	17.4	10.1	16.6	11.5	10.7	19.9	14.5	17.7	21.5	9.7	6.4	16.0	15.9	6.1	14.7	10.7	8.8	15.4	26.3	9.1	4.1	8.3	8.6	13.5	16.7	16.8	7.4	22.3	24.1	12.2	15.7	12.1	10.2	22.0	10.1	12.8	7.2	9.2	6.4	16.3	9.6	8.7	7.6	21.6	23.0	15.3	17.9	11.0	12.6	11.2	8.7	12.1	13.5	22.3	63.8	40.1	25.8	31.9	15.8	22.8	33.8	31.0	39.1	19.4	15.8	14.5	19.2	39.0	66.9	32.4	46.3	27.5	36.8	38.9	15.8	27.1	40.1	11.7	16.8	30.2	37.4	24.9	19.0	41.8	31.2	51.7	37.4	24.2	26.9	12.3	36.5	9.6	23.7	14.1	41.1	24.2	13.9	25.1	23.9	9.3	22.9	31.8	57.3	26.8	33.8	14.3	8.5	48.6	29.9	16.9	27.5	33.7	22.3	27.0	20.5	9.8	22.4	33.0	27.6	14.6	17.5	1.4	0.5	1.0	1.6	0.7	1.3	1.9	1.6	1.6	1.2	1.8	1.8	1.6	0.6	0.9	0.5	1.3	1.4	0.7	17.4	16.6	19.9	14.5	15.4	26.3	13.5	16.7	15.7	9.6	23.0	12.1	11.5	22.4	22.3	53.2	17.8	6.4	10.2	10.0	13.6	32.4	17.4	13.2	14.9	5.7	20.8	29.5	47.9	13.4	11.1	7.4	9.8	14.5	38.8	47.0	44.8	16.8	41.9	8.4	66.2	7.1	11.2	23.9	14.8	26.8	26.6	47.0	15.0	3.3	10.8	47.1	81.9	15.7	12.2	3.8	6.9	17.8	23.6	9.3	1.8	17.8	4.0	11.9	7.2	62.8	50.4	7.5	5.8	17.7	17.1	11.0	2.6	8.8	60.7	51.7	13.1	35.2	20.5	33.1	36.2	14.7	5.3	18.5	17.0	29.9	13.4	8.9
TRIM49D1	"TRIM49D, TRIM49D1P, TRIM49DP"	ENSG00000223417	"Tripartite motif containing 49D1"	C9J1S8	11	89911111-89921767	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	285	"basophil: 28.5"	"Lineage enriched"	"Detected in single"	285	"granulocytes: 28.5"	"Not detected"	"Not detected"											HPA072153			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"				Nucleoplasm	Cytosol	"HPA072153: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM49D2	"TRIM49D2P, TRIM49L, TRIM49L1"	ENSG00000233802	"Tripartite motif containing 49D2"	C9J1S8	11	89924064-89933063	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	186	"basophil: 18.6"	"Lineage enriched"	"Detected in single"	186	"granulocytes: 18.6"	"Not detected"	"Not detected"											HPA072153			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"				Nucleoplasm	Cytosol	"HPA072153: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRMT10B	"bA3J10.9, FLJ31455, RG9MTD3"	ENSG00000165275	"TRNA methyltransferase 10B"	Q6PF06	9	37753803-37778972	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021800	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane"	"HPA021800: AB_1856214"	"unprognostic (1.00e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.68e-2)"	"unprognostic (7.78e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (5.49e-3)"	"unprognostic (1.71e-2)"	"prognostic favorable (5.34e-4)"	"unprognostic (1.40e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.33e-3)"	5.6	6.9	7.3	5.7	8.1	6.0	6.2	10.7	8.0	8.3	5.8	8.3	4.4	7.1	4.4	5.5	7.6	4.1	4.9	6.8	7.3	6.9	6.4	4.9	7.4	7.9	7.6	9.5	7.9	3.9	6.7	3.8	7.1	8.3	3.5	7.3	6.1	4.2	4.4	10.7	7.1	4.0	6.6	8.1	6.7	3.4	7.6	4.0	7.6	2.1	4.2	7.6	7.1	9.8	4.7	5.6	7.0	6.2	4.2	3.3	3.1	4.4	3.3	4.5	3.9	3.3	4.1	8.7	3.3	3.4	2.7	5.3	3.3	5.5	4.1	3.7	5.6	7.8	14.8	3.5	7.6	8.0	5.2	3.8	5.5	4.3	7.4	5.3	4.7	10.4	6.2	3.6	3.4	3.3	8.1	6.2	6.2	5.0	6.7	8.1	2.4	4.6	4.3	4.2	9.4	9.0	3.7	4.7	4.1	4.4	5.0	5.7	4.8	3.6	5.1	5.9	4.0	4.2	6.1	6.9	2.1	6.1	7.3	3.4	2.7	1.5	3.1	2.4	3.8	3.3	2.8	3.1	1.2	4.3	3.3	3.0	2.8	2.4	1.7	2.3	1.9	1.5	7.3	8.1	10.7	8.0	6.8	7.3	7.9	7.6	7.1	6.6	7.6	9.8	13.2	3.2	8.9	30.3	20.3	7.4	11.4	8.9	15.9	16.2	13.5	16.5	7.4	14.3	8.4	3.7	6.2	16.1	11.0	7.9	11.7	11.3	2.1	7.1	14.1	12.8	13.8	13.7	25.4	12.5	8.6	14.0	13.7	9.1	14.5	17.3	13.6	8.1	8.2	16.8	27.5	14.0	8.2	10.4	9.5	0.9	14.6	12.2	10.6	19.7	15.5	15.9	25.7	37.2	45.7	10.0	6.7	23.7	9.1	14.2	11.4	9.0	7.8	13.5	26.3	13.0	11.1	4.2	5.3	9.7	7.5	12.2	16.4	12.3	10.9	9.4
TRNT1	"CCA1, CGI-47, MtCCA"	ENSG00000072756	"TRNA nucleotidyl transferase 1"	Q96Q11	3	3126933-3150879	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036938	Uncertain		Supported	Mitochondria		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA036938: AB_10670566"	"unprognostic (6.39e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.22e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.02e-1)"	9.7	10.0	7.2	8.9	7.2	3.5	8.5	7.9	8.0	7.8	7.0	8.1	4.4	8.8	5.5	9.4	7.6	8.3	8.4	7.4	7.2	17.2	10.0	8.4	9.7	7.1	7.3	8.3	8.4	8.3	10.3	10.5	7.1	11.3	7.6	4.0	7.7	6.3	9.3	6.4	7.9	8.3	7.3	10.7	9.1	6.5	7.4	9.8	11.3	7.6	10.9	13.1	7.9	8.0	20.0	29.6	18.2	9.8	24.1	21.5	20.5	19.9	17.4	21.6	20.9	25.0	20.9	35.6	12.8	22.4	32.0	12.6	24.6	18.6	26.5	24.6	13.3	28.7	25.3	24.9	31.4	32.2	20.8	17.9	25.0	20.2	6.8	15.0	21.0	24.1	25.1	9.8	35.9	37.2	22.0	21.4	15.2	29.2	19.0	20.5	28.1	32.5	26.1	25.8	10.8	15.9	31.6	20.6	18.5	26.3	18.7	16.3	14.8	22.8	18.7	23.6	25.7	12.6	31.4	43.4	17.2	27.6	25.0	49.4	12.4	36.4	16.4	18.1	16.0	25.8	20.8	18.1	16.8	15.7	22.7	20.1	16.6	19.8	19.0	15.6	18.6	11.2	7.2	7.2	7.9	8.0	7.4	7.2	7.1	7.3	7.1	7.3	7.4	8.0	20.7	16.0	13.4	15.3	30.2	14.8	29.0	19.9	24.5	13.5	12.1	11.0	14.3	2.8	16.3	18.4	14.6	25.8	23.5	10.6	45.0	19.1	2.3	15.8	19.0	21.1	8.4	16.6	23.8	9.9	17.8	19.9	23.4	12.0	22.8	20.7	12.5	9.2	13.3	10.1	27.0	10.7	16.2	11.0	13.3	2.9	10.8	13.3	7.2	23.4	20.3	17.1	18.6	23.6	34.7	10.6	9.2	8.6	30.7	30.9	11.0	32.7	11.4	15.7	0.0	14.9	17.4	20.8	17.9	23.4	13.1	28.3	22.0	24.7	13.5	23.9
TSG101	"TSG10, VPS23"	ENSG00000074319	"Tumor susceptibility 101"	Q99816	11	18468336-18526951	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Growth regulation, Host-virus interaction, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 296.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004283, HPA006161"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Nucleoli, Plasma membrane"	"CAB004283: AB_671392, HPA006161: AB_1080408"	"unprognostic (1.42e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.72e-3)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (5.67e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.15e-3)"	"unprognostic (4.27e-2)"	"prognostic favorable (5.52e-6)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.02e-3)"	"unprognostic (1.06e-1)"	40.4	55.6	41.1	32.2	42.2	60.8	56.6	43.1	50.8	44.8	45.7	49.5	42.8	40.2	56.3	56.7	49.3	36.5	68.2	42.1	44.5	70.1	62.3	43.9	42.9	42.4	42.3	44.6	45.4	61.5	36.5	61.4	42.4	43.1	59.0	43.6	46.4	41.1	77.1	47.2	43.4	42.9	43.9	34.0	45.4	55.5	41.8	45.9	52.4	83.0	57.4	46.9	42.2	46.5	51.3	79.1	73.7	51.1	82.2	85.4	63.7	77.1	103.0	92.2	90.3	54.3	27.5	65.5	49.2	86.4	103.7	77.0	74.0	70.3	102.0	95.4	87.7	41.1	38.6	79.7	106.3	64.6	69.8	75.0	139.9	48.6	131.6	102.2	76.8	68.4	66.9	55.2	112.7	85.7	45.7	66.8	45.1	115.6	81.5	37.0	72.5	54.7	63.6	68.8	52.2	88.6	75.7	61.6	101.1	77.1	59.7	64.8	43.1	63.0	38.0	126.4	59.4	37.2	76.0	56.9	64.5	34.2	80.5	187.8	69.8	155.7	50.4	81.6	52.4	78.5	48.0	54.0	66.1	69.2	51.5	54.9	123.6	57.9	114.3	54.5	84.4	91.1	41.1	42.2	43.1	50.8	42.1	44.5	42.4	42.3	42.4	43.9	41.8	46.5	63.0	64.1	57.5	22.9	44.4	42.6	81.5	159.2	26.7	41.0	39.2	42.2	68.0	42.9	90.4	44.1	25.0	191.9	34.2	85.5	125.2	112.4	48.0	58.4	36.0	54.4	61.6	74.5	29.1	101.3	107.7	48.6	32.6	48.9	44.9	46.2	47.2	36.0	79.6	37.0	28.4	65.0	156.6	45.2	33.6	21.2	56.2	51.6	56.9	26.2	82.3	86.1	54.6	32.2	32.8	132.7	76.2	43.2	47.0	103.0	72.2	126.8	113.4	43.3	46.0	44.7	81.2	177.6	153.7	32.8	48.4	296.1	38.1	91.5	47.8	97.4
TTC19	"FLJ20343, MGC19520"	ENSG00000011295	"Tetratricopeptide repeat domain 19"	Q6DKK2	17	15999784-16045015	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Electron transport, Respiratory chain, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 5.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023010, HPA052380"	Enhanced		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA023010: AB_1858429, HPA052380: AB_2681806"	"unprognostic (1.04e-2)"	"unprognostic (4.90e-3)"	"unprognostic (2.87e-2)"	"unprognostic (4.80e-3)"	"unprognostic (8.09e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.14e-2)"	"prognostic favorable (5.67e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.22e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.24e-1)"	6.6	11.4	8.1	3.8	7.8	11.2	7.5	19.4	11.6	6.9	8.4	8.0	10.3	6.9	5.2	6.8	5.8	5.2	8.6	8.8	9.6	8.7	7.7	6.6	4.6	7.9	7.4	6.9	12.4	11.2	8.0	5.8	7.9	6.8	5.7	9.9	9.1	4.2	8.8	9.5	9.8	3.8	6.3	4.5	8.4	3.6	8.0	3.9	10.6	4.4	3.3	6.3	6.7	10.5	7.0	4.1	7.6	12.1	6.4	5.6	4.0	3.1	4.6	3.1	3.8	6.5	12.8	8.9	9.8	4.3	4.6	9.1	9.9	8.3	3.8	12.5	10.2	8.2	9.2	6.3	9.1	9.3	11.6	5.6	7.0	2.6	11.4	9.6	7.1	12.4	4.6	7.7	6.8	7.6	7.5	6.8	10.0	11.8	3.0	7.8	8.0	8.2	11.6	10.5	6.6	5.5	7.6	9.8	16.6	24.6	6.9	4.6	13.1	4.2	1.2	6.1	7.5	4.8	1.5	4.2	9.8	9.8	9.5	5.2	0.7	1.8	0.7	0.7	1.2	0.9	0.9	1.2	0.7	1.1	1.0	1.3	0.7	0.6	0.7	1.1	1.0	0.4	8.1	7.8	19.4	11.6	8.8	9.6	7.9	7.4	7.9	6.3	8.0	10.5	51.0	41.7	38.6	69.5	60.8	105.3	83.5	30.8	70.6	147.8	65.1	47.9	34.8	42.9	35.4	46.0	143.9	75.7	62.8	59.7	70.5	50.0	59.4	49.4	41.5	60.3	45.6	32.4	115.1	41.2	41.9	34.2	43.8	67.9	31.1	46.8	42.8	36.0	25.6	129.5	100.9	52.3	26.4	25.8	76.7	7.2	41.0	46.5	55.2	35.6	34.8	73.9	70.0	54.3	57.8	47.7	57.9	33.4	34.5	89.1	75.4	47.1	26.5	180.4	46.0	56.5	40.2	30.2	31.1	56.9	116.8	65.5	68.9	69.9	63.3	72.7
TTC30B	"fleer, FLJ30990, IFT70B"	ENSG00000196659	"Tetratricopeptide repeat domain 30B"	Q8N4P2	2	177548998-177552796	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 43.3;Spermatocytes: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA051714, HPA052100, HPA052487"	Supported		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Centrosome	"HPA051714: AB_2681583, HPA052100: AB_2681726, HPA052487: AB_2681848"	"unprognostic (5.76e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.15e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.61e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.65e-1)"	1.7	1.6	1.7	1.8	1.8	0.8	5.3	1.8	1.8	3.4	3.3	3.3	2.6	3.3	6.8	2.0	10.3	2.1	1.7	1.6	1.7	4.9	2.5	3.2	2.2	2.3	2.6	3.4	2.4	5.1	1.6	1.7	2.1	2.8	3.0	5.2	3.7	3.2	0.4	2.4	2.9	2.5	2.5	2.3	3.9	7.0	2.0	3.2	8.2	0.5	2.4	1.9	0.8	2.6	2.5	3.7	4.7	0.9	4.1	4.8	3.2	1.4	4.5	3.9	4.1	2.1	6.1	0.9	3.9	2.8	4.5	6.0	5.7	6.2	3.7	1.4	2.8	1.7	2.2	1.8	3.5	2.2	2.9	4.0	5.7	3.8	2.9	4.7	3.1	4.5	2.3	0.8	2.3	4.2	4.4	3.4	2.2	3.3	0.9	3.4	4.1	1.0	5.9	2.7	11.4	6.2	1.8	4.1	2.9	6.4	4.2	4.2	2.7	2.1	1.1	2.8	1.2	2.1	2.6	0.3	4.9	0.9	3.7	2.7	1.4	1.2	0.6	1.3	0.4	0.5	0.4	0.7	1.6	1.4	0.8	0.8	0.8	0.9	1.0	1.1	0.4	0.7	1.7	1.8	1.8	1.8	1.6	1.7	2.3	2.6	2.1	2.5	2.0	2.6	1.8	3.2	4.6	1.3	2.8	0.6	0.6	5.0	2.8	2.2	3.1	2.8	1.4	5.7	7.9	0.0	2.1	2.5	0.4	4.8	5.9	4.8	10.8	12.8	3.7	2.5	1.2	1.3	0.7	2.7	1.1	3.3	5.1	1.9	1.3	3.2	2.5	2.8	1.2	5.0	0.8	2.4	6.1	1.3	0.6	6.6	1.5	1.3	1.8	1.9	1.4	7.2	4.1	1.5	1.1	2.6	0.5	2.2	4.1	0.6	2.6	5.3	43.3	11.5	0.0	2.7	1.8	24.5	3.7	2.3	0.9	0.5	1.3	5.4	1.8	0.2
TXNRD1	"GRIM-12, Trxr1, TXNR"	ENSG00000198431	"Thioredoxin reductase 1"	Q16881	12	104215779-104350307	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 459.7;Prostatic glandular cells: 557.4;Urothelial cells: 488.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 1452.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001395, CAB004607, CAB015834, HPA043871"	Approved		Supported	Nucleoplasm		NA	NA		6100000	"Cluster 46: Basophils - DNA binding"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB004607: AB_628405, CAB015834: , HPA001395: AB_1858377, HPA043871: AB_2678709"	"unprognostic (2.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.80e-2)"	47.1	148.1	22.5	40.6	21.1	64.7	28.0	20.9	22.6	28.0	37.3	50.9	58.4	47.9	21.0	30.7	39.0	55.9	65.8	21.1	29.8	37.9	46.5	63.0	34.4	55.2	26.7	34.1	19.0	33.8	21.2	39.1	33.3	41.0	45.6	20.1	20.8	60.6	67.8	12.4	39.4	51.6	22.9	27.8	52.1	37.8	24.6	42.8	30.4	64.0	34.1	141.6	30.1	25.7	228.4	1032.6	118.1	111.3	553.5	308.0	409.8	412.4	259.3	182.7	186.8	110.5	329.4	169.3	187.0	1452.6	682.1	77.7	235.7	158.6	214.1	82.7	101.8	143.1	765.8	468.0	885.7	226.3	149.9	176.9	159.8	403.7	128.1	557.1	634.0	227.9	200.5	77.5	276.8	109.1	233.4	102.7	114.4	453.0	1053.1	227.3	82.1	146.5	211.2	123.1	182.6	110.6	333.3	519.1	325.2	222.6	123.2	131.4	854.5	89.3	183.7	201.3	341.2	84.8	179.9	254.5	186.8	122.5	538.0	109.4	29.9	69.7	23.6	39.0	26.9	21.3	21.6	23.9	39.5	14.5	19.1	16.7	102.6	24.4	48.4	25.2	19.8	27.6	22.5	21.1	20.9	22.6	21.1	29.8	55.2	26.7	33.3	22.9	24.6	25.7	26.0	64.1	67.5	50.3	27.6	104.0	459.7	41.3	40.9	28.1	19.4	16.3	66.2	32.9	79.3	16.5	22.9	26.1	40.4	93.4	41.1	79.6	45.0	100.9	36.8	116.2	20.4	46.3	48.2	80.7	34.3	90.1	69.8	119.6	53.2	35.2	49.2	68.2	42.0	28.6	56.7	18.8	44.7	43.5	100.5	19.1	68.0	62.2	19.6	49.6	51.9	24.8	26.8	29.1	55.3	197.7	40.5	29.3	28.4	557.4	24.6	37.5	105.5	20.9	0.0	43.4	84.0	14.4	33.8	24.3	72.9	51.3	28.5	98.4	33.0	488.0
UGDH		ENSG00000109814	"UDP-glucose 6-dehydrogenase"	O60701	4	39498755-39528311	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Allosteric enzyme, Oxidoreductase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 137.7"	"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 345.5;Hepatocytes: 231.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 509.6;Hep G2: 595.9;U-2197: 375.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034444, HPA036656, HPA036657"	Enhanced		Supported	Nucleoplasm		Yes	No		1300000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"CAB034444: AB_2019602, HPA036656: AB_10671706, HPA036657: AB_10672360"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.96e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.78e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.81e-3)"	"unprognostic (6.86e-2)"	"prognostic unfavorable (5.51e-10)"	"unprognostic (2.48e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.97e-2)"	48.5	27.8	6.2	29.5	7.3	2.4	32.0	9.4	9.2	31.5	18.1	96.5	45.3	29.1	10.6	34.1	29.6	40.5	16.0	5.9	8.3	37.5	137.7	19.0	13.3	7.4	7.7	30.0	33.7	23.1	7.8	38.4	8.0	35.6	73.3	14.3	16.8	14.0	6.7	9.9	41.1	23.5	7.6	11.5	47.4	6.8	8.4	10.3	27.8	9.5	14.5	54.4	17.1	9.7	36.0	509.6	58.4	76.2	181.5	185.3	51.3	102.7	113.8	94.5	84.8	76.2	115.5	25.4	63.0	133.3	94.5	33.5	56.0	29.5	95.8	32.1	13.0	26.2	65.4	595.9	72.7	34.1	25.3	64.4	14.9	160.2	49.8	78.9	59.3	20.9	34.1	17.3	67.9	89.8	29.4	34.4	53.1	194.0	46.4	48.3	95.0	22.0	53.7	120.0	31.2	46.7	69.2	37.9	45.3	41.4	21.0	27.0	85.9	97.9	49.1	375.8	54.2	42.1	33.3	23.3	86.9	25.8	56.6	30.0	20.9	19.7	23.2	18.4	37.8	18.8	18.8	24.9	19.0	18.4	16.1	19.4	3.8	42.3	11.2	22.5	13.5	18.8	6.2	7.3	9.4	9.2	5.9	8.3	7.4	7.7	8.0	7.6	8.4	9.7	19.1	25.6	27.6	4.6	14.1	116.1	73.4	19.5	43.9	7.5	115.8	62.0	8.9	24.3	25.4	20.2	14.6	21.3	12.9	207.8	70.5	54.7	1.1	78.3	53.8	25.4	113.3	9.1	10.6	345.5	78.8	145.7	184.0	64.8	35.5	11.1	20.7	231.3	17.8	10.1	12.6	114.5	12.2	20.2	33.3	1.6	33.2	12.7	30.2	7.5	19.9	7.3	9.2	46.3	12.8	195.8	112.2	29.0	21.3	127.3	81.4	79.6	65.7	9.2	32.9	39.0	57.5	6.5	5.5	102.2	40.1	29.0	11.7	12.4	152.4	86.4
UGT2B11		ENSG00000213759	"UDP glucuronosyltransferase family 2 member B11"	O75310	4	69199951-69214748	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"breast: 239.4"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 13.7;Cholangiocytes: 7.2"	"Group enriched"	"Detected in some"	17	"breast cancer: 17.4;liver cancer: 13.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	42	"basophil: 4.7;eosinophil: 3.5"	"Lineage enriched"	"Detected in single"	47	"granulocytes: 4.7"	"Not detected"	"Not detected"											HPA045108	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 5: Breast - Unknown function"		"Cluster 35: Glandular cells - Unknown function"			"HPA045108: AB_2679218"	"unprognostic (1.12e-1)"						"unprognostic (1.18e-3)"			"unprognostic (1.49e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-3)"	0.1	0.0	0.0	0.1	0.0	0.1	239.4	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.9	0.0	0.5	11.4	0.0	0.0	0.0	3.6	9.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.5	0.0	7.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1
UHRF2	"MGC33463, NIRF, RNF107, TDRD23, URF2"	ENSG00000147854	"Ubiquitin like with PHD and ring finger domains 2"	Q96PU4	9	6413151-6507054	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 78.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026633, HPA026697"			Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA026633: AB_2732431, HPA026697: AB_2732432"	"unprognostic (1.08e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.14e-2)"	"unprognostic (6.21e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.50e-1)"	10.0	8.1	8.2	9.9	10.3	44.6	9.7	14.9	10.4	12.9	10.4	11.6	6.2	12.9	10.0	8.3	9.9	7.9	7.2	8.7	9.2	8.1	7.9	7.8	17.3	9.4	8.6	12.4	10.7	9.7	5.4	12.1	9.4	15.3	9.2	9.2	8.5	12.6	11.0	7.7	8.5	14.0	8.8	10.4	8.3	8.4	10.0	21.2	8.1	11.9	16.6	11.4	10.1	14.3	18.1	18.8	26.7	11.9	21.4	30.7	20.5	43.9	23.4	23.7	41.2	12.4	12.0	26.9	9.2	19.2	21.8	11.9	24.6	22.5	36.0	53.6	14.9	46.3	36.2	19.7	17.8	19.3	16.1	13.5	14.1	18.4	44.5	44.4	93.2	25.4	5.1	24.0	56.0	5.9	37.0	79.2	10.8	24.8	14.8	43.1	12.4	8.7	17.2	11.3	24.8	9.4	16.6	11.0	25.6	32.1	14.0	41.9	78.6	25.2	10.0	11.0	34.4	7.2	23.2	30.4	12.4	18.2	10.2	4.0	0.5	2.7	1.2	0.5	0.8	1.8	1.8	1.0	0.3	2.9	1.0	1.2	0.5	0.6	0.9	1.2	1.9	0.6	8.2	10.3	14.9	10.4	8.7	9.2	9.4	8.6	9.4	8.8	10.0	14.3	27.5	6.4	14.4	24.2	33.9	21.5	10.2	6.2	12.0	22.0	13.8	13.1	59.0	4.3	8.4	12.9	31.3	13.2	31.3	9.1	1.9	5.2	23.6	12.8	22.9	24.1	7.1	34.9	44.2	4.0	9.9	16.0	20.9	24.5	17.7	27.8	12.8	14.6	10.7	28.6	53.3	14.8	4.1	12.6	9.3	8.1	19.3	15.6	21.4	51.5	12.5	6.4	16.5	46.8	78.6	6.2	14.4	14.7	30.1	16.0	10.2	7.3	6.3	34.8	13.1	14.4	18.8	46.2	23.4	16.1	19.0	5.9	29.0	13.7	12.6	9.8
USF3	KIAA2018	ENSG00000176542	"Upstream transcription factor family member 3"	Q68DE3	3	113648385-113696646	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029243, HPA029245"	Uncertain		Uncertain	Nucleoplasm,Nucleoli,Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	Centrosome	"HPA029243: AB_10611114, HPA029245: AB_10600443"	"unprognostic (2.80e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.21e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.74e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.55e-2)"	7.1	4.9	5.6	3.0	5.9	10.2	6.7	8.8	8.0	5.5	7.5	7.5	2.8	5.3	7.8	6.8	6.2	2.4	7.0	6.2	5.3	8.2	16.4	5.9	5.3	5.4	5.4	5.8	8.5	6.0	6.7	2.8	5.6	5.9	3.9	5.6	6.4	2.7	18.7	7.4	8.3	2.4	5.2	8.7	7.5	4.8	5.3	6.7	6.2	8.5	4.6	6.0	6.1	6.8	4.6	3.4	4.1	3.9	9.8	3.7	2.8	1.8	2.9	1.7	1.6	3.2	1.9	8.0	3.2	4.6	2.8	2.8	4.5	3.6	3.3	2.7	1.9	5.7	2.2	5.3	2.9	10.5	6.2	5.5	6.4	3.2	3.6	2.6	4.2	5.9	2.7	4.1	3.7	6.4	5.9	5.8	3.0	6.1	3.4	2.5	3.2	3.2	6.3	6.3	1.9	3.0	4.3	2.4	5.5	2.8	3.3	7.7	5.7	2.7	6.0	1.5	2.6	4.8	2.9	9.2	3.1	4.3	2.0	2.2	1.0	1.7	1.3	1.3	1.0	1.0	0.9	1.0	0.8	2.3	1.1	1.2	3.2	1.2	1.8	2.3	0.5	0.7	5.6	5.9	8.8	8.0	6.2	5.3	5.4	5.4	5.6	5.2	5.3	6.8	27.1	22.4	15.1	0.0	30.1	0.0	11.2	0.0	15.9	19.5	19.7	12.6	0.0	14.3	6.2	25.8	14.6	8.1	42.7	13.1	25.4	8.4	6.7	28.3	18.6	15.6	6.1	17.0	0.0	11.8	4.2	13.3	18.3	22.8	5.1	6.7	20.3	46.3	7.8	13.5	0.0	10.2	0.0	22.6	0.0	10.9	13.1	17.0	0.0	0.0	16.4	12.4	29.9	0.0	0.0	12.5	12.4	13.9	17.5	18.4	23.6	29.2	12.4	18.8	6.6	27.6	13.8	13.1	6.0	15.8	0.0	14.5	20.0	12.2	10.9	19.5
VAMP7	"SYBL1, TI-VAMP, VAMP-7"	ENSG00000124333	"Vesicle associated membrane protein 7"	P51809	X	155881345-155943769	"Predicted intracellular proteins, Predicted membrane proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA036733	Approved		Supported	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"HPA036733: AB_10672228"	"unprognostic (7.54e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.15e-3)"	"unprognostic (2.70e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.95e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (2.83e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.97e-1)"	29.4	24.3	17.8	24.1	20.6	37.1	23.8	22.3	24.9	23.2	18.3	22.9	23.4	21.4	15.5	22.6	16.5	22.2	19.6	18.1	21.4	39.2	47.9	24.8	26.4	20.7	20.5	17.9	14.3	32.3	8.7	40.5	21.5	21.4	24.4	10.3	17.3	20.1	21.9	20.1	27.5	28.2	20.4	21.8	18.4	14.9	19.9	29.9	24.4	24.1	28.6	25.6	15.9	23.0	72.9	31.3	21.0	43.6	57.0	54.3	56.3	55.3	49.1	49.0	98.4	33.8	46.5	100.6	100.0	66.9	55.5	25.5	47.6	38.9	64.5	42.3	41.6	41.8	43.1	24.3	63.6	86.9	62.8	50.9	37.9	54.8	49.8	42.8	55.4	43.5	91.1	54.2	56.0	36.5	34.1	48.8	15.0	54.1	45.3	25.5	41.2	75.3	65.6	36.2	16.0	46.0	32.7	32.6	49.6	54.8	31.9	71.8	58.4	44.8	46.7	65.0	79.6	123.8	167.8	138.9	39.2	104.4	51.0	86.8	25.3	39.6	15.1	27.0	19.1	12.3	17.7	18.6	26.4	13.2	16.2	17.5	21.9	22.7	26.7	15.0	22.0	22.4	17.8	20.6	22.3	24.9	18.1	21.4	20.7	20.5	21.5	20.4	19.9	23.0	17.8	3.2	9.2	11.1	21.2	19.6	14.7	11.8	20.5	7.6	16.6	9.5	12.3	5.7	12.5	7.3	6.2	48.4	24.9	14.1	41.1	28.0	6.9	13.8	14.5	19.8	13.2	31.4	14.2	26.0	49.7	19.6	12.2	13.7	31.1	22.5	20.3	25.1	31.1	6.7	14.6	12.8	10.2	30.8	49.0	6.9	17.7	35.9	19.6	7.5	32.5	10.4	29.9	8.0	19.2	29.9	13.5	19.5	15.2	17.5	25.3	52.9	10.5	4.6	26.3	10.8	18.9	45.4	26.3	20.3	19.5	69.8	21.6	25.3	15.3	20.1
VAT1	"FLJ20230, VATI"	ENSG00000108828	"Vesicle amine transport 1"	Q99536	17	43014607-43025123	"Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 133.2;Hofbauer cells: 146.4;Melanocytes: 122.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 295.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"basophil: 104.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 104.0"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 680.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045170	Uncertain					NA	NA		2700000	"Cluster 46: Basophils - DNA binding"	"Cluster 31: Skin - Epidermis development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA045170: AB_10964166"	"unprognostic (2.22e-2)"	"unprognostic (4.41e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.67e-2)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.16e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.38e-1)"	"prognostic favorable (5.89e-4)"	"unprognostic (1.71e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.36e-2)"	180.4	251.5	53.6	32.1	57.6	86.5	137.5	55.3	67.3	160.8	54.8	97.5	25.7	121.4	65.0	132.6	78.4	85.6	74.7	47.3	129.9	70.5	44.5	111.7	29.0	88.4	132.3	184.8	67.2	54.7	103.7	83.9	173.9	64.9	32.9	7.6	86.3	52.2	29.2	194.3	65.1	94.2	60.5	40.3	56.1	79.2	93.3	63.7	68.3	45.8	33.7	109.5	126.3	77.3	38.9	225.0	53.6	119.0	556.9	435.5	75.5	94.2	282.1	89.7	167.1	139.7	83.2	7.7	128.8	395.8	283.7	58.9	94.1	81.6	82.7	14.4	127.6	36.2	107.3	279.5	357.7	177.6	271.5	234.3	119.2	154.0	71.2	203.8	428.9	230.5	77.3	12.1	227.3	37.2	262.2	76.6	68.1	111.6	106.2	37.3	66.1	19.4	102.2	76.6	50.0	94.6	51.3	29.5	680.8	217.9	82.5	99.4	431.7	199.9	92.5	226.2	22.9	19.4	30.2	14.3	203.1	132.0	31.4	104.0	16.6	24.9	13.1	7.9	15.3	19.9	18.5	13.6	8.4	19.5	16.8	10.4	5.1	11.1	9.2	4.1	13.4	19.0	53.6	57.6	55.3	67.3	47.3	129.9	88.4	132.3	173.9	60.5	93.3	77.3	133.2	22.4	13.9	1.0	17.2	28.4	14.2	17.9	34.1	1.1	29.5	30.2	31.6	17.2	10.7	23.9	4.2	6.5	6.5	9.2	17.6	99.7	27.5	14.2	32.5	71.0	15.1	12.6	2.3	43.4	45.1	91.4	8.2	32.6	77.2	93.8	73.9	15.8	146.4	5.0	2.4	4.1	4.1	40.0	32.4	45.2	51.9	43.9	122.7	6.5	16.1	4.2	3.1	3.5	4.1	49.6	10.4	58.6	19.6	25.5	36.5	60.1	12.6	1.8	13.1	19.4	39.1	12.8	15.5	35.1	33.5	11.1	12.6	31.2	4.7	21.8
VCP	"CDC48, IBMPFD, p97, TERA"	ENSG00000165280	"Valosin containing protein"	P55072	9	35053928-35072668	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair, Transport, Ubl conjugation pathway"	Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 540.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005593, HPA012728, HPA012814"	Supported		Enhanced	Nucleoplasm,Cytosol		No	No		34000000	"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Cytosol"		"CAB005593: AB_2214638, HPA012728: AB_1858730, HPA012814: AB_1858729"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.15e-2)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.78e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.24e-1)"	"prognostic favorable (9.63e-7)"	"unprognostic (1.83e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (9.11e-2)"	59.8	88.4	56.8	33.7	59.0	52.0	54.2	58.9	58.0	57.8	72.0	51.8	33.8	59.0	51.6	84.9	49.4	35.3	117.5	60.4	66.2	59.1	87.5	57.2	42.5	64.4	62.0	46.1	61.2	65.7	57.3	46.0	68.2	54.5	36.5	26.3	63.2	58.9	176.0	64.0	51.8	42.5	62.3	64.1	62.5	45.1	63.7	59.6	49.7	135.3	53.3	57.9	55.3	69.8	167.6	223.8	124.6	57.5	187.4	135.3	98.3	153.8	215.0	244.1	197.6	160.0	60.1	140.8	137.2	242.9	173.1	69.5	253.1	230.7	227.6	146.2	126.0	95.3	216.5	238.0	146.5	92.4	106.2	148.5	136.4	239.2	115.6	104.4	276.2	56.3	97.6	71.4	219.2	154.7	114.3	234.9	152.2	82.7	219.1	80.7	111.8	72.8	204.1	175.7	65.7	84.1	100.4	81.2	45.1	152.2	71.5	60.3	215.5	77.5	112.5	63.7	118.6	41.9	116.5	104.3	139.5	67.0	105.4	142.0	62.7	75.0	58.8	70.0	62.4	59.2	59.0	65.6	75.3	53.0	42.3	44.4	71.1	67.1	80.4	49.8	91.2	111.8	56.8	59.0	58.9	58.0	60.4	66.2	64.4	62.0	68.2	62.3	63.7	69.8	86.5	80.1	73.7	22.9	124.3	77.0	120.8	147.6	111.5	86.6	66.0	47.2	220.4	47.1	115.1	55.2	118.9	276.8	91.0	111.9	74.3	188.6	43.6	97.8	85.6	127.7	84.2	137.0	27.4	187.5	164.7	109.7	133.5	105.8	62.1	106.2	111.0	126.0	133.1	74.0	27.7	108.3	89.5	57.9	65.6	47.0	83.9	81.5	76.5	16.9	159.6	88.7	54.6	18.6	31.4	247.9	69.0	86.9	267.6	118.3	77.2	113.4	102.5	90.0	138.1	74.1	154.9	144.5	118.7	126.2	90.6	540.6	105.4	129.6	96.4	135.6
VPS37A	"FLJ32642, HCRP1, PQBP2, SPG53"	ENSG00000155975	"VPS37A subunit of ESCRT-I"	Q8NEZ2	8	17246931-17302427	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024705, HPA024781"	Supported		Approved	Vesicles,Centrosome,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles	"Centrosome, Cytosol"	"HPA024705: AB_10601776, HPA024781: AB_10602100"	"unprognostic (8.28e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.39e-3)"	"unprognostic (3.91e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.88e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.18e-1)"	18.9	19.4	11.9	14.8	15.1	15.4	18.5	28.7	17.5	21.1	5.0	16.8	20.9	19.4	14.3	20.2	13.7	16.8	36.2	10.1	13.6	25.0	27.8	16.2	14.2	11.2	12.5	18.4	17.5	33.8	12.4	29.7	12.1	20.2	17.2	55.0	12.5	23.2	39.4	14.7	17.5	24.4	10.0	12.3	14.5	32.3	12.2	17.5	18.9	31.2	15.2	25.1	15.0	18.4	17.2	27.3	24.0	21.7	51.8	41.5	25.8	60.8	50.2	53.9	45.9	17.6	16.2	14.6	31.6	48.7	50.1	16.7	27.2	26.4	63.8	15.1	7.8	26.5	13.7	20.2	59.7	11.3	25.1	39.7	50.2	50.4	51.5	38.0	38.7	22.7	20.2	36.8	57.7	11.7	32.0	26.9	23.4	38.2	14.2	15.4	26.5	17.6	45.8	23.4	27.1	14.4	23.8	23.9	37.9	47.1	15.6	22.2	33.4	33.1	16.7	47.6	32.0	12.0	25.0	17.2	37.5	19.9	33.8	34.0	17.2	16.5	13.9	13.1	17.1	10.5	13.4	13.6	13.4	10.8	12.0	14.8	17.6	24.5	12.4	11.8	13.3	14.1	11.9	15.1	28.7	17.5	10.1	13.6	11.2	12.5	12.1	10.0	12.2	18.4	31.8	16.0	15.6	19.6	21.2	39.5	32.7	33.1	18.8	26.4	19.3	13.5	40.7	14.3	25.8	7.3	58.4	36.1	20.5	15.8	37.2	29.3	93.2	20.9	29.0	24.6	18.0	26.1	32.4	15.5	59.2	27.0	15.8	28.4	9.5	16.8	24.3	23.1	44.6	21.9	30.7	16.6	30.5	17.5	22.7	39.6	25.7	25.3	21.4	20.6	22.4	25.8	15.5	24.1	34.0	31.2	13.1	25.9	21.5	50.6	27.8	48.8	18.8	60.2	26.3	21.5	36.6	111.6	43.4	22.5	37.8	113.0	22.7	17.1	14.6	52.6
VPS54	"HCC8, PPP1R164"	ENSG00000143952	"VPS54 subunit of GARP complex"	Q9P1Q0	2	63892146-64019428	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 81.8;Microglial cells: 76.8;Oligodendrocyte precursor cells: 105.6;Oligodendrocytes: 108.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055894, HPA067981, HPA070582"			Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	Nucleoplasm	"HPA055894: AB_2682961, HPA067981: AB_2685938, HPA070582: AB_2686282"	"unprognostic (1.35e-1)"	"unprognostic (3.37e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.47e-3)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (2.03e-4)"	"unprognostic (3.20e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.91e-2)"	11.7	11.5	8.1	10.6	9.7	15.0	14.5	13.5	9.6	13.5	10.9	11.6	13.0	14.4	12.3	10.8	12.4	10.4	8.4	7.8	8.5	16.0	14.4	13.1	11.1	8.8	8.7	14.6	17.0	28.3	13.0	13.5	8.9	17.4	13.4	17.3	36.8	12.8	9.3	10.9	12.2	12.8	8.5	12.9	14.4	13.4	8.5	13.2	17.7	9.9	11.2	10.9	9.8	11.0	23.3	11.9	22.5	17.4	15.7	17.1	16.6	14.3	21.4	15.0	14.9	22.0	14.9	15.8	10.5	20.1	22.3	10.7	22.1	12.9	27.1	23.0	15.9	14.7	10.0	38.9	15.0	10.3	6.2	16.3	19.8	10.5	22.7	18.0	23.0	11.3	16.6	13.4	19.4	10.1	10.9	11.5	13.8	22.9	9.1	10.8	21.8	9.0	17.1	13.1	13.1	19.6	12.8	16.3	17.8	17.3	11.9	20.6	16.8	19.3	15.3	11.8	23.9	30.8	8.7	20.4	14.3	20.5	16.4	1.0	0.7	0.3	0.5	0.6	0.5	0.6	0.4	0.5	0.4	0.7	0.6	0.5	0.6	0.7	0.5	0.6	0.9	0.2	8.1	9.7	13.5	9.6	7.8	8.5	8.8	8.7	8.9	8.5	8.5	11.0	16.6	16.0	22.3	62.7	5.2	11.1	8.7	6.4	3.4	20.9	11.8	9.8	14.3	15.7	14.2	1.8	12.5	6.5	6.4	11.1	1.9	6.8	53.9	9.3	16.6	13.4	13.2	2.1	71.6	13.2	6.8	11.8	15.8	11.0	2.5	15.2	10.8	15.4	8.1	23.5	81.8	17.4	2.0	9.8	9.3	37.4	18.6	12.2	5.4	76.8	9.6	9.4	3.1	105.6	108.9	11.3	12.8	12.4	7.7	17.3	11.6	9.9	10.6	16.2	19.7	13.4	12.8	14.9	8.3	9.4	10.4	5.5	7.5	15.9	12.9	13.8
Z84488.1		ENSG00000285446	"Novel protein"		6	116399395-116463696	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 1.3;choroid plexus: 1.7"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.3;GAMG: 1.1;HDLM-2: 1.4;hTEC/SVTERT24-B: 1.0;Karpas-707: 1.6;RPMI-8226: 1.3"															NA	NA			"Cluster 46: Basophils - DNA binding"		"Cluster 44: HDLM-2 - Immune response"																						0.1	0.0	0.3	0.0	0.3	0.1	0.0	0.2	0.6	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.2	0.8	0.0	0.1	0.1	0.0	0.8	0.5	0.1	0.0	0.0		0.0	0.8	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.2	0.0	1.3	0.1	0.0	0.0	0.1	0.0		0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.4	0.0	0.0	0.0	0.3	0.0	1.1	0.5	0.0	0.7	0.3	1.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.3	0.0	0.2	0.0	0.0	0.9	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.2	0.6	0.2	0.8	0.8	0.5	0.8	0.6	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZBTB14	"ZFP161, ZNF478"	ENSG00000198081	"Zinc finger and BTB domain containing 14"	O43829	18	5289019-5297053	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050758, HPA070819"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA050758: AB_2681226, HPA070819: AB_2686316"	"unprognostic (5.28e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.72e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.90e-2)"	10.3	8.6	9.3	14.7	10.5	9.6	12.5	11.4	12.2	9.6	7.4	10.4	8.7	9.9	16.4	12.4	10.6	12.0	8.6	8.7	9.6	11.2	13.4	11.1	24.7	9.5	10.3	15.6	14.4	12.0	4.8	9.1	9.6	9.8	10.0	7.3	12.2	12.1	8.5	14.0	9.3	8.7	10.2	16.2	11.9	5.9	9.5	21.8	15.5	8.4	21.8	9.6	5.2	11.4	9.0	11.8	15.1	11.2	11.0	14.5	10.0	8.8	13.0	12.0	10.5	11.3	11.5	31.2	7.6	10.7	13.9	8.2	11.2	13.2	12.2	6.0	6.0	12.4	11.1	10.5	7.8	15.8	14.4	11.6	10.9	8.5	7.9	13.0	19.2	22.3	8.1	10.1	12.4	9.9	23.8	10.5	13.4	11.1	6.0	14.0	9.7	9.2	10.0	10.8	13.3	13.0	13.4	8.8	14.3	15.0	10.5	17.9	10.7	15.6	12.8	12.2	13.3	6.4	6.9	19.9	16.4	13.3	14.0	9.8	5.5	14.1	8.7	7.8	8.6	7.5	11.0	10.0	8.2	10.4	11.6	11.1	1.2	7.6	7.5	6.1	7.6	7.3	9.3	10.5	11.4	12.2	8.7	9.6	9.5	10.3	9.6	10.2	9.5	11.4	8.8	6.4	6.7	5.9	8.5	2.4	1.6	2.9	5.2	7.4	5.6	4.3	3.6	1.5	2.2	5.5	0.0	5.3	6.3	5.5	5.9	4.9	0.8	4.3	5.5	7.4	1.2	9.1	2.9	3.3	5.5	4.6	0.5	3.7	15.9	6.0	11.7	6.9	7.1	5.0	3.1	5.1	8.2	7.5	4.5	2.8	5.9	6.3	1.8	1.0	7.8	10.8	6.2	2.5	6.6	3.5	4.0	5.7	2.2	2.4	5.7	5.5	2.5	5.9	0.0	6.0	5.7	1.0	9.3	4.2	3.0	2.2	8.8	5.1	5.2	1.5
ZBTB34	"KIAA1993, MGC24652, ZNF918"	ENSG00000177125	"Zinc finger and BTB domain containing 34"	Q8NCN2	9	126860665-126885878	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023893	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA023893: AB_2219180"	"unprognostic (2.96e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.72e-3)"	"unprognostic (6.59e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.56e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.96e-2)"	"unprognostic (5.15e-2)"	"unprognostic (9.32e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.55e-2)"	"unprognostic (3.23e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.01e-2)"	3.8	2.7	4.9	4.3	6.1	14.7	3.7	7.6	5.3	3.1	2.8	3.5	3.0	3.6	3.1	3.2	3.2	3.9	3.1	4.2	4.8	3.3	2.9	5.3	4.8	5.9	6.2	3.6	3.2	3.7	3.5	6.7	5.6	3.0	2.9	12.7	4.4	2.9	3.3	4.1	3.7	3.1	5.4	5.4	3.8	3.0	6.0	4.8	3.5	4.8	4.6	3.3	3.1	6.8	2.6	3.5	9.9	4.1	7.6	7.6	13.8	3.1	4.6	3.6	4.0	8.3	4.8	5.0	3.3	3.3	3.3	7.9	12.1	3.1	3.6	5.2	5.0	5.7	9.8	4.4	5.3	7.9	9.1	6.7	4.9	4.2	4.8	4.7	4.8	8.6	12.3	3.9	3.4	3.7	5.1	6.6	8.7	4.9	2.6	9.5	11.5	5.2	4.7	3.8	3.1	10.7	4.1	3.6	5.6	8.9	3.6	11.6	5.2	3.3	6.0	4.7	3.4	6.8	8.5	4.2	3.0	6.4	3.2	0.7	0.3	1.0	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.1	1.4	0.4	0.2	0.3	0.0	0.1	4.9	6.1	7.6	5.3	4.2	4.8	5.9	6.2	5.6	5.4	6.0	6.8	5.6	3.2	4.6	5.2	1.3	5.4	2.5	1.6	2.8	6.8	5.9	3.9	2.2	2.8	3.5	1.8	6.2	3.8	3.8	5.6	1.9	2.4	8.4	2.1	4.0	5.4	1.8	3.0	6.9	1.6	3.1	4.7	4.1	4.8	0.0	3.7	6.8	4.1	7.8	8.4	8.1	4.1	2.0	13.6	8.4	31.8	6.8	7.2	5.4	7.5	8.3	2.1	2.1	7.1	12.4	3.2	5.0	0.7	1.7	4.4	4.0	2.5	2.3	12.7	0.0	4.5	5.6	4.0	2.5	3.8	8.2	3.3	2.2	2.1	2.4	4.7
ZBTB39	"KIAA0352, ZNF922"	ENSG00000166860	"Zinc finger and BTB domain containing 39"	O15060	12	56998836-57006546	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 16.7;Early spermatids: 19.9;Horizontal cells: 21.9;Late spermatids: 20.3;Spermatogonia: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"RH-30: 46.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016866, HPA020306"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Vesicles		"HPA016866: AB_2669470, HPA020306: AB_2670406"	"unprognostic (2.06e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.68e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.54e-2)"	"unprognostic (7.00e-2)"	2.6	1.5	1.7	2.9	2.0	5.8	2.8	2.2	2.0	2.1	0.9	2.5	2.2	3.2	2.5	2.4	3.1	1.8	2.2	1.6	1.8	2.1	3.4	2.7	3.9	1.9	2.0	4.4	2.9	3.3	1.1	3.7	1.9	2.6	2.3	2.9	2.6	3.3	2.5	2.9	2.9	2.8	1.5	4.2	2.6	7.1	2.0	4.2	2.5	2.7	3.6	2.1	1.7	2.3	3.4	5.5	15.3	7.9	3.4	3.6	10.1	3.2	4.1	5.2	3.7	5.7	2.3	10.8	4.2	3.2	3.3	4.5	11.8	5.0	5.0	5.0	8.2	12.1	3.6	4.6	3.2	9.3	9.6	2.8	4.8	4.1	6.6	5.6	6.0	12.2	15.2	9.7	3.8	3.9	13.7	7.8	15.2	3.5	4.6	13.0	46.9	5.2	2.4	6.7	7.5	9.7	4.7	6.0	4.7	14.2	5.1	10.1	4.8	4.3	9.5	2.0	4.1	12.5	8.7	11.5	2.7	5.2	2.7	0.7	0.3	0.0	0.4	0.2	0.4	0.3	0.4	0.6	0.4	0.4	0.3	0.6	0.0	0.7	0.0	0.5	0.1	0.3	1.7	2.0	2.2	2.0	1.6	1.8	1.9	2.0	1.9	1.5	2.0	2.3	2.9	0.0	0.6	3.3	3.5	1.5	2.3	1.6	7.4	11.6	1.7	1.5	3.5	2.8	1.9	0.0	16.7	3.1	3.0	0.9	0.0	1.5	19.9	1.2	3.3	4.3	1.2	2.1	1.8	1.8	1.8	2.3	1.5	1.2	1.3	3.6	8.6	2.5	1.9	21.9	1.8	2.5	2.0	3.0	2.0	20.3	1.8	1.4	1.8	0.0	3.6	1.8	3.1	1.5	2.8	2.5	3.2	5.7	3.2	3.5	1.5	1.4	3.1	7.4	6.6	3.4	2.2	10.1	17.6	3.2	1.6	2.2	2.1	1.9	2.4	1.4
ZBTB9	"MGC23166, ZNF919"	ENSG00000213588	"Zinc finger and BTB domain containing 9"	Q96C00	6	33453970-33457544	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 4.5;Ionocytes: 6.1;Respiratory ciliated cells: 4.3;Suprabasal keratinocytes: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 11.6;BEWO: 11.3;GAMG: 16.5;HMC-1: 14.2;U-698: 12.0"	"Low region specificity"	"Detected in all"							"HPA036767, HPA058171"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA036767: AB_10696787, HPA058171: "	"unprognostic (1.79e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.85e-4)"	"unprognostic (4.20e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.95e-1)"	2.8	3.9	0.9	1.5	1.0	1.7	2.3	0.8	1.6	2.5	8.6	2.4	2.3	2.6	1.7	3.8	2.5	0.6	3.0	1.9	0.7	4.4	3.2	2.4	1.9	1.2	0.9	3.0	2.9	0.6	10.0	0.5	0.6	2.4	1.4	1.9	2.9	0.1	1.8	3.8	2.7	0.8	0.2	3.5	2.7	7.4	0.4	0.2	2.2	1.0	3.3	2.5	2.2	0.9	1.0	0.3	11.6	2.9	2.1	0.1	11.3	0.6	0.2	0.2	0.1	3.0	0.8	2.7	1.8	0.3	16.5	1.2	4.8	2.4	1.3	3.1	2.0	9.0	2.3	0.0	0.0	2.3	14.2	0.5	0.9	3.3	2.6	0.6	0.1	1.5	3.2	1.8	2.6	1.6	0.6	0.9	4.3	0.5	0.7	5.6	3.0	2.7	2.2	2.3	1.8	1.1	3.3	0.3	1.1	1.1	1.6	0.4	1.9	0.9	1.3	1.3	1.2	0.7	3.5	12.0	0.9	2.9	0.3	5.2	1.1	0.4	2.8	0.8	1.2	0.4	1.2	2.6	1.5	0.8	2.5	1.9	0.8	1.3	1.7	0.3	2.2	0.6	0.9	1.0	0.8	1.6	1.9	0.7	1.2	0.9	0.6	0.2	0.4	0.9	0.1	0.0	0.0	1.3	2.1	4.5	0.0	1.9	1.8	0.0	0.2	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.5	0.0	1.5	0.3	0.4	0.1	0.6	1.8	1.3	1.2	1.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.7	6.1	0.0	1.2	1.1	0.0	0.2	1.8	1.0	0.0	0.0	0.0	0.0	0.6	1.0	0.1	0.0	0.6	0.0	0.2	0.1	4.3	0.0	0.0	0.0	0.7	0.1	0.1	0.8	3.7	0.0	0.7	0.1	1.0	0.0
ZCWPW2	ZCW2	ENSG00000206559	"Zinc finger CW-type and PWWP domain containing 2"	Q504Y3	3	28348721-28538122	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 9.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 35.6;Early spermatids: 95.0;Excitatory neurons: 33.7;Inhibitory neurons: 34.9;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 31.7;Spermatocytes: 68.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035035, HPA039839"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA035035: AB_10602256, HPA039839: AB_2676708"	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.59e-3)"	"unprognostic (6.53e-2)"	"unprognostic (6.09e-4)"	"unprognostic (3.21e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-4)"	"unprognostic (1.06e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.38e-2)"	1.5	1.7	1.8	0.9	1.5	0.8	1.8	1.6	1.9	1.4	0.2	1.4	1.2	2.1	2.1	1.3	1.0	2.0	2.7	1.7	1.1	1.6	1.2	1.3	1.2	0.8	1.0	2.4	1.9	1.5	1.2	1.2	1.0	2.2	1.1	1.6	2.3	1.1	6.2	1.9	0.9	1.0	0.8	1.1	1.8	9.9	1.2	0.6	2.5	4.5	1.0	0.8	0.8	1.6	0.3	0.2	0.8	0.3	1.2	2.8	1.2	1.1	0.8	0.3	0.3	0.2	0.9	0.7	0.5	0.6	0.8	0.4	0.2	0.2	0.3	0.4	0.4	0.3	1.1	0.3	0.6	0.5	0.6	1.2	0.5	0.3	0.5	1.3	0.5	1.5	0.3	1.0	1.5	0.3	0.2	0.6	0.3	0.1	1.1	0.3	0.3	0.6	1.2	0.1	0.3	0.9	0.2	0.4	0.7	0.8	0.4	2.6	1.0	0.8	0.4	0.7	0.6	0.3	0.2	0.3	2.8	0.5	1.0	1.0	0.7	1.1	0.3	0.7	0.2	0.1	0.3	0.2	0.3	0.2	0.5	0.7	1.0	0.2	0.2	0.4	0.3	0.2	1.8	1.5	1.6	1.9	1.7	1.1	0.8	1.0	1.0	0.8	1.2	1.6	1.6	0.0	2.0	35.6	0.4	0.6	2.7	3.7	1.2	3.0	1.6	2.7	13.6	0.0	4.3	0.0	0.0	2.4	0.1	0.4	5.9	0.5	95.0	1.2	1.2	1.0	1.2	0.0	33.7	0.9	1.4	4.3	0.0	0.6	2.5	0.8	1.4	0.5	1.3	3.3	34.9	1.9	8.2	0.6	0.7	17.7	4.7	1.3	0.0	13.1	0.7	3.7	1.0	32.2	31.7	0.6	0.3	4.9	0.3	1.1	0.6	2.6	1.7	2.0	0.0	4.4	4.5	68.7	5.8	1.1	1.6	1.2	0.6	1.3	0.7	1.3
ZDHHC8	"KIAA1292, ZNF378"	ENSG00000099904	"Zinc finger DHHC-type palmitoyltransferase 8"	Q9ULC8	22	20129456-20148007	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003422	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 72: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA003422: AB_1080640"	"unprognostic (1.00e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (3.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.02e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.43e-3)"	"unprognostic (9.34e-3)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.57e-2)"	31.6	31.2	13.8	18.6	15.1	10.7	30.4	11.3	26.4	32.6	0.0	22.8	12.1	31.2	7.5	29.3	27.7	13.0	31.6	13.9	7.0	30.4	36.1	31.0	17.1	12.2	10.0	34.6	35.6	14.4	41.3	16.9	9.9	28.1	7.0	7.4	27.6	15.4	23.6	32.2	24.7	13.1	6.6	35.7	26.4	14.9	12.3	13.7	37.3	10.3	11.7	25.3	30.9	12.8	30.0	18.7	29.3	38.7	42.0	25.0	26.3	55.1	37.3	36.6	32.6	9.8	15.2	0.1	22.3	46.0	19.8	40.2	15.5	42.2	18.0	43.2	59.4	14.5	57.2	23.0	34.5	0.0	19.5	43.7	27.9	28.2	23.6	22.5	41.4	21.0	101.4	22.8	33.0	14.7	17.8	39.1	14.9	13.2	29.4	37.8	25.6	10.9	15.6	35.9	46.9	23.7	22.4	10.7	26.6	13.1	0.7	20.4	48.0	82.5	59.8	46.8	25.0	32.6	11.5	11.7	24.2	18.7	24.8	1.3	0.4	0.1	0.8	0.5	0.4	0.2	0.2	0.4	0.1	0.5	0.4	0.5	0.0	0.4	0.2	1.3	0.7	0.2	13.8	15.1	11.3	26.4	13.9	7.0	12.2	10.0	9.9	6.6	12.3	12.8	17.4	3.2	3.1	17.6	3.7	9.1	3.8	3.6	5.7	11.9	8.2	8.1	7.1	4.3	3.5	11.0	14.6	3.6	9.2	4.3	1.9	5.2	0.5	4.3	15.7	11.5	4.2	0.8	16.6	4.5	8.5	9.3	10.2	8.7	5.7	8.7	10.4	9.8	4.9	13.5	9.9	5.9	10.2	5.0	5.0	2.1	10.8	5.7	5.4	9.4	3.7	7.4	1.0	13.0	13.3	7.7	5.4	14.7	2.7	7.6	2.7	2.1	1.5	10.8	6.6	10.5	6.8	1.4	3.8	5.5	9.8	3.4	4.2	8.0	5.0	3.4
ZFP1	"FLJ34243, ZNF475"	ENSG00000184517	"ZFP1 zinc finger protein"	Q6P2D0	16	75148494-75172236	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-698: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044916, HPA062910"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA044916: AB_2679144, HPA062910: AB_2684902"	"unprognostic (1.39e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.24e-5)"	"unprognostic (1.36e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (9.80e-4)"	"unprognostic (5.55e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.08e-1)"	4.2	3.3	3.7	1.7	4.4	1.8	3.9	4.4	5.1	4.8	1.7	5.4	1.7	5.7	2.2	2.7	4.8	2.7	3.6	4.6	3.4	3.7	11.1	3.5	3.1	3.3	3.0	5.1	2.1	4.6	3.8	3.0	3.3	2.9	2.0	5.8	2.2	3.1	5.8	2.7	3.0	4.0	3.7	2.5	3.0	4.2	3.7	8.2	4.8	4.3	3.2	4.7	3.6	5.3	3.1	6.6	9.1	8.2	5.1	6.7	3.6	3.7	4.4	8.2	9.8	5.3	2.4	13.1	4.2	3.0	3.2	3.8	8.1	5.6	9.5	7.2	4.9	4.8	2.4	4.0	4.4	4.7	14.8	4.5	5.5	6.1	7.9	8.6	5.4	12.3	5.6	2.7	6.4	11.9	16.4	4.6	2.8	2.6	2.5	15.1	4.0	4.2	3.6	2.8	9.0	7.2	9.0	2.7	3.5	2.3	6.0	3.9	3.7	7.4	7.9	3.4	4.3	11.2	11.5	28.6	3.6	6.7	5.8	1.1	0.7	0.2	1.5	1.2	1.6	1.2	1.1	1.7	0.7	1.6	1.4	1.5	0.0	1.9	0.5	0.3	1.7	0.9	3.7	4.4	4.4	5.1	4.6	3.4	3.3	3.0	3.3	3.7	3.7	5.3	5.4	6.4	4.8	6.8	5.1	5.4	2.5	2.3	5.7	6.9	3.8	3.4	4.2	1.5	2.0	1.8	0.0	2.9	7.6	1.0	1.9	3.6	4.6	2.9	7.5	5.3	7.2	4.6	9.5	2.3	2.7	5.9	0.0	3.9	1.3	5.1	3.9	11.7	2.0	13.5	8.5	0.9	0.0	4.1	2.7	5.2	3.4	1.8	1.8	7.5	3.6	6.8	4.1	7.1	11.7	1.6	1.0	4.1	2.7	2.3	0.8	3.6	2.6	3.8	0.0	5.6	8.2	15.9	8.8	5.0	5.8	4.1	5.5	4.7	1.8	2.4
ZKSCAN4	"FLJ32136, P1P373C6, p373c6.1, ZNF307, ZNF427, ZSCAN36"	ENSG00000187626	"Zinc finger with KRAB and SCAN domains 4"	Q969J2	6	28241697-28252269	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA009637	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA009637: AB_2668244"	"unprognostic (4.29e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.90e-6)"	"prognostic favorable (5.04e-4)"	"unprognostic (8.73e-3)"	"unprognostic (1.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-2)"	"unprognostic (9.70e-2)"	"unprognostic (7.36e-3)"	2.7	2.7	1.6	1.9	1.6	1.0	2.6	2.7	2.0	3.5	1.6	2.9	2.0	3.5	2.0	2.5	2.6	1.4	2.2	1.6	1.6	2.7	3.0	2.0	3.4	1.6	1.5	3.2	2.3	2.3	2.1	2.1	1.7	2.7	2.0	2.2	2.9	1.9	1.6	2.9	3.6	1.5	1.5	8.6	2.5	8.9	1.6	4.1	2.4	1.6	3.3	2.9	2.8	1.9	1.4	1.0	2.8	4.7	3.2	3.1	2.6	1.8	2.9	2.6	2.9	1.6	1.2	3.9	3.3	2.1	1.6	1.6	2.9	2.3	2.7	1.8	3.1	3.3	2.5	2.2	2.2	6.6	2.9	3.4	2.8	2.3	2.3	3.3	2.7	3.4	3.1	0.8	2.2	1.4	4.4	6.9	2.2	0.6	1.9	3.4	3.9	2.5	1.6	1.1	4.3	3.1	1.5	2.0	3.3	2.5	1.7	3.0	2.2	2.9	1.7	1.7	1.8	2.5	2.6	1.8	1.0	6.5	1.7	2.8	1.9	2.2	1.9	1.6	2.2	1.8	1.8	1.8	3.2	1.7	2.7	2.6	2.5	2.4	1.9	4.2	1.8	1.4	1.6	1.6	2.7	2.0	1.6	1.6	1.6	1.5	1.7	1.5	1.6	1.9	1.7	0.0	0.5	2.6	2.2	0.4	0.5	1.0	1.2	1.1	1.5	1.4	1.3	2.8	2.7	1.8	2.1	3.9	3.9	2.2	0.0	2.7	9.8	1.3	3.2	2.2	3.5	3.8	7.9	2.0	2.8	2.5	3.1	1.4	2.5	4.2	2.5	1.0	4.5	1.7	6.5	1.5	0.0	10.7	1.8	6.9	2.8	2.9	1.8	7.5	2.6	2.2	3.1	2.5	3.9	1.7	4.9	3.8	1.3	0.4	2.3	1.7	0.4	1.7	0.0	1.6	1.6	27.4	2.4	1.6	0.3	1.1	2.1	3.5	2.3	0.3
ZMAT1	KIAA1789	ENSG00000166432	"Zinc finger matrin-type 1"	Q5H9K5	X	101882288-101932079	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 190.3;Oligodendrocyte precursor cells: 111.1;Oligodendrocytes: 112.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.2;U-266/70: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012827	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA012827: AB_1859070"	"unprognostic (9.30e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.20e-3)"	"unprognostic (2.22e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.09e-2)"	"prognostic favorable (1.72e-5)"	"unprognostic (6.33e-3)"	"unprognostic (1.72e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.38e-2)"	6.4	9.3	11.1	2.8	11.5	6.3	7.5	10.5	15.1	8.0	10.6	7.3	1.8	5.5	21.2	2.4	10.0	2.1	7.9	10.7	10.7	18.3	9.7	5.7	6.6	11.5	10.9	15.2	10.3	4.3	34.8	0.7	11.0	10.7	1.3	9.4	6.7	3.7	2.6	3.0	7.5	1.3	11.1	13.8	5.8	6.7	10.9	3.2	25.0	1.5	2.6	6.0	4.8	12.1	0.2	0.0	1.0	1.0	0.0	0.0	0.1	0.4	0.0	0.0	0.4	0.0	1.2	1.8	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.2	0.2	0.7	1.9	0.0	8.2	0.6	0.0	0.1	0.1	1.3	0.0	0.1	1.5	0.0	0.1	2.3	0.0	0.4	1.1	0.7	0.0	0.1	1.1	1.4	2.1	2.0	0.6	0.0	0.0	0.1	4.1	0.3	0.0	0.4	2.0	0.6	0.8	0.3	0.5	0.2	0.1	0.4	0.6	0.3	0.4	0.0	0.9	0.4	0.3	0.2	0.1	0.1	0.9	0.2	0.1	11.1	11.5	10.5	15.1	10.7	10.7	11.5	10.9	11.0	11.1	10.9	12.1	18.9	16.0	31.2	190.3	30.2	4.1	7.6	0.2	7.4	38.1	18.2	12.3	25.4	11.5	14.4	14.7	43.8	0.1	16.5	0.6	3.9	5.0	14.9	28.2	3.7	16.8	10.3	6.9	30.7	2.7	0.0	10.3	2.0	21.6	15.8	51.5	13.6	10.6	3.3	16.8	32.8	2.8	0.0	9.7	11.1	9.7	1.8	11.7	7.2	71.2	10.7	25.8	10.3	111.1	112.8	1.5	1.6	1.2	7.4	6.1	2.7	5.7	13.0	57.5	0.0	27.5	9.0	22.4	10.2	3.2	2.8	0.1	16.3	5.4	2.6	4.3
ZNF131	"pHZ-10, ZBTB35"	ENSG00000172262	"Zinc finger protein 131"	P52739	5	43065176-43192021	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007023, HPA027748, HPA074630"	Approved		Enhanced	"Nucleoplasm,Intermediate filaments"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Intermediate filaments"	"HPA007023: AB_2667726, HPA027748: AB_2672374, HPA074630: AB_2686705"	"unprognostic (1.23e-1)"	"unprognostic (8.24e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.18e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (2.52e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.94e-2)"	"unprognostic (5.83e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.46e-2)"	13.2	13.5	12.5	13.9	12.8	28.4	19.5	17.3	21.7	13.8	10.0	13.2	10.0	17.6	9.6	14.4	12.6	12.9	9.6	12.8	12.4	12.0	14.3	11.4	20.3	11.4	11.9	15.9	12.2	11.7	10.7	16.9	11.9	12.6	13.2	14.7	10.4	9.0	15.8	18.2	12.0	15.9	11.3	15.9	11.6	32.6	12.3	26.7	11.8	17.1	17.5	15.0	13.3	14.2	25.4	15.2	32.4	43.2	30.1	20.6	27.3	32.8	26.6	31.9	26.9	24.0	22.2	50.8	25.9	22.1	29.7	17.7	38.9	20.8	44.9	24.8	34.1	31.4	92.2	18.0	27.7	55.0	24.7	18.8	38.2	23.5	38.3	22.8	24.7	39.0	40.7	52.7	36.8	24.5	53.9	68.8	21.5	23.4	24.9	35.3	49.4	39.9	27.1	24.4	20.0	29.4	83.5	39.8	43.2	21.7	22.3	51.6	18.5	39.8	37.3	20.5	31.1	21.1	32.5	58.4	21.0	71.2	27.1	10.4	8.2	5.8	19.1	9.5	19.2	13.1	18.5	18.5	11.9	16.8	22.3	18.3	3.9	17.2	6.6	11.3	14.9	10.0	12.5	12.8	17.3	21.7	12.8	12.4	11.4	11.9	11.9	11.3	12.3	14.2	42.5	22.4	21.9	28.7	44.7	49.6	51.4	24.1	53.5	52.1	32.3	29.7	17.5	22.8	19.4	9.2	52.1	27.0	53.3	28.0	31.3	15.3	52.9	30.0	47.7	32.8	31.2	39.1	31.2	11.8	25.0	32.4	23.0	49.7	24.1	39.4	24.7	13.3	16.4	38.7	33.6	29.7	20.3	25.8	35.4	19.5	20.5	30.9	21.4	14.0	27.5	29.0	49.4	38.7	24.2	17.9	24.7	21.1	27.8	38.5	34.9	13.1	15.7	70.0	26.3	57.0	43.2	109.6	80.3	45.9	65.5	25.4	59.3	37.3	38.7	35.6
ZNF142	"KIAA0236, pHZ-49"	ENSG00000115568	"Zinc finger protein 142"	P52746	2	218633329-218659655	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA049594	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA049594: AB_2680829"	"unprognostic (2.17e-1)"	"unprognostic (4.43e-1)"	"unprognostic (8.20e-3)"	"unprognostic (9.08e-2)"	"unprognostic (3.54e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (2.94e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.20e-2)"	"unprognostic (9.63e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.05e-2)"	6.0	5.7	5.0	5.0	5.5	8.0	6.0	5.5	6.9	6.4	1.2	8.0	2.6	7.5	2.5	6.7	6.7	3.6	7.0	5.5	3.6	6.3	4.5	5.4	5.3	4.5	3.9	6.2	7.5	4.9	8.3	3.2	4.2	6.8	3.1	6.4	6.3	4.3	10.3	7.0	6.5	4.9	2.6	7.3	7.0	4.8	4.7	6.0	6.9	6.6	4.9	7.3	5.8	5.1	6.3	9.7	9.0	10.7	8.5	6.3	8.5	7.1	4.2	9.7	7.4	19.3	5.0	8.3	6.1	6.4	8.1	11.4	17.6	11.7	6.6	12.0	16.5	12.9	20.7	12.3	6.8	16.8	11.8	4.3	11.0	11.5	11.3	5.3	8.2	9.2	17.0	15.7	5.0	13.7	11.7	9.6	11.8	3.9	8.8	17.7	5.1	8.1	7.3	11.3	12.3	9.3	5.3	10.4	4.0	8.5	6.0	6.1	12.2	9.2	9.7	7.8	11.0	10.5	7.1	13.4	5.9	7.9	9.5	0.9	0.7	0.8	1.0	0.1	0.4	0.7	0.6	0.6	0.6	0.3	0.7	0.5	0.4	0.3	0.2	0.8	0.6	0.6	5.0	5.5	5.5	6.9	5.5	3.6	4.5	3.9	4.2	2.6	4.7	5.1	3.5	3.2	0.5	4.9	6.0	5.9	2.0	1.7	5.7	3.5	3.8	3.4	5.3	4.3	2.7	3.7	6.2	2.2	4.0	4.1	0.0	3.2	2.7	2.7	4.3	3.2	0.0	2.1	7.0	3.8	2.2	3.8	6.6	5.2	1.3	5.2	4.2	3.1	3.0	1.7	6.7	3.0	4.1	4.7	3.2	4.8	3.7	4.1	3.6	4.7	3.1	2.3	8.2	3.0	6.7	4.1	3.5	3.8	8.5	2.8	3.4	2.2	1.0	2.7	6.6	3.9	2.9	5.5	5.5	6.6	6.1	1.1	6.3	4.1	4.3	2.3
ZNF155	pHZ-96	ENSG00000204920	"Zinc finger protein 155"	Q12901	19	43967862-43998326	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 23.5;Excitatory neurons: 22.0;Inhibitory neurons: 16.1;Oligodendrocyte precursor cells: 24.6;Oligodendrocytes: 24.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA003220	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA003220: AB_1080675"	"unprognostic (2.71e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.98e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.57e-2)"	4.1	5.6	4.1	3.3	4.8	2.9	5.5	7.2	5.1	4.6	4.3	4.0	3.3	4.7	6.1	3.6	3.7	3.6	6.0	4.0	4.7	5.2	6.5	4.4	4.4	4.1	3.9	6.1	3.0	8.2	4.5	4.4	4.3	5.1	4.6	8.6	3.8	4.6	3.2	5.4	4.0	5.8	3.8	6.0	5.2	3.3	4.4	6.6	7.8	3.5	4.3	4.0	2.9	5.5	5.1	4.2	10.4	9.5	5.6	6.5	3.0	4.1	3.9	2.8	4.1	2.8	2.5	0.0	5.1	6.4	4.0	3.9	3.5	8.7	4.7	5.7	8.7	10.8	9.8	3.1	5.8	3.9	6.0	9.2	7.0	5.8	8.5	8.2	6.6	0.2	0.2	0.1	7.8	4.5	4.9	3.9	6.4	2.1	3.7	0.0	11.1	3.8	7.5	16.3	7.0	9.3	10.1	0.6	4.0	9.1	6.7	9.3	5.0	6.3	9.2	4.1	6.0	11.5	9.1	0.0	5.3	0.7	5.9	8.1	2.7	9.8	6.5	2.9	6.3	4.0	4.5	7.0	4.1	5.2	5.5	5.0	2.4	5.5	2.2	2.4	4.2	4.2	4.1	4.8	7.2	5.1	4.0	4.7	4.1	3.9	4.3	3.8	4.4	5.5	2.4	0.0	1.3	23.5	2.7	1.5	1.1	2.2	1.2	3.6	2.4	2.2	0.4	1.5	1.9	0.0	0.0	1.8	1.8	2.3	1.9	1.8	0.5	0.8	1.3	2.6	0.0	0.8	22.0	1.5	0.6	2.0	2.0	1.2	1.3	3.2	2.5	1.5	1.6	6.7	16.1	1.3	2.0	0.8	1.3	0.9	2.8	1.3	1.8	9.4	0.9	4.2	1.0	24.6	24.1	0.9	0.8	5.7	1.0	1.2	1.9	1.9	0.8	3.2	0.0	2.2	2.4	1.3	1.4	1.4	1.3	1.1	2.2	3.0	1.5	1.0
ZNF180	HHZ168	ENSG00000167384	"Zinc finger protein 180"	Q9UJW8	19	44474428-44500524	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028979, HPA028980"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA028979: AB_10600328, HPA028980: AB_10611524"	"unprognostic (2.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.13e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.16e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.37e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.38e-3)"	2.8	2.8	1.7	2.4	1.8	2.7	4.5	2.3	2.2	3.2	2.4	2.9	2.4	3.5	2.6	2.7	4.1	1.6	2.4	1.8	1.8	2.9	3.3	3.0	3.2	1.8	2.0	4.7	3.3	8.1	2.4	2.7	1.9	5.2	3.4	4.7	2.4	3.0	2.6	3.0	3.0	3.2	1.8	3.2	3.1	2.8	1.8	3.9	4.5	2.2	4.0	2.7	2.8	2.2	7.0	2.0	9.1	6.5	2.1	3.9	5.5	4.0	4.3	6.3	7.4	3.6	0.9	0.6	3.1	5.5	4.5	2.2	5.5	8.0	7.8	8.0	3.3	7.7	1.6	2.7	2.0	11.7	4.8	3.8	3.3	3.8	4.8	5.8	4.4	3.4	3.7	5.6	4.4	1.3	6.2	4.1	6.0	6.5	4.4	3.7	4.9	5.2	6.1	11.4	7.5	6.4	7.1	6.8	3.3	5.8	3.6	9.8	3.5	10.8	4.3	1.4	5.7	1.5	5.7	3.2	2.4	5.0	5.6	2.1	1.1	2.3	1.1	0.6	1.6	1.8	1.7	2.0	1.7	1.7	1.9	1.8	0.3	1.7	1.2	0.4	4.6	1.3	1.7	1.8	2.3	2.2	1.8	1.8	1.8	2.0	1.9	1.8	1.8	2.2	3.4	6.4	1.5	4.2	4.3	2.5	2.2	2.4	4.0	6.7	3.2	2.4	4.5	2.8	4.1	1.8	4.2	5.5	4.2	3.5	7.9	4.2	5.8	3.0	4.7	2.8	4.2	8.2	5.7	4.2	4.0	3.5	4.1	2.9	1.3	5.7	5.3	3.7	3.4	1.7	5.8	4.9	6.1	4.6	1.1	1.3	2.8	2.6	5.4	8.4	5.4	6.0	7.2	6.6	9.0	3.9	5.7	4.5	1.7	2.2	4.3	3.5	4.3	4.4	6.6	4.3	3.5	2.7	4.6	2.5	1.3	3.1	4.0	3.5	4.0	1.7
ZNF254	"BMZF-5, HD-ZNF1, ZNF539, ZNF91L"	ENSG00000213096	"Zinc finger protein 254"	O75437	19	24033405-24129968	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 113.9;Excitatory neurons: 78.6;Inhibitory neurons: 85.1;Oligodendrocyte precursor cells: 128.7;Oligodendrocytes: 107.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"																	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 68: Oligodendrocytes - Mixed function"				"unprognostic (8.39e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (8.60e-4)"	"unprognostic (4.11e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.96e-2)"	"unprognostic (5.98e-3)"	"unprognostic (4.86e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (9.96e-4)"	4.2	4.9	4.2	3.8	4.8	7.6	7.6	8.9	6.3	9.1	2.4	5.9	4.2	7.5	8.6	5.3	5.9	5.3	4.8	3.6	6.7	7.7	8.8	6.0	6.9	3.9	4.5	10.9	4.3	10.9	5.9	5.6	4.6	7.7	7.3	5.4	5.2	7.0	2.3	4.2	3.9	5.0	3.5	4.9	6.5	4.5	5.9	11.8	17.0	5.7	6.2	6.2	6.0	6.0	4.1	5.4	24.3	12.2	5.0	5.5	4.2	5.3	9.5	7.5	12.3	5.7	7.8	6.1	10.4	4.7	4.4	2.3	15.6	5.0	11.3	35.1	24.2	11.6	6.5	3.3	4.5	5.6	2.4	6.3	5.3	8.7	7.0	11.3	9.9	13.7	15.9	0.0	8.9	6.9	12.3	10.2	18.4	1.5	9.7	17.4	12.8	14.3	10.3	11.9	14.4	14.0	0.0	0.4	7.3	21.0	5.9	9.1	6.9	3.5	1.0	7.4	8.1	0.2	6.8	16.0	0.0	6.6	3.4	7.5	1.3	4.3	1.9	1.4	2.0	3.4	2.5	2.1	2.2	3.2	2.8	2.5	3.1	3.2	3.1	2.7	3.3	1.2	4.2	4.8	8.9	6.3	3.6	6.7	3.9	4.5	4.6	3.5	5.9	6.0	13.3	38.5	18.5	113.9	10.8	3.4	8.7	5.9	5.2	22.1	10.1	9.1	18.7	20.0	10.6	12.9	14.6	6.7	11.0	8.6	15.6	11.8	49.5	11.2	19.7	9.3	16.8	3.8	78.6	7.4	11.1	13.3	10.2	13.2	7.0	27.3	8.9	10.5	5.7	37.0	85.1	6.0	12.2	8.1	5.2	16.8	11.8	6.8	7.2	65.6	5.1	15.7	5.2	128.7	107.5	9.5	4.4	16.6	4.1	7.7	1.8	8.8	8.5	14.3	13.1	11.3	13.4	5.8	9.6	5.2	5.3	8.8	8.7	13.4	7.0	9.4
ZNF273	HZF9	ENSG00000198039	"Zinc finger protein 273"	Q14593	7	64870172-64930966	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 4.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 44.0;Inhibitory neurons: 51.2;Respiratory ciliated cells: 82.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.9"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA077549			Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA077549: AB_2732352"	"unprognostic (7.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.87e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.02e-5)"	"unprognostic (2.54e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.85e-2)"	0.4	0.1	0.2	0.2	0.2	2.4	1.2	1.0	0.7	0.8	0.1	0.2	0.3	0.6	0.1	0.5	0.8	0.1	0.2	0.2	0.2	0.2	0.1	0.4	1.1	0.5	0.4	0.9	0.3	0.2	0.0	0.5	0.3	0.4	0.4	0.4	0.4	0.3	0.3	4.0	0.1	0.2	0.3	0.4	0.2	2.1	0.2	1.2	1.5	0.3	1.0	0.4	0.6	0.3	1.8	1.3	2.8	4.1	0.4	0.9	2.3	0.8	0.5	1.2	2.2	2.0	1.6	4.7	2.4	0.4	2.2	0.6	5.6	1.1	1.0	2.3	2.1	2.5	0.6	0.7	0.2	2.4	1.7	0.7	0.7	2.0	1.8	0.8	1.1	6.9	6.7	1.8	1.4	1.6	5.3	2.7	5.7	1.0	2.0	5.5	4.2	2.8	0.6	1.1	2.6	2.7	2.2	1.1	1.3	5.4	2.1	3.5	0.5	1.4	1.5	1.0	1.7	1.7	2.4	6.8	0.3	2.4	1.0	2.0	0.2	1.2	0.3	0.3	0.6	1.2	0.7	0.5	0.6	1.0	0.5	0.9	0.4	0.2	0.2	0.6	0.8	0.3	0.2	0.2	1.0	0.7	0.2	0.2	0.5	0.4	0.3	0.3	0.2	0.3	8.2	3.2	2.3	22.5	12.9	25.0	6.2	8.8	6.8	5.5	7.6	4.7	4.3	1.5	11.1	1.8	0.0	6.8	4.9	0.5	7.9	3.4	25.0	27.1	4.7	7.1	0.0	30.7	44.0	2.9	13.1	7.8	3.6	4.4	3.8	13.4	6.4	1.1	3.6	5.0	51.2	2.0	8.2	3.1	3.5	13.5	6.2	4.1	5.4	15.0	3.9	3.6	7.2	20.1	11.6	2.6	6.1	3.4	2.8	3.6	0.6	1.6	82.0	3.2	0.0	4.8	4.4	21.6	11.4	9.7	18.9	2.9	7.2	5.2	3.5	3.1
ZNF358	"FLJ10390, ZFEND"	ENSG00000198816	"Zinc finger protein 358"	Q9NW07	19	7515292-7521025	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 126.5;Granulosa cells: 178.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030887, HPA063624"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 47: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA030887: AB_10602688, HPA063624: AB_2685064"	"unprognostic (1.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.82e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.52e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (4.30e-1)"	"unprognostic (4.48e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.72e-2)"	"unprognostic (3.60e-2)"	70.6	57.4	82.5	12.0	73.1	2.2	58.4	64.8	109.9	75.5	47.5	107.9	29.5	69.8	28.0	31.9	62.1	31.9	109.4	79.3	70.9	52.8	67.0	50.6	10.5	77.8	81.7	88.6	50.5	49.6	60.9	18.3	69.7	78.6	18.3	11.8	51.3	43.8	175.5	38.8	47.9	37.4	68.3	39.6	67.9	12.6	88.4	14.1	59.9	147.0	7.9	88.4	54.3	79.7	32.5	21.4	39.7	63.3	83.2	91.8	33.9	12.0	78.2	53.7	47.0	9.4	22.6	0.0	45.7	64.8	8.5	12.4	16.5	30.8	17.2	0.1	35.0	6.2	24.9	13.3	91.0	0.9	0.3	80.3	57.2	25.4	22.0	80.0	57.1	0.0	16.7	0.0	48.2	16.0	0.1	23.5	40.9	13.4	37.4	35.8	21.2	3.5	28.2	13.8	43.8	87.1	15.1	12.5	43.8	25.5	9.5	16.9	27.1	34.4	24.8	51.6	18.4	41.8	24.8	0.1	31.7	0.0	48.6	1.5	0.5	0.4	0.6	0.5	0.4	0.1	0.1	0.3	0.2	0.7	0.4	0.7	0.0	0.2	0.1	0.4	0.0	0.2	82.5	73.1	64.8	109.9	79.3	70.9	77.8	81.7	69.7	68.3	88.4	79.7	29.5	9.6	11.1	11.8	4.6	7.8	11.8	7.1	2.2	20.8	32.8	37.1	126.5	20.0	5.5	16.5	14.6	3.3	6.5	38.8	5.9	13.0	3.8	9.4	28.2	22.1	36.5	0.8	5.8	16.8	5.1	29.2	8.6	14.2	14.7	178.1	32.5	43.0	10.9	50.5	8.5	27.8	8.2	21.1	10.8	7.7	37.9	13.3	5.4	7.5	3.8	48.8	1.0	8.5	14.9	16.0	21.7	37.2	3.4	11.3	48.3	30.7	3.3	20.7	13.1	22.1	27.6	0.7	1.2	3.2	3.7	3.0	3.6	23.9	24.7	12.8
ZNF407	"FLJ13839, FLJ20307, KIAA1703"	ENSG00000215421	"Zinc finger protein 407"	Q9C0G0	18	74597870-75065671	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Astrocytes: 96.9;Excitatory neurons: 111.0;Inhibitory neurons: 100.2;Microglial cells: 113.4;Oligodendrocyte precursor cells: 122.6;Oligodendrocytes: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028255, HPA041673"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Plasma membrane"		"HPA028255: AB_10603466, HPA041673: AB_2677610"	"unprognostic (3.96e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.62e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.31e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.04e-4)"	"unprognostic (3.47e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (9.79e-5)"	"unprognostic (8.87e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.11e-2)"	2.4	1.9	2.9	3.1	3.5	5.3	2.9	8.0	2.8	2.7	8.6	2.8	2.2	3.7	1.9	2.5	2.7	2.1	3.2	2.3	2.9	2.4	2.2	2.4	3.3	3.6	3.0	4.8	2.2	3.9	1.5	2.7	4.1	2.8	2.2	2.9	2.4	2.8	3.9	2.3	2.4	3.1	2.9	3.4	2.3	4.0	3.2	5.5	3.6	3.6	3.0	2.4	2.0	4.1	3.9	4.0	4.4	4.1	3.2	4.7	3.2	5.1	4.4	3.7	4.0	1.7	2.2	5.6	1.5	7.1	2.5	4.5	4.2	5.5	5.4	9.3	2.6	7.1	5.5	3.2	2.9	10.9	6.0	4.3	2.4	5.9	5.1	3.5	5.6	3.9	4.1	8.0	5.7	3.1	5.3	1.5	2.6	1.4	3.6	5.4	5.8	4.4	2.6	7.2	4.2	4.0	4.7	2.9	3.6	3.2	3.4	4.6	7.9	8.3	3.5	2.3	4.1	2.8	6.2	5.7	3.0	4.6	5.0	1.6	0.7	0.9	1.0	0.9	1.0	0.8	0.8	0.6	0.3	0.8	0.9	1.1	2.2	1.1	0.6	1.3	0.2	0.4	2.9	3.5	8.0	2.8	2.3	2.9	3.6	3.0	4.1	2.9	3.2	4.1	16.5	6.4	6.3	96.9	10.6	3.2	5.0	3.0	2.8	11.2	6.3	6.0	19.4	2.8	4.9	5.5	6.2	4.2	11.4	6.9	0.0	4.3	4.6	8.6	15.3	10.0	4.2	3.4	111.0	2.9	2.7	7.6	17.3	14.4	1.3	10.2	3.3	5.5	3.2	5.0	100.2	5.7	2.0	5.3	2.8	3.3	5.3	7.6	5.4	113.4	6.1	6.2	8.2	122.6	130.5	4.8	6.0	4.5	11.1	4.4	4.3	2.6	6.2	13.2	6.6	10.8	8.1	9.0	12.8	5.6	4.1	5.2	10.1	12.1	6.0	3.9
ZNF443	ZK1	ENSG00000180855	"Zinc finger protein 443"	Q9Y2A4	19	12429706-12441021	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 10.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 13.3"									"HPA003150, HPA018683"	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	"Centriolar satellite"	"HPA003150: AB_1080725, HPA018683: AB_2669920"	"unprognostic (5.64e-3)"	"unprognostic (1.51e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.38e-3)"	"unprognostic (3.42e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.05e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (2.74e-7)"	"unprognostic (3.85e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.19e-2)"	"prognostic favorable (3.91e-4)"	1.4	1.7	3.2	1.4	3.3	0.6	4.2	3.6	3.8	2.9	2.5	2.8	2.0	2.7	3.1	2.6	2.6	2.1	1.8	2.9	3.1	3.8	3.2	1.6	1.8	3.2	3.3	2.3	2.6	2.8	1.9	3.2	3.0	3.1	3.3	3.3	2.9	3.2	1.1	3.8	2.2	1.8	3.1	1.6	2.4	1.8	3.4	4.0	2.4	1.7	2.2	2.8	2.8	2.9	3.1	1.4	5.4	4.9	1.6	1.3	7.4	2.2	1.6	3.0	2.8	3.0	0.9	3.7	3.9	1.8	1.2	1.8	3.6	2.3	2.5	0.0	1.8	1.5	1.9	7.0	0.4	3.5	4.1	1.2	1.4	1.5	0.7	2.0	1.7	4.5	2.6	0.0	3.3	3.8	13.3	4.8	4.6	3.1	4.6	1.5	5.7	4.5	3.6	11.6	2.6	4.2	3.7	2.0	0.5	3.0	0.0	4.3	1.2	5.9	2.4	3.2	2.2	2.2	3.6	2.3	0.8	3.5	1.2	2.5	0.6	0.9	1.0	0.3	3.7	2.1	2.2	2.2	1.1	1.7	1.9	1.4	0.4	1.6	0.2	0.6	1.8	1.0	3.2	3.3	3.6	3.8	2.9	3.1	3.2	3.3	3.0	3.1	3.4	2.9	3.5	0.0	0.5	10.7	2.4	1.0	1.5	1.2	2.2	1.2	2.8	2.3	2.3	2.8	1.4	0.0	4.2	7.7	2.6	1.8	1.9	2.7	6.3	2.9	1.2	2.8	3.0	1.7	8.9	1.2	1.2	1.4	1.1	3.4	0.0	3.7	1.4	1.6	1.3	1.7	8.1	2.1	2.0	0.9	1.5	2.7	0.6	1.0	0.0	3.7	0.1	3.0	5.2	8.5	5.0	1.1	2.8	2.2	0.6	0.6	1.7	2.2	2.3	2.2	0.0	1.0	1.7	5.0	6.6	3.0	2.6	1.6	2.1	1.2	2.6	0.7
ZNF567	MGC45586	ENSG00000189042	"Zinc finger protein 567"	Q8N184	19	36687612-36727701	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 86.7;Late spermatids: 153.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA023937	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA023937: AB_1859351"	"unprognostic (4.39e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.36e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.54e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.24e-2)"	"unprognostic (9.03e-2)"	3.3	3.7	2.7	2.9	2.7	3.4	5.8	5.1	4.1	4.1	3.3	3.4	2.3	5.1	4.2	3.1	3.9	3.2	3.1	2.8	3.0	3.3	4.8	3.4	4.7	2.1	2.6	4.6	2.6	5.5	4.8	5.6	2.3	5.2	2.8	4.9	3.6	5.0	2.3	3.3	3.0	4.5	2.5	4.5	3.3	9.5	3.2	6.6	4.8	3.1	4.9	4.2	3.5	3.0	7.1	5.5	9.8	8.7	5.5	5.4	9.3	5.1	7.8	5.7	9.1	3.1	2.5	4.4	6.0	4.6	4.2	1.8	9.1	5.3	7.7	8.8	4.7	8.4	6.0	3.0	5.0	10.8	6.2	8.4	6.2	5.4	10.5	7.4	6.7	8.9	3.3	2.3	6.9	4.5	13.9	4.1	9.4	4.8	4.3	6.8	13.5	6.4	3.8	10.7	7.3	7.8	9.5	4.7	4.9	10.9	5.9	7.2	4.2	7.5	7.6	3.8	5.8	8.8	7.8	14.9	0.0	4.3	6.7	5.0	1.8	5.8	5.7	1.5	4.8	5.7	6.2	5.4	3.2	7.0	6.0	6.1	0.9	6.8	1.6	2.2	5.5	2.5	2.7	2.7	5.1	4.1	2.8	3.0	2.1	2.6	2.3	2.5	3.2	3.0	15.5	6.4	6.9	4.6	15.3	11.7	12.5	7.4	7.4	9.0	13.4	14.7	5.8	5.7	8.8	9.2	10.4	15.3	13.3	3.8	3.9	8.6	86.7	13.4	7.8	9.9	4.2	11.6	12.8	5.1	13.5	7.7	8.2	11.1	17.2	11.7	12.8	6.5	7.5	11.8	11.2	4.6	4.1	5.1	3.7	153.0	9.9	4.7	7.2	11.2	6.7	8.1	14.4	8.5	11.9	4.4	6.2	15.1	5.9	13.1	3.7	6.7	4.8	6.1	6.6	11.5	10.1	42.2	13.4	6.1	17.6	27.5	13.2	12.2	4.4	13.3
ZNF587	"FLJ14710, FLJ20813, UBF-fl, ZF6"	ENSG00000198466	"Zinc finger protein 587"	Q96SQ5	19	57849859-57865117	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"RT4: 41.5"									"HPA042125, HPA043288, HPA056213"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 4: Stomach - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA042125: AB_2677862, HPA043288: AB_2678410, HPA056213: AB_2683069"	"unprognostic (1.61e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.53e-1)"	"unprognostic (6.60e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.84e-3)"	"prognostic unfavorable (7.98e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.68e-3)"	5.0	5.1	3.9	6.4	3.6	6.8	10.1	4.5	5.3	6.4	5.9	8.5	8.2	5.9	5.6	6.1	6.0	3.7	6.0	3.7	3.8	6.5	6.2	6.2	5.4	2.9	2.9	7.1	9.1	4.9	11.5	8.0	2.9	9.6	13.1	11.4	12.1	6.5	4.5	5.9	7.9	5.5	2.1	6.1	8.9	4.4	3.3	5.4	7.7	4.1	6.8	6.2	7.3	4.7	8.6	7.8	7.0	5.7	7.5	10.9	10.5	7.5	9.5	11.2	9.8	11.2	5.7	5.7	3.9	5.9	4.4	5.1	10.1	11.1	20.8	5.3	21.5	11.1	28.6	8.0	4.3	11.1	10.6	10.8	5.1	11.0	10.4	8.6	12.1	7.8	14.1	7.5	8.4	3.6	6.7	4.1	2.1	2.2	7.1	5.3	6.6	3.8	6.7	41.5	11.1	5.2	8.7	7.9	2.7	9.2	6.8	6.3	5.7	8.3	5.1	2.1	10.7	12.0	9.8	6.0	3.8	4.7	5.0	1.4	0.5	0.4	0.4	0.4	0.4	0.5	0.5	0.4	0.5	0.7	0.4	0.7	1.2	0.5	0.4	0.4	0.7	0.3	3.9	3.6	4.5	5.3	3.7	3.8	2.9	2.9	2.9	2.1	3.3	4.7	6.9	3.2	6.8	13.1	8.4	9.2	13.6	7.3	1.8	20.0	10.4	5.8	7.1	30.0	9.6	7.3	31.3	10.8	7.4	12.2	11.7	9.1	9.5	16.9	10.0	7.8	23.4	3.8	19.9	3.7	9.8	7.3	19.4	22.6	12.7	18.3	12.5	9.4	6.5	20.2	19.3	18.2	4.1	7.1	5.5	1.3	4.7	7.0	0.0	10.3	7.2	7.6	7.2	17.6	14.1	7.6	15.9	9.1	8.7	13.4	14.8	8.5	13.3	24.7	0.0	9.2	6.3	4.2	6.7	5.4	6.7	10.1	8.7	9.5	15.5	15.4
ZNF610	FLJ36040	ENSG00000167554	"Zinc finger protein 610"	Q8N9Z0	19	52336243-52367778	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 35.6;Late spermatids: 10.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 11.0"									"HPA055771, HPA078134"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA055771: AB_2682914, HPA078134: AB_2732372"	"unprognostic (1.13e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.52e-1)"	"unprognostic (8.75e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (3.38e-4)"	"unprognostic (5.54e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (1.05e-7)"	"unprognostic (2.46e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.88e-2)"	"unprognostic (5.73e-3)"	1.2	2.7	4.9	0.8	5.5	0.3	3.2	5.6	7.4	3.8	4.6	1.7	0.7	2.9	6.7	1.1	4.3	2.6	2.6	4.9	5.9	3.6	0.4	1.9	1.5	5.3	6.2	8.2	1.4	4.0	2.4	2.7	5.9	4.5	1.5	6.2	1.2	2.6	1.1	0.7	0.9	2.5	5.0	2.4	1.5	12.1	5.5	3.1	4.6	1.5	1.1	1.8	1.2	5.9	0.1	0.0	5.0	4.2	3.5	2.8	4.2	1.5	3.5	0.9	3.0	0.0	0.3	0.4	3.1	0.7	6.6	0.1	0.0	0.0	2.1	0.1	2.3	0.1	0.3	0.2	5.1	0.0	1.0	3.8	0.1	0.9	0.2	2.5	3.0	2.8	0.2	0.1	5.0	1.0	2.9	0.8	5.7	0.0	0.3	1.9	3.9	0.5	2.3	3.7	6.4	3.9	0.0	0.3	1.6	7.4	3.0	2.3	2.3	0.2	1.5	0.0	2.0	0.1	11.0	0.0	0.0	0.1	2.0	1.7	0.2	0.5	1.1	0.0	1.7	1.0	0.9	0.8	0.5	1.1	1.6	0.7	0.4	1.2	0.0	0.6	1.3	0.7	4.9	5.5	5.6	7.4	4.9	5.9	5.3	6.2	5.9	5.0	5.5	5.9	0.9	0.0	0.5	4.2	0.5	0.0	0.6	0.5	1.2	3.1	1.3	1.8	3.1	2.8	2.1	3.7	4.2	1.3	0.3	0.2	5.9	1.9	35.6	3.0	1.0	1.5	0.0	1.7	3.8	0.0	1.6	1.2	0.5	1.7	2.5	4.4	0.7	0.0	0.6	0.0	5.5	0.3	0.0	0.3	0.0	10.0	0.9	0.2	1.8	0.0	0.0	4.3	0.0	5.5	7.5	0.2	0.1	1.2	0.1	0.7	0.3	0.8	2.3	2.5	6.6	0.4	1.2	5.7	3.6	0.1	0.3	0.7	0.6	1.6	0.5	0.5
ZNF618	"KIAA1952, NEDD10"	ENSG00000157657	"Zinc finger protein 618"	Q5T7W0	9	113876282-114056591	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 33.0;REH: 31.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023116, HPA061732"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA023116: AB_10964204, HPA061732: AB_2684596"	"unprognostic (1.92e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.17e-3)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.61e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.24e-2)"	"prognostic favorable (5.22e-7)"	"unprognostic (4.57e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.51e-2)"	3.3	4.6	2.5	2.1	2.4	2.7	3.7	4.5	2.3	5.8	4.5	1.8	2.2	6.4	2.9	2.3	5.4	4.0	2.0	1.8	3.1	7.3	5.5	3.5	1.2	3.4	2.9	9.6	5.5	6.9	3.9	2.1	2.9	3.0	1.6	1.9	3.4	2.8	2.3	2.2	1.6	4.5	2.1	3.9	4.2	2.5	3.7	3.5	5.4	1.8	1.1	2.0	2.6	2.1	7.4	22.5	33.0	14.4	7.8	9.1	1.6	4.8	7.9	9.5	8.4	0.2	5.2	4.1	4.5	8.4	2.7	0.2	16.6	8.3	3.7	0.1	6.6	0.0	1.7	0.1	5.8	4.4	7.4	8.8	3.3	10.1	2.2	8.6	24.2	0.5	0.0	0.0	4.3	12.1	0.2	5.6	16.4	0.6	4.9	31.8	19.2	0.1	10.2	8.1	10.2	24.2	13.7	8.7	8.7	9.4	0.7	8.9	19.8	12.6	9.9	7.1	5.9	0.0	0.0	0.0	0.9	6.6	9.0	1.6	0.4	0.2	0.3	0.2	0.1	0.0	0.0	0.3	1.4	0.5	0.2	0.2	0.0	1.1	0.3	1.7	0.0	0.4	2.5	2.4	4.5	2.3	1.8	3.1	3.4	2.9	2.9	2.1	3.7	2.1	9.1	3.2	13.2	4.9	2.1	2.0	4.8	3.7	12.0	14.9	12.6	17.1	2.7	24.3	4.2	11.0	4.2	0.2	3.1	0.5	7.9	16.0	7.6	7.4	22.8	10.0	2.4	7.6	14.6	8.2	0.1	12.7	10.7	12.2	21.0	26.9	11.0	10.9	3.4	58.9	30.6	2.1	2.0	5.4	8.5	4.8	15.2	7.2	0.0	38.4	12.1	10.1	4.1	24.1	8.7	9.7	1.9	15.4	0.4	1.8	0.1	10.8	2.3	1.6	26.3	10.1	19.2	0.4	11.4	3.6	3.7	0.3	2.0	40.0	2.8	1.9
ZNF630	"BC037316, dJ54B20.2, FLJ20573, MGC138344"	ENSG00000221994	"Zinc finger protein 630"	Q2M218	X	47983356-48071658	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 5.0;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SiHa: 5.3"					"Low region specificity"	"Detected in all"			"HPA001053, HPA068130"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA001053: AB_2666183, HPA068130: AB_2685961"	"unprognostic (1.03e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.86e-3)"	"unprognostic (5.83e-2)"	"unprognostic (9.06e-3)"	"unprognostic (8.68e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (7.51e-5)"	1.9	2.2	3.8	1.5	4.0	0.9	2.8	5.0	4.8	3.6	4.1	2.5	1.8	2.6	2.8	2.1	2.6	2.5	2.7	3.6	3.8	2.4	1.4	2.1	1.8	4.0	4.1	4.7	3.2	4.2	2.6	1.6	4.2	3.8	2.5	3.7	2.3	2.8	1.0	1.9	1.8	2.4	3.8	2.3	2.9	0.7	4.2	0.9	3.7	1.2	1.5	3.0	2.7	4.6	1.0	0.7	0.2	0.0	0.1	0.0	0.0	1.4	0.5	1.1	0.6	2.3	4.0	0.1	0.8	1.4	1.6	1.8	0.0	0.8	0.9	0.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	1.0	4.0	2.3	0.0	2.6	0.7	0.0	0.0	4.2	2.5	4.3	0.0	0.0	1.5	3.5	1.2	0.5	1.0	0.0	1.7	2.2	2.3	1.8	5.3	3.7	1.4	3.2	4.3	0.9	1.3	0.0	1.8	1.8	0.0	0.0	3.7	0.0	0.0	0.1	3.3	2.3	0.8	2.0	0.8	0.3	0.9	1.0	0.7	0.7	1.5	0.6	0.9	1.0	0.9	0.7	0.3	0.4	0.5	0.9	3.8	4.0	5.0	4.8	3.6	3.8	4.0	4.1	4.2	3.8	4.2	4.6	0.8	0.0	0.0	2.6	1.4	0.1	1.0	0.8	3.4	2.5	1.6	1.3	1.6	0.0	0.8	1.8	0.0	0.1	0.4	0.9	1.9	1.4	0.0	1.2	1.9	1.2	4.2	0.8	2.2	1.1	0.9	1.4	1.1	1.3	0.0	4.0	1.8	0.3	0.9	0.0	2.6	1.6	0.0	0.0	0.0	0.2	0.3	0.7	0.0	1.0	1.3	0.7	0.0	5.0	3.2	1.0	0.6	0.4	1.0	0.9	1.1	0.7	0.5	1.0	6.6	1.4	1.4	0.2	0.4	1.7	0.3	0.3	1.1	4.0	1.0	0.8
ZNF638	"MGC26130, NP220, ZFML, Zfp638"	ENSG00000075292	"Zinc finger protein 638"	Q14966	2	71276561-71435069	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 342.3;Oligodendrocytes: 619.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036784, HPA057395"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA036784: AB_10672478, HPA057395: AB_2683426"	"unprognostic (2.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.28e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (8.73e-5)"	21.1	22.1	35.7	21.6	48.9	28.2	24.6	77.6	52.3	23.0	37.7	22.0	15.6	29.2	18.4	19.8	22.1	19.1	41.0	35.7	41.3	24.2	30.9	21.2	25.0	41.9	36.8	37.3	21.9	27.9	24.9	23.2	41.9	22.2	19.5	48.6	21.0	19.5	51.5	16.8	19.0	22.9	34.8	23.1	21.8	29.7	38.9	30.9	29.8	33.7	22.6	21.3	17.1	82.5	36.2	51.0	77.0	36.1	44.4	48.3	59.2	40.4	46.6	33.6	30.0	49.2	34.6	59.2	36.6	37.1	52.3	29.9	72.1	41.4	48.7	60.5	40.1	77.8	54.8	45.4	38.3	72.0	50.6	30.8	39.5	36.1	66.7	47.8	52.5	39.2	79.4	33.8	49.6	36.1	50.9	52.9	66.7	54.1	32.4	43.0	116.5	41.7	36.0	54.3	59.0	38.7	49.8	34.7	52.8	76.3	32.3	43.7	54.3	41.4	60.0	31.1	41.2	27.6	45.7	57.4	34.8	46.3	45.8	64.1	17.0	33.5	18.1	16.3	17.2	25.4	17.1	17.2	14.0	26.0	22.5	16.7	29.1	21.5	24.1	17.7	16.0	10.8	35.7	48.9	77.6	52.3	35.7	41.3	41.9	36.8	41.9	34.8	38.9	82.5	63.1	67.3	112.4	227.9	63.9	31.7	56.8	40.8	46.1	111.5	36.8	35.4	107.0	27.1	59.0	40.5	123.0	42.5	46.7	39.2	19.6	43.0	15.7	54.2	63.7	65.9	38.4	57.2	286.9	40.9	29.0	83.5	50.0	59.2	79.1	112.8	38.6	48.6	32.5	67.3	268.4	34.2	32.6	41.9	33.3	15.8	75.2	49.6	23.2	225.8	71.6	56.4	56.7	342.3	619.5	39.6	35.7	63.9	50.5	60.0	38.1	21.6	74.7	104.0	32.9	98.3	73.1	110.1	78.3	37.4	30.3	50.2	56.1	74.0	36.8	58.9
ZNF639	"ANC-2H01, ZASC1"	ENSG00000121864	"Zinc finger protein 639"	Q9UID6	3	179323031-179338583	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049023, HPA052163"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA049023: AB_2680603, HPA052163: AB_2681747"	"unprognostic (5.64e-2)"	"unprognostic (6.16e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (5.45e-5)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (7.74e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.58e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.56e-1)"	20.8	19.5	16.5	18.0	17.5	59.2	28.0	22.1	19.3	27.6	15.0	26.6	17.4	31.5	25.6	20.9	26.0	19.8	27.4	16.4	16.6	25.1	23.9	21.9	26.6	16.4	16.8	32.7	24.6	38.6	18.2	22.5	15.9	26.3	22.1	40.0	24.5	27.0	27.3	16.9	18.6	31.0	16.8	23.7	20.6	19.1	17.3	26.6	41.4	30.3	24.6	21.5	18.3	18.0	81.3	18.7	35.5	43.9	31.7	38.4	35.2	37.8	56.4	61.0	54.8	31.7	31.3	94.2	56.4	46.6	74.1	30.1	55.2	50.5	76.0	86.7	43.1	96.1	26.8	31.8	55.0	76.1	34.5	31.1	51.9	31.3	72.5	45.7	42.1	61.3	59.4	48.6	48.6	41.2	79.5	33.7	59.9	56.9	43.5	75.4	37.1	112.1	37.8	32.4	65.3	39.9	37.9	41.1	49.2	29.8	104.9	59.4	34.5	41.3	43.7	33.1	98.7	19.7	19.0	174.2	30.3	58.5	28.9	2.5	1.1	1.2	1.6	0.7	1.5	1.8	2.6	2.6	0.9	2.0	2.2	2.2	0.7	2.2	0.5	0.3	2.4	0.8	16.5	17.5	22.1	19.3	16.4	16.6	16.4	16.8	15.9	16.8	17.3	18.0	16.9	19.2	11.7	9.4	24.2	20.9	34.0	7.0	32.5	21.5	21.6	13.2	19.4	10.0	8.8	14.7	54.2	14.7	18.3	8.6	33.2	12.2	29.8	21.6	22.4	19.4	18.7	29.0	8.7	10.0	11.3	21.8	11.2	30.3	10.1	18.5	18.5	17.0	9.9	16.8	10.6	15.6	6.1	13.2	17.2	8.8	24.5	13.8	14.2	4.7	13.5	19.6	13.4	8.5	9.6	11.5	9.4	24.0	27.5	36.1	11.2	22.2	7.2	44.9	26.3	27.1	22.7	29.9	21.3	29.9	17.5	3.4	23.2	19.8	12.2	24.9
ZNF723	ZNF723P	ENSG00000268696	"Zinc finger protein 723"	P0DPD5	19	22832291-22858667	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	9	"testis: 3.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	25	"testis cancer: 3.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA			"Cluster 46: Basophils - DNA binding"			"Cluster 40: Granulosa cells - Unknown function"													"unprognostic (4.37e-2)"				"unprognostic (5.02e-2)"	"unprognostic (7.20e-2)"			0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.5	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZNF763	ZNF440L	ENSG00000197054	"Zinc finger protein 763"	Q0D2J5	19	11965037-11980617	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 10.4;Microglial cells: 7.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 5.2"									HPA047845	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA047845: AB_2680178"	"unprognostic (4.09e-3)"	"unprognostic (6.15e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.43e-1)"	"unprognostic (8.26e-3)"	"unprognostic (9.36e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.07e-6)"	"unprognostic (1.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.89e-3)"	3.8	3.1	2.5	2.2	2.9	1.9	4.3	3.1	3.0	3.2	2.1	3.4	2.3	3.5	2.9	1.9	3.6	1.7	4.0	2.2	2.3	5.9	2.4	2.9	3.6	2.7	2.5	6.0	4.5	4.8	2.8	3.1	2.8	3.6	3.0	6.9	3.3	2.3	2.0	2.8	4.4	2.2	2.2	5.3	3.5	4.7	2.5	4.3	4.9	1.5	3.4	3.5	2.8	3.9	0.2	0.0	1.7	1.8	1.0	0.3	5.2	1.6	1.0	1.2	0.9	0.5	0.3	1.5	1.2	1.2	0.4	0.5	0.0	0.7	0.4	0.3	0.0	0.7	0.1	0.1	0.2	0.9	1.8	2.5	1.1	0.3	0.1	0.4	0.2	2.4	0.3	0.6	0.8	0.1	2.0	0.5	0.5	0.1	0.2	0.1	0.0	0.6	2.4	1.6	0.3	0.5	0.1	0.1	0.3	3.0	3.1	0.7	0.2	1.7	0.1	1.3	0.3	2.3	3.3	0.5	0.4	0.4	0.3	8.5	1.4	4.4	2.2	1.9	1.7	2.2	2.0	3.1	2.5	7.6	2.2	2.6	7.4	3.8	4.1	1.9	1.2	1.6	2.5	2.9	3.1	3.0	2.2	2.3	2.7	2.5	2.8	2.2	2.5	3.9	1.1	3.2	4.8	6.2	2.1	0.1	0.4	0.4	2.2	2.5	1.1	0.6	1.1	0.0	2.7	0.0	10.4	5.7	2.1	0.6	1.9	0.9	5.3	0.7	0.6	0.7	1.2	0.0	4.9	0.4	1.7	1.4	1.1	0.7	1.3	4.3	0.4	0.7	1.4	0.0	4.0	1.9	0.0	1.9	0.2	0.8	1.5	1.2	0.0	7.5	1.1	3.3	3.1	4.0	6.0	0.5	0.5	1.9	0.1	0.3	2.1	1.6	1.9	6.6	0.0	0.9	0.8	4.0	1.6	0.6	0.0	1.8	0.9	1.3	0.9	0.2
ZNF829	DKFZp779O175	ENSG00000185869	"Zinc finger protein 829"	Q3KNS6	19	36888124-36916291	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 10.4"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 278.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 13.0"					"Low region specificity"	"Detected in all"			HPA073073			Approved	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA073073: AB_2686567"	"unprognostic (4.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.44e-4)"	"unprognostic (1.32e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.35e-4)"	"unprognostic (1.20e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.48e-4)"	"unprognostic (5.47e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.92e-4)"	1.1	0.9	0.7	1.2	0.6	1.1	2.0	1.9	1.0	1.1	0.1	0.9	0.9	1.6	1.0	0.9	1.3	0.9	1.2	0.6	0.7	1.2	0.8	1.0	1.5	0.3	0.5	2.4	0.9	1.9	0.5	1.5	0.4	1.3	0.7	1.9	1.1	1.2	0.5	1.8	0.7	1.4	0.3	1.5	0.9	10.4	0.8	1.5	1.7	0.8	1.4	1.0	0.9	0.9	0.0	0.8	2.9	0.1	1.5	2.2	1.2	3.3	1.9	3.9	5.5	0.0	0.5	0.1	3.9	2.1	3.7	0.6	0.0	2.3	4.6	0.0	4.1	1.6	0.1	0.1	1.6	0.0	4.2	2.3	2.1	4.3	0.0	1.3	0.4	1.2	0.0	0.1	3.9	0.7	0.7	0.8	5.1	0.0	0.0	0.0	3.7	1.5	1.1	4.5	3.2	4.7	0.1	0.0	2.8	3.8	3.0	0.2	1.1	2.4	3.4	3.3	3.4	7.9	13.0	5.0	0.0	0.0	6.1	1.4	0.2	0.9	0.9	0.1	1.4	0.8	1.0	1.4	0.3	1.2	1.4	1.5	0.4	0.7	0.2	0.5	1.0	0.3	0.7	0.6	1.9	1.0	0.6	0.7	0.3	0.5	0.4	0.3	0.8	0.9	3.0	0.0	3.4	2.0	4.7	1.5	1.9	1.2	1.2	6.8	2.5	2.0	5.6	2.8	3.7	3.7	4.2	4.0	5.5	0.6	0.0	2.7	278.1	3.1	4.4	3.7	0.0	1.3	4.2	1.0	2.5	3.9	0.5	3.1	1.3	5.5	2.9	0.6	1.5	11.8	3.8	1.0	0.0	1.0	4.6	58.9	5.9	1.4	3.6	1.0	1.7	2.6	5.2	6.0	4.1	0.8	0.1	7.2	1.3	1.9	0.3	1.3	1.6	11.1	0.0	5.9	4.6	10.6	11.2	1.1	2.7	4.2	3.8	3.1	0.5	1.1
ZSCAN12	"dJ29K1.2, KIAA0426, ZFP96, ZNF29K1, ZNF305, ZNF96"	ENSG00000158691	"Zinc finger and SCAN domain containing 12"	O43309	6	28378955-28399734	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006637, HPA007018"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA006637: AB_1080646, HPA007018: "	"unprognostic (1.44e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.22e-1)"	"unprognostic (8.35e-4)"	"unprognostic (1.51e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.00e-3)"	"unprognostic (4.73e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.71e-2)"	2.4	2.3	1.8	2.6	2.0	2.2	5.6	3.6	2.5	3.6	1.6	2.9	2.5	4.3	3.6	1.8	3.0	2.3	2.4	1.8	2.2	2.9	1.6	2.9	4.7	1.7	2.1	5.5	3.2	4.0	2.0	3.6	1.6	4.3	2.9	6.8	3.1	3.7	0.9	1.8	2.7	3.6	1.6	3.9	2.9	4.1	2.2	5.1	5.1	1.7	4.1	3.1	2.9	2.0	5.5	1.8	8.1	0.1	4.1	3.2	5.7	3.7	5.1	5.5	7.6	1.2	2.0	5.3	6.8	2.6	2.8	2.4	0.0	4.6	5.6	0.0	6.6	7.6	5.6	3.8	3.8	2.7	1.8	4.2	4.3	5.5	9.9	6.0	1.5	0.0	11.4	1.1	3.5	0.6	0.0	6.1	5.1	0.5	0.9	9.2	7.3	1.4	4.1	3.5	9.8	10.0	1.9	4.3	6.4	8.0	1.7	6.7	1.5	2.2	4.6	1.7	3.0	3.1	3.4	1.0	1.9	0.7	3.4	2.4	0.7	1.5	1.5	0.4	1.4	1.8	1.1	1.8	1.0	2.7	1.8	1.6	0.2	1.8	0.8	0.9	0.9	0.8	1.8	2.0	3.6	2.5	1.8	2.2	1.7	2.1	1.6	1.6	2.2	2.0	2.1	6.4	5.1	4.6	4.0	0.4	1.1	0.9	0.6	6.1	2.6	2.5	3.2	1.5	6.5	0.0	4.2	1.5	3.6	0.3	1.9	1.7	31.8	0.6	2.4	1.9	1.2	2.1	6.9	2.6	1.0	2.7	1.5	0.9	1.3	5.5	3.3	1.0	1.0	6.7	7.0	1.2	0.0	1.3	1.1	9.7	1.8	1.1	1.8	1.0	1.8	4.9	2.1	10.1	6.2	1.3	0.3	3.4	2.4	1.5	1.5	1.2	0.6	6.0	6.6	1.7	2.4	12.6	3.9	1.2	0.3	0.5	1.5	4.2	2.1	0.7
ZSCAN16	"dJ265C24.3, FLJ22191, ZNF392, ZNF435"	ENSG00000196812	"Zinc finger and SCAN domain containing 16"	Q9H4T2	6	28124609-28130082	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 69.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA007290	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 45: Intestine - Brush border"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA007290: AB_1080721"	"unprognostic (1.50e-1)"	"prognostic favorable (5.73e-4)"	"unprognostic (3.29e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.00e-2)"	"unprognostic (3.07e-2)"	"prognostic favorable (3.19e-4)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.14e-5)"	"unprognostic (2.50e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.37e-3)"	"prognostic favorable (3.41e-5)"	3.2	3.9	5.3	5.5	6.4	3.2	7.0	7.7	7.6	3.9	5.2	7.1	8.6	3.9	7.1	3.6	4.1	4.0	3.0	5.6	6.6	5.4	4.4	4.9	8.3	6.4	5.9	2.5	4.9	6.9	3.2	2.2	6.4	4.7	9.0	7.2	6.6	5.8	3.2	6.9	8.4	4.7	5.5	7.4	7.0	2.2	6.1	8.0	4.6	2.7	9.1	4.2	2.7	9.1	0.1	8.8	11.1	8.2	3.0	0.7	9.1	3.0	6.4	7.8	8.4	6.1	5.7	8.8	8.0	2.8	5.4	6.8	7.8	4.4	7.4	12.8	10.8	9.1	7.4	8.7	4.8	6.8	7.4	1.0	7.3	6.6	3.6	8.3	14.7	0.2	1.3	7.3	2.1	10.0	0.0	10.7	2.3	7.4	5.3	10.9	8.4	12.2	9.3	12.6	15.0	16.5	1.5	9.2	10.9	7.2	12.2	3.2	4.6	2.9	6.7	4.4	7.9	3.7	12.5	2.4	1.3	3.4	1.6	69.0	8.6	10.2	13.8	11.8	17.7	19.3	12.0	10.6	9.0	14.6	14.5	11.8	15.6	17.7	11.6	19.6	14.7	8.6	5.3	6.4	7.7	7.6	5.6	6.6	6.4	5.9	6.4	5.5	6.1	9.1	5.6	6.4	2.6	0.3	5.6	1.8	0.8	4.9	1.2	3.8	5.2	5.6	1.6	10.0	7.5	7.3	4.2	2.2	12.6	4.7	5.9	12.8	3.3	4.2	0.8	4.0	1.8	8.2	1.4	12.6	1.2	1.4	4.6	3.3	2.5	4.8	4.2	2.0	2.1	1.7	1.1	6.0	14.2	3.8	1.3	1.5	0.6	4.3	1.8	1.0	6.1	5.6	11.3	3.5	3.7	9.6	6.1	3.4	4.2	1.3	10.3	8.3	7.7	6.6	0.0	1.7	3.7	1.7	6.3	2.7	1.3	1.8	6.1	2.2	7.0	1.1
ZSCAN21	"DKFZp434L134, NY-REN-21, Zipro1, ZNF38"	ENSG00000166529	"Zinc finger and SCAN domain containing 21"	Q9Y5A6	7	100049774-100065040	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Meiosis, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016948, HPA023591"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Endoplasmic reticulum"		"HPA016948: , HPA023591: AB_1859037"	"unprognostic (2.44e-3)"	"unprognostic (3.77e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.42e-3)"	"unprognostic (8.59e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (6.09e-2)"	7.8	7.8	10.6	4.5	12.3	6.1	8.0	12.6	11.7	10.3	10.2	11.2	4.6	9.8	9.2	5.7	10.6	6.0	7.6	10.5	10.7	9.6	13.1	6.2	6.2	11.4	11.6	9.9	10.0	7.0	7.6	8.0	11.3	10.8	5.3	9.3	10.3	7.2	14.1	7.0	6.9	7.8	10.6	7.4	9.0	12.2	12.0	7.1	8.3	12.9	4.9	9.4	7.4	14.1	5.9	9.8	16.0	18.7	14.8	9.5	13.1	6.7	10.3	13.0	13.0	7.8	6.7	6.4	8.2	7.9	22.1	5.3	14.5	9.7	12.9	8.5	11.9	5.8	8.6	7.3	16.0	8.4	2.3	11.3	16.8	12.7	21.1	10.8	10.5	13.0	14.0	5.4	9.7	15.1	14.0	13.8	19.9	8.2	7.3	9.5	12.8	7.8	10.8	9.2	8.2	20.9	9.2	19.4	12.9	22.6	7.8	7.0	4.6	11.8	14.6	10.4	9.4	10.7	10.6	14.1	5.5	5.3	16.1	12.9	6.0	12.9	9.9	5.8	10.8	6.6	6.0	9.0	6.3	6.5	6.6	7.5	0.8	10.7	3.9	5.9	7.4	4.9	10.6	12.3	12.6	11.7	10.5	10.7	11.4	11.6	11.3	10.6	12.0	14.1	5.1	3.2	5.1	5.5	4.3	1.5	3.4	4.1	5.2	6.0	3.5	3.6	1.6	2.8	4.4	3.7	2.1	16.6	10.6	2.9	7.9	7.1	2.7	4.0	7.7	4.7	1.8	11.0	3.7	4.0	6.5	5.4	2.6	3.8	2.5	8.0	3.6	5.2	5.2	10.1	4.1	2.5	8.2	2.5	2.1	0.7	5.9	2.9	3.6	7.5	3.0	16.5	3.1	7.1	7.5	4.4	5.0	9.8	3.4	4.0	3.2	11.9	2.5	5.9	0.0	7.7	6.7	14.1	19.7	2.9	3.8	17.6	2.9	8.0	2.8	1.7
ZSWIM8	"4832404P21Rik, KIAA0913"	ENSG00000214655	"Zinc finger SWIM-type containing 8"	A7E2V4	10	73785606-73801797	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041244	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA041244: AB_10794269"	"unprognostic (8.83e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.00e-2)"	"prognostic favorable (5.61e-4)"	"unprognostic (3.11e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.52e-1)"	60.4	97.0	86.7	19.7	88.1	42.8	59.3	85.1	110.5	77.1	88.3	77.7	27.2	63.8	43.4	105.6	62.5	24.9	65.1	87.5	85.5	97.3	143.6	68.9	25.1	87.9	86.4	69.8	64.4	35.4	145.0	24.8	87.1	91.1	17.8	27.5	70.9	28.4	62.2	88.9	70.1	28.1	83.7	109.8	68.1	96.4	87.8	25.1	87.6	22.4	21.6	74.5	77.1	90.4	14.0	23.3	28.4	46.9	65.6	31.2	16.3	17.5	48.1	24.3	29.1	20.7	11.3	7.9	12.3	28.6	23.6	20.6	10.1	19.9	12.2	12.6	21.3	11.2	26.1	27.7	49.2	7.7	41.4	51.4	36.2	30.2	35.0	66.0	28.5	16.4	16.0	14.9	28.3	21.2	11.7	22.8	8.4	11.2	72.8	13.9	13.5	4.7	34.9	29.6	6.8	30.9	14.5	42.1	25.9	24.5	28.5	15.8	29.6	26.7	16.0	12.2	18.1	37.6	21.6	5.1	29.5	11.3	14.1	2.4	2.2	1.9	3.0	1.5	1.7	1.8	1.3	1.3	1.8	1.2	0.6	1.9	4.9	1.1	2.5	3.8	1.8	1.0	86.7	88.1	85.1	110.5	87.5	85.5	87.9	86.4	87.1	83.7	87.8	90.4	17.2	3.2	11.5	49.6	7.2	12.4	7.4	15.1	11.4	32.8	20.2	17.7	1.4	20.0	12.8	20.2	68.8	13.4	27.2	21.7	1.9	13.7	5.5	14.0	19.0	17.1	20.4	11.4	34.0	14.8	8.4	13.2	24.5	22.2	0.0	18.8	29.6	35.0	19.0	35.3	30.2	18.3	14.2	24.2	15.7	2.2	22.1	17.1	16.0	21.5	19.2	19.6	15.5	26.7	36.5	17.5	19.5	24.0	8.2	17.7	41.3	11.7	15.4	45.3	13.1	21.1	18.3	35.8	15.9	14.9	14.2	28.7	13.9	19.3	12.1	17.9